data_2l1u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l1u _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.34 -150.51 21.0 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.457 -0.777 . . . . 0.0 112.068 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.13 169.81 20.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.072 1.349 . . . . 0.0 112.645 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.56 144.71 50.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.247 2.619 . . . . 0.0 110.764 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -147.08 160.55 42.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 111.327 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 59.9 m -64.6 154.21 36.98 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 123.056 1.408 . . . . 0.0 112.077 171.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.269 9.0 p -113.8 27.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.808 153.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.21 -41.4 3.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.534 1.534 . . . . 0.0 112.104 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 17.5 p -109.99 -103.53 0.38 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.674 1.59 . . . . 0.0 112.444 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.55 -40.51 0.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.878 2.471 . . . . 0.0 113.37 -163.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -98.02 137.15 20.85 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -152.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.85 139.65 15.69 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.094 2.529 . . . . 0.0 111.531 161.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.19 -29.71 0.88 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -165.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -132.04 126.97 35.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.559 1.072 . . . . 0.0 111.548 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.1 m -86.82 133.23 33.66 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 120.659 -1.276 . . . . 0.0 110.798 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -11.93 23.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.124 1.37 . . . . 0.0 112.931 171.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -35.81 71.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.22 7.49 24.97 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.227 1.011 . . . . 0.0 112.465 176.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -61.37 131.97 52.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.068 0.849 . . . . 0.0 109.658 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 122.716 1.245 . . . . 0.0 112.582 174.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo . . . . . 0 CA--C 1.54 0.802 0 CA-C-O 125.185 2.077 . . . . 0.0 116.392 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -135.28 154.31 51.59 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 128.516 2.726 . . . . 0.0 110.806 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -138.45 107.04 5.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.885 1.674 . . . . 0.0 111.014 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.7 p -63.99 -15.07 58.48 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.25 160.62 40.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.373 0.669 . . . . 0.0 109.387 138.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 124.314 1.046 . . . . 0.0 109.259 166.077 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 CA-C-O 119.238 -0.757 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -96.27 148.86 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.048 0.924 . . . . 0.0 111.232 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.43 174.12 8.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.821 2.848 . . . . 0.0 110.197 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.08 156.84 33.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.003 1.321 . . . . 0.0 112.144 -167.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.95 121.89 3.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.405 1.882 . . . . 0.0 110.083 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -97.24 154.07 17.63 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.338 1.855 . . . . 0.0 112.237 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -147.99 111.15 4.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.729 1.212 . . . . 0.0 110.21 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.7 t -118.95 19.85 12.91 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.811 1.767 . . . . 0.0 112.834 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 -15.15 28.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.252 1.421 . . . . 0.0 114.009 -154.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.0 mt -84.94 10.61 11.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.806 1.642 . . . . 0.0 112.914 166.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.16 -5.01 81.41 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.63 1.586 . . . . 0.0 114.653 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 10.0 t -137.19 129.65 16.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.258 1.023 . . . . 0.0 111.401 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.57 135.11 12.82 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.126 2.551 . . . . 0.0 114.373 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.6 mmt-85 -127.77 157.3 40.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 129.967 3.307 . . . . 0.0 109.315 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.4 mtm -133.44 132.84 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.355 1.862 . . . . 0.0 108.308 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -139.26 149.36 44.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 112.151 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.11 150.69 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.283 1.433 . . . . 0.0 111.916 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.42 155.02 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 109.927 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 1.232 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 7.6 t -92.6 128.41 38.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 158.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -84.02 -24.24 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.253 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -64.74 -43.95 91.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.854 0.862 . . . . 0.0 112.447 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.232 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.8 OUTLIER -99.98 -15.07 18.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.66 2.384 . . . . 0.0 113.238 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.303 42.5 mt-10 64.31 24.82 13.38 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.935 2.094 . . . . 0.0 112.799 -168.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.82 98.32 8.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.796 2.039 . . . . 0.0 112.848 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -89.12 68.87 8.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.949 1.7 . . . . 0.0 112.345 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.59 -5.09 8.7 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -159.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.56 135.97 12.44 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.707 2.099 . . . . 0.0 112.171 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.49 152.8 33.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.09 0.956 . . . . 0.0 111.39 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.12 125.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 122.322 1.058 . . . . 0.0 112.834 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -129.76 145.06 55.48 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.802 1.241 . . . . 0.0 111.76 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.57 167.21 27.07 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.48 2.787 . . . . 0.0 112.419 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -109.14 -8.49 15.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.453 1.901 . . . . 0.0 115.336 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.1 -56.31 0.71 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.661 1.6 . . . . 0.0 114.512 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.75 -157.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 124.65 3.567 . . . . 0.0 113.271 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 154.98 13.56 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.661 1.584 . . . . 0.0 111.406 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -61.56 -7.48 8.99 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.443 2.762 . . . . 0.0 114.283 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 p -57.74 -26.78 62.3 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.876 1.27 . . . . 0.0 113.762 165.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.34 4.46 86.04 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.193 1.377 . . . . 0.0 116.054 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.94 149.88 8.48 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.98 127.39 50.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 110.99 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.37 103.14 12.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.253 1.421 . . . . 0.0 109.484 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.1 p -92.9 136.85 32.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.436 2.294 . . . . 0.0 110.55 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.05 133.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.158 -0.964 . . . . 0.0 109.239 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -110.48 133.04 53.65 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.0 m -82.71 16.37 2.23 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -164.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.66 -23.72 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.95 22.38 3.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.851 1.66 . . . . 0.0 113.576 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.4 mt -122.02 140.58 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.155 0.982 . . . . 0.0 112.993 -170.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -115.54 178.05 4.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.404 2.682 . . . . 0.0 112.15 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -150.63 148.31 28.47 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.467 1.107 . . . . 0.0 112.29 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -131.16 134.11 25.45 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.37 1.468 . . . . 0.0 109.41 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.86 171.57 15.28 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.185 2.59 . . . . 0.0 113.107 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -42.5 18.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.921 0.888 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt . . . . . 0 CA--C 1.55 0.978 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 -167.638 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.783 0.802 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.81 -154.53 26.0 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 125.369 1.461 . . . . 0.0 112.266 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 21.8 ptm -158.08 162.97 38.1 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -125.84 142.12 51.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.664 2.786 . . . . 0.0 110.77 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -154.91 166.23 34.18 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.343 1.857 . . . . 0.0 110.428 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.731 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 4.5 t -80.98 172.84 13.24 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.132 1.444 . . . . 0.0 113.298 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.07 -9.06 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.173 1.789 . . . . 0.0 112.908 163.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 92.4 m -103.99 -33.45 8.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.959 1.303 . . . . 0.0 113.648 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.731 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -99.32 -100.49 0.23 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.759 1.223 . . . . 0.0 111.619 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -165.09 -62.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.36 145.12 29.13 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -161.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.43 151.58 70.95 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.236 2.624 . . . . 0.0 111.214 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.2 tp -137.83 -33.81 0.7 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -166.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -144.98 140.27 28.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.161 1.346 . . . . 0.0 114.205 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -98.56 144.41 27.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.011 0.925 . . . . 0.0 112.965 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -13.21 40.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.161 1.384 . . . . 0.0 113.407 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -24.87 66.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -87.19 -3.08 59.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.828 2.451 . . . . 0.0 113.312 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 127.76 33.7 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.992 1.317 . . . . 0.0 110.864 -170.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -166.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 CA--C 1.534 0.501 0 CA-C-O 124.311 1.713 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.2 p -158.74 156.56 30.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.695 2.798 . . . . 0.0 110.016 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.08 158.78 43.57 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 108.072 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.2 p -91.62 -20.13 21.97 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 127.243 2.217 . . . . 0.0 112.71 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -150.87 152.96 34.45 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.591 1.156 . . . . 0.0 112.199 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 125.033 1.333 . . . . 0.0 109.588 166.085 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.19 0 CA-C-O 121.801 0.667 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.59 164.97 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.471 1.909 . . . . 0.0 112.494 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.09 177.8 4.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.579 1.552 . . . . 0.0 109.408 158.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.28 155.96 38.72 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.657 -174.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -151.98 121.16 6.71 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.262 1.825 . . . . 0.0 108.49 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.51 135.69 38.25 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.55 -0.719 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -94.01 25.53 3.66 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 122.389 1.09 . . . . 0.0 111.195 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -75.8 45.99 0.36 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.816 2.446 . . . . 0.0 111.305 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -127.19 -13.16 5.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.128 2.171 . . . . 0.0 113.287 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.14 18.39 21.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.941 2.496 . . . . 0.0 112.633 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.91 -6.67 54.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.686 1.136 . . . . 0.0 114.643 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.3 t -133.53 133.61 22.8 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.885 1.674 . . . . 0.0 110.628 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.38 152.48 60.79 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.623 2.882 . . . . 0.0 114.214 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -146.26 164.21 33.03 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 128.859 2.864 . . . . 0.0 109.763 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.4 ttp -119.0 135.33 54.67 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 151.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 153.16 42.41 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.714 1.206 . . . . 0.0 110.709 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.41 148.49 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 122.103 0.954 . . . . 0.0 112.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.82 148.87 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.431 1.093 . . . . 0.0 112.327 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.72 107.95 10.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.429 2.292 . . . . 0.0 104.898 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -74.99 -14.2 60.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 168.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -61.58 -40.13 93.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 112.205 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.8 p -124.76 -5.46 7.51 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 9.4 tt0 73.38 53.71 0.12 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.215 2.206 . . . . 0.0 116.118 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.0 153.43 41.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 113.922 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 134.96 55.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.65 1.58 . . . . 0.0 113.064 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 tp -123.98 -15.48 6.85 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -165.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.82 179.55 34.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.731 2.11 . . . . 0.0 112.486 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -179.48 6.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.495 1.141 . . . . 0.0 113.816 -167.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.2 137.17 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.73 2.012 . . . . 0.0 109.576 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.26 149.42 48.26 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.315 1.446 . . . . 0.0 112.249 -172.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.88 143.46 16.44 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.826 2.35 . . . . 0.0 109.805 160.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.84 22.94 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.838 -1.164 . . . . 0.0 113.557 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.59 -46.34 1.15 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 127.157 2.313 . . . . 0.0 115.887 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -83.53 -163.48 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.34 2.693 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 151.9 63.49 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 113.258 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.28 -15.84 50.74 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.189 2.593 . . . . 0.0 113.215 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 p -56.67 -23.4 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.022 1.329 . . . . 0.0 113.186 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 9.76 64.9 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.463 2.459 . . . . 0.0 116.603 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -53.03 152.32 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.302 1.551 . . . . 0.0 114.246 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -136.94 154.44 50.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.883 2.073 . . . . 0.0 108.957 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -92.94 142.5 27.23 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.524 0.73 . . . . 0.0 110.498 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.5 p -121.0 143.2 49.17 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.744 1.618 . . . . 0.0 112.561 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.35 165.3 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.21 -0.931 . . . . 0.0 112.755 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.89 126.41 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.063 1.345 . . . . 0.0 114.162 -165.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -77.62 46.52 0.55 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.173 1.789 . . . . 0.0 112.954 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.18 -47.28 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.465 1.506 . . . . 0.0 113.398 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.29 4.66 0.05 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.565 1.546 . . . . 0.0 114.058 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.0 mt -85.8 159.59 19.69 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.746 1.619 . . . . 0.0 110.382 -164.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -103.95 133.68 48.5 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.142 0.977 . . . . 0.0 112.989 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.1 138.94 14.26 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.36 -0.838 . . . . 0.0 111.773 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -138.31 153.32 72.83 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.891 1.277 . . . . 0.0 111.997 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.16 170.6 20.02 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.972 2.448 . . . . 0.0 112.859 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.428 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -91.74 -43.06 9.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.812 0.845 . . . . 0.0 111.73 -176.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 8.4 mmpt? . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 125.678 1.591 . . . . 0.0 114.767 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.7 m . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.92 -144.45 10.73 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.088 1.328 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ptm -132.74 162.75 30.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 112.517 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.96 139.76 52.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.962 2.905 . . . . 0.0 109.54 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.41 168.05 23.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.564 1.945 . . . . 0.0 109.423 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.879 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.0 OUTLIER -63.91 173.93 1.66 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 123.28 1.514 . . . . 0.0 112.578 176.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 p -122.98 -6.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.444 151.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.2 m -108.93 -27.73 9.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -168.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.879 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 13.8 p -109.28 -95.25 0.4 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.753 1.621 . . . . 0.0 112.017 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -157.37 -55.43 0.08 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.8 154.5 50.27 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 -154.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.37 143.86 71.69 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.169 1.913 . . . . 0.0 110.889 161.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.85 -51.93 2.64 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.374 1.07 . . . . 0.0 111.888 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -145.66 158.69 43.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.826 0.822 . . . . 0.0 112.033 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 p -85.63 135.05 33.95 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.441 1.096 . . . . 0.0 108.813 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -6.79 12.52 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.233 -0.917 . . . . 0.0 112.871 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -44.33 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 160.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -67.01 -10.5 50.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.862 1.665 . . . . 0.0 113.132 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -78.55 127.71 32.53 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.655 1.982 . . . . 0.0 110.969 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--N 1.326 -0.438 0 C-N-CA 127.052 2.141 . . . . 0.0 105.976 170.66 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 CA--C 1.532 0.381 0 CA-C-O 123.581 1.409 . . . . 0.0 114.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.9 p -140.95 158.12 44.38 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.215 1.806 . . . . 0.0 110.881 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.23 114.62 6.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.141 0.976 . . . . 0.0 108.976 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -73.07 -20.84 60.88 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.387 -0.821 . . . . 0.0 112.925 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -145.06 148.54 33.8 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.137 -0.977 . . . . 0.0 112.441 -174.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 124.992 1.317 . . . . 0.0 109.45 174.449 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.405 0 N-CA-C 113.968 0.347 . . . . 0.0 113.968 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.97 178.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 127.124 2.17 . . . . 0.0 110.455 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.51 175.2 8.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.857 2.063 . . . . 0.0 107.948 159.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -147.03 140.67 25.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -126.46 93.18 3.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.226 1.488 . . . . 0.0 112.108 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.97 144.03 57.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.29 -0.881 . . . . 0.0 108.7 155.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -146.24 52.27 1.14 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.294 1.521 . . . . 0.0 112.363 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -73.3 30.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.244 1.818 . . . . 0.0 114.529 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -109.8 0.31 18.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.333 1.453 . . . . 0.0 113.615 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.1 mt -80.16 6.66 11.11 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.267 1.027 . . . . 0.0 112.394 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -6.63 52.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.433 1.492 . . . . 0.0 113.941 -163.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.4 t -130.39 131.58 23.47 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.84 . . . . 0.0 110.09 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.39 131.43 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.088 2.525 . . . . 0.0 113.115 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -133.02 157.65 44.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.448 1.899 . . . . 0.0 109.788 166.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.2 mtm -131.61 136.02 47.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.777 2.031 . . . . 0.0 108.526 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.17 153.15 52.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 124.732 1.213 . . . . 0.0 110.828 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.25 144.44 28.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.346 1.058 . . . . 0.0 112.209 162.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.82 146.43 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.825 1.25 . . . . 0.0 110.979 173.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.2 t -74.79 112.17 10.73 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 124.039 1.876 . . . . 0.0 107.198 169.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -63.37 -24.56 67.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 112.422 -2.172 . . . . 0.0 112.04 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.16 -45.21 18.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.203 1.401 . . . . 0.0 114.419 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 8.2 p -113.53 -3.74 13.63 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.898 1.679 . . . . 0.0 115.195 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 71.31 46.29 0.44 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.677 1.991 . . . . 0.0 115.53 167.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.93 144.46 37.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -75.7 118.72 18.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.712 1.205 . . . . 0.0 110.416 170.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.61 -29.01 1.57 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -168.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.93 127.57 6.55 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 127.289 2.376 . . . . 0.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.97 146.34 35.51 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.025 -0.691 . . . . 0.0 111.083 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.98 142.07 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.526 1.531 . . . . 0.0 111.141 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -145.47 156.66 53.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.3 147.79 12.86 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.974 3.116 . . . . 0.0 112.804 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -97.82 -1.05 44.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.8 -55.15 0.77 Allowed Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.953 1.739 . . . . 0.0 116.103 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 -156.98 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 125.202 3.935 . . . . 0.0 113.54 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -51.93 159.57 1.37 Allowed Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.76 1.624 . . . . 0.0 112.097 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.34 -8.91 7.46 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.429 2.752 . . . . 0.0 114.665 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.7 p -55.26 -34.06 63.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.339 1.456 . . . . 0.0 112.914 165.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.97 3.98 86.22 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -57.3 138.21 55.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.703 1.252 . . . . 0.0 113.764 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -115.25 128.67 56.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.103 1.761 . . . . 0.0 108.893 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -111.17 109.9 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.729 1.211 . . . . 0.0 109.334 -169.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.5 m -95.7 148.61 22.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.183 2.193 . . . . 0.0 111.288 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -134.0 144.9 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.137 0.975 . . . . 0.0 109.882 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.25 107.31 9.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.306 1.051 . . . . 0.0 113.219 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.9 m -79.22 38.04 0.34 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.51 -27.88 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.05 -1.031 . . . . 0.0 112.096 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 15.86 7.84 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.032 2.133 . . . . 0.0 113.351 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.463 1.505 . . . . 0.0 111.945 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -112.26 160.71 17.37 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.43 1.492 . . . . 0.0 111.573 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.59 149.67 50.63 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.47 -0.769 . . . . 0.0 112.375 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -136.61 133.97 19.33 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.458 1.503 . . . . 0.0 108.938 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.77 170.28 14.26 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.883 2.389 . . . . 0.0 113.404 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -39.59 54.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.045 0.926 . . . . 0.0 112.42 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm . . . . . 0 CA--C 1.548 0.89 0 C-N-CA 125.093 1.357 . . . . 0.0 113.152 -171.715 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.61 -154.26 16.01 Favored Glycine 0 N--CA 1.465 0.627 0 C-N-CA 124.464 1.03 . . . . 0.0 113.814 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptp -156.05 163.59 39.49 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.036 1.334 . . . . 0.0 112.302 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.75 144.21 41.41 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 127.914 2.486 . . . . 0.0 111.014 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -141.81 161.68 37.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.004 1.721 . . . . 0.0 111.264 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 64.0 m -66.07 162.7 18.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 123.354 1.549 . . . . 0.0 113.235 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.29 1.44 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.963 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.7 m -129.4 -39.09 1.52 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -167.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 17.5 p -94.67 -85.34 0.31 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.587 1.085 . . . . 0.0 112.549 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.98 -74.51 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 p -110.46 155.65 41.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -151.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.95 138.39 33.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.294 1.996 . . . . 0.0 111.771 165.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.0 mt -135.35 -11.53 2.15 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.98 120.29 23.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.425 1.011 . . . . 0.0 111.534 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -92.8 131.6 37.7 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.812 1.768 . . . . 0.0 112.054 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -67.67 -7.53 27.54 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.742 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.35 -28.95 63.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 113.976 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 5.48 51.64 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 171.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -78.22 136.44 37.79 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.691 0.678 . . . . 0.0 109.439 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 CA--C 1.545 0.756 0 C-N-CA 123.611 0.764 . . . . 0.0 112.686 175.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo . . . . . 0 CA--C 1.538 0.681 0 CA-C-O 123.294 1.289 . . . . 0.0 114.259 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -159.33 148.61 18.39 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.532 1.933 . . . . 0.0 110.767 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -148.08 128.05 13.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.555 1.942 . . . . 0.0 109.59 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 p -73.35 -20.29 60.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -126.61 143.88 51.08 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.986 1.85 . . . . 0.0 113.897 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.794 0 CA-C-N 110.969 -2.832 . . . . 0.0 107.469 -177.954 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.182 0 CA-C-O 119.813 -0.437 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -98.47 163.41 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.841 0.829 . . . . 0.0 111.693 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.56 176.62 8.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.791 2.036 . . . . 0.0 112.502 -169.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.414 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -145.86 151.46 37.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.295 1.438 . . . . 0.0 112.875 -171.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.73 112.74 5.17 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.528 1.931 . . . . 0.0 108.82 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.04 131.6 37.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.963 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -98.82 17.42 19.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.015 1.326 . . . . 0.0 112.084 -168.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -70.33 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.891 2.876 . . . . 0.0 114.767 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -125.05 0.39 7.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.983 1.713 . . . . 0.0 113.766 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.9 mt -100.08 15.53 27.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 113.273 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.29 -9.43 54.48 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.408 1.48 . . . . 0.0 114.328 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.6 t -118.81 121.45 30.62 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.441 1.496 . . . . 0.0 110.224 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 125.01 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.332 2.022 . . . . 0.0 111.804 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -144.62 159.85 42.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.722 2.009 . . . . 0.0 109.909 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.8 mtp -128.51 127.13 41.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.938 2.095 . . . . 0.0 107.975 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.56 151.98 51.47 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.161 0.984 . . . . 0.0 110.677 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 m -133.82 148.8 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.993 1.317 . . . . 0.0 110.84 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.25 156.16 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.27 0.628 . . . . 0.0 111.432 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.924 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.3 t -92.61 118.91 31.51 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -83.59 -14.87 51.09 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.861 171.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -70.01 -51.01 35.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.064 0.945 . . . . 0.0 112.811 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.924 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 2.6 p -107.4 -7.75 16.53 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.833 1.653 . . . . 0.0 115.033 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 61.26 56.29 2.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.109 2.164 . . . . 0.0 114.039 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.79 146.13 43.2 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.693 1.197 . . . . 0.0 111.796 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.06 126.61 30.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.19 -0.944 . . . . 0.0 111.18 172.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.38 6.66 36.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.487 1.915 . . . . 0.0 113.216 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.8 -168.77 13.04 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 127.22 2.343 . . . . 0.0 112.584 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.23 163.85 36.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 123.012 1.386 . . . . 0.0 113.577 -165.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.64 135.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.28 1.832 . . . . 0.0 110.031 -165.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -148.13 154.17 42.4 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.021 1.329 . . . . 0.0 113.53 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.22 129.79 6.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.402 2.734 . . . . 0.0 109.763 163.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.31 -3.0 54.5 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.06 -54.64 0.38 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.238 1.399 . . . . 0.0 114.797 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.88 -165.02 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.469 2.779 . . . . 0.0 112.736 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 157.75 2.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.322 1.449 . . . . 0.0 111.862 173.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -57.44 -17.82 28.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.946 2.431 . . . . 0.0 113.479 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -23.24 36.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.599 1.56 . . . . 0.0 113.269 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.69 17.89 51.8 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 127.773 2.606 . . . . 0.0 115.427 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.02 140.1 56.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.413 1.107 . . . . 0.0 112.584 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -124.76 146.91 48.96 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.198 1.799 . . . . 0.0 110.318 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.48 129.58 42.6 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.269 1.427 . . . . 0.0 109.148 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.9 p -120.78 144.39 48.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.014 1.326 . . . . 0.0 111.055 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.2 tp -123.42 155.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 0.0 111.091 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -126.8 134.16 50.64 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.989 1.716 . . . . 0.0 107.448 161.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.4 m -81.7 50.67 1.55 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -163.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -50.99 -59.89 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.902 2.481 . . . . 0.0 115.236 -164.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.13 27.1 0.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.727 1.211 . . . . 0.0 114.024 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.3 mt -117.19 157.01 26.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.823 1.249 . . . . 0.0 110.358 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 166.42 10.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.825 1.65 . . . . 0.0 112.19 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -144.63 153.21 41.53 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.557 1.143 . . . . 0.0 112.203 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 151.97 67.42 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.442 1.897 . . . . 0.0 109.946 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.13 170.69 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.62 2.213 . . . . 0.0 112.921 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.55 -45.73 8.75 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.877 0.871 . . . . 0.0 111.95 -170.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt . . . . . 0 CA--C 1.546 0.809 0 C-N-CA 127.23 2.212 . . . . 0.0 112.371 179.001 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.437 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.6 m . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.91 -167.3 39.99 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 118.863 0.756 . . . . 0.0 113.119 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.7 ptp -156.2 159.44 38.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.256 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.89 144.47 50.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.134 2.573 . . . . 0.0 111.044 -170.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.53 155.7 37.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.655 1.982 . . . . 0.0 109.184 -168.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.787 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.8 t -77.79 167.65 21.2 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.808 1.766 . . . . 0.0 113.486 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -137.56 5.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 112.66 -2.064 . . . . 0.0 112.102 166.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.3 m -119.56 -31.37 4.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.782 1.633 . . . . 0.0 112.219 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.787 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 11.3 p -100.65 -103.24 0.24 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.509 1.523 . . . . 0.0 108.534 158.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.88 -31.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 p -81.64 155.71 70.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -161.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.45 136.97 45.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.166 1.911 . . . . 0.0 110.237 156.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.5 -39.13 0.82 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -157.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -157.47 152.6 25.89 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.444 1.02 . . . . 0.0 111.823 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -97.27 142.98 28.5 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.559 -1.338 . . . . 0.0 112.151 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 t -66.89 -10.32 47.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -42.36 64.35 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.937 1.695 . . . . 0.0 114.093 165.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.04 -1.36 28.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.289 1.435 . . . . 0.0 113.155 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -76.58 141.91 40.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.431 0.634 . . . . 0.0 111.334 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 . . . . . 0 C--N 1.319 -0.747 0 C-N-CA 124.782 1.233 . . . . 0.0 112.111 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.539 0.737 0 CA-C-O 122.183 0.826 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 p -153.07 139.23 18.34 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.217 1.407 . . . . 0.0 109.874 -165.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -155.11 114.13 3.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.852 0.861 . . . . 0.0 110.524 -154.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 p -75.79 -19.97 58.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -146.83 156.99 43.54 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.411 1.084 . . . . 0.0 111.269 173.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 125.073 1.349 . . . . 0.0 111.711 169.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.682 0 N-CA-C 113.613 0.205 . . . . 0.0 113.613 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.63 173.79 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.812 2.045 . . . . 0.0 112.404 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.66 -179.79 4.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.191 2.197 . . . . 0.0 110.083 -178.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.428 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 24.6 mmt85 -141.25 146.09 36.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.841 1.656 . . . . 0.0 109.832 -170.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -144.03 102.35 3.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.283 1.433 . . . . 0.0 111.496 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.42 149.87 35.09 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.018 -1.051 . . . . 0.0 111.233 165.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -134.38 29.63 3.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.8 1.286 . . . . 0.0 112.598 -170.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -73.63 35.52 0.09 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.535 1.934 . . . . 0.0 113.939 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.85 2.57 4.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.552 1.941 . . . . 0.0 112.797 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.3 15.08 5.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.394 1.878 . . . . 0.0 112.78 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.11 -3.53 65.51 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.8 1.191 . . . . 0.0 114.388 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 t -140.72 141.28 24.27 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 127.908 2.483 . . . . 0.0 110.164 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.67 129.33 16.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.809 2.339 . . . . 0.0 112.691 170.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -139.45 159.32 42.44 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.159 2.584 . . . . 0.0 108.515 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.9 ttm -143.35 134.68 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.575 1.55 . . . . 0.0 110.232 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -139.23 166.57 24.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.57 138.33 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.659 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.66 145.9 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 44.0 t -77.87 103.32 7.73 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.257 1.423 . . . . 0.0 107.551 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -57.4 -18.46 17.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.159 1.783 . . . . 0.0 112.562 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.82 -37.41 13.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 113.316 -167.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 12.3 p -121.15 1.88 10.33 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.645 1.978 . . . . 0.0 114.524 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.274 4.5 tt0 59.98 57.82 2.93 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.526 2.33 . . . . 0.0 113.294 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.4 129.67 35.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.747 1.219 . . . . 0.0 113.621 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.03 116.63 16.93 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.154 -0.966 . . . . 0.0 110.371 164.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -120.56 -36.44 3.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -169.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.39 146.31 18.33 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 128.24 2.829 . . . . 0.0 111.846 -166.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 158.64 38.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.377 0.671 . . . . 0.0 111.809 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.27 139.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.701 1.238 . . . . 0.0 111.45 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.99 150.29 38.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.39 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.59 133.85 19.48 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.321 2.681 . . . . 0.0 110.905 169.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.67 7.64 29.09 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.17 -49.94 0.55 Allowed Glycine 0 CA--C 1.541 1.657 0 C-N-CA 126.012 1.767 . . . . 0.0 114.777 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.09 -154.97 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.55 3.5 . . . . 0.0 112.108 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.29 157.83 3.04 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 126.493 1.917 . . . . 0.0 112.325 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -62.8 -8.86 14.51 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.378 2.719 . . . . 0.0 114.093 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.0 p -63.74 -24.14 67.65 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.813 -1.179 . . . . 0.0 112.261 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.22 20.49 33.29 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.844 2.64 . . . . 0.0 115.91 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -63.53 135.3 56.75 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.041 -1.27 . . . . 0.0 112.238 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -112.11 138.94 48.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 127.117 2.167 . . . . 0.0 108.503 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -107.03 128.31 54.25 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.468 1.107 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.7 p -121.76 149.1 43.78 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.617 1.567 . . . . 0.0 110.063 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.6 tt -131.65 164.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.546 -1.346 . . . . 0.0 109.76 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.1 124.54 24.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.21 -0.931 . . . . 0.0 112.528 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.1 m -79.91 36.44 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.974 1.309 . . . . 0.0 114.038 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.03 -37.91 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.168 1.787 . . . . 0.0 113.586 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.15 60.02 0.15 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.061 1.344 . . . . 0.0 113.125 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.27 171.68 13.72 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.761 1.625 . . . . 0.0 113.444 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 mmpt? -120.83 156.39 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.363 1.865 . . . . 0.0 114.609 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.12 150.99 22.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.452 1.501 . . . . 0.0 111.747 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.1 146.86 56.32 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.738 2.015 . . . . 0.0 111.551 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.72 169.67 19.58 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.265 1.976 . . . . 0.0 111.264 165.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 -38.53 7.08 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 111.904 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.437 ' HE3' ' HB ' ' A' ' 35' ' ' THR . 10.4 mmpt? . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 126.193 1.797 . . . . 0.0 112.442 161.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 C--O 1.224 -0.245 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.96 -142.35 10.25 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 121.012 -1.055 . . . . 0.0 111.263 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.3 ptp -155.66 157.2 36.29 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.625 1.202 . . . . 0.0 113.746 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -112.8 130.05 56.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 128.15 2.58 . . . . 0.0 107.652 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -151.58 168.33 25.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.736 1.214 . . . . 0.0 112.376 -161.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -74.89 172.14 12.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 123.648 1.69 . . . . 0.0 114.379 -178.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.67 0.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.409 157.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 97.7 m -112.62 -48.65 2.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.414 1.486 . . . . 0.0 112.345 -168.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 1.004 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 7.5 p -86.88 -80.63 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.742 1.217 . . . . 0.0 111.99 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.05 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.313 1.445 . . . . 0.0 114.645 163.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.1 p -101.68 159.01 30.67 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -158.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.68 155.56 49.39 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.961 3.107 . . . . 0.0 112.512 163.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.61 -31.15 0.57 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -172.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -132.04 122.23 25.14 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.889 -1.132 . . . . 0.0 108.717 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -82.9 136.46 34.58 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 120.388 -1.445 . . . . 0.0 109.241 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 t -58.54 -18.86 32.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.504 1.122 . . . . 0.0 112.76 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.83 -42.03 96.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.897 1.279 . . . . 0.0 113.813 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -74.45 -4.16 34.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.817 0.847 . . . . 0.0 112.706 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -74.54 135.15 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.337 1.055 . . . . 0.0 109.504 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.957 -163.587 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo . . . . . 0 CA--C 1.539 0.767 0 CA-C-O 122.82 1.092 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -138.5 152.79 48.57 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.042 1.737 . . . . 0.0 110.109 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -141.32 130.74 23.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 p -78.98 -12.66 60.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.32 150.72 50.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.799 1.285 . . . . 0.0 112.144 160.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 107.415 179.297 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.361 0 CA-C-O 118.98 -0.9 . . . . 0.0 114.383 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.1 pt -59.43 162.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -145.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tt -121.63 158.59 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.735 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.75 153.37 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.856 1.262 . . . . 0.0 111.673 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.45 133.31 13.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.464 1.906 . . . . 0.0 108.937 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.73 156.12 39.26 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.784 1.634 . . . . 0.0 112.055 163.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -133.55 118.61 18.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 164.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 t -115.53 20.95 14.39 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 122.136 0.97 . . . . 0.0 111.922 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -84.79 -6.3 59.35 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.703 2.401 . . . . 0.0 113.324 -168.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -86.83 10.29 16.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.028 2.131 . . . . 0.0 112.733 164.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.79 -0.17 57.89 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 124.67 1.129 . . . . 0.0 114.732 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.46 128.72 11.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.674 1.59 . . . . 0.0 110.211 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.89 139.39 19.51 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.674 2.249 . . . . 0.0 113.569 -170.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -134.49 165.67 24.64 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 130.665 3.586 . . . . 0.0 109.928 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mtm -132.62 133.95 44.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.192 2.197 . . . . 0.0 109.955 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -133.18 145.54 50.71 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.15 0.98 . . . . 0.0 112.955 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.56 146.17 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.42 1.888 . . . . 0.0 111.331 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 m -141.77 147.04 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.401 -0.812 . . . . 0.0 111.799 -169.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 48.2 t -74.51 97.9 3.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 123.69 1.709 . . . . 0.0 108.892 170.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -24.2 2.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.576 1.951 . . . . 0.0 112.69 165.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -83.79 -41.11 17.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.862 1.665 . . . . 0.0 114.456 -172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.864 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 24.7 p -126.97 1.08 6.58 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -175.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.258 13.1 mt-10 72.95 22.0 3.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.272 2.629 . . . . 0.0 115.068 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.0 94.53 9.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.338 1.055 . . . . 0.0 113.431 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.48 53.75 2.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.64 -7.24 38.15 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -160.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.01 130.27 8.33 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 126.662 2.077 . . . . 0.0 113.04 -167.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.82 153.36 36.64 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.904 -0.762 . . . . 0.0 110.802 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.97 128.82 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.795 0.838 . . . . 0.0 111.672 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -127.99 141.12 40.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.576 1.15 . . . . 0.0 112.502 -169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -73.21 162.57 40.24 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.62 2.88 . . . . 0.0 111.506 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -116.8 -0.84 12.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.71 -62.5 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.825 1.678 . . . . 0.0 114.822 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -69.6 -162.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.262 1 C-N-CA 125.714 4.276 . . . . 0.0 114.099 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -56.43 163.07 2.73 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 126.171 1.788 . . . . 0.0 113.057 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -59.21 -11.58 13.5 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 0.0 114.436 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 p -58.78 -23.87 60.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.029 1.332 . . . . 0.0 113.892 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.6 -3.61 62.62 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.908 1.718 . . . . 0.0 116.262 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -59.37 145.34 43.85 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.713 1.257 . . . . 0.0 112.426 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 128.9 55.55 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.265 1.026 . . . . 0.0 109.327 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -99.09 110.49 23.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.812 1.245 . . . . 0.0 109.935 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.9 m -113.48 112.43 23.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.242 2.217 . . . . 0.0 108.685 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.7 tt -136.46 118.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.51 0.724 . . . . 0.0 112.544 -167.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -80.56 -9.27 59.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.9 m -16.73 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.358 2.663 . . . . 0.0 116.262 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 -33.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.954 2.102 . . . . 0.0 112.126 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.18 2.46 5.87 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.665 1.586 . . . . 0.0 114.423 165.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.54 -174.19 2.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.921 2.888 . . . . 0.0 110.628 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.91 163.66 12.78 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.575 -1.328 . . . . 0.0 114.524 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.47 155.87 42.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.852 1.261 . . . . 0.0 112.397 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -149.13 150.11 31.26 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.825 1.65 . . . . 0.0 111.78 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.84 173.54 13.44 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.141 2.56 . . . . 0.0 113.17 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.02 -40.22 6.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -172.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.31 -157.72 25.65 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ptp -146.07 161.87 39.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.914 1.286 . . . . 0.0 113.862 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -125.38 131.04 53.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.085 2.554 . . . . 0.0 109.838 171.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -137.2 173.67 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.497 1.519 . . . . 0.0 110.056 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 1.053 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 4.5 t -65.92 158.79 27.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 123.217 1.484 . . . . 0.0 113.308 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.96 -3.59 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.096 168.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.8 m -125.01 -22.01 4.55 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.404 1.482 . . . . 0.0 114.629 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 1.053 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 7.5 p -122.11 -88.57 0.62 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.403 1.481 . . . . 0.0 113.104 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -152.6 -46.59 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -127.43 161.23 55.92 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -140.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.43 150.45 41.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.081 3.187 . . . . 0.0 113.34 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -137.36 -34.54 0.7 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -152.72 146.73 25.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.445 1.02 . . . . 0.0 112.474 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.5 p -81.66 145.82 30.36 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.644 -1.285 . . . . 0.0 111.356 169.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -61.4 -17.98 56.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.29 -34.83 66.85 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.897 1.679 . . . . 0.0 113.396 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -9.44 51.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.574 1.15 . . . . 0.0 112.216 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -70.58 108.17 4.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.187 0.903 . . . . 0.0 109.979 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 CA--C 1.541 0.607 0 C-N-CA 125.105 1.362 . . . . 0.0 114.577 -153.339 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.533 0.439 0 CA-C-O 123.3 1.292 . . . . 0.0 114.382 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.04 149.96 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.052 1.741 . . . . 0.0 110.628 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.97 108.74 8.56 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.293 1.837 . . . . 0.0 108.79 -162.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.3 p -67.1 -18.47 65.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.84 154.35 39.38 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.149 0.98 . . . . 0.0 110.988 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 123.734 0.813 . . . . 0.0 109.069 166.01 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 CA-C-O 119.959 -0.356 . . . . 0.0 113.771 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.21 167.2 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 122.441 1.115 . . . . 0.0 111.554 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.23 176.94 8.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.093 1.757 . . . . 0.0 110.469 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.436 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -157.7 163.57 38.03 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.913 1.685 . . . . 0.0 111.796 -167.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HD3' ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -162.9 156.64 20.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.911 2.884 . . . . 0.0 105.348 -157.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.41 ' H ' ' HD3' ' A' ' 82' ' ' ARG . 7.8 mp -124.47 151.64 44.33 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 127.283 2.233 . . . . 0.0 111.074 169.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.84 21.35 5.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.203 1.801 . . . . 0.0 111.422 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.7 t -69.57 32.51 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.494 2.318 . . . . 0.0 114.767 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 t -138.2 12.31 2.82 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.796 3.238 . . . . 0.0 111.032 -174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -109.18 22.98 15.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.876 2.47 . . . . 0.0 112.187 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.89 -16.33 58.67 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 125.064 1.316 . . . . 0.0 114.406 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 t -143.15 143.88 26.44 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.794 1.238 . . . . 0.0 110.608 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.88 133.79 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.477 2.118 . . . . 0.0 112.909 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -148.55 154.1 39.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 129.181 2.992 . . . . 0.0 109.25 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.2 mtt -135.0 145.67 48.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.496 2.319 . . . . 0.0 108.215 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -139.47 138.27 36.27 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.197 0.999 . . . . 0.0 111.37 -169.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.85 139.22 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 122.314 1.054 . . . . 0.0 112.092 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.43 152.4 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.848 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 40.1 t -89.54 121.21 31.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 164.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.41 -18.6 31.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.534 1.934 . . . . 0.0 111.883 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -67.8 -28.58 67.71 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 7.1 p -129.61 -3.82 4.76 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 126.225 1.81 . . . . 0.0 115.042 177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.272 11.6 mt-10 62.27 42.35 9.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 127.279 2.232 . . . . 0.0 113.761 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.89 52.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.608 1.963 . . . . 0.0 112.573 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 115.2 17.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 165.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.32 -35.42 3.8 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -170.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.87 132.82 5.74 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 127.005 2.241 . . . . 0.0 112.004 -164.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.51 28.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.086 0.946 . . . . 0.0 110.994 -172.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.49 127.92 32.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.147 -0.97 . . . . 0.0 109.577 -149.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -148.6 150.22 33.09 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.92 132.84 25.59 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.876 2.384 . . . . 0.0 110.174 156.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.04 11.92 10.6 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.22 -67.24 0.34 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.955 1.74 . . . . 0.0 112.311 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.38 -164.34 0.19 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.113 3.209 . . . . 0.0 112.192 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -61.0 143.84 91.44 Favored Pre-proline 0 N--CA 1.473 0.696 0 O-C-N 120.286 -1.509 . . . . 0.0 112.555 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.5 -2.42 8.3 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.904 3.069 . . . . 0.0 114.127 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -50.15 -35.4 25.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.159 1.345 . . . . 0.0 110.897 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -90.59 16.2 58.5 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.216 2.341 . . . . 0.0 117.098 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.59 149.11 11.19 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -116.68 139.66 50.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.721 1.608 . . . . 0.0 110.022 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.6 100.19 11.78 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 174.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.9 t -74.77 143.77 43.9 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.656 -0.652 . . . . 0.0 110.871 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.9 mt -140.61 132.58 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.021 0.528 . . . . 0.0 110.266 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.84 99.3 12.19 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -173.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.3 p -52.19 -31.16 30.4 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.2 p -46.68 -29.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.861 2.064 . . . . 0.0 115.258 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.96 10.7 40.81 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.3 170.86 15.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.174 1.789 . . . . 0.0 111.702 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 129.97 52.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 110.325 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.82 145.87 33.63 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 112.753 -171.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -154.65 150.42 21.7 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.01 1.324 . . . . 0.0 112.175 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.04 169.1 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.069 1.846 . . . . 0.0 111.613 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.67 -42.67 9.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.826 1.25 . . . . 0.0 111.683 176.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt . . . . . 0 CA--C 1.551 0.996 0 C-N-CA 127.358 2.263 . . . . 0.0 113.235 -178.625 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.87 -155.5 20.88 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.103 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 ptp -159.99 166.97 28.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -127.78 135.79 50.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.457 2.703 . . . . 0.0 109.629 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -144.96 155.68 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 0.0 110.753 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 m -68.3 167.17 14.98 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 123.401 1.572 . . . . 0.0 112.543 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.26 -8.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 113.504 -1.68 . . . . 0.0 111.927 152.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -97.2 -18.63 19.14 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.16 1.784 . . . . 0.0 114.73 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.1 p -118.73 -105.09 0.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.315 2.246 . . . . 0.0 109.013 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -163.36 -38.87 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.84 2.056 . . . . 0.0 113.699 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.21 140.5 24.45 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -165.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.95 146.66 65.95 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.388 2.059 . . . . 0.0 111.101 170.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.61 -27.87 2.32 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -134.52 127.11 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.426 -0.796 . . . . 0.0 112.324 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 p -84.44 141.12 31.04 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.696 -1.253 . . . . 0.0 110.196 164.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -18.32 23.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.111 0.964 . . . . 0.0 113.436 170.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.52 -41.79 61.27 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.92 1.688 . . . . 0.0 114.262 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -71.4 -8.92 56.96 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.592 1.557 . . . . 0.0 112.841 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -81.01 129.64 34.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.247 0.546 . . . . 0.0 112.019 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 160.878 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.537 0.641 0 CA-C-O 122.423 0.926 . . . . 0.0 114.321 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 t -154.81 153.67 31.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.466 1.507 . . . . 0.0 111.379 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.73 119.22 22.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.195 2.198 . . . . 0.0 107.471 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 p -70.31 -14.46 62.59 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -153.42 161.16 42.57 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.671 0 C-N-CA 126.145 1.778 . . . . 0.0 110.024 171.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 CA-C-O 118.705 -1.053 . . . . 0.0 113.232 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -96.72 159.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.355 1.077 . . . . 0.0 110.14 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -144.1 164.54 30.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.315 1.446 . . . . 0.0 111.029 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.98 158.87 43.43 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.42 112.2 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.169 2.587 . . . . 0.0 107.37 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.35 154.9 28.71 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.07 0.948 . . . . 0.0 110.861 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -141.01 34.96 1.74 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.828 0.823 . . . . 0.0 112.961 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -71.95 55.19 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 124.051 1.881 . . . . 0.0 109.629 157.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -142.18 8.36 1.83 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.038 2.535 . . . . 0.0 112.351 -167.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.4 mt -128.04 20.24 6.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.647 1.979 . . . . 0.0 112.571 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.42 2.17 73.24 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 120.976 -1.077 . . . . 0.0 115.588 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.6 t -135.39 138.91 29.91 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 127.327 2.251 . . . . 0.0 110.085 168.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.13 135.61 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.501 2.801 . . . . 0.0 114.658 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -144.68 158.42 43.79 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.298 2.639 . . . . 0.0 110.628 167.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.4 mtp -141.92 125.85 17.18 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.388 2.675 . . . . 0.0 107.864 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -133.18 146.48 51.57 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.872 -1.142 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.61 153.32 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.241 1.416 . . . . 0.0 110.962 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.03 140.63 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.259 1.424 . . . . 0.0 109.144 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 1.225 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 42.9 t -76.72 97.37 4.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 124.085 1.897 . . . . 0.0 106.604 160.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -66.83 -14.72 63.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.727 -1.578 . . . . 0.0 111.545 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -66.53 -50.48 63.05 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.885 1.274 . . . . 0.0 112.426 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.225 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.7 OUTLIER -100.89 -11.99 19.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.009 2.123 . . . . 0.0 114.281 -173.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 68.02 17.91 9.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.395 1.878 . . . . 0.0 113.994 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.7 86.11 2.73 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.057 1.408 . . . . 0.0 112.229 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -89.78 67.58 7.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.827 1.651 . . . . 0.0 113.404 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.275 0.0 OUTLIER -135.02 5.88 3.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 118.528 2.788 . . . . 0.0 118.528 -170.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.06 129.3 9.0 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.47 1.032 . . . . 0.0 112.679 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -147.71 160.74 42.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.8 142.45 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 123.692 1.71 . . . . 0.0 112.745 -171.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -149.1 156.59 40.26 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 127.322 2.249 . . . . 0.0 110.435 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.38 142.49 54.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.292 1.995 . . . . 0.0 109.444 165.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.94 18.05 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 113.583 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.64 -64.15 0.6 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.529 2.49 . . . . 0.0 112.739 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -86.53 -153.65 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.544 4.162 . . . . 0.0 113.516 -174.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.83 149.41 2.31 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 127.597 2.359 . . . . 0.0 113.712 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.81 -7.9 19.78 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.411 2.741 . . . . 0.0 114.498 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.1 p -58.87 -27.12 64.87 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.182 -0.949 . . . . 0.0 112.131 165.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -88.16 5.9 84.21 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.202 1.858 . . . . 0.0 116.324 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -58.88 127.3 31.52 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 1.428 . . . . 0.0 111.876 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -109.23 120.18 41.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.37 1.068 . . . . 0.0 109.583 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -90.37 76.19 6.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.825 1.298 . . . . 0.0 110.117 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.4 t -66.31 131.03 45.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.533 1.635 . . . . 0.0 111.59 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.3 tt -148.41 166.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.679 -1.601 . . . . 0.0 109.086 -168.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.44 134.56 46.33 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.256 -1.527 . . . . 0.0 113.889 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -81.04 -32.56 34.04 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.24 -33.56 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.86 2.56 14.22 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.3 mt -135.19 171.94 13.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.002 2.521 . . . . 0.0 110.034 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 9.7 mmpt? -109.82 159.38 17.25 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.933 -1.105 . . . . 0.0 112.694 168.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -148.59 153.0 37.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -146.33 145.97 25.92 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 125.797 1.639 . . . . 0.0 111.491 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.73 173.43 14.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.655 2.237 . . . . 0.0 112.072 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.6 t -100.06 -54.93 2.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.233 1.013 . . . . 0.0 111.28 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 126.542 1.937 . . . . 0.0 114.555 -174.1 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.38 -152.51 18.15 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptp -155.25 174.58 15.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.897 1.679 . . . . 0.0 113.011 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.47 148.28 52.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.715 1.606 . . . . 0.0 112.378 163.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -137.17 169.37 17.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.826 2.051 . . . . 0.0 111.758 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -76.21 168.4 20.12 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 123.781 1.753 . . . . 0.0 114.05 -177.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.54 26.33 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 127.352 2.261 . . . . 0.0 111.409 164.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.62 -41.08 2.03 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.508 1.523 . . . . 0.0 111.103 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 21.3 p -97.33 -99.16 0.2 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.139 1.376 . . . . 0.0 110.85 166.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.08 -49.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.021 1.328 . . . . 0.0 114.202 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -99.66 154.07 37.45 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -142.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.0 142.17 99.12 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.933 1.756 . . . . 0.0 110.336 158.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.33 -34.93 1.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.673 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -135.87 134.76 39.14 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 p -91.13 127.55 36.6 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.312 1.053 . . . . 0.0 109.46 164.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.46 -7.21 29.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 113.383 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.05 -33.13 70.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.663 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -75.69 7.81 3.5 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.149 0.979 . . . . 0.0 111.955 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -52.69 132.85 36.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.42 0.629 . . . . 0.0 111.432 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 CA--C 1.547 0.847 0 C-N-CA 124.902 1.281 . . . . 0.0 111.802 178.7 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.531 0.373 0 CA-C-O 123.063 1.193 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -157.83 144.92 18.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.643 1.977 . . . . 0.0 110.605 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -143.58 117.15 9.17 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.094 1.357 . . . . 0.0 109.832 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.4 p -69.19 -23.68 63.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -145.44 158.22 43.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.944 0.897 . . . . 0.0 112.006 162.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 124.335 1.054 . . . . 0.0 109.322 162.597 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.227 0 CA-C-O 118.952 -0.915 . . . . 0.0 114.592 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -93.74 161.87 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.816 1.77 . . . . 0.0 114.901 -171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.502 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -134.57 -178.07 4.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.513 2.325 . . . . 0.0 109.221 168.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.502 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -151.74 161.74 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.676 1.19 . . . . 0.0 113.482 -171.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.24 117.44 8.97 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 129.113 2.965 . . . . 0.0 106.487 -175.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.85 148.92 25.04 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.032 1.333 . . . . 0.0 112.314 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.56 36.88 3.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.957 1.303 . . . . 0.0 112.537 -163.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p -68.3 22.38 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.918 2.087 . . . . 0.0 115.492 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.3 t -126.66 -2.81 6.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.8 2.04 . . . . 0.0 113.455 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.54 12.37 7.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.544 1.538 . . . . 0.0 112.771 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.01 -9.59 65.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.49 1.519 . . . . 0.0 113.856 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.7 t -139.71 143.27 34.39 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.661 1.984 . . . . 0.0 109.683 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.71 133.62 43.08 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.041 1.827 . . . . 0.0 112.039 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -137.05 154.76 50.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.442 1.897 . . . . 0.0 109.475 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 ttm -133.47 134.65 43.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.54 1.536 . . . . 0.0 108.881 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -134.98 147.46 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.475 1.51 . . . . 0.0 110.575 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.61 146.9 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.188 1.395 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.71 144.4 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.218 1.007 . . . . 0.0 111.71 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.847 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 40.6 t -79.07 105.12 10.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 166.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -77.04 -7.7 56.14 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -69.0 -51.59 37.66 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.453 1.901 . . . . 0.0 112.03 172.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.847 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 17.5 p -112.09 -5.95 14.21 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.179 1.791 . . . . 0.0 114.453 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 62.4 63.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.028 2.531 . . . . 0.0 113.766 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.52 152.93 43.13 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -77.48 80.59 3.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.302 1.841 . . . . 0.0 112.511 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.255 3.4 mm? -91.63 48.13 1.43 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 124.121 1.915 . . . . 0.0 114.559 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.36 163.63 10.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 111.123 -2.762 . . . . 0.0 115.611 150.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.79 163.0 40.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.668 0.787 . . . . 0.0 111.255 -174.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.34 142.21 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.166 1.386 . . . . 0.0 112.049 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.22 153.54 73.19 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.098 1.759 . . . . 0.0 113.872 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.19 135.3 7.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.961 3.108 . . . . 0.0 112.006 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -118.61 4.78 11.65 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -162.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.62 -38.36 1.0 Allowed Glycine 0 CA--C 1.544 1.85 0 CA-C-O 117.458 -1.746 . . . . 0.0 116.347 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -101.24 -172.91 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.153 3.235 . . . . 0.0 113.226 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -51.51 156.99 1.91 Allowed Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 125.751 1.62 . . . . 0.0 112.363 163.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.93 -4.02 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.698 2.932 . . . . 0.0 114.359 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -20.37 65.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.207 1.403 . . . . 0.0 113.58 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.98 -90.38 0.47 Allowed Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.658 1.599 . . . . 0.0 112.765 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 50.28 140.45 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 131.581 3.952 . . . . 0.0 119.009 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -110.81 126.51 54.71 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.981 -1.074 . . . . 0.0 109.913 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -90.05 122.56 33.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.064 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.6 p -105.83 122.8 46.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.594 1.558 . . . . 0.0 110.488 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.09 166.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.884 1.674 . . . . 0.0 109.591 -175.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.42 108.63 2.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.512 1.125 . . . . 0.0 113.341 173.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.3 m -75.1 56.14 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.431 1.492 . . . . 0.0 111.48 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -41.38 -46.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 128.521 2.728 . . . . 0.0 114.641 -162.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.98 38.92 1.2 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.463 1.905 . . . . 0.0 110.491 166.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.8 mt -110.76 165.75 11.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.559 1.544 . . . . 0.0 111.014 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.8 mmpt? -94.82 146.09 24.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -163.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -141.32 149.28 41.0 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.202 -0.936 . . . . 0.0 112.353 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -144.73 148.51 39.84 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 124.947 1.299 . . . . 0.0 111.644 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.2 174.86 8.4 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.824 1.683 . . . . 0.0 110.023 163.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.87 -38.95 18.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.714 0.768 . . . . 0.0 112.003 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 127.651 2.38 . . . . 0.0 115.191 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.537 0.208 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.0 -160.85 31.83 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.654 1.121 . . . . 0.0 114.91 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -160.19 163.63 33.48 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.863 1.265 . . . . 0.0 113.861 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -95.85 145.5 25.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 128.475 2.71 . . . . 0.0 110.987 167.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -153.67 164.27 38.57 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.825 1.65 . . . . 0.0 112.307 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 69.3 m -67.12 166.13 14.53 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 123.893 1.806 . . . . 0.0 113.788 170.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.67 16.17 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 126.486 1.915 . . . . 0.0 112.69 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 47.7 t -127.38 -49.51 1.41 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.37 1.068 . . . . 0.0 112.493 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 9.1 p -96.68 -96.54 0.19 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.892 1.277 . . . . 0.0 112.919 -174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -155.26 -36.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.398 2.279 . . . . 0.0 113.563 -165.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p -82.23 118.23 71.21 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -160.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.31 153.69 77.06 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 120.997 1.132 . . . . 0.0 110.051 136.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.4 tp -152.14 -47.98 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -120.81 122.47 40.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.19 0.904 . . . . 0.0 110.657 -169.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.3 p -75.88 145.62 40.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 123.229 1.49 . . . . 0.0 111.041 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -75.86 -10.07 59.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.484 169.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.79 -40.06 78.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.439 1.496 . . . . 0.0 114.779 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.26 -0.1 53.62 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.342 1.026 . . . . 0.0 113.608 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -99.61 128.1 45.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -159.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.856 0.836 . . . . 0.0 111.688 168.746 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.535 0.56 0 CA-C-O 124.313 1.714 . . . . 0.0 115.876 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -149.54 155.52 40.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.247 2.219 . . . . 0.0 110.581 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.85 122.11 12.27 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.311 1.844 . . . . 0.0 108.374 -168.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -76.12 -7.61 55.15 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -164.55 154.42 13.95 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 157.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 C-N-CA 126.445 1.898 . . . . 0.0 113.026 175.869 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.8 178.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 122.595 1.188 . . . . 0.0 112.685 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -143.99 173.98 11.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.536 1.935 . . . . 0.0 111.611 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.4 ' H ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -146.62 147.71 31.34 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 113.868 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.07 109.71 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.628 1.971 . . . . 0.0 108.747 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.21 150.16 20.57 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.395 1.878 . . . . 0.0 109.069 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.11 120.54 4.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.151 0.887 . . . . 0.0 110.86 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -121.88 32.71 5.74 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.233 1.016 . . . . 0.0 110.423 164.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.5 m -107.36 -13.94 14.99 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 128.156 2.582 . . . . 0.0 113.47 -161.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.45 16.96 5.73 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 127.453 2.301 . . . . 0.0 111.955 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.28 -6.03 52.73 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.1 t -138.57 131.44 16.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.264 2.226 . . . . 0.0 108.999 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.33 144.15 25.75 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.081 2.52 . . . . 0.0 113.776 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -148.27 160.74 42.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 129.406 3.082 . . . . 0.0 112.315 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mtp -143.62 132.27 22.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.108 1.763 . . . . 0.0 109.017 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -138.16 150.09 46.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.125 0.875 . . . . 0.0 112.741 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 141.58 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 110.574 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.65 155.1 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 110.276 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.936 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 36.9 t -97.49 112.94 24.58 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 122.631 1.205 . . . . 0.0 108.111 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -67.33 -18.02 65.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.868 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -85.63 -38.56 18.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.553 1.141 . . . . 0.0 112.911 -171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.936 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 2.6 p -112.21 -13.41 13.5 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 127.709 2.403 . . . . 0.0 114.566 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 6.8 tt0 70.83 53.86 0.27 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.673 2.389 . . . . 0.0 116.151 173.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.34 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.707 1.203 . . . . 0.0 113.065 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.8 40.98 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.381 -0.825 . . . . 0.0 111.046 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.29 -27.13 19.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.079 1.419 . . . . 0.0 113.626 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.02 176.03 32.68 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 126.71 2.1 . . . . 0.0 113.634 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -153.3 167.24 30.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.653 1.216 . . . . 0.0 113.518 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.45 134.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 125.467 1.507 . . . . 0.0 109.024 -161.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.7 159.06 72.8 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.938 1.295 . . . . 0.0 111.999 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -67.11 146.15 75.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.354 2.036 . . . . 0.0 110.668 163.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -114.33 16.02 17.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.612 1.165 . . . . 0.0 113.79 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.46 -71.32 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.988 1.756 . . . . 0.0 112.495 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.51 179.53 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.609 2.873 . . . . 0.0 112.694 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -58.03 151.5 44.9 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.734 1.613 . . . . 0.0 112.735 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.57 -3.43 4.34 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.133 3.222 . . . . 0.0 115.264 -172.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -57.41 -29.12 63.86 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.666 -0.646 . . . . 0.0 112.088 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.41 16.19 60.2 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.19 2.328 . . . . 0.0 116.455 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -47.49 139.9 6.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.618 1.167 . . . . 0.0 113.958 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -114.97 136.21 53.38 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.106 1.762 . . . . 0.0 110.073 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.61 114.73 29.08 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.75 1.62 . . . . 0.0 110.82 -167.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 54.6 m -99.5 142.98 30.28 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.428 2.691 . . . . 0.0 111.504 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.7 mm -107.73 154.81 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.96 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.57 122.39 39.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.101 0.961 . . . . 0.0 112.183 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.7 m -77.39 49.5 0.72 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.391 1.076 . . . . 0.0 113.377 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.35 -55.5 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.28 -0.888 . . . . 0.0 112.633 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.08 -0.53 0.44 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.92 162.62 29.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.58 1.552 . . . . 0.0 110.703 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -108.53 160.81 15.61 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.276 1.43 . . . . 0.0 112.841 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -149.56 143.21 25.45 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.172 1.389 . . . . 0.0 110.449 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -135.17 155.72 78.71 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.243 1.417 . . . . 0.0 111.197 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.37 167.94 25.97 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.027 1.818 . . . . 0.0 112.047 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.58 -35.29 11.69 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.258 1.423 . . . . 0.0 112.723 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt . . . . . 0 CA--C 1.549 0.906 0 C-N-CA 126.105 1.762 . . . . 0.0 114.591 -176.026 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.54 -147.65 10.02 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.372 1.309 . . . . 0.0 116.372 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 ptp -134.54 179.89 6.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.251 1.82 . . . . 0.0 114.048 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.02 144.85 48.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 129.968 3.307 . . . . 0.0 108.695 159.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -144.88 151.13 38.24 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 110.931 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 74.1 m -71.38 161.76 30.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.134 1.445 . . . . 0.0 111.556 175.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.25 6.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.711 163.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.3 m -115.48 -57.24 2.26 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.907 1.283 . . . . 0.0 112.405 -165.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 1.7 p -81.19 -81.28 0.14 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.315 1.046 . . . . 0.0 111.928 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.72 -59.77 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.278 1.431 . . . . 0.0 113.218 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 p -96.85 165.92 14.96 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -154.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -59.36 152.39 61.16 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 120.66 0.906 . . . . 0.0 111.344 150.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 -31.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -128.11 132.77 48.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.58 -0.7 . . . . 0.0 110.935 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.6 m -76.66 140.53 40.96 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.023 -1.048 . . . . 0.0 109.705 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -64.85 -10.97 32.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.967 0.907 . . . . 0.0 112.521 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -87.68 -1.97 58.31 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.228 1.411 . . . . 0.0 113.666 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -95.29 130.12 42.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.594 1.158 . . . . 0.0 109.575 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 122.207 0.203 . . . . 0.0 110.576 -175.269 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo . . . . . 0 CA--C 1.548 1.209 0 N-CA-C 114.695 0.998 . . . . 0.0 114.695 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 157.72 43.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.184 2.194 . . . . 0.0 109.904 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -153.1 116.44 4.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.978 1.311 . . . . 0.0 110.058 -169.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.4 p -72.05 -23.91 61.45 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.19 166.66 20.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 113.335 172.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 124.414 1.085 . . . . 0.0 110.334 162.435 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.003 1.402 . . . . 0.0 111.485 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.91 177.24 8.03 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.97 1.708 . . . . 0.0 111.869 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 155.44 38.33 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.329 1.451 . . . . 0.0 112.903 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 118.59 5.53 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.779 2.832 . . . . 0.0 107.29 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -75.02 149.8 39.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 111.4 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -136.7 96.5 3.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.732 0.777 . . . . 0.0 111.29 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.3 t -111.03 21.95 15.84 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.603 1.161 . . . . 0.0 112.217 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -5.94 58.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -162.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -98.35 14.08 29.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.623 1.969 . . . . 0.0 111.712 164.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.48 -4.17 64.99 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.988 1.756 . . . . 0.0 115.279 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.0 t -123.52 109.42 30.77 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.166 1.387 . . . . 0.0 109.767 -175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.74 125.6 9.57 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.044 2.496 . . . . 0.0 113.158 -166.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 165.95 13.02 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.169 2.187 . . . . 0.0 109.881 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.37 122.81 44.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.444 1.498 . . . . 0.0 108.021 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -120.32 137.87 54.02 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.981 0.913 . . . . 0.0 109.802 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.55 145.67 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 121.241 -0.912 . . . . 0.0 111.497 -165.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.44 138.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.041 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 42.2 t -72.72 98.63 2.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 123.41 1.576 . . . . 0.0 107.843 161.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.54 -16.66 57.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.884 1.274 . . . . 0.0 111.924 167.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -71.09 -45.61 63.38 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.851 1.205 . . . . 0.0 113.619 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 3.9 p -123.42 8.81 9.04 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.093 2.157 . . . . 0.0 115.424 -169.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.56 15.7 9.81 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.73 2.012 . . . . 0.0 114.821 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.46 83.45 2.54 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.481 -1.387 . . . . 0.0 112.956 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -83.17 58.1 4.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.123 1.769 . . . . 0.0 113.81 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.05 7.97 2.71 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -162.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.43 135.4 12.67 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.056 1.789 . . . . 0.0 110.925 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 157.18 42.83 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.559 -0.965 . . . . 0.0 111.312 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.91 137.85 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.685 1.594 . . . . 0.0 111.505 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.31 149.46 54.96 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.0 1.32 . . . . 0.0 113.112 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.67 146.36 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.573 2.182 . . . . 0.0 110.019 157.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.65 12.5 18.46 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.13 -64.65 0.2 Allowed Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.646 1.117 . . . . 0.0 115.043 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.84 -172.76 1.42 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.935 3.09 . . . . 0.0 113.396 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.95 162.76 0.46 Allowed Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 125.188 1.395 . . . . 0.0 112.507 171.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 115' ' ' GLY . 43.7 Cg_endo -60.33 -5.64 4.37 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.138 2.559 . . . . 0.0 114.378 174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 18.03 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.635 1.974 . . . . 0.0 113.019 163.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 113' ' ' PRO . . . -154.15 19.0 0.64 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.428 1.966 . . . . 0.0 116.535 -171.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.71 161.33 29.74 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.489 1.145 . . . . 0.0 113.966 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -128.44 132.07 48.43 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.042 1.737 . . . . 0.0 109.368 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -99.64 130.85 45.9 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.033 0.933 . . . . 0.0 109.916 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.58 139.97 52.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.326 1.85 . . . . 0.0 109.844 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.8 tt -127.04 170.66 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 109.562 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.78 129.48 50.54 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.74 -1.225 . . . . 0.0 111.643 164.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -83.79 39.42 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.735 1.214 . . . . 0.0 114.251 -167.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -44.57 -36.61 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 -151.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.24 22.51 0.94 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.966 1.706 . . . . 0.0 112.093 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.8 mt -98.5 157.85 15.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 120.666 -1.271 . . . . 0.0 111.678 -155.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 142.65 36.86 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.746 1.26 . . . . 0.0 113.753 -161.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -153.21 144.18 22.91 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 120.321 -1.487 . . . . 0.0 111.215 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -140.08 153.38 69.22 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.921 1.688 . . . . 0.0 111.002 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.27 171.66 17.18 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.885 2.39 . . . . 0.0 112.296 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -38.1 14.22 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.318 1.447 . . . . 0.0 110.622 170.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 128.31 2.644 . . . . 0.0 112.48 -171.045 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.18 -149.93 16.0 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 114.394 0.517 . . . . 0.0 114.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.6 ptp -155.06 168.27 27.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.384 1.074 . . . . 0.0 113.262 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -122.18 139.17 54.07 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 128.809 2.844 . . . . 0.0 109.574 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.69 157.5 43.29 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.561 1.544 . . . . 0.0 110.871 -172.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 2.1 t -79.04 170.17 17.09 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.486 1.612 . . . . 0.0 114.238 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.28 13.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.496 1.918 . . . . 0.0 112.008 161.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.8 t -121.42 -33.22 3.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.09 1.356 . . . . 0.0 112.846 -173.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.677 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 3.6 p -102.29 -86.4 0.42 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.715 1.606 . . . . 0.0 111.348 167.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.1 -41.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 p -111.47 161.39 25.58 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -146.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.72 139.86 31.46 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.184 2.589 . . . . 0.0 111.888 159.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.5 mt -136.92 -23.31 1.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -135.83 141.89 44.75 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.524 1.057 . . . . 0.0 111.285 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.4 p -116.36 132.03 56.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.799 1.285 . . . . 0.0 112.123 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -5.04 19.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.997 1.319 . . . . 0.0 113.53 175.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.46 -26.8 68.12 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.793 -1.192 . . . . 0.0 112.419 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -90.67 5.97 45.9 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.824 1.25 . . . . 0.0 114.32 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 2.9 ttpt -59.43 131.91 52.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.046 0.938 . . . . 0.0 110.472 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 32.6 t80 . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 124.764 1.226 . . . . 0.0 112.397 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 CA--C 1.535 0.559 0 CA-C-O 122.774 1.072 . . . . 0.0 113.048 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.1 p -151.44 165.96 32.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.064 2.146 . . . . 0.0 111.292 -167.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.71 148.88 26.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.781 1.632 . . . . 0.0 109.641 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.6 p -96.56 -27.2 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.267 1.827 . . . . 0.0 113.068 169.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -145.92 155.09 42.63 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.449 1.499 . . . . 0.0 109.524 158.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.389 168.869 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 CA-C-O 119.463 -0.632 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.51 -177.81 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 122.066 0.936 . . . . 0.0 112.104 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.469 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.43 -179.3 6.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.63 1.972 . . . . 0.0 109.171 175.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.469 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 9.6 mmt180 -140.3 154.43 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.957 1.703 . . . . 0.0 109.316 -171.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -152.63 123.8 7.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.756 1.222 . . . . 0.0 110.241 165.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.23 159.03 18.97 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.752 1.621 . . . . 0.0 111.648 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -130.56 111.83 12.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -123.07 19.92 9.94 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 123.114 1.435 . . . . 0.0 111.488 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.88 -18.8 13.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -142.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.66 8.03 45.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 113.025 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.39 -10.03 73.61 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.854 1.693 . . . . 0.0 114.751 -173.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -109.65 126.68 28.61 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 0.0 110.717 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.79 127.37 2.66 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.414 2.743 . . . . 0.0 112.99 175.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -133.66 155.43 49.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.305 3.042 . . . . 0.0 108.717 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 42.5 mtp -140.48 124.02 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.414 1.485 . . . . 0.0 110.736 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -126.42 153.74 44.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.305 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.03 138.45 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.835 1.254 . . . . 0.0 110.759 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.77 148.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 122.103 0.954 . . . . 0.0 111.412 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 53.5 t -82.58 99.08 9.32 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.63 -20.47 66.3 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.687 -0.633 . . . . 0.0 111.566 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -64.25 -35.0 79.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.248 1.019 . . . . 0.0 111.79 -175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 26.4 p -131.8 -7.05 3.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.023 2.129 . . . . 0.0 115.464 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 69.34 59.62 0.32 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.89 2.876 . . . . 0.0 115.614 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.4 38.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 113.416 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.13 141.67 58.02 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 166.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.1 mt -108.48 -32.91 7.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.46 -169.62 35.59 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 127.487 2.47 . . . . 0.0 114.043 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -153.67 -179.48 7.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -152.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.22 145.92 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.805 1.642 . . . . 0.0 112.012 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.27 153.69 44.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.524 1.53 . . . . 0.0 111.965 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.81 137.0 15.57 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.524 2.816 . . . . 0.0 111.035 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.88 -0.07 41.97 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.52 -55.28 0.26 Allowed Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.05 1.786 . . . . 0.0 114.998 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -93.74 -153.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.279 3.319 . . . . 0.0 112.433 -169.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.45 171.22 0.29 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.327 2.251 . . . . 0.0 113.196 172.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -58.84 -5.98 3.08 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.954 2.436 . . . . 0.0 115.074 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -61.32 -26.42 67.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.71 1.204 . . . . 0.0 113.271 163.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.67 12.69 62.83 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.819 2.152 . . . . 0.0 115.765 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.92 132.61 49.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.335 1.067 . . . . 0.0 112.398 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -126.24 134.95 51.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.364 1.466 . . . . 0.0 108.711 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.89 138.58 41.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.052 0.941 . . . . 0.0 110.982 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 57.9 m -122.57 136.99 55.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.926 2.09 . . . . 0.0 109.466 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.0 tt -137.55 169.05 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.592 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.01 166.31 24.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -170.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -133.87 36.5 3.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.944 1.297 . . . . 0.0 113.356 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.06 -47.63 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.586 -1.321 . . . . 0.0 112.6 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 23.62 4.03 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.84 1.656 . . . . 0.0 112.781 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.9 mt -133.88 155.21 50.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.577 1.951 . . . . 0.0 110.13 -165.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -104.55 156.38 18.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.967 0.889 . . . . 0.0 113.359 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.11 153.31 33.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 111.426 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -139.0 150.87 66.72 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.538 . . . . 0.0 111.456 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.71 171.51 18.07 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.602 2.201 . . . . 0.0 112.559 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.33 -46.27 5.07 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.533 1.133 . . . . 0.0 112.011 -175.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.872 0 C-N-CA 127.631 2.372 . . . . 0.0 115.629 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.69 -153.7 19.33 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -151.52 165.68 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.958 1.303 . . . . 0.0 113.965 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.31 153.23 37.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.66 2.384 . . . . 0.0 111.342 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 161.57 37.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.906 1.682 . . . . 0.0 109.979 173.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 57.7 m -56.87 154.21 9.74 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 122.737 1.256 . . . . 0.0 110.16 164.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.51 -10.75 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.656 157.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 89.9 m -92.49 -46.71 7.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.23 -101.45 0.16 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.051 1.34 . . . . 0.0 110.248 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -159.47 -47.26 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.609 1.964 . . . . 0.0 112.98 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.04 153.62 38.45 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 125.923 1.689 . . . . 0.0 115.258 -157.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 135.97 15.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.342 2.028 . . . . 0.0 113.594 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.06 -30.44 12.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.432 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -157.09 157.95 35.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 112.162 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -101.65 147.22 26.7 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.274 -0.891 . . . . 0.0 111.412 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -17.27 63.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.482 1.113 . . . . 0.0 112.232 172.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -35.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.476 1.91 . . . . 0.0 113.747 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.56 -1.35 30.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.812 2.045 . . . . 0.0 112.53 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.58 116.96 8.89 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.784 0.802 . . . . 0.0 111.344 -171.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.5 t80 . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 124.956 1.302 . . . . 0.0 110.461 172.252 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 CA--C 1.541 0.853 0 CA-C-O 122.727 1.053 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.7 p -141.16 169.33 17.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.13 1.772 . . . . 0.0 111.256 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -149.41 141.32 23.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.85 1.26 . . . . 0.0 108.778 161.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -85.7 -16.83 37.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 0.0 113.799 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -158.38 159.8 36.2 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.068 1.747 . . . . 0.0 111.014 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.297 1.439 . . . . 0.0 109.408 -178.474 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.728 0 N-CA-C 114.784 0.673 . . . . 0.0 114.784 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.68 177.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 127.411 2.284 . . . . 0.0 111.12 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.91 170.35 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.588 1.555 . . . . 0.0 110.141 170.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.46 158.44 34.11 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -148.87 108.52 4.0 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 128.097 2.559 . . . . 0.0 108.699 -166.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.5 144.82 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.101 -0.999 . . . . 0.0 111.02 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -117.26 19.52 14.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.764 1.225 . . . . 0.0 112.486 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t -70.3 35.18 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.453 2.301 . . . . 0.0 114.211 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -110.74 -23.64 10.93 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.324 2.25 . . . . 0.0 113.562 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -97.28 14.95 24.31 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.45 1.9 . . . . 0.0 113.164 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.66 48.68 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.516 1.532 . . . . 0.0 114.836 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 37.7 t -111.06 103.53 54.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.341 1.857 . . . . 0.0 109.648 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.47 125.76 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.759 1.639 . . . . 0.0 111.613 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -151.26 156.96 41.92 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.807 2.443 . . . . 0.0 111.609 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.4 mtm -115.95 98.96 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.024 2.53 . . . . 0.0 107.407 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -83.06 148.6 27.43 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.118 -1.614 . . . . 0.0 108.974 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 m -138.22 145.47 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 122.343 1.068 . . . . 0.0 112.879 -167.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.602 HG13 ' H ' ' A' ' 103' ' ' LEU . 6.1 m -139.86 156.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.067 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.963 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 48.9 t -80.11 155.37 27.53 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-O 124.079 1.895 . . . . 0.0 108.517 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -114.67 -18.22 11.45 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 110.906 -2.861 . . . . 0.0 113.497 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.63 -41.79 95.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.77 0.828 . . . . 0.0 112.185 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.963 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -110.85 -20.66 12.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.859 2.464 . . . . 0.0 113.369 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 64.8 122.51 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.06 1.744 . . . . 0.0 112.27 -162.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 75.47 77.88 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.694 1.998 . . . . 0.0 115.765 164.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.332 2.9 t60 -85.57 -21.44 28.52 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.602 ' H ' HG13 ' A' ' 95' ' ' VAL . 3.2 tp 53.16 27.84 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.308 2.643 . . . . 0.0 116.023 163.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.8 -179.55 52.96 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 123.103 1.391 . . . . 0.0 109.817 159.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.06 162.87 40.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.44 1.59 . . . . 0.0 113.393 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.05 139.59 42.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.488 -169.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.41 144.25 52.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.49 142.72 49.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.204 2.603 . . . . 0.0 110.12 162.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -107.98 -3.13 19.08 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.57 -64.28 0.61 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.897 1.713 . . . . 0.0 114.215 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.01 -170.96 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 124.584 3.523 . . . . 0.0 114.438 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -50.02 159.82 0.74 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.761 1.624 . . . . 0.0 111.985 169.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.62 -5.42 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.861 2.374 . . . . 0.0 114.758 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -65.41 -10.88 37.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.753 1.621 . . . . 0.0 114.519 164.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.43 -9.17 48.06 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.831 1.682 . . . . 0.0 116.359 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -56.51 143.14 36.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.973 1.309 . . . . 0.0 113.061 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -129.67 133.94 47.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 110.283 -166.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -104.8 129.02 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.634 1.174 . . . . 0.0 110.047 -174.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.7 p -131.17 129.27 41.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.391 1.077 . . . . 0.0 111.969 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 122' ' ' SER . 7.0 tp -109.34 161.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.31 1.044 . . . . 0.0 110.631 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.411 ' H ' HD11 ' A' ' 120' ' ' ILE . 18.8 p30 -93.06 -21.51 19.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.83 1.252 . . . . 0.0 113.292 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.44 ' H ' HG13 ' A' ' 120' ' ' ILE . 50.6 m 58.25 19.67 6.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 p -71.85 -17.69 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.77 43.66 1.26 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.436 1.495 . . . . 0.0 113.167 -163.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.5 mt -117.55 156.01 28.82 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.759 1.266 . . . . 0.0 114.181 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -102.1 152.33 21.11 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.396 2.278 . . . . 0.0 109.76 157.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -146.32 145.59 30.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.81 0.844 . . . . 0.0 111.715 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -140.75 153.54 67.92 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.82 1.648 . . . . 0.0 110.553 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.38 171.9 14.28 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.373 2.049 . . . . 0.0 112.765 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.47 -37.89 22.55 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 128.932 2.893 . . . . 0.0 113.663 -174.663 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.512 -0.5 0 CA-C-O 121.235 0.54 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.21 -145.66 14.18 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.734 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.5 ptp -149.88 159.33 44.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 153.41 19.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.497 152.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -147.52 155.74 42.16 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.89 1.276 . . . . 0.0 109.785 158.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.45 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 71.5 m -61.57 165.86 4.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 124.134 1.921 . . . . 0.0 112.435 168.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.19 29.3 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.263 167.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 35.0 t -135.23 -47.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.107 1.363 . . . . 0.0 113.312 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.45 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 5.2 p -84.48 -84.57 0.14 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.854 1.262 . . . . 0.0 112.065 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -153.5 -48.94 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.5 p -145.02 165.07 23.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -139.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 144.4 46.87 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.409 2.74 . . . . 0.0 113.44 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -144.35 -4.63 0.79 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.38 129.05 21.53 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.525 -1.359 . . . . 0.0 110.299 169.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 p -94.48 142.45 27.42 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.164 -0.96 . . . . 0.0 111.488 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.17 -11.22 28.59 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.084 0.945 . . . . 0.0 113.336 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -38.92 72.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.43 -1.419 . . . . 0.0 114.054 163.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -73.32 -3.56 27.86 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.513 1.525 . . . . 0.0 112.619 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.56 130.72 44.3 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.275 1.03 . . . . 0.0 110.26 -173.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.6 t80 . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 126.961 2.104 . . . . 0.0 112.163 -170.128 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo . . . . . 0 CA--C 1.537 0.661 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.1 m -159.68 172.29 18.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.72 2.008 . . . . 0.0 110.271 169.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -140.19 121.76 15.21 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.393 1.877 . . . . 0.0 107.16 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -84.97 -10.8 56.67 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -160.93 164.1 31.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.106 0.962 . . . . 0.0 112.926 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 125.682 1.593 . . . . 0.0 109.331 172.222 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.387 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -108.02 149.44 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.502 1.651 . . . . 0.0 110.253 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 mp -125.56 167.56 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.668 1.587 . . . . 0.0 111.499 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.93 150.42 36.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.366 1.466 . . . . 0.0 111.391 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.98 117.79 4.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.918 1.687 . . . . 0.0 108.351 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.29 144.66 35.92 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.599 1.16 . . . . 0.0 111.416 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -124.8 34.45 4.99 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 123.009 1.385 . . . . 0.0 111.083 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -70.2 42.92 0.06 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 129.612 3.165 . . . . 0.0 112.48 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 t -126.08 -12.77 6.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.977 2.111 . . . . 0.0 113.277 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -98.14 16.89 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.953 2.101 . . . . 0.0 113.598 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.14 5.52 89.61 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 124.054 0.835 . . . . 0.0 115.019 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 31.9 t -141.74 135.62 14.76 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.742 2.417 . . . . 0.0 110.284 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.5 125.77 11.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.336 2.691 . . . . 0.0 112.569 173.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -136.17 156.37 48.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.637 2.375 . . . . 0.0 109.89 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.2 mtt -133.77 131.19 39.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.386 2.274 . . . . 0.0 108.527 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -132.43 148.66 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 121.163 -0.961 . . . . 0.0 111.898 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.73 147.93 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.077 1.351 . . . . 0.0 112.513 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.54 152.11 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.198 1.399 . . . . 0.0 111.495 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 1.248 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.6 t -90.07 117.55 28.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 164.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -97.55 -0.87 45.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.043 1.737 . . . . 0.0 113.188 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.405 ' HB2' ' SG ' ' A' ' 96' ' ' CYS . 30.8 mt-30 -63.21 -45.25 92.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.194 1.398 . . . . 0.0 110.404 162.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.248 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 1.7 p -125.4 -14.09 6.48 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.329 2.252 . . . . 0.0 115.197 -169.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.275 75.5 mt-10 74.61 60.11 0.07 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.887 2.475 . . . . 0.0 115.656 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.44 141.11 28.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.8 115.2 7.86 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.147 -0.97 . . . . 0.0 111.672 172.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 tp -97.68 -36.1 10.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.455 1.121 . . . . 0.0 113.774 -159.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.34 155.85 26.46 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 127.399 2.428 . . . . 0.0 112.876 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.44 146.16 29.46 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.745 0.818 . . . . 0.0 111.595 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.22 135.22 44.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 110.453 -155.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.49 152.07 41.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.21 156.48 25.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.502 3.468 . . . . 0.0 112.182 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -123.81 5.17 8.77 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -164.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.75 -59.82 0.68 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 117.839 -1.534 . . . . 0.0 115.682 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -62.59 -166.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.83 3.02 . . . . 0.0 112.58 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -55.52 159.33 4.87 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 110.602 169.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -57.9 -8.19 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.224 2.616 . . . . 0.0 114.283 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -24.63 15.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.019 1.328 . . . . 0.0 113.487 163.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.85 2.4 76.26 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.655 1.598 . . . . 0.0 116.275 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -51.0 139.56 17.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.59 1.195 . . . . 0.0 112.964 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -109.81 126.94 54.32 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.768 1.227 . . . . 0.0 108.534 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.83 98.04 8.34 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.886 0.875 . . . . 0.0 109.267 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.18 148.29 35.99 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.09 0.956 . . . . 0.0 110.626 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.98 157.17 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.467 1.107 . . . . 0.0 110.062 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 159.28 35.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 112.879 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -123.04 19.41 10.01 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.1 p -44.29 -39.72 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 126.243 1.817 . . . . 0.0 115.868 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.29 30.27 0.62 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.475 1.51 . . . . 0.0 112.804 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.43 173.24 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.591 1.556 . . . . 0.0 109.946 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -115.29 149.61 37.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 122.429 1.109 . . . . 0.0 113.257 173.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -159.21 133.11 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.591 1.156 . . . . 0.0 110.001 -168.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -145.06 152.13 50.46 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 124.796 1.238 . . . . 0.0 112.1 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.67 168.97 23.61 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.135 1.89 . . . . 0.0 112.402 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -41.11 12.83 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.339 1.056 . . . . 0.0 111.776 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 CA--C 1.547 0.827 0 C-N-CA 124.192 0.997 . . . . 0.0 111.652 177.334 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.552 ' HG1' ' CG ' ' A' ' 51' ' ' GLU . 1.3 t . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.48 -140.51 6.37 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.56 1.076 . . . . 0.0 114.638 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -155.33 161.8 40.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.473 1.13 . . . . 0.0 112.564 173.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -133.52 145.7 50.38 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.999 1.32 . . . . 0.0 111.336 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.63 164.04 38.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.583 1.153 . . . . 0.0 111.648 -161.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 69.7 m -59.07 157.58 9.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 123.451 1.596 . . . . 0.0 113.874 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.259 8.7 p -125.73 41.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.557 158.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.3 t -135.64 -48.01 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.706 1.202 . . . . 0.0 112.945 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 9.4 p -96.42 -89.96 0.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.522 1.529 . . . . 0.0 113.844 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.32 -30.75 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.043 2.137 . . . . 0.0 113.114 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.3 p -85.37 125.69 69.06 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -161.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.16 138.8 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.046 1.831 . . . . 0.0 111.403 160.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.17 -27.9 4.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.372 -163.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.68 137.99 18.46 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -84.07 136.46 34.01 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.299 -0.875 . . . . 0.0 109.693 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.8 m -62.38 -12.42 21.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.964 1.706 . . . . 0.0 114.387 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.552 ' CG ' ' HG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -60.4 -29.54 69.03 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.611 0.764 . . . . 0.0 111.322 172.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -74.68 -2.99 28.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.186 0.994 . . . . 0.0 113.497 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -53.45 128.25 28.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.774 0.716 . . . . 0.0 109.84 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 CA--C 1.537 0.657 0 CA-C-O 121.697 0.624 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 t -149.58 155.61 40.58 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 111.547 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.66 115.25 4.85 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.559 1.544 . . . . 0.0 109.253 -159.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -72.26 -16.76 61.93 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -146.94 155.54 42.36 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.929 0.892 . . . . 0.0 112.399 166.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 142.326 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.16 166.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 123.176 1.465 . . . . 0.0 111.995 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -133.87 176.36 8.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.88 2.072 . . . . 0.0 108.792 166.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.411 ' H ' HD22 ' A' ' 80' ' ' LEU . 7.0 ptt180 -147.3 146.7 29.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.9 0.88 . . . . 0.0 112.967 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.86 108.63 7.05 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.191 1.796 . . . . 0.0 109.205 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -89.69 149.22 22.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.393 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.52 120.01 6.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.659 1.184 . . . . 0.0 109.205 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -130.08 35.27 4.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.218 1.007 . . . . 0.0 110.605 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -130.92 -6.47 3.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.736 2.015 . . . . 0.0 114.606 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.21 24.39 1.88 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.702 2.001 . . . . 0.0 111.806 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.66 -10.27 46.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.636 2.065 . . . . 0.0 114.155 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.8 t -145.83 130.9 9.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.788 1.235 . . . . 0.0 109.807 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.25 133.01 23.7 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.094 2.53 . . . . 0.0 112.88 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -138.6 157.87 45.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.829 2.852 . . . . 0.0 111.741 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.3 mtt -138.76 128.03 24.24 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.392 2.277 . . . . 0.0 107.915 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.89 153.29 47.63 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.205 1.002 . . . . 0.0 111.325 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.76 141.32 44.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.206 1.402 . . . . 0.0 111.827 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -117.52 152.03 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.186 1.394 . . . . 0.0 109.591 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 1.109 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 40.4 t -93.02 120.91 33.81 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 165.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.56 -14.96 41.4 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 114.411 169.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -65.42 -38.36 89.7 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.691 0.796 . . . . 0.0 112.447 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.109 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 1.7 p -117.55 -12.22 10.38 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 127.604 2.361 . . . . 0.0 114.888 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.362 56.5 mt-10 62.19 64.1 1.0 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.912 2.485 . . . . 0.0 115.213 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.28 136.82 32.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -78.45 109.16 12.37 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.988 165.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.297 2.7 pp -141.27 -1.41 1.35 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 -172.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.0 142.04 13.5 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.746 1.641 . . . . 0.0 111.515 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.17 160.18 43.45 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.753 -0.851 . . . . 0.0 111.308 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.35 139.11 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 125.138 1.375 . . . . 0.0 111.125 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -145.87 154.11 50.89 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.869 1.268 . . . . 0.0 114.007 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -84.38 141.01 8.79 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.574 2.849 . . . . 0.0 111.27 171.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.36 28.86 4.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.352 1.461 . . . . 0.0 113.158 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.42 -50.96 0.82 Allowed Glycine 0 CA--C 1.542 1.748 0 C-N-CA 126.542 2.02 . . . . 0.0 115.241 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -87.72 -165.38 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.175 3.25 . . . . 0.0 112.295 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -56.28 149.13 38.91 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.819 1.648 . . . . 0.0 113.064 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -66.68 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 124.791 3.661 . . . . 0.0 115.261 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -31.51 62.09 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.85 -1.156 . . . . 0.0 112.373 162.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.0 14.12 65.17 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.88 150.57 28.2 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -165.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -105.42 137.73 42.77 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.902 1.681 . . . . 0.0 108.652 170.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -90.48 160.82 15.81 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 123.824 0.85 . . . . 0.0 109.721 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.9 p -150.3 155.76 40.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.057 1.343 . . . . 0.0 110.834 166.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 mm -118.85 165.81 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.36 1.864 . . . . 0.0 109.368 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.85 103.84 6.28 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.305 -1.497 . . . . 0.0 113.622 150.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -74.73 21.23 0.11 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.31 -19.71 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.067 1.747 . . . . 0.0 114.895 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.11 17.53 10.8 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.304 1.842 . . . . 0.0 114.923 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 61.5 mt -120.69 157.52 29.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.324 1.059 . . . . 0.0 113.174 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -104.57 161.9 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.267 2.227 . . . . 0.0 111.288 163.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -142.46 145.5 33.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 111.003 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -148.99 151.67 35.04 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.019 1.328 . . . . 0.0 112.144 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.91 170.31 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.801 2.334 . . . . 0.0 113.288 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.18 -44.25 12.35 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.836 1.303 . . . . 0.0 112.532 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 126.252 1.821 . . . . 0.0 112.016 -178.612 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.216 0.531 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.68 -160.2 23.89 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 114.125 0.41 . . . . 0.0 114.125 174.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.9 ptp -151.29 156.2 40.32 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.139 0.976 . . . . 0.0 113.052 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -104.4 140.72 37.52 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.464 2.706 . . . . 0.0 110.974 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -144.12 158.75 43.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.718 2.007 . . . . 0.0 110.861 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.946 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.3 t -72.86 168.39 19.0 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.833 1.778 . . . . 0.0 115.144 -172.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.72 3.97 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.774 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.9 t -117.57 -44.82 2.73 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 111.156 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.946 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 4.3 p -90.21 -104.46 0.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.963 1.705 . . . . 0.0 108.239 162.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -156.8 -50.07 0.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.799 1.64 . . . . 0.0 114.147 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 154.96 53.9 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -149.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.49 135.51 36.57 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.613 2.209 . . . . 0.0 111.037 162.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -22.89 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.42 120.41 10.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.997 -0.439 . . . . 0.0 110.8 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -86.04 135.08 33.77 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 123.565 1.65 . . . . 0.0 112.421 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -5.72 6.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.047 2.139 . . . . 0.0 112.885 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -23.69 57.86 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.705 1.202 . . . . 0.0 112.948 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.23 -1.13 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.652 1.181 . . . . 0.0 114.002 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -79.66 123.04 27.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.089 0.956 . . . . 0.0 111.143 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 122.426 1.108 . . . . 0.0 111.285 170.191 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 CA--C 1.538 0.711 0 CA-C-O 124.71 1.879 . . . . 0.0 114.888 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -149.78 163.58 37.62 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.984 2.514 . . . . 0.0 111.443 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -154.98 145.39 22.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.924 2.09 . . . . 0.0 108.838 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -73.62 -34.04 64.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.112 167.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -153.94 165.21 36.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.289 1.435 . . . . 0.0 110.973 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 148.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 119.384 -0.676 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.781 1.277 . . . . 0.0 112.417 174.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.12 177.73 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 128.576 2.751 . . . . 0.0 109.134 -173.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 154.9 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.74 105.93 6.35 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 126.488 1.915 . . . . 0.0 109.222 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.78 154.42 19.53 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.933 0.893 . . . . 0.0 111.064 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -143.06 113.89 7.6 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.713 1.205 . . . . 0.0 108.444 166.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -129.33 37.57 4.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.889 1.328 . . . . 0.0 110.269 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.8 t -113.79 -17.93 11.95 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 113.973 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.44 22.14 5.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.355 2.262 . . . . 0.0 111.847 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.68 -12.01 54.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.634 2.064 . . . . 0.0 114.761 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.09 130.23 23.4 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.219 1.408 . . . . 0.0 110.025 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.29 128.36 11.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.402 2.068 . . . . 0.0 112.12 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -133.18 155.95 48.38 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 128.08 2.552 . . . . 0.0 109.904 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.3 mtt -141.27 130.81 23.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.06 1.744 . . . . 0.0 109.423 -172.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -133.42 153.67 51.41 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.29 1.436 . . . . 0.0 110.735 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.94 145.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.239 1.016 . . . . 0.0 111.217 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.38 138.7 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.593 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.691 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 8.7 t -79.02 108.76 12.74 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 174.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -79.89 -7.71 58.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.285 1.034 . . . . 0.0 113.272 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.89 -39.5 94.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.323 1.049 . . . . 0.0 112.073 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.691 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 25.5 p -134.77 -5.83 2.47 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.361 43.3 mt-10 71.33 53.25 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.613 2.365 . . . . 0.0 114.051 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.74 134.04 51.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.833 1.653 . . . . 0.0 113.207 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -78.88 76.59 5.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.355 1.462 . . . . 0.0 112.307 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 3.24 6.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -171.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.9 172.41 19.31 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 122.825 1.236 . . . . 0.0 116.128 160.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -137.48 160.36 39.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 p -125.68 123.68 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.651 1.98 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.58 149.15 61.06 Favored Pre-proline 0 C--O 1.241 0.654 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.192 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.69 152.32 53.09 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.288 2.658 . . . . 0.0 112.347 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -100.63 -0.46 37.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.51 1.924 . . . . 0.0 115.129 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.94 -61.48 0.66 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.437 1.494 . . . . 0.0 115.098 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.47 -157.94 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 124.795 3.663 . . . . 0.0 112.902 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 150.53 31.1 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.758 1.223 . . . . 0.0 112.304 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.21 2.17 2.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.138 3.226 . . . . 0.0 114.464 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -59.48 -24.01 63.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.312 -0.868 . . . . 0.0 113.141 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.59 0.66 85.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.579 1.392 . . . . 0.0 116.579 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -60.39 146.11 45.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.669 1.235 . . . . 0.0 113.422 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.0 149.59 28.33 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.258 1.823 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -82.45 144.74 30.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.672 0.748 . . . . 0.0 111.834 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.3 p -129.49 134.63 47.89 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.57 2.748 . . . . 0.0 108.478 168.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.3 tp -127.85 126.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.358 -0.839 . . . . 0.0 112.265 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -119.68 3.05 11.17 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m -134.17 39.44 3.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.132 1.773 . . . . 0.0 111.766 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.24 -39.73 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -163.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.95 -11.76 0.53 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.588 2.755 . . . . 0.0 117.516 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.4 pp -126.24 176.47 7.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.547 1.939 . . . . 0.0 114.094 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.07 178.97 4.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 114.589 -165.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.59 160.92 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.766 1.226 . . . . 0.0 113.821 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.7 152.74 79.22 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.914 1.686 . . . . 0.0 110.663 160.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.56 167.88 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.595 1.53 . . . . 0.0 111.284 160.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.35 -45.18 9.19 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 112.507 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.546 0.815 0 C-N-CA 127.149 2.18 . . . . 0.0 113.469 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.223 -0.309 0 CA-C-O 121.537 0.684 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.31 -165.71 31.25 Favored Glycine 0 N--CA 1.474 1.22 0 O-C-N 119.914 -1.741 . . . . 0.0 116.013 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -155.57 161.25 40.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.502 1.121 . . . . 0.0 113.78 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.06 143.8 39.57 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 129.278 3.031 . . . . 0.0 111.018 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -136.76 165.19 26.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.968 2.107 . . . . 0.0 109.771 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 57.1 m -59.72 158.57 10.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.76 1.267 . . . . 0.0 111.311 170.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 p -92.09 12.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.653 156.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.0 m -121.18 -43.61 2.42 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -162.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 8.6 p -103.78 -92.89 0.34 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.283 1.401 . . . . 0.0 113.679 -175.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -160.73 -49.13 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.055 2.142 . . . . 0.0 113.7 -172.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p -113.02 156.71 42.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -158.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.82 152.49 16.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.73 2.953 . . . . 0.0 113.333 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.5 -26.39 1.84 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.262 1.025 . . . . 0.0 113.601 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.09 122.01 25.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.629 0.65 . . . . 0.0 112.041 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 p -85.3 130.92 34.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.947 -1.096 . . . . 0.0 109.55 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -9.75 24.08 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 123.135 1.445 . . . . 0.0 112.331 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.8 tt0 -58.18 -33.1 68.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.807 1.243 . . . . 0.0 114.144 166.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 8.1 mmpt? -83.28 0.65 44.74 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.961 1.704 . . . . 0.0 113.092 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 117.44 7.71 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 120.097 1.317 . . . . 0.0 110.154 -169.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -164.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 CA-C-O 122.873 1.114 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 p -158.38 153.2 24.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.403 1.481 . . . . 0.0 111.089 -164.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.84 148.65 45.63 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.769 2.028 . . . . 0.0 109.379 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.6 p -84.1 -25.9 29.38 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.053 1.741 . . . . 0.0 113.516 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -153.95 162.74 40.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.165 1.386 . . . . 0.0 112.146 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 124.752 1.221 . . . . 0.0 110.377 163.829 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 CA-C-O 119.503 -0.61 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.84 167.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.248 1.419 . . . . 0.0 112.204 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.69 173.62 11.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.14 1.776 . . . . 0.0 110.575 169.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 163.53 36.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.58 1.152 . . . . 0.0 113.157 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.73 118.23 6.51 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 127.147 2.179 . . . . 0.0 108.995 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.85 147.41 41.12 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.615 0.766 . . . . 0.0 110.579 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -129.4 51.86 2.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 123.961 1.839 . . . . 0.0 111.215 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.3 p -79.51 47.97 0.87 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.765 2.026 . . . . 0.0 110.72 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.93 -1.22 2.22 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.6 mt -90.07 10.84 22.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.675 1.19 . . . . 0.0 113.043 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.67 -9.31 6.31 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.209 1.385 . . . . 0.0 113.967 -166.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.73 109.75 20.55 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 126.578 1.951 . . . . 0.0 108.129 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.62 126.44 12.1 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.374 2.049 . . . . 0.0 112.849 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -122.95 151.7 41.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.209 1.803 . . . . 0.0 109.183 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 35.3 mtp -112.72 128.23 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.023 2.129 . . . . 0.0 105.77 164.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -124.9 144.94 50.07 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.804 -1.185 . . . . 0.0 111.943 172.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -145.48 138.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.31 1.053 . . . . 0.0 112.304 -156.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG13 ' H ' ' A' ' 103' ' ' LEU . 2.8 m -149.43 173.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.83 -1.169 . . . . 0.0 111.022 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 34.6 t -94.14 150.32 20.43 Favored 'General case' 0 N--CA 1.404 -2.773 0 C-N-CA 127.398 2.279 . . . . 0.0 106.575 168.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -110.27 -18.09 13.36 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 127.762 2.425 . . . . 0.0 112.795 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.56 -44.94 96.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.569 1.148 . . . . 0.0 112.209 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.204 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -96.71 -29.57 13.72 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.411 2.284 . . . . 0.0 111.462 175.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 67.37 124.44 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.61 1.195 . . . . 0.0 111.041 -154.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 71.96 85.26 0.12 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.956 2.102 . . . . 0.0 114.515 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.308 2.7 t60 -74.85 -14.6 60.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.539 ' H ' HG13 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 38.89 52.21 1.91 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.515 2.326 . . . . 0.0 113.591 -172.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.97 156.45 22.38 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 111.527 -2.579 . . . . 0.0 109.383 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.53 156.37 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.098 0.959 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.2 t -139.82 126.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 123.799 0.84 . . . . 0.0 109.487 -174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -133.59 152.26 78.71 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.015 0.926 . . . . 0.0 111.496 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.46 140.38 15.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.77 2.313 . . . . 0.0 110.33 160.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.57 -5.61 59.26 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.12 -46.35 0.48 Allowed Glycine 0 CA--C 1.542 1.758 0 C-N-CA 126.891 2.186 . . . . 0.0 113.991 -162.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.93 179.04 6.88 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 CA-C-N 120.981 2.391 . . . . 0.0 113.768 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.67 162.69 4.61 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.707 1.603 . . . . 0.0 111.819 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.25 -3.23 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.168 3.245 . . . . 0.0 116.088 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 t -81.09 -21.54 39.88 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.982 1.713 . . . . 0.0 114.319 170.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.66 16.29 59.88 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 127.346 2.403 . . . . 0.0 115.443 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -70.9 159.52 34.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -167.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -118.75 129.27 55.16 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 107.322 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -84.68 130.36 34.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.8 m -115.27 129.27 56.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.644 1.978 . . . . 0.0 108.784 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.32 175.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 120.434 1.47 . . . . 0.0 110.054 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.51 139.97 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.893 -1.129 . . . . 0.0 111.874 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.1 m -76.0 28.89 0.11 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -165.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.94 -30.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.83 41.56 0.77 Allowed 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.8 mt -132.06 153.64 50.22 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.056 -1.028 . . . . 0.0 112.947 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.58 153.72 35.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.316 1.846 . . . . 0.0 111.328 164.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -151.02 130.65 13.07 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.472 -0.767 . . . . 0.0 112.577 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -142.25 159.17 59.39 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 126.156 1.783 . . . . 0.0 111.702 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.46 164.63 33.53 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.613 2.209 . . . . 0.0 114.22 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.3 t -102.6 -66.79 0.91 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.257 2.623 . . . . 0.0 109.383 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 129.492 3.117 . . . . 0.0 112.127 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.58 -141.8 8.23 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.469 1.509 . . . . 0.0 111.584 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.6 ptp -144.54 162.46 36.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.402 1.081 . . . . 0.0 112.198 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.88 134.18 52.35 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 109.921 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -135.9 163.21 30.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 0.0 110.441 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.923 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 2.0 t -69.59 172.71 6.96 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 124.213 1.959 . . . . 0.0 114.802 -169.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.9 1.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 112.715 -2.038 . . . . 0.0 112.512 165.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.7 m -115.04 -26.89 7.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.177 1.391 . . . . 0.0 112.364 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.923 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 11.9 p -115.83 -98.11 0.45 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.608 1.963 . . . . 0.0 111.337 173.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.25 -50.18 0.07 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 p -95.62 160.01 31.31 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 116.563 2.061 . . . . 0.0 116.563 -150.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.35 132.83 40.24 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.841 2.361 . . . . 0.0 112.276 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -33.65 5.74 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.902 1.281 . . . . 0.0 111.66 -166.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.34 158.64 30.06 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.373 -0.83 . . . . 0.0 112.712 168.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 p -94.96 132.87 39.33 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 122.677 1.227 . . . . 0.0 110.953 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -4.83 24.12 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.11 0.964 . . . . 0.0 113.405 172.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.91 -29.36 64.24 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.578 1.951 . . . . 0.0 113.576 170.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.01 1.74 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.952 1.301 . . . . 0.0 113.621 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -69.89 121.43 17.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.315 1.846 . . . . 0.0 114.304 -167.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.417 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 CA--C 1.535 0.555 0 CA-C-O 123.961 1.567 . . . . 0.0 113.979 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.7 p -158.55 142.29 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.798 2.439 . . . . 0.0 109.533 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -155.3 132.32 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.794 2.038 . . . . 0.0 107.733 -170.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 p -68.96 -24.32 64.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -139.82 142.55 36.64 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.479 0.657 . . . . 0.0 112.13 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.829 0 C-N-CA 125.186 1.395 . . . . 0.0 111.555 173.893 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.554 0 CA-C-O 121.131 0.295 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.87 178.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.712 2.005 . . . . 0.0 111.874 -172.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.42 -177.59 4.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.186 2.194 . . . . 0.0 108.915 166.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -139.39 155.0 47.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.273 1.829 . . . . 0.0 110.742 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 118.57 10.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.85 2.06 . . . . 0.0 107.149 168.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.97 138.53 33.76 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.269 -0.895 . . . . 0.0 111.338 172.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.3 23.01 14.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.739 1.216 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.2 t -71.1 38.65 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.81 2.444 . . . . 0.0 113.362 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.27 10.89 6.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.475 2.71 . . . . 0.0 112.387 -174.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.96 14.42 14.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.238 1.815 . . . . 0.0 112.462 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.28 -12.22 7.55 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 126.019 1.771 . . . . 0.0 113.561 -171.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.9 t -102.22 107.05 51.56 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 108.616 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.19 126.96 12.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.554 1.503 . . . . 0.0 110.623 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -147.89 156.03 42.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.478 2.711 . . . . 0.0 109.629 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.2 mtt -125.99 125.93 43.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.63 2.372 . . . . 0.0 106.994 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -116.39 154.46 30.23 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 110.926 173.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.16 137.24 55.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 125.408 1.483 . . . . 0.0 110.514 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.73 143.4 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.436 0.636 . . . . 0.0 111.516 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.638 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 39.7 t -70.05 108.02 3.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 160.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -63.72 -22.12 66.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.055 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -83.01 -39.5 21.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 112.574 -167.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.638 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 18.3 p -115.36 6.04 14.76 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.963 1.705 . . . . 0.0 114.249 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.36 60.34 3.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.497 . . . . 0.0 114.616 174.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -150.01 148.77 29.45 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -69.6 136.35 51.14 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.871 0.868 . . . . 0.0 111.263 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.31 -20.99 1.39 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.0 151.56 23.77 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 127.078 2.275 . . . . 0.0 112.52 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.66 166.71 22.91 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 126.141 1.776 . . . . 0.0 111.557 172.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.9 t -143.54 136.17 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.396 1.879 . . . . 0.0 108.212 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -148.57 153.97 40.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.42 1.088 . . . . 0.0 113.069 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.91 135.43 7.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.996 2.464 . . . . 0.0 109.91 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.37 -1.5 45.72 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.22 -40.8 0.51 Allowed Glycine 0 CA--C 1.542 1.749 0 CA-C-O 117.376 -1.791 . . . . 0.0 116.559 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.68 -167.59 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.451 2.767 . . . . 0.0 113.446 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -55.45 160.71 3.48 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.752 1.621 . . . . 0.0 112.345 171.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -59.93 -9.43 9.83 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.659 2.906 . . . . 0.0 114.136 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -22.64 62.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.507 1.523 . . . . 0.0 113.087 170.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.65 19.05 54.06 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 126.405 1.955 . . . . 0.0 115.893 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -73.34 146.72 45.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -110.13 144.53 38.62 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.197 1.399 . . . . 0.0 109.308 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -91.39 137.66 32.19 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.009 1.724 . . . . 0.0 110.068 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.7 p -132.01 132.28 43.29 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.04 1.736 . . . . 0.0 112.769 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.2 mm -80.92 154.99 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.115 1.366 . . . . 0.0 110.611 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -91.22 -13.12 33.39 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.7 m 57.14 82.68 0.11 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.067 2.147 . . . . 0.0 114.417 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.455 HG11 ' H ' ' A' ' 124' ' ' ALA 0.299 3.4 p -93.57 -96.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 111.529 167.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.455 ' H ' HG11 ' A' ' 123' ' ' VAL . . . -157.07 20.92 0.31 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -166.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.99 173.98 6.79 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.687 1.585 . . . . 0.0 113.166 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.26 163.17 12.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.202 1.801 . . . . 0.0 112.735 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -150.79 148.16 28.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.169 1.387 . . . . 0.0 111.861 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -140.4 149.87 59.04 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.069 1.348 . . . . 0.0 111.525 170.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.83 171.32 10.73 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.081 2.521 . . . . 0.0 114.533 -165.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.02 -40.5 11.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.065 1.346 . . . . 0.0 113.903 -173.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 127.598 2.359 . . . . 0.0 113.76 -169.822 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.128 0.489 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.71 -153.12 14.22 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.124 0.868 . . . . 0.0 114.47 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.7 ptp -154.12 161.05 42.15 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.329 1.061 . . . . 0.0 112.895 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -120.0 148.37 43.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.787 2.435 . . . . 0.0 110.553 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.35 159.87 42.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.812 2.045 . . . . 0.0 109.503 -167.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 83.7 m -74.11 165.7 24.7 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.158 1.456 . . . . 0.0 111.802 158.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.62 -9.98 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.853 -1.522 . . . . 0.0 113.948 154.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 t -83.24 -46.34 12.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 112.441 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 15.1 p -85.15 -87.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.895 1.278 . . . . 0.0 111.337 170.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -148.9 -57.02 0.21 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.0 p -130.14 156.0 79.93 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -135.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.69 139.45 40.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.502 2.801 . . . . 0.0 112.732 164.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 mt -143.94 -18.78 0.58 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -135.2 134.71 40.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.317 1.417 . . . . 0.0 111.313 -167.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -101.51 122.06 43.11 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.959 1.303 . . . . 0.0 111.007 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -60.15 -15.45 24.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.475 1.51 . . . . 0.0 113.578 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.51 -31.27 67.73 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 130.252 3.421 . . . . 0.0 113.269 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' N ' ' HE2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -74.25 4.09 6.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.828 1.251 . . . . 0.0 111.793 177.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -62.61 134.72 56.75 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 120.661 -1.275 . . . . 0.0 114.018 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 CA--C 1.543 0.681 0 C-N-CA 127.179 2.192 . . . . 0.0 111.519 -176.617 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.54 0.82 0 N-CA-C 115.206 1.195 . . . . 0.0 115.206 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -129.91 178.51 6.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.78 142.35 17.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.821 3.649 . . . . 0.0 106.801 159.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 p -73.75 -35.1 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 111.402 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -146.33 157.32 43.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.718 1.247 . . . . 0.0 114.195 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 125.939 1.696 . . . . 0.0 110.113 166.576 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 pt -117.54 155.98 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.868 1.834 . . . . 0.0 114.564 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.497 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -136.08 176.62 8.52 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.595 2.758 . . . . 0.0 110.733 177.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.497 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -138.43 141.91 39.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.036 1.334 . . . . 0.0 113.375 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.42 112.7 10.53 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 108.314 173.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.6 mp -80.6 157.28 26.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 125.886 1.674 . . . . 0.0 111.076 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -131.18 108.89 10.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 t -118.44 24.5 10.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.032 1.396 . . . . 0.0 109.836 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.62 -6.71 9.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.393 1.877 . . . . 0.0 113.682 -154.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.5 mt -105.26 18.66 21.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.071 2.148 . . . . 0.0 112.689 170.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -7.01 64.45 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.061 1.315 . . . . 0.0 115.392 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 52.4 t -127.79 112.99 20.59 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.892 1.677 . . . . 0.0 109.648 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.68 125.88 7.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.778 2.319 . . . . 0.0 114.039 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -129.42 154.2 47.18 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.129 2.572 . . . . 0.0 110.222 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mtm -127.49 127.13 43.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.364 1.866 . . . . 0.0 108.224 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -123.25 144.59 49.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.813 0.816 . . . . 0.0 109.776 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.55 144.5 21.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.471 1.108 . . . . 0.0 109.608 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.4 m -128.28 151.82 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 0.0 111.301 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.831 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.2 t -93.02 119.04 31.86 Favored 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 126.71 2.004 . . . . 0.0 105.886 174.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -69.5 -16.77 63.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.606 1.962 . . . . 0.0 111.974 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -83.95 -45.84 12.72 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.831 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 2.2 p -106.78 -7.59 17.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.601 1.961 . . . . 0.0 113.835 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 63.15 40.76 8.64 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.24 1.816 . . . . 0.0 113.066 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.92 154.46 51.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.451 1.5 . . . . 0.0 111.907 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -80.98 90.06 5.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.145 0.978 . . . . 0.0 113.149 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -74.3 8.59 2.1 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -175.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.68 179.63 30.06 Favored Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.002 -1.061 . . . . 0.0 114.065 165.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 156.49 44.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 111.684 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.03 137.47 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.316 1.055 . . . . 0.0 111.751 -173.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.83 151.2 45.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 113.063 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.53 133.44 10.55 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.043 2.495 . . . . 0.0 109.305 162.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -93.87 1.57 56.35 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.43 -62.19 0.28 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.387 -1.229 . . . . 0.0 114.396 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.37 -177.12 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.549 2.832 . . . . 0.0 112.967 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.77 149.83 4.23 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.254 1.022 . . . . 0.0 111.506 170.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.51 -3.77 9.64 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.975 2.45 . . . . 0.0 114.149 -171.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.9 p -54.92 -30.94 59.62 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.639 -0.663 . . . . 0.0 111.943 162.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.9 10.13 74.91 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.882 2.182 . . . . 0.0 117.091 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -50.96 148.81 3.93 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.209 1.504 . . . . 0.0 113.957 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.7 132.02 43.57 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.695 1.198 . . . . 0.0 110.828 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.7 125.35 45.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.105 1.362 . . . . 0.0 110.275 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.5 p -108.13 126.06 52.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.897 2.079 . . . . 0.0 109.618 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.403 HD11 ' H ' ' A' ' 121' ' ' ASN . 7.1 tp -92.41 156.8 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.844 0.831 . . . . 0.0 109.845 176.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' H ' HD11 ' A' ' 120' ' ' ILE . 11.3 p30 -126.92 163.0 24.62 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.461 1.905 . . . . 0.0 109.957 169.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 m -96.42 18.43 13.97 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 p -47.39 -48.93 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -159.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.61 24.07 0.34 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.2 mt -125.07 154.92 40.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.426 1.09 . . . . 0.0 112.16 -161.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -128.01 157.14 41.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.779 2.032 . . . . 0.0 113.917 -171.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.4 143.16 33.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -167.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -137.94 152.98 73.23 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.597 1.559 . . . . 0.0 110.875 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.02 179.59 5.59 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.538 2.159 . . . . 0.0 112.022 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.447 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 5.8 t -102.59 -57.7 2.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.967 1.707 . . . . 0.0 111.469 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.447 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 9.3 mmpt? . . . . . 0 CA--C 1.554 1.102 0 C-N-CA 126.419 1.888 . . . . 0.0 112.976 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.62 -158.52 20.82 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 172.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ptp -155.2 167.55 29.99 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.436 1.494 . . . . 0.0 112.647 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.45 ' HH ' HD13 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -120.98 151.17 40.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 112.253 157.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -138.16 164.59 28.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.039 2.136 . . . . 0.0 109.834 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.593 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 59.4 m -62.16 169.72 2.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 124.085 1.898 . . . . 0.0 114.712 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 p -115.6 -2.37 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.952 -2.385 . . . . 0.0 112.301 169.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.2 m -124.57 -18.35 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -169.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 12.7 p -125.9 -101.29 0.37 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.137 1.375 . . . . 0.0 112.008 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -159.71 -35.77 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.404 2.282 . . . . 0.0 113.538 -170.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.44 124.32 87.96 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -157.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.43 127.02 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.066 1.844 . . . . 0.0 110.363 156.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.72 -45.07 1.63 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.931 -158.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -126.31 121.12 31.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.825 -171.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 p -82.28 131.13 35.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.185 0.993 . . . . 0.0 108.903 166.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -58.45 -13.95 6.66 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.236 1.815 . . . . 0.0 112.321 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.11 -43.6 87.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 127.098 2.159 . . . . 0.0 114.548 168.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.8 mmpt? -72.83 -2.09 19.27 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.215 1.406 . . . . 0.0 113.222 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -78.36 137.5 38.06 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.628 1.971 . . . . 0.0 110.522 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 CA--C 1.541 0.625 0 CA-C-O 123.0 1.381 . . . . 0.0 111.571 179.633 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.533 0.442 0 CA-C-O 124.618 1.841 . . . . 0.0 113.887 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.1 p -152.0 161.82 42.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 128.599 2.76 . . . . 0.0 110.427 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -157.15 168.29 27.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.365 2.266 . . . . 0.0 106.559 -169.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -127.55 -7.07 5.73 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 164.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -135.12 147.9 49.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 122.139 0.971 . . . . 0.0 111.858 160.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.461 0 C-N-CA 126.689 1.995 . . . . 0.0 105.811 165.358 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.616 0 CA-C-O 119.844 -0.42 . . . . 0.0 113.914 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -74.12 178.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 122.766 1.27 . . . . 0.0 113.091 -171.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 HD22 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.55 171.87 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.707 1.603 . . . . 0.0 110.152 174.136 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.428 ' H ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -160.79 157.78 27.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.766 1.627 . . . . 0.0 111.512 177.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -149.94 123.7 9.24 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.005 2.122 . . . . 0.0 107.916 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.03 147.35 42.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.745 161.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.04 23.27 11.47 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.201 1.001 . . . . 0.0 113.311 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.4 m -71.25 41.77 0.07 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.281 3.032 . . . . 0.0 112.876 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.88 -1.25 2.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 127.091 2.156 . . . . 0.0 113.438 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.9 mt -102.46 20.29 17.3 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.713 2.005 . . . . 0.0 112.224 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -9.11 60.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.049 1.309 . . . . 0.0 114.75 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.2 t -136.37 134.41 19.88 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 110.608 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 140.89 37.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.149 2.566 . . . . 0.0 113.366 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.2 mmt-85 -146.34 156.04 43.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.631 1.972 . . . . 0.0 111.308 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.25 119.81 20.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.608 1.563 . . . . 0.0 108.928 171.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -137.71 148.34 45.58 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.631 -0.668 . . . . 0.0 112.207 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.18 142.8 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.316 1.446 . . . . 0.0 112.296 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.91 157.43 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.807 1.243 . . . . 0.0 110.353 -172.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 49.1 t -92.98 128.43 38.85 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 123.008 1.385 . . . . 0.0 107.517 163.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -20.09 21.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.575 1.95 . . . . 0.0 112.166 170.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.82 -39.31 93.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.152 0.887 . . . . 0.0 112.616 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 1.095 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 1.6 p -119.05 -2.59 10.75 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.702 2.001 . . . . 0.0 114.856 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 52.43 63.67 2.15 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.461 1.505 . . . . 0.0 112.141 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -129.91 131.49 46.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.337 1.055 . . . . 0.0 112.04 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -90.87 103.29 16.02 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.194 -0.941 . . . . 0.0 109.578 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.0 mt -103.36 -40.49 6.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -160.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.51 148.63 20.02 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.873 1.702 . . . . 0.0 113.763 -161.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 159.35 42.95 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.468 1.107 . . . . 0.0 111.831 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.04 139.82 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 122.634 1.207 . . . . 0.0 111.37 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -147.95 154.98 44.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.572 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.39 135.79 13.61 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.681 2.921 . . . . 0.0 111.361 171.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -74.7 -4.61 38.44 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.95 -62.65 0.24 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.985 1.755 . . . . 0.0 114.213 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.12 -156.27 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.007 3.138 . . . . 0.0 112.707 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.96 160.51 0.81 Allowed Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 125.085 1.354 . . . . 0.0 112.217 170.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -58.34 -6.08 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.651 2.901 . . . . 0.0 114.949 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -30.17 67.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.011 0.924 . . . . 0.0 112.446 164.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.3 30.85 6.42 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 126.664 2.078 . . . . 0.0 114.995 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -72.37 143.23 48.66 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.313 1.045 . . . . 0.0 112.923 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -131.06 127.0 37.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.366 1.066 . . . . 0.0 109.629 169.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.25 127.77 38.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.035 0.534 . . . . 0.0 109.978 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 m -126.06 134.22 51.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.953 1.701 . . . . 0.0 110.081 -171.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.45 HD13 ' HH ' ' A' ' 38' ' ' TYR . 5.9 tt -131.61 164.2 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.142 . . . . 0.0 110.624 -171.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.02 -55.41 1.28 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 m 45.85 34.66 1.97 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.77 -24.67 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -157.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -139.63 17.17 2.53 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.773 1.629 . . . . 0.0 114.415 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.93 179.55 7.52 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.918 -1.114 . . . . 0.0 111.192 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -101.67 134.39 44.88 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.244 -0.91 . . . . 0.0 111.405 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -139.27 137.72 36.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.454 -171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -144.26 143.49 22.43 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.718 1.207 . . . . 0.0 110.831 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.12 168.53 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.472 1.448 . . . . 0.0 110.955 164.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.28 -44.68 5.34 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.666 1.186 . . . . 0.0 112.705 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 124.524 1.13 . . . . 0.0 112.488 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.43 23.11 8.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.586 1.954 . . . . 0.0 115.048 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -135.22 174.92 10.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.292 1.437 . . . . 0.0 114.327 -162.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -121.86 -25.81 4.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.821 1.248 . . . . 0.0 113.6 153.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -58.58 -64.28 0.98 Allowed 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 128.481 2.712 . . . . 0.0 111.965 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -64.21 -24.64 67.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.962 1.705 . . . . 0.0 113.302 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -74.47 -35.42 63.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.634 1.574 . . . . 0.0 112.849 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.2 mt -87.1 -27.07 23.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.719 1.208 . . . . 0.0 113.41 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -138.73 68.84 44.36 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 125.245 1.418 . . . . 0.0 111.67 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.27 157.57 49.25 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.295 2.663 . . . . 0.0 112.952 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -120.1 -78.61 0.59 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.247 1.019 . . . . 0.0 111.342 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -60.73 -28.08 68.41 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -85.95 -16.78 37.31 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.62 1.568 . . . . 0.0 113.832 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -89.24 -52.13 5.22 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.703 -0.623 . . . . 0.0 112.496 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.9 -33.91 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 O-C-N 121.723 -0.611 . . . . 0.0 111.409 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 p -66.22 -18.82 65.59 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.717 2.007 . . . . 0.0 115.38 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -87.62 -37.48 16.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.123 1.369 . . . . 0.0 112.37 164.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.21 -14.47 62.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.513 0.725 . . . . 0.0 112.454 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -66.04 54.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.442 1.897 . . . . 0.0 113.39 166.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.0 -4.66 0.04 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 169.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 t -140.04 159.99 40.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 123.635 1.683 . . . . 0.0 113.523 -169.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.15 163.36 12.32 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 127.465 2.306 . . . . 0.0 109.569 156.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.04 144.14 33.95 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.65 178.68 6.81 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.243 3.295 . . . . 0.0 111.225 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.5 t80 56.07 25.38 8.86 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 123.865 1.793 . . . . 0.0 113.402 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.29 -23.57 0.94 Allowed 'General case' 0 N--CA 1.469 0.488 1 C-N-CA 131.806 4.042 . . . . 0.0 114.332 -178.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.1 -101.91 0.31 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.75 1.643 . . . . 0.0 113.508 164.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.4 mtp -58.36 -18.5 28.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -2.41 58.1 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.694 1.198 . . . . 0.0 113.566 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.51 -13.25 49.61 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 119.715 -1.865 . . . . 0.0 115.069 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -91.55 -163.46 1.04 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.643 1.577 . . . . 0.0 112.84 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -68.28 160.97 28.3 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.22 -0.925 . . . . 0.0 111.434 170.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -135.44 112.52 10.36 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.253 1.421 . . . . 0.0 110.083 168.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.06 177.23 0.13 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.7 m -85.54 164.78 17.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.02 168.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.34 -150.51 21.0 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.457 -0.777 . . . . 0.0 112.068 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.13 169.81 20.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.072 1.349 . . . . 0.0 112.645 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.56 144.71 50.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.247 2.619 . . . . 0.0 110.764 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -147.08 160.55 42.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 111.327 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.9 m -64.6 154.21 36.98 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 123.056 1.408 . . . . 0.0 112.077 171.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.269 9.0 p -113.8 27.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.808 153.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.21 -41.4 3.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.534 1.534 . . . . 0.0 112.104 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.5 p -109.99 -103.53 0.38 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.674 1.59 . . . . 0.0 112.444 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.55 -40.51 0.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.878 2.471 . . . . 0.0 113.37 -163.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -98.02 137.15 20.85 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -152.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.85 139.65 15.69 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.094 2.529 . . . . 0.0 111.531 161.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.19 -29.71 0.88 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -165.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -132.04 126.97 35.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.559 1.072 . . . . 0.0 111.548 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.1 m -86.82 133.23 33.66 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 120.659 -1.276 . . . . 0.0 110.798 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -11.93 23.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.124 1.37 . . . . 0.0 112.931 171.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -35.81 71.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.22 7.49 24.97 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.227 1.011 . . . . 0.0 112.465 176.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -61.37 131.97 52.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.068 0.849 . . . . 0.0 109.658 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -66.62 68.87 0.06 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 122.716 1.245 . . . . 0.0 112.582 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 7.2 t -73.18 172.65 10.7 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.35 1.46 . . . . 0.0 110.787 168.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.316 11.7 p 50.78 10.78 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.92 -69.98 0.49 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 127.011 2.243 . . . . 0.0 110.241 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.84 -17.69 3.53 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.584 0.754 . . . . 0.0 112.784 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.09 -0.74 13.75 Favored Glycine 0 CA--C 1.538 1.525 0 O-C-N 120.498 -1.376 . . . . 0.0 114.448 -173.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.402 ' CG ' ' HD2' ' A' ' 61' ' ' PRO . 74.6 t90 -65.71 162.14 46.62 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 128.754 2.822 . . . . 0.0 112.102 -172.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD2' ' CG ' ' A' ' 60' ' ' TRP . 71.4 Cg_endo -75.15 81.42 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.578 2.185 . . . . 0.0 116.392 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -135.28 154.31 51.59 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 128.516 2.726 . . . . 0.0 110.806 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -138.45 107.04 5.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.885 1.674 . . . . 0.0 111.014 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.7 p -63.99 -15.07 58.48 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.25 160.62 40.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.373 0.669 . . . . 0.0 109.387 138.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.82 72.73 1.09 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.314 1.046 . . . . 0.0 109.259 166.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -94.67 128.6 41.45 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -154.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.23 -24.85 0.15 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.229 1.871 . . . . 0.0 113.698 173.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.7 p -142.42 154.27 44.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.405 1.482 . . . . 0.0 112.979 -168.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 132.46 18.83 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.627 1.571 . . . . 0.0 112.909 -170.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.58 -81.39 0.06 OUTLIER Glycine 0 N--CA 1.47 0.933 0 C-N-CA 126.957 2.218 . . . . 0.0 114.067 155.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -54.54 -30.93 55.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.763 1.225 . . . . 0.0 111.917 168.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -87.46 -2.01 58.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -74.8 -14.16 60.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.644 1.178 . . . . 0.0 113.344 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.5 t -95.31 -36.21 11.49 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.824 1.249 . . . . 0.0 111.271 163.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -68.57 -38.03 80.36 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.052 -1.03 . . . . 0.0 113.485 -173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -32.98 65.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.928 2.091 . . . . 0.0 113.639 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.17 16.69 75.29 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.238 -0.757 . . . . 0.0 112.33 -172.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -96.27 148.86 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.048 0.924 . . . . 0.0 111.232 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.43 174.12 8.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.821 2.848 . . . . 0.0 110.197 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.08 156.84 33.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.003 1.321 . . . . 0.0 112.144 -167.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.95 121.89 3.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.405 1.882 . . . . 0.0 110.083 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -97.24 154.07 17.63 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.338 1.855 . . . . 0.0 112.237 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -147.99 111.15 4.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.729 1.212 . . . . 0.0 110.21 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.7 t -118.95 19.85 12.91 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.811 1.767 . . . . 0.0 112.834 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 -15.15 28.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.252 1.421 . . . . 0.0 114.009 -154.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.0 mt -84.94 10.61 11.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.806 1.642 . . . . 0.0 112.914 166.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.16 -5.01 81.41 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.63 1.586 . . . . 0.0 114.653 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 10.0 t -137.19 129.65 16.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.258 1.023 . . . . 0.0 111.401 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.57 135.11 12.82 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.126 2.551 . . . . 0.0 114.373 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.6 mmt-85 -127.77 157.3 40.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 129.967 3.307 . . . . 0.0 109.315 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.4 mtm -133.44 132.84 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.355 1.862 . . . . 0.0 108.308 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -139.26 149.36 44.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 112.151 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.11 150.69 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.283 1.433 . . . . 0.0 111.916 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.42 155.02 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 109.927 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.6 t -92.6 128.41 38.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 158.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -84.02 -24.24 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.253 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -64.74 -43.95 91.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.854 0.862 . . . . 0.0 112.447 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.98 -15.07 18.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.66 2.384 . . . . 0.0 113.238 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.303 42.5 mt-10 64.31 24.82 13.38 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.935 2.094 . . . . 0.0 112.799 -168.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.82 98.32 8.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.796 2.039 . . . . 0.0 112.848 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -89.12 68.87 8.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.949 1.7 . . . . 0.0 112.345 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.59 -5.09 8.7 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -159.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.56 135.97 12.44 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.707 2.099 . . . . 0.0 112.171 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.49 152.8 33.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.09 0.956 . . . . 0.0 111.39 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.12 125.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 122.322 1.058 . . . . 0.0 112.834 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -129.76 145.06 55.48 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.802 1.241 . . . . 0.0 111.76 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.57 167.21 27.07 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.48 2.787 . . . . 0.0 112.419 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -109.14 -8.49 15.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.453 1.901 . . . . 0.0 115.336 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.1 -56.31 0.71 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.661 1.6 . . . . 0.0 114.512 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.75 -157.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 124.65 3.567 . . . . 0.0 113.271 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 154.98 13.56 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.661 1.584 . . . . 0.0 111.406 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -61.56 -7.48 8.99 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.443 2.762 . . . . 0.0 114.283 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 p -57.74 -26.78 62.3 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.876 1.27 . . . . 0.0 113.762 165.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.34 4.46 86.04 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.193 1.377 . . . . 0.0 116.054 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.94 149.88 8.48 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.98 127.39 50.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 110.99 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.37 103.14 12.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.253 1.421 . . . . 0.0 109.484 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.1 p -92.9 136.85 32.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.436 2.294 . . . . 0.0 110.55 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.05 133.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.158 -0.964 . . . . 0.0 109.239 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -110.48 133.04 53.65 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.0 m -82.71 16.37 2.23 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -164.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.66 -23.72 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.95 22.38 3.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.851 1.66 . . . . 0.0 113.576 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.4 mt -122.02 140.58 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.155 0.982 . . . . 0.0 112.993 -170.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -115.54 178.05 4.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.404 2.682 . . . . 0.0 112.15 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -150.63 148.31 28.47 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.467 1.107 . . . . 0.0 112.29 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -131.16 134.11 25.45 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.37 1.468 . . . . 0.0 109.41 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.86 171.57 15.28 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.185 2.59 . . . . 0.0 113.107 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -42.5 18.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.921 0.888 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -92.4 148.1 35.76 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.94 174.85 6.18 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.164 3.243 . . . . 0.0 114.889 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 64.49 3.17 1.8 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.417 2.287 . . . . 0.0 115.071 -165.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.26 -36.61 0.48 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.749 2.02 . . . . 0.0 110.785 161.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.25 132.32 42.02 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.279 -0.888 . . . . 0.0 110.49 155.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.1 tp -160.74 48.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.444 1.898 . . . . 0.0 109.523 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -47.79 40.25 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -160.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -92.3 163.38 13.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.869 0.868 . . . . 0.0 111.809 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -62.86 152.64 35.63 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.651 -0.656 . . . . 0.0 112.26 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -124.2 21.68 8.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.769 0.827 . . . . 0.0 112.979 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -103.95 172.69 6.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.983 1.313 . . . . 0.0 112.656 -160.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.66 -171.76 3.4 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.768 0.827 . . . . 0.0 111.947 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 . . . . . 0 C--O 1.249 1.028 0 C-N-CA 125.93 1.692 . . . . 0.0 115.407 -176.081 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.38 32.89 14.64 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.038 1.335 . . . . 0.0 114.111 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.79 -175.45 3.17 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.776 2.43 . . . . 0.0 111.26 172.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -113.09 -25.52 8.89 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.079 0.952 . . . . 0.0 112.672 159.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -59.31 -54.49 46.24 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.984 1.714 . . . . 0.0 112.966 -169.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -75.07 -24.91 58.26 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -63.85 -37.37 87.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.891 0.877 . . . . 0.0 112.156 165.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.7 mt -88.23 -20.85 24.96 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.838 1.655 . . . . 0.0 114.161 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 11.9 t -137.37 76.94 42.32 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 124.528 1.131 . . . . 0.0 112.371 168.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.26 178.07 8.09 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.029 3.153 . . . . 0.0 114.427 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -50.19 -46.45 54.4 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.57 -1.331 . . . . 0.0 112.956 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -58.08 -29.04 65.13 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -84.79 -26.24 27.64 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.548 1.539 . . . . 0.0 113.468 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.73 -45.84 23.55 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.996 1.319 . . . . 0.0 111.144 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.44 -19.71 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.205 1.402 . . . . 0.0 112.748 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.0 p -91.65 -31.28 15.91 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.163 2.185 . . . . 0.0 113.285 170.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -64.67 -49.06 72.43 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.338 1.455 . . . . 0.0 111.829 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.02 -4.39 49.64 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.32 1.048 . . . . 0.0 111.988 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -27.08 83.24 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 130.525 3.53 . . . . 0.0 116.141 -175.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.44 55.72 0.24 Allowed Glycine 0 N--CA 1.467 0.735 0 CA-C-N 111.477 -2.601 . . . . 0.0 111.773 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.3 t -110.24 128.9 55.75 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.755 1.622 . . . . 0.0 111.436 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -107.54 138.19 44.21 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.559 2.743 . . . . 0.0 107.43 162.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.59 150.33 14.38 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -171.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.99 179.7 5.83 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.525 2.816 . . . . 0.0 111.272 162.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 64.1 28.1 14.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.225 1.81 . . . . 0.0 114.887 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.55 -30.39 2.23 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 128.608 2.763 . . . . 0.0 114.674 164.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.63 -104.96 0.29 Allowed Glycine 0 N--CA 1.467 0.715 0 CA-C-N 119.967 1.258 . . . . 0.0 114.25 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 10.5 ttm -56.83 -23.03 40.98 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.272 1.029 . . . . 0.0 113.495 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -85.05 -6.59 59.32 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 117.958 -1.02 . . . . 0.0 113.496 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -79.64 47.95 0.89 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 121.135 1.789 . . . . 0.0 113.692 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -139.71 172.65 12.49 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.058 1.743 . . . . 0.0 113.071 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -68.58 158.51 33.83 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.598 0.759 . . . . 0.0 112.121 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -122.2 99.14 6.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.085 -1.009 . . . . 0.0 111.427 -159.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.03 170.19 15.95 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -167.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -76.77 164.63 25.67 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.081 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.81 -154.53 26.0 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 125.369 1.461 . . . . 0.0 112.266 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 21.8 ptm -158.08 162.97 38.1 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -125.84 142.12 51.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.664 2.786 . . . . 0.0 110.77 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -154.91 166.23 34.18 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.343 1.857 . . . . 0.0 110.428 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 4.5 t -80.98 172.84 13.24 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.132 1.444 . . . . 0.0 113.298 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.07 -9.06 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.173 1.789 . . . . 0.0 112.908 163.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 92.4 m -103.99 -33.45 8.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.959 1.303 . . . . 0.0 113.648 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.462 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -99.32 -100.49 0.23 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.759 1.223 . . . . 0.0 111.619 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -165.09 -62.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.36 145.12 29.13 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -161.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.43 151.58 70.95 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.236 2.624 . . . . 0.0 111.214 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.2 tp -137.83 -33.81 0.7 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -166.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -144.98 140.27 28.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.161 1.346 . . . . 0.0 114.205 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -98.56 144.41 27.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.011 0.925 . . . . 0.0 112.965 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -13.21 40.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.161 1.384 . . . . 0.0 113.407 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -24.87 66.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -87.19 -3.08 59.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.828 2.451 . . . . 0.0 113.312 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 127.76 33.7 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.992 1.317 . . . . 0.0 110.864 -170.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.88 117.08 10.1 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -166.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.5 m -84.65 56.09 3.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.5 1.12 . . . . 0.0 113.659 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.0 p -70.91 164.48 25.31 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.495 -0.753 . . . . 0.0 111.87 168.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.86 -1.82 26.81 Favored Glycine 0 CA--C 1.541 1.694 0 O-C-N 121.139 -0.976 . . . . 0.0 114.908 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.68 -25.45 13.85 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.017 1.727 . . . . 0.0 112.17 169.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.57 6.01 61.53 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.295 1.426 . . . . 0.0 113.598 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.407 ' CD1' ' HD2' ' A' ' 61' ' ' PRO . 91.8 t90 -50.56 144.49 12.36 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.193 1.797 . . . . 0.0 113.646 -166.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD2' ' CD1' ' A' ' 60' ' ' TRP . 37.5 Cg_endo -65.58 100.33 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.173 2.582 . . . . 0.0 114.166 -171.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.2 p -158.74 156.56 30.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.695 2.798 . . . . 0.0 110.016 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.08 158.78 43.57 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 108.072 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.2 p -91.62 -20.13 21.97 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 127.243 2.217 . . . . 0.0 112.71 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -150.87 152.96 34.45 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.591 1.156 . . . . 0.0 112.199 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.62 91.65 3.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.033 1.333 . . . . 0.0 109.588 166.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -133.81 129.66 36.86 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.441 1.496 . . . . 0.0 108.871 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.96 -28.0 0.12 Allowed Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.814 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.4 ' O ' ' HE2' ' A' ' 70' ' ' LYS . 92.4 p -86.96 150.13 24.29 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.059 1.429 . . . . 0.0 111.064 163.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -151.94 141.61 21.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 129.134 2.974 . . . . 0.0 111.798 -175.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.68 -79.08 0.09 OUTLIER Glycine 0 N--CA 1.472 1.068 0 C-N-CA 126.676 2.084 . . . . 0.0 115.03 155.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.85 -27.71 65.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.542 0.737 . . . . 0.0 112.651 167.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -121.6 108.55 13.71 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.708 0.766 . . . . 0.0 109.27 156.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -172.17 13.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.789 2.036 . . . . 0.0 111.992 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.5 t -74.98 -34.85 62.05 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.194 -0.941 . . . . 0.0 109.74 -170.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -127.75 -60.15 1.18 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.434 1.094 . . . . 0.0 113.9 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.1 p -167.06 -37.3 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -161.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.33 -33.15 2.75 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 125.557 1.551 . . . . 0.0 112.507 -164.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.59 164.97 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.471 1.909 . . . . 0.0 112.494 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.09 177.8 4.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.579 1.552 . . . . 0.0 109.408 158.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.28 155.96 38.72 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.657 -174.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -151.98 121.16 6.71 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.262 1.825 . . . . 0.0 108.49 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.51 135.69 38.25 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.55 -0.719 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -94.01 25.53 3.66 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 122.389 1.09 . . . . 0.0 111.195 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -75.8 45.99 0.36 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.816 2.446 . . . . 0.0 111.305 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -127.19 -13.16 5.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.128 2.171 . . . . 0.0 113.287 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.14 18.39 21.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.941 2.496 . . . . 0.0 112.633 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.91 -6.67 54.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.686 1.136 . . . . 0.0 114.643 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.3 t -133.53 133.61 22.8 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.885 1.674 . . . . 0.0 110.628 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.38 152.48 60.79 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.623 2.882 . . . . 0.0 114.214 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -146.26 164.21 33.03 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 128.859 2.864 . . . . 0.0 109.763 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.4 ttp -119.0 135.33 54.67 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 151.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 153.16 42.41 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.714 1.206 . . . . 0.0 110.709 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.41 148.49 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 122.103 0.954 . . . . 0.0 112.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.82 148.87 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.431 1.093 . . . . 0.0 112.327 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.72 107.95 10.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.429 2.292 . . . . 0.0 104.898 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -74.99 -14.2 60.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 168.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -61.58 -40.13 93.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 112.205 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.8 p -124.76 -5.46 7.51 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 9.4 tt0 73.38 53.71 0.12 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.215 2.206 . . . . 0.0 116.118 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.0 153.43 41.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 113.922 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 134.96 55.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.65 1.58 . . . . 0.0 113.064 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 tp -123.98 -15.48 6.85 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -165.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.82 179.55 34.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.731 2.11 . . . . 0.0 112.486 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -179.48 6.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.495 1.141 . . . . 0.0 113.816 -167.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.2 137.17 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.73 2.012 . . . . 0.0 109.576 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.26 149.42 48.26 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.315 1.446 . . . . 0.0 112.249 -172.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.88 143.46 16.44 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.826 2.35 . . . . 0.0 109.805 160.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.84 22.94 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.838 -1.164 . . . . 0.0 113.557 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.59 -46.34 1.15 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 127.157 2.313 . . . . 0.0 115.887 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -83.53 -163.48 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.34 2.693 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 151.9 63.49 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 113.258 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.28 -15.84 50.74 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.189 2.593 . . . . 0.0 113.215 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 p -56.67 -23.4 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.022 1.329 . . . . 0.0 113.186 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 9.76 64.9 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.463 2.459 . . . . 0.0 116.603 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -53.03 152.32 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.302 1.551 . . . . 0.0 114.246 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -136.94 154.44 50.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.883 2.073 . . . . 0.0 108.957 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -92.94 142.5 27.23 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.524 0.73 . . . . 0.0 110.498 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.5 p -121.0 143.2 49.17 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.744 1.618 . . . . 0.0 112.561 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.35 165.3 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.21 -0.931 . . . . 0.0 112.755 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.89 126.41 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.063 1.345 . . . . 0.0 114.162 -165.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -77.62 46.52 0.55 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.173 1.789 . . . . 0.0 112.954 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.18 -47.28 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.465 1.506 . . . . 0.0 113.398 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.29 4.66 0.05 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.565 1.546 . . . . 0.0 114.058 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.0 mt -85.8 159.59 19.69 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.746 1.619 . . . . 0.0 110.382 -164.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -103.95 133.68 48.5 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.142 0.977 . . . . 0.0 112.989 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.1 138.94 14.26 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.36 -0.838 . . . . 0.0 111.773 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -138.31 153.32 72.83 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.891 1.277 . . . . 0.0 111.997 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.16 170.6 20.02 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.972 2.448 . . . . 0.0 112.859 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.428 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -91.74 -43.06 9.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.812 0.845 . . . . 0.0 111.73 -176.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 8.4 mmpt? -66.06 150.03 97.1 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.678 1.591 . . . . 0.0 114.767 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -66.37 177.65 3.09 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.484 2.79 . . . . 0.0 113.319 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 61.15 17.4 8.07 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.337 1.855 . . . . 0.0 114.242 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.93 1.27 1.65 Allowed 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.49 162.26 37.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.067 1.347 . . . . 0.0 111.586 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.2 tp -157.48 60.95 0.49 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.237 1.815 . . . . 0.0 108.406 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -72.98 -55.12 7.0 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.855 1.662 . . . . 0.0 114.172 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.66 162.74 25.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.016 1.28 . . . . 0.0 114.247 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -66.82 136.45 55.45 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.423 -0.798 . . . . 0.0 110.024 160.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -96.3 -150.57 0.33 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -156.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 56.23 33.29 21.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.308 1.843 . . . . 0.0 115.611 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -141.73 176.3 9.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.846 1.258 . . . . 0.0 110.213 168.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.192 1.397 . . . . 0.0 110.485 172.368 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.88 29.8 2.29 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.035 0.934 . . . . 0.0 112.902 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -142.62 162.44 35.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.383 1.473 . . . . 0.0 111.321 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -87.97 -26.93 22.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.487 0.715 . . . . 0.0 111.691 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -56.65 -41.23 76.82 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.506 1.522 . . . . 0.0 110.386 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -68.27 -33.76 74.95 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.868 1.267 . . . . 0.0 113.708 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -75.66 -39.87 56.96 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.051 0.94 . . . . 0.0 112.115 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -85.49 -21.06 28.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.2 1.0 . . . . 0.0 112.971 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.33 78.13 76.37 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.959 1.703 . . . . 0.0 109.17 169.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.9 -173.19 1.66 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.247 3.298 . . . . 0.0 114.181 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -51.26 -49.49 61.08 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.58 1.952 . . . . 0.0 114.289 -171.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -58.0 -38.36 75.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.311 0.644 . . . . 0.0 112.054 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -72.23 -40.72 67.56 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.303 0.641 . . . . 0.0 112.017 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -45.8 87.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.893 1.277 . . . . 0.0 110.492 173.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.29 -39.1 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.574 0.749 . . . . 0.0 112.481 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 p -84.15 -22.62 30.96 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 119.696 1.135 . . . . 0.0 113.625 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -67.43 -40.5 85.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.069 2.148 . . . . 0.0 110.074 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 20' ' ' GLY . 76.1 mm-40 -94.71 -54.66 3.41 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.874 0.734 . . . . 0.0 111.357 173.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.9 tptp 42.58 6.75 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 121.795 3.998 . . . . 0.0 121.795 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 18' ' ' GLU . . . -135.01 -17.83 0.88 Allowed Glycine 0 C--N 1.305 -1.192 0 C-N-CA 127.688 2.566 . . . . 0.0 114.193 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 t -147.88 169.54 19.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.383 1.873 . . . . 0.0 110.567 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -112.92 173.18 6.51 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.431 148.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.09 150.97 66.83 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.397 1.079 . . . . 0.0 110.766 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.15 96.37 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.355 2.037 . . . . 0.0 111.721 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -76.62 15.17 0.67 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 -173.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 178.13 -24.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 128.546 2.738 . . . . 0.0 112.741 -172.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.67 -98.91 0.09 OUTLIER Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.82 1.2 . . . . 0.0 114.527 171.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 29.6 mtm -57.47 -17.68 14.63 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 169.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.62 7.35 45.29 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.663 1.585 . . . . 0.0 113.864 172.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mt -116.18 -4.24 11.95 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.87 -9.91 58.99 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -171.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -4.42 32.76 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -162.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.59 117.29 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 129.419 3.088 . . . . 0.0 115.993 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -76.19 165.52 24.79 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.7 m -144.01 158.07 43.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.68 2.792 . . . . 0.0 108.629 168.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.92 -144.45 10.73 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.088 1.328 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ptm -132.74 162.75 30.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 112.517 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.96 139.76 52.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.962 2.905 . . . . 0.0 109.54 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.41 168.05 23.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.564 1.945 . . . . 0.0 109.423 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.91 173.93 1.66 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 123.28 1.514 . . . . 0.0 112.578 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 p -122.98 -6.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.444 151.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.2 m -108.93 -27.73 9.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -168.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.8 p -109.28 -95.25 0.4 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.753 1.621 . . . . 0.0 112.017 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -157.37 -55.43 0.08 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.8 154.5 50.27 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 -154.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.37 143.86 71.69 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.169 1.913 . . . . 0.0 110.889 161.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.85 -51.93 2.64 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.374 1.07 . . . . 0.0 111.888 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -145.66 158.69 43.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.826 0.822 . . . . 0.0 112.033 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 p -85.63 135.05 33.95 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.441 1.096 . . . . 0.0 108.813 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -6.79 12.52 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.233 -0.917 . . . . 0.0 112.871 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -44.33 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 160.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -67.01 -10.5 50.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.862 1.665 . . . . 0.0 113.132 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -78.55 127.71 32.53 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.655 1.982 . . . . 0.0 110.969 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.89 117.68 34.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.052 2.141 . . . . 0.0 105.976 170.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 10.3 t -171.08 152.42 3.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 111.736 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.6 p -150.77 28.33 0.7 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.535 1.534 . . . . 0.0 111.957 161.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.86 -65.21 2.94 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 120.637 -1.289 . . . . 0.0 111.176 -163.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.05 -32.12 61.46 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.375 1.07 . . . . 0.0 112.235 170.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -19.6 59.2 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 117.941 -1.477 . . . . 0.0 114.254 165.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.3 t90 58.93 134.77 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.352 0 N-CA-C 118.079 2.622 . . . . 0.0 118.079 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.71 107.1 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.874 2.383 . . . . 0.0 114.479 -163.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.9 p -140.95 158.12 44.38 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.215 1.806 . . . . 0.0 110.881 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.23 114.62 6.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.141 0.976 . . . . 0.0 108.976 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -73.07 -20.84 60.88 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.387 -0.821 . . . . 0.0 112.925 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -145.06 148.54 33.8 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.137 -0.977 . . . . 0.0 112.441 -174.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.34 85.19 2.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.992 1.317 . . . . 0.0 109.45 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -135.11 113.99 11.94 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.318 1.047 . . . . 0.0 110.67 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 167.91 -37.44 0.22 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.005 1.764 . . . . 0.0 111.431 -170.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -69.85 148.5 48.98 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 142.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.91 145.13 6.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.143 2.177 . . . . 0.0 113.108 158.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.29 -92.83 1.01 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.976 1.75 . . . . 0.0 111.332 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -45.68 -39.09 7.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.724 2.01 . . . . 0.0 115.243 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.37 -31.19 65.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.745 2.018 . . . . 0.0 115.367 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -100.48 20.46 14.91 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 127.114 2.166 . . . . 0.0 111.353 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -77.53 -34.63 53.87 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.302 152.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -137.47 -66.29 0.51 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -171.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.1 p -164.42 -44.3 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 128.715 2.806 . . . . 0.0 111.47 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.95 -14.89 24.21 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 126.566 2.031 . . . . 0.0 113.968 -167.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.97 178.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 127.124 2.17 . . . . 0.0 110.455 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.51 175.2 8.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.857 2.063 . . . . 0.0 107.948 159.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -147.03 140.67 25.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -126.46 93.18 3.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.226 1.488 . . . . 0.0 112.108 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.97 144.03 57.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.29 -0.881 . . . . 0.0 108.7 155.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -146.24 52.27 1.14 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.294 1.521 . . . . 0.0 112.363 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -73.3 30.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.244 1.818 . . . . 0.0 114.529 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -109.8 0.31 18.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.333 1.453 . . . . 0.0 113.615 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.1 mt -80.16 6.66 11.11 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.267 1.027 . . . . 0.0 112.394 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -6.63 52.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.433 1.492 . . . . 0.0 113.941 -163.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.4 t -130.39 131.58 23.47 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.84 . . . . 0.0 110.09 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.39 131.43 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.088 2.525 . . . . 0.0 113.115 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -133.02 157.65 44.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.448 1.899 . . . . 0.0 109.788 166.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.2 mtm -131.61 136.02 47.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.777 2.031 . . . . 0.0 108.526 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.17 153.15 52.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 124.732 1.213 . . . . 0.0 110.828 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.25 144.44 28.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.346 1.058 . . . . 0.0 112.209 162.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.8 m -111.82 146.43 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.825 1.25 . . . . 0.0 110.979 173.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.79 112.17 10.73 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 124.039 1.876 . . . . 0.0 107.198 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -63.37 -24.56 67.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 112.422 -2.172 . . . . 0.0 112.04 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.16 -45.21 18.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.203 1.401 . . . . 0.0 114.419 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.2 p -113.53 -3.74 13.63 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.898 1.679 . . . . 0.0 115.195 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 71.31 46.29 0.44 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.677 1.991 . . . . 0.0 115.53 167.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.93 144.46 37.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -75.7 118.72 18.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.712 1.205 . . . . 0.0 110.416 170.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.61 -29.01 1.57 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -168.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.93 127.57 6.55 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 127.289 2.376 . . . . 0.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.97 146.34 35.51 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.025 -0.691 . . . . 0.0 111.083 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.98 142.07 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.526 1.531 . . . . 0.0 111.141 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -145.47 156.66 53.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.3 147.79 12.86 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.974 3.116 . . . . 0.0 112.804 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -97.82 -1.05 44.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.8 -55.15 0.77 Allowed Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.953 1.739 . . . . 0.0 116.103 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 -156.98 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 125.202 3.935 . . . . 0.0 113.54 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -51.93 159.57 1.37 Allowed Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.76 1.624 . . . . 0.0 112.097 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.34 -8.91 7.46 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.429 2.752 . . . . 0.0 114.665 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.7 p -55.26 -34.06 63.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.339 1.456 . . . . 0.0 112.914 165.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.97 3.98 86.22 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -57.3 138.21 55.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.703 1.252 . . . . 0.0 113.764 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -115.25 128.67 56.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.103 1.761 . . . . 0.0 108.893 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -111.17 109.9 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.729 1.211 . . . . 0.0 109.334 -169.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.5 m -95.7 148.61 22.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.183 2.193 . . . . 0.0 111.288 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -134.0 144.9 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.137 0.975 . . . . 0.0 109.882 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.25 107.31 9.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.306 1.051 . . . . 0.0 113.219 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.9 m -79.22 38.04 0.34 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.51 -27.88 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.05 -1.031 . . . . 0.0 112.096 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 15.86 7.84 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.032 2.133 . . . . 0.0 113.351 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.463 1.505 . . . . 0.0 111.945 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -112.26 160.71 17.37 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.43 1.492 . . . . 0.0 111.573 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.59 149.67 50.63 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.47 -0.769 . . . . 0.0 112.375 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -136.61 133.97 19.33 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.458 1.503 . . . . 0.0 108.938 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.77 170.28 14.26 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.883 2.389 . . . . 0.0 113.404 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -39.59 54.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.045 0.926 . . . . 0.0 112.42 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -73.88 144.66 82.94 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.093 1.357 . . . . 0.0 113.152 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 134' ' ' ALA . 48.0 Cg_endo -68.26 175.68 6.48 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.646 2.897 . . . . 0.0 113.896 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 67.84 -10.88 0.37 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.277 3.031 . . . . 0.0 114.414 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 132' ' ' PRO . . . -98.75 -7.68 27.25 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.628 2.371 . . . . 0.0 113.094 170.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -119.41 143.14 47.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.874 1.67 . . . . 0.0 107.51 156.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.17 42.04 0.44 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.748 1.261 . . . . 0.0 111.048 -166.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -78.28 29.18 0.18 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.703 2.001 . . . . 0.0 113.312 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.69 139.94 24.89 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.84 1.656 . . . . 0.0 113.522 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -128.08 34.49 4.58 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.941 -1.099 . . . . 0.0 113.523 -169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -133.5 -31.66 1.2 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' A' ' 142' ' ' HIS . 13.5 t-80 50.81 -164.5 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.248 1.819 . . . . 0.0 114.266 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.584 ' H ' ' CG ' ' A' ' 141' ' ' HIS . 90.8 m-70 -99.97 150.99 21.85 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.426 1.49 . . . . 0.0 109.592 159.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.3 t60 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.421 1.088 . . . . 0.0 111.435 -168.245 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ppp? . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.96 -68.68 0.42 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.164 1.385 . . . . 0.0 110.88 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.27 177.76 9.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.291 1.436 . . . . 0.0 111.604 161.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -106.51 -35.33 7.11 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 161.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.414 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -60.44 -59.88 4.7 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 124.791 1.236 . . . . 0.0 111.001 -166.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -66.65 -31.51 72.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.845 1.258 . . . . 0.0 112.763 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -69.15 -35.89 76.84 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.587 0.755 . . . . 0.0 112.545 175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.88 -26.15 34.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.5 p -121.88 64.99 18.73 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.272 1.429 . . . . 0.0 113.448 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.9 -168.41 0.62 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.541 2.161 . . . . 0.0 115.163 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -50.46 -47.84 56.83 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.35 1.86 . . . . 0.0 114.338 -168.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -61.38 -28.34 69.17 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -78.83 -35.16 44.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.149 0.98 . . . . 0.0 112.221 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -62.73 -55.03 30.33 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.699 0.761 . . . . 0.0 111.257 171.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.58 -38.5 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.684 0.794 . . . . 0.0 110.953 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 p -70.11 -26.04 63.78 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.297 -0.877 . . . . 0.0 113.122 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -39.92 75.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.318 1.047 . . . . 0.0 110.848 174.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 20' ' ' GLY . 16.9 mm-40 -72.03 -30.84 65.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.499 0.32 . . . . 0.0 111.417 170.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.38 33.49 0.09 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.819 2.047 . . . . 0.0 113.783 166.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 18' ' ' GLU . . . -153.88 24.39 0.72 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 128.408 2.909 . . . . 0.0 113.087 -172.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 t -106.97 110.71 22.93 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.944 1.697 . . . . 0.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -146.66 -164.86 2.08 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 128.933 2.893 . . . . 0.0 108.349 174.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 69.98 157.3 0.16 Allowed Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 127.038 2.135 . . . . 0.0 116.1 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.59 127.98 5.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.783 2.322 . . . . 0.0 111.941 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -91.1 -96.11 0.12 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.214 1.006 . . . . 0.0 110.933 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.74 -28.63 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.941 2.896 . . . . 0.0 109.942 -163.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.39 -117.93 10.23 Favored Glycine 0 C--N 1.339 0.701 0 O-C-N 120.542 -1.349 . . . . 0.0 111.235 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.6 mtm -55.41 -30.91 61.31 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.25 0.62 . . . . 0.0 112.087 169.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -8.15 55.52 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.06 -32.18 72.35 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.765 -1.209 . . . . 0.0 113.029 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -162.21 -58.53 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.814 0.733 . . . . 0.0 112.583 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.6 -35.48 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.765 2.826 . . . . 0.0 109.39 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.312 14.3 mmtm 66.74 129.4 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 130.073 3.349 . . . . 0.0 116.363 -173.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -124.81 171.42 10.15 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.299 2.24 . . . . 0.0 112.254 -166.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -126.82 154.35 44.44 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.81 1.244 . . . . 0.0 109.619 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.61 -154.26 16.01 Favored Glycine 0 N--CA 1.465 0.627 0 C-N-CA 124.464 1.03 . . . . 0.0 113.814 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptp -156.05 163.59 39.49 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.036 1.334 . . . . 0.0 112.302 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.75 144.21 41.41 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 127.914 2.486 . . . . 0.0 111.014 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -141.81 161.68 37.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.004 1.721 . . . . 0.0 111.264 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 64.0 m -66.07 162.7 18.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 123.354 1.549 . . . . 0.0 113.235 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.29 1.44 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.963 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.7 m -129.4 -39.09 1.52 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -167.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.5 p -94.67 -85.34 0.31 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.587 1.085 . . . . 0.0 112.549 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.98 -74.51 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 p -110.46 155.65 41.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -151.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.95 138.39 33.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.294 1.996 . . . . 0.0 111.771 165.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.0 mt -135.35 -11.53 2.15 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.98 120.29 23.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.425 1.011 . . . . 0.0 111.534 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -92.8 131.6 37.7 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.812 1.768 . . . . 0.0 112.054 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -67.67 -7.53 27.54 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.742 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.35 -28.95 63.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 113.976 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 5.48 51.64 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 171.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -78.22 136.44 37.79 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.691 0.678 . . . . 0.0 109.439 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -75.69 57.26 0.98 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.611 0.764 . . . . 0.0 112.686 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 72.2 m -58.8 -35.53 72.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.917 1.687 . . . . 0.0 112.552 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 p -86.01 -5.38 59.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.921 2.488 . . . . 0.0 114.225 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.14 -124.99 2.22 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.831 1.205 . . . . 0.0 112.829 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 m -67.98 -19.39 64.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.629 1.572 . . . . 0.0 113.334 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.68 7.58 88.1 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.784 1.183 . . . . 0.0 113.347 -165.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -101.94 137.27 19.47 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.818 2.047 . . . . 0.0 110.811 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.54 111.31 2.99 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.329 2.019 . . . . 0.0 114.259 -160.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -159.33 148.61 18.39 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.532 1.933 . . . . 0.0 110.767 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -148.08 128.05 13.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.555 1.942 . . . . 0.0 109.59 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 p -73.35 -20.29 60.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -126.61 143.88 51.08 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.986 1.85 . . . . 0.0 113.897 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.31 111.8 8.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 110.969 -2.832 . . . . 0.0 107.469 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -62.82 28.61 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.563 2.745 . . . . 0.0 114.655 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -99.39 37.7 3.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.41 2.433 . . . . 0.0 113.518 -168.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.3 t -51.76 156.39 1.44 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 123.029 1.395 . . . . 0.0 112.821 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.43 135.27 55.07 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.85 2.46 . . . . 0.0 112.032 -162.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.09 -70.33 1.83 Allowed Glycine 0 N--CA 1.469 0.85 0 C-N-CA 126.144 1.83 . . . . 0.0 114.019 167.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 m -50.16 -33.61 19.62 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.999 2.52 . . . . 0.0 112.622 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -138.42 126.88 23.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 152.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -139.18 19.99 2.6 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.023 1.329 . . . . 0.0 112.773 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -119.61 -37.55 3.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 127.161 2.184 . . . . 0.0 112.256 -173.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -83.84 -28.34 28.09 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.349 1.46 . . . . 0.0 112.517 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.8 p -85.02 -56.04 3.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.978 166.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.41 22.01 55.34 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.291 0.948 . . . . 0.0 112.536 -167.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -98.47 163.41 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.841 0.829 . . . . 0.0 111.693 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.56 176.62 8.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.791 2.036 . . . . 0.0 112.502 -169.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.414 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -145.86 151.46 37.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.295 1.438 . . . . 0.0 112.875 -171.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.73 112.74 5.17 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.528 1.931 . . . . 0.0 108.82 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.04 131.6 37.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.963 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -98.82 17.42 19.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.015 1.326 . . . . 0.0 112.084 -168.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -70.33 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.891 2.876 . . . . 0.0 114.767 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -125.05 0.39 7.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.983 1.713 . . . . 0.0 113.766 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.9 mt -100.08 15.53 27.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 113.273 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.29 -9.43 54.48 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.408 1.48 . . . . 0.0 114.328 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.6 t -118.81 121.45 30.62 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.441 1.496 . . . . 0.0 110.224 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 125.01 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.332 2.022 . . . . 0.0 111.804 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -144.62 159.85 42.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.722 2.009 . . . . 0.0 109.909 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.8 mtp -128.51 127.13 41.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.938 2.095 . . . . 0.0 107.975 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.56 151.98 51.47 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.161 0.984 . . . . 0.0 110.677 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 m -133.82 148.8 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.993 1.317 . . . . 0.0 110.84 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.25 156.16 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.27 0.628 . . . . 0.0 111.432 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.3 t -92.61 118.91 31.51 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -83.59 -14.87 51.09 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.861 171.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -70.01 -51.01 35.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.064 0.945 . . . . 0.0 112.811 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.6 p -107.4 -7.75 16.53 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.833 1.653 . . . . 0.0 115.033 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 61.26 56.29 2.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.109 2.164 . . . . 0.0 114.039 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.79 146.13 43.2 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.693 1.197 . . . . 0.0 111.796 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.06 126.61 30.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.19 -0.944 . . . . 0.0 111.18 172.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.38 6.66 36.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.487 1.915 . . . . 0.0 113.216 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.8 -168.77 13.04 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 127.22 2.343 . . . . 0.0 112.584 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.23 163.85 36.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 123.012 1.386 . . . . 0.0 113.577 -165.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.64 135.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.28 1.832 . . . . 0.0 110.031 -165.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -148.13 154.17 42.4 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.021 1.329 . . . . 0.0 113.53 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.22 129.79 6.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.402 2.734 . . . . 0.0 109.763 163.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.31 -3.0 54.5 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.06 -54.64 0.38 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.238 1.399 . . . . 0.0 114.797 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.88 -165.02 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.469 2.779 . . . . 0.0 112.736 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 157.75 2.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.322 1.449 . . . . 0.0 111.862 173.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -57.44 -17.82 28.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.946 2.431 . . . . 0.0 113.479 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -23.24 36.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.599 1.56 . . . . 0.0 113.269 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.69 17.89 51.8 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 127.773 2.606 . . . . 0.0 115.427 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.02 140.1 56.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.413 1.107 . . . . 0.0 112.584 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -124.76 146.91 48.96 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.198 1.799 . . . . 0.0 110.318 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.48 129.58 42.6 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.269 1.427 . . . . 0.0 109.148 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.9 p -120.78 144.39 48.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.014 1.326 . . . . 0.0 111.055 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.2 tp -123.42 155.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 0.0 111.091 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -126.8 134.16 50.64 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.989 1.716 . . . . 0.0 107.448 161.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.4 m -81.7 50.67 1.55 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -163.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -50.99 -59.89 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.902 2.481 . . . . 0.0 115.236 -164.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.13 27.1 0.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.727 1.211 . . . . 0.0 114.024 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.3 mt -117.19 157.01 26.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.823 1.249 . . . . 0.0 110.358 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 166.42 10.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.825 1.65 . . . . 0.0 112.19 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -144.63 153.21 41.53 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.557 1.143 . . . . 0.0 112.203 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 151.97 67.42 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.442 1.897 . . . . 0.0 109.946 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.13 170.69 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.62 2.213 . . . . 0.0 112.921 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.55 -45.73 8.75 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.877 0.871 . . . . 0.0 111.95 -170.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -78.79 158.52 75.36 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.23 2.212 . . . . 0.0 112.371 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.67 -177.55 1.9 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.809 2.339 . . . . 0.0 112.447 161.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.2 22.92 13.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.796 1.638 . . . . 0.0 114.414 169.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.31 -13.55 58.29 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.772 1.629 . . . . 0.0 114.005 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 71.66 146.08 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.546 2.738 . . . . 0.0 114.7 -170.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . 0.276 1.1 pt? -94.42 12.7 26.24 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -63.28 -26.82 68.95 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 127.896 2.478 . . . . 0.0 111.99 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -62.87 -14.66 48.93 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -75.54 -13.01 60.34 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.509 1.524 . . . . 0.0 114.496 171.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.417 ' CG ' ' H ' ' A' ' 141' ' ' HIS . 53.9 t-80 -67.19 174.52 3.14 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.984 1.714 . . . . 0.0 113.685 -172.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.417 ' H ' ' CG ' ' A' ' 140' ' ' HIS . 33.1 m-70 -70.47 64.19 0.27 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.701 2.4 . . . . 0.0 111.647 175.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -136.03 55.51 1.86 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.554 2.741 . . . . 0.0 106.837 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 3.7 m80 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.464 1.906 . . . . 0.0 111.873 -163.24 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.406 0.146 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.87 -25.29 67.83 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.367 -0.833 . . . . 0.0 111.895 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -138.57 173.52 11.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.818 2.047 . . . . 0.0 110.516 159.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -94.15 -31.98 13.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.02 1.328 . . . . 0.0 111.63 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -57.13 -46.23 82.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.111 0.964 . . . . 0.0 111.001 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -60.28 -30.31 69.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.312 1.045 . . . . 0.0 113.332 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -90.8 -31.73 16.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.441 1.896 . . . . 0.0 113.243 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.54 -39.24 81.2 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.282 1.833 . . . . 0.0 111.395 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 p -122.74 74.2 45.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.396 1.478 . . . . 0.0 111.27 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.94 147.24 89.08 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.41 2.074 . . . . 0.0 113.579 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -82.01 -50.05 9.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -159.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -60.5 -33.53 72.75 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.359 171.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -65.93 -51.18 60.87 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 122.725 0.41 . . . . 0.0 110.483 172.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.03 -40.39 93.41 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.218 0.532 . . . . 0.0 111.402 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.93 -49.93 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.125 0.97 . . . . 0.0 112.704 171.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 p -77.92 -13.01 60.03 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.789 1.636 . . . . 0.0 115.259 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.7 tpt85 -77.81 -8.31 57.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.912 2.885 . . . . 0.0 110.776 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -134.71 -56.21 0.83 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.379 0.609 . . . . 0.0 112.314 161.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.94 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 118.141 2.645 . . . . 0.0 118.141 -165.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.67 15.02 1.4 Allowed Glycine 0 CA--C 1.537 1.452 0 C-N-CA 126.979 2.228 . . . . 0.0 115.611 -171.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -83.63 79.35 9.48 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 123.109 1.433 . . . . 0.0 113.973 -165.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -76.84 136.76 38.93 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.266 -1.521 . . . . 0.0 109.378 167.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.42 144.91 29.77 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.089 0.955 . . . . 0.0 112.26 -173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -91.09 -174.61 0.67 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 121.971 1.781 . . . . 0.0 115.502 -158.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -45.46 4.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 1 C-N-CA 134.611 5.165 . . . . 0.0 119.145 175.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.4 m -137.97 17.71 2.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 118.875 2.917 . . . . 0.0 118.875 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -132.17 -66.57 0.09 OUTLIER Glycine 0 N--CA 1.469 0.862 0 O-C-N 120.916 -1.115 . . . . 0.0 112.604 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.4 mtp -69.52 -9.19 52.82 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -19.49 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 170.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.78 51.83 0.97 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.495 1.043 . . . . 0.0 111.23 -164.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -130.25 147.33 51.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -160.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -103.62 -136.56 0.34 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.735 2.014 . . . . 0.0 109.267 162.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -150.05 115.65 5.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.952 1.701 . . . . 0.0 111.055 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.89 179.96 1.01 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.763 1.268 . . . . 0.0 112.016 161.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.437 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.6 m -137.59 151.04 47.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.385 1.874 . . . . 0.0 108.535 177.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.91 -167.3 39.99 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 118.863 0.756 . . . . 0.0 113.119 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.7 ptp -156.2 159.44 38.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.256 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.89 144.47 50.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.134 2.573 . . . . 0.0 111.044 -170.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.53 155.7 37.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.655 1.982 . . . . 0.0 109.184 -168.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.79 167.65 21.2 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.808 1.766 . . . . 0.0 113.486 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -137.56 5.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 112.66 -2.064 . . . . 0.0 112.102 166.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.3 m -119.56 -31.37 4.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.782 1.633 . . . . 0.0 112.219 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.3 p -100.65 -103.24 0.24 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.509 1.523 . . . . 0.0 108.534 158.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.88 -31.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 p -81.64 155.71 70.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -161.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.45 136.97 45.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.166 1.911 . . . . 0.0 110.237 156.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.5 -39.13 0.82 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -157.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -157.47 152.6 25.89 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.444 1.02 . . . . 0.0 111.823 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -97.27 142.98 28.5 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.559 -1.338 . . . . 0.0 112.151 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 t -66.89 -10.32 47.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -42.36 64.35 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.937 1.695 . . . . 0.0 114.093 165.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.04 -1.36 28.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.289 1.435 . . . . 0.0 113.155 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -76.58 141.91 40.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.431 0.634 . . . . 0.0 111.334 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -82.47 129.23 34.86 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.782 1.233 . . . . 0.0 112.111 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.1 m 47.06 -145.73 0.24 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.853 2.061 . . . . 0.0 113.649 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.9 p -72.07 -34.67 68.9 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.454 -1.404 . . . . 0.0 113.059 169.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.33 40.93 86.52 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.41 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.4 m -54.57 -38.28 66.49 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.189 1.796 . . . . 0.0 115.192 -164.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.28 -5.46 14.71 Favored Glycine 0 N--CA 1.474 1.233 0 C-N-CA 124.124 0.868 . . . . 0.0 113.03 163.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.446 ' CH2' ' HB3' ' A' ' 119' ' ' CYS . 0.6 OUTLIER -134.91 73.95 65.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.885 -0.773 . . . . 0.0 112.239 -155.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -65.92 131.8 28.36 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.366 2.044 . . . . 0.0 110.766 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 p -153.07 139.23 18.34 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.217 1.407 . . . . 0.0 109.874 -165.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -155.11 114.13 3.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.852 0.861 . . . . 0.0 110.524 -154.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 p -75.79 -19.97 58.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -146.83 156.99 43.54 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.411 1.084 . . . . 0.0 111.269 173.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.55 39.14 1.0 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.073 1.349 . . . . 0.0 111.711 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -75.96 104.24 6.4 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.626 -1.296 . . . . 0.0 110.389 -174.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.34 -11.81 0.08 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.587 -1.118 . . . . 0.0 114.963 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.4 p -74.14 149.01 41.22 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.062 1.345 . . . . 0.0 112.04 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 128.38 18.9 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.714 1.206 . . . . 0.0 113.804 -158.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.91 -70.98 0.57 Allowed Glycine 0 N--CA 1.472 1.098 0 C-N-CA 128.42 2.914 . . . . 0.0 114.682 158.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 m -74.53 -31.99 62.33 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.454 1.502 . . . . 0.0 110.62 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.07 25.67 11.32 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 124.181 1.943 . . . . 0.0 110.576 -168.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -144.69 -1.67 0.88 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.34 3.056 . . . . 0.0 109.631 -168.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -68.43 -37.25 80.1 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.796 0.807 . . . . 0.0 109.825 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -143.47 -46.55 0.29 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.919 0.888 . . . . 0.0 113.337 166.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 79' ' ' ILE . 13.2 p -161.92 -41.35 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.415 1.486 . . . . 0.0 113.776 -172.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.76 -22.65 0.87 Allowed Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.528 1.061 . . . . 0.0 113.613 -161.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 77' ' ' THR . 37.0 pt -118.63 173.79 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.812 2.045 . . . . 0.0 112.404 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.66 -179.79 4.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.191 2.197 . . . . 0.0 110.083 -178.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.428 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 24.6 mmt85 -141.25 146.09 36.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.841 1.656 . . . . 0.0 109.832 -170.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -144.03 102.35 3.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.283 1.433 . . . . 0.0 111.496 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.42 149.87 35.09 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.018 -1.051 . . . . 0.0 111.233 165.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -134.38 29.63 3.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.8 1.286 . . . . 0.0 112.598 -170.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -73.63 35.52 0.09 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.535 1.934 . . . . 0.0 113.939 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.85 2.57 4.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.552 1.941 . . . . 0.0 112.797 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.3 15.08 5.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.394 1.878 . . . . 0.0 112.78 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.11 -3.53 65.51 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.8 1.191 . . . . 0.0 114.388 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 t -140.72 141.28 24.27 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 127.908 2.483 . . . . 0.0 110.164 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.67 129.33 16.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.809 2.339 . . . . 0.0 112.691 170.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -139.45 159.32 42.44 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.159 2.584 . . . . 0.0 108.515 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.9 ttm -143.35 134.68 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.575 1.55 . . . . 0.0 110.232 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -139.23 166.57 24.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.57 138.33 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.659 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.66 145.9 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.87 103.32 7.73 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.257 1.423 . . . . 0.0 107.551 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -57.4 -18.46 17.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.159 1.783 . . . . 0.0 112.562 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.82 -37.41 13.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 113.316 -167.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.3 p -121.15 1.88 10.33 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.645 1.978 . . . . 0.0 114.524 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.274 4.5 tt0 59.98 57.82 2.93 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.526 2.33 . . . . 0.0 113.294 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.4 129.67 35.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.747 1.219 . . . . 0.0 113.621 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.03 116.63 16.93 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.154 -0.966 . . . . 0.0 110.371 164.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -120.56 -36.44 3.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -169.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.39 146.31 18.33 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 128.24 2.829 . . . . 0.0 111.846 -166.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 158.64 38.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.377 0.671 . . . . 0.0 111.809 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.27 139.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.701 1.238 . . . . 0.0 111.45 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.99 150.29 38.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.39 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.59 133.85 19.48 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.321 2.681 . . . . 0.0 110.905 169.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.67 7.64 29.09 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.17 -49.94 0.55 Allowed Glycine 0 CA--C 1.541 1.657 0 C-N-CA 126.012 1.767 . . . . 0.0 114.777 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.09 -154.97 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.55 3.5 . . . . 0.0 112.108 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.29 157.83 3.04 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 126.493 1.917 . . . . 0.0 112.325 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -62.8 -8.86 14.51 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.378 2.719 . . . . 0.0 114.093 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.0 p -63.74 -24.14 67.65 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.813 -1.179 . . . . 0.0 112.261 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.22 20.49 33.29 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.844 2.64 . . . . 0.0 115.91 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -63.53 135.3 56.75 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.041 -1.27 . . . . 0.0 112.238 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -112.11 138.94 48.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 127.117 2.167 . . . . 0.0 108.503 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -107.03 128.31 54.25 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.468 1.107 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.446 ' HB3' ' CH2' ' A' ' 60' ' ' TRP . 31.7 p -121.76 149.1 43.78 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.617 1.567 . . . . 0.0 110.063 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.6 tt -131.65 164.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.546 -1.346 . . . . 0.0 109.76 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.1 124.54 24.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.21 -0.931 . . . . 0.0 112.528 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.1 m -79.91 36.44 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.974 1.309 . . . . 0.0 114.038 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.03 -37.91 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.168 1.787 . . . . 0.0 113.586 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.15 60.02 0.15 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.061 1.344 . . . . 0.0 113.125 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.27 171.68 13.72 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.761 1.625 . . . . 0.0 113.444 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 mmpt? -120.83 156.39 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.363 1.865 . . . . 0.0 114.609 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.12 150.99 22.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.452 1.501 . . . . 0.0 111.747 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.1 146.86 56.32 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.738 2.015 . . . . 0.0 111.551 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.72 169.67 19.58 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.265 1.976 . . . . 0.0 111.264 165.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 -38.53 7.08 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 111.904 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.437 ' HE3' ' HB ' ' A' ' 35' ' ' THR . 10.4 mmpt? -45.93 148.25 1.47 Allowed Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.193 1.797 . . . . 0.0 112.442 161.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.15 172.55 7.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.441 2.094 . . . . 0.0 113.495 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 56.56 55.59 6.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.356 1.462 . . . . 0.0 110.826 -172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.82 -32.74 72.66 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.693 0.797 . . . . 0.0 111.724 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 62.58 159.57 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.525 1.93 . . . . 0.0 113.816 -172.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 tt 55.64 38.76 30.58 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 123.015 1.388 . . . . 0.0 109.87 -159.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -69.08 -58.63 3.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.703 2.001 . . . . 0.0 112.114 -162.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -152.98 166.3 32.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.654 1.982 . . . . 0.0 110.242 165.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -80.12 172.34 13.89 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.339 1.056 . . . . 0.0 113.208 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -55.47 140.19 41.14 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.964 -1.085 . . . . 0.0 111.449 171.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.73 159.46 41.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.494 0.717 . . . . 0.0 111.942 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -65.34 133.41 51.32 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.792 0.837 . . . . 0.0 111.386 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 . . . . . 0 C--O 1.255 1.349 0 C-N-CA 124.811 1.244 . . . . 0.0 109.71 177.706 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.25 46.89 0.16 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.678 1.191 . . . . 0.0 113.312 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -141.51 156.79 45.71 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.365 -1.459 . . . . 0.0 113.523 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -83.9 -31.92 25.43 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.045 0.938 . . . . 0.0 112.594 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -62.83 -38.91 92.64 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 123.662 0.785 . . . . 0.0 110.644 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -29.13 56.44 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.29 1.036 . . . . 0.0 113.504 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -80.61 -45.89 16.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.33 1.452 . . . . 0.0 111.464 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.61 -46.77 71.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.942 0.897 . . . . 0.0 111.982 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.27 78.73 35.13 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.932 2.493 . . . . 0.0 110.018 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.07 177.19 4.59 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.376 2.717 . . . . 0.0 113.82 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -52.6 -45.12 66.41 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 119.98 -1.7 . . . . 0.0 114.035 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -65.47 -20.01 66.18 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -84.09 -39.2 19.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.963 1.305 . . . . 0.0 111.474 166.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -64.17 -40.86 97.01 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.891 -1.756 . . . . 0.0 111.562 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.2 t -72.5 -0.17 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.98 2.512 . . . . 0.0 113.175 174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -109.07 -34.69 6.53 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.561 -1.337 . . . . 0.0 112.94 161.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.53 -46.57 53.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.436 1.095 . . . . 0.0 111.912 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.42 -31.65 70.59 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.268 0.627 . . . . 0.0 111.037 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -89.2 30.12 1.0 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.698 1.199 . . . . 0.0 113.336 -172.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.59 23.46 0.16 Allowed Glycine 0 CA--C 1.53 1.006 0 N-CA-C 115.917 1.127 . . . . 0.0 115.917 -169.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -133.05 135.19 45.22 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.622 1.569 . . . . 0.0 110.833 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -115.99 138.99 50.7 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.823 1.649 . . . . 0.0 112.425 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.01 149.71 17.07 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 125.577 1.551 . . . . 0.0 113.398 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.88 136.68 3.1 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.25 3.3 . . . . 0.0 113.679 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -147.37 -82.25 0.13 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.15 -34.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 129.179 2.992 . . . . 0.0 108.957 -157.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.0 -102.64 0.6 Allowed Glycine 0 C--N 1.339 0.7 0 O-C-N 120.475 -1.391 . . . . 0.0 113.442 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.7 mtp -53.16 -37.24 61.69 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.634 -0.333 . . . . 0.0 111.504 167.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -80.08 2.04 25.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.734 1.213 . . . . 0.0 113.535 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.3 mt -77.1 -47.88 19.3 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.814 1.188 . . . . 0.0 111.473 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -169.53 0.43 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.0 t30 58.27 162.5 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -171.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -153.89 121.48 5.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.608 2.363 . . . . 0.0 108.28 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.38 171.15 2.02 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 119.39 3.107 . . . . 0.0 119.39 -166.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.4 m -73.84 164.81 26.15 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 127.59 2.356 . . . . 0.0 107.781 163.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.96 -142.35 10.25 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 121.012 -1.055 . . . . 0.0 111.263 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.3 ptp -155.66 157.2 36.29 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.625 1.202 . . . . 0.0 113.746 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -112.8 130.05 56.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 128.15 2.58 . . . . 0.0 107.652 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -151.58 168.33 25.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.736 1.214 . . . . 0.0 112.376 -161.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 172.14 12.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 123.648 1.69 . . . . 0.0 114.379 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.67 0.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.409 157.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 97.7 m -112.62 -48.65 2.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.414 1.486 . . . . 0.0 112.345 -168.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.5 p -86.88 -80.63 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.742 1.217 . . . . 0.0 111.99 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.05 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.313 1.445 . . . . 0.0 114.645 163.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.1 p -101.68 159.01 30.67 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -158.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.68 155.56 49.39 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.961 3.107 . . . . 0.0 112.512 163.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.61 -31.15 0.57 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -172.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -132.04 122.23 25.14 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.889 -1.132 . . . . 0.0 108.717 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -82.9 136.46 34.58 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 120.388 -1.445 . . . . 0.0 109.241 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 t -58.54 -18.86 32.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.504 1.122 . . . . 0.0 112.76 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.83 -42.03 96.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.897 1.279 . . . . 0.0 113.813 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -74.45 -4.16 34.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.817 0.847 . . . . 0.0 112.706 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -74.54 135.15 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.337 1.055 . . . . 0.0 109.504 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.68 119.77 13.62 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.957 -163.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.1 m 58.4 -66.67 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.616 2.367 . . . . 0.0 113.962 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.5 p -160.13 -9.29 0.05 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.877 2.071 . . . . 0.0 113.057 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.95 97.45 0.04 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.952 1.739 . . . . 0.0 113.9 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.02 -9.99 35.62 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.503 1.921 . . . . 0.0 115.171 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.59 -28.26 7.54 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.457 1.98 . . . . 0.0 110.496 -155.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.63 121.25 84.71 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 161.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -105.0 109.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.458 2.106 . . . . 0.0 114.218 -173.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -138.5 152.79 48.57 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.042 1.737 . . . . 0.0 110.109 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -141.32 130.74 23.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 p -78.98 -12.66 60.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.32 150.72 50.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.799 1.285 . . . . 0.0 112.144 160.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.91 103.3 5.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 107.415 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -53.86 85.31 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.558 1.943 . . . . 0.0 112.57 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.17 32.0 6.59 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.356 1.455 . . . . 0.0 114.281 -169.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.7 m -48.56 141.12 7.31 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.903 1.335 . . . . 0.0 114.126 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -131.65 148.66 52.61 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 130.184 3.393 . . . . 0.0 108.341 170.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.15 -87.4 0.68 Allowed Glycine 0 N--CA 1.466 0.656 0 C-N-CA 125.456 1.503 . . . . 0.0 112.781 168.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 m -46.63 -32.1 3.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.508 1.923 . . . . 0.0 113.897 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -147.45 126.45 12.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 160.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -132.61 -0.89 3.5 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 124.715 1.206 . . . . 0.0 111.606 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 t -97.01 -23.97 16.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.647 1.179 . . . . 0.0 111.543 -170.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -75.3 -33.93 61.24 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 79' ' ' ILE . 22.1 p -109.77 -50.35 2.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.988 2.115 . . . . 0.0 111.15 -165.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.98 -17.29 0.14 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.88 1.705 . . . . 0.0 114.383 -164.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 77' ' ' THR . 36.1 pt -59.43 162.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -145.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tt -121.63 158.59 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.735 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.75 153.37 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.856 1.262 . . . . 0.0 111.673 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.45 133.31 13.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.464 1.906 . . . . 0.0 108.937 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.73 156.12 39.26 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.784 1.634 . . . . 0.0 112.055 163.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -133.55 118.61 18.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 164.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 t -115.53 20.95 14.39 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 122.136 0.97 . . . . 0.0 111.922 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -84.79 -6.3 59.35 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.703 2.401 . . . . 0.0 113.324 -168.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -86.83 10.29 16.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.028 2.131 . . . . 0.0 112.733 164.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.79 -0.17 57.89 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 124.67 1.129 . . . . 0.0 114.732 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.46 128.72 11.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.674 1.59 . . . . 0.0 110.211 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.89 139.39 19.51 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.674 2.249 . . . . 0.0 113.569 -170.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -134.49 165.67 24.64 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 130.665 3.586 . . . . 0.0 109.928 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mtm -132.62 133.95 44.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.192 2.197 . . . . 0.0 109.955 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -133.18 145.54 50.71 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.15 0.98 . . . . 0.0 112.955 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.56 146.17 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.42 1.888 . . . . 0.0 111.331 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 m -141.77 147.04 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.401 -0.812 . . . . 0.0 111.799 -169.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.2 t -74.51 97.9 3.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 123.69 1.709 . . . . 0.0 108.892 170.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -24.2 2.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.576 1.951 . . . . 0.0 112.69 165.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -83.79 -41.11 17.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.862 1.665 . . . . 0.0 114.456 -172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.7 p -126.97 1.08 6.58 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.258 13.1 mt-10 72.95 22.0 3.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.272 2.629 . . . . 0.0 115.068 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.0 94.53 9.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.338 1.055 . . . . 0.0 113.431 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.48 53.75 2.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.64 -7.24 38.15 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -160.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.01 130.27 8.33 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 126.662 2.077 . . . . 0.0 113.04 -167.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.82 153.36 36.64 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.904 -0.762 . . . . 0.0 110.802 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.97 128.82 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.795 0.838 . . . . 0.0 111.672 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -127.99 141.12 40.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.576 1.15 . . . . 0.0 112.502 -169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -73.21 162.57 40.24 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.62 2.88 . . . . 0.0 111.506 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -116.8 -0.84 12.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.71 -62.5 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.825 1.678 . . . . 0.0 114.822 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -69.6 -162.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.262 1 C-N-CA 125.714 4.276 . . . . 0.0 114.099 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -56.43 163.07 2.73 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 126.171 1.788 . . . . 0.0 113.057 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -59.21 -11.58 13.5 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 0.0 114.436 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 p -58.78 -23.87 60.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.029 1.332 . . . . 0.0 113.892 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.6 -3.61 62.62 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.908 1.718 . . . . 0.0 116.262 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -59.37 145.34 43.85 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.713 1.257 . . . . 0.0 112.426 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 128.9 55.55 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.265 1.026 . . . . 0.0 109.327 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -99.09 110.49 23.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.812 1.245 . . . . 0.0 109.935 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.9 m -113.48 112.43 23.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.242 2.217 . . . . 0.0 108.685 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.7 tt -136.46 118.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.51 0.724 . . . . 0.0 112.544 -167.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -80.56 -9.27 59.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.9 m -16.73 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.358 2.663 . . . . 0.0 116.262 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 -33.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.954 2.102 . . . . 0.0 112.126 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.18 2.46 5.87 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.665 1.586 . . . . 0.0 114.423 165.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.54 -174.19 2.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.921 2.888 . . . . 0.0 110.628 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.91 163.66 12.78 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.575 -1.328 . . . . 0.0 114.524 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.47 155.87 42.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.852 1.261 . . . . 0.0 112.397 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -149.13 150.11 31.26 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.825 1.65 . . . . 0.0 111.78 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.84 173.54 13.44 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.141 2.56 . . . . 0.0 113.17 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.02 -40.22 6.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 153.19 94.78 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -172.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.05 176.38 2.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.333 2.689 . . . . 0.0 113.442 166.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 59.43 25.7 14.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.827 1.651 . . . . 0.0 114.316 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -104.51 7.28 35.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.251 2.221 . . . . 0.0 113.537 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.1 90.04 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.87 1.668 . . . . 0.0 112.95 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -143.34 37.0 1.36 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.034 2.134 . . . . 0.0 110.429 -170.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.66 -57.98 4.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.962 2.505 . . . . 0.0 111.269 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -162.96 -169.6 2.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.559 2.344 . . . . 0.0 108.085 153.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -140.06 162.56 34.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.499 1.12 . . . . 0.0 111.056 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -73.38 64.51 0.83 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.005 1.322 . . . . 0.0 112.24 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.91 162.56 29.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.891 1.676 . . . . 0.0 112.939 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 67.5 m80 64.37 155.14 0.06 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.171 2.188 . . . . 0.0 115.224 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 5.0 p80 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 126.072 1.749 . . . . 0.0 110.151 176.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.33 -37.86 0.1 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -145.13 175.72 10.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.42 1.088 . . . . 0.0 113.838 -166.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -108.09 -38.0 5.9 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.228 1.011 . . . . 0.0 112.547 159.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' CD ' ' H ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -63.52 -59.92 4.02 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.906 1.283 . . . . 0.0 111.437 -164.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -57.65 -31.4 66.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.032 1.333 . . . . 0.0 112.472 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -73.07 -36.24 66.81 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.312 1.445 . . . . 0.0 111.831 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pp -92.93 -22.92 18.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -127.66 64.06 62.35 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.372 1.069 . . . . 0.0 113.768 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.83 153.77 72.29 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 124.162 3.241 . . . . 0.0 113.999 167.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -92.12 -66.82 0.9 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.723 -0.61 . . . . 0.0 111.601 164.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -55.59 -32.71 63.31 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -77.23 -17.15 58.68 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.559 1.544 . . . . 0.0 114.439 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -99.37 -42.69 6.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.13 0.972 . . . . 0.0 112.472 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.85 -23.31 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.039 1.736 . . . . 0.0 111.829 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.19 -25.7 62.64 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.593 1.557 . . . . 0.0 112.909 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -79.8 -22.39 43.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.635 1.174 . . . . 0.0 113.014 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -130.2 -26.27 2.37 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? 30.46 75.98 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.749 2.42 . . . . 0.0 115.572 166.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.45 5.9 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 114.224 -1.353 . . . . 0.0 115.052 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -89.91 173.82 8.02 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 123.219 1.485 . . . . 0.0 111.96 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -115.64 162.1 17.73 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 127.264 2.226 . . . . 0.0 111.662 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 66.95 153.09 0.13 Allowed Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 128.591 2.756 . . . . 0.0 115.53 -170.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -94.79 127.93 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.858 3.039 . . . . 0.0 111.229 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -71.62 0.29 9.01 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 -170.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.23 -23.68 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.118 2.567 . . . . 0.0 112.021 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.83 -104.88 0.64 Allowed Glycine 0 C--N 1.34 0.788 0 O-C-N 120.879 -1.138 . . . . 0.0 112.146 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.7 ttm -55.65 -23.9 30.67 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 171.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.74 6.62 47.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.1 mt -120.65 -25.63 5.47 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.825 2.45 . . . . 0.0 112.865 168.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -158.83 159.41 35.05 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -169.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.87 -157.84 0.63 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.937 1.695 . . . . 0.0 110.146 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -130.29 109.96 11.16 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.278 2.231 . . . . 0.0 108.118 172.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -116.49 168.52 10.09 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 126.896 2.079 . . . . 0.0 112.82 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -109.13 144.11 37.62 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.534 1.534 . . . . 0.0 107.692 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.31 -157.72 25.65 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ptp -146.07 161.87 39.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.914 1.286 . . . . 0.0 113.862 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -125.38 131.04 53.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.085 2.554 . . . . 0.0 109.838 171.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -137.2 173.67 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.497 1.519 . . . . 0.0 110.056 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.92 158.79 27.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 123.217 1.484 . . . . 0.0 113.308 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.96 -3.59 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.096 168.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.8 m -125.01 -22.01 4.55 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.404 1.482 . . . . 0.0 114.629 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.5 p -122.11 -88.57 0.62 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.403 1.481 . . . . 0.0 113.104 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -152.6 -46.59 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -127.43 161.23 55.92 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -140.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.43 150.45 41.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.081 3.187 . . . . 0.0 113.34 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -137.36 -34.54 0.7 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -152.72 146.73 25.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.445 1.02 . . . . 0.0 112.474 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.5 p -81.66 145.82 30.36 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.644 -1.285 . . . . 0.0 111.356 169.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -61.4 -17.98 56.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.29 -34.83 66.85 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.897 1.679 . . . . 0.0 113.396 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -9.44 51.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.574 1.15 . . . . 0.0 112.216 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -70.58 108.17 4.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.187 0.903 . . . . 0.0 109.979 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.05 149.8 8.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.105 1.362 . . . . 0.0 114.577 -153.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 2.7 t -86.08 45.29 1.21 Allowed 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.925 -1.109 . . . . 0.0 112.494 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.1 p -79.09 160.78 26.92 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.784 -0.573 . . . . 0.0 111.809 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.32 4.04 5.28 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 p -112.37 -35.78 5.48 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.143 1.472 . . . . 0.0 113.335 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.08 8.06 64.03 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 123.857 0.741 . . . . 0.0 113.326 -165.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 74.2 t90 -63.39 137.83 97.19 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.138 0.975 . . . . 0.0 110.666 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.58 104.65 1.91 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.112 1.875 . . . . 0.0 114.382 -157.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.04 149.96 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.052 1.741 . . . . 0.0 110.628 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.97 108.74 8.56 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.293 1.837 . . . . 0.0 108.79 -162.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.3 p -67.1 -18.47 65.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.84 154.35 39.38 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.149 0.98 . . . . 0.0 110.988 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.93 74.27 10.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.734 0.813 . . . . 0.0 109.069 166.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -74.13 84.15 1.82 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.411 1.1 . . . . 0.0 112.234 -169.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.28 -21.6 0.07 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.943 2.211 . . . . 0.0 112.252 -167.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 t -108.37 142.77 38.21 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.597 1.198 . . . . 0.0 112.712 161.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 1.4 tptt -148.1 98.12 2.88 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.681 1.992 . . . . 0.0 113.611 -169.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.92 -66.21 0.47 Allowed Glycine 0 N--CA 1.473 1.113 0 C-N-CA 127.928 2.68 . . . . 0.0 115.633 159.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -27.83 26.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.646 1.578 . . . . 0.0 112.294 165.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.527 ' HB2' ' H ' ' A' ' 70' ' ' LYS . 31.9 m-20 -86.11 30.9 0.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.656 1.217 . . . . 0.0 113.818 -161.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -78.14 -15.44 58.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.174 1.789 . . . . 0.0 114.032 -161.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.83 -11.88 7.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.328 1.051 . . . . 0.0 112.669 171.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -65.1 -23.59 67.2 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.405 1.082 . . . . 0.0 113.443 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.17 -29.35 63.58 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.695 2.398 . . . . 0.0 115.072 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.19 14.07 76.59 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.781 0.705 . . . . 0.0 113.771 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.21 167.2 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 122.441 1.115 . . . . 0.0 111.554 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.23 176.94 8.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.093 1.757 . . . . 0.0 110.469 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.436 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -157.7 163.57 38.03 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.913 1.685 . . . . 0.0 111.796 -167.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HD3' ' H ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -162.9 156.64 20.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.911 2.884 . . . . 0.0 105.348 -157.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.41 ' H ' ' HD3' ' A' ' 82' ' ' ARG . 7.8 mp -124.47 151.64 44.33 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 127.283 2.233 . . . . 0.0 111.074 169.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.84 21.35 5.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.203 1.801 . . . . 0.0 111.422 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.7 t -69.57 32.51 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.494 2.318 . . . . 0.0 114.767 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 t -138.2 12.31 2.82 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.796 3.238 . . . . 0.0 111.032 -174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -109.18 22.98 15.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.876 2.47 . . . . 0.0 112.187 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.89 -16.33 58.67 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 125.064 1.316 . . . . 0.0 114.406 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 t -143.15 143.88 26.44 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.794 1.238 . . . . 0.0 110.608 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.88 133.79 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.477 2.118 . . . . 0.0 112.909 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -148.55 154.1 39.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 129.181 2.992 . . . . 0.0 109.25 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.2 mtt -135.0 145.67 48.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.496 2.319 . . . . 0.0 108.215 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -139.47 138.27 36.27 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.197 0.999 . . . . 0.0 111.37 -169.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.85 139.22 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 122.314 1.054 . . . . 0.0 112.092 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.43 152.4 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.848 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.1 t -89.54 121.21 31.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 164.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.41 -18.6 31.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.534 1.934 . . . . 0.0 111.883 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -67.8 -28.58 67.71 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.1 p -129.61 -3.82 4.76 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 126.225 1.81 . . . . 0.0 115.042 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.272 11.6 mt-10 62.27 42.35 9.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 127.279 2.232 . . . . 0.0 113.761 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.89 52.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.608 1.963 . . . . 0.0 112.573 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 115.2 17.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 165.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.32 -35.42 3.8 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -170.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.87 132.82 5.74 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 127.005 2.241 . . . . 0.0 112.004 -164.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.51 28.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.086 0.946 . . . . 0.0 110.994 -172.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.49 127.92 32.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.147 -0.97 . . . . 0.0 109.577 -149.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -148.6 150.22 33.09 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.92 132.84 25.59 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.876 2.384 . . . . 0.0 110.174 156.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.04 11.92 10.6 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.22 -67.24 0.34 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.955 1.74 . . . . 0.0 112.311 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.38 -164.34 0.19 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.113 3.209 . . . . 0.0 112.192 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -61.0 143.84 91.44 Favored Pre-proline 0 N--CA 1.473 0.696 0 O-C-N 120.286 -1.509 . . . . 0.0 112.555 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.5 -2.42 8.3 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.904 3.069 . . . . 0.0 114.127 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -50.15 -35.4 25.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.159 1.345 . . . . 0.0 110.897 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -90.59 16.2 58.5 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.216 2.341 . . . . 0.0 117.098 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.59 149.11 11.19 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -116.68 139.66 50.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.721 1.608 . . . . 0.0 110.022 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.6 100.19 11.78 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 174.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.9 t -74.77 143.77 43.9 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.656 -0.652 . . . . 0.0 110.871 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.9 mt -140.61 132.58 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.021 0.528 . . . . 0.0 110.266 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.84 99.3 12.19 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -173.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.3 p -52.19 -31.16 30.4 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.2 p -46.68 -29.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.861 2.064 . . . . 0.0 115.258 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.96 10.7 40.81 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.3 170.86 15.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.174 1.789 . . . . 0.0 111.702 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 129.97 52.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 110.325 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.82 145.87 33.63 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 112.753 -171.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -154.65 150.42 21.7 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.01 1.324 . . . . 0.0 112.175 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.04 169.1 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.069 1.846 . . . . 0.0 111.613 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.67 -42.67 9.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.826 1.25 . . . . 0.0 111.683 176.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -57.21 152.43 30.83 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.358 2.263 . . . . 0.0 113.235 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.17 -178.81 1.2 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.667 2.911 . . . . 0.0 113.481 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.18 14.7 6.86 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.377 1.871 . . . . 0.0 114.618 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -147.35 -60.81 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.515 1.526 . . . . 0.0 111.569 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.91 35.77 0.59 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.197 -0.939 . . . . 0.0 113.344 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 16.1 tp -153.57 37.25 0.46 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.033 1.333 . . . . 0.0 113.17 -172.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -83.08 37.96 0.57 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.024 2.13 . . . . 0.0 112.967 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -58.19 164.3 2.48 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.711 2.804 . . . . 0.0 115.155 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -134.16 93.84 3.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.937 1.695 . . . . 0.0 109.313 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -123.68 44.39 2.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.591 1.156 . . . . 0.0 112.325 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -148.97 151.31 34.35 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.232 1.813 . . . . 0.0 110.244 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.85 154.55 50.48 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.725 1.61 . . . . 0.0 111.301 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.9 p80 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.701 1.6 . . . . 0.0 114.414 178.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' C ' ' H ' ' A' ' 3' ' ' ASP . 26.7 ttt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.825 0.345 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.19 -9.87 0.15 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.545 2.338 . . . . 0.0 115.121 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 1' ' ' MET . 6.0 p-10 -79.25 170.4 16.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.116 1.767 . . . . 0.0 111.347 163.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -98.96 -28.55 13.38 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.923 0.889 . . . . 0.0 112.918 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -52.77 -48.82 66.53 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.428 1.091 . . . . 0.0 112.174 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HZ3' ' CD ' ' A' ' 11' ' ' GLU . 1.8 mptt -74.89 -29.46 61.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.704 1.202 . . . . 0.0 112.573 177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -69.67 -41.01 76.07 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.915 1.286 . . . . 0.0 112.415 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -93.72 -24.8 17.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.715 1.206 . . . . 0.0 114.009 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.34 58.67 32.35 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.109 1.763 . . . . 0.0 111.103 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.04 133.29 37.75 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.239 1.96 . . . . 0.0 112.65 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' CD ' ' HZ3' ' A' ' 6' ' ' LYS . 67.4 mt-10 -92.84 -51.97 4.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.586 -148.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -59.47 -29.99 68.21 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 167.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -77.17 -24.36 51.47 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.749 2.02 . . . . 0.0 114.216 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -83.27 -42.38 17.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.457 1.503 . . . . 0.0 111.072 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.96 -30.66 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.457 1.103 . . . . 0.0 113.52 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -72.96 -25.77 61.13 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.08 1.352 . . . . 0.0 112.933 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -27.32 68.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.14 2.176 . . . . 0.0 110.545 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -130.21 -19.12 3.19 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.4 tptm 6.82 67.56 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.687 3.195 . . . . 0.0 119.023 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.1 -12.64 3.32 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 114.315 -1.311 . . . . 0.0 114.712 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 t -47.84 135.9 11.59 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.266 1.826 . . . . 0.0 111.368 172.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -130.86 140.56 50.24 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 112.796 -2.002 . . . . 0.0 113.521 171.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.25 153.68 15.33 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.874 2.47 . . . . 0.0 108.468 171.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.38 101.71 1.29 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 121.995 1.797 . . . . 0.0 112.354 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -142.6 -24.68 0.64 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 m -65.8 -15.88 63.29 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.34 1.856 . . . . 0.0 114.594 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.94 -108.41 0.95 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.388 1.47 . . . . 0.0 112.753 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 9.4 mtm -62.25 -12.83 22.66 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.431 ' HA ' ' HE3' ' A' ' 33' ' ' LYS . 0.2 OUTLIER -99.94 4.1 44.78 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.655 1.582 . . . . 0.0 114.498 171.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.86 -41.38 17.53 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.368 1.44 . . . . 0.0 113.388 169.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -101.92 151.54 21.98 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.048 0.939 . . . . 0.0 112.878 -174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 50.2 -162.38 0.05 Allowed 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.028 1.331 . . . . 0.0 113.656 -169.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 29' ' ' TYR . 19.2 mmtt -178.74 144.93 0.28 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.429 1.091 . . . . 0.0 112.106 119.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -46.38 173.8 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.977 2.911 . . . . 0.0 117.068 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.19 142.93 26.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.316 1.846 . . . . 0.0 107.397 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.87 -155.5 20.88 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.103 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 ptp -159.99 166.97 28.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -127.78 135.79 50.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.457 2.703 . . . . 0.0 109.629 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -144.96 155.68 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 0.0 110.753 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 m -68.3 167.17 14.98 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 123.401 1.572 . . . . 0.0 112.543 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.26 -8.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 113.504 -1.68 . . . . 0.0 111.927 152.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -97.2 -18.63 19.14 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.16 1.784 . . . . 0.0 114.73 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.1 p -118.73 -105.09 0.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.315 2.246 . . . . 0.0 109.013 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -163.36 -38.87 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.84 2.056 . . . . 0.0 113.699 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.21 140.5 24.45 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -165.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.95 146.66 65.95 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.388 2.059 . . . . 0.0 111.101 170.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.61 -27.87 2.32 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -134.52 127.11 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.426 -0.796 . . . . 0.0 112.324 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 p -84.44 141.12 31.04 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.696 -1.253 . . . . 0.0 110.196 164.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -18.32 23.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.111 0.964 . . . . 0.0 113.436 170.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.52 -41.79 61.27 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.92 1.688 . . . . 0.0 114.262 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -71.4 -8.92 56.96 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.592 1.557 . . . . 0.0 112.841 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -81.01 129.64 34.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.247 0.546 . . . . 0.0 112.019 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -68.44 138.26 55.14 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 160.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.1 t -158.98 -32.16 0.07 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 p -44.18 90.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.574 2.75 . . . . 0.0 115.227 -169.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.77 -1.72 71.83 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 117.993 -1.448 . . . . 0.0 116.459 170.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.8 m -135.48 -10.43 2.16 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.079 1.94 . . . . 0.0 111.805 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.97 -8.7 5.96 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 120.669 -1.269 . . . . 0.0 115.152 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -63.17 144.39 97.39 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -155.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -90.82 107.46 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.201 1.934 . . . . 0.0 114.321 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 t -154.81 153.67 31.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.466 1.507 . . . . 0.0 111.379 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.73 119.22 22.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.195 2.198 . . . . 0.0 107.471 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 p -70.31 -14.46 62.59 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -153.42 161.16 42.57 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.41 69.14 1.1 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.145 1.778 . . . . 0.0 110.024 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.34 100.92 0.87 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.298 1.047 . . . . 0.0 110.969 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.19 -12.9 2.09 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.772 1.177 . . . . 0.0 112.208 -158.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.1 p -107.3 147.26 30.49 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.851 1.261 . . . . 0.0 110.865 145.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.25 59.31 1.16 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.997 1.719 . . . . 0.0 115.591 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.66 -62.04 0.05 OUTLIER Glycine 0 N--CA 1.476 1.364 0 C-N-CA 127.553 2.501 . . . . 0.0 115.464 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 t -49.51 -42.65 44.19 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.754 2.021 . . . . 0.0 110.953 159.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -113.37 94.67 4.98 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.618 1.567 . . . . 0.0 108.937 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -133.43 -38.58 0.93 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.556 1.542 . . . . 0.0 110.628 175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.9 t -73.84 -34.31 64.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.394 1.478 . . . . 0.0 110.947 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.99 -28.89 70.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -20.75 63.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.576 1.151 . . . . 0.0 112.908 -173.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.48 12.46 58.8 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.705 -1.053 . . . . 0.0 113.232 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -96.72 159.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.355 1.077 . . . . 0.0 110.14 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -144.1 164.54 30.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.315 1.446 . . . . 0.0 111.029 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.98 158.87 43.43 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.42 112.2 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.169 2.587 . . . . 0.0 107.37 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.35 154.9 28.71 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.07 0.948 . . . . 0.0 110.861 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -141.01 34.96 1.74 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.828 0.823 . . . . 0.0 112.961 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -71.95 55.19 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 124.051 1.881 . . . . 0.0 109.629 157.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -142.18 8.36 1.83 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.038 2.535 . . . . 0.0 112.351 -167.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.4 mt -128.04 20.24 6.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.647 1.979 . . . . 0.0 112.571 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.42 2.17 73.24 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 120.976 -1.077 . . . . 0.0 115.588 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.6 t -135.39 138.91 29.91 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 127.327 2.251 . . . . 0.0 110.085 168.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.13 135.61 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.501 2.801 . . . . 0.0 114.658 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -144.68 158.42 43.79 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.298 2.639 . . . . 0.0 110.628 167.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.4 mtp -141.92 125.85 17.18 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.388 2.675 . . . . 0.0 107.864 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -133.18 146.48 51.57 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.872 -1.142 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.61 153.32 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.241 1.416 . . . . 0.0 110.962 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.03 140.63 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.259 1.424 . . . . 0.0 109.144 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.72 97.37 4.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 124.085 1.897 . . . . 0.0 106.604 160.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -66.83 -14.72 63.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.727 -1.578 . . . . 0.0 111.545 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -66.53 -50.48 63.05 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.885 1.274 . . . . 0.0 112.426 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -100.89 -11.99 19.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.009 2.123 . . . . 0.0 114.281 -173.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 68.02 17.91 9.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.395 1.878 . . . . 0.0 113.994 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.7 86.11 2.73 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.057 1.408 . . . . 0.0 112.229 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -89.78 67.58 7.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.827 1.651 . . . . 0.0 113.404 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.275 0.0 OUTLIER -135.02 5.88 3.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 118.528 2.788 . . . . 0.0 118.528 -170.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.06 129.3 9.0 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.47 1.032 . . . . 0.0 112.679 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -147.71 160.74 42.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.8 142.45 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 123.692 1.71 . . . . 0.0 112.745 -171.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -149.1 156.59 40.26 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 127.322 2.249 . . . . 0.0 110.435 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.38 142.49 54.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.292 1.995 . . . . 0.0 109.444 165.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.94 18.05 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 113.583 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.64 -64.15 0.6 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.529 2.49 . . . . 0.0 112.739 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -86.53 -153.65 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.544 4.162 . . . . 0.0 113.516 -174.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.83 149.41 2.31 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 127.597 2.359 . . . . 0.0 113.712 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.81 -7.9 19.78 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.411 2.741 . . . . 0.0 114.498 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.1 p -58.87 -27.12 64.87 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.182 -0.949 . . . . 0.0 112.131 165.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -88.16 5.9 84.21 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.202 1.858 . . . . 0.0 116.324 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -58.88 127.3 31.52 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 1.428 . . . . 0.0 111.876 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -109.23 120.18 41.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.37 1.068 . . . . 0.0 109.583 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -90.37 76.19 6.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.825 1.298 . . . . 0.0 110.117 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.4 t -66.31 131.03 45.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.533 1.635 . . . . 0.0 111.59 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.3 tt -148.41 166.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.679 -1.601 . . . . 0.0 109.086 -168.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.44 134.56 46.33 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.256 -1.527 . . . . 0.0 113.889 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -81.04 -32.56 34.04 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.24 -33.56 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.86 2.56 14.22 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.3 mt -135.19 171.94 13.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.002 2.521 . . . . 0.0 110.034 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 9.7 mmpt? -109.82 159.38 17.25 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.933 -1.105 . . . . 0.0 112.694 168.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -148.59 153.0 37.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -146.33 145.97 25.92 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 125.797 1.639 . . . . 0.0 111.491 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.73 173.43 14.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.655 2.237 . . . . 0.0 112.072 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.6 t -100.06 -54.93 2.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.233 1.013 . . . . 0.0 111.28 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -51.12 139.93 23.18 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.542 1.937 . . . . 0.0 114.555 -174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.28 171.72 17.73 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.717 2.278 . . . . 0.0 113.999 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 61.75 22.47 13.01 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.999 2.119 . . . . 0.0 114.365 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.8 -17.59 40.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.504 1.522 . . . . 0.0 113.846 -173.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.83 173.51 0.27 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.905 2.482 . . . . 0.0 115.923 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.5 tp -164.13 57.94 0.15 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.557 2.343 . . . . 0.0 107.922 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.01 -37.19 8.81 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.777 2.431 . . . . 0.0 114.376 -169.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -156.18 148.66 23.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.161 1.384 . . . . 0.0 109.895 159.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -82.66 -11.15 58.57 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -165.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -150.87 127.29 10.7 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.899 1.227 . . . . 0.0 114.091 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -156.2 159.81 39.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.96 1.304 . . . . 0.0 112.773 162.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -158.56 152.2 23.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.385 2.274 . . . . 0.0 107.565 159.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 N--CA 1.48 1.058 0 CA-C-N 119.796 1.18 . . . . 0.0 111.673 166.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mpp? . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.6 2.12 18.48 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.909 1.284 . . . . 0.0 113.206 169.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -97.08 139.11 33.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.105 2.162 . . . . 0.0 113.649 -173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -75.75 -27.9 58.29 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.998 1.719 . . . . 0.0 110.925 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -51.84 -52.26 50.65 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.949 1.3 . . . . 0.0 110.385 172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -74.66 -31.37 61.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -67.53 -37.62 83.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.744 0.818 . . . . 0.0 111.836 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.8 mt -88.8 -26.55 21.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.151 1.38 . . . . 0.0 113.378 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.258 11.8 t -135.12 85.45 33.89 Favored Pre-proline 0 N--CA 1.478 0.941 0 CA-C-N 119.641 1.11 . . . . 0.0 113.219 167.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.31 -179.25 5.28 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.352 2.701 . . . . 0.0 114.564 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -47.7 -48.84 29.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.284 1.434 . . . . 0.0 112.904 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -61.23 -32.17 71.95 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.582 0.753 . . . . 0.0 112.022 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -78.76 -36.62 42.78 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.292 1.037 . . . . 0.0 111.61 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.79 -43.48 65.62 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.604 1.093 . . . . 0.0 110.843 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.96 -37.47 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 120.993 -1.067 . . . . 0.0 111.739 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -68.54 -29.04 67.53 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.399 1.454 . . . . 0.0 112.388 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -62.88 -39.08 93.35 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.429 0.558 . . . . 0.0 110.979 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 20' ' ' GLY . 5.8 mm-40 -75.48 -28.35 59.19 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 121.481 0.658 . . . . 0.0 111.166 171.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -74.74 22.99 0.1 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 18' ' ' GLU . . . -132.7 -18.96 1.07 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 127.024 2.25 . . . . 0.0 115.025 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -90.95 105.09 17.59 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 123.271 1.51 . . . . 0.0 111.897 -172.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 143.59 45.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.218 149.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -166.82 153.81 8.41 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.16 -177.44 2.65 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.372 3.381 . . . . 0.0 112.001 163.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.1 t80 61.67 -8.1 0.1 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 p -30.6 -44.24 0.05 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.53 1.932 . . . . 0.0 112.259 137.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.95 -99.79 0.52 Allowed Glycine 0 N--CA 1.466 0.684 0 O-C-N 121.116 -0.99 . . . . 0.0 113.438 160.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.1 ttm -54.91 -33.7 62.38 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.114 -0.639 . . . . 0.0 111.225 167.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -11.02 60.66 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.1 mt -86.26 -15.82 39.53 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.838 1.255 . . . . 0.0 112.134 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -138.79 4.83 2.35 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.8 110.45 4.27 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.42 -1.425 . . . . 0.0 112.607 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 4.0 mmpt? -152.19 130.98 12.42 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.371 2.668 . . . . 0.0 107.456 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -68.3 169.67 10.14 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 128.309 2.644 . . . . 0.0 115.409 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 m -85.52 152.01 23.5 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.414 1.086 . . . . 0.0 108.167 165.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.38 -152.51 18.15 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptp -155.25 174.58 15.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.897 1.679 . . . . 0.0 113.011 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.47 148.28 52.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.715 1.606 . . . . 0.0 112.378 163.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -137.17 169.37 17.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.826 2.051 . . . . 0.0 111.758 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -76.21 168.4 20.12 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 123.781 1.753 . . . . 0.0 114.05 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.54 26.33 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 127.352 2.261 . . . . 0.0 111.409 164.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.62 -41.08 2.03 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.508 1.523 . . . . 0.0 111.103 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.3 p -97.33 -99.16 0.2 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.139 1.376 . . . . 0.0 110.85 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.08 -49.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.021 1.328 . . . . 0.0 114.202 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -99.66 154.07 37.45 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -142.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.0 142.17 99.12 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.933 1.756 . . . . 0.0 110.336 158.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.33 -34.93 1.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.673 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -135.87 134.76 39.14 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 p -91.13 127.55 36.6 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.312 1.053 . . . . 0.0 109.46 164.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.46 -7.21 29.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 113.383 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.05 -33.13 70.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.663 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -75.69 7.81 3.5 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.149 0.979 . . . . 0.0 111.955 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -52.69 132.85 36.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.42 0.629 . . . . 0.0 111.432 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -73.22 143.79 47.01 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.902 1.281 . . . . 0.0 111.802 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.4 m 47.55 -164.45 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.597 1.959 . . . . 0.0 114.558 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.6 p -101.8 -93.35 0.3 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.345 -1.472 . . . . 0.0 112.204 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.59 25.95 6.89 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 117.542 1.777 . . . . 0.0 117.542 -157.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.88 -13.1 54.43 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.394 2.097 . . . . 0.0 111.146 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.55 1.29 4.48 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.364 1.459 . . . . 0.0 114.358 -170.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -93.95 134.65 25.75 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 118.629 1.215 . . . . 0.0 114.161 -152.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.58 105.11 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.983 2.455 . . . . 0.0 112.92 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -157.83 144.92 18.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.643 1.977 . . . . 0.0 110.605 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -143.58 117.15 9.17 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.094 1.357 . . . . 0.0 109.832 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.4 p -69.19 -23.68 63.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -145.44 158.22 43.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.944 0.897 . . . . 0.0 112.006 162.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.03 71.28 5.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.335 1.054 . . . . 0.0 109.322 162.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -79.97 100.24 8.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.862 0.839 . . . . 0.0 111.065 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.34 -34.14 0.02 OUTLIER Glycine 0 CA--C 1.537 1.446 0 C-N-CA 128.818 3.104 . . . . 0.0 110.068 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.5 p -125.05 144.15 50.55 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.094 1.757 . . . . 0.0 113.482 174.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -139.05 134.98 33.71 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.947 2.099 . . . . 0.0 110.367 170.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.71 -79.1 0.01 OUTLIER Glycine 0 N--CA 1.476 1.318 0 C-N-CA 128.81 3.1 . . . . 0.0 115.232 162.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.8 m -50.12 -27.46 5.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.101 2.16 . . . . 0.0 114.247 165.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.54 15.39 10.34 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -166.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -62.29 -35.23 78.39 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.284 -1.51 . . . . 0.0 112.012 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.8 t -81.85 -24.28 35.89 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.211 0.604 . . . . 0.0 111.565 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -66.58 -21.0 66.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.68 -22.63 67.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.703 1.201 . . . . 0.0 112.933 169.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.95 6.04 54.81 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.952 -0.915 . . . . 0.0 114.592 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -93.74 161.87 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.816 1.77 . . . . 0.0 114.901 -171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.502 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -134.57 -178.07 4.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.513 2.325 . . . . 0.0 109.221 168.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.502 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -151.74 161.74 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.676 1.19 . . . . 0.0 113.482 -171.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.24 117.44 8.97 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 129.113 2.965 . . . . 0.0 106.487 -175.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.85 148.92 25.04 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.032 1.333 . . . . 0.0 112.314 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.56 36.88 3.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.957 1.303 . . . . 0.0 112.537 -163.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p -68.3 22.38 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.918 2.087 . . . . 0.0 115.492 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.3 t -126.66 -2.81 6.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.8 2.04 . . . . 0.0 113.455 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.54 12.37 7.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.544 1.538 . . . . 0.0 112.771 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.01 -9.59 65.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.49 1.519 . . . . 0.0 113.856 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.7 t -139.71 143.27 34.39 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.661 1.984 . . . . 0.0 109.683 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.71 133.62 43.08 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.041 1.827 . . . . 0.0 112.039 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -137.05 154.76 50.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.442 1.897 . . . . 0.0 109.475 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 ttm -133.47 134.65 43.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.54 1.536 . . . . 0.0 108.881 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -134.98 147.46 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.475 1.51 . . . . 0.0 110.575 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.61 146.9 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.188 1.395 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.71 144.4 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.218 1.007 . . . . 0.0 111.71 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.6 t -79.07 105.12 10.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 166.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -77.04 -7.7 56.14 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -69.0 -51.59 37.66 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.453 1.901 . . . . 0.0 112.03 172.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 17.5 p -112.09 -5.95 14.21 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.179 1.791 . . . . 0.0 114.453 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 62.4 63.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.028 2.531 . . . . 0.0 113.766 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.52 152.93 43.13 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -77.48 80.59 3.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.302 1.841 . . . . 0.0 112.511 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.255 3.4 mm? -91.63 48.13 1.43 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 124.121 1.915 . . . . 0.0 114.559 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.36 163.63 10.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 111.123 -2.762 . . . . 0.0 115.611 150.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.79 163.0 40.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.668 0.787 . . . . 0.0 111.255 -174.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.34 142.21 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.166 1.386 . . . . 0.0 112.049 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.22 153.54 73.19 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.098 1.759 . . . . 0.0 113.872 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.19 135.3 7.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.961 3.108 . . . . 0.0 112.006 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -118.61 4.78 11.65 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -162.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.62 -38.36 1.0 Allowed Glycine 0 CA--C 1.544 1.85 0 CA-C-O 117.458 -1.746 . . . . 0.0 116.347 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -101.24 -172.91 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.153 3.235 . . . . 0.0 113.226 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -51.51 156.99 1.91 Allowed Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 125.751 1.62 . . . . 0.0 112.363 163.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.93 -4.02 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.698 2.932 . . . . 0.0 114.359 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -20.37 65.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.207 1.403 . . . . 0.0 113.58 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.98 -90.38 0.47 Allowed Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.658 1.599 . . . . 0.0 112.765 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 50.28 140.45 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 131.581 3.952 . . . . 0.0 119.009 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -110.81 126.51 54.71 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.981 -1.074 . . . . 0.0 109.913 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -90.05 122.56 33.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.064 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.6 p -105.83 122.8 46.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.594 1.558 . . . . 0.0 110.488 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.09 166.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.884 1.674 . . . . 0.0 109.591 -175.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.42 108.63 2.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.512 1.125 . . . . 0.0 113.341 173.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.3 m -75.1 56.14 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.431 1.492 . . . . 0.0 111.48 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -41.38 -46.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 128.521 2.728 . . . . 0.0 114.641 -162.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.98 38.92 1.2 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.463 1.905 . . . . 0.0 110.491 166.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.8 mt -110.76 165.75 11.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.559 1.544 . . . . 0.0 111.014 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.8 mmpt? -94.82 146.09 24.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -163.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -141.32 149.28 41.0 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.202 -0.936 . . . . 0.0 112.353 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -144.73 148.51 39.84 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 124.947 1.299 . . . . 0.0 111.644 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.2 174.86 8.4 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.824 1.683 . . . . 0.0 110.023 163.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.87 -38.95 18.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.714 0.768 . . . . 0.0 112.003 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.62 155.77 19.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.651 2.38 . . . . 0.0 115.191 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.63 179.0 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.907 3.071 . . . . 0.0 113.47 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.88 2.92 1.07 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.467 2.307 . . . . 0.0 114.163 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.08 -31.54 0.2 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.89 1.676 . . . . 0.0 113.031 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.15 154.94 16.98 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.918 0.887 . . . . 0.0 111.461 155.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.9 tp -157.99 44.91 0.33 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.735 1.614 . . . . 0.0 110.207 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.71 -34.07 76.4 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -161.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -151.16 170.99 18.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.45 1.1 . . . . 0.0 111.964 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -70.61 138.69 51.02 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.877 -0.515 . . . . 0.0 109.837 160.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -120.01 155.33 33.08 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.706 0.802 . . . . 0.0 112.108 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -47.16 -41.14 17.25 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 32.7 m80 44.19 47.11 7.6 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . 0.347 0.3 OUTLIER . . . . . 0 C--O 1.247 0.939 0 C-N-CA 128.209 2.604 . . . . 0.0 117.571 168.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 119.557 -0.258 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.33 -51.43 0.14 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.467 0.707 . . . . 0.0 111.762 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -157.08 171.25 20.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.447 1.499 . . . . 0.0 111.223 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -90.32 -30.77 17.26 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.469 1.108 . . . . 0.0 111.37 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -61.86 -46.34 89.84 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.543 0.737 . . . . 0.0 109.67 -172.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -57.9 -31.98 67.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.771 1.228 . . . . 0.0 113.882 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -82.39 -36.71 26.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.25 1.82 . . . . 0.0 112.619 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.72 -38.65 67.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.147 1.779 . . . . 0.0 112.609 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.26 69.48 80.25 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.848 1.659 . . . . 0.0 111.514 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.94 -178.8 2.19 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.31 2.674 . . . . 0.0 113.602 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -49.75 -50.15 45.47 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.241 -1.537 . . . . 0.0 113.71 -167.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -61.69 -31.77 71.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.303 0.641 . . . . 0.0 112.239 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -77.62 -37.51 49.98 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.601 1.161 . . . . 0.0 111.756 176.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -71.47 -44.99 63.74 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.246 1.018 . . . . 0.0 111.126 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.5 t -71.15 -32.43 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.092 1.357 . . . . 0.0 111.995 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 p -69.03 -16.04 63.61 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 121.364 1.893 . . . . 0.0 113.93 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -44.54 13.48 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.079 0.952 . . . . 0.0 110.34 164.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -71.12 -19.19 62.47 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -75.71 28.84 0.11 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.615 -1.303 . . . . 0.0 113.257 165.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 18' ' ' GLU . . . -171.56 27.51 0.1 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.101 1.334 . . . . 0.0 113.918 -167.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 t -134.82 173.54 11.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.614 1.566 . . . . 0.0 111.118 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -121.27 160.75 23.26 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 127.045 2.138 . . . . 0.0 112.376 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.63 159.85 27.99 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 124.816 1.246 . . . . 0.0 111.636 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.27 155.5 67.38 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.893 2.395 . . . . 0.0 115.478 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.53 -34.47 75.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.89 1.676 . . . . 0.0 113.023 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.0 m 62.92 -37.66 0.15 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 131.61 3.964 . . . . 0.0 114.616 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.76 -106.34 0.68 Allowed Glycine 0 C--O 1.224 -0.472 0 C-N-CA 126.412 1.958 . . . . 0.0 112.922 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.1 mtt -57.43 -27.35 62.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.329 0.651 . . . . 0.0 112.396 170.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -80.12 6.71 10.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.864 1.266 . . . . 0.0 114.054 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -82.95 12.27 5.14 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.297 1.039 . . . . 0.0 112.753 156.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -70.79 -23.96 62.49 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.786 -1.196 . . . . 0.0 114.211 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -144.92 108.07 4.55 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.633 0.773 . . . . 0.0 112.363 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -140.82 113.92 8.48 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.038 1.735 . . . . 0.0 108.537 165.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -93.89 179.34 5.38 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.24 1.816 . . . . 0.0 112.944 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -83.58 166.13 18.47 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.127 1.371 . . . . 0.0 111.003 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.0 -160.85 31.83 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.654 1.121 . . . . 0.0 114.91 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -160.19 163.63 33.48 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.863 1.265 . . . . 0.0 113.861 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -95.85 145.5 25.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 128.475 2.71 . . . . 0.0 110.987 167.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -153.67 164.27 38.57 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.825 1.65 . . . . 0.0 112.307 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 69.3 m -67.12 166.13 14.53 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 123.893 1.806 . . . . 0.0 113.788 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.67 16.17 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 126.486 1.915 . . . . 0.0 112.69 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 47.7 t -127.38 -49.51 1.41 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.37 1.068 . . . . 0.0 112.493 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 9.1 p -96.68 -96.54 0.19 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.892 1.277 . . . . 0.0 112.919 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -155.26 -36.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.398 2.279 . . . . 0.0 113.563 -165.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p -82.23 118.23 71.21 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -160.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.31 153.69 77.06 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 120.997 1.132 . . . . 0.0 110.051 136.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.4 tp -152.14 -47.98 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -120.81 122.47 40.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.19 0.904 . . . . 0.0 110.657 -169.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.3 p -75.88 145.62 40.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 123.229 1.49 . . . . 0.0 111.041 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -75.86 -10.07 59.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.484 169.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.79 -40.06 78.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.439 1.496 . . . . 0.0 114.779 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.26 -0.1 53.62 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.342 1.026 . . . . 0.0 113.608 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -99.61 128.1 45.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -159.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -57.8 130.95 48.81 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.856 0.836 . . . . 0.0 111.688 168.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.1 m -125.62 -1.11 7.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.796 1.238 . . . . 0.0 113.876 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.5 p -78.44 131.32 36.85 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 156.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.47 -22.21 76.39 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.859 -1.151 . . . . 0.0 114.579 -175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 p -72.71 -37.28 67.85 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.053 2.541 . . . . 0.0 113.52 170.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.1 -27.42 73.71 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.395 0.998 . . . . 0.0 112.446 166.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 18.0 t90 65.6 141.04 0.06 OUTLIER Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 129.292 3.037 . . . . 0.0 113.72 169.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.94 98.86 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.932 2.421 . . . . 0.0 115.876 -163.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -149.54 155.52 40.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.247 2.219 . . . . 0.0 110.581 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.85 122.11 12.27 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.311 1.844 . . . . 0.0 108.374 -168.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -76.12 -7.61 55.15 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -164.55 154.42 13.95 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 157.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.07 58.98 0.92 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.445 1.898 . . . . 0.0 113.026 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -80.02 120.2 23.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.331 1.052 . . . . 0.0 110.903 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.82 -34.29 0.08 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.026 1.774 . . . . 0.0 111.866 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.1 m -144.89 149.06 34.65 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.834 2.053 . . . . 0.0 110.07 168.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -139.32 130.55 26.72 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.744 2.018 . . . . 0.0 112.137 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.75 -70.85 0.71 Allowed Glycine 0 N--CA 1.474 1.222 0 C-N-CA 125.814 1.673 . . . . 0.0 114.664 165.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -47.81 -35.4 10.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.597 2.359 . . . . 0.0 112.905 169.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -154.06 114.9 4.02 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.639 0.775 . . . . 0.0 110.644 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -136.66 28.63 2.96 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.466 1.507 . . . . 0.0 112.186 161.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 t -158.34 -21.62 0.08 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -7.52 51.79 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.464 1.906 . . . . 0.0 113.547 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 p -49.14 -38.58 25.79 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 128.635 2.774 . . . . 0.0 113.758 157.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.55 13.81 79.44 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.437 1.017 . . . . 0.0 112.948 -175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.8 178.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 122.595 1.188 . . . . 0.0 112.685 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -143.99 173.98 11.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.536 1.935 . . . . 0.0 111.611 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.4 ' H ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -146.62 147.71 31.34 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 113.868 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.07 109.71 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.628 1.971 . . . . 0.0 108.747 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.21 150.16 20.57 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.395 1.878 . . . . 0.0 109.069 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.11 120.54 4.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.151 0.887 . . . . 0.0 110.86 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -121.88 32.71 5.74 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.233 1.016 . . . . 0.0 110.423 164.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.5 m -107.36 -13.94 14.99 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 128.156 2.582 . . . . 0.0 113.47 -161.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.45 16.96 5.73 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 127.453 2.301 . . . . 0.0 111.955 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.28 -6.03 52.73 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.1 t -138.57 131.44 16.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.264 2.226 . . . . 0.0 108.999 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.33 144.15 25.75 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.081 2.52 . . . . 0.0 113.776 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -148.27 160.74 42.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 129.406 3.082 . . . . 0.0 112.315 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mtp -143.62 132.27 22.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.108 1.763 . . . . 0.0 109.017 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -138.16 150.09 46.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.125 0.875 . . . . 0.0 112.741 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 141.58 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 110.574 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.65 155.1 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 110.276 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 36.9 t -97.49 112.94 24.58 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 122.631 1.205 . . . . 0.0 108.111 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -67.33 -18.02 65.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.868 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -85.63 -38.56 18.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.553 1.141 . . . . 0.0 112.911 -171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.6 p -112.21 -13.41 13.5 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 127.709 2.403 . . . . 0.0 114.566 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 6.8 tt0 70.83 53.86 0.27 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.673 2.389 . . . . 0.0 116.151 173.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.34 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.707 1.203 . . . . 0.0 113.065 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.8 40.98 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.381 -0.825 . . . . 0.0 111.046 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.29 -27.13 19.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.079 1.419 . . . . 0.0 113.626 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.02 176.03 32.68 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 126.71 2.1 . . . . 0.0 113.634 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -153.3 167.24 30.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.653 1.216 . . . . 0.0 113.518 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.45 134.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 125.467 1.507 . . . . 0.0 109.024 -161.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.7 159.06 72.8 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.938 1.295 . . . . 0.0 111.999 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -67.11 146.15 75.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.354 2.036 . . . . 0.0 110.668 163.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -114.33 16.02 17.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.612 1.165 . . . . 0.0 113.79 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.46 -71.32 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.988 1.756 . . . . 0.0 112.495 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.51 179.53 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.609 2.873 . . . . 0.0 112.694 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -58.03 151.5 44.9 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.734 1.613 . . . . 0.0 112.735 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.57 -3.43 4.34 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.133 3.222 . . . . 0.0 115.264 -172.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -57.41 -29.12 63.86 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.666 -0.646 . . . . 0.0 112.088 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.41 16.19 60.2 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.19 2.328 . . . . 0.0 116.455 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -47.49 139.9 6.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.618 1.167 . . . . 0.0 113.958 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -114.97 136.21 53.38 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.106 1.762 . . . . 0.0 110.073 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.61 114.73 29.08 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.75 1.62 . . . . 0.0 110.82 -167.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 54.6 m -99.5 142.98 30.28 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.428 2.691 . . . . 0.0 111.504 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.7 mm -107.73 154.81 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.96 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.57 122.39 39.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.101 0.961 . . . . 0.0 112.183 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.7 m -77.39 49.5 0.72 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.391 1.076 . . . . 0.0 113.377 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.35 -55.5 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.28 -0.888 . . . . 0.0 112.633 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.08 -0.53 0.44 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.92 162.62 29.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.58 1.552 . . . . 0.0 110.703 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -108.53 160.81 15.61 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.276 1.43 . . . . 0.0 112.841 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -149.56 143.21 25.45 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.172 1.389 . . . . 0.0 110.449 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -135.17 155.72 78.71 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.243 1.417 . . . . 0.0 111.197 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.37 167.94 25.97 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.027 1.818 . . . . 0.0 112.047 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.58 -35.29 11.69 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.258 1.423 . . . . 0.0 112.723 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.454 ' HE3' ' HD2' ' A' ' 132' ' ' PRO . 25.0 mmmt -67.54 144.88 98.06 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 126.105 1.762 . . . . 0.0 114.591 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.454 ' HD2' ' HE3' ' A' ' 131' ' ' LYS . 38.0 Cg_endo -60.97 171.85 3.45 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.836 2.358 . . . . 0.0 112.876 158.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 58.4 16.91 4.41 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.298 1.839 . . . . 0.0 114.024 -170.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.67 37.7 1.34 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.421 2.288 . . . . 0.0 111.139 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 61.8 41.7 11.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.572 1.549 . . . . 0.0 114.859 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.06 43.39 1.32 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.218 1.407 . . . . 0.0 111.566 162.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.7 13.87 9.65 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -49.44 144.9 5.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.144 1.777 . . . . 0.0 115.118 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -157.41 163.91 38.06 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.226 1.01 . . . . 0.0 111.361 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.64 -157.19 0.24 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 122.821 0.449 . . . . 0.0 110.891 161.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.52 149.22 4.5 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.766 -1.209 . . . . 0.0 112.283 173.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -142.51 171.77 13.61 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.839 2.056 . . . . 0.0 109.294 -170.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 13.3 m170 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.761 -1.114 . . . . 0.0 112.04 170.448 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 tmm? . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.94 67.15 0.54 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.255 1.422 . . . . 0.0 112.845 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.99 165.37 25.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.272 156.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -112.93 -27.25 8.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.025 0.93 . . . . 0.0 113.352 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.278 0.0 OUTLIER -56.19 -54.41 45.54 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.968 2.907 . . . . 0.0 111.863 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -62.89 -27.73 69.56 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -76.47 -36.63 57.77 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.237 1.815 . . . . 0.0 113.721 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.6 mt -82.37 -20.36 37.34 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.887 1.275 . . . . 0.0 113.916 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 14.0 t -140.72 50.14 1.94 Allowed Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 146.28 67.59 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.999 3.132 . . . . 0.0 115.055 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -95.25 -57.38 2.43 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.414 1.086 . . . . 0.0 112.348 -163.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -59.87 -32.19 70.47 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.196 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.92 -45.35 71.07 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 124.156 0.982 . . . . 0.0 111.675 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -65.86 -41.75 91.28 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.001 1.273 . . . . 0.0 112.218 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.06 -38.87 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.902 -1.047 . . . . 0.0 112.49 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -80.4 -32.65 37.49 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.354 1.461 . . . . 0.0 112.388 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -52.18 66.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.213 1.005 . . . . 0.0 109.385 170.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -11.27 59.86 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.135 0.493 . . . . 0.0 111.945 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 59.09 1.4 Allowed 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.318 -2.113 . . . . 0.0 113.66 161.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.95 -6.35 0.22 Allowed Glycine 0 N--CA 1.465 0.621 0 N-CA-C 117.292 1.677 . . . . 0.0 117.292 -168.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.7 t -144.59 133.18 22.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.678 1.239 . . . . 0.0 111.932 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -121.59 145.98 47.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.483 1.913 . . . . 0.0 110.426 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.08 155.51 80.01 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -166.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.22 179.81 5.78 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.32 3.347 . . . . 0.0 112.735 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -49.14 -29.58 5.55 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.1 m 68.1 -28.63 0.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.241 2.617 . . . . 0.0 114.572 172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.25 -102.71 0.11 Allowed Glycine 0 N--CA 1.468 0.801 0 C-N-CA 126.146 1.831 . . . . 0.0 114.147 170.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.8 mtt -55.93 -25.61 44.06 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 171.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -84.34 -1.74 55.92 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.016 1.327 . . . . 0.0 112.997 175.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.22 89.39 3.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.946 1.298 . . . . 0.0 109.602 160.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -53.71 159.55 1.58 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 163.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -56.27 161.92 2.28 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -147.38 117.44 7.27 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 122.173 0.987 . . . . 0.0 112.313 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.03 176.1 0.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.146 2.178 . . . . 0.0 113.283 157.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.36 -176.06 2.83 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -163.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.54 -147.65 10.02 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.372 1.309 . . . . 0.0 116.372 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 ptp -134.54 179.89 6.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.251 1.82 . . . . 0.0 114.048 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.02 144.85 48.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 129.968 3.307 . . . . 0.0 108.695 159.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -144.88 151.13 38.24 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 110.931 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.38 161.76 30.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.134 1.445 . . . . 0.0 111.556 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.25 6.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.711 163.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.3 m -115.48 -57.24 2.26 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.907 1.283 . . . . 0.0 112.405 -165.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.7 p -81.19 -81.28 0.14 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.315 1.046 . . . . 0.0 111.928 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.72 -59.77 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.278 1.431 . . . . 0.0 113.218 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 p -96.85 165.92 14.96 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -154.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -59.36 152.39 61.16 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 120.66 0.906 . . . . 0.0 111.344 150.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 -31.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -128.11 132.77 48.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.58 -0.7 . . . . 0.0 110.935 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.6 m -76.66 140.53 40.96 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.023 -1.048 . . . . 0.0 109.705 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -64.85 -10.97 32.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.967 0.907 . . . . 0.0 112.521 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -87.68 -1.97 58.31 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.228 1.411 . . . . 0.0 113.666 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -95.29 130.12 42.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.594 1.158 . . . . 0.0 109.575 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -67.84 117.87 10.31 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.207 0.203 . . . . 0.0 110.576 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 66.4 m 57.01 -62.7 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.648 2.779 . . . . 0.0 116.699 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.7 p 61.57 162.29 0.07 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.17 1.788 . . . . 0.0 113.645 -158.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.12 2.11 45.44 Favored Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.613 -1.304 . . . . 0.0 115.264 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.17 -7.16 29.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.447 1.899 . . . . 0.0 112.618 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.85 -9.62 10.92 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.959 1.266 . . . . 0.0 114.673 -169.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.23 127.53 27.74 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.168 1.387 . . . . 0.0 111.131 -175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -111.65 125.36 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 122.986 2.458 . . . . 0.0 114.695 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 157.72 43.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.184 2.194 . . . . 0.0 109.904 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -153.1 116.44 4.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.978 1.311 . . . . 0.0 110.058 -169.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.4 p -72.05 -23.91 61.45 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.19 166.66 20.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 113.335 172.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.57 78.63 9.14 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.414 1.085 . . . . 0.0 110.334 162.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -72.2 140.07 48.53 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.399 -0.813 . . . . 0.0 112.171 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.07 -32.55 2.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 126.401 1.953 . . . . 0.0 111.604 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.3 134.04 55.35 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 128.03 2.532 . . . . 0.0 112.757 -175.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.85 130.35 31.66 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.521 1.928 . . . . 0.0 112.401 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.88 -77.98 0.1 Allowed Glycine 0 N--CA 1.474 1.181 0 C-N-CA 125.962 1.744 . . . . 0.0 115.009 159.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.71 -29.55 68.19 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.976 1.311 . . . . 0.0 111.76 167.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -89.34 9.17 27.09 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -165.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -82.69 2.17 34.93 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -169.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.2 t -103.01 -29.89 11.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.904 1.282 . . . . 0.0 111.78 153.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.52 -23.49 63.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.499 1.52 . . . . 0.0 113.677 -169.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.8 p -51.51 -38.11 52.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.373 1.869 . . . . 0.0 113.189 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.28 13.71 70.75 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.198 -170.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.003 1.402 . . . . 0.0 111.485 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.91 177.24 8.03 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.97 1.708 . . . . 0.0 111.869 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 155.44 38.33 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.329 1.451 . . . . 0.0 112.903 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 118.59 5.53 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.779 2.832 . . . . 0.0 107.29 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -75.02 149.8 39.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 111.4 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -136.7 96.5 3.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.732 0.777 . . . . 0.0 111.29 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.3 t -111.03 21.95 15.84 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.603 1.161 . . . . 0.0 112.217 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -5.94 58.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -162.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -98.35 14.08 29.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.623 1.969 . . . . 0.0 111.712 164.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.48 -4.17 64.99 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.988 1.756 . . . . 0.0 115.279 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.0 t -123.52 109.42 30.77 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.166 1.387 . . . . 0.0 109.767 -175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.74 125.6 9.57 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.044 2.496 . . . . 0.0 113.158 -166.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 165.95 13.02 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.169 2.187 . . . . 0.0 109.881 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.37 122.81 44.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.444 1.498 . . . . 0.0 108.021 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -120.32 137.87 54.02 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.981 0.913 . . . . 0.0 109.802 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.55 145.67 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 121.241 -0.912 . . . . 0.0 111.497 -165.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.44 138.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.041 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 42.2 t -72.72 98.63 2.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 123.41 1.576 . . . . 0.0 107.843 161.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.54 -16.66 57.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.884 1.274 . . . . 0.0 111.924 167.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -71.09 -45.61 63.38 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.851 1.205 . . . . 0.0 113.619 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.9 p -123.42 8.81 9.04 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.093 2.157 . . . . 0.0 115.424 -169.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.56 15.7 9.81 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.73 2.012 . . . . 0.0 114.821 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.46 83.45 2.54 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.481 -1.387 . . . . 0.0 112.956 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -83.17 58.1 4.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.123 1.769 . . . . 0.0 113.81 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.05 7.97 2.71 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -162.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.43 135.4 12.67 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.056 1.789 . . . . 0.0 110.925 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 157.18 42.83 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.559 -0.965 . . . . 0.0 111.312 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.91 137.85 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.685 1.594 . . . . 0.0 111.505 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.31 149.46 54.96 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.0 1.32 . . . . 0.0 113.112 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.67 146.36 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.573 2.182 . . . . 0.0 110.019 157.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.65 12.5 18.46 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.13 -64.65 0.2 Allowed Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.646 1.117 . . . . 0.0 115.043 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.84 -172.76 1.42 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.935 3.09 . . . . 0.0 113.396 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.95 162.76 0.46 Allowed Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 125.188 1.395 . . . . 0.0 112.507 171.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 115' ' ' GLY . 43.7 Cg_endo -60.33 -5.64 4.37 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.138 2.559 . . . . 0.0 114.378 174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 18.03 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.635 1.974 . . . . 0.0 113.019 163.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 113' ' ' PRO . . . -154.15 19.0 0.64 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.428 1.966 . . . . 0.0 116.535 -171.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.71 161.33 29.74 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.489 1.145 . . . . 0.0 113.966 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -128.44 132.07 48.43 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.042 1.737 . . . . 0.0 109.368 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -99.64 130.85 45.9 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.033 0.933 . . . . 0.0 109.916 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.58 139.97 52.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.326 1.85 . . . . 0.0 109.844 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.8 tt -127.04 170.66 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 109.562 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.78 129.48 50.54 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.74 -1.225 . . . . 0.0 111.643 164.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -83.79 39.42 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.735 1.214 . . . . 0.0 114.251 -167.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -44.57 -36.61 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 -151.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.24 22.51 0.94 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.966 1.706 . . . . 0.0 112.093 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.8 mt -98.5 157.85 15.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 120.666 -1.271 . . . . 0.0 111.678 -155.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 142.65 36.86 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.746 1.26 . . . . 0.0 113.753 -161.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -153.21 144.18 22.91 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 120.321 -1.487 . . . . 0.0 111.215 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -140.08 153.38 69.22 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.921 1.688 . . . . 0.0 111.002 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.27 171.66 17.18 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.885 2.39 . . . . 0.0 112.296 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -38.1 14.22 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.318 1.447 . . . . 0.0 110.622 170.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -89.33 144.29 32.09 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 128.31 2.644 . . . . 0.0 112.48 -171.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.34 -164.9 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.263 3.309 . . . . 0.0 113.068 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 61.41 38.52 16.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.705 1.602 . . . . 0.0 113.314 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.27 -10.23 52.95 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.34 1.456 . . . . 0.0 113.732 -173.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -95.19 125.03 39.55 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.519 1.528 . . . . 0.0 111.545 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.2 tp -161.77 55.17 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.686 1.594 . . . . 0.0 110.055 -176.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -48.72 -40.12 27.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.1 1.76 . . . . 0.0 113.66 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -149.76 152.81 35.85 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.138 2.175 . . . . 0.0 110.1 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.4 167.99 20.86 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -85.24 165.76 17.08 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.33 -0.857 . . . . 0.0 111.419 169.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.8 177.99 7.45 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -145.98 155.26 42.71 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.48 2.312 . . . . 0.0 109.42 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 . . . . . 0 C--O 1.251 1.183 0 C-N-CA 125.943 1.697 . . . . 0.0 112.059 -169.931 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 ttp . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.965 0.412 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.83 -37.07 0.12 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.675 1.19 . . . . 0.0 110.892 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.84 170.67 7.74 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.555 2.342 . . . . 0.0 113.449 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -112.27 -25.18 9.4 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 147.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -65.24 -48.1 74.46 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.68 1.192 . . . . 0.0 113.106 -168.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -68.43 -29.65 68.35 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.654 1.182 . . . . 0.0 112.823 174.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -75.12 -38.5 61.06 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.681 1.192 . . . . 0.0 112.15 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.49 -23.38 32.19 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -136.47 86.12 24.34 Favored Pre-proline 0 N--CA 1.474 0.728 0 CA-C-N 118.829 0.74 . . . . 0.0 111.516 166.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.59 166.66 17.09 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.645 2.23 . . . . 0.0 113.422 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.14 -37.63 87.97 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 119.868 -1.77 . . . . 0.0 113.943 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -58.01 -39.57 78.63 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 166.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -69.01 -39.1 79.51 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.67 -1.269 . . . . 0.0 111.322 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -64.55 -44.28 91.29 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.804 1.242 . . . . 0.0 111.738 177.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.73 -53.04 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.089 173.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 p -61.39 -31.6 71.51 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.679 1.127 . . . . 0.0 112.249 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.73 -29.76 70.91 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.926 0.891 . . . . 0.0 112.053 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -104.75 -11.95 16.57 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.259 0.623 . . . . 0.0 112.617 174.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -64.67 -3.62 3.39 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 117.989 2.588 . . . . 0.0 117.989 -170.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.41 11.86 9.04 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 128.998 3.19 . . . . 0.0 116.099 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 t -81.56 108.1 14.86 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.824 1.312 . . . . 0.0 109.926 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.45 147.23 40.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.705 2.002 . . . . 0.0 111.396 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -143.58 145.77 32.74 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.622 1.569 . . . . 0.0 111.826 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.48 179.13 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.048 3.165 . . . . 0.0 112.825 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' C ' ' H ' ' A' ' 27' ' ' GLY . 49.8 t80 67.2 -37.81 0.32 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 129.022 2.929 . . . . 0.0 115.724 174.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t 67.3 -40.93 0.41 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 127.991 2.516 . . . . 0.0 113.186 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 25' ' ' PHE . . . 47.93 -100.92 0.03 OUTLIER Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.503 2.001 . . . . 0.0 114.791 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.4 mtm -60.28 -16.03 30.48 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.452 ' CZ ' ' HE3' ' A' ' 33' ' ' LYS . 3.0 m-30 -99.92 2.96 44.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.561 1.944 . . . . 0.0 112.799 175.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.46 -30.36 64.5 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 120.422 1.465 . . . . 0.0 114.358 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -93.43 -165.71 1.38 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.789 1.235 . . . . 0.0 109.372 164.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 61.3 -162.41 0.27 Allowed 'General case' 0 CA--C 1.556 1.184 0 O-C-N 121.611 -0.681 . . . . 0.0 111.943 166.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HE3' ' CZ ' ' A' ' 29' ' ' TYR . 68.6 mmtt 54.33 35.84 23.86 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.298 1.839 . . . . 0.0 115.137 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -63.37 -175.66 0.12 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 130.843 3.657 . . . . 0.0 115.049 -173.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.59 156.37 35.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.476 1.51 . . . . 0.0 107.9 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.18 -149.93 16.0 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 114.394 0.517 . . . . 0.0 114.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.6 ptp -155.06 168.27 27.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.384 1.074 . . . . 0.0 113.262 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -122.18 139.17 54.07 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 128.809 2.844 . . . . 0.0 109.574 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.69 157.5 43.29 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.561 1.544 . . . . 0.0 110.871 -172.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.1 t -79.04 170.17 17.09 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.486 1.612 . . . . 0.0 114.238 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.28 13.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.496 1.918 . . . . 0.0 112.008 161.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.8 t -121.42 -33.22 3.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.09 1.356 . . . . 0.0 112.846 -173.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.6 p -102.29 -86.4 0.42 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.715 1.606 . . . . 0.0 111.348 167.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.1 -41.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 p -111.47 161.39 25.58 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -146.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.72 139.86 31.46 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.184 2.589 . . . . 0.0 111.888 159.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.5 mt -136.92 -23.31 1.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -135.83 141.89 44.75 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.524 1.057 . . . . 0.0 111.285 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.4 p -116.36 132.03 56.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.799 1.285 . . . . 0.0 112.123 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -5.04 19.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.997 1.319 . . . . 0.0 113.53 175.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.46 -26.8 68.12 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.793 -1.192 . . . . 0.0 112.419 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -90.67 5.97 45.9 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.824 1.25 . . . . 0.0 114.32 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 2.9 ttpt -59.43 131.91 52.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.046 0.938 . . . . 0.0 110.472 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 32.6 t80 -83.17 156.9 22.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.764 1.226 . . . . 0.0 112.397 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 2.5 t 63.55 -166.72 0.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.155 1.782 . . . . 0.0 113.916 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.9 p -94.88 -151.02 0.32 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.447 2.299 . . . . 0.0 112.321 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.97 88.09 0.02 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 151.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -129.3 -9.94 4.68 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.87 1.668 . . . . 0.0 110.48 174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.36 3.9 5.86 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.182 1.849 . . . . 0.0 115.725 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -90.99 120.08 68.73 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 118.5 1.15 . . . . 0.0 112.341 -162.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.9 109.2 2.62 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.079 2.519 . . . . 0.0 113.048 -168.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.1 p -151.44 165.96 32.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.064 2.146 . . . . 0.0 111.292 -167.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.71 148.88 26.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.781 1.632 . . . . 0.0 109.641 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.6 p -96.56 -27.2 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.267 1.827 . . . . 0.0 113.068 169.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -145.92 155.09 42.63 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.449 1.499 . . . . 0.0 109.524 158.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.31 77.14 9.14 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.389 168.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -74.54 134.52 42.19 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.949 -1.095 . . . . 0.0 111.67 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.76 -38.78 1.33 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 128.005 2.717 . . . . 0.0 109.946 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 p -112.86 148.36 35.07 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 128.454 2.702 . . . . 0.0 111.322 169.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.7 123.25 10.43 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.809 1.644 . . . . 0.0 112.422 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.41 -83.05 0.03 OUTLIER Glycine 0 N--CA 1.472 1.08 0 C-N-CA 127.174 2.321 . . . . 0.0 114.197 163.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.9 m -58.45 -25.17 61.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.931 1.292 . . . . 0.0 112.317 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -85.04 2.52 42.85 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 122.307 1.051 . . . . 0.0 112.95 -167.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.27 -18.48 64.55 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.405 1.482 . . . . 0.0 114.61 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -100.75 -36.44 9.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.849 1.659 . . . . 0.0 111.446 167.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -70.68 -26.7 63.55 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 -167.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.28 -32.04 64.18 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.397 2.279 . . . . 0.0 112.619 170.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.39 18.35 69.5 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.59 1.091 . . . . 0.0 112.696 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.51 -177.81 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 122.066 0.936 . . . . 0.0 112.104 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.469 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.43 -179.3 6.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.63 1.972 . . . . 0.0 109.171 175.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.469 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 9.6 mmt180 -140.3 154.43 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.957 1.703 . . . . 0.0 109.316 -171.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -152.63 123.8 7.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.756 1.222 . . . . 0.0 110.241 165.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.23 159.03 18.97 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.752 1.621 . . . . 0.0 111.648 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -130.56 111.83 12.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -123.07 19.92 9.94 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 123.114 1.435 . . . . 0.0 111.488 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.88 -18.8 13.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -142.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.66 8.03 45.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 113.025 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.39 -10.03 73.61 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.854 1.693 . . . . 0.0 114.751 -173.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -109.65 126.68 28.61 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 0.0 110.717 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.79 127.37 2.66 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.414 2.743 . . . . 0.0 112.99 175.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -133.66 155.43 49.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.305 3.042 . . . . 0.0 108.717 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 42.5 mtp -140.48 124.02 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.414 1.485 . . . . 0.0 110.736 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -126.42 153.74 44.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.305 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.03 138.45 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.835 1.254 . . . . 0.0 110.759 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.77 148.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 122.103 0.954 . . . . 0.0 111.412 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 53.5 t -82.58 99.08 9.32 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.63 -20.47 66.3 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.687 -0.633 . . . . 0.0 111.566 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -64.25 -35.0 79.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.248 1.019 . . . . 0.0 111.79 -175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -131.8 -7.05 3.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.023 2.129 . . . . 0.0 115.464 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 69.34 59.62 0.32 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.89 2.876 . . . . 0.0 115.614 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.4 38.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 113.416 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.13 141.67 58.02 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 166.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.1 mt -108.48 -32.91 7.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.46 -169.62 35.59 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 127.487 2.47 . . . . 0.0 114.043 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -153.67 -179.48 7.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -152.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.22 145.92 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.805 1.642 . . . . 0.0 112.012 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.27 153.69 44.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.524 1.53 . . . . 0.0 111.965 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.81 137.0 15.57 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.524 2.816 . . . . 0.0 111.035 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.88 -0.07 41.97 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.52 -55.28 0.26 Allowed Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.05 1.786 . . . . 0.0 114.998 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -93.74 -153.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.279 3.319 . . . . 0.0 112.433 -169.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.45 171.22 0.29 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.327 2.251 . . . . 0.0 113.196 172.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -58.84 -5.98 3.08 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.954 2.436 . . . . 0.0 115.074 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -61.32 -26.42 67.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.71 1.204 . . . . 0.0 113.271 163.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.67 12.69 62.83 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.819 2.152 . . . . 0.0 115.765 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.92 132.61 49.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.335 1.067 . . . . 0.0 112.398 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -126.24 134.95 51.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.364 1.466 . . . . 0.0 108.711 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.89 138.58 41.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.052 0.941 . . . . 0.0 110.982 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 57.9 m -122.57 136.99 55.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.926 2.09 . . . . 0.0 109.466 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.0 tt -137.55 169.05 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.592 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.01 166.31 24.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -170.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -133.87 36.5 3.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.944 1.297 . . . . 0.0 113.356 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.06 -47.63 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.586 -1.321 . . . . 0.0 112.6 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 23.62 4.03 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.84 1.656 . . . . 0.0 112.781 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.9 mt -133.88 155.21 50.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.577 1.951 . . . . 0.0 110.13 -165.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -104.55 156.38 18.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.967 0.889 . . . . 0.0 113.359 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.11 153.31 33.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 111.426 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -139.0 150.87 66.72 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.538 . . . . 0.0 111.456 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.71 171.51 18.07 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.602 2.201 . . . . 0.0 112.559 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.33 -46.27 5.07 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.533 1.133 . . . . 0.0 112.011 -175.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.76 160.03 1.57 Allowed Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.631 2.372 . . . . 0.0 115.629 175.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.25 -165.51 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.926 3.084 . . . . 0.0 112.709 164.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.89 42.57 7.59 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.94 1.696 . . . . 0.0 113.869 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.11 -16.48 61.02 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.784 1.234 . . . . 0.0 112.912 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.53 129.92 42.79 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.415 1.086 . . . . 0.0 111.151 170.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.41 29.27 1.05 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -168.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -52.65 -31.37 36.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.655 1.982 . . . . 0.0 114.473 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -130.08 133.93 47.02 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.155 1.382 . . . . 0.0 110.212 174.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -155.06 120.31 4.95 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.168 0.987 . . . . 0.0 110.648 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -154.61 163.74 39.76 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.642 0.777 . . . . 0.0 112.412 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -86.47 141.11 29.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -143.83 168.4 20.03 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.203 2.201 . . . . 0.0 109.675 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 126.79 2.036 . . . . 0.0 114.833 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.42 -84.51 0.63 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.19 0.996 . . . . 0.0 109.822 171.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -103.9 -177.27 3.32 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.787 2.035 . . . . 0.0 112.886 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -99.43 -30.86 11.95 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.134 0.974 . . . . 0.0 113.191 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -58.04 -48.23 80.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.172 1.789 . . . . 0.0 111.079 -173.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -62.98 -24.9 68.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.885 1.274 . . . . 0.0 112.971 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -85.79 -45.38 11.66 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.327 1.851 . . . . 0.0 113.308 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.76 -32.21 31.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.337 1.055 . . . . 0.0 113.753 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -131.08 64.78 74.92 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 125.565 1.546 . . . . 0.0 109.938 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -64.57 159.6 43.94 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.118 2.545 . . . . 0.0 113.616 -172.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -111.26 -69.19 0.88 Allowed 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 123.954 0.901 . . . . 0.0 109.258 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.55 -34.54 72.79 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.229 0.538 . . . . 0.0 112.215 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.16 -24.07 43.52 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 176.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -81.09 -47.42 13.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.539 1.063 . . . . 0.0 111.805 172.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -53.29 -40.09 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.45 1.5 . . . . 0.0 111.998 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.26 -18.95 60.93 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 174.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.57 -27.01 27.58 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.18 0.992 . . . . 0.0 111.77 171.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -100.39 -7.27 24.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -68.1 51.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.072 1.349 . . . . 0.0 113.732 172.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.99 19.04 0.02 OUTLIER Glycine 0 CA--C 1.544 1.847 0 C-N-CA 127.641 2.543 . . . . 0.0 115.966 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 t -89.17 77.97 7.43 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.986 1.374 . . . . 0.0 114.706 -158.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -78.46 177.68 8.33 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.042 -1.662 . . . . 0.0 113.951 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.81 155.61 0.16 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 128.695 2.798 . . . . 0.0 117.43 171.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.28 93.26 0.75 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.205 2.603 . . . . 0.0 112.294 176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -108.79 -17.51 13.92 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -171.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 m -48.62 -22.74 0.82 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.435 1.894 . . . . 0.0 114.368 170.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.02 -107.46 0.56 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.984 1.278 . . . . 0.0 113.557 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.0 mtt -62.07 -12.85 21.3 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.87 7.52 41.55 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.12 1.768 . . . . 0.0 114.088 171.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.76 47.39 0.33 Allowed 'General case' 0 CA--C 1.552 1.048 0 O-C-N 119.645 -1.909 . . . . 0.0 112.861 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -141.63 18.31 2.18 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -168.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -148.52 151.19 34.71 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.729 -1.232 . . . . 0.0 112.143 165.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -149.79 113.94 5.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.68 1.992 . . . . 0.0 110.54 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.86 176.89 7.68 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.511 1.524 . . . . 0.0 113.668 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 m -128.36 155.48 44.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.773 1.629 . . . . 0.0 109.792 -162.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.69 -153.7 19.33 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -151.52 165.68 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.958 1.303 . . . . 0.0 113.965 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.31 153.23 37.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.66 2.384 . . . . 0.0 111.342 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 161.57 37.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.906 1.682 . . . . 0.0 109.979 173.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.87 154.21 9.74 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 122.737 1.256 . . . . 0.0 110.16 164.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.51 -10.75 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.656 157.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 89.9 m -92.49 -46.71 7.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.23 -101.45 0.16 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.051 1.34 . . . . 0.0 110.248 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -159.47 -47.26 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.609 1.964 . . . . 0.0 112.98 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.04 153.62 38.45 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 125.923 1.689 . . . . 0.0 115.258 -157.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 135.97 15.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.342 2.028 . . . . 0.0 113.594 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.06 -30.44 12.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.432 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -157.09 157.95 35.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 112.162 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -101.65 147.22 26.7 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.274 -0.891 . . . . 0.0 111.412 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -17.27 63.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.482 1.113 . . . . 0.0 112.232 172.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -35.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.476 1.91 . . . . 0.0 113.747 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.56 -1.35 30.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.812 2.045 . . . . 0.0 112.53 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.58 116.96 8.89 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.784 0.802 . . . . 0.0 111.344 -171.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -81.37 136.32 35.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.956 1.302 . . . . 0.0 110.461 172.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 24.6 t 63.06 106.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.4 1.88 . . . . 0.0 112.999 -167.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.3 p -77.22 30.09 0.14 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.756 1.622 . . . . 0.0 113.833 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.12 -114.94 0.23 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.318 1.913 . . . . 0.0 115.018 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.2 p -121.79 -116.04 0.31 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.198 1.799 . . . . 0.0 112.283 -165.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.74 22.63 2.74 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.841 1.2 . . . . 0.0 115.031 -171.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.93 104.06 47.38 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.712 1.205 . . . . 0.0 112.11 -159.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -93.89 117.16 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.771 2.314 . . . . 0.0 112.274 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.7 p -141.16 169.33 17.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.13 1.772 . . . . 0.0 111.256 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -149.41 141.32 23.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.85 1.26 . . . . 0.0 108.778 161.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -85.7 -16.83 37.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 0.0 113.799 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -158.38 159.8 36.2 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.068 1.747 . . . . 0.0 111.014 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.72 86.9 2.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.297 1.439 . . . . 0.0 109.408 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -105.9 119.52 39.39 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.96 0.904 . . . . 0.0 110.981 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.94 -33.21 0.48 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.45 1.5 . . . . 0.0 113.024 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.51 116.25 16.03 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.277 1.031 . . . . 0.0 112.194 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.9 mmpt? -139.25 137.88 36.3 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 126.408 1.883 . . . . 0.0 110.902 -173.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.88 -80.52 0.24 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 125.32 1.438 . . . . 0.0 115.007 162.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.9 m -52.32 -33.03 40.69 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.486 1.114 . . . . 0.0 111.317 162.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -124.77 18.94 8.63 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.594 1.187 . . . . 0.0 113.928 -166.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -127.18 -5.18 6.11 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.861 1.664 . . . . 0.0 110.721 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.77 -40.15 63.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.255 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -126.82 -56.92 1.36 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 164.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 p -162.72 -47.79 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -167.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.44 -7.71 3.49 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 124.501 1.048 . . . . 0.0 114.784 -160.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.68 177.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 127.411 2.284 . . . . 0.0 111.12 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.91 170.35 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.588 1.555 . . . . 0.0 110.141 170.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.46 158.44 34.11 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -148.87 108.52 4.0 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 128.097 2.559 . . . . 0.0 108.699 -166.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.5 144.82 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.101 -0.999 . . . . 0.0 111.02 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -117.26 19.52 14.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.764 1.225 . . . . 0.0 112.486 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t -70.3 35.18 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.453 2.301 . . . . 0.0 114.211 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -110.74 -23.64 10.93 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.324 2.25 . . . . 0.0 113.562 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -97.28 14.95 24.31 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.45 1.9 . . . . 0.0 113.164 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.66 48.68 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.516 1.532 . . . . 0.0 114.836 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 37.7 t -111.06 103.53 54.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.341 1.857 . . . . 0.0 109.648 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.47 125.76 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.759 1.639 . . . . 0.0 111.613 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -151.26 156.96 41.92 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.807 2.443 . . . . 0.0 111.609 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.4 mtm -115.95 98.96 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.024 2.53 . . . . 0.0 107.407 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -83.06 148.6 27.43 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.118 -1.614 . . . . 0.0 108.974 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 m -138.22 145.47 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 122.343 1.068 . . . . 0.0 112.879 -167.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.602 HG13 ' H ' ' A' ' 103' ' ' LEU . 6.1 m -139.86 156.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.067 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.9 t -80.11 155.37 27.53 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-O 124.079 1.895 . . . . 0.0 108.517 164.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -114.67 -18.22 11.45 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 110.906 -2.861 . . . . 0.0 113.497 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.63 -41.79 95.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.77 0.828 . . . . 0.0 112.185 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -110.85 -20.66 12.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.859 2.464 . . . . 0.0 113.369 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 64.8 122.51 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.06 1.744 . . . . 0.0 112.27 -162.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 75.47 77.88 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.694 1.998 . . . . 0.0 115.765 164.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.332 2.9 t60 -85.57 -21.44 28.52 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.602 ' H ' HG13 ' A' ' 95' ' ' VAL . 3.2 tp 53.16 27.84 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.308 2.643 . . . . 0.0 116.023 163.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.8 -179.55 52.96 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 123.103 1.391 . . . . 0.0 109.817 159.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.06 162.87 40.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.44 1.59 . . . . 0.0 113.393 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.05 139.59 42.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.488 -169.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.41 144.25 52.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.49 142.72 49.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.204 2.603 . . . . 0.0 110.12 162.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -107.98 -3.13 19.08 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.57 -64.28 0.61 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.897 1.713 . . . . 0.0 114.215 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.01 -170.96 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 124.584 3.523 . . . . 0.0 114.438 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -50.02 159.82 0.74 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.761 1.624 . . . . 0.0 111.985 169.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.62 -5.42 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.861 2.374 . . . . 0.0 114.758 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -65.41 -10.88 37.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.753 1.621 . . . . 0.0 114.519 164.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.43 -9.17 48.06 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.831 1.682 . . . . 0.0 116.359 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -56.51 143.14 36.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.973 1.309 . . . . 0.0 113.061 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -129.67 133.94 47.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 110.283 -166.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -104.8 129.02 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.634 1.174 . . . . 0.0 110.047 -174.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.7 p -131.17 129.27 41.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.391 1.077 . . . . 0.0 111.969 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 122' ' ' SER . 7.0 tp -109.34 161.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.31 1.044 . . . . 0.0 110.631 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.411 ' H ' HD11 ' A' ' 120' ' ' ILE . 18.8 p30 -93.06 -21.51 19.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.83 1.252 . . . . 0.0 113.292 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.44 ' H ' HG13 ' A' ' 120' ' ' ILE . 50.6 m 58.25 19.67 6.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 p -71.85 -17.69 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.77 43.66 1.26 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.436 1.495 . . . . 0.0 113.167 -163.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.5 mt -117.55 156.01 28.82 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.759 1.266 . . . . 0.0 114.181 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -102.1 152.33 21.11 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.396 2.278 . . . . 0.0 109.76 157.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -146.32 145.59 30.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.81 0.844 . . . . 0.0 111.715 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -140.75 153.54 67.92 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.82 1.648 . . . . 0.0 110.553 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.38 171.9 14.28 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.373 2.049 . . . . 0.0 112.765 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.47 -37.89 22.55 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -71.39 160.05 83.72 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 128.932 2.893 . . . . 0.0 113.663 -174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.05 -179.16 0.5 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.102 2.535 . . . . 0.0 112.948 161.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 60.87 28.64 18.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.817 1.647 . . . . 0.0 113.296 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.35 -13.58 60.13 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.362 1.465 . . . . 0.0 112.669 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 52.01 57.41 6.52 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.045 1.738 . . . . 0.0 114.962 169.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.0 mt -139.66 40.88 2.02 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.508 1.923 . . . . 0.0 111.535 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.62 -31.24 32.52 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.389 1.476 . . . . 0.0 113.326 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -144.89 162.73 36.11 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.183 -0.948 . . . . 0.0 110.15 149.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -72.54 -52.97 13.34 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.797 -0.565 . . . . 0.0 111.756 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.62 161.54 40.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.448 1.499 . . . . 0.0 111.696 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -88.75 -23.73 22.84 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 62.04 -40.15 0.14 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 129.303 3.041 . . . . 0.0 119.149 172.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.037 1.335 . . . . 0.0 112.097 -157.461 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.91 17.37 0.77 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.937 1.295 . . . . 0.0 113.492 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.38 151.36 39.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 123.818 1.771 . . . . 0.0 114.506 -174.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -85.0 -29.47 24.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.253 -1.794 . . . . 0.0 111.297 -172.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -60.74 -42.6 97.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.964 0.906 . . . . 0.0 110.717 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -66.81 -27.5 67.62 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -75.76 -40.11 55.9 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.857 1.663 . . . . 0.0 112.875 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.46 -44.28 78.99 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.79 -0.569 . . . . 0.0 111.431 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 t -133.46 78.24 63.33 Favored Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 125.087 1.355 . . . . 0.0 112.448 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.02 174.91 5.21 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.106 2.537 . . . . 0.0 113.627 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -53.01 -44.8 67.57 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.196 -1.565 . . . . 0.0 113.739 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -61.08 -29.67 69.89 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -77.34 -39.03 49.04 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.298 1.039 . . . . 0.0 112.216 169.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -59.74 -44.34 93.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.932 1.293 . . . . 0.0 110.828 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.8 -30.96 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 174.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -89.35 -17.65 28.46 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 120.371 1.441 . . . . 0.0 113.435 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -61.62 -27.78 68.9 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.39 1.876 . . . . 0.0 111.782 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -127.72 -32.88 2.33 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 167.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HZ3' ' CE1' ' A' ' 102' ' ' HIS . 0.0 OUTLIER 48.23 21.28 0.33 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 118.61 2.819 . . . . 0.0 118.61 -176.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.6 3.25 0.08 OUTLIER Glycine 0 CA--C 1.53 1.021 0 N-CA-C 117.011 1.564 . . . . 0.0 117.011 -172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -132.34 149.64 52.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.444 1.122 . . . . 0.0 112.642 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -139.44 159.09 42.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 128.491 2.716 . . . . 0.0 108.304 163.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.69 65.4 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.153 0.981 . . . . 0.0 112.571 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.56 118.83 5.64 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.679 2.253 . . . . 0.0 111.582 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -142.18 -17.07 0.74 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -26.06 43.4 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.484 -1.385 . . . . 0.0 112.81 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.9 -107.3 0.9 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 125.467 1.508 . . . . 0.0 113.614 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.2 ttm -54.68 -29.36 52.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.416 0.687 . . . . 0.0 112.45 170.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -90.61 8.56 33.6 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.965 1.306 . . . . 0.0 113.941 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.1 mt -72.7 73.05 1.07 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.119 -1.613 . . . . 0.0 110.802 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -76.63 -23.88 53.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.188 1.795 . . . . 0.0 113.659 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 56.49 -1.06 0.05 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.905 2.482 . . . . 0.0 117.256 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -155.45 114.62 3.59 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.294 2.238 . . . . 0.0 109.077 -168.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -129.3 -176.66 3.95 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.918 2.087 . . . . 0.0 110.925 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t -132.2 155.69 47.78 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 127.655 2.382 . . . . 0.0 111.862 169.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.21 -145.66 14.18 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.734 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.5 ptp -149.88 159.33 44.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 153.41 19.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.497 152.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -147.52 155.74 42.16 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.89 1.276 . . . . 0.0 109.785 158.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.45 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 71.5 m -61.57 165.86 4.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 124.134 1.921 . . . . 0.0 112.435 168.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.19 29.3 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.263 167.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 35.0 t -135.23 -47.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.107 1.363 . . . . 0.0 113.312 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.45 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 5.2 p -84.48 -84.57 0.14 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.854 1.262 . . . . 0.0 112.065 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -153.5 -48.94 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.5 p -145.02 165.07 23.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -139.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 144.4 46.87 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.409 2.74 . . . . 0.0 113.44 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -144.35 -4.63 0.79 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.38 129.05 21.53 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.525 -1.359 . . . . 0.0 110.299 169.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 p -94.48 142.45 27.42 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.164 -0.96 . . . . 0.0 111.488 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.17 -11.22 28.59 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.084 0.945 . . . . 0.0 113.336 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -38.92 72.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.43 -1.419 . . . . 0.0 114.054 163.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -73.32 -3.56 27.86 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.513 1.525 . . . . 0.0 112.619 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.56 130.72 44.3 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.275 1.03 . . . . 0.0 110.26 -173.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -128.45 170.42 13.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.961 2.104 . . . . 0.0 112.163 -170.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.8 t 66.2 155.95 0.09 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.352 1.861 . . . . 0.0 113.729 -165.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.2 p -153.83 -168.56 3.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.812 1.645 . . . . 0.0 111.492 -167.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.68 -69.97 1.17 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.535 1.54 . . . . 0.0 114.142 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -83.82 -14.1 52.14 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.059 1.743 . . . . 0.0 113.71 -170.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.07 0.04 87.33 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.736 1.16 . . . . 0.0 113.472 -165.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -69.99 142.45 90.54 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 124.934 1.294 . . . . 0.0 114.151 -170.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -91.78 143.01 2.8 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.468 2.779 . . . . 0.0 115.486 -166.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.1 m -159.68 172.29 18.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.72 2.008 . . . . 0.0 110.271 169.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -140.19 121.76 15.21 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.393 1.877 . . . . 0.0 107.16 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -84.97 -10.8 56.67 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -160.93 164.1 31.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.106 0.962 . . . . 0.0 112.926 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.5 87.42 2.66 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.682 1.593 . . . . 0.0 109.331 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -70.72 161.38 30.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.511 1.124 . . . . 0.0 112.029 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.34 1.28 75.37 Favored Glycine 0 CA--C 1.541 1.679 0 O-C-N 121.153 -0.967 . . . . 0.0 115.345 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.8 t -133.35 147.25 51.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.243 1.817 . . . . 0.0 110.493 166.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 1.3 tptt -144.3 73.14 1.37 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -159.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.99 -67.53 0.47 Allowed Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.017 1.77 . . . . 0.0 114.082 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -31.88 71.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.751 0.82 . . . . 0.0 111.123 167.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.497 ' HB2' ' H ' ' A' ' 70' ' ' LYS . 11.6 m-20 -89.28 8.75 28.81 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -170.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.82 -33.89 76.16 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.078 -1.014 . . . . 0.0 111.851 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 t -89.57 -19.3 25.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.717 1.207 . . . . 0.0 112.154 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -72.19 -19.4 61.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.681 1.592 . . . . 0.0 112.904 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -55.1 -48.25 73.83 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.165 1.386 . . . . 0.0 112.932 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.11 17.67 79.57 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.3 -160.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -108.02 149.44 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.502 1.651 . . . . 0.0 110.253 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 mp -125.56 167.56 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.668 1.587 . . . . 0.0 111.499 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.93 150.42 36.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.366 1.466 . . . . 0.0 111.391 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.98 117.79 4.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.918 1.687 . . . . 0.0 108.351 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.29 144.66 35.92 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.599 1.16 . . . . 0.0 111.416 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -124.8 34.45 4.99 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 123.009 1.385 . . . . 0.0 111.083 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -70.2 42.92 0.06 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 129.612 3.165 . . . . 0.0 112.48 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 t -126.08 -12.77 6.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.977 2.111 . . . . 0.0 113.277 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -98.14 16.89 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.953 2.101 . . . . 0.0 113.598 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.14 5.52 89.61 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 124.054 0.835 . . . . 0.0 115.019 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 31.9 t -141.74 135.62 14.76 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.742 2.417 . . . . 0.0 110.284 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.5 125.77 11.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.336 2.691 . . . . 0.0 112.569 173.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -136.17 156.37 48.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.637 2.375 . . . . 0.0 109.89 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.2 mtt -133.77 131.19 39.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.386 2.274 . . . . 0.0 108.527 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -132.43 148.66 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 121.163 -0.961 . . . . 0.0 111.898 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.73 147.93 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.077 1.351 . . . . 0.0 112.513 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.54 152.11 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.198 1.399 . . . . 0.0 111.495 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 98' ' ' GLN . 43.6 t -90.07 117.55 28.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 164.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -97.55 -0.87 45.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.043 1.737 . . . . 0.0 113.188 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.405 ' HB2' ' SG ' ' A' ' 96' ' ' CYS . 30.8 mt-30 -63.21 -45.25 92.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.194 1.398 . . . . 0.0 110.404 162.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 p -125.4 -14.09 6.48 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.329 2.252 . . . . 0.0 115.197 -169.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.275 75.5 mt-10 74.61 60.11 0.07 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.887 2.475 . . . . 0.0 115.656 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.44 141.11 28.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.462 ' CE1' ' HZ3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -68.8 115.2 7.86 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.147 -0.97 . . . . 0.0 111.672 172.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 tp -97.68 -36.1 10.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.455 1.121 . . . . 0.0 113.774 -159.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.34 155.85 26.46 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 127.399 2.428 . . . . 0.0 112.876 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.44 146.16 29.46 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.745 0.818 . . . . 0.0 111.595 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.22 135.22 44.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 110.453 -155.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.49 152.07 41.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.21 156.48 25.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.502 3.468 . . . . 0.0 112.182 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -123.81 5.17 8.77 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -164.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.75 -59.82 0.68 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 117.839 -1.534 . . . . 0.0 115.682 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -62.59 -166.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.83 3.02 . . . . 0.0 112.58 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -55.52 159.33 4.87 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 110.602 169.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -57.9 -8.19 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.224 2.616 . . . . 0.0 114.283 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -24.63 15.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.019 1.328 . . . . 0.0 113.487 163.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.85 2.4 76.26 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.655 1.598 . . . . 0.0 116.275 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -51.0 139.56 17.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.59 1.195 . . . . 0.0 112.964 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -109.81 126.94 54.32 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.768 1.227 . . . . 0.0 108.534 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.83 98.04 8.34 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.886 0.875 . . . . 0.0 109.267 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.18 148.29 35.99 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.09 0.956 . . . . 0.0 110.626 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.98 157.17 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.467 1.107 . . . . 0.0 110.062 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 159.28 35.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 112.879 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -123.04 19.41 10.01 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.1 p -44.29 -39.72 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 126.243 1.817 . . . . 0.0 115.868 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.29 30.27 0.62 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.475 1.51 . . . . 0.0 112.804 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.43 173.24 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.591 1.556 . . . . 0.0 109.946 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -115.29 149.61 37.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 122.429 1.109 . . . . 0.0 113.257 173.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -159.21 133.11 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.591 1.156 . . . . 0.0 110.001 -168.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -145.06 152.13 50.46 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 124.796 1.238 . . . . 0.0 112.1 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.67 168.97 23.61 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.135 1.89 . . . . 0.0 112.402 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -41.11 12.83 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.339 1.056 . . . . 0.0 111.776 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -66.57 147.6 98.93 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.192 0.997 . . . . 0.0 111.652 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.33 178.57 4.78 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.517 2.811 . . . . 0.0 113.798 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 66.32 36.85 5.11 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.212 2.205 . . . . 0.0 112.959 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.83 -20.23 60.51 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.807 1.243 . . . . 0.0 112.642 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.9 143.36 50.09 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.535 1.534 . . . . 0.0 111.311 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.0 tp -159.19 37.01 0.21 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.863 1.265 . . . . 0.0 112.043 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . 0.262 10.8 tt0 45.43 44.72 9.8 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.8 2.84 . . . . 0.0 113.776 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.95 161.25 30.36 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.679 -1.6 . . . . 0.0 112.913 170.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 9.6 m170 56.79 96.52 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.101 1.76 . . . . 0.0 115.547 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -55.23 120.9 7.73 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.531 -1.356 . . . . 0.0 109.974 164.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -71.16 -17.38 62.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -162.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -152.3 -50.19 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.076 1.75 . . . . 0.0 110.641 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 . . . . . 0 C--O 1.245 0.858 0 C-N-CA 128.845 2.858 . . . . 0.0 108.39 170.583 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 ttp . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 117.431 -1.271 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.15 -85.52 0.12 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.176 1.353 . . . . 0.0 111.856 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -120.29 -178.67 3.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.104 1.362 . . . . 0.0 111.756 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -103.37 -26.44 12.91 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.069 0.948 . . . . 0.0 112.994 171.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -53.48 -52.67 58.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.387 1.875 . . . . 0.0 111.651 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.4 -28.04 67.59 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -70.39 -37.2 74.48 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.168 0.987 . . . . 0.0 112.408 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.95 -19.84 22.02 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -137.31 58.19 16.74 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 171.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.08 140.13 27.81 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.212 3.275 . . . . 0.0 116.018 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -88.66 -52.26 5.24 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.297 1.839 . . . . 0.0 111.554 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -54.99 -21.01 10.43 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.796 2.038 . . . . 0.0 113.728 169.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -95.32 -20.74 18.9 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.359 1.863 . . . . 0.0 114.212 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -89.92 -53.99 4.25 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.445 1.498 . . . . 0.0 112.321 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.3 t -65.44 -24.59 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.885 -1.135 . . . . 0.0 112.34 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -68.47 -25.17 64.85 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.456 1.902 . . . . 0.0 113.079 171.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -67.21 -40.3 86.43 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.033 0.833 . . . . 0.0 111.501 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.22 -24.16 43.29 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.489 0.493 . . . . 0.0 110.669 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -66.86 63.58 0.05 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.29 2.236 . . . . 0.0 114.76 172.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.05 -21.29 0.13 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.928 1.728 . . . . 0.0 114.761 169.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 t -91.57 73.92 5.93 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 117.819 0.81 . . . . 0.0 111.779 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -68.78 142.15 55.0 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 123.232 1.491 . . . . 0.0 111.801 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.18 143.61 33.08 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 113.489 -1.687 . . . . 0.0 113.365 -158.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.35 168.96 23.57 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.368 2.712 . . . . 0.0 111.597 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -61.26 -29.94 70.16 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 t 69.67 -37.63 0.38 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.549 2.74 . . . . 0.0 113.509 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.29 -101.0 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.797 2.141 . . . . 0.0 114.824 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.6 mtp -59.11 -22.4 60.8 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -99.65 10.53 41.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.577 1.951 . . . . 0.0 113.091 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.97 65.72 0.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.034 -1.041 . . . . 0.0 111.282 161.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -65.59 154.17 39.5 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.485 1.914 . . . . 0.0 113.684 -171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.87 122.32 17.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.403 0.681 . . . . 0.0 110.674 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -143.84 -2.31 0.94 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -163.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 51.41 -160.93 0.09 Allowed 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 127.896 2.478 . . . . 0.0 114.648 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.552 ' HG1' ' CG ' ' A' ' 51' ' ' GLU . 1.3 t -136.66 175.25 9.78 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -166.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.48 -140.51 6.37 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.56 1.076 . . . . 0.0 114.638 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -155.33 161.8 40.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.473 1.13 . . . . 0.0 112.564 173.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -133.52 145.7 50.38 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.999 1.32 . . . . 0.0 111.336 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.63 164.04 38.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.583 1.153 . . . . 0.0 111.648 -161.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 69.7 m -59.07 157.58 9.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 123.451 1.596 . . . . 0.0 113.874 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.259 8.7 p -125.73 41.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.557 158.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.3 t -135.64 -48.01 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.706 1.202 . . . . 0.0 112.945 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 9.4 p -96.42 -89.96 0.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.522 1.529 . . . . 0.0 113.844 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.32 -30.75 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.043 2.137 . . . . 0.0 113.114 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.3 p -85.37 125.69 69.06 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -161.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.16 138.8 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.046 1.831 . . . . 0.0 111.403 160.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.17 -27.9 4.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.372 -163.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.68 137.99 18.46 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -84.07 136.46 34.01 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.299 -0.875 . . . . 0.0 109.693 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.8 m -62.38 -12.42 21.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.964 1.706 . . . . 0.0 114.387 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.552 ' CG ' ' HG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -60.4 -29.54 69.03 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.611 0.764 . . . . 0.0 111.322 172.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -74.68 -2.99 28.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.186 0.994 . . . . 0.0 113.497 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -53.45 128.25 28.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.774 0.716 . . . . 0.0 109.84 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -67.12 164.99 16.81 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 18.1 t -52.6 137.9 29.48 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.071 0.949 . . . . 0.0 111.461 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.28 36.3 p 49.29 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.493 2.317 . . . . 0.0 114.099 -162.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.9 55.01 19.98 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.503 1.525 . . . . 0.0 113.117 168.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.1 p -79.48 -82.48 0.1 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.389 1.476 . . . . 0.0 112.763 -161.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.09 -11.95 71.92 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.003 0.811 . . . . 0.0 112.949 163.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -97.03 105.71 26.01 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.432 1.493 . . . . 0.0 111.056 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -84.96 123.36 2.74 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.393 2.062 . . . . 0.0 111.879 -170.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 t -149.58 155.61 40.58 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 111.547 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.66 115.25 4.85 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.559 1.544 . . . . 0.0 109.253 -159.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -72.26 -16.76 61.93 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -146.94 155.54 42.36 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.929 0.892 . . . . 0.0 112.399 166.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.04 108.02 3.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 142.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -112.98 152.7 29.1 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.86 1.664 . . . . 0.0 111.871 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.48 -30.4 4.9 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.611 1.101 . . . . 0.0 111.526 -156.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 p -107.62 133.28 52.3 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.345 1.858 . . . . 0.0 112.868 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -148.85 132.21 16.57 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.349 2.259 . . . . 0.0 110.613 174.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.76 -81.46 0.01 OUTLIER Glycine 0 N--CA 1.47 0.944 0 C-N-CA 127.257 2.361 . . . . 0.0 114.761 157.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -28.1 40.14 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.429 1.492 . . . . 0.0 112.278 168.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.84 4.67 53.54 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.02 -12.61 60.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.186 1.395 . . . . 0.0 113.255 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -103.0 -30.62 10.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.451 0.569 . . . . 0.0 112.053 163.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -73.75 -25.59 60.25 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.74 -30.64 56.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.427 1.491 . . . . 0.0 112.362 167.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.18 73.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.662 1.125 . . . . 0.0 112.73 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.16 166.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 123.176 1.465 . . . . 0.0 111.995 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -133.87 176.36 8.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.88 2.072 . . . . 0.0 108.792 166.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.411 ' H ' HD22 ' A' ' 80' ' ' LEU . 7.0 ptt180 -147.3 146.7 29.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.9 0.88 . . . . 0.0 112.967 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.86 108.63 7.05 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.191 1.796 . . . . 0.0 109.205 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -89.69 149.22 22.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.393 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.52 120.01 6.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.659 1.184 . . . . 0.0 109.205 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -130.08 35.27 4.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.218 1.007 . . . . 0.0 110.605 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -130.92 -6.47 3.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.736 2.015 . . . . 0.0 114.606 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.21 24.39 1.88 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.702 2.001 . . . . 0.0 111.806 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.66 -10.27 46.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.636 2.065 . . . . 0.0 114.155 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.8 t -145.83 130.9 9.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.788 1.235 . . . . 0.0 109.807 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.25 133.01 23.7 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.094 2.53 . . . . 0.0 112.88 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -138.6 157.87 45.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.829 2.852 . . . . 0.0 111.741 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.3 mtt -138.76 128.03 24.24 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.392 2.277 . . . . 0.0 107.915 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.89 153.29 47.63 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.205 1.002 . . . . 0.0 111.325 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.76 141.32 44.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.206 1.402 . . . . 0.0 111.827 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -117.52 152.03 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.186 1.394 . . . . 0.0 109.591 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.4 t -93.02 120.91 33.81 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 165.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.56 -14.96 41.4 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 114.411 169.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -65.42 -38.36 89.7 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.691 0.796 . . . . 0.0 112.447 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.55 -12.22 10.38 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 127.604 2.361 . . . . 0.0 114.888 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.362 56.5 mt-10 62.19 64.1 1.0 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.912 2.485 . . . . 0.0 115.213 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.28 136.82 32.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -78.45 109.16 12.37 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.988 165.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.297 2.7 pp -141.27 -1.41 1.35 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 -172.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.0 142.04 13.5 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.746 1.641 . . . . 0.0 111.515 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.17 160.18 43.45 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.753 -0.851 . . . . 0.0 111.308 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.35 139.11 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 125.138 1.375 . . . . 0.0 111.125 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -145.87 154.11 50.89 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.869 1.268 . . . . 0.0 114.007 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -84.38 141.01 8.79 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.574 2.849 . . . . 0.0 111.27 171.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.36 28.86 4.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.352 1.461 . . . . 0.0 113.158 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.42 -50.96 0.82 Allowed Glycine 0 CA--C 1.542 1.748 0 C-N-CA 126.542 2.02 . . . . 0.0 115.241 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -87.72 -165.38 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.175 3.25 . . . . 0.0 112.295 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -56.28 149.13 38.91 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.819 1.648 . . . . 0.0 113.064 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -66.68 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 124.791 3.661 . . . . 0.0 115.261 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -31.51 62.09 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.85 -1.156 . . . . 0.0 112.373 162.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.0 14.12 65.17 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.88 150.57 28.2 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -165.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -105.42 137.73 42.77 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.902 1.681 . . . . 0.0 108.652 170.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -90.48 160.82 15.81 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 123.824 0.85 . . . . 0.0 109.721 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.9 p -150.3 155.76 40.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.057 1.343 . . . . 0.0 110.834 166.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 mm -118.85 165.81 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.36 1.864 . . . . 0.0 109.368 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.85 103.84 6.28 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.305 -1.497 . . . . 0.0 113.622 150.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -74.73 21.23 0.11 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.31 -19.71 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.067 1.747 . . . . 0.0 114.895 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.11 17.53 10.8 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.304 1.842 . . . . 0.0 114.923 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 61.5 mt -120.69 157.52 29.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.324 1.059 . . . . 0.0 113.174 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -104.57 161.9 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.267 2.227 . . . . 0.0 111.288 163.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -142.46 145.5 33.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 111.003 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -148.99 151.67 35.04 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.019 1.328 . . . . 0.0 112.144 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.91 170.31 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.801 2.334 . . . . 0.0 113.288 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.18 -44.25 12.35 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.836 1.303 . . . . 0.0 112.532 -178.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -64.26 148.18 96.12 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 126.252 1.821 . . . . 0.0 112.016 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.18 -179.97 2.08 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.7 2.267 . . . . 0.0 112.566 168.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.96 32.16 15.74 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.183 1.393 . . . . 0.0 113.756 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.24 -19.85 57.97 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.55 1.14 . . . . 0.0 112.897 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.15 145.38 25.95 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.361 1.064 . . . . 0.0 110.881 167.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.86 35.34 2.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.461 1.505 . . . . 0.0 111.904 -166.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -58.76 -9.47 1.79 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.546 1.538 . . . . 0.0 114.901 -174.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -63.32 -21.85 66.51 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.94 172.17 9.47 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.267 1.427 . . . . 0.0 112.96 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -148.57 131.48 16.16 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.422 -0.799 . . . . 0.0 111.049 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 49.49 -179.36 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 128.964 2.906 . . . . 0.0 117.953 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -125.76 166.97 15.82 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.364 1.866 . . . . 0.0 108.953 165.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 . . . . . 0 C--O 1.251 1.161 0 C-N-CA 124.897 1.279 . . . . 0.0 112.235 178.821 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 ttm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 118.119 -0.944 . . . . 0.0 108.907 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.63 29.97 10.16 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -135.63 168.34 19.45 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.889 2.076 . . . . 0.0 110.207 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -118.28 -40.14 2.97 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 169.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -57.7 8.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.051 1.34 . . . . 0.0 110.919 -172.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -64.24 -25.87 68.25 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.262 1.025 . . . . 0.0 112.956 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -74.19 -39.91 62.85 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.84 -21.75 54.57 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.121 1.368 . . . . 0.0 114.478 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.6 t -126.81 64.4 58.71 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.092 1.357 . . . . 0.0 111.551 171.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.12 131.84 5.17 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.666 2.244 . . . . 0.0 114.452 -168.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -82.13 -60.23 2.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.777 -158.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -27.39 50.57 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.198 1.399 . . . . 0.0 113.353 170.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.4 -12.12 35.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.382 1.873 . . . . 0.0 113.3 -176.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -106.21 -41.92 5.21 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.387 1.075 . . . . 0.0 113.602 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -50.87 -33.66 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.796 0.838 . . . . 0.0 111.532 173.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 p -79.01 -19.55 51.28 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 128.83 2.852 . . . . 0.0 114.738 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -82.68 -43.22 17.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.618 1.567 . . . . 0.0 110.241 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -92.41 -46.13 7.82 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.482 -174.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.44 12.3 ptpt 42.54 24.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 1 N-CA-C 122.18 4.141 . . . . 0.0 122.18 171.782 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.7 46.87 0.14 Allowed Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.276 0.941 . . . . 0.0 111.921 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 t -122.51 101.38 7.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.114 1.366 . . . . 0.0 113.982 -161.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.06 144.77 30.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.902 0.881 . . . . 0.0 111.008 161.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.77 155.3 19.95 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.555 1.542 . . . . 0.0 110.833 -176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.76 94.85 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.225 1.95 . . . . 0.0 112.479 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -143.05 -87.09 0.14 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.84 2.056 . . . . 0.0 110.644 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.4 t 69.0 -42.53 0.49 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.0 2.12 . . . . 0.0 111.543 -163.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.93 -107.95 0.64 Allowed Glycine 0 C--O 1.224 -0.483 0 C-N-CA 126.619 2.057 . . . . 0.0 114.281 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.1 ttm -57.43 -21.04 34.18 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.159 0.984 . . . . 0.0 113.311 173.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.92 9.05 40.76 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.29 38.46 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.072 1.349 . . . . 0.0 114.473 169.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 33' ' ' LYS . 48.0 p30 -115.61 174.7 5.88 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.007 2.523 . . . . 0.0 111.648 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -74.67 43.12 0.18 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 122.591 1.186 . . . . 0.0 112.863 165.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 31' ' ' ASN 0.273 40.3 mmtm 55.3 86.29 0.06 Allowed 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 130.963 3.705 . . . . 0.0 115.059 168.167 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -81.88 168.48 17.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 112.109 -2.314 . . . . 0.0 112.762 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m -120.65 163.18 18.45 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 125.79 1.636 . . . . 0.0 110.082 -160.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.68 -160.2 23.89 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 114.125 0.41 . . . . 0.0 114.125 174.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.9 ptp -151.29 156.2 40.32 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.139 0.976 . . . . 0.0 113.052 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -104.4 140.72 37.52 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.464 2.706 . . . . 0.0 110.974 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -144.12 158.75 43.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.718 2.007 . . . . 0.0 110.861 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 1.3 t -72.86 168.39 19.0 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.833 1.778 . . . . 0.0 115.144 -172.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.72 3.97 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.774 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.9 t -117.57 -44.82 2.73 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 111.156 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 4.3 p -90.21 -104.46 0.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.963 1.705 . . . . 0.0 108.239 162.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -156.8 -50.07 0.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.799 1.64 . . . . 0.0 114.147 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 154.96 53.9 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -149.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.49 135.51 36.57 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.613 2.209 . . . . 0.0 111.037 162.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -22.89 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.42 120.41 10.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.997 -0.439 . . . . 0.0 110.8 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -86.04 135.08 33.77 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 123.565 1.65 . . . . 0.0 112.421 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -5.72 6.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.047 2.139 . . . . 0.0 112.885 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -23.69 57.86 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.705 1.202 . . . . 0.0 112.948 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.23 -1.13 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.652 1.181 . . . . 0.0 114.002 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -79.66 123.04 27.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.089 0.956 . . . . 0.0 111.143 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -77.61 70.14 3.95 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 122.426 1.108 . . . . 0.0 111.285 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.92 -6.03 59.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 p -71.6 45.73 0.11 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.855 2.862 . . . . 0.0 114.329 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.38 -63.86 0.19 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.287 0.946 . . . . 0.0 113.248 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -101.74 -9.81 20.51 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.542 0.671 . . . . 0.0 112.456 -161.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.43 11.12 46.31 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.102 0.858 . . . . 0.0 114.011 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -79.84 147.46 66.5 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -157.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.53 89.49 1.32 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.062 2.508 . . . . 0.0 114.888 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -149.78 163.58 37.62 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.984 2.514 . . . . 0.0 111.443 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -154.98 145.39 22.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.924 2.09 . . . . 0.0 108.838 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -73.62 -34.04 64.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.112 167.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -153.94 165.21 36.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.289 1.435 . . . . 0.0 110.973 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.58 92.22 6.5 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 148.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.37 130.18 45.33 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 165.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.44 -28.9 1.63 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.093 1.33 . . . . 0.0 111.723 -166.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.7 p -134.25 147.27 50.65 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.986 1.315 . . . . 0.0 114.506 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -148.81 110.58 4.53 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 126.63 1.972 . . . . 0.0 110.055 175.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.17 -81.37 0.01 OUTLIER Glycine 0 N--CA 1.479 1.56 0 C-N-CA 126.747 2.118 . . . . 0.0 114.799 167.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.0 m -45.25 -34.68 2.96 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.109 1.763 . . . . 0.0 113.037 164.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.488 ' HB2' ' H ' ' A' ' 70' ' ' LYS . 35.9 m-20 -107.71 9.88 29.04 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -54.03 -39.76 66.46 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 112.245 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.99 -11.43 24.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.173 1.389 . . . . 0.0 112.388 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -66.87 -25.44 66.41 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.388 -0.82 . . . . 0.0 112.0 171.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.7 p -49.97 -45.56 51.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.75 2.02 . . . . 0.0 114.049 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.23 24.94 76.46 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.384 -0.676 . . . . 0.0 112.296 -160.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.781 1.277 . . . . 0.0 112.417 174.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.12 177.73 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 128.576 2.751 . . . . 0.0 109.134 -173.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 154.9 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.74 105.93 6.35 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 126.488 1.915 . . . . 0.0 109.222 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.78 154.42 19.53 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.933 0.893 . . . . 0.0 111.064 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -143.06 113.89 7.6 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.713 1.205 . . . . 0.0 108.444 166.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -129.33 37.57 4.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.889 1.328 . . . . 0.0 110.269 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.8 t -113.79 -17.93 11.95 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 113.973 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.44 22.14 5.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.355 2.262 . . . . 0.0 111.847 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.68 -12.01 54.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.634 2.064 . . . . 0.0 114.761 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.09 130.23 23.4 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.219 1.408 . . . . 0.0 110.025 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.29 128.36 11.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.402 2.068 . . . . 0.0 112.12 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -133.18 155.95 48.38 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 128.08 2.552 . . . . 0.0 109.904 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.3 mtt -141.27 130.81 23.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.06 1.744 . . . . 0.0 109.423 -172.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -133.42 153.67 51.41 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.29 1.436 . . . . 0.0 110.735 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.94 145.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.239 1.016 . . . . 0.0 111.217 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.38 138.7 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.593 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.7 t -79.02 108.76 12.74 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -79.89 -7.71 58.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.285 1.034 . . . . 0.0 113.272 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.89 -39.5 94.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.323 1.049 . . . . 0.0 112.073 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.5 p -134.77 -5.83 2.47 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.361 43.3 mt-10 71.33 53.25 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.613 2.365 . . . . 0.0 114.051 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.74 134.04 51.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.833 1.653 . . . . 0.0 113.207 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -78.88 76.59 5.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.355 1.462 . . . . 0.0 112.307 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 3.24 6.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -171.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.9 172.41 19.31 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 122.825 1.236 . . . . 0.0 116.128 160.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -137.48 160.36 39.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 p -125.68 123.68 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.651 1.98 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.58 149.15 61.06 Favored Pre-proline 0 C--O 1.241 0.654 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.192 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.69 152.32 53.09 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.288 2.658 . . . . 0.0 112.347 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -100.63 -0.46 37.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.51 1.924 . . . . 0.0 115.129 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.94 -61.48 0.66 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.437 1.494 . . . . 0.0 115.098 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.47 -157.94 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 124.795 3.663 . . . . 0.0 112.902 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 150.53 31.1 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.758 1.223 . . . . 0.0 112.304 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.21 2.17 2.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.138 3.226 . . . . 0.0 114.464 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -59.48 -24.01 63.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.312 -0.868 . . . . 0.0 113.141 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.59 0.66 85.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.579 1.392 . . . . 0.0 116.579 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -60.39 146.11 45.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.669 1.235 . . . . 0.0 113.422 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.0 149.59 28.33 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.258 1.823 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -82.45 144.74 30.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.672 0.748 . . . . 0.0 111.834 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.3 p -129.49 134.63 47.89 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.57 2.748 . . . . 0.0 108.478 168.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.3 tp -127.85 126.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.358 -0.839 . . . . 0.0 112.265 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -119.68 3.05 11.17 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m -134.17 39.44 3.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.132 1.773 . . . . 0.0 111.766 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.24 -39.73 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -163.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.95 -11.76 0.53 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.588 2.755 . . . . 0.0 117.516 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.4 pp -126.24 176.47 7.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.547 1.939 . . . . 0.0 114.094 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.07 178.97 4.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 114.589 -165.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.59 160.92 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.766 1.226 . . . . 0.0 113.821 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.7 152.74 79.22 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.914 1.686 . . . . 0.0 110.663 160.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.56 167.88 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.595 1.53 . . . . 0.0 111.284 160.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.35 -45.18 9.19 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 112.507 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.65 160.26 62.1 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 127.149 2.18 . . . . 0.0 113.469 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.87 -177.33 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.92 3.08 . . . . 0.0 113.44 167.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 58.4 37.94 25.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.36 1.464 . . . . 0.0 113.131 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.47 -14.63 56.79 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.657 1.983 . . . . 0.0 113.447 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.31 -177.77 6.85 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.99 1.316 . . . . 0.0 111.262 168.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.0 tp 68.33 47.76 0.94 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.866 1.266 . . . . 0.0 111.406 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.66 -27.27 66.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.589 1.156 . . . . 0.0 113.03 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -89.64 173.3 8.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.271 1.029 . . . . 0.0 110.908 165.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -63.97 161.57 15.54 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -75.66 -147.22 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.04 2.136 . . . . 0.0 109.846 165.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 59.3 t60 56.72 30.62 17.91 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 172.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -78.54 54.57 1.48 Allowed 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.013 -1.68 . . . . 0.0 113.102 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 . . . . . 0 C--O 1.252 1.189 0 C-N-CA 127.934 2.493 . . . . 0.0 110.942 -177.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 118.558 -0.734 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.31 -79.78 0.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.238 1.015 . . . . 0.0 110.155 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.47 154.46 40.19 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -115.11 -31.05 6.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.432 1.493 . . . . 0.0 111.773 167.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -58.23 -65.26 0.68 Allowed 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 127.712 2.405 . . . . 0.0 111.655 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -67.99 -25.09 65.24 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 125.616 1.567 . . . . 0.0 112.995 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -66.47 -39.63 88.9 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.697 1.599 . . . . 0.0 112.715 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.27 -24.53 17.41 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -139.66 85.46 14.75 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.718 1.207 . . . . 0.0 111.187 170.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.16 161.42 32.39 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.167 2.578 . . . . 0.0 113.243 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.64 -71.29 0.76 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.073 0.549 . . . . 0.0 110.837 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -62.86 -30.55 71.6 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.729 -0.607 . . . . 0.0 111.685 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -19.45 45.5 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -77.73 -54.22 6.62 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.535 1.061 . . . . 0.0 110.433 165.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 t -50.17 -50.92 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.764 1.226 . . . . 0.0 112.108 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.7 p -63.44 -25.79 68.43 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.33 1.052 . . . . 0.0 112.897 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -67.68 -17.19 64.5 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.179 1.792 . . . . 0.0 112.801 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -122.95 -8.12 8.36 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.249 1.019 . . . . 0.0 112.822 171.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -70.28 71.8 0.44 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.532 2.333 . . . . 0.0 113.474 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.16 12.05 71.51 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 113.772 -1.558 . . . . 0.0 114.496 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 t -123.68 162.68 22.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.373 2.269 . . . . 0.0 106.647 160.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -109.31 149.53 29.33 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.059 0.943 . . . . 0.0 110.092 170.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.63 156.78 48.61 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.184 0.993 . . . . 0.0 112.968 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.37 83.4 2.23 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.538 2.159 . . . . 0.0 112.95 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -117.58 -23.09 7.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.03 -2.35 . . . . 0.0 113.372 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.14 19.64 2.21 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 162.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.64 -46.35 38.32 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 120.728 -1.232 . . . . 0.0 115.412 -168.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.7 mtp -66.69 -10.49 47.12 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -104.61 -5.85 21.06 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 128.494 2.718 . . . . 0.0 112.879 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.1 mt -112.86 -15.29 12.94 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.746 1.618 . . . . 0.0 112.729 -177.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.87 18.95 13.44 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -173.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.25 50.3 m-20 51.04 -149.51 0.31 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.707 -151.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -115.5 10.6 15.72 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.917 1.69 . . . . 0.0 115.504 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -177.4 0.1 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.179 2.592 . . . . 0.0 115.112 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -126.26 153.63 44.51 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.298 1.439 . . . . 0.0 109.987 -164.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.31 -165.71 31.25 Favored Glycine 0 N--CA 1.474 1.22 0 O-C-N 119.914 -1.741 . . . . 0.0 116.013 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -155.57 161.25 40.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.502 1.121 . . . . 0.0 113.78 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.06 143.8 39.57 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 129.278 3.031 . . . . 0.0 111.018 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -136.76 165.19 26.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.968 2.107 . . . . 0.0 109.771 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.72 158.57 10.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.76 1.267 . . . . 0.0 111.311 170.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 p -92.09 12.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.653 156.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.0 m -121.18 -43.61 2.42 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -162.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.6 p -103.78 -92.89 0.34 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.283 1.401 . . . . 0.0 113.679 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -160.73 -49.13 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.055 2.142 . . . . 0.0 113.7 -172.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p -113.02 156.71 42.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -158.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.82 152.49 16.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.73 2.953 . . . . 0.0 113.333 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.5 -26.39 1.84 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.262 1.025 . . . . 0.0 113.601 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.09 122.01 25.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.629 0.65 . . . . 0.0 112.041 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 p -85.3 130.92 34.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.947 -1.096 . . . . 0.0 109.55 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -9.75 24.08 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 123.135 1.445 . . . . 0.0 112.331 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.8 tt0 -58.18 -33.1 68.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.807 1.243 . . . . 0.0 114.144 166.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 8.1 mmpt? -83.28 0.65 44.74 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.961 1.704 . . . . 0.0 113.092 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 117.44 7.71 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 120.097 1.317 . . . . 0.0 110.154 -169.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.8 135.19 54.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -164.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 72.4 m -58.51 163.34 3.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.656 1.583 . . . . 0.0 113.753 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.279 97.6 p 57.07 -6.63 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.706 2.802 . . . . 0.0 117.941 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.78 111.75 3.69 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 119.939 1.245 . . . . 0.0 110.857 164.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.5 p -71.9 -63.42 1.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.606 1.162 . . . . 0.0 113.645 -162.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.75 -22.51 53.08 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.858 0.742 . . . . 0.0 112.375 153.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.78 111.01 3.07 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -155.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.18 114.84 3.4 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.874 2.383 . . . . 0.0 111.661 -168.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 p -158.38 153.2 24.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.403 1.481 . . . . 0.0 111.089 -164.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.84 148.65 45.63 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.769 2.028 . . . . 0.0 109.379 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.6 p -84.1 -25.9 29.38 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.053 1.741 . . . . 0.0 113.516 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -153.95 162.74 40.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.165 1.386 . . . . 0.0 112.146 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.54 52.5 2.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.752 1.221 . . . . 0.0 110.377 163.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -74.98 112.46 11.24 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.664 0.745 . . . . 0.0 111.302 -169.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.14 -41.26 1.07 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 127.273 2.368 . . . . 0.0 108.205 -153.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.2 p -91.16 161.29 15.14 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.182 1.793 . . . . 0.0 112.369 155.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -157.76 106.19 2.05 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.936 2.494 . . . . 0.0 112.636 169.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.58 -73.76 0.01 OUTLIER Glycine 0 N--CA 1.474 1.181 0 C-N-CA 128.503 2.954 . . . . 0.0 115.735 160.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.9 -24.9 66.15 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.715 1.606 . . . . 0.0 111.59 170.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.35 3.0 4.07 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 -165.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -80.72 3.25 22.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.289 1.836 . . . . 0.0 114.06 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t -105.22 -15.15 15.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.332 1.053 . . . . 0.0 111.813 160.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -99.3 -34.22 10.41 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -168.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -18.39 65.26 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -168.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.74 16.16 71.89 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.584 -0.697 . . . . 0.0 112.912 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.84 167.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.248 1.419 . . . . 0.0 112.204 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.69 173.62 11.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.14 1.776 . . . . 0.0 110.575 169.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 163.53 36.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.58 1.152 . . . . 0.0 113.157 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.73 118.23 6.51 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 127.147 2.179 . . . . 0.0 108.995 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.85 147.41 41.12 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.615 0.766 . . . . 0.0 110.579 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -129.4 51.86 2.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 123.961 1.839 . . . . 0.0 111.215 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.3 p -79.51 47.97 0.87 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.765 2.026 . . . . 0.0 110.72 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.93 -1.22 2.22 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.6 mt -90.07 10.84 22.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.675 1.19 . . . . 0.0 113.043 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.67 -9.31 6.31 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.209 1.385 . . . . 0.0 113.967 -166.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.73 109.75 20.55 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 126.578 1.951 . . . . 0.0 108.129 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.62 126.44 12.1 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.374 2.049 . . . . 0.0 112.849 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -122.95 151.7 41.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.209 1.803 . . . . 0.0 109.183 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 35.3 mtp -112.72 128.23 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.023 2.129 . . . . 0.0 105.77 164.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -124.9 144.94 50.07 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.804 -1.185 . . . . 0.0 111.943 172.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -145.48 138.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.31 1.053 . . . . 0.0 112.304 -156.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG13 ' H ' ' A' ' 103' ' ' LEU . 2.8 m -149.43 173.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.83 -1.169 . . . . 0.0 111.022 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.6 t -94.14 150.32 20.43 Favored 'General case' 0 N--CA 1.404 -2.773 0 C-N-CA 127.398 2.279 . . . . 0.0 106.575 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -110.27 -18.09 13.36 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 127.762 2.425 . . . . 0.0 112.795 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.56 -44.94 96.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.569 1.148 . . . . 0.0 112.209 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -96.71 -29.57 13.72 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.411 2.284 . . . . 0.0 111.462 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 67.37 124.44 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.61 1.195 . . . . 0.0 111.041 -154.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 71.96 85.26 0.12 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.956 2.102 . . . . 0.0 114.515 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.308 2.7 t60 -74.85 -14.6 60.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.539 ' H ' HG13 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 38.89 52.21 1.91 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.515 2.326 . . . . 0.0 113.591 -172.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.97 156.45 22.38 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 111.527 -2.579 . . . . 0.0 109.383 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.53 156.37 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.098 0.959 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.2 t -139.82 126.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 123.799 0.84 . . . . 0.0 109.487 -174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -133.59 152.26 78.71 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.015 0.926 . . . . 0.0 111.496 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.46 140.38 15.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.77 2.313 . . . . 0.0 110.33 160.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.57 -5.61 59.26 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.12 -46.35 0.48 Allowed Glycine 0 CA--C 1.542 1.758 0 C-N-CA 126.891 2.186 . . . . 0.0 113.991 -162.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.93 179.04 6.88 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 CA-C-N 120.981 2.391 . . . . 0.0 113.768 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.67 162.69 4.61 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.707 1.603 . . . . 0.0 111.819 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.25 -3.23 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.168 3.245 . . . . 0.0 116.088 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 t -81.09 -21.54 39.88 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.982 1.713 . . . . 0.0 114.319 170.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.66 16.29 59.88 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 127.346 2.403 . . . . 0.0 115.443 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -70.9 159.52 34.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -167.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -118.75 129.27 55.16 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 107.322 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -84.68 130.36 34.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.8 m -115.27 129.27 56.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.644 1.978 . . . . 0.0 108.784 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.32 175.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 120.434 1.47 . . . . 0.0 110.054 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.51 139.97 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.893 -1.129 . . . . 0.0 111.874 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.1 m -76.0 28.89 0.11 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -165.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.94 -30.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.83 41.56 0.77 Allowed 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.8 mt -132.06 153.64 50.22 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.056 -1.028 . . . . 0.0 112.947 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.58 153.72 35.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.316 1.846 . . . . 0.0 111.328 164.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -151.02 130.65 13.07 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.472 -0.767 . . . . 0.0 112.577 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -142.25 159.17 59.39 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 126.156 1.783 . . . . 0.0 111.702 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.46 164.63 33.53 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.613 2.209 . . . . 0.0 114.22 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.3 t -102.6 -66.79 0.91 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.257 2.623 . . . . 0.0 109.383 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.48 179.25 1.35 Allowed Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 129.492 3.117 . . . . 0.0 112.127 171.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -106.87 -178.96 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 124.383 3.389 . . . . 0.0 113.594 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 76.97 21.61 1.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.383 2.273 . . . . 0.0 116.323 169.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.19 -31.75 73.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.553 0.741 . . . . 0.0 111.813 167.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.54 179.47 0.07 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.547 2.339 . . . . 0.0 115.685 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.17 31.79 0.39 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -171.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.43 -53.78 42.92 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -149.88 158.0 43.73 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -170.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -68.1 160.38 29.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.312 1.445 . . . . 0.0 112.789 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -46.7 137.93 6.54 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.314 1.446 . . . . 0.0 112.653 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -83.1 172.88 12.23 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -59.5 134.12 56.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.18 0.592 . . . . 0.0 110.458 164.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 124.056 0.942 . . . . 0.0 112.474 -178.768 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.061 -0.019 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.65 26.14 0.33 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.977 1.311 . . . . 0.0 112.425 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -161.02 175.41 12.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.544 1.538 . . . . 0.0 111.367 -153.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.3 m95 -98.99 -34.02 10.59 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.194 0.997 . . . . 0.0 111.855 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -62.29 -51.21 68.59 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.003 0.921 . . . . 0.0 111.309 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -67.34 -25.13 65.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -78.08 -32.91 50.97 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.875 2.07 . . . . 0.0 112.983 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.273 3.6 pp -87.24 -24.04 24.52 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 174.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -120.57 60.91 8.33 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 119.596 1.089 . . . . 0.0 113.489 166.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.45 130.05 9.73 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.845 1.697 . . . . 0.0 113.411 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -78.51 -57.96 3.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.953 -153.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -64.41 -10.83 27.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.89 1.676 . . . . 0.0 114.129 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -99.27 -12.66 20.17 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.614 2.365 . . . . 0.0 115.352 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -110.44 -48.8 3.12 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.419 1.488 . . . . 0.0 113.233 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -63.12 -28.05 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.284 -0.885 . . . . 0.0 110.869 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -5.04 1.0 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 130.816 3.646 . . . . 0.0 114.716 170.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -71.74 -17.53 62.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 117.453 -1.26 . . . . 0.0 111.961 164.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.84 -7.85 0.1 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 171.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 11.64 86.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.731 2.812 . . . . 0.0 114.885 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.83 42.02 0.72 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 128.11 2.767 . . . . 0.0 116.433 -169.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -80.38 105.84 11.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.299 1.44 . . . . 0.0 112.083 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -55.92 154.41 7.37 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.675 1.99 . . . . 0.0 113.173 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.42 155.79 80.85 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 127.197 2.199 . . . . 0.0 112.707 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.31 177.94 2.87 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.488 3.459 . . . . 0.0 112.956 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' A' ' 27' ' ' GLY . 47.3 m-85 64.81 -7.89 0.25 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.4 m -51.9 26.15 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.81 1 C-N-CA 132.211 4.204 . . . . 0.0 114.472 149.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 25' ' ' PHE . . . -51.07 -28.97 19.68 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -166.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.5 mtp -75.83 -23.42 55.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.755 1.264 . . . . 0.0 114.279 171.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.32 -10.8 40.0 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 128.621 2.768 . . . . 0.0 112.05 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -98.41 66.09 1.7 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.268 1.827 . . . . 0.0 107.823 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -134.21 -151.95 0.46 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.628 1.571 . . . . 0.0 112.86 -152.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 34' ' ' GLU . 6.5 m-20 -67.7 76.34 0.19 Allowed 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.015 -1.053 . . . . 0.0 110.852 164.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -67.29 12.45 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 126.74 2.016 . . . . 0.0 115.323 176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 32' ' ' ASN . 2.6 tt0 46.51 -169.52 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 131.08 3.752 . . . . 0.0 115.176 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -142.44 157.69 44.49 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.118 1.367 . . . . 0.0 110.172 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.58 -141.8 8.23 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.469 1.509 . . . . 0.0 111.584 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.6 ptp -144.54 162.46 36.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.402 1.081 . . . . 0.0 112.198 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.88 134.18 52.35 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 109.921 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -135.9 163.21 30.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 0.0 110.441 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.59 172.71 6.96 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 124.213 1.959 . . . . 0.0 114.802 -169.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.9 1.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 112.715 -2.038 . . . . 0.0 112.512 165.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.7 m -115.04 -26.89 7.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.177 1.391 . . . . 0.0 112.364 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.9 p -115.83 -98.11 0.45 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.608 1.963 . . . . 0.0 111.337 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.25 -50.18 0.07 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 p -95.62 160.01 31.31 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 116.563 2.061 . . . . 0.0 116.563 -150.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.35 132.83 40.24 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.841 2.361 . . . . 0.0 112.276 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -33.65 5.74 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.902 1.281 . . . . 0.0 111.66 -166.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.34 158.64 30.06 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.373 -0.83 . . . . 0.0 112.712 168.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 p -94.96 132.87 39.33 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 122.677 1.227 . . . . 0.0 110.953 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -4.83 24.12 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.11 0.964 . . . . 0.0 113.405 172.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.91 -29.36 64.24 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.578 1.951 . . . . 0.0 113.576 170.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.01 1.74 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.952 1.301 . . . . 0.0 113.621 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -69.89 121.43 17.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.315 1.846 . . . . 0.0 114.304 -167.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -83.74 79.5 9.44 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.9 t 68.96 135.12 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.708 2.803 . . . . 0.0 117.107 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.4 p -85.22 -6.66 59.26 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.7 -25.26 68.81 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 119.425 1.011 . . . . 0.0 114.541 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 m -109.89 -5.53 15.48 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.376 1.47 . . . . 0.0 111.14 166.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.07 -7.61 15.44 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 126.879 2.18 . . . . 0.0 114.672 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -90.22 133.97 32.31 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -138.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.9 103.75 1.23 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.766 2.311 . . . . 0.0 113.979 -168.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.7 p -158.55 142.29 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.798 2.439 . . . . 0.0 109.533 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -155.3 132.32 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.794 2.038 . . . . 0.0 107.733 -170.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 p -68.96 -24.32 64.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -139.82 142.55 36.64 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.479 0.657 . . . . 0.0 112.13 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.64 39.35 0.61 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.186 1.395 . . . . 0.0 111.555 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -78.18 119.37 21.47 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.421 -1.424 . . . . 0.0 110.742 -173.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.71 -34.09 0.17 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.215 1.388 . . . . 0.0 111.921 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.55 125.19 28.8 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.029 1.332 . . . . 0.0 109.766 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -135.77 119.03 16.65 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.266 1.426 . . . . 0.0 113.46 -162.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.34 -78.63 1.27 Allowed Glycine 0 N--CA 1.464 0.5 0 C-N-CA 124.722 1.154 . . . . 0.0 111.815 172.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -29.28 55.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.289 1.036 . . . . 0.0 113.311 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -105.64 -9.05 17.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.792 1.282 . . . . 0.0 113.526 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.51 4.55 38.71 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 127.098 2.159 . . . . 0.0 110.862 -171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.0 t -70.14 -32.43 70.42 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 165.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -129.98 -73.6 0.56 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.686 1.194 . . . . 0.0 113.303 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.2 p -167.04 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.019 1.728 . . . . 0.0 113.592 -165.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.2 -10.67 7.51 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.968 1.27 . . . . 0.0 113.784 -162.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.87 178.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.712 2.005 . . . . 0.0 111.874 -172.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.42 -177.59 4.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.186 2.194 . . . . 0.0 108.915 166.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -139.39 155.0 47.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.273 1.829 . . . . 0.0 110.742 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 118.57 10.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.85 2.06 . . . . 0.0 107.149 168.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.97 138.53 33.76 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.269 -0.895 . . . . 0.0 111.338 172.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.3 23.01 14.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.739 1.216 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.2 t -71.1 38.65 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.81 2.444 . . . . 0.0 113.362 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.27 10.89 6.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.475 2.71 . . . . 0.0 112.387 -174.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.96 14.42 14.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.238 1.815 . . . . 0.0 112.462 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.28 -12.22 7.55 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 126.019 1.771 . . . . 0.0 113.561 -171.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.9 t -102.22 107.05 51.56 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 108.616 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.19 126.96 12.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.554 1.503 . . . . 0.0 110.623 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -147.89 156.03 42.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.478 2.711 . . . . 0.0 109.629 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.2 mtt -125.99 125.93 43.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.63 2.372 . . . . 0.0 106.994 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -116.39 154.46 30.23 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 110.926 173.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.16 137.24 55.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 125.408 1.483 . . . . 0.0 110.514 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.73 143.4 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.436 0.636 . . . . 0.0 111.516 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.7 t -70.05 108.02 3.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 160.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -63.72 -22.12 66.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.055 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -83.01 -39.5 21.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 112.574 -167.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 18.3 p -115.36 6.04 14.76 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.963 1.705 . . . . 0.0 114.249 172.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.36 60.34 3.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.497 . . . . 0.0 114.616 174.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -150.01 148.77 29.45 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -69.6 136.35 51.14 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.871 0.868 . . . . 0.0 111.263 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.31 -20.99 1.39 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.0 151.56 23.77 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 127.078 2.275 . . . . 0.0 112.52 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.66 166.71 22.91 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 126.141 1.776 . . . . 0.0 111.557 172.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.9 t -143.54 136.17 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.396 1.879 . . . . 0.0 108.212 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -148.57 153.97 40.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.42 1.088 . . . . 0.0 113.069 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.91 135.43 7.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.996 2.464 . . . . 0.0 109.91 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.37 -1.5 45.72 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.22 -40.8 0.51 Allowed Glycine 0 CA--C 1.542 1.749 0 CA-C-O 117.376 -1.791 . . . . 0.0 116.559 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.68 -167.59 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.451 2.767 . . . . 0.0 113.446 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -55.45 160.71 3.48 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.752 1.621 . . . . 0.0 112.345 171.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -59.93 -9.43 9.83 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.659 2.906 . . . . 0.0 114.136 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -22.64 62.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.507 1.523 . . . . 0.0 113.087 170.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.65 19.05 54.06 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 126.405 1.955 . . . . 0.0 115.893 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -73.34 146.72 45.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -110.13 144.53 38.62 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.197 1.399 . . . . 0.0 109.308 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -91.39 137.66 32.19 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.009 1.724 . . . . 0.0 110.068 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.7 p -132.01 132.28 43.29 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.04 1.736 . . . . 0.0 112.769 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.2 mm -80.92 154.99 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.115 1.366 . . . . 0.0 110.611 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -91.22 -13.12 33.39 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.7 m 57.14 82.68 0.11 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.067 2.147 . . . . 0.0 114.417 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.455 HG11 ' H ' ' A' ' 124' ' ' ALA 0.299 3.4 p -93.57 -96.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 111.529 167.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.455 ' H ' HG11 ' A' ' 123' ' ' VAL . . . -157.07 20.92 0.31 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -166.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.99 173.98 6.79 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.687 1.585 . . . . 0.0 113.166 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.26 163.17 12.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.202 1.801 . . . . 0.0 112.735 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -150.79 148.16 28.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.169 1.387 . . . . 0.0 111.861 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -140.4 149.87 59.04 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.069 1.348 . . . . 0.0 111.525 170.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.83 171.32 10.73 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.081 2.521 . . . . 0.0 114.533 -165.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.02 -40.5 11.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.065 1.346 . . . . 0.0 113.903 -173.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -95.64 157.41 36.12 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 127.598 2.359 . . . . 0.0 113.76 -169.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.05 173.92 3.56 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.007 2.472 . . . . 0.0 113.669 164.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 64.78 0.66 1.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.52 2.728 . . . . 0.0 114.558 -170.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -115.38 7.14 15.0 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.749 2.02 . . . . 0.0 113.702 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -140.99 163.32 33.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.249 1.819 . . . . 0.0 110.917 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -148.79 30.53 0.81 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -170.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -55.72 -27.95 53.17 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.931 1.692 . . . . 0.0 114.525 -173.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -65.73 -20.74 66.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.193 1.797 . . . . 0.0 115.239 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 12.3 m170 57.24 170.38 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.611 2.364 . . . . 0.0 114.932 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -56.56 117.15 3.59 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.688 1.595 . . . . 0.0 111.903 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -125.17 174.24 8.21 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.336 1.454 . . . . 0.0 113.02 -173.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -61.44 153.89 25.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.992 0.901 . . . . 0.0 112.414 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.376 1.87 . . . . 0.0 108.259 171.745 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 119.304 -0.379 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.05 8.49 1.48 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.163 1.785 . . . . 0.0 115.589 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -94.14 167.0 11.85 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.618 1.967 . . . . 0.0 112.77 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -91.15 -26.49 19.06 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.537 1.135 . . . . 0.0 111.452 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -58.4 -46.65 86.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 124.674 1.19 . . . . 0.0 110.336 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.63 -36.18 82.96 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -67.42 -36.54 81.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.879 0.872 . . . . 0.0 113.118 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -83.36 -11.41 57.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.717 2.407 . . . . 0.0 114.49 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.4 p -115.58 57.04 1.2 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.193 1.397 . . . . 0.0 114.36 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.0 -177.85 3.18 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.596 2.197 . . . . 0.0 113.434 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -49.24 -49.07 44.91 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.321 -1.487 . . . . 0.0 113.596 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.07 -34.1 67.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.595 1.158 . . . . 0.0 112.923 176.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -84.47 -35.24 23.11 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.46 1.504 . . . . 0.0 111.11 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -41.37 85.67 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.798 -1.189 . . . . 0.0 110.986 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.97 -35.13 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.157 1.383 . . . . 0.0 112.513 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 p -89.41 -22.86 22.34 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.851 1.26 . . . . 0.0 113.303 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -63.22 -44.06 96.37 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.838 1.655 . . . . 0.0 110.944 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -111.26 -21.89 11.65 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HZ2' ' CD2' ' A' ' 102' ' ' HIS . 11.3 tptm 15.21 72.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.016 2.527 . . . . 0.0 116.475 165.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.33 47.76 0.63 Allowed Glycine 0 N--CA 1.47 0.942 0 CA-C-N 113.352 -1.749 . . . . 0.0 113.291 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 t -117.98 174.31 6.27 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.78 1.632 . . . . 0.0 112.259 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -121.63 149.52 43.07 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 128.298 2.639 . . . . 0.0 111.963 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.73 144.67 12.33 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.756 0.822 . . . . 0.0 112.241 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.75 129.84 7.38 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.241 2.627 . . . . 0.0 111.573 175.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -136.6 -22.69 1.26 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 117.535 2.42 . . . . 0.0 117.535 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.21 -17.43 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 119.984 1.266 . . . . 0.0 114.404 -167.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.42 -108.69 2.52 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.896 1.226 . . . . 0.0 112.946 172.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.0 mtp -57.58 -31.1 65.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 167.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -3.61 49.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.38 -0.825 . . . . 0.0 112.607 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -89.36 -24.5 21.95 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.415 1.086 . . . . 0.0 112.468 170.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.24 -30.39 19.72 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.724 1.147 . . . . 0.0 112.47 166.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 57.53 -68.11 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.094 2.958 . . . . 0.0 118.545 164.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -160.44 117.91 2.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.255 2.622 . . . . 0.0 108.766 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.38 1.1 mp0 51.13 -147.46 0.41 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 149.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 t -100.15 178.41 4.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.455 1.102 . . . . 0.0 111.545 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.71 -153.12 14.22 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.124 0.868 . . . . 0.0 114.47 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.7 ptp -154.12 161.05 42.15 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.329 1.061 . . . . 0.0 112.895 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -120.0 148.37 43.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.787 2.435 . . . . 0.0 110.553 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.35 159.87 42.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.812 2.045 . . . . 0.0 109.503 -167.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.7 m -74.11 165.7 24.7 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.158 1.456 . . . . 0.0 111.802 158.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.62 -9.98 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.853 -1.522 . . . . 0.0 113.948 154.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 t -83.24 -46.34 12.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 112.441 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 p -85.15 -87.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.895 1.278 . . . . 0.0 111.337 170.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -148.9 -57.02 0.21 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.0 p -130.14 156.0 79.93 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -135.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.69 139.45 40.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.502 2.801 . . . . 0.0 112.732 164.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 mt -143.94 -18.78 0.58 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -135.2 134.71 40.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.317 1.417 . . . . 0.0 111.313 -167.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -101.51 122.06 43.11 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.959 1.303 . . . . 0.0 111.007 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -60.15 -15.45 24.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.475 1.51 . . . . 0.0 113.578 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.51 -31.27 67.73 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 130.252 3.421 . . . . 0.0 113.269 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' N ' ' HE2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -74.25 4.09 6.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.828 1.251 . . . . 0.0 111.793 177.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -62.61 134.72 56.75 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 120.661 -1.275 . . . . 0.0 114.018 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -129.88 132.12 46.31 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.179 2.192 . . . . 0.0 111.519 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.8 t 37.68 37.82 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 129.45 3.1 . . . . 0.0 117.489 170.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 p -121.48 -67.0 1.0 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.672 1.189 . . . . 0.0 113.102 -166.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.07 -74.94 0.08 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.044 1.307 . . . . 0.0 112.674 -174.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 m -139.17 -36.06 0.54 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.332 2.253 . . . . 0.0 111.656 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.93 -31.61 61.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.039 0.828 . . . . 0.0 114.752 -167.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.29 134.21 5.61 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.655 0.782 . . . . 0.0 111.315 164.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.61 121.17 4.58 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.606 2.204 . . . . 0.0 115.206 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -129.91 178.51 6.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.78 142.35 17.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.821 3.649 . . . . 0.0 106.801 159.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 p -73.75 -35.1 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 111.402 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -146.33 157.32 43.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.718 1.247 . . . . 0.0 114.195 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.15 69.4 10.11 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.939 1.696 . . . . 0.0 110.113 166.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.417 ' HB3' ' HE3' ' A' ' 52' ' ' LYS . 23.1 t80 -79.47 130.27 35.25 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.343 -0.848 . . . . 0.0 112.094 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.71 -37.04 0.07 OUTLIER Glycine 0 CA--C 1.536 1.388 0 C-N-CA 127.27 2.367 . . . . 0.0 111.292 167.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.2 p -125.05 140.85 52.54 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.19 1.396 . . . . 0.0 114.608 -173.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -137.51 135.94 37.22 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.914 2.486 . . . . 0.0 111.007 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.44 -80.69 0.11 Allowed Glycine 0 N--CA 1.468 0.822 0 C-N-CA 127.103 2.287 . . . . 0.0 113.249 157.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.2 m -45.69 -38.49 6.89 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.094 2.158 . . . . 0.0 112.774 167.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -119.04 19.08 13.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -164.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -65.74 -34.68 78.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.789 0.836 . . . . 0.0 112.794 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.1 t -92.51 -23.08 19.22 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.426 1.091 . . . . 0.0 111.803 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -71.45 -13.13 61.73 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.162 1.385 . . . . 0.0 113.682 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.7 p -48.63 -39.54 24.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.853 1.661 . . . . 0.0 112.605 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.24 17.69 76.11 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.011 -167.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 pt -117.54 155.98 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.868 1.834 . . . . 0.0 114.564 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.497 ' CD2' ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -136.08 176.62 8.52 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.595 2.758 . . . . 0.0 110.733 177.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.497 ' H ' ' CD2' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -138.43 141.91 39.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.036 1.334 . . . . 0.0 113.375 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.42 112.7 10.53 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 108.314 173.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.6 mp -80.6 157.28 26.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 125.886 1.674 . . . . 0.0 111.076 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -131.18 108.89 10.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 t -118.44 24.5 10.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.032 1.396 . . . . 0.0 109.836 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.62 -6.71 9.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.393 1.877 . . . . 0.0 113.682 -154.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.5 mt -105.26 18.66 21.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.071 2.148 . . . . 0.0 112.689 170.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -7.01 64.45 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.061 1.315 . . . . 0.0 115.392 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 52.4 t -127.79 112.99 20.59 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.892 1.677 . . . . 0.0 109.648 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.68 125.88 7.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.778 2.319 . . . . 0.0 114.039 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -129.42 154.2 47.18 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.129 2.572 . . . . 0.0 110.222 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mtm -127.49 127.13 43.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.364 1.866 . . . . 0.0 108.224 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -123.25 144.59 49.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.813 0.816 . . . . 0.0 109.776 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.55 144.5 21.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.471 1.108 . . . . 0.0 109.608 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.4 m -128.28 151.82 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 0.0 111.301 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.2 t -93.02 119.04 31.86 Favored 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 126.71 2.004 . . . . 0.0 105.886 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -69.5 -16.77 63.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.606 1.962 . . . . 0.0 111.974 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -83.95 -45.84 12.72 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.2 p -106.78 -7.59 17.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.601 1.961 . . . . 0.0 113.835 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 63.15 40.76 8.64 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.24 1.816 . . . . 0.0 113.066 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.92 154.46 51.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.451 1.5 . . . . 0.0 111.907 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CD2' ' HZ2' ' A' ' 19' ' ' LYS . 2.7 p-80 -80.98 90.06 5.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.145 0.978 . . . . 0.0 113.149 -176.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -74.3 8.59 2.1 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -175.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.68 179.63 30.06 Favored Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.002 -1.061 . . . . 0.0 114.065 165.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 156.49 44.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 111.684 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.03 137.47 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.316 1.055 . . . . 0.0 111.751 -173.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.83 151.2 45.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 113.063 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.53 133.44 10.55 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.043 2.495 . . . . 0.0 109.305 162.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -93.87 1.57 56.35 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.43 -62.19 0.28 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.387 -1.229 . . . . 0.0 114.396 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.37 -177.12 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.549 2.832 . . . . 0.0 112.967 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.77 149.83 4.23 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.254 1.022 . . . . 0.0 111.506 170.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.51 -3.77 9.64 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.975 2.45 . . . . 0.0 114.149 -171.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.9 p -54.92 -30.94 59.62 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.639 -0.663 . . . . 0.0 111.943 162.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.9 10.13 74.91 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.882 2.182 . . . . 0.0 117.091 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -50.96 148.81 3.93 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.209 1.504 . . . . 0.0 113.957 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.7 132.02 43.57 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.695 1.198 . . . . 0.0 110.828 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.7 125.35 45.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.105 1.362 . . . . 0.0 110.275 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.5 p -108.13 126.06 52.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.897 2.079 . . . . 0.0 109.618 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.403 HD11 ' H ' ' A' ' 121' ' ' ASN . 7.1 tp -92.41 156.8 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.844 0.831 . . . . 0.0 109.845 176.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' H ' HD11 ' A' ' 120' ' ' ILE . 11.3 p30 -126.92 163.0 24.62 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.461 1.905 . . . . 0.0 109.957 169.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 m -96.42 18.43 13.97 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 p -47.39 -48.93 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -159.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.61 24.07 0.34 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.2 mt -125.07 154.92 40.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.426 1.09 . . . . 0.0 112.16 -161.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -128.01 157.14 41.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.779 2.032 . . . . 0.0 113.917 -171.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.4 143.16 33.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -167.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -137.94 152.98 73.23 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.597 1.559 . . . . 0.0 110.875 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.02 179.59 5.59 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.538 2.159 . . . . 0.0 112.022 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.447 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 5.8 t -102.59 -57.7 2.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.967 1.707 . . . . 0.0 111.469 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.447 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 9.3 mmpt? -70.0 157.77 88.96 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 126.419 1.888 . . . . 0.0 112.976 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.4 -173.23 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.97 3.114 . . . . 0.0 113.639 167.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 59.74 29.48 19.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.988 1.715 . . . . 0.0 113.903 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -155.29 44.35 0.47 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.493 2.317 . . . . 0.0 110.906 -171.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.12 36.4 25.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.724 2.01 . . . . 0.0 114.174 -174.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.7 tp -148.15 37.74 0.87 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.269 1.828 . . . . 0.0 111.552 -171.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -73.11 0.34 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.743 1.217 . . . . 0.0 111.832 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -169.98 -172.11 1.29 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.737 2.015 . . . . 0.0 110.813 172.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 59.05 86.3 0.09 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.185 1.794 . . . . 0.0 114.685 163.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -122.84 25.61 8.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.811 1.244 . . . . 0.0 112.742 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -155.78 126.71 6.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.314 1.046 . . . . 0.0 111.384 -165.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.449 ' CG ' ' H ' ' A' ' 143' ' ' HIS . 2.5 t-80 53.52 -162.05 0.11 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.881 1.672 . . . . 0.0 113.994 177.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.449 ' H ' ' CG ' ' A' ' 142' ' ' HIS . 11.9 t-160 . . . . . 0 C--O 1.251 1.145 0 C-N-CA 126.62 1.968 . . . . 0.0 113.178 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.08 19.87 7.76 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -171.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -139.0 176.33 8.78 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.07 1.748 . . . . 0.0 112.673 -168.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -115.82 -32.35 5.49 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 164.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -63.51 -59.99 3.93 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -173.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -63.34 -29.17 70.53 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.659 1.584 . . . . 0.0 112.244 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -71.76 -42.6 66.99 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.754 2.022 . . . . 0.0 112.058 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.1 mt -77.97 -33.42 51.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.841 1.256 . . . . 0.0 112.796 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.275 12.2 t -128.73 76.77 78.48 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.33 160.58 46.64 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.023 3.149 . . . . 0.0 113.299 170.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.48 -66.47 1.04 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.569 1.148 . . . . 0.0 110.706 174.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -53.2 -26.06 16.09 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.164 1.785 . . . . 0.0 113.722 175.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.58 -16.98 21.75 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.229 1.412 . . . . 0.0 113.829 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.48 -54.47 3.78 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 111.506 175.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.49 -23.29 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 O-C-N 120.314 -1.491 . . . . 0.0 111.964 -172.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -68.25 -23.73 64.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.087 2.155 . . . . 0.0 112.649 172.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -67.4 -48.31 67.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.145 1.378 . . . . 0.0 110.369 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -73.13 -25.9 61.02 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.837 0.855 . . . . 0.0 111.095 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -71.56 61.28 0.35 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.388 1.875 . . . . 0.0 112.935 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.06 -6.98 0.12 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.509 1.528 . . . . 0.0 116.637 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 t -139.89 178.82 6.98 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.421 1.488 . . . . 0.0 110.987 -174.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -105.21 149.95 25.51 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.98 1.712 . . . . 0.0 111.811 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.61 154.32 44.1 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.792 1.237 . . . . 0.0 112.379 -173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.48 142.35 48.91 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.331 2.687 . . . . 0.0 111.527 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -80.75 45.14 0.78 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.1 m -67.69 24.96 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 128.712 2.805 . . . . 0.0 114.559 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.23 -56.17 5.49 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 126.599 2.047 . . . . 0.0 117.254 -165.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.2 ttm -64.2 -16.06 61.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.486 1.143 . . . . 0.0 114.077 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.9 -2.66 34.2 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.601 2.76 . . . . 0.0 112.159 176.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.7 mt -103.7 -9.46 19.11 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.18 1.792 . . . . 0.0 112.801 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -154.43 -32.89 0.1 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.742 1.617 . . . . 0.0 113.694 164.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.3 t30 55.04 -81.6 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.16 1.784 . . . . 0.0 112.718 -166.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -151.01 4.35 0.47 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -69.31 175.22 4.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 123.439 1.59 . . . . 0.0 113.104 173.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m -146.63 154.46 41.5 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.496 1.518 . . . . 0.0 109.788 -166.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.62 -158.52 20.82 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 172.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ptp -155.2 167.55 29.99 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.436 1.494 . . . . 0.0 112.647 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.45 ' HH ' HD13 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -120.98 151.17 40.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 112.253 157.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -138.16 164.59 28.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.039 2.136 . . . . 0.0 109.834 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.445 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 59.4 m -62.16 169.72 2.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 124.085 1.898 . . . . 0.0 114.712 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 p -115.6 -2.37 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.952 -2.385 . . . . 0.0 112.301 169.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.2 m -124.57 -18.35 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -169.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 12.7 p -125.9 -101.29 0.37 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.137 1.375 . . . . 0.0 112.008 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -159.71 -35.77 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.404 2.282 . . . . 0.0 113.538 -170.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.44 124.32 87.96 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -157.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.43 127.02 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.066 1.844 . . . . 0.0 110.363 156.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.72 -45.07 1.63 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.931 -158.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -126.31 121.12 31.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.825 -171.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 p -82.28 131.13 35.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.185 0.993 . . . . 0.0 108.903 166.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -58.45 -13.95 6.66 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.236 1.815 . . . . 0.0 112.321 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.11 -43.6 87.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 127.098 2.159 . . . . 0.0 114.548 168.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.8 mmpt? -72.83 -2.09 19.27 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.215 1.406 . . . . 0.0 113.222 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -78.36 137.5 38.06 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.628 1.971 . . . . 0.0 110.522 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -84.29 61.85 6.81 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 123.0 1.381 . . . . 0.0 111.571 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.8 t -101.35 109.5 21.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.181 0.992 . . . . 0.0 110.471 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.7 p -157.78 -40.47 0.07 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.557 1.143 . . . . 0.0 112.416 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.39 -49.67 0.39 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.305 1.431 . . . . 0.0 113.503 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.7 m -112.06 -20.56 11.91 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.302 1.041 . . . . 0.0 111.078 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.15 6.15 6.92 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.543 1.068 . . . . 0.0 114.483 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -65.58 142.61 98.35 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.663 1.185 . . . . 0.0 111.043 -170.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.04 96.84 0.63 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 CA-C-O 124.618 1.841 . . . . 0.0 113.887 -164.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.1 p -152.0 161.82 42.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 128.599 2.76 . . . . 0.0 110.427 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -157.15 168.29 27.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.365 2.266 . . . . 0.0 106.559 -169.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -127.55 -7.07 5.73 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 164.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -135.12 147.9 49.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 122.139 0.971 . . . . 0.0 111.858 160.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.57 108.97 4.65 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.689 1.995 . . . . 0.0 105.811 165.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HH ' ' CD2' ' A' ' 76' ' ' HIS . 2.4 t80 -30.08 95.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 129.803 3.241 . . . . 0.0 112.408 172.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.1 19.06 35.58 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.181 1.372 . . . . 0.0 114.109 -162.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -55.95 143.69 31.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.071 2.548 . . . . 0.0 115.125 -171.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.4 mmpt? -139.23 142.43 37.84 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 128.456 2.702 . . . . 0.0 111.342 172.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.88 -57.37 3.09 Favored Glycine 0 N--CA 1.478 1.476 0 C-N-CA 126.516 2.008 . . . . 0.0 114.82 163.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -25.92 64.91 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.0 1.32 . . . . 0.0 112.72 160.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -146.17 136.29 23.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.342 2.257 . . . . 0.0 109.811 167.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -139.74 7.02 2.28 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.497 1.519 . . . . 0.0 114.702 152.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 t -96.32 -41.32 8.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.719 1.208 . . . . 0.0 113.148 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.511 ' CD2' ' HH ' ' A' ' 67' ' ' TYR . 2.7 t-80 -77.38 -32.98 55.27 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.906 1.682 . . . . 0.0 113.442 -174.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.7 p -116.16 -54.57 2.47 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.037 1.735 . . . . 0.0 108.823 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.96 18.17 32.29 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.198 1.38 . . . . 0.0 113.914 -173.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -74.12 178.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 122.766 1.27 . . . . 0.0 113.091 -171.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 HD22 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.55 171.87 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.707 1.603 . . . . 0.0 110.152 174.136 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.428 ' H ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -160.79 157.78 27.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.766 1.627 . . . . 0.0 111.512 177.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -149.94 123.7 9.24 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.005 2.122 . . . . 0.0 107.916 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.03 147.35 42.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.745 161.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.04 23.27 11.47 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.201 1.001 . . . . 0.0 113.311 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.4 m -71.25 41.77 0.07 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.281 3.032 . . . . 0.0 112.876 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.88 -1.25 2.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 127.091 2.156 . . . . 0.0 113.438 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.9 mt -102.46 20.29 17.3 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.713 2.005 . . . . 0.0 112.224 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -9.11 60.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.049 1.309 . . . . 0.0 114.75 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.2 t -136.37 134.41 19.88 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 110.608 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 140.89 37.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.149 2.566 . . . . 0.0 113.366 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.2 mmt-85 -146.34 156.04 43.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.631 1.972 . . . . 0.0 111.308 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.25 119.81 20.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.608 1.563 . . . . 0.0 108.928 171.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -137.71 148.34 45.58 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.631 -0.668 . . . . 0.0 112.207 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.18 142.8 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.316 1.446 . . . . 0.0 112.296 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.91 157.43 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.807 1.243 . . . . 0.0 110.353 -172.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 49.1 t -92.98 128.43 38.85 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 123.008 1.385 . . . . 0.0 107.517 163.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -20.09 21.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.575 1.95 . . . . 0.0 112.166 170.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.82 -39.31 93.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.152 0.887 . . . . 0.0 112.616 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.05 -2.59 10.75 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.702 2.001 . . . . 0.0 114.856 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 52.43 63.67 2.15 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.461 1.505 . . . . 0.0 112.141 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -129.91 131.49 46.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.337 1.055 . . . . 0.0 112.04 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -90.87 103.29 16.02 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.194 -0.941 . . . . 0.0 109.578 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.0 mt -103.36 -40.49 6.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -160.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.51 148.63 20.02 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.873 1.702 . . . . 0.0 113.763 -161.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 159.35 42.95 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.468 1.107 . . . . 0.0 111.831 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.04 139.82 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 122.634 1.207 . . . . 0.0 111.37 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -147.95 154.98 44.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.572 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.39 135.79 13.61 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.681 2.921 . . . . 0.0 111.361 171.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -74.7 -4.61 38.44 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.95 -62.65 0.24 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.985 1.755 . . . . 0.0 114.213 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.12 -156.27 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.007 3.138 . . . . 0.0 112.707 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.96 160.51 0.81 Allowed Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 125.085 1.354 . . . . 0.0 112.217 170.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -58.34 -6.08 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.651 2.901 . . . . 0.0 114.949 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -30.17 67.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.011 0.924 . . . . 0.0 112.446 164.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.3 30.85 6.42 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 126.664 2.078 . . . . 0.0 114.995 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -72.37 143.23 48.66 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.313 1.045 . . . . 0.0 112.923 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -131.06 127.0 37.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.366 1.066 . . . . 0.0 109.629 169.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.25 127.77 38.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.035 0.534 . . . . 0.0 109.978 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 m -126.06 134.22 51.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.953 1.701 . . . . 0.0 110.081 -171.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.45 HD13 ' HH ' ' A' ' 38' ' ' TYR . 5.9 tt -131.61 164.2 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.142 . . . . 0.0 110.624 -171.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.02 -55.41 1.28 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 m 45.85 34.66 1.97 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.77 -24.67 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -157.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -139.63 17.17 2.53 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.773 1.629 . . . . 0.0 114.415 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.93 179.55 7.52 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.918 -1.114 . . . . 0.0 111.192 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -101.67 134.39 44.88 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.244 -0.91 . . . . 0.0 111.405 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -139.27 137.72 36.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.454 -171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -144.26 143.49 22.43 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.718 1.207 . . . . 0.0 110.831 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.12 168.53 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.472 1.448 . . . . 0.0 110.955 164.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.28 -44.68 5.34 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.666 1.186 . . . . 0.0 112.705 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.43 148.06 1.78 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.524 1.13 . . . . 0.0 112.488 167.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.38 -175.41 1.3 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.011 2.474 . . . . 0.0 113.243 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . 0.258 . . 69.2 32.2 3.72 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.987 2.115 . . . . 0.0 114.532 -166.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.65 -20.24 29.74 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.032 1.333 . . . . 0.0 114.067 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 52.99 44.04 30.96 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.836 1.654 . . . . 0.0 114.916 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.4 tp -139.95 40.08 1.97 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.885 1.326 . . . . 0.0 111.716 -164.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.39 -42.83 70.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.285 1.434 . . . . 0.0 114.099 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -139.06 170.61 15.66 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.061 1.345 . . . . 0.0 111.86 -176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -132.28 -153.19 0.54 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.926 1.29 . . . . 0.0 110.298 -170.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -110.78 -41.73 4.2 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.184 -0.947 . . . . 0.0 113.225 166.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 55.73 174.25 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.447 1.099 . . . . 0.0 113.021 -164.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -127.92 158.08 38.8 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.414 1.486 . . . . 0.0 109.174 167.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.801 1.24 . . . . 0.0 112.005 172.613 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.34 -150.51 21.0 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.457 -0.777 . . . . 0.0 112.068 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.13 169.81 20.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.072 1.349 . . . . 0.0 112.645 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.56 144.71 50.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.247 2.619 . . . . 0.0 110.764 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -147.08 160.55 42.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 111.327 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 59.9 m -64.6 154.21 36.98 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 123.056 1.408 . . . . 0.0 112.077 171.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.269 9.0 p -113.8 27.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.808 153.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.21 -41.4 3.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.534 1.534 . . . . 0.0 112.104 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 17.5 p -109.99 -103.53 0.38 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.674 1.59 . . . . 0.0 112.444 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.55 -40.51 0.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.878 2.471 . . . . 0.0 113.37 -163.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -98.02 137.15 20.85 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -152.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.85 139.65 15.69 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.094 2.529 . . . . 0.0 111.531 161.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.19 -29.71 0.88 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -165.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -132.04 126.97 35.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.559 1.072 . . . . 0.0 111.548 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.1 m -86.82 133.23 33.66 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 120.659 -1.276 . . . . 0.0 110.798 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -11.93 23.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.124 1.37 . . . . 0.0 112.931 171.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -35.81 71.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.22 7.49 24.97 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.227 1.011 . . . . 0.0 112.465 176.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -61.37 131.97 52.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.068 0.849 . . . . 0.0 109.658 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 122.716 1.245 . . . . 0.0 112.582 174.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo . . . . . 0 CA--C 1.54 0.802 0 CA-C-O 125.185 2.077 . . . . 0.0 116.392 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -135.28 154.31 51.59 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 128.516 2.726 . . . . 0.0 110.806 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -138.45 107.04 5.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.885 1.674 . . . . 0.0 111.014 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.7 p -63.99 -15.07 58.48 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.25 160.62 40.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.373 0.669 . . . . 0.0 109.387 138.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 124.314 1.046 . . . . 0.0 109.259 166.077 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 CA-C-O 119.238 -0.757 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -96.27 148.86 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.048 0.924 . . . . 0.0 111.232 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.43 174.12 8.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.821 2.848 . . . . 0.0 110.197 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.08 156.84 33.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.003 1.321 . . . . 0.0 112.144 -167.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.95 121.89 3.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.405 1.882 . . . . 0.0 110.083 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -97.24 154.07 17.63 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.338 1.855 . . . . 0.0 112.237 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -147.99 111.15 4.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.729 1.212 . . . . 0.0 110.21 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.7 t -118.95 19.85 12.91 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.811 1.767 . . . . 0.0 112.834 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 -15.15 28.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.252 1.421 . . . . 0.0 114.009 -154.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.0 mt -84.94 10.61 11.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.806 1.642 . . . . 0.0 112.914 166.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.16 -5.01 81.41 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.63 1.586 . . . . 0.0 114.653 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 10.0 t -137.19 129.65 16.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.258 1.023 . . . . 0.0 111.401 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.57 135.11 12.82 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.126 2.551 . . . . 0.0 114.373 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.6 mmt-85 -127.77 157.3 40.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 129.967 3.307 . . . . 0.0 109.315 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.4 mtm -133.44 132.84 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.355 1.862 . . . . 0.0 108.308 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -139.26 149.36 44.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 112.151 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.11 150.69 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.283 1.433 . . . . 0.0 111.916 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.42 155.02 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 109.927 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 1.232 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 7.6 t -92.6 128.41 38.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 158.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -84.02 -24.24 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.253 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -64.74 -43.95 91.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.854 0.862 . . . . 0.0 112.447 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.232 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.8 OUTLIER -99.98 -15.07 18.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.66 2.384 . . . . 0.0 113.238 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.303 42.5 mt-10 64.31 24.82 13.38 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.935 2.094 . . . . 0.0 112.799 -168.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.82 98.32 8.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.796 2.039 . . . . 0.0 112.848 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -89.12 68.87 8.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.949 1.7 . . . . 0.0 112.345 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.59 -5.09 8.7 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -159.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.56 135.97 12.44 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.707 2.099 . . . . 0.0 112.171 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.49 152.8 33.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.09 0.956 . . . . 0.0 111.39 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.12 125.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 122.322 1.058 . . . . 0.0 112.834 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -129.76 145.06 55.48 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.802 1.241 . . . . 0.0 111.76 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.57 167.21 27.07 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.48 2.787 . . . . 0.0 112.419 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -109.14 -8.49 15.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.453 1.901 . . . . 0.0 115.336 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.1 -56.31 0.71 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.661 1.6 . . . . 0.0 114.512 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.75 -157.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 124.65 3.567 . . . . 0.0 113.271 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 154.98 13.56 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.661 1.584 . . . . 0.0 111.406 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -61.56 -7.48 8.99 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.443 2.762 . . . . 0.0 114.283 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 p -57.74 -26.78 62.3 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.876 1.27 . . . . 0.0 113.762 165.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.34 4.46 86.04 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.193 1.377 . . . . 0.0 116.054 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.94 149.88 8.48 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.98 127.39 50.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 110.99 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.37 103.14 12.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.253 1.421 . . . . 0.0 109.484 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.1 p -92.9 136.85 32.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.436 2.294 . . . . 0.0 110.55 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.05 133.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.158 -0.964 . . . . 0.0 109.239 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -110.48 133.04 53.65 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.0 m -82.71 16.37 2.23 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -164.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.66 -23.72 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.95 22.38 3.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.851 1.66 . . . . 0.0 113.576 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.4 mt -122.02 140.58 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.155 0.982 . . . . 0.0 112.993 -170.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -115.54 178.05 4.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.404 2.682 . . . . 0.0 112.15 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -150.63 148.31 28.47 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.467 1.107 . . . . 0.0 112.29 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -131.16 134.11 25.45 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.37 1.468 . . . . 0.0 109.41 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.86 171.57 15.28 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.185 2.59 . . . . 0.0 113.107 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -42.5 18.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.921 0.888 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt . . . . . 0 CA--C 1.55 0.978 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 -167.638 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.783 0.802 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 129' ' ' PRO . . . 145.81 -154.53 26.0 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 125.369 1.461 . . . . 0.0 112.266 -175.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 21.8 ptm -158.08 162.97 38.1 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -125.84 142.12 51.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.664 2.786 . . . . 0.0 110.77 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -154.91 166.23 34.18 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.343 1.857 . . . . 0.0 110.428 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 4.5 t -80.98 172.84 13.24 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.132 1.444 . . . . 0.0 113.298 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.07 -9.06 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.173 1.789 . . . . 0.0 112.908 163.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 92.4 m -103.99 -33.45 8.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.959 1.303 . . . . 0.0 113.648 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -99.32 -100.49 0.23 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.759 1.223 . . . . 0.0 111.619 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -165.09 -62.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.36 145.12 29.13 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -161.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.43 151.58 70.95 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.236 2.624 . . . . 0.0 111.214 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.2 tp -137.83 -33.81 0.7 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -166.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -144.98 140.27 28.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.161 1.346 . . . . 0.0 114.205 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -98.56 144.41 27.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.011 0.925 . . . . 0.0 112.965 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -13.21 40.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.161 1.384 . . . . 0.0 113.407 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -24.87 66.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -87.19 -3.08 59.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.828 2.451 . . . . 0.0 113.312 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 127.76 33.7 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.992 1.317 . . . . 0.0 110.864 -170.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -166.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 CA--C 1.534 0.501 0 CA-C-O 124.311 1.713 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.2 p -158.74 156.56 30.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.695 2.798 . . . . 0.0 110.016 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.08 158.78 43.57 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 108.072 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.2 p -91.62 -20.13 21.97 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 127.243 2.217 . . . . 0.0 112.71 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -150.87 152.96 34.45 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.591 1.156 . . . . 0.0 112.199 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 125.033 1.333 . . . . 0.0 109.588 166.085 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.19 0 CA-C-O 121.801 0.667 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.59 164.97 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.471 1.909 . . . . 0.0 112.494 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.09 177.8 4.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.579 1.552 . . . . 0.0 109.408 158.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.28 155.96 38.72 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.657 -174.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -151.98 121.16 6.71 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.262 1.825 . . . . 0.0 108.49 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.51 135.69 38.25 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.55 -0.719 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -94.01 25.53 3.66 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 122.389 1.09 . . . . 0.0 111.195 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -75.8 45.99 0.36 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.816 2.446 . . . . 0.0 111.305 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -127.19 -13.16 5.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.128 2.171 . . . . 0.0 113.287 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.14 18.39 21.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.941 2.496 . . . . 0.0 112.633 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.91 -6.67 54.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.686 1.136 . . . . 0.0 114.643 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.3 t -133.53 133.61 22.8 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.885 1.674 . . . . 0.0 110.628 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.38 152.48 60.79 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.623 2.882 . . . . 0.0 114.214 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -146.26 164.21 33.03 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 128.859 2.864 . . . . 0.0 109.763 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.4 ttp -119.0 135.33 54.67 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 151.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 153.16 42.41 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.714 1.206 . . . . 0.0 110.709 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.41 148.49 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 122.103 0.954 . . . . 0.0 112.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.82 148.87 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.431 1.093 . . . . 0.0 112.327 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.72 107.95 10.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.429 2.292 . . . . 0.0 104.898 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -74.99 -14.2 60.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 168.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -61.58 -40.13 93.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 112.205 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.8 p -124.76 -5.46 7.51 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 9.4 tt0 73.38 53.71 0.12 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.215 2.206 . . . . 0.0 116.118 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.0 153.43 41.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 113.922 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 134.96 55.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.65 1.58 . . . . 0.0 113.064 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 tp -123.98 -15.48 6.85 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -165.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.82 179.55 34.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.731 2.11 . . . . 0.0 112.486 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -179.48 6.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.495 1.141 . . . . 0.0 113.816 -167.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.2 137.17 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.73 2.012 . . . . 0.0 109.576 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.26 149.42 48.26 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.315 1.446 . . . . 0.0 112.249 -172.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.88 143.46 16.44 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.826 2.35 . . . . 0.0 109.805 160.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.84 22.94 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.838 -1.164 . . . . 0.0 113.557 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.59 -46.34 1.15 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 127.157 2.313 . . . . 0.0 115.887 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -83.53 -163.48 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.34 2.693 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 151.9 63.49 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 113.258 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.28 -15.84 50.74 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.189 2.593 . . . . 0.0 113.215 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 p -56.67 -23.4 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.022 1.329 . . . . 0.0 113.186 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 9.76 64.9 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.463 2.459 . . . . 0.0 116.603 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -53.03 152.32 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.302 1.551 . . . . 0.0 114.246 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -136.94 154.44 50.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.883 2.073 . . . . 0.0 108.957 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -92.94 142.5 27.23 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.524 0.73 . . . . 0.0 110.498 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.5 p -121.0 143.2 49.17 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.744 1.618 . . . . 0.0 112.561 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.35 165.3 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.21 -0.931 . . . . 0.0 112.755 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.89 126.41 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.063 1.345 . . . . 0.0 114.162 -165.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -77.62 46.52 0.55 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.173 1.789 . . . . 0.0 112.954 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.18 -47.28 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.465 1.506 . . . . 0.0 113.398 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.29 4.66 0.05 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.565 1.546 . . . . 0.0 114.058 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.0 mt -85.8 159.59 19.69 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.746 1.619 . . . . 0.0 110.382 -164.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -103.95 133.68 48.5 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.142 0.977 . . . . 0.0 112.989 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.1 138.94 14.26 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.36 -0.838 . . . . 0.0 111.773 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -138.31 153.32 72.83 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.891 1.277 . . . . 0.0 111.997 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.436 ' HA ' ' HA3' ' A' ' 36' ' ' GLY . 87.1 Cg_endo -75.16 170.6 20.02 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.972 2.448 . . . . 0.0 112.859 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.44 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -91.74 -43.06 9.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.812 0.845 . . . . 0.0 111.73 -176.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 8.4 mmpt? . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 125.678 1.591 . . . . 0.0 114.767 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.7 m . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.92 -144.45 10.73 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.088 1.328 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ptm -132.74 162.75 30.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 112.517 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.96 139.76 52.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.962 2.905 . . . . 0.0 109.54 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.41 168.05 23.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.564 1.945 . . . . 0.0 109.423 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.0 OUTLIER -63.91 173.93 1.66 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 123.28 1.514 . . . . 0.0 112.578 176.406 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 p -122.98 -6.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.444 151.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.2 m -108.93 -27.73 9.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -168.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 13.8 p -109.28 -95.25 0.4 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.753 1.621 . . . . 0.0 112.017 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -157.37 -55.43 0.08 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.8 154.5 50.27 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 -154.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.37 143.86 71.69 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.169 1.913 . . . . 0.0 110.889 161.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.85 -51.93 2.64 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.374 1.07 . . . . 0.0 111.888 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -145.66 158.69 43.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.826 0.822 . . . . 0.0 112.033 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 p -85.63 135.05 33.95 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.441 1.096 . . . . 0.0 108.813 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -6.79 12.52 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.233 -0.917 . . . . 0.0 112.871 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -44.33 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 160.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -67.01 -10.5 50.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.862 1.665 . . . . 0.0 113.132 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -78.55 127.71 32.53 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.655 1.982 . . . . 0.0 110.969 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--N 1.326 -0.438 0 C-N-CA 127.052 2.141 . . . . 0.0 105.976 170.66 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 CA--C 1.532 0.381 0 CA-C-O 123.581 1.409 . . . . 0.0 114.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.9 p -140.95 158.12 44.38 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.215 1.806 . . . . 0.0 110.881 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.23 114.62 6.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.141 0.976 . . . . 0.0 108.976 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -73.07 -20.84 60.88 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.387 -0.821 . . . . 0.0 112.925 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -145.06 148.54 33.8 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.137 -0.977 . . . . 0.0 112.441 -174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 124.992 1.317 . . . . 0.0 109.45 174.449 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.405 0 N-CA-C 113.968 0.347 . . . . 0.0 113.968 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.97 178.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 127.124 2.17 . . . . 0.0 110.455 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.51 175.2 8.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.857 2.063 . . . . 0.0 107.948 159.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.495 HH11 HD13 ' A' ' 83' ' ' LEU . 1.9 ppt_? -147.03 140.67 25.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -126.46 93.18 3.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.226 1.488 . . . . 0.0 112.108 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD13 HH11 ' A' ' 81' ' ' ARG . 6.5 mp -62.97 144.03 57.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.29 -0.881 . . . . 0.0 108.7 155.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -146.24 52.27 1.14 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.294 1.521 . . . . 0.0 112.363 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -73.3 30.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.244 1.818 . . . . 0.0 114.529 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -109.8 0.31 18.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.333 1.453 . . . . 0.0 113.615 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.1 mt -80.16 6.66 11.11 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.267 1.027 . . . . 0.0 112.394 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -6.63 52.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.433 1.492 . . . . 0.0 113.941 -163.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.4 t -130.39 131.58 23.47 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.84 . . . . 0.0 110.09 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.39 131.43 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.088 2.525 . . . . 0.0 113.115 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -133.02 157.65 44.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.448 1.899 . . . . 0.0 109.788 166.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.2 mtm -131.61 136.02 47.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.777 2.031 . . . . 0.0 108.526 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.17 153.15 52.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 124.732 1.213 . . . . 0.0 110.828 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.25 144.44 28.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.346 1.058 . . . . 0.0 112.209 162.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 102' ' ' HIS . 2.8 m -111.82 146.43 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.825 1.25 . . . . 0.0 110.979 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.715 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.2 t -74.79 112.17 10.73 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 124.039 1.876 . . . . 0.0 107.198 169.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -63.37 -24.56 67.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 112.422 -2.172 . . . . 0.0 112.04 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.16 -45.21 18.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.203 1.401 . . . . 0.0 114.419 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.715 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 8.2 p -113.53 -3.74 13.63 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.898 1.679 . . . . 0.0 115.195 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 71.31 46.29 0.44 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.677 1.991 . . . . 0.0 115.53 167.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.93 144.46 37.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.406 ' HB3' HG12 ' A' ' 95' ' ' VAL . 13.9 p-80 -75.7 118.72 18.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.712 1.205 . . . . 0.0 110.416 170.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.61 -29.01 1.57 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -168.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.93 127.57 6.55 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 127.289 2.376 . . . . 0.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.97 146.34 35.51 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.025 -0.691 . . . . 0.0 111.083 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.98 142.07 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.526 1.531 . . . . 0.0 111.141 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -145.47 156.66 53.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.3 147.79 12.86 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.974 3.116 . . . . 0.0 112.804 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -97.82 -1.05 44.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.8 -55.15 0.77 Allowed Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.953 1.739 . . . . 0.0 116.103 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 -156.98 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 125.202 3.935 . . . . 0.0 113.54 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -51.93 159.57 1.37 Allowed Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.76 1.624 . . . . 0.0 112.097 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.34 -8.91 7.46 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.429 2.752 . . . . 0.0 114.665 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.7 p -55.26 -34.06 63.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.339 1.456 . . . . 0.0 112.914 165.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.97 3.98 86.22 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -57.3 138.21 55.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.703 1.252 . . . . 0.0 113.764 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -115.25 128.67 56.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.103 1.761 . . . . 0.0 108.893 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -111.17 109.9 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.729 1.211 . . . . 0.0 109.334 -169.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.5 m -95.7 148.61 22.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.183 2.193 . . . . 0.0 111.288 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -134.0 144.9 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.137 0.975 . . . . 0.0 109.882 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.25 107.31 9.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.306 1.051 . . . . 0.0 113.219 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.9 m -79.22 38.04 0.34 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.51 -27.88 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.05 -1.031 . . . . 0.0 112.096 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 15.86 7.84 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.032 2.133 . . . . 0.0 113.351 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.463 1.505 . . . . 0.0 111.945 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -112.26 160.71 17.37 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.43 1.492 . . . . 0.0 111.573 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.59 149.67 50.63 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.47 -0.769 . . . . 0.0 112.375 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -136.61 133.97 19.33 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.458 1.503 . . . . 0.0 108.938 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.77 170.28 14.26 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.883 2.389 . . . . 0.0 113.404 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -39.59 54.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.045 0.926 . . . . 0.0 112.42 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm . . . . . 0 CA--C 1.548 0.89 0 C-N-CA 125.093 1.357 . . . . 0.0 113.152 -171.715 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.61 -154.26 16.01 Favored Glycine 0 N--CA 1.465 0.627 0 C-N-CA 124.464 1.03 . . . . 0.0 113.814 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptp -156.05 163.59 39.49 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.036 1.334 . . . . 0.0 112.302 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.75 144.21 41.41 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 127.914 2.486 . . . . 0.0 111.014 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -141.81 161.68 37.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.004 1.721 . . . . 0.0 111.264 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 64.0 m -66.07 162.7 18.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 123.354 1.549 . . . . 0.0 113.235 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.29 1.44 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.963 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.7 m -129.4 -39.09 1.52 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -167.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 17.5 p -94.67 -85.34 0.31 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.587 1.085 . . . . 0.0 112.549 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.98 -74.51 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 p -110.46 155.65 41.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -151.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.95 138.39 33.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.294 1.996 . . . . 0.0 111.771 165.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.0 mt -135.35 -11.53 2.15 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.98 120.29 23.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.425 1.011 . . . . 0.0 111.534 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -92.8 131.6 37.7 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.812 1.768 . . . . 0.0 112.054 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -67.67 -7.53 27.54 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.742 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.35 -28.95 63.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 113.976 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 5.48 51.64 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 171.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -78.22 136.44 37.79 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.691 0.678 . . . . 0.0 109.439 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 CA--C 1.545 0.756 0 C-N-CA 123.611 0.764 . . . . 0.0 112.686 175.854 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo . . . . . 0 CA--C 1.538 0.681 0 CA-C-O 123.294 1.289 . . . . 0.0 114.259 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -159.33 148.61 18.39 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.532 1.933 . . . . 0.0 110.767 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -148.08 128.05 13.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.555 1.942 . . . . 0.0 109.59 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 p -73.35 -20.29 60.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -126.61 143.88 51.08 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.986 1.85 . . . . 0.0 113.897 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.794 0 CA-C-N 110.969 -2.832 . . . . 0.0 107.469 -177.954 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.182 0 CA-C-O 119.813 -0.437 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -98.47 163.41 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.841 0.829 . . . . 0.0 111.693 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.56 176.62 8.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.791 2.036 . . . . 0.0 112.502 -169.478 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.555 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -145.86 151.46 37.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.295 1.438 . . . . 0.0 112.875 -171.056 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.73 112.74 5.17 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.528 1.931 . . . . 0.0 108.82 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.04 131.6 37.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.963 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -98.82 17.42 19.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.015 1.326 . . . . 0.0 112.084 -168.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -70.33 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.891 2.876 . . . . 0.0 114.767 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -125.05 0.39 7.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.983 1.713 . . . . 0.0 113.766 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.9 mt -100.08 15.53 27.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 113.273 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.29 -9.43 54.48 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.408 1.48 . . . . 0.0 114.328 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.6 t -118.81 121.45 30.62 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.441 1.496 . . . . 0.0 110.224 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 125.01 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.332 2.022 . . . . 0.0 111.804 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -144.62 159.85 42.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.722 2.009 . . . . 0.0 109.909 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.8 mtp -128.51 127.13 41.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.938 2.095 . . . . 0.0 107.975 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.56 151.98 51.47 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.161 0.984 . . . . 0.0 110.677 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 m -133.82 148.8 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.993 1.317 . . . . 0.0 110.84 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.25 156.16 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.27 0.628 . . . . 0.0 111.432 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.841 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.3 t -92.61 118.91 31.51 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -83.59 -14.87 51.09 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.861 171.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -70.01 -51.01 35.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.064 0.945 . . . . 0.0 112.811 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.841 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 2.6 p -107.4 -7.75 16.53 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.833 1.653 . . . . 0.0 115.033 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 61.26 56.29 2.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.109 2.164 . . . . 0.0 114.039 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.79 146.13 43.2 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.693 1.197 . . . . 0.0 111.796 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.06 126.61 30.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.19 -0.944 . . . . 0.0 111.18 172.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.38 6.66 36.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.487 1.915 . . . . 0.0 113.216 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.8 -168.77 13.04 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 127.22 2.343 . . . . 0.0 112.584 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.23 163.85 36.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 123.012 1.386 . . . . 0.0 113.577 -165.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.64 135.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.28 1.832 . . . . 0.0 110.031 -165.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -148.13 154.17 42.4 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.021 1.329 . . . . 0.0 113.53 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.22 129.79 6.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.402 2.734 . . . . 0.0 109.763 163.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.31 -3.0 54.5 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.06 -54.64 0.38 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.238 1.399 . . . . 0.0 114.797 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.88 -165.02 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.469 2.779 . . . . 0.0 112.736 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 157.75 2.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.322 1.449 . . . . 0.0 111.862 173.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -57.44 -17.82 28.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.946 2.431 . . . . 0.0 113.479 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -23.24 36.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.599 1.56 . . . . 0.0 113.269 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.69 17.89 51.8 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 127.773 2.606 . . . . 0.0 115.427 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.02 140.1 56.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.413 1.107 . . . . 0.0 112.584 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -124.76 146.91 48.96 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.198 1.799 . . . . 0.0 110.318 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.48 129.58 42.6 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.269 1.427 . . . . 0.0 109.148 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.9 p -120.78 144.39 48.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.014 1.326 . . . . 0.0 111.055 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.2 tp -123.42 155.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 0.0 111.091 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -126.8 134.16 50.64 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.989 1.716 . . . . 0.0 107.448 161.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.4 m -81.7 50.67 1.55 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -163.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -50.99 -59.89 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.902 2.481 . . . . 0.0 115.236 -164.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.13 27.1 0.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.727 1.211 . . . . 0.0 114.024 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.3 mt -117.19 157.01 26.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.823 1.249 . . . . 0.0 110.358 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 166.42 10.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.825 1.65 . . . . 0.0 112.19 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -144.63 153.21 41.53 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.557 1.143 . . . . 0.0 112.203 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 151.97 67.42 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.442 1.897 . . . . 0.0 109.946 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.13 170.69 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.62 2.213 . . . . 0.0 112.921 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.55 -45.73 8.75 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.877 0.871 . . . . 0.0 111.95 -170.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt . . . . . 0 CA--C 1.546 0.809 0 C-N-CA 127.23 2.212 . . . . 0.0 112.371 179.001 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.428 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.6 m . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.91 -167.3 39.99 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 118.863 0.756 . . . . 0.0 113.119 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.7 ptp -156.2 159.44 38.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.256 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.89 144.47 50.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.134 2.573 . . . . 0.0 111.044 -170.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.53 155.7 37.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.655 1.982 . . . . 0.0 109.184 -168.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.857 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 1.8 t -77.79 167.65 21.2 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.808 1.766 . . . . 0.0 113.486 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -137.56 5.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 112.66 -2.064 . . . . 0.0 112.102 166.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 99' ' ' CYS . 91.3 m -119.56 -31.37 4.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.782 1.633 . . . . 0.0 112.219 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.857 ' HG ' ' HG ' ' A' ' 40' ' ' CYS . 11.3 p -100.65 -103.24 0.24 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.509 1.523 . . . . 0.0 108.534 158.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.88 -31.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 p -81.64 155.71 70.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -161.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.45 136.97 45.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.166 1.911 . . . . 0.0 110.237 156.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.5 -39.13 0.82 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -157.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -157.47 152.6 25.89 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.444 1.02 . . . . 0.0 111.823 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -97.27 142.98 28.5 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.559 -1.338 . . . . 0.0 112.151 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 t -66.89 -10.32 47.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -42.36 64.35 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.937 1.695 . . . . 0.0 114.093 165.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.04 -1.36 28.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.289 1.435 . . . . 0.0 113.155 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -76.58 141.91 40.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.431 0.634 . . . . 0.0 111.334 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 . . . . . 0 C--N 1.319 -0.747 0 C-N-CA 124.782 1.233 . . . . 0.0 112.111 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.539 0.737 0 CA-C-O 122.183 0.826 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 p -153.07 139.23 18.34 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.217 1.407 . . . . 0.0 109.874 -165.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -155.11 114.13 3.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.852 0.861 . . . . 0.0 110.524 -154.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 p -75.79 -19.97 58.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -146.83 156.99 43.54 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.411 1.084 . . . . 0.0 111.269 173.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 125.073 1.349 . . . . 0.0 111.711 169.936 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.682 0 N-CA-C 113.613 0.205 . . . . 0.0 113.613 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.63 173.79 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.812 2.045 . . . . 0.0 112.404 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.66 -179.79 4.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.191 2.197 . . . . 0.0 110.083 -178.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.619 ' H ' HD23 ' A' ' 80' ' ' LEU . 24.6 mmt85 -141.25 146.09 36.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.841 1.656 . . . . 0.0 109.832 -170.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -144.03 102.35 3.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.283 1.433 . . . . 0.0 111.496 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.42 149.87 35.09 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.018 -1.051 . . . . 0.0 111.233 165.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -134.38 29.63 3.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.8 1.286 . . . . 0.0 112.598 -170.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -73.63 35.52 0.09 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.535 1.934 . . . . 0.0 113.939 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.85 2.57 4.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.552 1.941 . . . . 0.0 112.797 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.3 15.08 5.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.394 1.878 . . . . 0.0 112.78 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.11 -3.53 65.51 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.8 1.191 . . . . 0.0 114.388 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 t -140.72 141.28 24.27 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 127.908 2.483 . . . . 0.0 110.164 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.67 129.33 16.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.809 2.339 . . . . 0.0 112.691 170.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -139.45 159.32 42.44 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.159 2.584 . . . . 0.0 108.515 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.9 ttm -143.35 134.68 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.575 1.55 . . . . 0.0 110.232 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -139.23 166.57 24.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.57 138.33 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.659 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.66 145.9 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 44.0 t -77.87 103.32 7.73 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.257 1.423 . . . . 0.0 107.551 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -57.4 -18.46 17.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.159 1.783 . . . . 0.0 112.562 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.82 -37.41 13.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 113.316 -167.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 12.3 p -121.15 1.88 10.33 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.645 1.978 . . . . 0.0 114.524 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.274 4.5 tt0 59.98 57.82 2.93 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.526 2.33 . . . . 0.0 113.294 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.4 129.67 35.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.747 1.219 . . . . 0.0 113.621 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -76.03 116.63 16.93 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.154 -0.966 . . . . 0.0 110.371 164.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -120.56 -36.44 3.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -169.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.39 146.31 18.33 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 128.24 2.829 . . . . 0.0 111.846 -166.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 158.64 38.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.377 0.671 . . . . 0.0 111.809 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.27 139.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.701 1.238 . . . . 0.0 111.45 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.99 150.29 38.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.39 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.59 133.85 19.48 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.321 2.681 . . . . 0.0 110.905 169.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.67 7.64 29.09 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.17 -49.94 0.55 Allowed Glycine 0 CA--C 1.541 1.657 0 C-N-CA 126.012 1.767 . . . . 0.0 114.777 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.09 -154.97 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.55 3.5 . . . . 0.0 112.108 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.29 157.83 3.04 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 126.493 1.917 . . . . 0.0 112.325 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -62.8 -8.86 14.51 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.378 2.719 . . . . 0.0 114.093 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.0 p -63.74 -24.14 67.65 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.813 -1.179 . . . . 0.0 112.261 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.22 20.49 33.29 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.844 2.64 . . . . 0.0 115.91 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -63.53 135.3 56.75 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.041 -1.27 . . . . 0.0 112.238 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -112.11 138.94 48.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 127.117 2.167 . . . . 0.0 108.503 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -107.03 128.31 54.25 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.468 1.107 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.7 p -121.76 149.1 43.78 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.617 1.567 . . . . 0.0 110.063 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.6 tt -131.65 164.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.546 -1.346 . . . . 0.0 109.76 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.1 124.54 24.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.21 -0.931 . . . . 0.0 112.528 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.1 m -79.91 36.44 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.974 1.309 . . . . 0.0 114.038 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.03 -37.91 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.168 1.787 . . . . 0.0 113.586 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.15 60.02 0.15 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.061 1.344 . . . . 0.0 113.125 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.27 171.68 13.72 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.761 1.625 . . . . 0.0 113.444 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 mmpt? -120.83 156.39 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.363 1.865 . . . . 0.0 114.609 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.12 150.99 22.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.452 1.501 . . . . 0.0 111.747 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.1 146.86 56.32 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.738 2.015 . . . . 0.0 111.551 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.72 169.67 19.58 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.265 1.976 . . . . 0.0 111.264 165.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 -38.53 7.08 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 111.904 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HE3' ' HB ' ' A' ' 35' ' ' THR . 10.4 mmpt? . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 126.193 1.797 . . . . 0.0 112.442 161.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 C--O 1.224 -0.245 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.96 -142.35 10.25 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 121.012 -1.055 . . . . 0.0 111.263 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.3 ptp -155.66 157.2 36.29 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.625 1.202 . . . . 0.0 113.746 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -112.8 130.05 56.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 128.15 2.58 . . . . 0.0 107.652 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -151.58 168.33 25.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.736 1.214 . . . . 0.0 112.376 -161.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.944 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -74.89 172.14 12.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 123.648 1.69 . . . . 0.0 114.379 -178.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.67 0.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.409 157.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 97.7 m -112.62 -48.65 2.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.414 1.486 . . . . 0.0 112.345 -168.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.944 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 7.5 p -86.88 -80.63 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.742 1.217 . . . . 0.0 111.99 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.05 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.313 1.445 . . . . 0.0 114.645 163.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.1 p -101.68 159.01 30.67 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -158.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.68 155.56 49.39 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.961 3.107 . . . . 0.0 112.512 163.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.61 -31.15 0.57 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -172.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -132.04 122.23 25.14 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.889 -1.132 . . . . 0.0 108.717 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -82.9 136.46 34.58 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 120.388 -1.445 . . . . 0.0 109.241 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 t -58.54 -18.86 32.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.504 1.122 . . . . 0.0 112.76 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 3.5 tt0 -60.83 -42.03 96.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.897 1.279 . . . . 0.0 113.813 175.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.1 mmpt? -74.45 -4.16 34.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.817 0.847 . . . . 0.0 112.706 174.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -74.54 135.15 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.337 1.055 . . . . 0.0 109.504 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.957 -163.587 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo . . . . . 0 CA--C 1.539 0.767 0 CA-C-O 122.82 1.092 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -138.5 152.79 48.57 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.042 1.737 . . . . 0.0 110.109 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -141.32 130.74 23.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 p -78.98 -12.66 60.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.32 150.72 50.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.799 1.285 . . . . 0.0 112.144 160.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 107.415 179.297 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.361 0 CA-C-O 118.98 -0.9 . . . . 0.0 114.383 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.1 pt -59.43 162.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -145.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tt -121.63 158.59 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.735 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.75 153.37 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.856 1.262 . . . . 0.0 111.673 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.45 133.31 13.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.464 1.906 . . . . 0.0 108.937 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.73 156.12 39.26 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.784 1.634 . . . . 0.0 112.055 163.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -133.55 118.61 18.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 164.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 t -115.53 20.95 14.39 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 122.136 0.97 . . . . 0.0 111.922 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -84.79 -6.3 59.35 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.703 2.401 . . . . 0.0 113.324 -168.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -86.83 10.29 16.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.028 2.131 . . . . 0.0 112.733 164.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.79 -0.17 57.89 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 124.67 1.129 . . . . 0.0 114.732 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.46 128.72 11.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.674 1.59 . . . . 0.0 110.211 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.89 139.39 19.51 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.674 2.249 . . . . 0.0 113.569 -170.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -134.49 165.67 24.64 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 130.665 3.586 . . . . 0.0 109.928 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mtm -132.62 133.95 44.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.192 2.197 . . . . 0.0 109.955 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -133.18 145.54 50.71 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.15 0.98 . . . . 0.0 112.955 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.56 146.17 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.42 1.888 . . . . 0.0 111.331 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 m -141.77 147.04 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.401 -0.812 . . . . 0.0 111.799 -169.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.643 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 48.2 t -74.51 97.9 3.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 123.69 1.709 . . . . 0.0 108.892 170.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -24.2 2.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.576 1.951 . . . . 0.0 112.69 165.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -83.79 -41.11 17.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.862 1.665 . . . . 0.0 114.456 -172.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.643 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 24.7 p -126.97 1.08 6.58 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -175.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.258 13.1 mt-10 72.95 22.0 3.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.272 2.629 . . . . 0.0 115.068 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.0 94.53 9.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.338 1.055 . . . . 0.0 113.431 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.48 53.75 2.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.64 -7.24 38.15 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -160.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.01 130.27 8.33 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 126.662 2.077 . . . . 0.0 113.04 -167.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.82 153.36 36.64 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.904 -0.762 . . . . 0.0 110.802 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.97 128.82 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.795 0.838 . . . . 0.0 111.672 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -127.99 141.12 40.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.576 1.15 . . . . 0.0 112.502 -169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -73.21 162.57 40.24 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.62 2.88 . . . . 0.0 111.506 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -116.8 -0.84 12.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.71 -62.5 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.825 1.678 . . . . 0.0 114.822 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -69.6 -162.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.262 1 C-N-CA 125.714 4.276 . . . . 0.0 114.099 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -56.43 163.07 2.73 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 126.171 1.788 . . . . 0.0 113.057 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -59.21 -11.58 13.5 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 0.0 114.436 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 p -58.78 -23.87 60.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.029 1.332 . . . . 0.0 113.892 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.6 -3.61 62.62 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.908 1.718 . . . . 0.0 116.262 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -59.37 145.34 43.85 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.713 1.257 . . . . 0.0 112.426 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 128.9 55.55 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.265 1.026 . . . . 0.0 109.327 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -99.09 110.49 23.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.812 1.245 . . . . 0.0 109.935 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.9 m -113.48 112.43 23.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.242 2.217 . . . . 0.0 108.685 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.7 tt -136.46 118.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.51 0.724 . . . . 0.0 112.544 -167.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -80.56 -9.27 59.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.9 m -16.73 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.358 2.663 . . . . 0.0 116.262 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 -33.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.954 2.102 . . . . 0.0 112.126 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.18 2.46 5.87 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.665 1.586 . . . . 0.0 114.423 165.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.54 -174.19 2.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.921 2.888 . . . . 0.0 110.628 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.91 163.66 12.78 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.575 -1.328 . . . . 0.0 114.524 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.47 155.87 42.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.852 1.261 . . . . 0.0 112.397 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -149.13 150.11 31.26 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.825 1.65 . . . . 0.0 111.78 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.84 173.54 13.44 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.141 2.56 . . . . 0.0 113.17 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.02 -40.22 6.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -172.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.31 -157.72 25.65 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ptp -146.07 161.87 39.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.914 1.286 . . . . 0.0 113.862 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 127' ' ' PHE . 46.6 m-85 -125.38 131.04 53.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.085 2.554 . . . . 0.0 109.838 171.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -137.2 173.67 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.497 1.519 . . . . 0.0 110.056 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 1.016 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 4.5 t -65.92 158.79 27.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 123.217 1.484 . . . . 0.0 113.308 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.96 -3.59 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.096 168.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.8 m -125.01 -22.01 4.55 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.404 1.482 . . . . 0.0 114.629 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 1.016 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 7.5 p -122.11 -88.57 0.62 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.403 1.481 . . . . 0.0 113.104 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -152.6 -46.59 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -127.43 161.23 55.92 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -140.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.43 150.45 41.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.081 3.187 . . . . 0.0 113.34 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -137.36 -34.54 0.7 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -152.72 146.73 25.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.445 1.02 . . . . 0.0 112.474 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.5 p -81.66 145.82 30.36 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.644 -1.285 . . . . 0.0 111.356 169.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -61.4 -17.98 56.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.29 -34.83 66.85 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.897 1.679 . . . . 0.0 113.396 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -9.44 51.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.574 1.15 . . . . 0.0 112.216 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -70.58 108.17 4.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.187 0.903 . . . . 0.0 109.979 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 CA--C 1.541 0.607 0 C-N-CA 125.105 1.362 . . . . 0.0 114.577 -153.339 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.533 0.439 0 CA-C-O 123.3 1.292 . . . . 0.0 114.382 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.04 149.96 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.052 1.741 . . . . 0.0 110.628 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.97 108.74 8.56 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.293 1.837 . . . . 0.0 108.79 -162.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.3 p -67.1 -18.47 65.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.84 154.35 39.38 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.149 0.98 . . . . 0.0 110.988 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 123.734 0.813 . . . . 0.0 109.069 166.01 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 CA-C-O 119.959 -0.356 . . . . 0.0 113.771 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.21 167.2 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 122.441 1.115 . . . . 0.0 111.554 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.23 176.94 8.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.093 1.757 . . . . 0.0 110.469 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.542 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -157.7 163.57 38.03 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.913 1.685 . . . . 0.0 111.796 -167.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.9 156.64 20.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.911 2.884 . . . . 0.0 105.348 -157.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -124.47 151.64 44.33 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 127.283 2.233 . . . . 0.0 111.074 169.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.84 21.35 5.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.203 1.801 . . . . 0.0 111.422 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.7 t -69.57 32.51 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.494 2.318 . . . . 0.0 114.767 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 t -138.2 12.31 2.82 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.796 3.238 . . . . 0.0 111.032 -174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -109.18 22.98 15.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.876 2.47 . . . . 0.0 112.187 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.89 -16.33 58.67 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 125.064 1.316 . . . . 0.0 114.406 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 t -143.15 143.88 26.44 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.794 1.238 . . . . 0.0 110.608 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.88 133.79 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.477 2.118 . . . . 0.0 112.909 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -148.55 154.1 39.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 129.181 2.992 . . . . 0.0 109.25 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.2 mtt -135.0 145.67 48.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.496 2.319 . . . . 0.0 108.215 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -139.47 138.27 36.27 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.197 0.999 . . . . 0.0 111.37 -169.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.85 139.22 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 122.314 1.054 . . . . 0.0 112.092 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.43 152.4 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.848 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 40.1 t -89.54 121.21 31.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 164.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.41 -18.6 31.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.534 1.934 . . . . 0.0 111.883 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -67.8 -28.58 67.71 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 7.1 p -129.61 -3.82 4.76 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 126.225 1.81 . . . . 0.0 115.042 177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.272 11.6 mt-10 62.27 42.35 9.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 127.279 2.232 . . . . 0.0 113.761 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.89 52.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.608 1.963 . . . . 0.0 112.573 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 115.2 17.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 165.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.32 -35.42 3.8 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -170.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.87 132.82 5.74 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 127.005 2.241 . . . . 0.0 112.004 -164.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.51 28.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.086 0.946 . . . . 0.0 110.994 -172.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.49 127.92 32.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.147 -0.97 . . . . 0.0 109.577 -149.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -148.6 150.22 33.09 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.92 132.84 25.59 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.876 2.384 . . . . 0.0 110.174 156.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.04 11.92 10.6 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.22 -67.24 0.34 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.955 1.74 . . . . 0.0 112.311 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.38 -164.34 0.19 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.113 3.209 . . . . 0.0 112.192 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -61.0 143.84 91.44 Favored Pre-proline 0 N--CA 1.473 0.696 0 O-C-N 120.286 -1.509 . . . . 0.0 112.555 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.5 -2.42 8.3 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.904 3.069 . . . . 0.0 114.127 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -50.15 -35.4 25.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.159 1.345 . . . . 0.0 110.897 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -90.59 16.2 58.5 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.216 2.341 . . . . 0.0 117.098 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.59 149.11 11.19 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -116.68 139.66 50.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.721 1.608 . . . . 0.0 110.022 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.6 100.19 11.78 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 174.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.9 t -74.77 143.77 43.9 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.656 -0.652 . . . . 0.0 110.871 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.9 mt -140.61 132.58 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.021 0.528 . . . . 0.0 110.266 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.84 99.3 12.19 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -173.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.3 p -52.19 -31.16 30.4 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.2 p -46.68 -29.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.861 2.064 . . . . 0.0 115.258 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.96 10.7 40.81 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.3 170.86 15.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.174 1.789 . . . . 0.0 111.702 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 129.97 52.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 110.325 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 43.8 p90 -142.82 145.87 33.63 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 112.753 -171.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -154.65 150.42 21.7 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.01 1.324 . . . . 0.0 112.175 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.04 169.1 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.069 1.846 . . . . 0.0 111.613 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.67 -42.67 9.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.826 1.25 . . . . 0.0 111.683 176.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt . . . . . 0 CA--C 1.551 0.996 0 C-N-CA 127.358 2.263 . . . . 0.0 113.235 -178.625 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.87 -155.5 20.88 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.103 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 ptp -159.99 166.97 28.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -127.78 135.79 50.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.457 2.703 . . . . 0.0 109.629 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -144.96 155.68 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 0.0 110.753 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 m -68.3 167.17 14.98 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 123.401 1.572 . . . . 0.0 112.543 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.26 -8.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 113.504 -1.68 . . . . 0.0 111.927 152.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -97.2 -18.63 19.14 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.16 1.784 . . . . 0.0 114.73 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.1 p -118.73 -105.09 0.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.315 2.246 . . . . 0.0 109.013 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -163.36 -38.87 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.84 2.056 . . . . 0.0 113.699 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.21 140.5 24.45 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -165.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.95 146.66 65.95 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.388 2.059 . . . . 0.0 111.101 170.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.61 -27.87 2.32 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -134.52 127.11 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.426 -0.796 . . . . 0.0 112.324 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 p -84.44 141.12 31.04 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.696 -1.253 . . . . 0.0 110.196 164.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -18.32 23.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.111 0.964 . . . . 0.0 113.436 170.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.52 -41.79 61.27 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.92 1.688 . . . . 0.0 114.262 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -71.4 -8.92 56.96 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.592 1.557 . . . . 0.0 112.841 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -81.01 129.64 34.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.247 0.546 . . . . 0.0 112.019 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 160.878 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.537 0.641 0 CA-C-O 122.423 0.926 . . . . 0.0 114.321 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 t -154.81 153.67 31.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.466 1.507 . . . . 0.0 111.379 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.73 119.22 22.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.195 2.198 . . . . 0.0 107.471 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 p -70.31 -14.46 62.59 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -153.42 161.16 42.57 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.671 0 C-N-CA 126.145 1.778 . . . . 0.0 110.024 171.909 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 CA-C-O 118.705 -1.053 . . . . 0.0 113.232 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -96.72 159.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.355 1.077 . . . . 0.0 110.14 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -144.1 164.54 30.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.315 1.446 . . . . 0.0 111.029 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.98 158.87 43.43 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.42 112.2 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.169 2.587 . . . . 0.0 107.37 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.35 154.9 28.71 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.07 0.948 . . . . 0.0 110.861 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -141.01 34.96 1.74 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.828 0.823 . . . . 0.0 112.961 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -71.95 55.19 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 124.051 1.881 . . . . 0.0 109.629 157.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -142.18 8.36 1.83 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.038 2.535 . . . . 0.0 112.351 -167.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.4 mt -128.04 20.24 6.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.647 1.979 . . . . 0.0 112.571 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.42 2.17 73.24 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 120.976 -1.077 . . . . 0.0 115.588 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.6 t -135.39 138.91 29.91 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 127.327 2.251 . . . . 0.0 110.085 168.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.13 135.61 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.501 2.801 . . . . 0.0 114.658 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -144.68 158.42 43.79 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.298 2.639 . . . . 0.0 110.628 167.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.4 mtp -141.92 125.85 17.18 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.388 2.675 . . . . 0.0 107.864 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -133.18 146.48 51.57 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.872 -1.142 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.61 153.32 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.241 1.416 . . . . 0.0 110.962 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.03 140.63 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.259 1.424 . . . . 0.0 109.144 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 1.225 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 42.9 t -76.72 97.37 4.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 124.085 1.897 . . . . 0.0 106.604 160.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -66.83 -14.72 63.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.727 -1.578 . . . . 0.0 111.545 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -66.53 -50.48 63.05 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.885 1.274 . . . . 0.0 112.426 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.225 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.7 OUTLIER -100.89 -11.99 19.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.009 2.123 . . . . 0.0 114.281 -173.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 68.02 17.91 9.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.395 1.878 . . . . 0.0 113.994 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . . . -75.7 86.11 2.73 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.057 1.408 . . . . 0.0 112.229 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -89.78 67.58 7.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.827 1.651 . . . . 0.0 113.404 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.275 0.0 OUTLIER -135.02 5.88 3.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 118.528 2.788 . . . . 0.0 118.528 -170.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.06 129.3 9.0 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.47 1.032 . . . . 0.0 112.679 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -147.71 160.74 42.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.8 142.45 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 123.692 1.71 . . . . 0.0 112.745 -171.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -149.1 156.59 40.26 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 127.322 2.249 . . . . 0.0 110.435 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.38 142.49 54.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.292 1.995 . . . . 0.0 109.444 165.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.94 18.05 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 113.583 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.64 -64.15 0.6 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.529 2.49 . . . . 0.0 112.739 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -86.53 -153.65 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.544 4.162 . . . . 0.0 113.516 -174.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.83 149.41 2.31 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 127.597 2.359 . . . . 0.0 113.712 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.81 -7.9 19.78 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.411 2.741 . . . . 0.0 114.498 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.1 p -58.87 -27.12 64.87 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.182 -0.949 . . . . 0.0 112.131 165.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -88.16 5.9 84.21 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.202 1.858 . . . . 0.0 116.324 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -58.88 127.3 31.52 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 1.428 . . . . 0.0 111.876 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -109.23 120.18 41.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.37 1.068 . . . . 0.0 109.583 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -90.37 76.19 6.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.825 1.298 . . . . 0.0 110.117 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.4 t -66.31 131.03 45.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.533 1.635 . . . . 0.0 111.59 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.3 tt -148.41 166.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.679 -1.601 . . . . 0.0 109.086 -168.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.44 134.56 46.33 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.256 -1.527 . . . . 0.0 113.889 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -81.04 -32.56 34.04 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.24 -33.56 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.86 2.56 14.22 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.3 mt -135.19 171.94 13.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.002 2.521 . . . . 0.0 110.034 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 9.7 mmpt? -109.82 159.38 17.25 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.933 -1.105 . . . . 0.0 112.694 168.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -148.59 153.0 37.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -146.33 145.97 25.92 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 125.797 1.639 . . . . 0.0 111.491 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.73 173.43 14.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.655 2.237 . . . . 0.0 112.072 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.6 t -100.06 -54.93 2.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.233 1.013 . . . . 0.0 111.28 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 126.542 1.937 . . . . 0.0 114.555 -174.1 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.38 -152.51 18.15 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptp -155.25 174.58 15.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.897 1.679 . . . . 0.0 113.011 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.47 148.28 52.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.715 1.606 . . . . 0.0 112.378 163.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -137.17 169.37 17.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.826 2.051 . . . . 0.0 111.758 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.81 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -76.21 168.4 20.12 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 123.781 1.753 . . . . 0.0 114.05 -177.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.54 26.33 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 127.352 2.261 . . . . 0.0 111.409 164.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.62 -41.08 2.03 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.508 1.523 . . . . 0.0 111.103 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.81 ' HG ' ' HG ' ' A' ' 40' ' ' CYS . 21.3 p -97.33 -99.16 0.2 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.139 1.376 . . . . 0.0 110.85 166.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.08 -49.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.021 1.328 . . . . 0.0 114.202 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -99.66 154.07 37.45 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -142.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.0 142.17 99.12 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.933 1.756 . . . . 0.0 110.336 158.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.33 -34.93 1.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.673 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -135.87 134.76 39.14 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 p -91.13 127.55 36.6 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.312 1.053 . . . . 0.0 109.46 164.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.46 -7.21 29.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 113.383 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 4.9 mt-10 -59.05 -33.13 70.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.663 167.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 6.9 mmpt? -75.69 7.81 3.5 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.149 0.979 . . . . 0.0 111.955 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . 16.0 ttpp -52.69 132.85 36.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.42 0.629 . . . . 0.0 111.432 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 CA--C 1.547 0.847 0 C-N-CA 124.902 1.281 . . . . 0.0 111.802 178.7 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.531 0.373 0 CA-C-O 123.063 1.193 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -157.83 144.92 18.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.643 1.977 . . . . 0.0 110.605 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -143.58 117.15 9.17 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.094 1.357 . . . . 0.0 109.832 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.4 p -69.19 -23.68 63.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -145.44 158.22 43.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.944 0.897 . . . . 0.0 112.006 162.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 124.335 1.054 . . . . 0.0 109.322 162.597 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.227 0 CA-C-O 118.952 -0.915 . . . . 0.0 114.592 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -93.74 161.87 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.816 1.77 . . . . 0.0 114.901 -171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -134.57 -178.07 4.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.513 2.325 . . . . 0.0 109.221 168.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.583 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -151.74 161.74 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.676 1.19 . . . . 0.0 113.482 -171.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.24 117.44 8.97 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 129.113 2.965 . . . . 0.0 106.487 -175.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.85 148.92 25.04 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.032 1.333 . . . . 0.0 112.314 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.56 36.88 3.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.957 1.303 . . . . 0.0 112.537 -163.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p -68.3 22.38 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.918 2.087 . . . . 0.0 115.492 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.3 t -126.66 -2.81 6.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.8 2.04 . . . . 0.0 113.455 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.54 12.37 7.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.544 1.538 . . . . 0.0 112.771 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.01 -9.59 65.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.49 1.519 . . . . 0.0 113.856 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.7 t -139.71 143.27 34.39 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.661 1.984 . . . . 0.0 109.683 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.71 133.62 43.08 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.041 1.827 . . . . 0.0 112.039 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -137.05 154.76 50.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.442 1.897 . . . . 0.0 109.475 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 ttm -133.47 134.65 43.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.54 1.536 . . . . 0.0 108.881 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -134.98 147.46 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.475 1.51 . . . . 0.0 110.575 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.61 146.9 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.188 1.395 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.71 144.4 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.218 1.007 . . . . 0.0 111.71 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 40.6 t -79.07 105.12 10.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 166.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -77.04 -7.7 56.14 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -69.0 -51.59 37.66 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.453 1.901 . . . . 0.0 112.03 172.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 17.5 p -112.09 -5.95 14.21 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.179 1.791 . . . . 0.0 114.453 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 62.4 63.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.028 2.531 . . . . 0.0 113.766 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.52 152.93 43.13 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -77.48 80.59 3.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.302 1.841 . . . . 0.0 112.511 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 103' ' ' LEU 0.255 3.4 mm? -91.63 48.13 1.43 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 124.121 1.915 . . . . 0.0 114.559 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.36 163.63 10.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 111.123 -2.762 . . . . 0.0 115.611 150.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.79 163.0 40.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.668 0.787 . . . . 0.0 111.255 -174.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.34 142.21 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.166 1.386 . . . . 0.0 112.049 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.22 153.54 73.19 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.098 1.759 . . . . 0.0 113.872 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.19 135.3 7.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.961 3.108 . . . . 0.0 112.006 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -118.61 4.78 11.65 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -162.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.62 -38.36 1.0 Allowed Glycine 0 CA--C 1.544 1.85 0 CA-C-O 117.458 -1.746 . . . . 0.0 116.347 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -101.24 -172.91 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.153 3.235 . . . . 0.0 113.226 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -51.51 156.99 1.91 Allowed Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 125.751 1.62 . . . . 0.0 112.363 163.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.93 -4.02 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.698 2.932 . . . . 0.0 114.359 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -20.37 65.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.207 1.403 . . . . 0.0 113.58 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.98 -90.38 0.47 Allowed Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.658 1.599 . . . . 0.0 112.765 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 50.28 140.45 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 131.581 3.952 . . . . 0.0 119.009 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -110.81 126.51 54.71 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.981 -1.074 . . . . 0.0 109.913 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -90.05 122.56 33.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.064 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.6 p -105.83 122.8 46.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.594 1.558 . . . . 0.0 110.488 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.09 166.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.884 1.674 . . . . 0.0 109.591 -175.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.42 108.63 2.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.512 1.125 . . . . 0.0 113.341 173.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.3 m -75.1 56.14 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.431 1.492 . . . . 0.0 111.48 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -41.38 -46.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 128.521 2.728 . . . . 0.0 114.641 -162.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.98 38.92 1.2 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.463 1.905 . . . . 0.0 110.491 166.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.8 mt -110.76 165.75 11.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.559 1.544 . . . . 0.0 111.014 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.8 mmpt? -94.82 146.09 24.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -163.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -141.32 149.28 41.0 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.202 -0.936 . . . . 0.0 112.353 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -144.73 148.51 39.84 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 124.947 1.299 . . . . 0.0 111.644 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.2 174.86 8.4 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.824 1.683 . . . . 0.0 110.023 163.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.87 -38.95 18.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.714 0.768 . . . . 0.0 112.003 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 127.651 2.38 . . . . 0.0 115.191 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.433 HG23 ' CB ' ' A' ' 130' ' ' SER . 6.9 t . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.537 0.208 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.0 -160.85 31.83 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.654 1.121 . . . . 0.0 114.91 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -160.19 163.63 33.48 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.863 1.265 . . . . 0.0 113.861 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -95.85 145.5 25.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 128.475 2.71 . . . . 0.0 110.987 167.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -153.67 164.27 38.57 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.825 1.65 . . . . 0.0 112.307 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 69.3 m -67.12 166.13 14.53 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 123.893 1.806 . . . . 0.0 113.788 170.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.67 16.17 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 126.486 1.915 . . . . 0.0 112.69 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 47.7 t -127.38 -49.51 1.41 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.37 1.068 . . . . 0.0 112.493 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 9.1 p -96.68 -96.54 0.19 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.892 1.277 . . . . 0.0 112.919 -174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -155.26 -36.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.398 2.279 . . . . 0.0 113.563 -165.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p -82.23 118.23 71.21 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -160.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.31 153.69 77.06 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 120.997 1.132 . . . . 0.0 110.051 136.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.4 tp -152.14 -47.98 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -120.81 122.47 40.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.19 0.904 . . . . 0.0 110.657 -169.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.3 p -75.88 145.62 40.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 123.229 1.49 . . . . 0.0 111.041 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -75.86 -10.07 59.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.484 169.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.79 -40.06 78.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.439 1.496 . . . . 0.0 114.779 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.26 -0.1 53.62 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.342 1.026 . . . . 0.0 113.608 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -99.61 128.1 45.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -159.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.856 0.836 . . . . 0.0 111.688 168.746 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.535 0.56 0 CA-C-O 124.313 1.714 . . . . 0.0 115.876 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -149.54 155.52 40.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.247 2.219 . . . . 0.0 110.581 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.85 122.11 12.27 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.311 1.844 . . . . 0.0 108.374 -168.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -76.12 -7.61 55.15 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -164.55 154.42 13.95 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 157.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 C-N-CA 126.445 1.898 . . . . 0.0 113.026 175.869 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.8 178.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 122.595 1.188 . . . . 0.0 112.685 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -143.99 173.98 11.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.536 1.935 . . . . 0.0 111.611 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.549 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -146.62 147.71 31.34 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 113.868 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.07 109.71 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.628 1.971 . . . . 0.0 108.747 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.21 150.16 20.57 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.395 1.878 . . . . 0.0 109.069 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.11 120.54 4.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.151 0.887 . . . . 0.0 110.86 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -121.88 32.71 5.74 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.233 1.016 . . . . 0.0 110.423 164.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.5 m -107.36 -13.94 14.99 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 128.156 2.582 . . . . 0.0 113.47 -161.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.45 16.96 5.73 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 127.453 2.301 . . . . 0.0 111.955 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.28 -6.03 52.73 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.1 t -138.57 131.44 16.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.264 2.226 . . . . 0.0 108.999 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.33 144.15 25.75 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.081 2.52 . . . . 0.0 113.776 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -148.27 160.74 42.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 129.406 3.082 . . . . 0.0 112.315 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mtp -143.62 132.27 22.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.108 1.763 . . . . 0.0 109.017 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -138.16 150.09 46.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.125 0.875 . . . . 0.0 112.741 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 141.58 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 110.574 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.65 155.1 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 110.276 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 36.9 t -97.49 112.94 24.58 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 122.631 1.205 . . . . 0.0 108.111 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -67.33 -18.02 65.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.868 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -85.63 -38.56 18.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.553 1.141 . . . . 0.0 112.911 -171.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 2.6 p -112.21 -13.41 13.5 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 127.709 2.403 . . . . 0.0 114.566 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 6.8 tt0 70.83 53.86 0.27 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.673 2.389 . . . . 0.0 116.151 173.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.34 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.707 1.203 . . . . 0.0 113.065 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.8 40.98 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.381 -0.825 . . . . 0.0 111.046 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.29 -27.13 19.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.079 1.419 . . . . 0.0 113.626 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.02 176.03 32.68 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 126.71 2.1 . . . . 0.0 113.634 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -153.3 167.24 30.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.653 1.216 . . . . 0.0 113.518 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.45 134.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 125.467 1.507 . . . . 0.0 109.024 -161.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.7 159.06 72.8 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.938 1.295 . . . . 0.0 111.999 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -67.11 146.15 75.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.354 2.036 . . . . 0.0 110.668 163.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -114.33 16.02 17.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.612 1.165 . . . . 0.0 113.79 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.46 -71.32 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.988 1.756 . . . . 0.0 112.495 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.51 179.53 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.609 2.873 . . . . 0.0 112.694 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -58.03 151.5 44.9 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.734 1.613 . . . . 0.0 112.735 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.57 -3.43 4.34 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.133 3.222 . . . . 0.0 115.264 -172.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -57.41 -29.12 63.86 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.666 -0.646 . . . . 0.0 112.088 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.41 16.19 60.2 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.19 2.328 . . . . 0.0 116.455 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -47.49 139.9 6.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.618 1.167 . . . . 0.0 113.958 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -114.97 136.21 53.38 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.106 1.762 . . . . 0.0 110.073 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.61 114.73 29.08 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.75 1.62 . . . . 0.0 110.82 -167.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 54.6 m -99.5 142.98 30.28 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.428 2.691 . . . . 0.0 111.504 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.7 mm -107.73 154.81 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.96 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.57 122.39 39.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.101 0.961 . . . . 0.0 112.183 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.7 m -77.39 49.5 0.72 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.391 1.076 . . . . 0.0 113.377 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.35 -55.5 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.28 -0.888 . . . . 0.0 112.633 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.08 -0.53 0.44 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.92 162.62 29.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.58 1.552 . . . . 0.0 110.703 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -108.53 160.81 15.61 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.276 1.43 . . . . 0.0 112.841 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -149.56 143.21 25.45 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.172 1.389 . . . . 0.0 110.449 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -135.17 155.72 78.71 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.243 1.417 . . . . 0.0 111.197 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.37 167.94 25.97 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.027 1.818 . . . . 0.0 112.047 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.433 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -95.58 -35.29 11.69 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.258 1.423 . . . . 0.0 112.723 -177.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt . . . . . 0 CA--C 1.549 0.906 0 C-N-CA 126.105 1.762 . . . . 0.0 114.591 -176.026 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.54 -147.65 10.02 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.372 1.309 . . . . 0.0 116.372 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 ptp -134.54 179.89 6.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.251 1.82 . . . . 0.0 114.048 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.02 144.85 48.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 129.968 3.307 . . . . 0.0 108.695 159.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -144.88 151.13 38.24 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 110.931 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 74.1 m -71.38 161.76 30.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.134 1.445 . . . . 0.0 111.556 175.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.25 6.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.711 163.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.3 m -115.48 -57.24 2.26 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.907 1.283 . . . . 0.0 112.405 -165.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 1.7 p -81.19 -81.28 0.14 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.315 1.046 . . . . 0.0 111.928 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.72 -59.77 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.278 1.431 . . . . 0.0 113.218 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 p -96.85 165.92 14.96 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -154.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -59.36 152.39 61.16 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 120.66 0.906 . . . . 0.0 111.344 150.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 -31.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -128.11 132.77 48.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.58 -0.7 . . . . 0.0 110.935 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.6 m -76.66 140.53 40.96 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.023 -1.048 . . . . 0.0 109.705 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -64.85 -10.97 32.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.967 0.907 . . . . 0.0 112.521 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -87.68 -1.97 58.31 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.228 1.411 . . . . 0.0 113.666 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -95.29 130.12 42.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.594 1.158 . . . . 0.0 109.575 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 122.207 0.203 . . . . 0.0 110.576 -175.269 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo . . . . . 0 CA--C 1.548 1.209 0 N-CA-C 114.695 0.998 . . . . 0.0 114.695 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 157.72 43.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.184 2.194 . . . . 0.0 109.904 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -153.1 116.44 4.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.978 1.311 . . . . 0.0 110.058 -169.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.4 p -72.05 -23.91 61.45 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.19 166.66 20.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 113.335 172.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 124.414 1.085 . . . . 0.0 110.334 162.435 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.003 1.402 . . . . 0.0 111.485 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.91 177.24 8.03 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.97 1.708 . . . . 0.0 111.869 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 155.44 38.33 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.329 1.451 . . . . 0.0 112.903 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 118.59 5.53 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.779 2.832 . . . . 0.0 107.29 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -75.02 149.8 39.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 111.4 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -136.7 96.5 3.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.732 0.777 . . . . 0.0 111.29 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.3 t -111.03 21.95 15.84 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.603 1.161 . . . . 0.0 112.217 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -5.94 58.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -162.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -98.35 14.08 29.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.623 1.969 . . . . 0.0 111.712 164.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.48 -4.17 64.99 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.988 1.756 . . . . 0.0 115.279 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.0 t -123.52 109.42 30.77 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.166 1.387 . . . . 0.0 109.767 -175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.74 125.6 9.57 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.044 2.496 . . . . 0.0 113.158 -166.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 165.95 13.02 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.169 2.187 . . . . 0.0 109.881 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.37 122.81 44.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.444 1.498 . . . . 0.0 108.021 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -120.32 137.87 54.02 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.981 0.913 . . . . 0.0 109.802 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.55 145.67 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 121.241 -0.912 . . . . 0.0 111.497 -165.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.44 138.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.041 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 42.2 t -72.72 98.63 2.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 123.41 1.576 . . . . 0.0 107.843 161.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.54 -16.66 57.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.884 1.274 . . . . 0.0 111.924 167.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -71.09 -45.61 63.38 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.851 1.205 . . . . 0.0 113.619 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 3.9 p -123.42 8.81 9.04 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.093 2.157 . . . . 0.0 115.424 -169.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.56 15.7 9.81 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.73 2.012 . . . . 0.0 114.821 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . . . -75.46 83.45 2.54 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.481 -1.387 . . . . 0.0 112.956 -175.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -83.17 58.1 4.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.123 1.769 . . . . 0.0 113.81 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.05 7.97 2.71 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -162.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.43 135.4 12.67 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.056 1.789 . . . . 0.0 110.925 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 157.18 42.83 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.559 -0.965 . . . . 0.0 111.312 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.91 137.85 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.685 1.594 . . . . 0.0 111.505 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.31 149.46 54.96 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.0 1.32 . . . . 0.0 113.112 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.67 146.36 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.573 2.182 . . . . 0.0 110.019 157.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.65 12.5 18.46 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.13 -64.65 0.2 Allowed Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.646 1.117 . . . . 0.0 115.043 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.84 -172.76 1.42 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.935 3.09 . . . . 0.0 113.396 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.95 162.76 0.46 Allowed Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 125.188 1.395 . . . . 0.0 112.507 171.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -60.33 -5.64 4.37 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.138 2.559 . . . . 0.0 114.378 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 18.03 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.635 1.974 . . . . 0.0 113.019 163.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -154.15 19.0 0.64 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.428 1.966 . . . . 0.0 116.535 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.71 161.33 29.74 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.489 1.145 . . . . 0.0 113.966 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -128.44 132.07 48.43 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.042 1.737 . . . . 0.0 109.368 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -99.64 130.85 45.9 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.033 0.933 . . . . 0.0 109.916 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.58 139.97 52.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.326 1.85 . . . . 0.0 109.844 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.8 tt -127.04 170.66 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 109.562 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.78 129.48 50.54 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.74 -1.225 . . . . 0.0 111.643 164.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -83.79 39.42 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.735 1.214 . . . . 0.0 114.251 -167.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -44.57 -36.61 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 -151.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.24 22.51 0.94 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.966 1.706 . . . . 0.0 112.093 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.8 mt -98.5 157.85 15.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 120.666 -1.271 . . . . 0.0 111.678 -155.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 142.65 36.86 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.746 1.26 . . . . 0.0 113.753 -161.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -153.21 144.18 22.91 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 120.321 -1.487 . . . . 0.0 111.215 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -140.08 153.38 69.22 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.921 1.688 . . . . 0.0 111.002 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.27 171.66 17.18 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.885 2.39 . . . . 0.0 112.296 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -38.1 14.22 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.318 1.447 . . . . 0.0 110.622 170.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 128.31 2.644 . . . . 0.0 112.48 -171.045 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.18 -149.93 16.0 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 114.394 0.517 . . . . 0.0 114.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.6 ptp -155.06 168.27 27.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.384 1.074 . . . . 0.0 113.262 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -122.18 139.17 54.07 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 128.809 2.844 . . . . 0.0 109.574 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.69 157.5 43.29 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.561 1.544 . . . . 0.0 110.871 -172.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 2.1 t -79.04 170.17 17.09 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.486 1.612 . . . . 0.0 114.238 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.28 13.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.496 1.918 . . . . 0.0 112.008 161.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.8 t -121.42 -33.22 3.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.09 1.356 . . . . 0.0 112.846 -173.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 3.6 p -102.29 -86.4 0.42 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.715 1.606 . . . . 0.0 111.348 167.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.1 -41.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 p -111.47 161.39 25.58 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -146.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.72 139.86 31.46 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.184 2.589 . . . . 0.0 111.888 159.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.5 mt -136.92 -23.31 1.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -135.83 141.89 44.75 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.524 1.057 . . . . 0.0 111.285 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.4 p -116.36 132.03 56.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.799 1.285 . . . . 0.0 112.123 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -5.04 19.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.997 1.319 . . . . 0.0 113.53 175.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.46 -26.8 68.12 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.793 -1.192 . . . . 0.0 112.419 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -90.67 5.97 45.9 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.824 1.25 . . . . 0.0 114.32 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 2.9 ttpt -59.43 131.91 52.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.046 0.938 . . . . 0.0 110.472 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.418 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 32.6 t80 . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 124.764 1.226 . . . . 0.0 112.397 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 CA--C 1.535 0.559 0 CA-C-O 122.774 1.072 . . . . 0.0 113.048 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.1 p -151.44 165.96 32.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.064 2.146 . . . . 0.0 111.292 -167.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.71 148.88 26.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.781 1.632 . . . . 0.0 109.641 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.6 p -96.56 -27.2 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.267 1.827 . . . . 0.0 113.068 169.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -145.92 155.09 42.63 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.449 1.499 . . . . 0.0 109.524 158.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.389 168.869 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 CA-C-O 119.463 -0.632 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.51 -177.81 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 122.066 0.936 . . . . 0.0 112.104 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.43 -179.3 6.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.63 1.972 . . . . 0.0 109.171 175.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.637 ' H ' HD23 ' A' ' 80' ' ' LEU . 9.6 mmt180 -140.3 154.43 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.957 1.703 . . . . 0.0 109.316 -171.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -152.63 123.8 7.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.756 1.222 . . . . 0.0 110.241 165.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.23 159.03 18.97 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.752 1.621 . . . . 0.0 111.648 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -130.56 111.83 12.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -123.07 19.92 9.94 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 123.114 1.435 . . . . 0.0 111.488 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.88 -18.8 13.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -142.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.66 8.03 45.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 113.025 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.39 -10.03 73.61 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.854 1.693 . . . . 0.0 114.751 -173.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -109.65 126.68 28.61 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 0.0 110.717 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.79 127.37 2.66 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.414 2.743 . . . . 0.0 112.99 175.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -133.66 155.43 49.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.305 3.042 . . . . 0.0 108.717 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 42.5 mtp -140.48 124.02 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.414 1.485 . . . . 0.0 110.736 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -126.42 153.74 44.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.305 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.03 138.45 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.835 1.254 . . . . 0.0 110.759 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.77 148.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 122.103 0.954 . . . . 0.0 111.412 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 53.5 t -82.58 99.08 9.32 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.63 -20.47 66.3 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.687 -0.633 . . . . 0.0 111.566 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -64.25 -35.0 79.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.248 1.019 . . . . 0.0 111.79 -175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 26.4 p -131.8 -7.05 3.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.023 2.129 . . . . 0.0 115.464 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 69.34 59.62 0.32 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.89 2.876 . . . . 0.0 115.614 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.4 38.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 113.416 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.13 141.67 58.02 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 166.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.1 mt -108.48 -32.91 7.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.46 -169.62 35.59 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 127.487 2.47 . . . . 0.0 114.043 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.67 -179.48 7.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -152.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.22 145.92 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.805 1.642 . . . . 0.0 112.012 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.27 153.69 44.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.524 1.53 . . . . 0.0 111.965 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.81 137.0 15.57 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.524 2.816 . . . . 0.0 111.035 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.88 -0.07 41.97 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.52 -55.28 0.26 Allowed Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.05 1.786 . . . . 0.0 114.998 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -93.74 -153.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.279 3.319 . . . . 0.0 112.433 -169.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.45 171.22 0.29 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.327 2.251 . . . . 0.0 113.196 172.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -58.84 -5.98 3.08 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.954 2.436 . . . . 0.0 115.074 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -61.32 -26.42 67.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.71 1.204 . . . . 0.0 113.271 163.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.67 12.69 62.83 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.819 2.152 . . . . 0.0 115.765 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.92 132.61 49.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.335 1.067 . . . . 0.0 112.398 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -126.24 134.95 51.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.364 1.466 . . . . 0.0 108.711 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.89 138.58 41.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.052 0.941 . . . . 0.0 110.982 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 57.9 m -122.57 136.99 55.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.926 2.09 . . . . 0.0 109.466 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.0 tt -137.55 169.05 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.592 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.01 166.31 24.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -170.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -133.87 36.5 3.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.944 1.297 . . . . 0.0 113.356 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.06 -47.63 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.586 -1.321 . . . . 0.0 112.6 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 23.62 4.03 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.84 1.656 . . . . 0.0 112.781 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.9 mt -133.88 155.21 50.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.577 1.951 . . . . 0.0 110.13 -165.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -104.55 156.38 18.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.967 0.889 . . . . 0.0 113.359 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.11 153.31 33.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 111.426 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -139.0 150.87 66.72 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.538 . . . . 0.0 111.456 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.71 171.51 18.07 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.602 2.201 . . . . 0.0 112.559 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.33 -46.27 5.07 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.533 1.133 . . . . 0.0 112.011 -175.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.872 0 C-N-CA 127.631 2.372 . . . . 0.0 115.629 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.69 -153.7 19.33 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.432 ' HA ' ' H ' ' A' ' 50' ' ' SER . 1.8 pmm? -151.52 165.68 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.958 1.303 . . . . 0.0 113.965 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.31 153.23 37.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.66 2.384 . . . . 0.0 111.342 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 161.57 37.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.906 1.682 . . . . 0.0 109.979 173.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.87 154.21 9.74 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 122.737 1.256 . . . . 0.0 110.16 164.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.51 -10.75 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.656 157.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 89.9 m -92.49 -46.71 7.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.23 -101.45 0.16 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.051 1.34 . . . . 0.0 110.248 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -159.47 -47.26 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.609 1.964 . . . . 0.0 112.98 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.04 153.62 38.45 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 125.923 1.689 . . . . 0.0 115.258 -157.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 135.97 15.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.342 2.028 . . . . 0.0 113.594 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.06 -30.44 12.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.432 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -157.09 157.95 35.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 112.162 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -101.65 147.22 26.7 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.274 -0.891 . . . . 0.0 111.412 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -64.67 -17.27 63.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.482 1.113 . . . . 0.0 112.232 172.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -35.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.476 1.91 . . . . 0.0 113.747 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.56 -1.35 30.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.812 2.045 . . . . 0.0 112.53 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.58 116.96 8.89 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.784 0.802 . . . . 0.0 111.344 -171.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.5 t80 . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 124.956 1.302 . . . . 0.0 110.461 172.252 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 CA--C 1.541 0.853 0 CA-C-O 122.727 1.053 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.7 p -141.16 169.33 17.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.13 1.772 . . . . 0.0 111.256 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -149.41 141.32 23.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.85 1.26 . . . . 0.0 108.778 161.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -85.7 -16.83 37.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 0.0 113.799 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -158.38 159.8 36.2 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.068 1.747 . . . . 0.0 111.014 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.297 1.439 . . . . 0.0 109.408 -178.474 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.728 0 N-CA-C 114.784 0.673 . . . . 0.0 114.784 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.68 177.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 127.411 2.284 . . . . 0.0 111.12 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.91 170.35 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.588 1.555 . . . . 0.0 110.141 170.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.46 158.44 34.11 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -148.87 108.52 4.0 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 128.097 2.559 . . . . 0.0 108.699 -166.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.5 144.82 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.101 -0.999 . . . . 0.0 111.02 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -117.26 19.52 14.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.764 1.225 . . . . 0.0 112.486 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t -70.3 35.18 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.453 2.301 . . . . 0.0 114.211 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -110.74 -23.64 10.93 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.324 2.25 . . . . 0.0 113.562 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -97.28 14.95 24.31 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.45 1.9 . . . . 0.0 113.164 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.66 48.68 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.516 1.532 . . . . 0.0 114.836 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 37.7 t -111.06 103.53 54.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.341 1.857 . . . . 0.0 109.648 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.47 125.76 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.759 1.639 . . . . 0.0 111.613 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -151.26 156.96 41.92 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.807 2.443 . . . . 0.0 111.609 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.4 mtm -115.95 98.96 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.024 2.53 . . . . 0.0 107.407 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -83.06 148.6 27.43 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.118 -1.614 . . . . 0.0 108.974 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 m -138.22 145.47 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 122.343 1.068 . . . . 0.0 112.879 -167.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.656 HG12 ' H ' ' A' ' 103' ' ' LEU . 6.1 m -139.86 156.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.067 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.879 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 48.9 t -80.11 155.37 27.53 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-O 124.079 1.895 . . . . 0.0 108.517 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -114.67 -18.22 11.45 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 110.906 -2.861 . . . . 0.0 113.497 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.63 -41.79 95.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.77 0.828 . . . . 0.0 112.185 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.879 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -110.85 -20.66 12.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.859 2.464 . . . . 0.0 113.369 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 64.8 122.51 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.06 1.744 . . . . 0.0 112.27 -162.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 75.47 77.88 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.694 1.998 . . . . 0.0 115.765 164.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.579 ' HB2' ' H ' ' A' ' 96' ' ' CYS 0.332 2.9 t60 -85.57 -21.44 28.52 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.656 ' H ' HG12 ' A' ' 95' ' ' VAL . 3.2 tp 53.16 27.84 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.308 2.643 . . . . 0.0 116.023 163.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.8 -179.55 52.96 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 123.103 1.391 . . . . 0.0 109.817 159.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.06 162.87 40.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.44 1.59 . . . . 0.0 113.393 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.05 139.59 42.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.488 -169.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.41 144.25 52.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.49 142.72 49.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.204 2.603 . . . . 0.0 110.12 162.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -107.98 -3.13 19.08 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.57 -64.28 0.61 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.897 1.713 . . . . 0.0 114.215 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.01 -170.96 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 124.584 3.523 . . . . 0.0 114.438 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -50.02 159.82 0.74 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.761 1.624 . . . . 0.0 111.985 169.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.62 -5.42 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.861 2.374 . . . . 0.0 114.758 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -65.41 -10.88 37.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.753 1.621 . . . . 0.0 114.519 164.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.43 -9.17 48.06 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.831 1.682 . . . . 0.0 116.359 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -56.51 143.14 36.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.973 1.309 . . . . 0.0 113.061 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -129.67 133.94 47.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 110.283 -166.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -104.8 129.02 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.634 1.174 . . . . 0.0 110.047 -174.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.7 p -131.17 129.27 41.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.391 1.077 . . . . 0.0 111.969 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 122' ' ' SER . 7.0 tp -109.34 161.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.31 1.044 . . . . 0.0 110.631 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -93.06 -21.51 19.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.83 1.252 . . . . 0.0 113.292 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.464 ' H ' HG13 ' A' ' 120' ' ' ILE . 50.6 m 58.25 19.67 6.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 p -71.85 -17.69 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.77 43.66 1.26 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.436 1.495 . . . . 0.0 113.167 -163.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.5 mt -117.55 156.01 28.82 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.759 1.266 . . . . 0.0 114.181 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -102.1 152.33 21.11 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.396 2.278 . . . . 0.0 109.76 157.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -146.32 145.59 30.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.81 0.844 . . . . 0.0 111.715 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -140.75 153.54 67.92 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.82 1.648 . . . . 0.0 110.553 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.38 171.9 14.28 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.373 2.049 . . . . 0.0 112.765 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.47 -37.89 22.55 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 128.932 2.893 . . . . 0.0 113.663 -174.663 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.512 -0.5 0 CA-C-O 121.235 0.54 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.21 -145.66 14.18 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.734 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.5 ptp -149.88 159.33 44.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 153.41 19.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.497 152.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -147.52 155.74 42.16 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.89 1.276 . . . . 0.0 109.785 158.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.45 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 71.5 m -61.57 165.86 4.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 124.134 1.921 . . . . 0.0 112.435 168.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.19 29.3 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.263 167.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 35.0 t -135.23 -47.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.107 1.363 . . . . 0.0 113.312 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.45 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 5.2 p -84.48 -84.57 0.14 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.854 1.262 . . . . 0.0 112.065 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -153.5 -48.94 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.5 p -145.02 165.07 23.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -139.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 144.4 46.87 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.409 2.74 . . . . 0.0 113.44 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -144.35 -4.63 0.79 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.38 129.05 21.53 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.525 -1.359 . . . . 0.0 110.299 169.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 p -94.48 142.45 27.42 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.164 -0.96 . . . . 0.0 111.488 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.17 -11.22 28.59 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.084 0.945 . . . . 0.0 113.336 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -38.92 72.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.43 -1.419 . . . . 0.0 114.054 163.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -73.32 -3.56 27.86 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.513 1.525 . . . . 0.0 112.619 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -65.56 130.72 44.3 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.275 1.03 . . . . 0.0 110.26 -173.24 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 61.6 t80 . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 126.961 2.104 . . . . 0.0 112.163 -170.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo . . . . . 0 CA--C 1.537 0.661 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.1 m -159.68 172.29 18.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.72 2.008 . . . . 0.0 110.271 169.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -140.19 121.76 15.21 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.393 1.877 . . . . 0.0 107.16 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -84.97 -10.8 56.67 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -160.93 164.1 31.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.106 0.962 . . . . 0.0 112.926 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 125.682 1.593 . . . . 0.0 109.331 172.222 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.387 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -108.02 149.44 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.502 1.651 . . . . 0.0 110.253 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 mp -125.56 167.56 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.668 1.587 . . . . 0.0 111.499 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.93 150.42 36.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.366 1.466 . . . . 0.0 111.391 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.98 117.79 4.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.918 1.687 . . . . 0.0 108.351 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.29 144.66 35.92 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.599 1.16 . . . . 0.0 111.416 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -124.8 34.45 4.99 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 123.009 1.385 . . . . 0.0 111.083 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -70.2 42.92 0.06 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 129.612 3.165 . . . . 0.0 112.48 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 t -126.08 -12.77 6.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.977 2.111 . . . . 0.0 113.277 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -98.14 16.89 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.953 2.101 . . . . 0.0 113.598 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.14 5.52 89.61 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 124.054 0.835 . . . . 0.0 115.019 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 31.9 t -141.74 135.62 14.76 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.742 2.417 . . . . 0.0 110.284 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.5 125.77 11.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.336 2.691 . . . . 0.0 112.569 173.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -136.17 156.37 48.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.637 2.375 . . . . 0.0 109.89 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.2 mtt -133.77 131.19 39.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.386 2.274 . . . . 0.0 108.527 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -132.43 148.66 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 121.163 -0.961 . . . . 0.0 111.898 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.73 147.93 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.077 1.351 . . . . 0.0 112.513 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.54 152.11 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.198 1.399 . . . . 0.0 111.495 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 1.248 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.6 t -90.07 117.55 28.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 164.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -97.55 -0.87 45.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.043 1.737 . . . . 0.0 113.188 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HB2' ' SG ' ' A' ' 96' ' ' CYS . 30.8 mt-30 -63.21 -45.25 92.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.194 1.398 . . . . 0.0 110.404 162.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.248 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 1.7 p -125.4 -14.09 6.48 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.329 2.252 . . . . 0.0 115.197 -169.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.275 75.5 mt-10 74.61 60.11 0.07 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.887 2.475 . . . . 0.0 115.656 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.44 141.11 28.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.8 115.2 7.86 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.147 -0.97 . . . . 0.0 111.672 172.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 tp -97.68 -36.1 10.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.455 1.121 . . . . 0.0 113.774 -159.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.34 155.85 26.46 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 127.399 2.428 . . . . 0.0 112.876 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.44 146.16 29.46 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.745 0.818 . . . . 0.0 111.595 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.22 135.22 44.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 110.453 -155.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.49 152.07 41.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.21 156.48 25.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.502 3.468 . . . . 0.0 112.182 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -123.81 5.17 8.77 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -164.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.75 -59.82 0.68 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 117.839 -1.534 . . . . 0.0 115.682 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -62.59 -166.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.83 3.02 . . . . 0.0 112.58 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -55.52 159.33 4.87 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 110.602 169.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -57.9 -8.19 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.224 2.616 . . . . 0.0 114.283 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -24.63 15.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.019 1.328 . . . . 0.0 113.487 163.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.85 2.4 76.26 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.655 1.598 . . . . 0.0 116.275 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -51.0 139.56 17.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.59 1.195 . . . . 0.0 112.964 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -109.81 126.94 54.32 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.768 1.227 . . . . 0.0 108.534 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.83 98.04 8.34 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.886 0.875 . . . . 0.0 109.267 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.18 148.29 35.99 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.09 0.956 . . . . 0.0 110.626 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.98 157.17 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.467 1.107 . . . . 0.0 110.062 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 159.28 35.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 112.879 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -123.04 19.41 10.01 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.1 p -44.29 -39.72 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 126.243 1.817 . . . . 0.0 115.868 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.29 30.27 0.62 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.475 1.51 . . . . 0.0 112.804 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.43 173.24 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.591 1.556 . . . . 0.0 109.946 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -115.29 149.61 37.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 122.429 1.109 . . . . 0.0 113.257 173.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -159.21 133.11 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.591 1.156 . . . . 0.0 110.001 -168.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -145.06 152.13 50.46 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 124.796 1.238 . . . . 0.0 112.1 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.67 168.97 23.61 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.135 1.89 . . . . 0.0 112.402 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -41.11 12.83 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.339 1.056 . . . . 0.0 111.776 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 CA--C 1.547 0.827 0 C-N-CA 124.192 0.997 . . . . 0.0 111.652 177.334 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.618 HG23 ' HB2' ' A' ' 130' ' ' SER . 1.3 t . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.48 -140.51 6.37 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.56 1.076 . . . . 0.0 114.638 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -155.33 161.8 40.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.473 1.13 . . . . 0.0 112.564 173.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -133.52 145.7 50.38 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.999 1.32 . . . . 0.0 111.336 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.63 164.04 38.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.583 1.153 . . . . 0.0 111.648 -161.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 69.7 m -59.07 157.58 9.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 123.451 1.596 . . . . 0.0 113.874 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.259 8.7 p -125.73 41.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.557 158.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.3 t -135.64 -48.01 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.706 1.202 . . . . 0.0 112.945 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 9.4 p -96.42 -89.96 0.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.522 1.529 . . . . 0.0 113.844 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.32 -30.75 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.043 2.137 . . . . 0.0 113.114 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.3 p -85.37 125.69 69.06 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -161.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.16 138.8 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.046 1.831 . . . . 0.0 111.403 160.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.17 -27.9 4.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.372 -163.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.68 137.99 18.46 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -84.07 136.46 34.01 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.299 -0.875 . . . . 0.0 109.693 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.8 m -62.38 -12.42 21.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.964 1.706 . . . . 0.0 114.387 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -29.54 69.03 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.611 0.764 . . . . 0.0 111.322 172.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -74.68 -2.99 28.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.186 0.994 . . . . 0.0 113.497 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 16.2 ttpp -53.45 128.25 28.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.774 0.716 . . . . 0.0 109.84 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 CA--C 1.537 0.657 0 CA-C-O 121.697 0.624 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 t -149.58 155.61 40.58 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 111.547 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.66 115.25 4.85 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.559 1.544 . . . . 0.0 109.253 -159.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -72.26 -16.76 61.93 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -146.94 155.54 42.36 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.929 0.892 . . . . 0.0 112.399 166.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 142.326 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.16 166.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 123.176 1.465 . . . . 0.0 111.995 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -133.87 176.36 8.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.88 2.072 . . . . 0.0 108.792 166.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.568 ' H ' HD23 ' A' ' 80' ' ' LEU . 7.0 ptt180 -147.3 146.7 29.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.9 0.88 . . . . 0.0 112.967 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.86 108.63 7.05 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.191 1.796 . . . . 0.0 109.205 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -89.69 149.22 22.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.393 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.52 120.01 6.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.659 1.184 . . . . 0.0 109.205 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -130.08 35.27 4.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.218 1.007 . . . . 0.0 110.605 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -130.92 -6.47 3.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.736 2.015 . . . . 0.0 114.606 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.21 24.39 1.88 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.702 2.001 . . . . 0.0 111.806 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.66 -10.27 46.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.636 2.065 . . . . 0.0 114.155 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.8 t -145.83 130.9 9.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.788 1.235 . . . . 0.0 109.807 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.25 133.01 23.7 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.094 2.53 . . . . 0.0 112.88 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -138.6 157.87 45.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.829 2.852 . . . . 0.0 111.741 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.3 mtt -138.76 128.03 24.24 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.392 2.277 . . . . 0.0 107.915 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.89 153.29 47.63 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.205 1.002 . . . . 0.0 111.325 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.76 141.32 44.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.206 1.402 . . . . 0.0 111.827 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -117.52 152.03 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.186 1.394 . . . . 0.0 109.591 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 1.067 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 40.4 t -93.02 120.91 33.81 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 165.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.56 -14.96 41.4 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 114.411 169.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -65.42 -38.36 89.7 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.691 0.796 . . . . 0.0 112.447 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.067 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 1.7 p -117.55 -12.22 10.38 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 127.604 2.361 . . . . 0.0 114.888 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.362 56.5 mt-10 62.19 64.1 1.0 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.912 2.485 . . . . 0.0 115.213 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.28 136.82 32.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -78.45 109.16 12.37 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.988 165.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.297 2.7 pp -141.27 -1.41 1.35 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 -172.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.0 142.04 13.5 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.746 1.641 . . . . 0.0 111.515 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.17 160.18 43.45 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.753 -0.851 . . . . 0.0 111.308 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.35 139.11 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 125.138 1.375 . . . . 0.0 111.125 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -145.87 154.11 50.89 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.869 1.268 . . . . 0.0 114.007 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -84.38 141.01 8.79 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.574 2.849 . . . . 0.0 111.27 171.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.36 28.86 4.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.352 1.461 . . . . 0.0 113.158 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.42 -50.96 0.82 Allowed Glycine 0 CA--C 1.542 1.748 0 C-N-CA 126.542 2.02 . . . . 0.0 115.241 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -87.72 -165.38 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.175 3.25 . . . . 0.0 112.295 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -56.28 149.13 38.91 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.819 1.648 . . . . 0.0 113.064 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -66.68 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 124.791 3.661 . . . . 0.0 115.261 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -31.51 62.09 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.85 -1.156 . . . . 0.0 112.373 162.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.0 14.12 65.17 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.88 150.57 28.2 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -165.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -105.42 137.73 42.77 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.902 1.681 . . . . 0.0 108.652 170.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -90.48 160.82 15.81 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 123.824 0.85 . . . . 0.0 109.721 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.9 p -150.3 155.76 40.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.057 1.343 . . . . 0.0 110.834 166.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 mm -118.85 165.81 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.36 1.864 . . . . 0.0 109.368 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.85 103.84 6.28 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.305 -1.497 . . . . 0.0 113.622 150.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -74.73 21.23 0.11 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.31 -19.71 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.067 1.747 . . . . 0.0 114.895 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.11 17.53 10.8 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.304 1.842 . . . . 0.0 114.923 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 61.5 mt -120.69 157.52 29.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.324 1.059 . . . . 0.0 113.174 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -104.57 161.9 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.267 2.227 . . . . 0.0 111.288 163.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -142.46 145.5 33.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 111.003 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -148.99 151.67 35.04 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.019 1.328 . . . . 0.0 112.144 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.91 170.31 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.801 2.334 . . . . 0.0 113.288 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.618 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.8 OUTLIER -86.18 -44.25 12.35 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.836 1.303 . . . . 0.0 112.532 -178.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 126.252 1.821 . . . . 0.0 112.016 -178.612 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.216 0.531 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.68 -160.2 23.89 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 114.125 0.41 . . . . 0.0 114.125 174.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.9 ptp -151.29 156.2 40.32 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.139 0.976 . . . . 0.0 113.052 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -104.4 140.72 37.52 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.464 2.706 . . . . 0.0 110.974 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -144.12 158.75 43.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.718 2.007 . . . . 0.0 110.861 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.3 t -72.86 168.39 19.0 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.833 1.778 . . . . 0.0 115.144 -172.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.72 3.97 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.774 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.9 t -117.57 -44.82 2.73 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 111.156 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 4.3 p -90.21 -104.46 0.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.963 1.705 . . . . 0.0 108.239 162.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -156.8 -50.07 0.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.799 1.64 . . . . 0.0 114.147 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 154.96 53.9 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -149.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.49 135.51 36.57 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.613 2.209 . . . . 0.0 111.037 162.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -22.89 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.42 120.41 10.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.997 -0.439 . . . . 0.0 110.8 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -86.04 135.08 33.77 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 123.565 1.65 . . . . 0.0 112.421 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -5.72 6.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.047 2.139 . . . . 0.0 112.885 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -23.69 57.86 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.705 1.202 . . . . 0.0 112.948 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.23 -1.13 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.652 1.181 . . . . 0.0 114.002 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -79.66 123.04 27.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.089 0.956 . . . . 0.0 111.143 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 122.426 1.108 . . . . 0.0 111.285 170.191 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 CA--C 1.538 0.711 0 CA-C-O 124.71 1.879 . . . . 0.0 114.888 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -149.78 163.58 37.62 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.984 2.514 . . . . 0.0 111.443 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -154.98 145.39 22.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.924 2.09 . . . . 0.0 108.838 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -73.62 -34.04 64.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.112 167.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -153.94 165.21 36.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.289 1.435 . . . . 0.0 110.973 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 148.911 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 119.384 -0.676 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.781 1.277 . . . . 0.0 112.417 174.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.12 177.73 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 128.576 2.751 . . . . 0.0 109.134 -173.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 154.9 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.74 105.93 6.35 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 126.488 1.915 . . . . 0.0 109.222 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.78 154.42 19.53 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.933 0.893 . . . . 0.0 111.064 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -143.06 113.89 7.6 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.713 1.205 . . . . 0.0 108.444 166.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -129.33 37.57 4.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.889 1.328 . . . . 0.0 110.269 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.8 t -113.79 -17.93 11.95 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 113.973 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.44 22.14 5.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.355 2.262 . . . . 0.0 111.847 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.68 -12.01 54.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.634 2.064 . . . . 0.0 114.761 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.09 130.23 23.4 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.219 1.408 . . . . 0.0 110.025 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.29 128.36 11.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.402 2.068 . . . . 0.0 112.12 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -133.18 155.95 48.38 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 128.08 2.552 . . . . 0.0 109.904 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.3 mtt -141.27 130.81 23.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.06 1.744 . . . . 0.0 109.423 -172.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -133.42 153.67 51.41 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.29 1.436 . . . . 0.0 110.735 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.94 145.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.239 1.016 . . . . 0.0 111.217 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.38 138.7 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.593 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.5 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 8.7 t -79.02 108.76 12.74 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 174.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -79.89 -7.71 58.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.285 1.034 . . . . 0.0 113.272 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.89 -39.5 94.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.323 1.049 . . . . 0.0 112.073 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.5 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 25.5 p -134.77 -5.83 2.47 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.361 43.3 mt-10 71.33 53.25 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.613 2.365 . . . . 0.0 114.051 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.74 134.04 51.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.833 1.653 . . . . 0.0 113.207 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -78.88 76.59 5.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.355 1.462 . . . . 0.0 112.307 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 3.24 6.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -171.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.9 172.41 19.31 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 122.825 1.236 . . . . 0.0 116.128 160.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -137.48 160.36 39.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 p -125.68 123.68 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.651 1.98 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.58 149.15 61.06 Favored Pre-proline 0 C--O 1.241 0.654 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.192 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.69 152.32 53.09 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.288 2.658 . . . . 0.0 112.347 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -100.63 -0.46 37.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.51 1.924 . . . . 0.0 115.129 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.94 -61.48 0.66 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.437 1.494 . . . . 0.0 115.098 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.47 -157.94 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 124.795 3.663 . . . . 0.0 112.902 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 150.53 31.1 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.758 1.223 . . . . 0.0 112.304 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.21 2.17 2.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.138 3.226 . . . . 0.0 114.464 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -59.48 -24.01 63.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.312 -0.868 . . . . 0.0 113.141 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.59 0.66 85.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.579 1.392 . . . . 0.0 116.579 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -60.39 146.11 45.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.669 1.235 . . . . 0.0 113.422 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.0 149.59 28.33 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.258 1.823 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -82.45 144.74 30.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.672 0.748 . . . . 0.0 111.834 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.3 p -129.49 134.63 47.89 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.57 2.748 . . . . 0.0 108.478 168.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.3 tp -127.85 126.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.358 -0.839 . . . . 0.0 112.265 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -119.68 3.05 11.17 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m -134.17 39.44 3.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.132 1.773 . . . . 0.0 111.766 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.24 -39.73 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -163.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.95 -11.76 0.53 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.588 2.755 . . . . 0.0 117.516 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.4 pp -126.24 176.47 7.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.547 1.939 . . . . 0.0 114.094 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.07 178.97 4.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 114.589 -165.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.59 160.92 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.766 1.226 . . . . 0.0 113.821 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.7 152.74 79.22 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.914 1.686 . . . . 0.0 110.663 160.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.56 167.88 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.595 1.53 . . . . 0.0 111.284 160.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.35 -45.18 9.19 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 112.507 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.546 0.815 0 C-N-CA 127.149 2.18 . . . . 0.0 113.469 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.223 -0.309 0 CA-C-O 121.537 0.684 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.31 -165.71 31.25 Favored Glycine 0 N--CA 1.474 1.22 0 O-C-N 119.914 -1.741 . . . . 0.0 116.013 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -155.57 161.25 40.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.502 1.121 . . . . 0.0 113.78 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.06 143.8 39.57 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 129.278 3.031 . . . . 0.0 111.018 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -136.76 165.19 26.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.968 2.107 . . . . 0.0 109.771 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 57.1 m -59.72 158.57 10.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.76 1.267 . . . . 0.0 111.311 170.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 p -92.09 12.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.653 156.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.0 m -121.18 -43.61 2.42 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -162.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 8.6 p -103.78 -92.89 0.34 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.283 1.401 . . . . 0.0 113.679 -175.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -160.73 -49.13 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.055 2.142 . . . . 0.0 113.7 -172.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p -113.02 156.71 42.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -158.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.82 152.49 16.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.73 2.953 . . . . 0.0 113.333 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.5 -26.39 1.84 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.262 1.025 . . . . 0.0 113.601 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.09 122.01 25.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.629 0.65 . . . . 0.0 112.041 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 p -85.3 130.92 34.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.947 -1.096 . . . . 0.0 109.55 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -9.75 24.08 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 123.135 1.445 . . . . 0.0 112.331 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.8 tt0 -58.18 -33.1 68.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.807 1.243 . . . . 0.0 114.144 166.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 8.1 mmpt? -83.28 0.65 44.74 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.961 1.704 . . . . 0.0 113.092 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 117.44 7.71 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 120.097 1.317 . . . . 0.0 110.154 -169.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -164.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 CA-C-O 122.873 1.114 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 p -158.38 153.2 24.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.403 1.481 . . . . 0.0 111.089 -164.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.84 148.65 45.63 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.769 2.028 . . . . 0.0 109.379 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.6 p -84.1 -25.9 29.38 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.053 1.741 . . . . 0.0 113.516 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -153.95 162.74 40.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.165 1.386 . . . . 0.0 112.146 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 124.752 1.221 . . . . 0.0 110.377 163.829 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 CA-C-O 119.503 -0.61 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.84 167.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.248 1.419 . . . . 0.0 112.204 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.69 173.62 11.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.14 1.776 . . . . 0.0 110.575 169.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 163.53 36.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.58 1.152 . . . . 0.0 113.157 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.73 118.23 6.51 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 127.147 2.179 . . . . 0.0 108.995 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.85 147.41 41.12 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.615 0.766 . . . . 0.0 110.579 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -129.4 51.86 2.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 123.961 1.839 . . . . 0.0 111.215 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.3 p -79.51 47.97 0.87 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.765 2.026 . . . . 0.0 110.72 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.93 -1.22 2.22 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.6 mt -90.07 10.84 22.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.675 1.19 . . . . 0.0 113.043 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.67 -9.31 6.31 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.209 1.385 . . . . 0.0 113.967 -166.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.73 109.75 20.55 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 126.578 1.951 . . . . 0.0 108.129 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.62 126.44 12.1 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.374 2.049 . . . . 0.0 112.849 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -122.95 151.7 41.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.209 1.803 . . . . 0.0 109.183 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 35.3 mtp -112.72 128.23 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.023 2.129 . . . . 0.0 105.77 164.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -124.9 144.94 50.07 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.804 -1.185 . . . . 0.0 111.943 172.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -145.48 138.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.31 1.053 . . . . 0.0 112.304 -156.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 103' ' ' LEU . 2.8 m -149.43 173.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.83 -1.169 . . . . 0.0 111.022 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 34.6 t -94.14 150.32 20.43 Favored 'General case' 0 N--CA 1.404 -2.773 0 C-N-CA 127.398 2.279 . . . . 0.0 106.575 168.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -110.27 -18.09 13.36 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 127.762 2.425 . . . . 0.0 112.795 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.56 -44.94 96.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.569 1.148 . . . . 0.0 112.209 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -96.71 -29.57 13.72 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.411 2.284 . . . . 0.0 111.462 175.521 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 67.37 124.44 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.61 1.195 . . . . 0.0 111.041 -154.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 71.96 85.26 0.12 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.956 2.102 . . . . 0.0 114.515 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.308 2.7 t60 -74.85 -14.6 60.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.514 ' H ' HG12 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 38.89 52.21 1.91 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.515 2.326 . . . . 0.0 113.591 -172.32 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.97 156.45 22.38 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 111.527 -2.579 . . . . 0.0 109.383 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.53 156.37 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.098 0.959 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.2 t -139.82 126.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 123.799 0.84 . . . . 0.0 109.487 -174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -133.59 152.26 78.71 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.015 0.926 . . . . 0.0 111.496 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.46 140.38 15.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.77 2.313 . . . . 0.0 110.33 160.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.57 -5.61 59.26 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.12 -46.35 0.48 Allowed Glycine 0 CA--C 1.542 1.758 0 C-N-CA 126.891 2.186 . . . . 0.0 113.991 -162.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.93 179.04 6.88 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 CA-C-N 120.981 2.391 . . . . 0.0 113.768 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.67 162.69 4.61 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.707 1.603 . . . . 0.0 111.819 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.25 -3.23 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.168 3.245 . . . . 0.0 116.088 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 t -81.09 -21.54 39.88 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.982 1.713 . . . . 0.0 114.319 170.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.66 16.29 59.88 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 127.346 2.403 . . . . 0.0 115.443 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -70.9 159.52 34.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -167.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -118.75 129.27 55.16 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 107.322 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -84.68 130.36 34.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.8 m -115.27 129.27 56.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.644 1.978 . . . . 0.0 108.784 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.32 175.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 120.434 1.47 . . . . 0.0 110.054 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.51 139.97 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.893 -1.129 . . . . 0.0 111.874 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.1 m -76.0 28.89 0.11 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -165.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.94 -30.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.83 41.56 0.77 Allowed 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.8 mt -132.06 153.64 50.22 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.056 -1.028 . . . . 0.0 112.947 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.58 153.72 35.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.316 1.846 . . . . 0.0 111.328 164.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -151.02 130.65 13.07 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.472 -0.767 . . . . 0.0 112.577 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -142.25 159.17 59.39 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 126.156 1.783 . . . . 0.0 111.702 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.46 164.63 33.53 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.613 2.209 . . . . 0.0 114.22 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.3 t -102.6 -66.79 0.91 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.257 2.623 . . . . 0.0 109.383 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 129.492 3.117 . . . . 0.0 112.127 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.58 -141.8 8.23 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.469 1.509 . . . . 0.0 111.584 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.6 ptp -144.54 162.46 36.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.402 1.081 . . . . 0.0 112.198 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.88 134.18 52.35 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 109.921 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -135.9 163.21 30.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 0.0 110.441 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.854 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 2.0 t -69.59 172.71 6.96 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 124.213 1.959 . . . . 0.0 114.802 -169.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.9 1.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 112.715 -2.038 . . . . 0.0 112.512 165.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.7 m -115.04 -26.89 7.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.177 1.391 . . . . 0.0 112.364 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.854 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 11.9 p -115.83 -98.11 0.45 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.608 1.963 . . . . 0.0 111.337 173.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.25 -50.18 0.07 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 p -95.62 160.01 31.31 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 116.563 2.061 . . . . 0.0 116.563 -150.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.35 132.83 40.24 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.841 2.361 . . . . 0.0 112.276 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -33.65 5.74 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.902 1.281 . . . . 0.0 111.66 -166.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.34 158.64 30.06 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.373 -0.83 . . . . 0.0 112.712 168.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 p -94.96 132.87 39.33 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 122.677 1.227 . . . . 0.0 110.953 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -4.83 24.12 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.11 0.964 . . . . 0.0 113.405 172.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.91 -29.36 64.24 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.578 1.951 . . . . 0.0 113.576 170.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.01 1.74 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.952 1.301 . . . . 0.0 113.621 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -69.89 121.43 17.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.315 1.846 . . . . 0.0 114.304 -167.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.417 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 CA--C 1.535 0.555 0 CA-C-O 123.961 1.567 . . . . 0.0 113.979 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.7 p -158.55 142.29 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.798 2.439 . . . . 0.0 109.533 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -155.3 132.32 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.794 2.038 . . . . 0.0 107.733 -170.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 p -68.96 -24.32 64.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -139.82 142.55 36.64 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.479 0.657 . . . . 0.0 112.13 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.829 0 C-N-CA 125.186 1.395 . . . . 0.0 111.555 173.893 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.554 0 CA-C-O 121.131 0.295 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.87 178.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.712 2.005 . . . . 0.0 111.874 -172.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.42 -177.59 4.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.186 2.194 . . . . 0.0 108.915 166.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -139.39 155.0 47.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.273 1.829 . . . . 0.0 110.742 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 118.57 10.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.85 2.06 . . . . 0.0 107.149 168.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.97 138.53 33.76 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.269 -0.895 . . . . 0.0 111.338 172.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.3 23.01 14.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.739 1.216 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.2 t -71.1 38.65 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.81 2.444 . . . . 0.0 113.362 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.27 10.89 6.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.475 2.71 . . . . 0.0 112.387 -174.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.96 14.42 14.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.238 1.815 . . . . 0.0 112.462 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.28 -12.22 7.55 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 126.019 1.771 . . . . 0.0 113.561 -171.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.9 t -102.22 107.05 51.56 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 108.616 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.19 126.96 12.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.554 1.503 . . . . 0.0 110.623 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -147.89 156.03 42.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.478 2.711 . . . . 0.0 109.629 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.2 mtt -125.99 125.93 43.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.63 2.372 . . . . 0.0 106.994 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -116.39 154.46 30.23 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 110.926 173.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.16 137.24 55.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 125.408 1.483 . . . . 0.0 110.514 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.73 143.4 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.436 0.636 . . . . 0.0 111.516 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 39.7 t -70.05 108.02 3.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 160.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -63.72 -22.12 66.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.055 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -83.01 -39.5 21.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 112.574 -167.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 18.3 p -115.36 6.04 14.76 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.963 1.705 . . . . 0.0 114.249 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.36 60.34 3.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.497 . . . . 0.0 114.616 174.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -150.01 148.77 29.45 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -69.6 136.35 51.14 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.871 0.868 . . . . 0.0 111.263 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.31 -20.99 1.39 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.0 151.56 23.77 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 127.078 2.275 . . . . 0.0 112.52 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.66 166.71 22.91 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 126.141 1.776 . . . . 0.0 111.557 172.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.9 t -143.54 136.17 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.396 1.879 . . . . 0.0 108.212 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -148.57 153.97 40.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.42 1.088 . . . . 0.0 113.069 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.91 135.43 7.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.996 2.464 . . . . 0.0 109.91 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.37 -1.5 45.72 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.22 -40.8 0.51 Allowed Glycine 0 CA--C 1.542 1.749 0 CA-C-O 117.376 -1.791 . . . . 0.0 116.559 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.68 -167.59 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.451 2.767 . . . . 0.0 113.446 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -55.45 160.71 3.48 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.752 1.621 . . . . 0.0 112.345 171.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -59.93 -9.43 9.83 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.659 2.906 . . . . 0.0 114.136 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -22.64 62.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.507 1.523 . . . . 0.0 113.087 170.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.65 19.05 54.06 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 126.405 1.955 . . . . 0.0 115.893 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -73.34 146.72 45.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -110.13 144.53 38.62 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.197 1.399 . . . . 0.0 109.308 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -91.39 137.66 32.19 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.009 1.724 . . . . 0.0 110.068 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.7 p -132.01 132.28 43.29 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.04 1.736 . . . . 0.0 112.769 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 122' ' ' SER . 10.2 mm -80.92 154.99 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.115 1.366 . . . . 0.0 110.611 174.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -91.22 -13.12 33.39 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 120' ' ' ILE . 68.7 m 57.14 82.68 0.11 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.067 2.147 . . . . 0.0 114.417 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 124' ' ' ALA 0.299 3.4 p -93.57 -96.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 111.529 167.183 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.43 ' H ' HG13 ' A' ' 123' ' ' VAL . . . -157.07 20.92 0.31 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -166.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.99 173.98 6.79 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.687 1.585 . . . . 0.0 113.166 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.26 163.17 12.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.202 1.801 . . . . 0.0 112.735 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -150.79 148.16 28.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.169 1.387 . . . . 0.0 111.861 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -140.4 149.87 59.04 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.069 1.348 . . . . 0.0 111.525 170.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.83 171.32 10.73 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.081 2.521 . . . . 0.0 114.533 -165.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.02 -40.5 11.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.065 1.346 . . . . 0.0 113.903 -173.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 127.598 2.359 . . . . 0.0 113.76 -169.822 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 130' ' ' SER . 1.2 t . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.128 0.489 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.71 -153.12 14.22 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.124 0.868 . . . . 0.0 114.47 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.7 ptp -154.12 161.05 42.15 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.329 1.061 . . . . 0.0 112.895 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -120.0 148.37 43.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.787 2.435 . . . . 0.0 110.553 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.35 159.87 42.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.812 2.045 . . . . 0.0 109.503 -167.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 83.7 m -74.11 165.7 24.7 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.158 1.456 . . . . 0.0 111.802 158.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.62 -9.98 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.853 -1.522 . . . . 0.0 113.948 154.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 t -83.24 -46.34 12.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 112.441 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 15.1 p -85.15 -87.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.895 1.278 . . . . 0.0 111.337 170.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -148.9 -57.02 0.21 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.0 p -130.14 156.0 79.93 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -135.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.69 139.45 40.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.502 2.801 . . . . 0.0 112.732 164.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 mt -143.94 -18.78 0.58 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -135.2 134.71 40.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.317 1.417 . . . . 0.0 111.313 -167.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -101.51 122.06 43.11 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.959 1.303 . . . . 0.0 111.007 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -60.15 -15.45 24.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.475 1.51 . . . . 0.0 113.578 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.415 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.51 -31.27 67.73 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 130.252 3.421 . . . . 0.0 113.269 178.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.25 4.09 6.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.828 1.251 . . . . 0.0 111.793 177.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -62.61 134.72 56.75 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 120.661 -1.275 . . . . 0.0 114.018 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 CA--C 1.543 0.681 0 C-N-CA 127.179 2.192 . . . . 0.0 111.519 -176.617 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.54 0.82 0 N-CA-C 115.206 1.195 . . . . 0.0 115.206 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -129.91 178.51 6.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.78 142.35 17.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.821 3.649 . . . . 0.0 106.801 159.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 p -73.75 -35.1 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 111.402 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -146.33 157.32 43.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.718 1.247 . . . . 0.0 114.195 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 125.939 1.696 . . . . 0.0 110.113 166.576 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 pt -117.54 155.98 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.868 1.834 . . . . 0.0 114.564 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -136.08 176.62 8.52 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.595 2.758 . . . . 0.0 110.733 177.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.629 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -138.43 141.91 39.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.036 1.334 . . . . 0.0 113.375 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.42 112.7 10.53 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 108.314 173.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.6 mp -80.6 157.28 26.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 125.886 1.674 . . . . 0.0 111.076 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -131.18 108.89 10.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 t -118.44 24.5 10.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.032 1.396 . . . . 0.0 109.836 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.62 -6.71 9.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.393 1.877 . . . . 0.0 113.682 -154.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.5 mt -105.26 18.66 21.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.071 2.148 . . . . 0.0 112.689 170.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -7.01 64.45 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.061 1.315 . . . . 0.0 115.392 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 52.4 t -127.79 112.99 20.59 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.892 1.677 . . . . 0.0 109.648 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.68 125.88 7.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.778 2.319 . . . . 0.0 114.039 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -129.42 154.2 47.18 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.129 2.572 . . . . 0.0 110.222 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mtm -127.49 127.13 43.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.364 1.866 . . . . 0.0 108.224 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -123.25 144.59 49.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.813 0.816 . . . . 0.0 109.776 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.55 144.5 21.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.471 1.108 . . . . 0.0 109.608 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.4 m -128.28 151.82 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 0.0 111.301 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.744 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 43.2 t -93.02 119.04 31.86 Favored 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 126.71 2.004 . . . . 0.0 105.886 174.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -69.5 -16.77 63.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.606 1.962 . . . . 0.0 111.974 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -83.95 -45.84 12.72 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.744 ' HG ' ' HG ' ' A' ' 96' ' ' CYS . 2.2 p -106.78 -7.59 17.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.601 1.961 . . . . 0.0 113.835 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 63.15 40.76 8.64 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.24 1.816 . . . . 0.0 113.066 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.92 154.46 51.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.451 1.5 . . . . 0.0 111.907 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -80.98 90.06 5.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.145 0.978 . . . . 0.0 113.149 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -74.3 8.59 2.1 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -175.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.68 179.63 30.06 Favored Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.002 -1.061 . . . . 0.0 114.065 165.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 156.49 44.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 111.684 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.03 137.47 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.316 1.055 . . . . 0.0 111.751 -173.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.83 151.2 45.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 113.063 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.53 133.44 10.55 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.043 2.495 . . . . 0.0 109.305 162.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -93.87 1.57 56.35 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.43 -62.19 0.28 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.387 -1.229 . . . . 0.0 114.396 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.37 -177.12 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.549 2.832 . . . . 0.0 112.967 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.77 149.83 4.23 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.254 1.022 . . . . 0.0 111.506 170.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.51 -3.77 9.64 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.975 2.45 . . . . 0.0 114.149 -171.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.9 p -54.92 -30.94 59.62 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.639 -0.663 . . . . 0.0 111.943 162.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.9 10.13 74.91 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.882 2.182 . . . . 0.0 117.091 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -50.96 148.81 3.93 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.209 1.504 . . . . 0.0 113.957 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.7 132.02 43.57 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.695 1.198 . . . . 0.0 110.828 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.7 125.35 45.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.105 1.362 . . . . 0.0 110.275 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.5 p -108.13 126.06 52.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.897 2.079 . . . . 0.0 109.618 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -92.41 156.8 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.844 0.831 . . . . 0.0 109.845 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -126.92 163.0 24.62 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.461 1.905 . . . . 0.0 109.957 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 m -96.42 18.43 13.97 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 p -47.39 -48.93 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -159.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.61 24.07 0.34 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.2 mt -125.07 154.92 40.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.426 1.09 . . . . 0.0 112.16 -161.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -128.01 157.14 41.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.779 2.032 . . . . 0.0 113.917 -171.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.4 143.16 33.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -167.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -137.94 152.98 73.23 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.597 1.559 . . . . 0.0 110.875 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.02 179.59 5.59 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.538 2.159 . . . . 0.0 112.022 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.497 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 5.8 t -102.59 -57.7 2.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.967 1.707 . . . . 0.0 111.469 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.497 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 9.3 mmpt? . . . . . 0 CA--C 1.554 1.102 0 C-N-CA 126.419 1.888 . . . . 0.0 112.976 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.62 -158.52 20.82 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 172.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ptp -155.2 167.55 29.99 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.436 1.494 . . . . 0.0 112.647 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.98 151.17 40.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 112.253 157.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -138.16 164.59 28.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.039 2.136 . . . . 0.0 109.834 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 59.4 m -62.16 169.72 2.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 124.085 1.898 . . . . 0.0 114.712 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 p -115.6 -2.37 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.952 -2.385 . . . . 0.0 112.301 169.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.2 m -124.57 -18.35 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -169.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 12.7 p -125.9 -101.29 0.37 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.137 1.375 . . . . 0.0 112.008 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -159.71 -35.77 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.404 2.282 . . . . 0.0 113.538 -170.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.44 124.32 87.96 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -157.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.43 127.02 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.066 1.844 . . . . 0.0 110.363 156.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.72 -45.07 1.63 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.931 -158.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -126.31 121.12 31.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.825 -171.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 p -82.28 131.13 35.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.185 0.993 . . . . 0.0 108.903 166.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -58.45 -13.95 6.66 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.236 1.815 . . . . 0.0 112.321 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.11 -43.6 87.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 127.098 2.159 . . . . 0.0 114.548 168.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.8 mmpt? -72.83 -2.09 19.27 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.215 1.406 . . . . 0.0 113.222 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -78.36 137.5 38.06 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.628 1.971 . . . . 0.0 110.522 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 CA--C 1.541 0.625 0 CA-C-O 123.0 1.381 . . . . 0.0 111.571 179.633 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.533 0.442 0 CA-C-O 124.618 1.841 . . . . 0.0 113.887 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.1 p -152.0 161.82 42.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 128.599 2.76 . . . . 0.0 110.427 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -157.15 168.29 27.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.365 2.266 . . . . 0.0 106.559 -169.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -127.55 -7.07 5.73 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 164.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -135.12 147.9 49.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 122.139 0.971 . . . . 0.0 111.858 160.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.461 0 C-N-CA 126.689 1.995 . . . . 0.0 105.811 165.358 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.616 0 CA-C-O 119.844 -0.42 . . . . 0.0 113.914 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -74.12 178.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 122.766 1.27 . . . . 0.0 113.091 -171.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.55 171.87 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.707 1.603 . . . . 0.0 110.152 174.136 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.629 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -160.79 157.78 27.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.766 1.627 . . . . 0.0 111.512 177.282 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -149.94 123.7 9.24 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.005 2.122 . . . . 0.0 107.916 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.03 147.35 42.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.745 161.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.04 23.27 11.47 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.201 1.001 . . . . 0.0 113.311 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.4 m -71.25 41.77 0.07 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.281 3.032 . . . . 0.0 112.876 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.88 -1.25 2.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 127.091 2.156 . . . . 0.0 113.438 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.9 mt -102.46 20.29 17.3 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.713 2.005 . . . . 0.0 112.224 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -9.11 60.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.049 1.309 . . . . 0.0 114.75 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.2 t -136.37 134.41 19.88 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 110.608 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 140.89 37.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.149 2.566 . . . . 0.0 113.366 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.2 mmt-85 -146.34 156.04 43.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.631 1.972 . . . . 0.0 111.308 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.25 119.81 20.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.608 1.563 . . . . 0.0 108.928 171.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -137.71 148.34 45.58 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.631 -0.668 . . . . 0.0 112.207 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.18 142.8 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.316 1.446 . . . . 0.0 112.296 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.91 157.43 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.807 1.243 . . . . 0.0 110.353 -172.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 1.043 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 49.1 t -92.98 128.43 38.85 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 123.008 1.385 . . . . 0.0 107.517 163.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -20.09 21.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.575 1.95 . . . . 0.0 112.166 170.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.82 -39.31 93.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.152 0.887 . . . . 0.0 112.616 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 1.043 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 1.6 p -119.05 -2.59 10.75 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.702 2.001 . . . . 0.0 114.856 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 52.43 63.67 2.15 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.461 1.505 . . . . 0.0 112.141 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -129.91 131.49 46.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.337 1.055 . . . . 0.0 112.04 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -90.87 103.29 16.02 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.194 -0.941 . . . . 0.0 109.578 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.0 mt -103.36 -40.49 6.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -160.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.51 148.63 20.02 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.873 1.702 . . . . 0.0 113.763 -161.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 159.35 42.95 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.468 1.107 . . . . 0.0 111.831 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.04 139.82 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 122.634 1.207 . . . . 0.0 111.37 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -147.95 154.98 44.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.572 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.39 135.79 13.61 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.681 2.921 . . . . 0.0 111.361 171.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -74.7 -4.61 38.44 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.95 -62.65 0.24 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.985 1.755 . . . . 0.0 114.213 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.12 -156.27 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.007 3.138 . . . . 0.0 112.707 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.96 160.51 0.81 Allowed Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 125.085 1.354 . . . . 0.0 112.217 170.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -58.34 -6.08 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.651 2.901 . . . . 0.0 114.949 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -30.17 67.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.011 0.924 . . . . 0.0 112.446 164.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.3 30.85 6.42 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 126.664 2.078 . . . . 0.0 114.995 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -72.37 143.23 48.66 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.313 1.045 . . . . 0.0 112.923 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -131.06 127.0 37.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.366 1.066 . . . . 0.0 109.629 169.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.25 127.77 38.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.035 0.534 . . . . 0.0 109.978 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 m -126.06 134.22 51.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.953 1.701 . . . . 0.0 110.081 -171.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.9 tt -131.61 164.2 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.142 . . . . 0.0 110.624 -171.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.02 -55.41 1.28 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 m 45.85 34.66 1.97 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.77 -24.67 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -157.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -139.63 17.17 2.53 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.773 1.629 . . . . 0.0 114.415 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.93 179.55 7.52 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.918 -1.114 . . . . 0.0 111.192 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -101.67 134.39 44.88 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.244 -0.91 . . . . 0.0 111.405 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -139.27 137.72 36.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.454 -171.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -144.26 143.49 22.43 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.718 1.207 . . . . 0.0 110.831 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.12 168.53 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.472 1.448 . . . . 0.0 110.955 164.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.28 -44.68 5.34 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.666 1.186 . . . . 0.0 112.705 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 124.524 1.13 . . . . 0.0 112.488 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.43 23.11 8.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.586 1.954 . . . . 0.0 115.048 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -135.22 174.92 10.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.292 1.437 . . . . 0.0 114.327 -162.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -121.86 -25.81 4.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.821 1.248 . . . . 0.0 113.6 153.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -58.58 -64.28 0.98 Allowed 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 128.481 2.712 . . . . 0.0 111.965 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -64.21 -24.64 67.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.962 1.705 . . . . 0.0 113.302 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -74.47 -35.42 63.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.634 1.574 . . . . 0.0 112.849 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.2 mt -87.1 -27.07 23.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.719 1.208 . . . . 0.0 113.41 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -138.73 68.84 44.36 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 125.245 1.418 . . . . 0.0 111.67 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.27 157.57 49.25 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.295 2.663 . . . . 0.0 112.952 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -120.1 -78.61 0.59 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.247 1.019 . . . . 0.0 111.342 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -60.73 -28.08 68.41 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -85.95 -16.78 37.31 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.62 1.568 . . . . 0.0 113.832 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -89.24 -52.13 5.22 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.703 -0.623 . . . . 0.0 112.496 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.9 -33.91 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 O-C-N 121.723 -0.611 . . . . 0.0 111.409 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 p -66.22 -18.82 65.59 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.717 2.007 . . . . 0.0 115.38 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -87.62 -37.48 16.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.123 1.369 . . . . 0.0 112.37 164.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.21 -14.47 62.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.513 0.725 . . . . 0.0 112.454 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -66.04 54.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.442 1.897 . . . . 0.0 113.39 166.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.0 -4.66 0.04 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 169.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 t -140.04 159.99 40.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 123.635 1.683 . . . . 0.0 113.523 -169.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.15 163.36 12.32 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 127.465 2.306 . . . . 0.0 109.569 156.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.04 144.14 33.95 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.65 178.68 6.81 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.243 3.295 . . . . 0.0 111.225 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.5 t80 56.07 25.38 8.86 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 123.865 1.793 . . . . 0.0 113.402 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.29 -23.57 0.94 Allowed 'General case' 0 N--CA 1.469 0.488 1 C-N-CA 131.806 4.042 . . . . 0.0 114.332 -178.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.1 -101.91 0.31 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.75 1.643 . . . . 0.0 113.508 164.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.4 mtp -58.36 -18.5 28.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -2.41 58.1 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.694 1.198 . . . . 0.0 113.566 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.51 -13.25 49.61 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 119.715 -1.865 . . . . 0.0 115.069 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -91.55 -163.46 1.04 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.643 1.577 . . . . 0.0 112.84 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -68.28 160.97 28.3 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.22 -0.925 . . . . 0.0 111.434 170.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -135.44 112.52 10.36 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.253 1.421 . . . . 0.0 110.083 168.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.06 177.23 0.13 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.7 m -85.54 164.78 17.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.02 168.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.34 -150.51 21.0 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.457 -0.777 . . . . 0.0 112.068 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.13 169.81 20.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.072 1.349 . . . . 0.0 112.645 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.56 144.71 50.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.247 2.619 . . . . 0.0 110.764 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -147.08 160.55 42.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 111.327 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.9 m -64.6 154.21 36.98 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 123.056 1.408 . . . . 0.0 112.077 171.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.269 9.0 p -113.8 27.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.808 153.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.21 -41.4 3.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.534 1.534 . . . . 0.0 112.104 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.5 p -109.99 -103.53 0.38 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.674 1.59 . . . . 0.0 112.444 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.55 -40.51 0.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.878 2.471 . . . . 0.0 113.37 -163.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -98.02 137.15 20.85 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -152.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.85 139.65 15.69 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.094 2.529 . . . . 0.0 111.531 161.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.19 -29.71 0.88 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -165.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -132.04 126.97 35.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.559 1.072 . . . . 0.0 111.548 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.1 m -86.82 133.23 33.66 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 120.659 -1.276 . . . . 0.0 110.798 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -11.93 23.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.124 1.37 . . . . 0.0 112.931 171.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -35.81 71.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.22 7.49 24.97 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.227 1.011 . . . . 0.0 112.465 176.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -61.37 131.97 52.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.068 0.849 . . . . 0.0 109.658 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -66.62 68.87 0.06 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 122.716 1.245 . . . . 0.0 112.582 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 7.2 t -73.18 172.65 10.7 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.35 1.46 . . . . 0.0 110.787 168.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.316 11.7 p 50.78 10.78 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.92 -69.98 0.49 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 127.011 2.243 . . . . 0.0 110.241 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.84 -17.69 3.53 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.584 0.754 . . . . 0.0 112.784 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.09 -0.74 13.75 Favored Glycine 0 CA--C 1.538 1.525 0 O-C-N 120.498 -1.376 . . . . 0.0 114.448 -173.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.44 ' CG ' ' HD2' ' A' ' 61' ' ' PRO . 74.6 t90 -65.71 162.14 46.62 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 128.754 2.822 . . . . 0.0 112.102 -172.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 60' ' ' TRP . 71.4 Cg_endo -75.15 81.42 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.578 2.185 . . . . 0.0 116.392 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -135.28 154.31 51.59 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 128.516 2.726 . . . . 0.0 110.806 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -138.45 107.04 5.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.885 1.674 . . . . 0.0 111.014 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.7 p -63.99 -15.07 58.48 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.25 160.62 40.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.373 0.669 . . . . 0.0 109.387 138.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.82 72.73 1.09 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.314 1.046 . . . . 0.0 109.259 166.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -94.67 128.6 41.45 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -154.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.23 -24.85 0.15 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.229 1.871 . . . . 0.0 113.698 173.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.7 p -142.42 154.27 44.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.405 1.482 . . . . 0.0 112.979 -168.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 132.46 18.83 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.627 1.571 . . . . 0.0 112.909 -170.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.58 -81.39 0.06 OUTLIER Glycine 0 N--CA 1.47 0.933 0 C-N-CA 126.957 2.218 . . . . 0.0 114.067 155.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -54.54 -30.93 55.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.763 1.225 . . . . 0.0 111.917 168.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -87.46 -2.01 58.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -74.8 -14.16 60.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.644 1.178 . . . . 0.0 113.344 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.5 t -95.31 -36.21 11.49 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.824 1.249 . . . . 0.0 111.271 163.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -68.57 -38.03 80.36 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.052 -1.03 . . . . 0.0 113.485 -173.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -32.98 65.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.928 2.091 . . . . 0.0 113.639 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.17 16.69 75.29 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.238 -0.757 . . . . 0.0 112.33 -172.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -96.27 148.86 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.048 0.924 . . . . 0.0 111.232 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.43 174.12 8.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.821 2.848 . . . . 0.0 110.197 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.08 156.84 33.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.003 1.321 . . . . 0.0 112.144 -167.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.95 121.89 3.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.405 1.882 . . . . 0.0 110.083 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -97.24 154.07 17.63 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.338 1.855 . . . . 0.0 112.237 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -147.99 111.15 4.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.729 1.212 . . . . 0.0 110.21 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.7 t -118.95 19.85 12.91 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.811 1.767 . . . . 0.0 112.834 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 -15.15 28.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.252 1.421 . . . . 0.0 114.009 -154.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.0 mt -84.94 10.61 11.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.806 1.642 . . . . 0.0 112.914 166.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.16 -5.01 81.41 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.63 1.586 . . . . 0.0 114.653 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 10.0 t -137.19 129.65 16.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.258 1.023 . . . . 0.0 111.401 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.57 135.11 12.82 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.126 2.551 . . . . 0.0 114.373 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.6 mmt-85 -127.77 157.3 40.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 129.967 3.307 . . . . 0.0 109.315 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.4 mtm -133.44 132.84 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.355 1.862 . . . . 0.0 108.308 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -139.26 149.36 44.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 112.151 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.11 150.69 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.283 1.433 . . . . 0.0 111.916 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.42 155.02 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 109.927 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.6 t -92.6 128.41 38.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 158.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -84.02 -24.24 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.253 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -64.74 -43.95 91.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.854 0.862 . . . . 0.0 112.447 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.98 -15.07 18.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.66 2.384 . . . . 0.0 113.238 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.303 42.5 mt-10 64.31 24.82 13.38 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.935 2.094 . . . . 0.0 112.799 -168.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.82 98.32 8.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.796 2.039 . . . . 0.0 112.848 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -89.12 68.87 8.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.949 1.7 . . . . 0.0 112.345 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.59 -5.09 8.7 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -159.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.56 135.97 12.44 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.707 2.099 . . . . 0.0 112.171 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.49 152.8 33.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.09 0.956 . . . . 0.0 111.39 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.12 125.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 122.322 1.058 . . . . 0.0 112.834 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -129.76 145.06 55.48 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.802 1.241 . . . . 0.0 111.76 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.57 167.21 27.07 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.48 2.787 . . . . 0.0 112.419 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -109.14 -8.49 15.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.453 1.901 . . . . 0.0 115.336 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.1 -56.31 0.71 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.661 1.6 . . . . 0.0 114.512 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.75 -157.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 124.65 3.567 . . . . 0.0 113.271 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 154.98 13.56 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.661 1.584 . . . . 0.0 111.406 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -61.56 -7.48 8.99 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.443 2.762 . . . . 0.0 114.283 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 p -57.74 -26.78 62.3 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.876 1.27 . . . . 0.0 113.762 165.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.34 4.46 86.04 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.193 1.377 . . . . 0.0 116.054 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.94 149.88 8.48 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.98 127.39 50.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 110.99 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.37 103.14 12.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.253 1.421 . . . . 0.0 109.484 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.1 p -92.9 136.85 32.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.436 2.294 . . . . 0.0 110.55 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.05 133.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.158 -0.964 . . . . 0.0 109.239 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -110.48 133.04 53.65 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.0 m -82.71 16.37 2.23 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -164.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.66 -23.72 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.95 22.38 3.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.851 1.66 . . . . 0.0 113.576 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.4 mt -122.02 140.58 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.155 0.982 . . . . 0.0 112.993 -170.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -115.54 178.05 4.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.404 2.682 . . . . 0.0 112.15 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -150.63 148.31 28.47 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.467 1.107 . . . . 0.0 112.29 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -131.16 134.11 25.45 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.37 1.468 . . . . 0.0 109.41 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.86 171.57 15.28 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.185 2.59 . . . . 0.0 113.107 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -42.5 18.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.921 0.888 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -92.4 148.1 35.76 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.94 174.85 6.18 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.164 3.243 . . . . 0.0 114.889 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 64.49 3.17 1.8 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.417 2.287 . . . . 0.0 115.071 -165.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.26 -36.61 0.48 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.749 2.02 . . . . 0.0 110.785 161.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.25 132.32 42.02 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.279 -0.888 . . . . 0.0 110.49 155.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.1 tp -160.74 48.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.444 1.898 . . . . 0.0 109.523 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -47.79 40.25 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -160.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -92.3 163.38 13.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.869 0.868 . . . . 0.0 111.809 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -62.86 152.64 35.63 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.651 -0.656 . . . . 0.0 112.26 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -124.2 21.68 8.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.769 0.827 . . . . 0.0 112.979 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -103.95 172.69 6.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.983 1.313 . . . . 0.0 112.656 -160.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.66 -171.76 3.4 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.768 0.827 . . . . 0.0 111.947 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 . . . . . 0 C--O 1.249 1.028 0 C-N-CA 125.93 1.692 . . . . 0.0 115.407 -176.081 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.38 32.89 14.64 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.038 1.335 . . . . 0.0 114.111 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.79 -175.45 3.17 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.776 2.43 . . . . 0.0 111.26 172.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -113.09 -25.52 8.89 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.079 0.952 . . . . 0.0 112.672 159.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -59.31 -54.49 46.24 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.984 1.714 . . . . 0.0 112.966 -169.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -75.07 -24.91 58.26 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -63.85 -37.37 87.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.891 0.877 . . . . 0.0 112.156 165.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.7 mt -88.23 -20.85 24.96 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.838 1.655 . . . . 0.0 114.161 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 11.9 t -137.37 76.94 42.32 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 124.528 1.131 . . . . 0.0 112.371 168.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.26 178.07 8.09 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.029 3.153 . . . . 0.0 114.427 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -50.19 -46.45 54.4 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.57 -1.331 . . . . 0.0 112.956 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -58.08 -29.04 65.13 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -84.79 -26.24 27.64 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.548 1.539 . . . . 0.0 113.468 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.73 -45.84 23.55 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.996 1.319 . . . . 0.0 111.144 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.44 -19.71 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.205 1.402 . . . . 0.0 112.748 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.0 p -91.65 -31.28 15.91 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.163 2.185 . . . . 0.0 113.285 170.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -64.67 -49.06 72.43 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.338 1.455 . . . . 0.0 111.829 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.02 -4.39 49.64 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.32 1.048 . . . . 0.0 111.988 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -27.08 83.24 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 130.525 3.53 . . . . 0.0 116.141 -175.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.44 55.72 0.24 Allowed Glycine 0 N--CA 1.467 0.735 0 CA-C-N 111.477 -2.601 . . . . 0.0 111.773 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.3 t -110.24 128.9 55.75 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.755 1.622 . . . . 0.0 111.436 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -107.54 138.19 44.21 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.559 2.743 . . . . 0.0 107.43 162.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.59 150.33 14.38 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -171.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.99 179.7 5.83 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.525 2.816 . . . . 0.0 111.272 162.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 64.1 28.1 14.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.225 1.81 . . . . 0.0 114.887 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.55 -30.39 2.23 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 128.608 2.763 . . . . 0.0 114.674 164.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.63 -104.96 0.29 Allowed Glycine 0 N--CA 1.467 0.715 0 CA-C-N 119.967 1.258 . . . . 0.0 114.25 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 10.5 ttm -56.83 -23.03 40.98 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.272 1.029 . . . . 0.0 113.495 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -85.05 -6.59 59.32 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 117.958 -1.02 . . . . 0.0 113.496 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -79.64 47.95 0.89 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 121.135 1.789 . . . . 0.0 113.692 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -139.71 172.65 12.49 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.058 1.743 . . . . 0.0 113.071 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -68.58 158.51 33.83 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.598 0.759 . . . . 0.0 112.121 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -122.2 99.14 6.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.085 -1.009 . . . . 0.0 111.427 -159.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.03 170.19 15.95 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -167.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -76.77 164.63 25.67 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.081 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 129' ' ' PRO . . . 145.81 -154.53 26.0 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 125.369 1.461 . . . . 0.0 112.266 -175.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 21.8 ptm -158.08 162.97 38.1 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -125.84 142.12 51.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.664 2.786 . . . . 0.0 110.77 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -154.91 166.23 34.18 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.343 1.857 . . . . 0.0 110.428 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 4.5 t -80.98 172.84 13.24 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.132 1.444 . . . . 0.0 113.298 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.07 -9.06 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.173 1.789 . . . . 0.0 112.908 163.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 92.4 m -103.99 -33.45 8.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.959 1.303 . . . . 0.0 113.648 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.462 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -99.32 -100.49 0.23 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.759 1.223 . . . . 0.0 111.619 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -165.09 -62.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.36 145.12 29.13 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -161.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.43 151.58 70.95 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.236 2.624 . . . . 0.0 111.214 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.2 tp -137.83 -33.81 0.7 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -166.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -144.98 140.27 28.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.161 1.346 . . . . 0.0 114.205 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -98.56 144.41 27.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.011 0.925 . . . . 0.0 112.965 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -13.21 40.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.161 1.384 . . . . 0.0 113.407 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -24.87 66.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -87.19 -3.08 59.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.828 2.451 . . . . 0.0 113.312 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 127.76 33.7 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.992 1.317 . . . . 0.0 110.864 -170.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.88 117.08 10.1 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -166.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.5 m -84.65 56.09 3.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.5 1.12 . . . . 0.0 113.659 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.0 p -70.91 164.48 25.31 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.495 -0.753 . . . . 0.0 111.87 168.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.86 -1.82 26.81 Favored Glycine 0 CA--C 1.541 1.694 0 O-C-N 121.139 -0.976 . . . . 0.0 114.908 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.68 -25.45 13.85 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.017 1.727 . . . . 0.0 112.17 169.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.57 6.01 61.53 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.295 1.426 . . . . 0.0 113.598 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.422 ' CD1' ' HD2' ' A' ' 61' ' ' PRO . 91.8 t90 -50.56 144.49 12.36 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.193 1.797 . . . . 0.0 113.646 -166.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 60' ' ' TRP . 37.5 Cg_endo -65.58 100.33 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.173 2.582 . . . . 0.0 114.166 -171.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.2 p -158.74 156.56 30.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.695 2.798 . . . . 0.0 110.016 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.08 158.78 43.57 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 108.072 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.2 p -91.62 -20.13 21.97 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 127.243 2.217 . . . . 0.0 112.71 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -150.87 152.96 34.45 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.591 1.156 . . . . 0.0 112.199 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.62 91.65 3.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.033 1.333 . . . . 0.0 109.588 166.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -133.81 129.66 36.86 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.441 1.496 . . . . 0.0 108.871 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.96 -28.0 0.12 Allowed Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.814 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' HE2' ' A' ' 70' ' ' LYS . 92.4 p -86.96 150.13 24.29 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.059 1.429 . . . . 0.0 111.064 163.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -151.94 141.61 21.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 129.134 2.974 . . . . 0.0 111.798 -175.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.68 -79.08 0.09 OUTLIER Glycine 0 N--CA 1.472 1.068 0 C-N-CA 126.676 2.084 . . . . 0.0 115.03 155.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.85 -27.71 65.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.542 0.737 . . . . 0.0 112.651 167.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -121.6 108.55 13.71 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.708 0.766 . . . . 0.0 109.27 156.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -172.17 13.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.789 2.036 . . . . 0.0 111.992 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.5 t -74.98 -34.85 62.05 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.194 -0.941 . . . . 0.0 109.74 -170.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -127.75 -60.15 1.18 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.434 1.094 . . . . 0.0 113.9 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.1 p -167.06 -37.3 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -161.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.33 -33.15 2.75 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 125.557 1.551 . . . . 0.0 112.507 -164.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.59 164.97 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.471 1.909 . . . . 0.0 112.494 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.09 177.8 4.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.579 1.552 . . . . 0.0 109.408 158.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.28 155.96 38.72 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.657 -174.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -151.98 121.16 6.71 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.262 1.825 . . . . 0.0 108.49 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.51 135.69 38.25 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.55 -0.719 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -94.01 25.53 3.66 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 122.389 1.09 . . . . 0.0 111.195 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -75.8 45.99 0.36 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.816 2.446 . . . . 0.0 111.305 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -127.19 -13.16 5.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.128 2.171 . . . . 0.0 113.287 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.14 18.39 21.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.941 2.496 . . . . 0.0 112.633 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.91 -6.67 54.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.686 1.136 . . . . 0.0 114.643 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.3 t -133.53 133.61 22.8 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.885 1.674 . . . . 0.0 110.628 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.38 152.48 60.79 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.623 2.882 . . . . 0.0 114.214 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -146.26 164.21 33.03 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 128.859 2.864 . . . . 0.0 109.763 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.4 ttp -119.0 135.33 54.67 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 151.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 153.16 42.41 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.714 1.206 . . . . 0.0 110.709 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.41 148.49 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 122.103 0.954 . . . . 0.0 112.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.82 148.87 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.431 1.093 . . . . 0.0 112.327 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.72 107.95 10.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.429 2.292 . . . . 0.0 104.898 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -74.99 -14.2 60.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 168.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -61.58 -40.13 93.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 112.205 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.8 p -124.76 -5.46 7.51 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 9.4 tt0 73.38 53.71 0.12 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.215 2.206 . . . . 0.0 116.118 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.0 153.43 41.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 113.922 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 134.96 55.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.65 1.58 . . . . 0.0 113.064 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 tp -123.98 -15.48 6.85 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -165.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.82 179.55 34.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.731 2.11 . . . . 0.0 112.486 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -179.48 6.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.495 1.141 . . . . 0.0 113.816 -167.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.2 137.17 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.73 2.012 . . . . 0.0 109.576 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.26 149.42 48.26 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.315 1.446 . . . . 0.0 112.249 -172.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.88 143.46 16.44 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.826 2.35 . . . . 0.0 109.805 160.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.84 22.94 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.838 -1.164 . . . . 0.0 113.557 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.59 -46.34 1.15 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 127.157 2.313 . . . . 0.0 115.887 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -83.53 -163.48 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.34 2.693 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 151.9 63.49 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 113.258 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.28 -15.84 50.74 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.189 2.593 . . . . 0.0 113.215 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 p -56.67 -23.4 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.022 1.329 . . . . 0.0 113.186 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 9.76 64.9 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.463 2.459 . . . . 0.0 116.603 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -53.03 152.32 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.302 1.551 . . . . 0.0 114.246 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -136.94 154.44 50.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.883 2.073 . . . . 0.0 108.957 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -92.94 142.5 27.23 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.524 0.73 . . . . 0.0 110.498 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.5 p -121.0 143.2 49.17 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.744 1.618 . . . . 0.0 112.561 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.35 165.3 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.21 -0.931 . . . . 0.0 112.755 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.89 126.41 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.063 1.345 . . . . 0.0 114.162 -165.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -77.62 46.52 0.55 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.173 1.789 . . . . 0.0 112.954 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.18 -47.28 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.465 1.506 . . . . 0.0 113.398 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.29 4.66 0.05 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.565 1.546 . . . . 0.0 114.058 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.0 mt -85.8 159.59 19.69 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.746 1.619 . . . . 0.0 110.382 -164.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -103.95 133.68 48.5 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.142 0.977 . . . . 0.0 112.989 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.1 138.94 14.26 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.36 -0.838 . . . . 0.0 111.773 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -138.31 153.32 72.83 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.891 1.277 . . . . 0.0 111.997 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.436 ' HA ' ' HA3' ' A' ' 36' ' ' GLY . 87.1 Cg_endo -75.16 170.6 20.02 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.972 2.448 . . . . 0.0 112.859 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.44 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -91.74 -43.06 9.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.812 0.845 . . . . 0.0 111.73 -176.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 8.4 mmpt? -66.06 150.03 97.1 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.678 1.591 . . . . 0.0 114.767 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -66.37 177.65 3.09 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.484 2.79 . . . . 0.0 113.319 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 61.15 17.4 8.07 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.337 1.855 . . . . 0.0 114.242 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.93 1.27 1.65 Allowed 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.49 162.26 37.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.067 1.347 . . . . 0.0 111.586 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.2 tp -157.48 60.95 0.49 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.237 1.815 . . . . 0.0 108.406 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -72.98 -55.12 7.0 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.855 1.662 . . . . 0.0 114.172 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.66 162.74 25.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.016 1.28 . . . . 0.0 114.247 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -66.82 136.45 55.45 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.423 -0.798 . . . . 0.0 110.024 160.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -96.3 -150.57 0.33 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -156.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 56.23 33.29 21.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.308 1.843 . . . . 0.0 115.611 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -141.73 176.3 9.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.846 1.258 . . . . 0.0 110.213 168.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.192 1.397 . . . . 0.0 110.485 172.368 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.88 29.8 2.29 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.035 0.934 . . . . 0.0 112.902 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -142.62 162.44 35.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.383 1.473 . . . . 0.0 111.321 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -87.97 -26.93 22.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.487 0.715 . . . . 0.0 111.691 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -56.65 -41.23 76.82 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.506 1.522 . . . . 0.0 110.386 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -68.27 -33.76 74.95 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.868 1.267 . . . . 0.0 113.708 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -75.66 -39.87 56.96 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.051 0.94 . . . . 0.0 112.115 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -85.49 -21.06 28.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.2 1.0 . . . . 0.0 112.971 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.33 78.13 76.37 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.959 1.703 . . . . 0.0 109.17 169.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.9 -173.19 1.66 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.247 3.298 . . . . 0.0 114.181 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -51.26 -49.49 61.08 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.58 1.952 . . . . 0.0 114.289 -171.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -58.0 -38.36 75.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.311 0.644 . . . . 0.0 112.054 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -72.23 -40.72 67.56 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.303 0.641 . . . . 0.0 112.017 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -45.8 87.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.893 1.277 . . . . 0.0 110.492 173.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.29 -39.1 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.574 0.749 . . . . 0.0 112.481 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 p -84.15 -22.62 30.96 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 119.696 1.135 . . . . 0.0 113.625 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -67.43 -40.5 85.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.069 2.148 . . . . 0.0 110.074 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -94.71 -54.66 3.41 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.874 0.734 . . . . 0.0 111.357 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.9 tptp 42.58 6.75 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 121.795 3.998 . . . . 0.0 121.795 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.01 -17.83 0.88 Allowed Glycine 0 C--N 1.305 -1.192 0 C-N-CA 127.688 2.566 . . . . 0.0 114.193 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 t -147.88 169.54 19.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.383 1.873 . . . . 0.0 110.567 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -112.92 173.18 6.51 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.431 148.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.09 150.97 66.83 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.397 1.079 . . . . 0.0 110.766 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.15 96.37 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.355 2.037 . . . . 0.0 111.721 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -76.62 15.17 0.67 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 -173.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 178.13 -24.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 128.546 2.738 . . . . 0.0 112.741 -172.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' H ' HD12 ' A' ' 30' ' ' LEU . . . 57.67 -98.91 0.09 OUTLIER Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.82 1.2 . . . . 0.0 114.527 171.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 29.6 mtm -57.47 -17.68 14.63 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 169.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.62 7.35 45.29 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.663 1.585 . . . . 0.0 113.864 172.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 27' ' ' GLY . 10.0 mt -116.18 -4.24 11.95 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.87 -9.91 58.99 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -171.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -4.42 32.76 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -162.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.59 117.29 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 129.419 3.088 . . . . 0.0 115.993 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -76.19 165.52 24.79 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.7 m -144.01 158.07 43.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.68 2.792 . . . . 0.0 108.629 168.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.92 -144.45 10.73 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.088 1.328 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ptm -132.74 162.75 30.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 112.517 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.96 139.76 52.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.962 2.905 . . . . 0.0 109.54 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.41 168.05 23.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.564 1.945 . . . . 0.0 109.423 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.91 173.93 1.66 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 123.28 1.514 . . . . 0.0 112.578 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 p -122.98 -6.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.444 151.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.2 m -108.93 -27.73 9.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -168.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.8 p -109.28 -95.25 0.4 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.753 1.621 . . . . 0.0 112.017 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -157.37 -55.43 0.08 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.8 154.5 50.27 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 -154.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.37 143.86 71.69 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.169 1.913 . . . . 0.0 110.889 161.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.85 -51.93 2.64 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.374 1.07 . . . . 0.0 111.888 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -145.66 158.69 43.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.826 0.822 . . . . 0.0 112.033 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 p -85.63 135.05 33.95 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.441 1.096 . . . . 0.0 108.813 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -6.79 12.52 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.233 -0.917 . . . . 0.0 112.871 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -44.33 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 160.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -67.01 -10.5 50.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.862 1.665 . . . . 0.0 113.132 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -78.55 127.71 32.53 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.655 1.982 . . . . 0.0 110.969 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.89 117.68 34.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.052 2.141 . . . . 0.0 105.976 170.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 10.3 t -171.08 152.42 3.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 111.736 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.6 p -150.77 28.33 0.7 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.535 1.534 . . . . 0.0 111.957 161.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.86 -65.21 2.94 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 120.637 -1.289 . . . . 0.0 111.176 -163.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.05 -32.12 61.46 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.375 1.07 . . . . 0.0 112.235 170.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -19.6 59.2 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 117.941 -1.477 . . . . 0.0 114.254 165.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.3 t90 58.93 134.77 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.352 0 N-CA-C 118.079 2.622 . . . . 0.0 118.079 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.71 107.1 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.874 2.383 . . . . 0.0 114.479 -163.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.9 p -140.95 158.12 44.38 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.215 1.806 . . . . 0.0 110.881 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.23 114.62 6.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.141 0.976 . . . . 0.0 108.976 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -73.07 -20.84 60.88 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.387 -0.821 . . . . 0.0 112.925 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -145.06 148.54 33.8 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.137 -0.977 . . . . 0.0 112.441 -174.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.34 85.19 2.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.992 1.317 . . . . 0.0 109.45 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -135.11 113.99 11.94 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.318 1.047 . . . . 0.0 110.67 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 167.91 -37.44 0.22 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.005 1.764 . . . . 0.0 111.431 -170.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -69.85 148.5 48.98 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 142.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.91 145.13 6.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.143 2.177 . . . . 0.0 113.108 158.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.29 -92.83 1.01 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.976 1.75 . . . . 0.0 111.332 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -45.68 -39.09 7.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.724 2.01 . . . . 0.0 115.243 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.37 -31.19 65.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.745 2.018 . . . . 0.0 115.367 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -100.48 20.46 14.91 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 127.114 2.166 . . . . 0.0 111.353 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -77.53 -34.63 53.87 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.302 152.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -137.47 -66.29 0.51 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -171.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.1 p -164.42 -44.3 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 128.715 2.806 . . . . 0.0 111.47 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.95 -14.89 24.21 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 126.566 2.031 . . . . 0.0 113.968 -167.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.97 178.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 127.124 2.17 . . . . 0.0 110.455 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.51 175.2 8.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.857 2.063 . . . . 0.0 107.948 159.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.495 HH11 HD13 ' A' ' 83' ' ' LEU . 1.9 ppt_? -147.03 140.67 25.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -126.46 93.18 3.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.226 1.488 . . . . 0.0 112.108 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD13 HH11 ' A' ' 81' ' ' ARG . 6.5 mp -62.97 144.03 57.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.29 -0.881 . . . . 0.0 108.7 155.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -146.24 52.27 1.14 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.294 1.521 . . . . 0.0 112.363 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -73.3 30.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.244 1.818 . . . . 0.0 114.529 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -109.8 0.31 18.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.333 1.453 . . . . 0.0 113.615 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.1 mt -80.16 6.66 11.11 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.267 1.027 . . . . 0.0 112.394 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -6.63 52.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.433 1.492 . . . . 0.0 113.941 -163.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.4 t -130.39 131.58 23.47 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.84 . . . . 0.0 110.09 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.39 131.43 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.088 2.525 . . . . 0.0 113.115 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -133.02 157.65 44.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.448 1.899 . . . . 0.0 109.788 166.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.2 mtm -131.61 136.02 47.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.777 2.031 . . . . 0.0 108.526 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.17 153.15 52.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 124.732 1.213 . . . . 0.0 110.828 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.25 144.44 28.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.346 1.058 . . . . 0.0 112.209 162.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 102' ' ' HIS . 2.8 m -111.82 146.43 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.825 1.25 . . . . 0.0 110.979 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.79 112.17 10.73 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 124.039 1.876 . . . . 0.0 107.198 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -63.37 -24.56 67.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 112.422 -2.172 . . . . 0.0 112.04 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.16 -45.21 18.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.203 1.401 . . . . 0.0 114.419 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.2 p -113.53 -3.74 13.63 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.898 1.679 . . . . 0.0 115.195 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 71.31 46.29 0.44 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.677 1.991 . . . . 0.0 115.53 167.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.93 144.46 37.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.406 ' HB3' HG12 ' A' ' 95' ' ' VAL . 13.9 p-80 -75.7 118.72 18.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.712 1.205 . . . . 0.0 110.416 170.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.61 -29.01 1.57 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -168.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.93 127.57 6.55 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 127.289 2.376 . . . . 0.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.97 146.34 35.51 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.025 -0.691 . . . . 0.0 111.083 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.98 142.07 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.526 1.531 . . . . 0.0 111.141 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -145.47 156.66 53.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.3 147.79 12.86 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.974 3.116 . . . . 0.0 112.804 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -97.82 -1.05 44.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.8 -55.15 0.77 Allowed Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.953 1.739 . . . . 0.0 116.103 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 -156.98 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 125.202 3.935 . . . . 0.0 113.54 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -51.93 159.57 1.37 Allowed Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.76 1.624 . . . . 0.0 112.097 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.34 -8.91 7.46 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.429 2.752 . . . . 0.0 114.665 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.7 p -55.26 -34.06 63.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.339 1.456 . . . . 0.0 112.914 165.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.97 3.98 86.22 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -57.3 138.21 55.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.703 1.252 . . . . 0.0 113.764 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -115.25 128.67 56.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.103 1.761 . . . . 0.0 108.893 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -111.17 109.9 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.729 1.211 . . . . 0.0 109.334 -169.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.5 m -95.7 148.61 22.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.183 2.193 . . . . 0.0 111.288 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -134.0 144.9 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.137 0.975 . . . . 0.0 109.882 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.25 107.31 9.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.306 1.051 . . . . 0.0 113.219 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.9 m -79.22 38.04 0.34 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.51 -27.88 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.05 -1.031 . . . . 0.0 112.096 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 15.86 7.84 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.032 2.133 . . . . 0.0 113.351 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.463 1.505 . . . . 0.0 111.945 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -112.26 160.71 17.37 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.43 1.492 . . . . 0.0 111.573 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.59 149.67 50.63 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.47 -0.769 . . . . 0.0 112.375 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -136.61 133.97 19.33 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.458 1.503 . . . . 0.0 108.938 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.77 170.28 14.26 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.883 2.389 . . . . 0.0 113.404 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -39.59 54.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.045 0.926 . . . . 0.0 112.42 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -73.88 144.66 82.94 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.093 1.357 . . . . 0.0 113.152 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.26 175.68 6.48 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.646 2.897 . . . . 0.0 113.896 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 67.84 -10.88 0.37 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.277 3.031 . . . . 0.0 114.414 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.75 -7.68 27.25 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.628 2.371 . . . . 0.0 113.094 170.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -119.41 143.14 47.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.874 1.67 . . . . 0.0 107.51 156.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.17 42.04 0.44 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.748 1.261 . . . . 0.0 111.048 -166.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -78.28 29.18 0.18 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.703 2.001 . . . . 0.0 113.312 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.69 139.94 24.89 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.84 1.656 . . . . 0.0 113.522 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -128.08 34.49 4.58 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.941 -1.099 . . . . 0.0 113.523 -169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -133.5 -31.66 1.2 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.411 ' CG ' ' H ' ' A' ' 142' ' ' HIS . 13.5 t-80 50.81 -164.5 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.248 1.819 . . . . 0.0 114.266 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.411 ' H ' ' CG ' ' A' ' 141' ' ' HIS . 90.8 m-70 -99.97 150.99 21.85 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.426 1.49 . . . . 0.0 109.592 159.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.3 t60 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.421 1.088 . . . . 0.0 111.435 -168.245 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ppp? . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.96 -68.68 0.42 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.164 1.385 . . . . 0.0 110.88 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.27 177.76 9.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.291 1.436 . . . . 0.0 111.604 161.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -106.51 -35.33 7.11 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 161.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -60.44 -59.88 4.7 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 124.791 1.236 . . . . 0.0 111.001 -166.077 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -66.65 -31.51 72.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.845 1.258 . . . . 0.0 112.763 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -69.15 -35.89 76.84 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.587 0.755 . . . . 0.0 112.545 175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.88 -26.15 34.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.5 p -121.88 64.99 18.73 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.272 1.429 . . . . 0.0 113.448 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.9 -168.41 0.62 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.541 2.161 . . . . 0.0 115.163 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -50.46 -47.84 56.83 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.35 1.86 . . . . 0.0 114.338 -168.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -61.38 -28.34 69.17 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -78.83 -35.16 44.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.149 0.98 . . . . 0.0 112.221 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -62.73 -55.03 30.33 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.699 0.761 . . . . 0.0 111.257 171.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.58 -38.5 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.684 0.794 . . . . 0.0 110.953 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 p -70.11 -26.04 63.78 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.297 -0.877 . . . . 0.0 113.122 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -39.92 75.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.318 1.047 . . . . 0.0 110.848 174.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -72.03 -30.84 65.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.499 0.32 . . . . 0.0 111.417 170.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.38 33.49 0.09 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.819 2.047 . . . . 0.0 113.783 166.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.88 24.39 0.72 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 128.408 2.909 . . . . 0.0 113.087 -172.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 t -106.97 110.71 22.93 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.944 1.697 . . . . 0.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -146.66 -164.86 2.08 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 128.933 2.893 . . . . 0.0 108.349 174.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 69.98 157.3 0.16 Allowed Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 127.038 2.135 . . . . 0.0 116.1 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.59 127.98 5.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.783 2.322 . . . . 0.0 111.941 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -91.1 -96.11 0.12 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.214 1.006 . . . . 0.0 110.933 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.74 -28.63 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.941 2.896 . . . . 0.0 109.942 -163.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.39 -117.93 10.23 Favored Glycine 0 C--N 1.339 0.701 0 O-C-N 120.542 -1.349 . . . . 0.0 111.235 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.6 mtm -55.41 -30.91 61.31 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.25 0.62 . . . . 0.0 112.087 169.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -8.15 55.52 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.06 -32.18 72.35 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.765 -1.209 . . . . 0.0 113.029 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -162.21 -58.53 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.814 0.733 . . . . 0.0 112.583 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.6 -35.48 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.765 2.826 . . . . 0.0 109.39 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.312 14.3 mmtm 66.74 129.4 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 130.073 3.349 . . . . 0.0 116.363 -173.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -124.81 171.42 10.15 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.299 2.24 . . . . 0.0 112.254 -166.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -126.82 154.35 44.44 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.81 1.244 . . . . 0.0 109.619 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.61 -154.26 16.01 Favored Glycine 0 N--CA 1.465 0.627 0 C-N-CA 124.464 1.03 . . . . 0.0 113.814 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptp -156.05 163.59 39.49 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.036 1.334 . . . . 0.0 112.302 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.75 144.21 41.41 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 127.914 2.486 . . . . 0.0 111.014 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -141.81 161.68 37.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.004 1.721 . . . . 0.0 111.264 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 64.0 m -66.07 162.7 18.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 123.354 1.549 . . . . 0.0 113.235 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.29 1.44 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.963 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.7 m -129.4 -39.09 1.52 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -167.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.5 p -94.67 -85.34 0.31 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.587 1.085 . . . . 0.0 112.549 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.98 -74.51 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 p -110.46 155.65 41.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -151.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.95 138.39 33.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.294 1.996 . . . . 0.0 111.771 165.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.0 mt -135.35 -11.53 2.15 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.98 120.29 23.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.425 1.011 . . . . 0.0 111.534 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -92.8 131.6 37.7 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.812 1.768 . . . . 0.0 112.054 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -67.67 -7.53 27.54 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.742 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.35 -28.95 63.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 113.976 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 5.48 51.64 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 171.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -78.22 136.44 37.79 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.691 0.678 . . . . 0.0 109.439 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -75.69 57.26 0.98 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.611 0.764 . . . . 0.0 112.686 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 72.2 m -58.8 -35.53 72.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.917 1.687 . . . . 0.0 112.552 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 p -86.01 -5.38 59.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.921 2.488 . . . . 0.0 114.225 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.14 -124.99 2.22 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.831 1.205 . . . . 0.0 112.829 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 m -67.98 -19.39 64.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.629 1.572 . . . . 0.0 113.334 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.68 7.58 88.1 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.784 1.183 . . . . 0.0 113.347 -165.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -101.94 137.27 19.47 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.818 2.047 . . . . 0.0 110.811 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.54 111.31 2.99 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.329 2.019 . . . . 0.0 114.259 -160.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -159.33 148.61 18.39 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.532 1.933 . . . . 0.0 110.767 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -148.08 128.05 13.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.555 1.942 . . . . 0.0 109.59 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 p -73.35 -20.29 60.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -126.61 143.88 51.08 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.986 1.85 . . . . 0.0 113.897 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.31 111.8 8.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 110.969 -2.832 . . . . 0.0 107.469 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -62.82 28.61 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.563 2.745 . . . . 0.0 114.655 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -99.39 37.7 3.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.41 2.433 . . . . 0.0 113.518 -168.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.3 t -51.76 156.39 1.44 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 123.029 1.395 . . . . 0.0 112.821 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.43 135.27 55.07 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.85 2.46 . . . . 0.0 112.032 -162.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.09 -70.33 1.83 Allowed Glycine 0 N--CA 1.469 0.85 0 C-N-CA 126.144 1.83 . . . . 0.0 114.019 167.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 m -50.16 -33.61 19.62 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.999 2.52 . . . . 0.0 112.622 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -138.42 126.88 23.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 152.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -139.18 19.99 2.6 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.023 1.329 . . . . 0.0 112.773 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -119.61 -37.55 3.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 127.161 2.184 . . . . 0.0 112.256 -173.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -83.84 -28.34 28.09 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.349 1.46 . . . . 0.0 112.517 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.8 p -85.02 -56.04 3.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.978 166.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.41 22.01 55.34 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.291 0.948 . . . . 0.0 112.536 -167.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -98.47 163.41 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.841 0.829 . . . . 0.0 111.693 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.56 176.62 8.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.791 2.036 . . . . 0.0 112.502 -169.478 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.555 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -145.86 151.46 37.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.295 1.438 . . . . 0.0 112.875 -171.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.73 112.74 5.17 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.528 1.931 . . . . 0.0 108.82 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.04 131.6 37.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.963 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -98.82 17.42 19.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.015 1.326 . . . . 0.0 112.084 -168.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -70.33 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.891 2.876 . . . . 0.0 114.767 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -125.05 0.39 7.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.983 1.713 . . . . 0.0 113.766 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.9 mt -100.08 15.53 27.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 113.273 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.29 -9.43 54.48 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.408 1.48 . . . . 0.0 114.328 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.6 t -118.81 121.45 30.62 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.441 1.496 . . . . 0.0 110.224 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 125.01 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.332 2.022 . . . . 0.0 111.804 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -144.62 159.85 42.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.722 2.009 . . . . 0.0 109.909 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.8 mtp -128.51 127.13 41.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.938 2.095 . . . . 0.0 107.975 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.56 151.98 51.47 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.161 0.984 . . . . 0.0 110.677 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 m -133.82 148.8 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.993 1.317 . . . . 0.0 110.84 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.25 156.16 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.27 0.628 . . . . 0.0 111.432 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.3 t -92.61 118.91 31.51 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -83.59 -14.87 51.09 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.861 171.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -70.01 -51.01 35.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.064 0.945 . . . . 0.0 112.811 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.6 p -107.4 -7.75 16.53 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.833 1.653 . . . . 0.0 115.033 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 61.26 56.29 2.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.109 2.164 . . . . 0.0 114.039 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.79 146.13 43.2 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.693 1.197 . . . . 0.0 111.796 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.06 126.61 30.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.19 -0.944 . . . . 0.0 111.18 172.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.38 6.66 36.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.487 1.915 . . . . 0.0 113.216 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.8 -168.77 13.04 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 127.22 2.343 . . . . 0.0 112.584 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.23 163.85 36.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 123.012 1.386 . . . . 0.0 113.577 -165.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.64 135.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.28 1.832 . . . . 0.0 110.031 -165.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -148.13 154.17 42.4 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.021 1.329 . . . . 0.0 113.53 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.22 129.79 6.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.402 2.734 . . . . 0.0 109.763 163.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.31 -3.0 54.5 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.06 -54.64 0.38 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.238 1.399 . . . . 0.0 114.797 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.88 -165.02 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.469 2.779 . . . . 0.0 112.736 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 157.75 2.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.322 1.449 . . . . 0.0 111.862 173.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -57.44 -17.82 28.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.946 2.431 . . . . 0.0 113.479 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -23.24 36.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.599 1.56 . . . . 0.0 113.269 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.69 17.89 51.8 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 127.773 2.606 . . . . 0.0 115.427 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.02 140.1 56.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.413 1.107 . . . . 0.0 112.584 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -124.76 146.91 48.96 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.198 1.799 . . . . 0.0 110.318 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.48 129.58 42.6 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.269 1.427 . . . . 0.0 109.148 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.9 p -120.78 144.39 48.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.014 1.326 . . . . 0.0 111.055 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.2 tp -123.42 155.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 0.0 111.091 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -126.8 134.16 50.64 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.989 1.716 . . . . 0.0 107.448 161.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.4 m -81.7 50.67 1.55 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -163.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -50.99 -59.89 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.902 2.481 . . . . 0.0 115.236 -164.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.13 27.1 0.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.727 1.211 . . . . 0.0 114.024 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.3 mt -117.19 157.01 26.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.823 1.249 . . . . 0.0 110.358 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 166.42 10.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.825 1.65 . . . . 0.0 112.19 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -144.63 153.21 41.53 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.557 1.143 . . . . 0.0 112.203 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 151.97 67.42 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.442 1.897 . . . . 0.0 109.946 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.13 170.69 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.62 2.213 . . . . 0.0 112.921 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.55 -45.73 8.75 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.877 0.871 . . . . 0.0 111.95 -170.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -78.79 158.52 75.36 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.23 2.212 . . . . 0.0 112.371 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.67 -177.55 1.9 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.809 2.339 . . . . 0.0 112.447 161.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.2 22.92 13.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.796 1.638 . . . . 0.0 114.414 169.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.31 -13.55 58.29 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.772 1.629 . . . . 0.0 114.005 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 71.66 146.08 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.546 2.738 . . . . 0.0 114.7 -170.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . 0.276 1.1 pt? -94.42 12.7 26.24 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -63.28 -26.82 68.95 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 127.896 2.478 . . . . 0.0 111.99 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -62.87 -14.66 48.93 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -75.54 -13.01 60.34 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.509 1.524 . . . . 0.0 114.496 171.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -67.19 174.52 3.14 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.984 1.714 . . . . 0.0 113.685 -172.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -70.47 64.19 0.27 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.701 2.4 . . . . 0.0 111.647 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -136.03 55.51 1.86 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.554 2.741 . . . . 0.0 106.837 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 3.7 m80 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.464 1.906 . . . . 0.0 111.873 -163.24 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.406 0.146 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.87 -25.29 67.83 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.367 -0.833 . . . . 0.0 111.895 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -138.57 173.52 11.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.818 2.047 . . . . 0.0 110.516 159.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -94.15 -31.98 13.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.02 1.328 . . . . 0.0 111.63 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -57.13 -46.23 82.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.111 0.964 . . . . 0.0 111.001 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -60.28 -30.31 69.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.312 1.045 . . . . 0.0 113.332 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -90.8 -31.73 16.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.441 1.896 . . . . 0.0 113.243 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.54 -39.24 81.2 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.282 1.833 . . . . 0.0 111.395 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 p -122.74 74.2 45.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.396 1.478 . . . . 0.0 111.27 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.94 147.24 89.08 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.41 2.074 . . . . 0.0 113.579 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -82.01 -50.05 9.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -159.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -60.5 -33.53 72.75 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.359 171.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -65.93 -51.18 60.87 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 122.725 0.41 . . . . 0.0 110.483 172.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.03 -40.39 93.41 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.218 0.532 . . . . 0.0 111.402 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.93 -49.93 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.125 0.97 . . . . 0.0 112.704 171.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 p -77.92 -13.01 60.03 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.789 1.636 . . . . 0.0 115.259 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.7 tpt85 -77.81 -8.31 57.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.912 2.885 . . . . 0.0 110.776 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -134.71 -56.21 0.83 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.379 0.609 . . . . 0.0 112.314 161.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.94 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 118.141 2.645 . . . . 0.0 118.141 -165.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.67 15.02 1.4 Allowed Glycine 0 CA--C 1.537 1.452 0 C-N-CA 126.979 2.228 . . . . 0.0 115.611 -171.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -83.63 79.35 9.48 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 123.109 1.433 . . . . 0.0 113.973 -165.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -76.84 136.76 38.93 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.266 -1.521 . . . . 0.0 109.378 167.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.42 144.91 29.77 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.089 0.955 . . . . 0.0 112.26 -173.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -91.09 -174.61 0.67 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 121.971 1.781 . . . . 0.0 115.502 -158.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -45.46 4.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 1 C-N-CA 134.611 5.165 . . . . 0.0 119.145 175.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.4 m -137.97 17.71 2.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 118.875 2.917 . . . . 0.0 118.875 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -132.17 -66.57 0.09 OUTLIER Glycine 0 N--CA 1.469 0.862 0 O-C-N 120.916 -1.115 . . . . 0.0 112.604 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.4 mtp -69.52 -9.19 52.82 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -19.49 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 170.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.78 51.83 0.97 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.495 1.043 . . . . 0.0 111.23 -164.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -130.25 147.33 51.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -160.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -103.62 -136.56 0.34 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.735 2.014 . . . . 0.0 109.267 162.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -150.05 115.65 5.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.952 1.701 . . . . 0.0 111.055 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.89 179.96 1.01 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.763 1.268 . . . . 0.0 112.016 161.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.428 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.6 m -137.59 151.04 47.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.385 1.874 . . . . 0.0 108.535 177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.91 -167.3 39.99 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 118.863 0.756 . . . . 0.0 113.119 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.7 ptp -156.2 159.44 38.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.256 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.89 144.47 50.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.134 2.573 . . . . 0.0 111.044 -170.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.53 155.7 37.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.655 1.982 . . . . 0.0 109.184 -168.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.79 167.65 21.2 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.808 1.766 . . . . 0.0 113.486 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -137.56 5.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 112.66 -2.064 . . . . 0.0 112.102 166.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 99' ' ' CYS . 91.3 m -119.56 -31.37 4.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.782 1.633 . . . . 0.0 112.219 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.3 p -100.65 -103.24 0.24 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.509 1.523 . . . . 0.0 108.534 158.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.88 -31.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 p -81.64 155.71 70.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -161.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.45 136.97 45.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.166 1.911 . . . . 0.0 110.237 156.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.5 -39.13 0.82 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -157.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -157.47 152.6 25.89 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.444 1.02 . . . . 0.0 111.823 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -97.27 142.98 28.5 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.559 -1.338 . . . . 0.0 112.151 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 t -66.89 -10.32 47.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -42.36 64.35 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.937 1.695 . . . . 0.0 114.093 165.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.04 -1.36 28.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.289 1.435 . . . . 0.0 113.155 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -76.58 141.91 40.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.431 0.634 . . . . 0.0 111.334 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -82.47 129.23 34.86 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.782 1.233 . . . . 0.0 112.111 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.1 m 47.06 -145.73 0.24 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.853 2.061 . . . . 0.0 113.649 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.9 p -72.07 -34.67 68.9 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.454 -1.404 . . . . 0.0 113.059 169.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.33 40.93 86.52 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.41 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.4 m -54.57 -38.28 66.49 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.189 1.796 . . . . 0.0 115.192 -164.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.28 -5.46 14.71 Favored Glycine 0 N--CA 1.474 1.233 0 C-N-CA 124.124 0.868 . . . . 0.0 113.03 163.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 119' ' ' CYS . 0.6 OUTLIER -134.91 73.95 65.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.885 -0.773 . . . . 0.0 112.239 -155.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -65.92 131.8 28.36 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.366 2.044 . . . . 0.0 110.766 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 p -153.07 139.23 18.34 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.217 1.407 . . . . 0.0 109.874 -165.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -155.11 114.13 3.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.852 0.861 . . . . 0.0 110.524 -154.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 p -75.79 -19.97 58.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -146.83 156.99 43.54 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.411 1.084 . . . . 0.0 111.269 173.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.55 39.14 1.0 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.073 1.349 . . . . 0.0 111.711 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -75.96 104.24 6.4 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.626 -1.296 . . . . 0.0 110.389 -174.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.34 -11.81 0.08 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.587 -1.118 . . . . 0.0 114.963 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.4 p -74.14 149.01 41.22 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.062 1.345 . . . . 0.0 112.04 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 128.38 18.9 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.714 1.206 . . . . 0.0 113.804 -158.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.91 -70.98 0.57 Allowed Glycine 0 N--CA 1.472 1.098 0 C-N-CA 128.42 2.914 . . . . 0.0 114.682 158.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 m -74.53 -31.99 62.33 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.454 1.502 . . . . 0.0 110.62 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.07 25.67 11.32 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 124.181 1.943 . . . . 0.0 110.576 -168.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -144.69 -1.67 0.88 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.34 3.056 . . . . 0.0 109.631 -168.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -68.43 -37.25 80.1 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.796 0.807 . . . . 0.0 109.825 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -143.47 -46.55 0.29 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.919 0.888 . . . . 0.0 113.337 166.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.2 p -161.92 -41.35 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.415 1.486 . . . . 0.0 113.776 -172.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.76 -22.65 0.87 Allowed Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.528 1.061 . . . . 0.0 113.613 -161.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.63 173.79 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.812 2.045 . . . . 0.0 112.404 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.66 -179.79 4.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.191 2.197 . . . . 0.0 110.083 -178.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.619 ' H ' HD23 ' A' ' 80' ' ' LEU . 24.6 mmt85 -141.25 146.09 36.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.841 1.656 . . . . 0.0 109.832 -170.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -144.03 102.35 3.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.283 1.433 . . . . 0.0 111.496 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.42 149.87 35.09 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.018 -1.051 . . . . 0.0 111.233 165.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -134.38 29.63 3.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.8 1.286 . . . . 0.0 112.598 -170.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -73.63 35.52 0.09 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.535 1.934 . . . . 0.0 113.939 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.85 2.57 4.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.552 1.941 . . . . 0.0 112.797 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.3 15.08 5.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.394 1.878 . . . . 0.0 112.78 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.11 -3.53 65.51 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.8 1.191 . . . . 0.0 114.388 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 t -140.72 141.28 24.27 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 127.908 2.483 . . . . 0.0 110.164 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.67 129.33 16.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.809 2.339 . . . . 0.0 112.691 170.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -139.45 159.32 42.44 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.159 2.584 . . . . 0.0 108.515 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.9 ttm -143.35 134.68 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.575 1.55 . . . . 0.0 110.232 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -139.23 166.57 24.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.57 138.33 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.659 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.66 145.9 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.87 103.32 7.73 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.257 1.423 . . . . 0.0 107.551 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -57.4 -18.46 17.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.159 1.783 . . . . 0.0 112.562 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.82 -37.41 13.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 113.316 -167.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 42' ' ' CYS . 12.3 p -121.15 1.88 10.33 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.645 1.978 . . . . 0.0 114.524 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.274 4.5 tt0 59.98 57.82 2.93 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.526 2.33 . . . . 0.0 113.294 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.4 129.67 35.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.747 1.219 . . . . 0.0 113.621 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -76.03 116.63 16.93 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.154 -0.966 . . . . 0.0 110.371 164.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -120.56 -36.44 3.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -169.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.39 146.31 18.33 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 128.24 2.829 . . . . 0.0 111.846 -166.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 158.64 38.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.377 0.671 . . . . 0.0 111.809 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.27 139.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.701 1.238 . . . . 0.0 111.45 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.99 150.29 38.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.39 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.59 133.85 19.48 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.321 2.681 . . . . 0.0 110.905 169.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.67 7.64 29.09 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.17 -49.94 0.55 Allowed Glycine 0 CA--C 1.541 1.657 0 C-N-CA 126.012 1.767 . . . . 0.0 114.777 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.09 -154.97 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.55 3.5 . . . . 0.0 112.108 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.29 157.83 3.04 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 126.493 1.917 . . . . 0.0 112.325 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -62.8 -8.86 14.51 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.378 2.719 . . . . 0.0 114.093 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.0 p -63.74 -24.14 67.65 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.813 -1.179 . . . . 0.0 112.261 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.22 20.49 33.29 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.844 2.64 . . . . 0.0 115.91 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -63.53 135.3 56.75 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.041 -1.27 . . . . 0.0 112.238 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -112.11 138.94 48.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 127.117 2.167 . . . . 0.0 108.503 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -107.03 128.31 54.25 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.468 1.107 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.483 ' HB3' ' CH2' ' A' ' 60' ' ' TRP . 31.7 p -121.76 149.1 43.78 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.617 1.567 . . . . 0.0 110.063 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.6 tt -131.65 164.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.546 -1.346 . . . . 0.0 109.76 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.1 124.54 24.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.21 -0.931 . . . . 0.0 112.528 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.1 m -79.91 36.44 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.974 1.309 . . . . 0.0 114.038 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.03 -37.91 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.168 1.787 . . . . 0.0 113.586 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.15 60.02 0.15 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.061 1.344 . . . . 0.0 113.125 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.27 171.68 13.72 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.761 1.625 . . . . 0.0 113.444 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 mmpt? -120.83 156.39 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.363 1.865 . . . . 0.0 114.609 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.12 150.99 22.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.452 1.501 . . . . 0.0 111.747 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.1 146.86 56.32 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.738 2.015 . . . . 0.0 111.551 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.72 169.67 19.58 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.265 1.976 . . . . 0.0 111.264 165.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 -38.53 7.08 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 111.904 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HE3' ' HB ' ' A' ' 35' ' ' THR . 10.4 mmpt? -45.93 148.25 1.47 Allowed Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.193 1.797 . . . . 0.0 112.442 161.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.15 172.55 7.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.441 2.094 . . . . 0.0 113.495 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 56.56 55.59 6.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.356 1.462 . . . . 0.0 110.826 -172.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.82 -32.74 72.66 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.693 0.797 . . . . 0.0 111.724 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 62.58 159.57 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.525 1.93 . . . . 0.0 113.816 -172.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 tt 55.64 38.76 30.58 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 123.015 1.388 . . . . 0.0 109.87 -159.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -69.08 -58.63 3.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.703 2.001 . . . . 0.0 112.114 -162.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -152.98 166.3 32.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.654 1.982 . . . . 0.0 110.242 165.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -80.12 172.34 13.89 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.339 1.056 . . . . 0.0 113.208 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -55.47 140.19 41.14 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.964 -1.085 . . . . 0.0 111.449 171.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.73 159.46 41.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.494 0.717 . . . . 0.0 111.942 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -65.34 133.41 51.32 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.792 0.837 . . . . 0.0 111.386 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 . . . . . 0 C--O 1.255 1.349 0 C-N-CA 124.811 1.244 . . . . 0.0 109.71 177.706 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.25 46.89 0.16 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.678 1.191 . . . . 0.0 113.312 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -141.51 156.79 45.71 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.365 -1.459 . . . . 0.0 113.523 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -83.9 -31.92 25.43 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.045 0.938 . . . . 0.0 112.594 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -62.83 -38.91 92.64 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 123.662 0.785 . . . . 0.0 110.644 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -29.13 56.44 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.29 1.036 . . . . 0.0 113.504 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -80.61 -45.89 16.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.33 1.452 . . . . 0.0 111.464 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.61 -46.77 71.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.942 0.897 . . . . 0.0 111.982 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.27 78.73 35.13 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.932 2.493 . . . . 0.0 110.018 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.07 177.19 4.59 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.376 2.717 . . . . 0.0 113.82 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -52.6 -45.12 66.41 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 119.98 -1.7 . . . . 0.0 114.035 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -65.47 -20.01 66.18 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -84.09 -39.2 19.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.963 1.305 . . . . 0.0 111.474 166.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -64.17 -40.86 97.01 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.891 -1.756 . . . . 0.0 111.562 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.485 ' CG1' HG11 ' A' ' 123' ' ' VAL . 77.2 t -72.5 -0.17 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.98 2.512 . . . . 0.0 113.175 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -109.07 -34.69 6.53 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.561 -1.337 . . . . 0.0 112.94 161.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.53 -46.57 53.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.436 1.095 . . . . 0.0 111.912 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.42 -31.65 70.59 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.268 0.627 . . . . 0.0 111.037 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -89.2 30.12 1.0 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.698 1.199 . . . . 0.0 113.336 -172.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.59 23.46 0.16 Allowed Glycine 0 CA--C 1.53 1.006 0 N-CA-C 115.917 1.127 . . . . 0.0 115.917 -169.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -133.05 135.19 45.22 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.622 1.569 . . . . 0.0 110.833 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -115.99 138.99 50.7 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.823 1.649 . . . . 0.0 112.425 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.01 149.71 17.07 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 125.577 1.551 . . . . 0.0 113.398 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.88 136.68 3.1 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.25 3.3 . . . . 0.0 113.679 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -147.37 -82.25 0.13 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.15 -34.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 129.179 2.992 . . . . 0.0 108.957 -157.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.0 -102.64 0.6 Allowed Glycine 0 C--N 1.339 0.7 0 O-C-N 120.475 -1.391 . . . . 0.0 113.442 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.7 mtp -53.16 -37.24 61.69 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.634 -0.333 . . . . 0.0 111.504 167.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -80.08 2.04 25.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.734 1.213 . . . . 0.0 113.535 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.3 mt -77.1 -47.88 19.3 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.814 1.188 . . . . 0.0 111.473 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -169.53 0.43 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.0 t30 58.27 162.5 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -171.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -153.89 121.48 5.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.608 2.363 . . . . 0.0 108.28 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.38 171.15 2.02 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 119.39 3.107 . . . . 0.0 119.39 -166.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.4 m -73.84 164.81 26.15 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 127.59 2.356 . . . . 0.0 107.781 163.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.96 -142.35 10.25 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 121.012 -1.055 . . . . 0.0 111.263 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.3 ptp -155.66 157.2 36.29 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.625 1.202 . . . . 0.0 113.746 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -112.8 130.05 56.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 128.15 2.58 . . . . 0.0 107.652 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -151.58 168.33 25.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.736 1.214 . . . . 0.0 112.376 -161.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 172.14 12.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 123.648 1.69 . . . . 0.0 114.379 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.67 0.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.409 157.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 97.7 m -112.62 -48.65 2.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.414 1.486 . . . . 0.0 112.345 -168.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.5 p -86.88 -80.63 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.742 1.217 . . . . 0.0 111.99 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.05 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.313 1.445 . . . . 0.0 114.645 163.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.1 p -101.68 159.01 30.67 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -158.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.68 155.56 49.39 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.961 3.107 . . . . 0.0 112.512 163.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.61 -31.15 0.57 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -172.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -132.04 122.23 25.14 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.889 -1.132 . . . . 0.0 108.717 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -82.9 136.46 34.58 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 120.388 -1.445 . . . . 0.0 109.241 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 t -58.54 -18.86 32.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.504 1.122 . . . . 0.0 112.76 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 3.5 tt0 -60.83 -42.03 96.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.897 1.279 . . . . 0.0 113.813 175.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.1 mmpt? -74.45 -4.16 34.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.817 0.847 . . . . 0.0 112.706 174.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -74.54 135.15 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.337 1.055 . . . . 0.0 109.504 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.68 119.77 13.62 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.957 -163.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.1 m 58.4 -66.67 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.616 2.367 . . . . 0.0 113.962 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.5 p -160.13 -9.29 0.05 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.877 2.071 . . . . 0.0 113.057 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.95 97.45 0.04 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.952 1.739 . . . . 0.0 113.9 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.02 -9.99 35.62 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.503 1.921 . . . . 0.0 115.171 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.59 -28.26 7.54 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.457 1.98 . . . . 0.0 110.496 -155.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.63 121.25 84.71 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 161.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -105.0 109.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.458 2.106 . . . . 0.0 114.218 -173.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -138.5 152.79 48.57 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.042 1.737 . . . . 0.0 110.109 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -141.32 130.74 23.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 p -78.98 -12.66 60.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.32 150.72 50.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.799 1.285 . . . . 0.0 112.144 160.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.91 103.3 5.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 107.415 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -53.86 85.31 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.558 1.943 . . . . 0.0 112.57 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.17 32.0 6.59 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.356 1.455 . . . . 0.0 114.281 -169.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.7 m -48.56 141.12 7.31 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.903 1.335 . . . . 0.0 114.126 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -131.65 148.66 52.61 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 130.184 3.393 . . . . 0.0 108.341 170.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.15 -87.4 0.68 Allowed Glycine 0 N--CA 1.466 0.656 0 C-N-CA 125.456 1.503 . . . . 0.0 112.781 168.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 m -46.63 -32.1 3.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.508 1.923 . . . . 0.0 113.897 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -147.45 126.45 12.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 160.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -132.61 -0.89 3.5 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 124.715 1.206 . . . . 0.0 111.606 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 t -97.01 -23.97 16.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.647 1.179 . . . . 0.0 111.543 -170.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -75.3 -33.93 61.24 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 p -109.77 -50.35 2.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.988 2.115 . . . . 0.0 111.15 -165.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.98 -17.29 0.14 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.88 1.705 . . . . 0.0 114.383 -164.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.1 pt -59.43 162.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -145.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tt -121.63 158.59 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.735 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.75 153.37 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.856 1.262 . . . . 0.0 111.673 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.45 133.31 13.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.464 1.906 . . . . 0.0 108.937 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.73 156.12 39.26 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.784 1.634 . . . . 0.0 112.055 163.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -133.55 118.61 18.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 164.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 t -115.53 20.95 14.39 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 122.136 0.97 . . . . 0.0 111.922 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -84.79 -6.3 59.35 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.703 2.401 . . . . 0.0 113.324 -168.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -86.83 10.29 16.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.028 2.131 . . . . 0.0 112.733 164.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.79 -0.17 57.89 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 124.67 1.129 . . . . 0.0 114.732 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.46 128.72 11.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.674 1.59 . . . . 0.0 110.211 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.89 139.39 19.51 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.674 2.249 . . . . 0.0 113.569 -170.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -134.49 165.67 24.64 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 130.665 3.586 . . . . 0.0 109.928 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mtm -132.62 133.95 44.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.192 2.197 . . . . 0.0 109.955 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -133.18 145.54 50.71 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.15 0.98 . . . . 0.0 112.955 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.56 146.17 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.42 1.888 . . . . 0.0 111.331 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 m -141.77 147.04 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.401 -0.812 . . . . 0.0 111.799 -169.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.2 t -74.51 97.9 3.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 123.69 1.709 . . . . 0.0 108.892 170.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -24.2 2.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.576 1.951 . . . . 0.0 112.69 165.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -83.79 -41.11 17.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.862 1.665 . . . . 0.0 114.456 -172.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.7 p -126.97 1.08 6.58 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.258 13.1 mt-10 72.95 22.0 3.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.272 2.629 . . . . 0.0 115.068 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.0 94.53 9.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.338 1.055 . . . . 0.0 113.431 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.48 53.75 2.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.64 -7.24 38.15 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -160.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.01 130.27 8.33 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 126.662 2.077 . . . . 0.0 113.04 -167.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.82 153.36 36.64 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.904 -0.762 . . . . 0.0 110.802 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.97 128.82 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.795 0.838 . . . . 0.0 111.672 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -127.99 141.12 40.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.576 1.15 . . . . 0.0 112.502 -169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -73.21 162.57 40.24 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.62 2.88 . . . . 0.0 111.506 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -116.8 -0.84 12.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.71 -62.5 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.825 1.678 . . . . 0.0 114.822 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -69.6 -162.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.262 1 C-N-CA 125.714 4.276 . . . . 0.0 114.099 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -56.43 163.07 2.73 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 126.171 1.788 . . . . 0.0 113.057 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -59.21 -11.58 13.5 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 0.0 114.436 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 p -58.78 -23.87 60.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.029 1.332 . . . . 0.0 113.892 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.6 -3.61 62.62 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.908 1.718 . . . . 0.0 116.262 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -59.37 145.34 43.85 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.713 1.257 . . . . 0.0 112.426 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 128.9 55.55 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.265 1.026 . . . . 0.0 109.327 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -99.09 110.49 23.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.812 1.245 . . . . 0.0 109.935 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.9 m -113.48 112.43 23.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.242 2.217 . . . . 0.0 108.685 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.7 tt -136.46 118.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.51 0.724 . . . . 0.0 112.544 -167.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -80.56 -9.27 59.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.9 m -16.73 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.358 2.663 . . . . 0.0 116.262 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.485 HG11 ' CG1' ' A' ' 15' ' ' VAL . 7.6 p -132.68 -33.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.954 2.102 . . . . 0.0 112.126 -173.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.18 2.46 5.87 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.665 1.586 . . . . 0.0 114.423 165.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.54 -174.19 2.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.921 2.888 . . . . 0.0 110.628 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.91 163.66 12.78 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.575 -1.328 . . . . 0.0 114.524 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.47 155.87 42.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.852 1.261 . . . . 0.0 112.397 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -149.13 150.11 31.26 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.825 1.65 . . . . 0.0 111.78 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.84 173.54 13.44 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.141 2.56 . . . . 0.0 113.17 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.02 -40.22 6.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 153.19 94.78 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -172.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.05 176.38 2.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.333 2.689 . . . . 0.0 113.442 166.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 59.43 25.7 14.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.827 1.651 . . . . 0.0 114.316 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -104.51 7.28 35.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.251 2.221 . . . . 0.0 113.537 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.1 90.04 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.87 1.668 . . . . 0.0 112.95 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -143.34 37.0 1.36 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.034 2.134 . . . . 0.0 110.429 -170.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.66 -57.98 4.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.962 2.505 . . . . 0.0 111.269 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -162.96 -169.6 2.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.559 2.344 . . . . 0.0 108.085 153.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -140.06 162.56 34.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.499 1.12 . . . . 0.0 111.056 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -73.38 64.51 0.83 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.005 1.322 . . . . 0.0 112.24 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.91 162.56 29.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.891 1.676 . . . . 0.0 112.939 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 67.5 m80 64.37 155.14 0.06 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.171 2.188 . . . . 0.0 115.224 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 5.0 p80 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 126.072 1.749 . . . . 0.0 110.151 176.989 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.33 -37.86 0.1 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -145.13 175.72 10.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.42 1.088 . . . . 0.0 113.838 -166.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -108.09 -38.0 5.9 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.228 1.011 . . . . 0.0 112.547 159.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -63.52 -59.92 4.02 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.906 1.283 . . . . 0.0 111.437 -164.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -57.65 -31.4 66.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.032 1.333 . . . . 0.0 112.472 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -73.07 -36.24 66.81 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.312 1.445 . . . . 0.0 111.831 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pp -92.93 -22.92 18.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -127.66 64.06 62.35 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.372 1.069 . . . . 0.0 113.768 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.83 153.77 72.29 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 124.162 3.241 . . . . 0.0 113.999 167.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -92.12 -66.82 0.9 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.723 -0.61 . . . . 0.0 111.601 164.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -55.59 -32.71 63.31 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -77.23 -17.15 58.68 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.559 1.544 . . . . 0.0 114.439 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -99.37 -42.69 6.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.13 0.972 . . . . 0.0 112.472 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.85 -23.31 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.039 1.736 . . . . 0.0 111.829 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.19 -25.7 62.64 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.593 1.557 . . . . 0.0 112.909 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -79.8 -22.39 43.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.635 1.174 . . . . 0.0 113.014 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -130.2 -26.27 2.37 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? 30.46 75.98 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.749 2.42 . . . . 0.0 115.572 166.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.45 5.9 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 114.224 -1.353 . . . . 0.0 115.052 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -89.91 173.82 8.02 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 123.219 1.485 . . . . 0.0 111.96 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -115.64 162.1 17.73 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 127.264 2.226 . . . . 0.0 111.662 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 66.95 153.09 0.13 Allowed Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 128.591 2.756 . . . . 0.0 115.53 -170.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -94.79 127.93 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.858 3.039 . . . . 0.0 111.229 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -71.62 0.29 9.01 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 -170.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.23 -23.68 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.118 2.567 . . . . 0.0 112.021 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.83 -104.88 0.64 Allowed Glycine 0 C--N 1.34 0.788 0 O-C-N 120.879 -1.138 . . . . 0.0 112.146 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.7 ttm -55.65 -23.9 30.67 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 171.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.74 6.62 47.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.1 mt -120.65 -25.63 5.47 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.825 2.45 . . . . 0.0 112.865 168.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -158.83 159.41 35.05 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -169.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.87 -157.84 0.63 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.937 1.695 . . . . 0.0 110.146 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -130.29 109.96 11.16 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.278 2.231 . . . . 0.0 108.118 172.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -116.49 168.52 10.09 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 126.896 2.079 . . . . 0.0 112.82 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -109.13 144.11 37.62 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.534 1.534 . . . . 0.0 107.692 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.31 -157.72 25.65 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ptp -146.07 161.87 39.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.914 1.286 . . . . 0.0 113.862 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 127' ' ' PHE . 46.6 m-85 -125.38 131.04 53.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.085 2.554 . . . . 0.0 109.838 171.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -137.2 173.67 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.497 1.519 . . . . 0.0 110.056 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.92 158.79 27.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 123.217 1.484 . . . . 0.0 113.308 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.96 -3.59 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.096 168.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.8 m -125.01 -22.01 4.55 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.404 1.482 . . . . 0.0 114.629 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.5 p -122.11 -88.57 0.62 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.403 1.481 . . . . 0.0 113.104 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -152.6 -46.59 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -127.43 161.23 55.92 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -140.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.43 150.45 41.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.081 3.187 . . . . 0.0 113.34 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -137.36 -34.54 0.7 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -152.72 146.73 25.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.445 1.02 . . . . 0.0 112.474 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 67' ' ' TYR . 85.5 p -81.66 145.82 30.36 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.644 -1.285 . . . . 0.0 111.356 169.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -61.4 -17.98 56.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.29 -34.83 66.85 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.897 1.679 . . . . 0.0 113.396 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -9.44 51.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.574 1.15 . . . . 0.0 112.216 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -70.58 108.17 4.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.187 0.903 . . . . 0.0 109.979 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.05 149.8 8.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.105 1.362 . . . . 0.0 114.577 -153.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 2.7 t -86.08 45.29 1.21 Allowed 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.925 -1.109 . . . . 0.0 112.494 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.1 p -79.09 160.78 26.92 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.784 -0.573 . . . . 0.0 111.809 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.32 4.04 5.28 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 p -112.37 -35.78 5.48 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.143 1.472 . . . . 0.0 113.335 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.08 8.06 64.03 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 123.857 0.741 . . . . 0.0 113.326 -165.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 74.2 t90 -63.39 137.83 97.19 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.138 0.975 . . . . 0.0 110.666 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.58 104.65 1.91 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.112 1.875 . . . . 0.0 114.382 -157.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.04 149.96 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.052 1.741 . . . . 0.0 110.628 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.97 108.74 8.56 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.293 1.837 . . . . 0.0 108.79 -162.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.3 p -67.1 -18.47 65.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.84 154.35 39.38 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.149 0.98 . . . . 0.0 110.988 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.93 74.27 10.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.734 0.813 . . . . 0.0 109.069 166.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.433 ' HB3' ' H ' ' A' ' 49' ' ' SER . 14.7 t80 -74.13 84.15 1.82 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.411 1.1 . . . . 0.0 112.234 -169.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.28 -21.6 0.07 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.943 2.211 . . . . 0.0 112.252 -167.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 t -108.37 142.77 38.21 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.597 1.198 . . . . 0.0 112.712 161.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 1.4 tptt -148.1 98.12 2.88 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.681 1.992 . . . . 0.0 113.611 -169.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.92 -66.21 0.47 Allowed Glycine 0 N--CA 1.473 1.113 0 C-N-CA 127.928 2.68 . . . . 0.0 115.633 159.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -27.83 26.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.646 1.578 . . . . 0.0 112.294 165.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.542 ' HB2' ' H ' ' A' ' 70' ' ' LYS . 31.9 m-20 -86.11 30.9 0.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.656 1.217 . . . . 0.0 113.818 -161.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -78.14 -15.44 58.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.174 1.789 . . . . 0.0 114.032 -161.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.83 -11.88 7.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.328 1.051 . . . . 0.0 112.669 171.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -65.1 -23.59 67.2 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.405 1.082 . . . . 0.0 113.443 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.17 -29.35 63.58 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.695 2.398 . . . . 0.0 115.072 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.19 14.07 76.59 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.781 0.705 . . . . 0.0 113.771 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.21 167.2 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 122.441 1.115 . . . . 0.0 111.554 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.23 176.94 8.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.093 1.757 . . . . 0.0 110.469 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.542 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -157.7 163.57 38.03 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.913 1.685 . . . . 0.0 111.796 -167.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.9 156.64 20.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.911 2.884 . . . . 0.0 105.348 -157.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -124.47 151.64 44.33 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 127.283 2.233 . . . . 0.0 111.074 169.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.84 21.35 5.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.203 1.801 . . . . 0.0 111.422 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.7 t -69.57 32.51 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.494 2.318 . . . . 0.0 114.767 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 t -138.2 12.31 2.82 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.796 3.238 . . . . 0.0 111.032 -174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -109.18 22.98 15.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.876 2.47 . . . . 0.0 112.187 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.89 -16.33 58.67 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 125.064 1.316 . . . . 0.0 114.406 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 t -143.15 143.88 26.44 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.794 1.238 . . . . 0.0 110.608 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.88 133.79 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.477 2.118 . . . . 0.0 112.909 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -148.55 154.1 39.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 129.181 2.992 . . . . 0.0 109.25 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.2 mtt -135.0 145.67 48.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.496 2.319 . . . . 0.0 108.215 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -139.47 138.27 36.27 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.197 0.999 . . . . 0.0 111.37 -169.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.85 139.22 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 122.314 1.054 . . . . 0.0 112.092 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.43 152.4 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.848 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.1 t -89.54 121.21 31.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 164.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.41 -18.6 31.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.534 1.934 . . . . 0.0 111.883 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -67.8 -28.58 67.71 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.1 p -129.61 -3.82 4.76 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 126.225 1.81 . . . . 0.0 115.042 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.272 11.6 mt-10 62.27 42.35 9.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 127.279 2.232 . . . . 0.0 113.761 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.89 52.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.608 1.963 . . . . 0.0 112.573 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 115.2 17.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 165.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.32 -35.42 3.8 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -170.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.87 132.82 5.74 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 127.005 2.241 . . . . 0.0 112.004 -164.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.51 28.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.086 0.946 . . . . 0.0 110.994 -172.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.49 127.92 32.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.147 -0.97 . . . . 0.0 109.577 -149.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -148.6 150.22 33.09 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.92 132.84 25.59 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.876 2.384 . . . . 0.0 110.174 156.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.04 11.92 10.6 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.22 -67.24 0.34 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.955 1.74 . . . . 0.0 112.311 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.38 -164.34 0.19 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.113 3.209 . . . . 0.0 112.192 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -61.0 143.84 91.44 Favored Pre-proline 0 N--CA 1.473 0.696 0 O-C-N 120.286 -1.509 . . . . 0.0 112.555 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.5 -2.42 8.3 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.904 3.069 . . . . 0.0 114.127 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -50.15 -35.4 25.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.159 1.345 . . . . 0.0 110.897 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -90.59 16.2 58.5 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.216 2.341 . . . . 0.0 117.098 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.59 149.11 11.19 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -116.68 139.66 50.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.721 1.608 . . . . 0.0 110.022 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.6 100.19 11.78 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 174.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.9 t -74.77 143.77 43.9 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.656 -0.652 . . . . 0.0 110.871 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.9 mt -140.61 132.58 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.021 0.528 . . . . 0.0 110.266 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.84 99.3 12.19 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -173.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.3 p -52.19 -31.16 30.4 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.2 p -46.68 -29.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.861 2.064 . . . . 0.0 115.258 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.96 10.7 40.81 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.3 170.86 15.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.174 1.789 . . . . 0.0 111.702 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 129.97 52.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 110.325 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 43.8 p90 -142.82 145.87 33.63 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 112.753 -171.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -154.65 150.42 21.7 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.01 1.324 . . . . 0.0 112.175 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.04 169.1 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.069 1.846 . . . . 0.0 111.613 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.67 -42.67 9.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.826 1.25 . . . . 0.0 111.683 176.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -57.21 152.43 30.83 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.358 2.263 . . . . 0.0 113.235 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.17 -178.81 1.2 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.667 2.911 . . . . 0.0 113.481 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.18 14.7 6.86 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.377 1.871 . . . . 0.0 114.618 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -147.35 -60.81 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.515 1.526 . . . . 0.0 111.569 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.91 35.77 0.59 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.197 -0.939 . . . . 0.0 113.344 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 16.1 tp -153.57 37.25 0.46 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.033 1.333 . . . . 0.0 113.17 -172.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -83.08 37.96 0.57 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.024 2.13 . . . . 0.0 112.967 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -58.19 164.3 2.48 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.711 2.804 . . . . 0.0 115.155 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -134.16 93.84 3.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.937 1.695 . . . . 0.0 109.313 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -123.68 44.39 2.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.591 1.156 . . . . 0.0 112.325 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -148.97 151.31 34.35 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.232 1.813 . . . . 0.0 110.244 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.85 154.55 50.48 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.725 1.61 . . . . 0.0 111.301 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.9 p80 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.701 1.6 . . . . 0.0 114.414 178.736 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.825 0.345 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.19 -9.87 0.15 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.545 2.338 . . . . 0.0 115.121 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.25 170.4 16.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.116 1.767 . . . . 0.0 111.347 163.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -98.96 -28.55 13.38 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.923 0.889 . . . . 0.0 112.918 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -52.77 -48.82 66.53 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.428 1.091 . . . . 0.0 112.174 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -74.89 -29.46 61.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.704 1.202 . . . . 0.0 112.573 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -69.67 -41.01 76.07 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.915 1.286 . . . . 0.0 112.415 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -93.72 -24.8 17.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.715 1.206 . . . . 0.0 114.009 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.34 58.67 32.35 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.109 1.763 . . . . 0.0 111.103 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.04 133.29 37.75 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.239 1.96 . . . . 0.0 112.65 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -92.84 -51.97 4.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.586 -148.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -59.47 -29.99 68.21 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 167.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -77.17 -24.36 51.47 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.749 2.02 . . . . 0.0 114.216 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -83.27 -42.38 17.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.457 1.503 . . . . 0.0 111.072 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.96 -30.66 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.457 1.103 . . . . 0.0 113.52 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -72.96 -25.77 61.13 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.08 1.352 . . . . 0.0 112.933 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -27.32 68.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.14 2.176 . . . . 0.0 110.545 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -130.21 -19.12 3.19 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.4 tptm 6.82 67.56 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.687 3.195 . . . . 0.0 119.023 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.1 -12.64 3.32 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 114.315 -1.311 . . . . 0.0 114.712 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 t -47.84 135.9 11.59 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.266 1.826 . . . . 0.0 111.368 172.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -130.86 140.56 50.24 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 112.796 -2.002 . . . . 0.0 113.521 171.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.25 153.68 15.33 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.874 2.47 . . . . 0.0 108.468 171.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.38 101.71 1.29 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 121.995 1.797 . . . . 0.0 112.354 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -142.6 -24.68 0.64 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . 5.6 m -65.8 -15.88 63.29 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.34 1.856 . . . . 0.0 114.594 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.94 -108.41 0.95 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.388 1.47 . . . . 0.0 112.753 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 9.4 mtm -62.25 -12.83 22.66 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 26' ' ' SER . 0.2 OUTLIER -99.94 4.1 44.78 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.655 1.582 . . . . 0.0 114.498 171.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.86 -41.38 17.53 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.368 1.44 . . . . 0.0 113.388 169.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -101.92 151.54 21.98 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.048 0.939 . . . . 0.0 112.878 -174.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 50.2 -162.38 0.05 Allowed 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.028 1.331 . . . . 0.0 113.656 -169.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 29' ' ' TYR . 19.2 mmtt -178.74 144.93 0.28 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.429 1.091 . . . . 0.0 112.106 119.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -46.38 173.8 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.977 2.911 . . . . 0.0 117.068 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.19 142.93 26.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.316 1.846 . . . . 0.0 107.397 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.87 -155.5 20.88 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.103 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 ptp -159.99 166.97 28.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -127.78 135.79 50.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.457 2.703 . . . . 0.0 109.629 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -144.96 155.68 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 0.0 110.753 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 m -68.3 167.17 14.98 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 123.401 1.572 . . . . 0.0 112.543 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.26 -8.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 113.504 -1.68 . . . . 0.0 111.927 152.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -97.2 -18.63 19.14 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.16 1.784 . . . . 0.0 114.73 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.1 p -118.73 -105.09 0.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.315 2.246 . . . . 0.0 109.013 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -163.36 -38.87 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.84 2.056 . . . . 0.0 113.699 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.21 140.5 24.45 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -165.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.95 146.66 65.95 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.388 2.059 . . . . 0.0 111.101 170.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.61 -27.87 2.32 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -134.52 127.11 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.426 -0.796 . . . . 0.0 112.324 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 p -84.44 141.12 31.04 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.696 -1.253 . . . . 0.0 110.196 164.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -18.32 23.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.111 0.964 . . . . 0.0 113.436 170.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.52 -41.79 61.27 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.92 1.688 . . . . 0.0 114.262 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -71.4 -8.92 56.96 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.592 1.557 . . . . 0.0 112.841 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -81.01 129.64 34.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.247 0.546 . . . . 0.0 112.019 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -68.44 138.26 55.14 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 160.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.1 t -158.98 -32.16 0.07 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 p -44.18 90.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.574 2.75 . . . . 0.0 115.227 -169.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.77 -1.72 71.83 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 117.993 -1.448 . . . . 0.0 116.459 170.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.8 m -135.48 -10.43 2.16 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.079 1.94 . . . . 0.0 111.805 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.97 -8.7 5.96 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 120.669 -1.269 . . . . 0.0 115.152 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -63.17 144.39 97.39 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -155.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -90.82 107.46 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.201 1.934 . . . . 0.0 114.321 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 t -154.81 153.67 31.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.466 1.507 . . . . 0.0 111.379 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.73 119.22 22.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.195 2.198 . . . . 0.0 107.471 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 p -70.31 -14.46 62.59 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -153.42 161.16 42.57 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.41 69.14 1.1 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.145 1.778 . . . . 0.0 110.024 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.34 100.92 0.87 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.298 1.047 . . . . 0.0 110.969 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.19 -12.9 2.09 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.772 1.177 . . . . 0.0 112.208 -158.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.1 p -107.3 147.26 30.49 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.851 1.261 . . . . 0.0 110.865 145.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.25 59.31 1.16 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.997 1.719 . . . . 0.0 115.591 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.66 -62.04 0.05 OUTLIER Glycine 0 N--CA 1.476 1.364 0 C-N-CA 127.553 2.501 . . . . 0.0 115.464 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 t -49.51 -42.65 44.19 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.754 2.021 . . . . 0.0 110.953 159.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -113.37 94.67 4.98 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.618 1.567 . . . . 0.0 108.937 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -133.43 -38.58 0.93 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.556 1.542 . . . . 0.0 110.628 175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.9 t -73.84 -34.31 64.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.394 1.478 . . . . 0.0 110.947 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.99 -28.89 70.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -20.75 63.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.576 1.151 . . . . 0.0 112.908 -173.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.48 12.46 58.8 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.705 -1.053 . . . . 0.0 113.232 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -96.72 159.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.355 1.077 . . . . 0.0 110.14 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -144.1 164.54 30.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.315 1.446 . . . . 0.0 111.029 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.98 158.87 43.43 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.42 112.2 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.169 2.587 . . . . 0.0 107.37 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.35 154.9 28.71 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.07 0.948 . . . . 0.0 110.861 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -141.01 34.96 1.74 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.828 0.823 . . . . 0.0 112.961 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -71.95 55.19 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 124.051 1.881 . . . . 0.0 109.629 157.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -142.18 8.36 1.83 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.038 2.535 . . . . 0.0 112.351 -167.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.4 mt -128.04 20.24 6.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.647 1.979 . . . . 0.0 112.571 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.42 2.17 73.24 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 120.976 -1.077 . . . . 0.0 115.588 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.6 t -135.39 138.91 29.91 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 127.327 2.251 . . . . 0.0 110.085 168.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.13 135.61 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.501 2.801 . . . . 0.0 114.658 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -144.68 158.42 43.79 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.298 2.639 . . . . 0.0 110.628 167.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.4 mtp -141.92 125.85 17.18 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.388 2.675 . . . . 0.0 107.864 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -133.18 146.48 51.57 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.872 -1.142 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.61 153.32 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.241 1.416 . . . . 0.0 110.962 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.03 140.63 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.259 1.424 . . . . 0.0 109.144 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 42.9 t -76.72 97.37 4.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 124.085 1.897 . . . . 0.0 106.604 160.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -66.83 -14.72 63.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.727 -1.578 . . . . 0.0 111.545 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -66.53 -50.48 63.05 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.885 1.274 . . . . 0.0 112.426 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -100.89 -11.99 19.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.009 2.123 . . . . 0.0 114.281 -173.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 68.02 17.91 9.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.395 1.878 . . . . 0.0 113.994 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . . . -75.7 86.11 2.73 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.057 1.408 . . . . 0.0 112.229 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -89.78 67.58 7.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.827 1.651 . . . . 0.0 113.404 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.275 0.0 OUTLIER -135.02 5.88 3.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 118.528 2.788 . . . . 0.0 118.528 -170.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.06 129.3 9.0 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.47 1.032 . . . . 0.0 112.679 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -147.71 160.74 42.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.8 142.45 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 123.692 1.71 . . . . 0.0 112.745 -171.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -149.1 156.59 40.26 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 127.322 2.249 . . . . 0.0 110.435 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.38 142.49 54.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.292 1.995 . . . . 0.0 109.444 165.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.94 18.05 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 113.583 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.64 -64.15 0.6 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.529 2.49 . . . . 0.0 112.739 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -86.53 -153.65 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.544 4.162 . . . . 0.0 113.516 -174.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.83 149.41 2.31 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 127.597 2.359 . . . . 0.0 113.712 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.81 -7.9 19.78 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.411 2.741 . . . . 0.0 114.498 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.1 p -58.87 -27.12 64.87 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.182 -0.949 . . . . 0.0 112.131 165.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -88.16 5.9 84.21 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.202 1.858 . . . . 0.0 116.324 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -58.88 127.3 31.52 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 1.428 . . . . 0.0 111.876 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -109.23 120.18 41.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.37 1.068 . . . . 0.0 109.583 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -90.37 76.19 6.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.825 1.298 . . . . 0.0 110.117 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.4 t -66.31 131.03 45.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.533 1.635 . . . . 0.0 111.59 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.3 tt -148.41 166.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.679 -1.601 . . . . 0.0 109.086 -168.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.44 134.56 46.33 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.256 -1.527 . . . . 0.0 113.889 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -81.04 -32.56 34.04 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.24 -33.56 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.86 2.56 14.22 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.3 mt -135.19 171.94 13.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.002 2.521 . . . . 0.0 110.034 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 9.7 mmpt? -109.82 159.38 17.25 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.933 -1.105 . . . . 0.0 112.694 168.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -148.59 153.0 37.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -146.33 145.97 25.92 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 125.797 1.639 . . . . 0.0 111.491 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.73 173.43 14.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.655 2.237 . . . . 0.0 112.072 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.6 t -100.06 -54.93 2.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.233 1.013 . . . . 0.0 111.28 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -51.12 139.93 23.18 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.542 1.937 . . . . 0.0 114.555 -174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.28 171.72 17.73 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.717 2.278 . . . . 0.0 113.999 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 61.75 22.47 13.01 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.999 2.119 . . . . 0.0 114.365 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.8 -17.59 40.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.504 1.522 . . . . 0.0 113.846 -173.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.83 173.51 0.27 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.905 2.482 . . . . 0.0 115.923 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.5 tp -164.13 57.94 0.15 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.557 2.343 . . . . 0.0 107.922 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.01 -37.19 8.81 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.777 2.431 . . . . 0.0 114.376 -169.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -156.18 148.66 23.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.161 1.384 . . . . 0.0 109.895 159.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -82.66 -11.15 58.57 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -165.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -150.87 127.29 10.7 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.899 1.227 . . . . 0.0 114.091 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -156.2 159.81 39.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.96 1.304 . . . . 0.0 112.773 162.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -158.56 152.2 23.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.385 2.274 . . . . 0.0 107.565 159.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 N--CA 1.48 1.058 0 CA-C-N 119.796 1.18 . . . . 0.0 111.673 166.0 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mpp? . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.6 2.12 18.48 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.909 1.284 . . . . 0.0 113.206 169.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -97.08 139.11 33.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.105 2.162 . . . . 0.0 113.649 -173.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -75.75 -27.9 58.29 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.998 1.719 . . . . 0.0 110.925 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -51.84 -52.26 50.65 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.949 1.3 . . . . 0.0 110.385 172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -74.66 -31.37 61.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -67.53 -37.62 83.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.744 0.818 . . . . 0.0 111.836 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.8 mt -88.8 -26.55 21.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.151 1.38 . . . . 0.0 113.378 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.258 11.8 t -135.12 85.45 33.89 Favored Pre-proline 0 N--CA 1.478 0.941 0 CA-C-N 119.641 1.11 . . . . 0.0 113.219 167.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.31 -179.25 5.28 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.352 2.701 . . . . 0.0 114.564 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -47.7 -48.84 29.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.284 1.434 . . . . 0.0 112.904 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -61.23 -32.17 71.95 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.582 0.753 . . . . 0.0 112.022 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -78.76 -36.62 42.78 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.292 1.037 . . . . 0.0 111.61 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.79 -43.48 65.62 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.604 1.093 . . . . 0.0 110.843 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.96 -37.47 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 120.993 -1.067 . . . . 0.0 111.739 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -68.54 -29.04 67.53 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.399 1.454 . . . . 0.0 112.388 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -62.88 -39.08 93.35 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.429 0.558 . . . . 0.0 110.979 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -75.48 -28.35 59.19 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 121.481 0.658 . . . . 0.0 111.166 171.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -74.74 22.99 0.1 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.7 -18.96 1.07 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 127.024 2.25 . . . . 0.0 115.025 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -90.95 105.09 17.59 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 123.271 1.51 . . . . 0.0 111.897 -172.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 143.59 45.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.218 149.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -166.82 153.81 8.41 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.16 -177.44 2.65 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.372 3.381 . . . . 0.0 112.001 163.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.1 t80 61.67 -8.1 0.1 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 p -30.6 -44.24 0.05 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.53 1.932 . . . . 0.0 112.259 137.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.95 -99.79 0.52 Allowed Glycine 0 N--CA 1.466 0.684 0 O-C-N 121.116 -0.99 . . . . 0.0 113.438 160.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.1 ttm -54.91 -33.7 62.38 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.114 -0.639 . . . . 0.0 111.225 167.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -11.02 60.66 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.1 mt -86.26 -15.82 39.53 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.838 1.255 . . . . 0.0 112.134 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -138.79 4.83 2.35 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.8 110.45 4.27 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.42 -1.425 . . . . 0.0 112.607 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 4.0 mmpt? -152.19 130.98 12.42 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.371 2.668 . . . . 0.0 107.456 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -68.3 169.67 10.14 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 128.309 2.644 . . . . 0.0 115.409 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 m -85.52 152.01 23.5 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.414 1.086 . . . . 0.0 108.167 165.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.38 -152.51 18.15 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptp -155.25 174.58 15.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.897 1.679 . . . . 0.0 113.011 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.47 148.28 52.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.715 1.606 . . . . 0.0 112.378 163.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -137.17 169.37 17.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.826 2.051 . . . . 0.0 111.758 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -76.21 168.4 20.12 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 123.781 1.753 . . . . 0.0 114.05 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.54 26.33 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 127.352 2.261 . . . . 0.0 111.409 164.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.62 -41.08 2.03 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.508 1.523 . . . . 0.0 111.103 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.3 p -97.33 -99.16 0.2 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.139 1.376 . . . . 0.0 110.85 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.08 -49.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.021 1.328 . . . . 0.0 114.202 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -99.66 154.07 37.45 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -142.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.0 142.17 99.12 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.933 1.756 . . . . 0.0 110.336 158.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.33 -34.93 1.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.673 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -135.87 134.76 39.14 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 p -91.13 127.55 36.6 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.312 1.053 . . . . 0.0 109.46 164.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.46 -7.21 29.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 113.383 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 4.9 mt-10 -59.05 -33.13 70.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.663 167.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 6.9 mmpt? -75.69 7.81 3.5 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.149 0.979 . . . . 0.0 111.955 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . 16.0 ttpp -52.69 132.85 36.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.42 0.629 . . . . 0.0 111.432 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -73.22 143.79 47.01 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.902 1.281 . . . . 0.0 111.802 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.4 m 47.55 -164.45 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.597 1.959 . . . . 0.0 114.558 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.6 p -101.8 -93.35 0.3 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.345 -1.472 . . . . 0.0 112.204 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.59 25.95 6.89 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 117.542 1.777 . . . . 0.0 117.542 -157.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.88 -13.1 54.43 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.394 2.097 . . . . 0.0 111.146 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.55 1.29 4.48 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.364 1.459 . . . . 0.0 114.358 -170.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -93.95 134.65 25.75 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 118.629 1.215 . . . . 0.0 114.161 -152.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.58 105.11 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.983 2.455 . . . . 0.0 112.92 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -157.83 144.92 18.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.643 1.977 . . . . 0.0 110.605 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -143.58 117.15 9.17 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.094 1.357 . . . . 0.0 109.832 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.4 p -69.19 -23.68 63.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -145.44 158.22 43.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.944 0.897 . . . . 0.0 112.006 162.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.03 71.28 5.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.335 1.054 . . . . 0.0 109.322 162.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -79.97 100.24 8.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.862 0.839 . . . . 0.0 111.065 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.34 -34.14 0.02 OUTLIER Glycine 0 CA--C 1.537 1.446 0 C-N-CA 128.818 3.104 . . . . 0.0 110.068 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.5 p -125.05 144.15 50.55 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.094 1.757 . . . . 0.0 113.482 174.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -139.05 134.98 33.71 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.947 2.099 . . . . 0.0 110.367 170.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.71 -79.1 0.01 OUTLIER Glycine 0 N--CA 1.476 1.318 0 C-N-CA 128.81 3.1 . . . . 0.0 115.232 162.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.8 m -50.12 -27.46 5.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.101 2.16 . . . . 0.0 114.247 165.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.54 15.39 10.34 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -166.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -62.29 -35.23 78.39 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.284 -1.51 . . . . 0.0 112.012 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.8 t -81.85 -24.28 35.89 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.211 0.604 . . . . 0.0 111.565 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -66.58 -21.0 66.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.68 -22.63 67.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.703 1.201 . . . . 0.0 112.933 169.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.95 6.04 54.81 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.952 -0.915 . . . . 0.0 114.592 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -93.74 161.87 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.816 1.77 . . . . 0.0 114.901 -171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -134.57 -178.07 4.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.513 2.325 . . . . 0.0 109.221 168.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.583 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -151.74 161.74 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.676 1.19 . . . . 0.0 113.482 -171.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.24 117.44 8.97 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 129.113 2.965 . . . . 0.0 106.487 -175.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.85 148.92 25.04 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.032 1.333 . . . . 0.0 112.314 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.56 36.88 3.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.957 1.303 . . . . 0.0 112.537 -163.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p -68.3 22.38 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.918 2.087 . . . . 0.0 115.492 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.3 t -126.66 -2.81 6.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.8 2.04 . . . . 0.0 113.455 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.54 12.37 7.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.544 1.538 . . . . 0.0 112.771 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.01 -9.59 65.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.49 1.519 . . . . 0.0 113.856 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.7 t -139.71 143.27 34.39 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.661 1.984 . . . . 0.0 109.683 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.71 133.62 43.08 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.041 1.827 . . . . 0.0 112.039 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -137.05 154.76 50.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.442 1.897 . . . . 0.0 109.475 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 ttm -133.47 134.65 43.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.54 1.536 . . . . 0.0 108.881 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -134.98 147.46 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.475 1.51 . . . . 0.0 110.575 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.61 146.9 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.188 1.395 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.71 144.4 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.218 1.007 . . . . 0.0 111.71 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.6 t -79.07 105.12 10.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 166.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -77.04 -7.7 56.14 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -69.0 -51.59 37.66 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.453 1.901 . . . . 0.0 112.03 172.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 17.5 p -112.09 -5.95 14.21 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.179 1.791 . . . . 0.0 114.453 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 62.4 63.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.028 2.531 . . . . 0.0 113.766 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.52 152.93 43.13 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -77.48 80.59 3.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.302 1.841 . . . . 0.0 112.511 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 103' ' ' LEU 0.255 3.4 mm? -91.63 48.13 1.43 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 124.121 1.915 . . . . 0.0 114.559 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.36 163.63 10.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 111.123 -2.762 . . . . 0.0 115.611 150.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.79 163.0 40.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.668 0.787 . . . . 0.0 111.255 -174.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.34 142.21 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.166 1.386 . . . . 0.0 112.049 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.22 153.54 73.19 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.098 1.759 . . . . 0.0 113.872 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.19 135.3 7.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.961 3.108 . . . . 0.0 112.006 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -118.61 4.78 11.65 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -162.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.62 -38.36 1.0 Allowed Glycine 0 CA--C 1.544 1.85 0 CA-C-O 117.458 -1.746 . . . . 0.0 116.347 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -101.24 -172.91 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.153 3.235 . . . . 0.0 113.226 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -51.51 156.99 1.91 Allowed Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 125.751 1.62 . . . . 0.0 112.363 163.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.93 -4.02 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.698 2.932 . . . . 0.0 114.359 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -20.37 65.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.207 1.403 . . . . 0.0 113.58 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.98 -90.38 0.47 Allowed Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.658 1.599 . . . . 0.0 112.765 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 50.28 140.45 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 131.581 3.952 . . . . 0.0 119.009 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -110.81 126.51 54.71 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.981 -1.074 . . . . 0.0 109.913 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -90.05 122.56 33.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.064 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.6 p -105.83 122.8 46.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.594 1.558 . . . . 0.0 110.488 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.09 166.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.884 1.674 . . . . 0.0 109.591 -175.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.42 108.63 2.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.512 1.125 . . . . 0.0 113.341 173.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.3 m -75.1 56.14 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.431 1.492 . . . . 0.0 111.48 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -41.38 -46.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 128.521 2.728 . . . . 0.0 114.641 -162.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.98 38.92 1.2 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.463 1.905 . . . . 0.0 110.491 166.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.8 mt -110.76 165.75 11.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.559 1.544 . . . . 0.0 111.014 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.8 mmpt? -94.82 146.09 24.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -163.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -141.32 149.28 41.0 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.202 -0.936 . . . . 0.0 112.353 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -144.73 148.51 39.84 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 124.947 1.299 . . . . 0.0 111.644 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.2 174.86 8.4 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.824 1.683 . . . . 0.0 110.023 163.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.87 -38.95 18.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.714 0.768 . . . . 0.0 112.003 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.62 155.77 19.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.651 2.38 . . . . 0.0 115.191 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.63 179.0 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.907 3.071 . . . . 0.0 113.47 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.88 2.92 1.07 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.467 2.307 . . . . 0.0 114.163 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.08 -31.54 0.2 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.89 1.676 . . . . 0.0 113.031 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.15 154.94 16.98 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.918 0.887 . . . . 0.0 111.461 155.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.9 tp -157.99 44.91 0.33 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.735 1.614 . . . . 0.0 110.207 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.71 -34.07 76.4 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -161.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -151.16 170.99 18.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.45 1.1 . . . . 0.0 111.964 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -70.61 138.69 51.02 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.877 -0.515 . . . . 0.0 109.837 160.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -120.01 155.33 33.08 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.706 0.802 . . . . 0.0 112.108 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -47.16 -41.14 17.25 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 32.7 m80 44.19 47.11 7.6 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . 0.347 0.3 OUTLIER . . . . . 0 C--O 1.247 0.939 0 C-N-CA 128.209 2.604 . . . . 0.0 117.571 168.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 119.557 -0.258 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.33 -51.43 0.14 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.467 0.707 . . . . 0.0 111.762 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -157.08 171.25 20.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.447 1.499 . . . . 0.0 111.223 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -90.32 -30.77 17.26 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.469 1.108 . . . . 0.0 111.37 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -61.86 -46.34 89.84 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.543 0.737 . . . . 0.0 109.67 -172.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -57.9 -31.98 67.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.771 1.228 . . . . 0.0 113.882 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -82.39 -36.71 26.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.25 1.82 . . . . 0.0 112.619 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.72 -38.65 67.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.147 1.779 . . . . 0.0 112.609 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.26 69.48 80.25 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.848 1.659 . . . . 0.0 111.514 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.94 -178.8 2.19 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.31 2.674 . . . . 0.0 113.602 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -49.75 -50.15 45.47 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.241 -1.537 . . . . 0.0 113.71 -167.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -61.69 -31.77 71.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.303 0.641 . . . . 0.0 112.239 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -77.62 -37.51 49.98 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.601 1.161 . . . . 0.0 111.756 176.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -71.47 -44.99 63.74 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.246 1.018 . . . . 0.0 111.126 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.5 t -71.15 -32.43 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.092 1.357 . . . . 0.0 111.995 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 p -69.03 -16.04 63.61 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 121.364 1.893 . . . . 0.0 113.93 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -44.54 13.48 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.079 0.952 . . . . 0.0 110.34 164.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -19.19 62.47 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -75.71 28.84 0.11 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.615 -1.303 . . . . 0.0 113.257 165.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.56 27.51 0.1 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.101 1.334 . . . . 0.0 113.918 -167.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 t -134.82 173.54 11.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.614 1.566 . . . . 0.0 111.118 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -121.27 160.75 23.26 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 127.045 2.138 . . . . 0.0 112.376 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.63 159.85 27.99 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 124.816 1.246 . . . . 0.0 111.636 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.27 155.5 67.38 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.893 2.395 . . . . 0.0 115.478 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.53 -34.47 75.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.89 1.676 . . . . 0.0 113.023 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.0 m 62.92 -37.66 0.15 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 131.61 3.964 . . . . 0.0 114.616 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.76 -106.34 0.68 Allowed Glycine 0 C--O 1.224 -0.472 0 C-N-CA 126.412 1.958 . . . . 0.0 112.922 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.1 mtt -57.43 -27.35 62.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.329 0.651 . . . . 0.0 112.396 170.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -80.12 6.71 10.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.864 1.266 . . . . 0.0 114.054 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -82.95 12.27 5.14 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.297 1.039 . . . . 0.0 112.753 156.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -70.79 -23.96 62.49 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.786 -1.196 . . . . 0.0 114.211 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -144.92 108.07 4.55 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.633 0.773 . . . . 0.0 112.363 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -140.82 113.92 8.48 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.038 1.735 . . . . 0.0 108.537 165.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -93.89 179.34 5.38 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.24 1.816 . . . . 0.0 112.944 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.433 HG23 ' CB ' ' A' ' 130' ' ' SER . 6.9 t -83.58 166.13 18.47 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.127 1.371 . . . . 0.0 111.003 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.0 -160.85 31.83 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.654 1.121 . . . . 0.0 114.91 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -160.19 163.63 33.48 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.863 1.265 . . . . 0.0 113.861 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -95.85 145.5 25.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 128.475 2.71 . . . . 0.0 110.987 167.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -153.67 164.27 38.57 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.825 1.65 . . . . 0.0 112.307 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 69.3 m -67.12 166.13 14.53 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 123.893 1.806 . . . . 0.0 113.788 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.67 16.17 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 126.486 1.915 . . . . 0.0 112.69 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 47.7 t -127.38 -49.51 1.41 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.37 1.068 . . . . 0.0 112.493 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 9.1 p -96.68 -96.54 0.19 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.892 1.277 . . . . 0.0 112.919 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -155.26 -36.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.398 2.279 . . . . 0.0 113.563 -165.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p -82.23 118.23 71.21 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -160.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.31 153.69 77.06 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 120.997 1.132 . . . . 0.0 110.051 136.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.4 tp -152.14 -47.98 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -120.81 122.47 40.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.19 0.904 . . . . 0.0 110.657 -169.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.3 p -75.88 145.62 40.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 123.229 1.49 . . . . 0.0 111.041 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -75.86 -10.07 59.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.484 169.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.79 -40.06 78.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.439 1.496 . . . . 0.0 114.779 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.26 -0.1 53.62 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.342 1.026 . . . . 0.0 113.608 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -99.61 128.1 45.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -159.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -57.8 130.95 48.81 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.856 0.836 . . . . 0.0 111.688 168.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.1 m -125.62 -1.11 7.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.796 1.238 . . . . 0.0 113.876 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.5 p -78.44 131.32 36.85 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 156.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.47 -22.21 76.39 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.859 -1.151 . . . . 0.0 114.579 -175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 p -72.71 -37.28 67.85 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.053 2.541 . . . . 0.0 113.52 170.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.1 -27.42 73.71 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.395 0.998 . . . . 0.0 112.446 166.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 18.0 t90 65.6 141.04 0.06 OUTLIER Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 129.292 3.037 . . . . 0.0 113.72 169.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.94 98.86 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.932 2.421 . . . . 0.0 115.876 -163.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -149.54 155.52 40.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.247 2.219 . . . . 0.0 110.581 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.85 122.11 12.27 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.311 1.844 . . . . 0.0 108.374 -168.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -76.12 -7.61 55.15 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -164.55 154.42 13.95 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 157.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.07 58.98 0.92 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.445 1.898 . . . . 0.0 113.026 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -80.02 120.2 23.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.331 1.052 . . . . 0.0 110.903 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.82 -34.29 0.08 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.026 1.774 . . . . 0.0 111.866 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.1 m -144.89 149.06 34.65 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.834 2.053 . . . . 0.0 110.07 168.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -139.32 130.55 26.72 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.744 2.018 . . . . 0.0 112.137 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.75 -70.85 0.71 Allowed Glycine 0 N--CA 1.474 1.222 0 C-N-CA 125.814 1.673 . . . . 0.0 114.664 165.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -47.81 -35.4 10.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.597 2.359 . . . . 0.0 112.905 169.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -154.06 114.9 4.02 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.639 0.775 . . . . 0.0 110.644 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -136.66 28.63 2.96 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.466 1.507 . . . . 0.0 112.186 161.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 t -158.34 -21.62 0.08 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -7.52 51.79 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.464 1.906 . . . . 0.0 113.547 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 p -49.14 -38.58 25.79 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 128.635 2.774 . . . . 0.0 113.758 157.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.55 13.81 79.44 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.437 1.017 . . . . 0.0 112.948 -175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.8 178.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 122.595 1.188 . . . . 0.0 112.685 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -143.99 173.98 11.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.536 1.935 . . . . 0.0 111.611 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.549 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -146.62 147.71 31.34 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 113.868 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.07 109.71 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.628 1.971 . . . . 0.0 108.747 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.21 150.16 20.57 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.395 1.878 . . . . 0.0 109.069 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.11 120.54 4.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.151 0.887 . . . . 0.0 110.86 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -121.88 32.71 5.74 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.233 1.016 . . . . 0.0 110.423 164.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.5 m -107.36 -13.94 14.99 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 128.156 2.582 . . . . 0.0 113.47 -161.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.45 16.96 5.73 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 127.453 2.301 . . . . 0.0 111.955 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.28 -6.03 52.73 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.1 t -138.57 131.44 16.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.264 2.226 . . . . 0.0 108.999 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.33 144.15 25.75 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.081 2.52 . . . . 0.0 113.776 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -148.27 160.74 42.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 129.406 3.082 . . . . 0.0 112.315 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mtp -143.62 132.27 22.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.108 1.763 . . . . 0.0 109.017 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -138.16 150.09 46.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.125 0.875 . . . . 0.0 112.741 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 141.58 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 110.574 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.65 155.1 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 110.276 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 36.9 t -97.49 112.94 24.58 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 122.631 1.205 . . . . 0.0 108.111 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -67.33 -18.02 65.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.868 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -85.63 -38.56 18.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.553 1.141 . . . . 0.0 112.911 -171.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.6 p -112.21 -13.41 13.5 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 127.709 2.403 . . . . 0.0 114.566 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 6.8 tt0 70.83 53.86 0.27 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.673 2.389 . . . . 0.0 116.151 173.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.34 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.707 1.203 . . . . 0.0 113.065 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.8 40.98 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.381 -0.825 . . . . 0.0 111.046 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.29 -27.13 19.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.079 1.419 . . . . 0.0 113.626 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.02 176.03 32.68 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 126.71 2.1 . . . . 0.0 113.634 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -153.3 167.24 30.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.653 1.216 . . . . 0.0 113.518 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.45 134.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 125.467 1.507 . . . . 0.0 109.024 -161.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.7 159.06 72.8 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.938 1.295 . . . . 0.0 111.999 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -67.11 146.15 75.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.354 2.036 . . . . 0.0 110.668 163.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -114.33 16.02 17.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.612 1.165 . . . . 0.0 113.79 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.46 -71.32 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.988 1.756 . . . . 0.0 112.495 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.51 179.53 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.609 2.873 . . . . 0.0 112.694 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -58.03 151.5 44.9 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.734 1.613 . . . . 0.0 112.735 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.57 -3.43 4.34 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.133 3.222 . . . . 0.0 115.264 -172.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -57.41 -29.12 63.86 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.666 -0.646 . . . . 0.0 112.088 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.41 16.19 60.2 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.19 2.328 . . . . 0.0 116.455 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -47.49 139.9 6.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.618 1.167 . . . . 0.0 113.958 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -114.97 136.21 53.38 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.106 1.762 . . . . 0.0 110.073 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.61 114.73 29.08 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.75 1.62 . . . . 0.0 110.82 -167.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 54.6 m -99.5 142.98 30.28 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.428 2.691 . . . . 0.0 111.504 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.7 mm -107.73 154.81 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.96 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.57 122.39 39.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.101 0.961 . . . . 0.0 112.183 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.7 m -77.39 49.5 0.72 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.391 1.076 . . . . 0.0 113.377 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.35 -55.5 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.28 -0.888 . . . . 0.0 112.633 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.08 -0.53 0.44 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.92 162.62 29.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.58 1.552 . . . . 0.0 110.703 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -108.53 160.81 15.61 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.276 1.43 . . . . 0.0 112.841 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -149.56 143.21 25.45 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.172 1.389 . . . . 0.0 110.449 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -135.17 155.72 78.71 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.243 1.417 . . . . 0.0 111.197 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.37 167.94 25.97 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.027 1.818 . . . . 0.0 112.047 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.433 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -95.58 -35.29 11.69 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.258 1.423 . . . . 0.0 112.723 -177.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.434 ' HE3' ' HD2' ' A' ' 132' ' ' PRO . 25.0 mmmt -67.54 144.88 98.06 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 126.105 1.762 . . . . 0.0 114.591 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.434 ' HD2' ' HE3' ' A' ' 131' ' ' LYS . 38.0 Cg_endo -60.97 171.85 3.45 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.836 2.358 . . . . 0.0 112.876 158.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 58.4 16.91 4.41 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.298 1.839 . . . . 0.0 114.024 -170.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.67 37.7 1.34 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.421 2.288 . . . . 0.0 111.139 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 61.8 41.7 11.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.572 1.549 . . . . 0.0 114.859 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.06 43.39 1.32 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.218 1.407 . . . . 0.0 111.566 162.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.7 13.87 9.65 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -49.44 144.9 5.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.144 1.777 . . . . 0.0 115.118 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -157.41 163.91 38.06 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.226 1.01 . . . . 0.0 111.361 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.64 -157.19 0.24 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 122.821 0.449 . . . . 0.0 110.891 161.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.52 149.22 4.5 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.766 -1.209 . . . . 0.0 112.283 173.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -142.51 171.77 13.61 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.839 2.056 . . . . 0.0 109.294 -170.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 13.3 m170 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.761 -1.114 . . . . 0.0 112.04 170.448 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 tmm? . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.94 67.15 0.54 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.255 1.422 . . . . 0.0 112.845 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.99 165.37 25.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.272 156.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -112.93 -27.25 8.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.025 0.93 . . . . 0.0 113.352 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.278 0.0 OUTLIER -56.19 -54.41 45.54 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.968 2.907 . . . . 0.0 111.863 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -62.89 -27.73 69.56 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -76.47 -36.63 57.77 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.237 1.815 . . . . 0.0 113.721 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.6 mt -82.37 -20.36 37.34 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.887 1.275 . . . . 0.0 113.916 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 14.0 t -140.72 50.14 1.94 Allowed Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 146.28 67.59 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.999 3.132 . . . . 0.0 115.055 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -95.25 -57.38 2.43 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.414 1.086 . . . . 0.0 112.348 -163.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -59.87 -32.19 70.47 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.196 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.92 -45.35 71.07 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 124.156 0.982 . . . . 0.0 111.675 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -65.86 -41.75 91.28 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.001 1.273 . . . . 0.0 112.218 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.06 -38.87 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.902 -1.047 . . . . 0.0 112.49 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -80.4 -32.65 37.49 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.354 1.461 . . . . 0.0 112.388 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -52.18 66.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.213 1.005 . . . . 0.0 109.385 170.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -11.27 59.86 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.135 0.493 . . . . 0.0 111.945 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 59.09 1.4 Allowed 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.318 -2.113 . . . . 0.0 113.66 161.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.95 -6.35 0.22 Allowed Glycine 0 N--CA 1.465 0.621 0 N-CA-C 117.292 1.677 . . . . 0.0 117.292 -168.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.7 t -144.59 133.18 22.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.678 1.239 . . . . 0.0 111.932 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -121.59 145.98 47.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.483 1.913 . . . . 0.0 110.426 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.08 155.51 80.01 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -166.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.22 179.81 5.78 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.32 3.347 . . . . 0.0 112.735 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -49.14 -29.58 5.55 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.1 m 68.1 -28.63 0.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.241 2.617 . . . . 0.0 114.572 172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.25 -102.71 0.11 Allowed Glycine 0 N--CA 1.468 0.801 0 C-N-CA 126.146 1.831 . . . . 0.0 114.147 170.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.8 mtt -55.93 -25.61 44.06 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 171.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -84.34 -1.74 55.92 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.016 1.327 . . . . 0.0 112.997 175.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.22 89.39 3.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.946 1.298 . . . . 0.0 109.602 160.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -53.71 159.55 1.58 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 163.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -56.27 161.92 2.28 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -147.38 117.44 7.27 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 122.173 0.987 . . . . 0.0 112.313 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.03 176.1 0.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.146 2.178 . . . . 0.0 113.283 157.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.36 -176.06 2.83 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -163.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.54 -147.65 10.02 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.372 1.309 . . . . 0.0 116.372 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 ptp -134.54 179.89 6.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.251 1.82 . . . . 0.0 114.048 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.02 144.85 48.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 129.968 3.307 . . . . 0.0 108.695 159.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -144.88 151.13 38.24 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 110.931 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.38 161.76 30.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.134 1.445 . . . . 0.0 111.556 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.25 6.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.711 163.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.3 m -115.48 -57.24 2.26 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.907 1.283 . . . . 0.0 112.405 -165.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.7 p -81.19 -81.28 0.14 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.315 1.046 . . . . 0.0 111.928 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.72 -59.77 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.278 1.431 . . . . 0.0 113.218 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 p -96.85 165.92 14.96 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -154.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -59.36 152.39 61.16 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 120.66 0.906 . . . . 0.0 111.344 150.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 -31.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -128.11 132.77 48.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.58 -0.7 . . . . 0.0 110.935 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.6 m -76.66 140.53 40.96 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.023 -1.048 . . . . 0.0 109.705 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -64.85 -10.97 32.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.967 0.907 . . . . 0.0 112.521 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -87.68 -1.97 58.31 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.228 1.411 . . . . 0.0 113.666 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -95.29 130.12 42.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.594 1.158 . . . . 0.0 109.575 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -67.84 117.87 10.31 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.207 0.203 . . . . 0.0 110.576 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 66.4 m 57.01 -62.7 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.648 2.779 . . . . 0.0 116.699 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.7 p 61.57 162.29 0.07 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.17 1.788 . . . . 0.0 113.645 -158.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.12 2.11 45.44 Favored Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.613 -1.304 . . . . 0.0 115.264 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.17 -7.16 29.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.447 1.899 . . . . 0.0 112.618 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.85 -9.62 10.92 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.959 1.266 . . . . 0.0 114.673 -169.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.23 127.53 27.74 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.168 1.387 . . . . 0.0 111.131 -175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -111.65 125.36 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 122.986 2.458 . . . . 0.0 114.695 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 157.72 43.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.184 2.194 . . . . 0.0 109.904 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -153.1 116.44 4.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.978 1.311 . . . . 0.0 110.058 -169.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.4 p -72.05 -23.91 61.45 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.19 166.66 20.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 113.335 172.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.57 78.63 9.14 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.414 1.085 . . . . 0.0 110.334 162.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -72.2 140.07 48.53 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.399 -0.813 . . . . 0.0 112.171 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.07 -32.55 2.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 126.401 1.953 . . . . 0.0 111.604 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.3 134.04 55.35 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 128.03 2.532 . . . . 0.0 112.757 -175.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.85 130.35 31.66 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.521 1.928 . . . . 0.0 112.401 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.88 -77.98 0.1 Allowed Glycine 0 N--CA 1.474 1.181 0 C-N-CA 125.962 1.744 . . . . 0.0 115.009 159.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.71 -29.55 68.19 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.976 1.311 . . . . 0.0 111.76 167.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -89.34 9.17 27.09 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -165.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -82.69 2.17 34.93 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -169.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.2 t -103.01 -29.89 11.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.904 1.282 . . . . 0.0 111.78 153.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.52 -23.49 63.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.499 1.52 . . . . 0.0 113.677 -169.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.8 p -51.51 -38.11 52.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.373 1.869 . . . . 0.0 113.189 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.28 13.71 70.75 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.198 -170.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.003 1.402 . . . . 0.0 111.485 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.91 177.24 8.03 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.97 1.708 . . . . 0.0 111.869 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 155.44 38.33 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.329 1.451 . . . . 0.0 112.903 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 118.59 5.53 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.779 2.832 . . . . 0.0 107.29 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -75.02 149.8 39.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 111.4 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -136.7 96.5 3.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.732 0.777 . . . . 0.0 111.29 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.3 t -111.03 21.95 15.84 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.603 1.161 . . . . 0.0 112.217 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -5.94 58.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -162.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -98.35 14.08 29.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.623 1.969 . . . . 0.0 111.712 164.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.48 -4.17 64.99 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.988 1.756 . . . . 0.0 115.279 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.0 t -123.52 109.42 30.77 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.166 1.387 . . . . 0.0 109.767 -175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.74 125.6 9.57 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.044 2.496 . . . . 0.0 113.158 -166.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 165.95 13.02 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.169 2.187 . . . . 0.0 109.881 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.37 122.81 44.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.444 1.498 . . . . 0.0 108.021 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -120.32 137.87 54.02 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.981 0.913 . . . . 0.0 109.802 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.55 145.67 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 121.241 -0.912 . . . . 0.0 111.497 -165.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.44 138.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.041 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 42.2 t -72.72 98.63 2.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 123.41 1.576 . . . . 0.0 107.843 161.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.54 -16.66 57.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.884 1.274 . . . . 0.0 111.924 167.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -71.09 -45.61 63.38 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.851 1.205 . . . . 0.0 113.619 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.9 p -123.42 8.81 9.04 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.093 2.157 . . . . 0.0 115.424 -169.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.56 15.7 9.81 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.73 2.012 . . . . 0.0 114.821 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . . . -75.46 83.45 2.54 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.481 -1.387 . . . . 0.0 112.956 -175.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -83.17 58.1 4.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.123 1.769 . . . . 0.0 113.81 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.05 7.97 2.71 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -162.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.43 135.4 12.67 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.056 1.789 . . . . 0.0 110.925 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 157.18 42.83 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.559 -0.965 . . . . 0.0 111.312 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.91 137.85 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.685 1.594 . . . . 0.0 111.505 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.31 149.46 54.96 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.0 1.32 . . . . 0.0 113.112 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.67 146.36 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.573 2.182 . . . . 0.0 110.019 157.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.65 12.5 18.46 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.13 -64.65 0.2 Allowed Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.646 1.117 . . . . 0.0 115.043 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.84 -172.76 1.42 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.935 3.09 . . . . 0.0 113.396 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.95 162.76 0.46 Allowed Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 125.188 1.395 . . . . 0.0 112.507 171.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -60.33 -5.64 4.37 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.138 2.559 . . . . 0.0 114.378 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 18.03 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.635 1.974 . . . . 0.0 113.019 163.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -154.15 19.0 0.64 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.428 1.966 . . . . 0.0 116.535 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.71 161.33 29.74 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.489 1.145 . . . . 0.0 113.966 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -128.44 132.07 48.43 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.042 1.737 . . . . 0.0 109.368 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -99.64 130.85 45.9 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.033 0.933 . . . . 0.0 109.916 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.58 139.97 52.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.326 1.85 . . . . 0.0 109.844 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.8 tt -127.04 170.66 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 109.562 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.78 129.48 50.54 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.74 -1.225 . . . . 0.0 111.643 164.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -83.79 39.42 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.735 1.214 . . . . 0.0 114.251 -167.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -44.57 -36.61 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 -151.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.24 22.51 0.94 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.966 1.706 . . . . 0.0 112.093 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.8 mt -98.5 157.85 15.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 120.666 -1.271 . . . . 0.0 111.678 -155.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 142.65 36.86 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.746 1.26 . . . . 0.0 113.753 -161.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -153.21 144.18 22.91 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 120.321 -1.487 . . . . 0.0 111.215 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -140.08 153.38 69.22 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.921 1.688 . . . . 0.0 111.002 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.27 171.66 17.18 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.885 2.39 . . . . 0.0 112.296 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -38.1 14.22 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.318 1.447 . . . . 0.0 110.622 170.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -89.33 144.29 32.09 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 128.31 2.644 . . . . 0.0 112.48 -171.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.34 -164.9 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.263 3.309 . . . . 0.0 113.068 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 61.41 38.52 16.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.705 1.602 . . . . 0.0 113.314 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.27 -10.23 52.95 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.34 1.456 . . . . 0.0 113.732 -173.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -95.19 125.03 39.55 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.519 1.528 . . . . 0.0 111.545 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.2 tp -161.77 55.17 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.686 1.594 . . . . 0.0 110.055 -176.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -48.72 -40.12 27.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.1 1.76 . . . . 0.0 113.66 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -149.76 152.81 35.85 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.138 2.175 . . . . 0.0 110.1 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.4 167.99 20.86 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -85.24 165.76 17.08 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.33 -0.857 . . . . 0.0 111.419 169.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.8 177.99 7.45 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -145.98 155.26 42.71 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.48 2.312 . . . . 0.0 109.42 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 . . . . . 0 C--O 1.251 1.183 0 C-N-CA 125.943 1.697 . . . . 0.0 112.059 -169.931 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 ttp . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.965 0.412 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.83 -37.07 0.12 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.675 1.19 . . . . 0.0 110.892 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.84 170.67 7.74 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.555 2.342 . . . . 0.0 113.449 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -112.27 -25.18 9.4 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 147.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -65.24 -48.1 74.46 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.68 1.192 . . . . 0.0 113.106 -168.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -68.43 -29.65 68.35 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.654 1.182 . . . . 0.0 112.823 174.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -75.12 -38.5 61.06 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.681 1.192 . . . . 0.0 112.15 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.49 -23.38 32.19 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -136.47 86.12 24.34 Favored Pre-proline 0 N--CA 1.474 0.728 0 CA-C-N 118.829 0.74 . . . . 0.0 111.516 166.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.59 166.66 17.09 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.645 2.23 . . . . 0.0 113.422 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.14 -37.63 87.97 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 119.868 -1.77 . . . . 0.0 113.943 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -58.01 -39.57 78.63 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 166.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -69.01 -39.1 79.51 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.67 -1.269 . . . . 0.0 111.322 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -64.55 -44.28 91.29 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.804 1.242 . . . . 0.0 111.738 177.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.73 -53.04 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.089 173.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 p -61.39 -31.6 71.51 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.679 1.127 . . . . 0.0 112.249 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.73 -29.76 70.91 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.926 0.891 . . . . 0.0 112.053 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -104.75 -11.95 16.57 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.259 0.623 . . . . 0.0 112.617 174.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -64.67 -3.62 3.39 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 117.989 2.588 . . . . 0.0 117.989 -170.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.41 11.86 9.04 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 128.998 3.19 . . . . 0.0 116.099 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 t -81.56 108.1 14.86 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.824 1.312 . . . . 0.0 109.926 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.45 147.23 40.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.705 2.002 . . . . 0.0 111.396 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -143.58 145.77 32.74 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.622 1.569 . . . . 0.0 111.826 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.48 179.13 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.048 3.165 . . . . 0.0 112.825 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.8 t80 67.2 -37.81 0.32 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 129.022 2.929 . . . . 0.0 115.724 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t 67.3 -40.93 0.41 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 127.991 2.516 . . . . 0.0 113.186 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 47.93 -100.92 0.03 OUTLIER Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.503 2.001 . . . . 0.0 114.791 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.4 mtm -60.28 -16.03 30.48 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.452 ' CZ ' ' HE3' ' A' ' 33' ' ' LYS . 3.0 m-30 -99.92 2.96 44.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.561 1.944 . . . . 0.0 112.799 175.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.46 -30.36 64.5 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 120.422 1.465 . . . . 0.0 114.358 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -93.43 -165.71 1.38 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.789 1.235 . . . . 0.0 109.372 164.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 61.3 -162.41 0.27 Allowed 'General case' 0 CA--C 1.556 1.184 0 O-C-N 121.611 -0.681 . . . . 0.0 111.943 166.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HE3' ' CZ ' ' A' ' 29' ' ' TYR . 68.6 mmtt 54.33 35.84 23.86 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.298 1.839 . . . . 0.0 115.137 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -63.37 -175.66 0.12 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 130.843 3.657 . . . . 0.0 115.049 -173.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.59 156.37 35.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.476 1.51 . . . . 0.0 107.9 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.18 -149.93 16.0 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 114.394 0.517 . . . . 0.0 114.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.6 ptp -155.06 168.27 27.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.384 1.074 . . . . 0.0 113.262 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -122.18 139.17 54.07 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 128.809 2.844 . . . . 0.0 109.574 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.69 157.5 43.29 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.561 1.544 . . . . 0.0 110.871 -172.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.1 t -79.04 170.17 17.09 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.486 1.612 . . . . 0.0 114.238 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.28 13.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.496 1.918 . . . . 0.0 112.008 161.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.8 t -121.42 -33.22 3.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.09 1.356 . . . . 0.0 112.846 -173.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.6 p -102.29 -86.4 0.42 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.715 1.606 . . . . 0.0 111.348 167.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.1 -41.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 p -111.47 161.39 25.58 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -146.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.72 139.86 31.46 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.184 2.589 . . . . 0.0 111.888 159.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.5 mt -136.92 -23.31 1.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -135.83 141.89 44.75 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.524 1.057 . . . . 0.0 111.285 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.4 p -116.36 132.03 56.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.799 1.285 . . . . 0.0 112.123 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -5.04 19.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.997 1.319 . . . . 0.0 113.53 175.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.46 -26.8 68.12 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.793 -1.192 . . . . 0.0 112.419 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -90.67 5.97 45.9 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.824 1.25 . . . . 0.0 114.32 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 2.9 ttpt -59.43 131.91 52.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.046 0.938 . . . . 0.0 110.472 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.418 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 32.6 t80 -83.17 156.9 22.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.764 1.226 . . . . 0.0 112.397 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 2.5 t 63.55 -166.72 0.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.155 1.782 . . . . 0.0 113.916 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.9 p -94.88 -151.02 0.32 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.447 2.299 . . . . 0.0 112.321 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.97 88.09 0.02 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 151.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -129.3 -9.94 4.68 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.87 1.668 . . . . 0.0 110.48 174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.36 3.9 5.86 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.182 1.849 . . . . 0.0 115.725 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -90.99 120.08 68.73 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 118.5 1.15 . . . . 0.0 112.341 -162.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.9 109.2 2.62 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.079 2.519 . . . . 0.0 113.048 -168.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.1 p -151.44 165.96 32.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.064 2.146 . . . . 0.0 111.292 -167.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.71 148.88 26.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.781 1.632 . . . . 0.0 109.641 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.6 p -96.56 -27.2 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.267 1.827 . . . . 0.0 113.068 169.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -145.92 155.09 42.63 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.449 1.499 . . . . 0.0 109.524 158.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.31 77.14 9.14 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.389 168.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -74.54 134.52 42.19 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.949 -1.095 . . . . 0.0 111.67 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.76 -38.78 1.33 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 128.005 2.717 . . . . 0.0 109.946 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 p -112.86 148.36 35.07 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 128.454 2.702 . . . . 0.0 111.322 169.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.7 123.25 10.43 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.809 1.644 . . . . 0.0 112.422 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.41 -83.05 0.03 OUTLIER Glycine 0 N--CA 1.472 1.08 0 C-N-CA 127.174 2.321 . . . . 0.0 114.197 163.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.9 m -58.45 -25.17 61.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.931 1.292 . . . . 0.0 112.317 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -85.04 2.52 42.85 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 122.307 1.051 . . . . 0.0 112.95 -167.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.27 -18.48 64.55 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.405 1.482 . . . . 0.0 114.61 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -100.75 -36.44 9.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.849 1.659 . . . . 0.0 111.446 167.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -70.68 -26.7 63.55 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 -167.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.28 -32.04 64.18 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.397 2.279 . . . . 0.0 112.619 170.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.39 18.35 69.5 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.59 1.091 . . . . 0.0 112.696 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.51 -177.81 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 122.066 0.936 . . . . 0.0 112.104 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.43 -179.3 6.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.63 1.972 . . . . 0.0 109.171 175.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.637 ' H ' HD23 ' A' ' 80' ' ' LEU . 9.6 mmt180 -140.3 154.43 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.957 1.703 . . . . 0.0 109.316 -171.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -152.63 123.8 7.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.756 1.222 . . . . 0.0 110.241 165.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.23 159.03 18.97 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.752 1.621 . . . . 0.0 111.648 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -130.56 111.83 12.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -123.07 19.92 9.94 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 123.114 1.435 . . . . 0.0 111.488 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.88 -18.8 13.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -142.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.66 8.03 45.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 113.025 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.39 -10.03 73.61 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.854 1.693 . . . . 0.0 114.751 -173.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -109.65 126.68 28.61 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 0.0 110.717 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.79 127.37 2.66 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.414 2.743 . . . . 0.0 112.99 175.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -133.66 155.43 49.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.305 3.042 . . . . 0.0 108.717 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 42.5 mtp -140.48 124.02 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.414 1.485 . . . . 0.0 110.736 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -126.42 153.74 44.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.305 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.03 138.45 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.835 1.254 . . . . 0.0 110.759 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.77 148.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 122.103 0.954 . . . . 0.0 111.412 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 53.5 t -82.58 99.08 9.32 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.63 -20.47 66.3 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.687 -0.633 . . . . 0.0 111.566 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -64.25 -35.0 79.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.248 1.019 . . . . 0.0 111.79 -175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -131.8 -7.05 3.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.023 2.129 . . . . 0.0 115.464 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 69.34 59.62 0.32 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.89 2.876 . . . . 0.0 115.614 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.4 38.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 113.416 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.13 141.67 58.02 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 166.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.1 mt -108.48 -32.91 7.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.46 -169.62 35.59 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 127.487 2.47 . . . . 0.0 114.043 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -153.67 -179.48 7.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -152.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.22 145.92 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.805 1.642 . . . . 0.0 112.012 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.27 153.69 44.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.524 1.53 . . . . 0.0 111.965 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.81 137.0 15.57 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.524 2.816 . . . . 0.0 111.035 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.88 -0.07 41.97 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.52 -55.28 0.26 Allowed Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.05 1.786 . . . . 0.0 114.998 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -93.74 -153.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.279 3.319 . . . . 0.0 112.433 -169.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.45 171.22 0.29 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.327 2.251 . . . . 0.0 113.196 172.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -58.84 -5.98 3.08 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.954 2.436 . . . . 0.0 115.074 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -61.32 -26.42 67.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.71 1.204 . . . . 0.0 113.271 163.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.67 12.69 62.83 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.819 2.152 . . . . 0.0 115.765 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.92 132.61 49.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.335 1.067 . . . . 0.0 112.398 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -126.24 134.95 51.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.364 1.466 . . . . 0.0 108.711 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.89 138.58 41.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.052 0.941 . . . . 0.0 110.982 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 57.9 m -122.57 136.99 55.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.926 2.09 . . . . 0.0 109.466 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.0 tt -137.55 169.05 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.592 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.01 166.31 24.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -170.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -133.87 36.5 3.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.944 1.297 . . . . 0.0 113.356 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.06 -47.63 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.586 -1.321 . . . . 0.0 112.6 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 23.62 4.03 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.84 1.656 . . . . 0.0 112.781 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.9 mt -133.88 155.21 50.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.577 1.951 . . . . 0.0 110.13 -165.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -104.55 156.38 18.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.967 0.889 . . . . 0.0 113.359 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.11 153.31 33.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 111.426 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -139.0 150.87 66.72 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.538 . . . . 0.0 111.456 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.71 171.51 18.07 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.602 2.201 . . . . 0.0 112.559 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.33 -46.27 5.07 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.533 1.133 . . . . 0.0 112.011 -175.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.76 160.03 1.57 Allowed Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.631 2.372 . . . . 0.0 115.629 175.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.25 -165.51 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.926 3.084 . . . . 0.0 112.709 164.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.89 42.57 7.59 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.94 1.696 . . . . 0.0 113.869 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.11 -16.48 61.02 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.784 1.234 . . . . 0.0 112.912 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.53 129.92 42.79 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.415 1.086 . . . . 0.0 111.151 170.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.41 29.27 1.05 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -168.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -52.65 -31.37 36.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.655 1.982 . . . . 0.0 114.473 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -130.08 133.93 47.02 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.155 1.382 . . . . 0.0 110.212 174.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -155.06 120.31 4.95 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.168 0.987 . . . . 0.0 110.648 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -154.61 163.74 39.76 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.642 0.777 . . . . 0.0 112.412 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -86.47 141.11 29.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -143.83 168.4 20.03 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.203 2.201 . . . . 0.0 109.675 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 126.79 2.036 . . . . 0.0 114.833 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.42 -84.51 0.63 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.19 0.996 . . . . 0.0 109.822 171.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -103.9 -177.27 3.32 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.787 2.035 . . . . 0.0 112.886 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -99.43 -30.86 11.95 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.134 0.974 . . . . 0.0 113.191 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -58.04 -48.23 80.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.172 1.789 . . . . 0.0 111.079 -173.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -62.98 -24.9 68.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.885 1.274 . . . . 0.0 112.971 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -85.79 -45.38 11.66 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.327 1.851 . . . . 0.0 113.308 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.76 -32.21 31.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.337 1.055 . . . . 0.0 113.753 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -131.08 64.78 74.92 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 125.565 1.546 . . . . 0.0 109.938 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -64.57 159.6 43.94 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.118 2.545 . . . . 0.0 113.616 -172.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -111.26 -69.19 0.88 Allowed 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 123.954 0.901 . . . . 0.0 109.258 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.55 -34.54 72.79 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.229 0.538 . . . . 0.0 112.215 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.16 -24.07 43.52 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 176.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -81.09 -47.42 13.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.539 1.063 . . . . 0.0 111.805 172.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -53.29 -40.09 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.45 1.5 . . . . 0.0 111.998 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.26 -18.95 60.93 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 174.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.57 -27.01 27.58 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.18 0.992 . . . . 0.0 111.77 171.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -100.39 -7.27 24.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -68.1 51.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.072 1.349 . . . . 0.0 113.732 172.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.99 19.04 0.02 OUTLIER Glycine 0 CA--C 1.544 1.847 0 C-N-CA 127.641 2.543 . . . . 0.0 115.966 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 t -89.17 77.97 7.43 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.986 1.374 . . . . 0.0 114.706 -158.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -78.46 177.68 8.33 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.042 -1.662 . . . . 0.0 113.951 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.81 155.61 0.16 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 128.695 2.798 . . . . 0.0 117.43 171.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.28 93.26 0.75 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.205 2.603 . . . . 0.0 112.294 176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.42 ' H ' HG21 ' A' ' 58' ' ' THR . 27.3 p90 -108.79 -17.51 13.92 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -171.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 m -48.62 -22.74 0.82 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.435 1.894 . . . . 0.0 114.368 170.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.02 -107.46 0.56 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.984 1.278 . . . . 0.0 113.557 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.0 mtt -62.07 -12.85 21.3 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.87 7.52 41.55 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.12 1.768 . . . . 0.0 114.088 171.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.76 47.39 0.33 Allowed 'General case' 0 CA--C 1.552 1.048 0 O-C-N 119.645 -1.909 . . . . 0.0 112.861 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -141.63 18.31 2.18 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -168.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -148.52 151.19 34.71 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.729 -1.232 . . . . 0.0 112.143 165.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -149.79 113.94 5.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.68 1.992 . . . . 0.0 110.54 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.86 176.89 7.68 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.511 1.524 . . . . 0.0 113.668 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 m -128.36 155.48 44.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.773 1.629 . . . . 0.0 109.792 -162.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.69 -153.7 19.33 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.432 ' HA ' ' H ' ' A' ' 50' ' ' SER . 1.8 pmm? -151.52 165.68 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.958 1.303 . . . . 0.0 113.965 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.31 153.23 37.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.66 2.384 . . . . 0.0 111.342 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 161.57 37.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.906 1.682 . . . . 0.0 109.979 173.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.87 154.21 9.74 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 122.737 1.256 . . . . 0.0 110.16 164.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.51 -10.75 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.656 157.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 89.9 m -92.49 -46.71 7.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.23 -101.45 0.16 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.051 1.34 . . . . 0.0 110.248 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -159.47 -47.26 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.609 1.964 . . . . 0.0 112.98 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.04 153.62 38.45 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 125.923 1.689 . . . . 0.0 115.258 -157.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 135.97 15.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.342 2.028 . . . . 0.0 113.594 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.06 -30.44 12.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.432 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -157.09 157.95 35.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 112.162 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -101.65 147.22 26.7 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.274 -0.891 . . . . 0.0 111.412 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -64.67 -17.27 63.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.482 1.113 . . . . 0.0 112.232 172.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -35.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.476 1.91 . . . . 0.0 113.747 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.56 -1.35 30.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.812 2.045 . . . . 0.0 112.53 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.58 116.96 8.89 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.784 0.802 . . . . 0.0 111.344 -171.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -81.37 136.32 35.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.956 1.302 . . . . 0.0 110.461 172.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 24.6 t 63.06 106.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.4 1.88 . . . . 0.0 112.999 -167.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.3 p -77.22 30.09 0.14 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.756 1.622 . . . . 0.0 113.833 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.12 -114.94 0.23 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.318 1.913 . . . . 0.0 115.018 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.42 HG21 ' H ' ' A' ' 25' ' ' PHE . 16.2 p -121.79 -116.04 0.31 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.198 1.799 . . . . 0.0 112.283 -165.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.74 22.63 2.74 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.841 1.2 . . . . 0.0 115.031 -171.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.93 104.06 47.38 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.712 1.205 . . . . 0.0 112.11 -159.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -93.89 117.16 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.771 2.314 . . . . 0.0 112.274 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.7 p -141.16 169.33 17.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.13 1.772 . . . . 0.0 111.256 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -149.41 141.32 23.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.85 1.26 . . . . 0.0 108.778 161.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -85.7 -16.83 37.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 0.0 113.799 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -158.38 159.8 36.2 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.068 1.747 . . . . 0.0 111.014 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.72 86.9 2.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.297 1.439 . . . . 0.0 109.408 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -105.9 119.52 39.39 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.96 0.904 . . . . 0.0 110.981 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.94 -33.21 0.48 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.45 1.5 . . . . 0.0 113.024 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.51 116.25 16.03 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.277 1.031 . . . . 0.0 112.194 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.9 mmpt? -139.25 137.88 36.3 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 126.408 1.883 . . . . 0.0 110.902 -173.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.88 -80.52 0.24 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 125.32 1.438 . . . . 0.0 115.007 162.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.9 m -52.32 -33.03 40.69 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.486 1.114 . . . . 0.0 111.317 162.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -124.77 18.94 8.63 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.594 1.187 . . . . 0.0 113.928 -166.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -127.18 -5.18 6.11 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.861 1.664 . . . . 0.0 110.721 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.77 -40.15 63.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.255 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -126.82 -56.92 1.36 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 164.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 p -162.72 -47.79 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -167.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.44 -7.71 3.49 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 124.501 1.048 . . . . 0.0 114.784 -160.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.68 177.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 127.411 2.284 . . . . 0.0 111.12 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.91 170.35 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.588 1.555 . . . . 0.0 110.141 170.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.46 158.44 34.11 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -148.87 108.52 4.0 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 128.097 2.559 . . . . 0.0 108.699 -166.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.5 144.82 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.101 -0.999 . . . . 0.0 111.02 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -117.26 19.52 14.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.764 1.225 . . . . 0.0 112.486 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t -70.3 35.18 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.453 2.301 . . . . 0.0 114.211 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -110.74 -23.64 10.93 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.324 2.25 . . . . 0.0 113.562 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -97.28 14.95 24.31 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.45 1.9 . . . . 0.0 113.164 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.66 48.68 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.516 1.532 . . . . 0.0 114.836 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 37.7 t -111.06 103.53 54.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.341 1.857 . . . . 0.0 109.648 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.47 125.76 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.759 1.639 . . . . 0.0 111.613 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -151.26 156.96 41.92 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.807 2.443 . . . . 0.0 111.609 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.4 mtm -115.95 98.96 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.024 2.53 . . . . 0.0 107.407 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -83.06 148.6 27.43 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.118 -1.614 . . . . 0.0 108.974 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 m -138.22 145.47 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 122.343 1.068 . . . . 0.0 112.879 -167.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.656 HG12 ' H ' ' A' ' 103' ' ' LEU . 6.1 m -139.86 156.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.067 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.579 ' H ' ' HB2' ' A' ' 102' ' ' HIS . 48.9 t -80.11 155.37 27.53 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-O 124.079 1.895 . . . . 0.0 108.517 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -114.67 -18.22 11.45 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 110.906 -2.861 . . . . 0.0 113.497 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.63 -41.79 95.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.77 0.828 . . . . 0.0 112.185 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -110.85 -20.66 12.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.859 2.464 . . . . 0.0 113.369 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 64.8 122.51 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.06 1.744 . . . . 0.0 112.27 -162.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 75.47 77.88 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.694 1.998 . . . . 0.0 115.765 164.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.579 ' HB2' ' H ' ' A' ' 96' ' ' CYS 0.332 2.9 t60 -85.57 -21.44 28.52 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.656 ' H ' HG12 ' A' ' 95' ' ' VAL . 3.2 tp 53.16 27.84 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.308 2.643 . . . . 0.0 116.023 163.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.8 -179.55 52.96 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 123.103 1.391 . . . . 0.0 109.817 159.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.06 162.87 40.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.44 1.59 . . . . 0.0 113.393 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.05 139.59 42.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.488 -169.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.41 144.25 52.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.49 142.72 49.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.204 2.603 . . . . 0.0 110.12 162.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -107.98 -3.13 19.08 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.57 -64.28 0.61 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.897 1.713 . . . . 0.0 114.215 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.01 -170.96 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 124.584 3.523 . . . . 0.0 114.438 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -50.02 159.82 0.74 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.761 1.624 . . . . 0.0 111.985 169.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.62 -5.42 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.861 2.374 . . . . 0.0 114.758 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -65.41 -10.88 37.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.753 1.621 . . . . 0.0 114.519 164.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.43 -9.17 48.06 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.831 1.682 . . . . 0.0 116.359 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -56.51 143.14 36.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.973 1.309 . . . . 0.0 113.061 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -129.67 133.94 47.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 110.283 -166.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -104.8 129.02 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.634 1.174 . . . . 0.0 110.047 -174.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.7 p -131.17 129.27 41.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.391 1.077 . . . . 0.0 111.969 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 122' ' ' SER . 7.0 tp -109.34 161.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.31 1.044 . . . . 0.0 110.631 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -93.06 -21.51 19.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.83 1.252 . . . . 0.0 113.292 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.464 ' H ' HG13 ' A' ' 120' ' ' ILE . 50.6 m 58.25 19.67 6.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 p -71.85 -17.69 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.77 43.66 1.26 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.436 1.495 . . . . 0.0 113.167 -163.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.5 mt -117.55 156.01 28.82 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.759 1.266 . . . . 0.0 114.181 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -102.1 152.33 21.11 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.396 2.278 . . . . 0.0 109.76 157.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -146.32 145.59 30.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.81 0.844 . . . . 0.0 111.715 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -140.75 153.54 67.92 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.82 1.648 . . . . 0.0 110.553 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.38 171.9 14.28 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.373 2.049 . . . . 0.0 112.765 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.47 -37.89 22.55 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -71.39 160.05 83.72 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 128.932 2.893 . . . . 0.0 113.663 -174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.05 -179.16 0.5 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.102 2.535 . . . . 0.0 112.948 161.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 60.87 28.64 18.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.817 1.647 . . . . 0.0 113.296 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.35 -13.58 60.13 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.362 1.465 . . . . 0.0 112.669 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 52.01 57.41 6.52 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.045 1.738 . . . . 0.0 114.962 169.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.0 mt -139.66 40.88 2.02 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.508 1.923 . . . . 0.0 111.535 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.62 -31.24 32.52 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.389 1.476 . . . . 0.0 113.326 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -144.89 162.73 36.11 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.183 -0.948 . . . . 0.0 110.15 149.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -72.54 -52.97 13.34 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.797 -0.565 . . . . 0.0 111.756 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.62 161.54 40.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.448 1.499 . . . . 0.0 111.696 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -88.75 -23.73 22.84 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 62.04 -40.15 0.14 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 129.303 3.041 . . . . 0.0 119.149 172.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.037 1.335 . . . . 0.0 112.097 -157.461 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.91 17.37 0.77 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.937 1.295 . . . . 0.0 113.492 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.38 151.36 39.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 123.818 1.771 . . . . 0.0 114.506 -174.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -85.0 -29.47 24.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.253 -1.794 . . . . 0.0 111.297 -172.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -60.74 -42.6 97.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.964 0.906 . . . . 0.0 110.717 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -66.81 -27.5 67.62 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -75.76 -40.11 55.9 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.857 1.663 . . . . 0.0 112.875 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.46 -44.28 78.99 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.79 -0.569 . . . . 0.0 111.431 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 t -133.46 78.24 63.33 Favored Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 125.087 1.355 . . . . 0.0 112.448 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.02 174.91 5.21 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.106 2.537 . . . . 0.0 113.627 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -53.01 -44.8 67.57 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.196 -1.565 . . . . 0.0 113.739 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -61.08 -29.67 69.89 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -77.34 -39.03 49.04 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.298 1.039 . . . . 0.0 112.216 169.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -59.74 -44.34 93.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.932 1.293 . . . . 0.0 110.828 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.8 -30.96 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 174.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -89.35 -17.65 28.46 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 120.371 1.441 . . . . 0.0 113.435 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -61.62 -27.78 68.9 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.39 1.876 . . . . 0.0 111.782 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -127.72 -32.88 2.33 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 167.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HZ2' ' CE1' ' A' ' 102' ' ' HIS . 0.0 OUTLIER 48.23 21.28 0.33 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 118.61 2.819 . . . . 0.0 118.61 -176.153 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.6 3.25 0.08 OUTLIER Glycine 0 CA--C 1.53 1.021 0 N-CA-C 117.011 1.564 . . . . 0.0 117.011 -172.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -132.34 149.64 52.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.444 1.122 . . . . 0.0 112.642 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -139.44 159.09 42.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 128.491 2.716 . . . . 0.0 108.304 163.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.69 65.4 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.153 0.981 . . . . 0.0 112.571 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.56 118.83 5.64 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.679 2.253 . . . . 0.0 111.582 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -142.18 -17.07 0.74 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -26.06 43.4 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.484 -1.385 . . . . 0.0 112.81 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.9 -107.3 0.9 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 125.467 1.508 . . . . 0.0 113.614 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.2 ttm -54.68 -29.36 52.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.416 0.687 . . . . 0.0 112.45 170.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -90.61 8.56 33.6 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.965 1.306 . . . . 0.0 113.941 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.1 mt -72.7 73.05 1.07 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.119 -1.613 . . . . 0.0 110.802 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -76.63 -23.88 53.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.188 1.795 . . . . 0.0 113.659 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 56.49 -1.06 0.05 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.905 2.482 . . . . 0.0 117.256 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -155.45 114.62 3.59 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.294 2.238 . . . . 0.0 109.077 -168.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -129.3 -176.66 3.95 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.918 2.087 . . . . 0.0 110.925 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t -132.2 155.69 47.78 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 127.655 2.382 . . . . 0.0 111.862 169.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.21 -145.66 14.18 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.734 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.5 ptp -149.88 159.33 44.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 153.41 19.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.497 152.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -147.52 155.74 42.16 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.89 1.276 . . . . 0.0 109.785 158.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.45 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 71.5 m -61.57 165.86 4.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 124.134 1.921 . . . . 0.0 112.435 168.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.19 29.3 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.263 167.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 35.0 t -135.23 -47.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.107 1.363 . . . . 0.0 113.312 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.45 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 5.2 p -84.48 -84.57 0.14 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.854 1.262 . . . . 0.0 112.065 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -153.5 -48.94 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.5 p -145.02 165.07 23.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -139.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 144.4 46.87 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.409 2.74 . . . . 0.0 113.44 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -144.35 -4.63 0.79 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.38 129.05 21.53 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.525 -1.359 . . . . 0.0 110.299 169.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 p -94.48 142.45 27.42 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.164 -0.96 . . . . 0.0 111.488 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.17 -11.22 28.59 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.084 0.945 . . . . 0.0 113.336 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -38.92 72.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.43 -1.419 . . . . 0.0 114.054 163.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -73.32 -3.56 27.86 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.513 1.525 . . . . 0.0 112.619 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -65.56 130.72 44.3 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.275 1.03 . . . . 0.0 110.26 -173.24 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 61.6 t80 -128.45 170.42 13.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.961 2.104 . . . . 0.0 112.163 -170.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.8 t 66.2 155.95 0.09 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.352 1.861 . . . . 0.0 113.729 -165.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.2 p -153.83 -168.56 3.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.812 1.645 . . . . 0.0 111.492 -167.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.68 -69.97 1.17 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.535 1.54 . . . . 0.0 114.142 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -83.82 -14.1 52.14 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.059 1.743 . . . . 0.0 113.71 -170.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.07 0.04 87.33 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.736 1.16 . . . . 0.0 113.472 -165.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -69.99 142.45 90.54 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 124.934 1.294 . . . . 0.0 114.151 -170.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -91.78 143.01 2.8 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.468 2.779 . . . . 0.0 115.486 -166.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.1 m -159.68 172.29 18.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.72 2.008 . . . . 0.0 110.271 169.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -140.19 121.76 15.21 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.393 1.877 . . . . 0.0 107.16 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -84.97 -10.8 56.67 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -160.93 164.1 31.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.106 0.962 . . . . 0.0 112.926 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.5 87.42 2.66 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.682 1.593 . . . . 0.0 109.331 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -70.72 161.38 30.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.511 1.124 . . . . 0.0 112.029 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.34 1.28 75.37 Favored Glycine 0 CA--C 1.541 1.679 0 O-C-N 121.153 -0.967 . . . . 0.0 115.345 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.8 t -133.35 147.25 51.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.243 1.817 . . . . 0.0 110.493 166.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 1.3 tptt -144.3 73.14 1.37 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -159.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.99 -67.53 0.47 Allowed Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.017 1.77 . . . . 0.0 114.082 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -31.88 71.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.751 0.82 . . . . 0.0 111.123 167.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 70' ' ' LYS . 11.6 m-20 -89.28 8.75 28.81 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -170.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.82 -33.89 76.16 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.078 -1.014 . . . . 0.0 111.851 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 t -89.57 -19.3 25.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.717 1.207 . . . . 0.0 112.154 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -72.19 -19.4 61.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.681 1.592 . . . . 0.0 112.904 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -55.1 -48.25 73.83 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.165 1.386 . . . . 0.0 112.932 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.11 17.67 79.57 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.3 -160.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -108.02 149.44 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.502 1.651 . . . . 0.0 110.253 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 mp -125.56 167.56 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.668 1.587 . . . . 0.0 111.499 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.93 150.42 36.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.366 1.466 . . . . 0.0 111.391 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.98 117.79 4.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.918 1.687 . . . . 0.0 108.351 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.29 144.66 35.92 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.599 1.16 . . . . 0.0 111.416 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -124.8 34.45 4.99 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 123.009 1.385 . . . . 0.0 111.083 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -70.2 42.92 0.06 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 129.612 3.165 . . . . 0.0 112.48 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 t -126.08 -12.77 6.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.977 2.111 . . . . 0.0 113.277 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -98.14 16.89 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.953 2.101 . . . . 0.0 113.598 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.14 5.52 89.61 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 124.054 0.835 . . . . 0.0 115.019 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 31.9 t -141.74 135.62 14.76 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.742 2.417 . . . . 0.0 110.284 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.5 125.77 11.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.336 2.691 . . . . 0.0 112.569 173.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -136.17 156.37 48.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.637 2.375 . . . . 0.0 109.89 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.2 mtt -133.77 131.19 39.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.386 2.274 . . . . 0.0 108.527 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -132.43 148.66 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 121.163 -0.961 . . . . 0.0 111.898 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.73 147.93 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.077 1.351 . . . . 0.0 112.513 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.54 152.11 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.198 1.399 . . . . 0.0 111.495 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 98' ' ' GLN . 43.6 t -90.07 117.55 28.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 164.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -97.55 -0.87 45.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.043 1.737 . . . . 0.0 113.188 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HB2' ' SG ' ' A' ' 96' ' ' CYS . 30.8 mt-30 -63.21 -45.25 92.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.194 1.398 . . . . 0.0 110.404 162.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 p -125.4 -14.09 6.48 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.329 2.252 . . . . 0.0 115.197 -169.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.275 75.5 mt-10 74.61 60.11 0.07 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.887 2.475 . . . . 0.0 115.656 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.44 141.11 28.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.526 ' CE1' ' HZ2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -68.8 115.2 7.86 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.147 -0.97 . . . . 0.0 111.672 172.32 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 tp -97.68 -36.1 10.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.455 1.121 . . . . 0.0 113.774 -159.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.34 155.85 26.46 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 127.399 2.428 . . . . 0.0 112.876 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.44 146.16 29.46 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.745 0.818 . . . . 0.0 111.595 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.22 135.22 44.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 110.453 -155.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.49 152.07 41.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.21 156.48 25.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.502 3.468 . . . . 0.0 112.182 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -123.81 5.17 8.77 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -164.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.75 -59.82 0.68 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 117.839 -1.534 . . . . 0.0 115.682 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -62.59 -166.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.83 3.02 . . . . 0.0 112.58 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -55.52 159.33 4.87 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 110.602 169.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -57.9 -8.19 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.224 2.616 . . . . 0.0 114.283 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -24.63 15.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.019 1.328 . . . . 0.0 113.487 163.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.85 2.4 76.26 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.655 1.598 . . . . 0.0 116.275 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -51.0 139.56 17.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.59 1.195 . . . . 0.0 112.964 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -109.81 126.94 54.32 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.768 1.227 . . . . 0.0 108.534 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.83 98.04 8.34 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.886 0.875 . . . . 0.0 109.267 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.18 148.29 35.99 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.09 0.956 . . . . 0.0 110.626 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.98 157.17 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.467 1.107 . . . . 0.0 110.062 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 159.28 35.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 112.879 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -123.04 19.41 10.01 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.1 p -44.29 -39.72 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 126.243 1.817 . . . . 0.0 115.868 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.29 30.27 0.62 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.475 1.51 . . . . 0.0 112.804 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.43 173.24 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.591 1.556 . . . . 0.0 109.946 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -115.29 149.61 37.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 122.429 1.109 . . . . 0.0 113.257 173.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -159.21 133.11 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.591 1.156 . . . . 0.0 110.001 -168.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -145.06 152.13 50.46 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 124.796 1.238 . . . . 0.0 112.1 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.67 168.97 23.61 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.135 1.89 . . . . 0.0 112.402 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -41.11 12.83 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.339 1.056 . . . . 0.0 111.776 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -66.57 147.6 98.93 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.192 0.997 . . . . 0.0 111.652 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.33 178.57 4.78 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.517 2.811 . . . . 0.0 113.798 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 66.32 36.85 5.11 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.212 2.205 . . . . 0.0 112.959 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.83 -20.23 60.51 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.807 1.243 . . . . 0.0 112.642 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.9 143.36 50.09 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.535 1.534 . . . . 0.0 111.311 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.0 tp -159.19 37.01 0.21 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.863 1.265 . . . . 0.0 112.043 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . 0.262 10.8 tt0 45.43 44.72 9.8 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.8 2.84 . . . . 0.0 113.776 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.95 161.25 30.36 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.679 -1.6 . . . . 0.0 112.913 170.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 9.6 m170 56.79 96.52 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.101 1.76 . . . . 0.0 115.547 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -55.23 120.9 7.73 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.531 -1.356 . . . . 0.0 109.974 164.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -71.16 -17.38 62.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -162.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -152.3 -50.19 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.076 1.75 . . . . 0.0 110.641 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 . . . . . 0 C--O 1.245 0.858 0 C-N-CA 128.845 2.858 . . . . 0.0 108.39 170.583 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 ttp . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 117.431 -1.271 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.15 -85.52 0.12 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.176 1.353 . . . . 0.0 111.856 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -120.29 -178.67 3.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.104 1.362 . . . . 0.0 111.756 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -103.37 -26.44 12.91 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.069 0.948 . . . . 0.0 112.994 171.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -53.48 -52.67 58.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.387 1.875 . . . . 0.0 111.651 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.4 -28.04 67.59 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -70.39 -37.2 74.48 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.168 0.987 . . . . 0.0 112.408 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.95 -19.84 22.02 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -137.31 58.19 16.74 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 171.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.08 140.13 27.81 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.212 3.275 . . . . 0.0 116.018 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -88.66 -52.26 5.24 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.297 1.839 . . . . 0.0 111.554 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -54.99 -21.01 10.43 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.796 2.038 . . . . 0.0 113.728 169.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -95.32 -20.74 18.9 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.359 1.863 . . . . 0.0 114.212 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -89.92 -53.99 4.25 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.445 1.498 . . . . 0.0 112.321 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.3 t -65.44 -24.59 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.885 -1.135 . . . . 0.0 112.34 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -68.47 -25.17 64.85 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.456 1.902 . . . . 0.0 113.079 171.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -67.21 -40.3 86.43 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.033 0.833 . . . . 0.0 111.501 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.22 -24.16 43.29 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.489 0.493 . . . . 0.0 110.669 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -66.86 63.58 0.05 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.29 2.236 . . . . 0.0 114.76 172.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.05 -21.29 0.13 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.928 1.728 . . . . 0.0 114.761 169.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 t -91.57 73.92 5.93 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 117.819 0.81 . . . . 0.0 111.779 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -68.78 142.15 55.0 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 123.232 1.491 . . . . 0.0 111.801 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.18 143.61 33.08 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 113.489 -1.687 . . . . 0.0 113.365 -158.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.35 168.96 23.57 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.368 2.712 . . . . 0.0 111.597 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -61.26 -29.94 70.16 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 t 69.67 -37.63 0.38 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.549 2.74 . . . . 0.0 113.509 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.29 -101.0 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.797 2.141 . . . . 0.0 114.824 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.6 mtp -59.11 -22.4 60.8 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -99.65 10.53 41.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.577 1.951 . . . . 0.0 113.091 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.97 65.72 0.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.034 -1.041 . . . . 0.0 111.282 161.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -65.59 154.17 39.5 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.485 1.914 . . . . 0.0 113.684 -171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.87 122.32 17.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.403 0.681 . . . . 0.0 110.674 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -143.84 -2.31 0.94 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -163.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 51.41 -160.93 0.09 Allowed 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 127.896 2.478 . . . . 0.0 114.648 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.618 HG23 ' HB2' ' A' ' 130' ' ' SER . 1.3 t -136.66 175.25 9.78 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -166.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.48 -140.51 6.37 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.56 1.076 . . . . 0.0 114.638 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -155.33 161.8 40.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.473 1.13 . . . . 0.0 112.564 173.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -133.52 145.7 50.38 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.999 1.32 . . . . 0.0 111.336 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.63 164.04 38.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.583 1.153 . . . . 0.0 111.648 -161.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 69.7 m -59.07 157.58 9.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 123.451 1.596 . . . . 0.0 113.874 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.259 8.7 p -125.73 41.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.557 158.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.3 t -135.64 -48.01 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.706 1.202 . . . . 0.0 112.945 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 9.4 p -96.42 -89.96 0.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.522 1.529 . . . . 0.0 113.844 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.32 -30.75 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.043 2.137 . . . . 0.0 113.114 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.3 p -85.37 125.69 69.06 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -161.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.16 138.8 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.046 1.831 . . . . 0.0 111.403 160.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.17 -27.9 4.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.372 -163.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.68 137.99 18.46 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -84.07 136.46 34.01 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.299 -0.875 . . . . 0.0 109.693 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.8 m -62.38 -12.42 21.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.964 1.706 . . . . 0.0 114.387 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -29.54 69.03 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.611 0.764 . . . . 0.0 111.322 172.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -74.68 -2.99 28.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.186 0.994 . . . . 0.0 113.497 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 16.2 ttpp -53.45 128.25 28.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.774 0.716 . . . . 0.0 109.84 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -67.12 164.99 16.81 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 18.1 t -52.6 137.9 29.48 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.071 0.949 . . . . 0.0 111.461 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.28 36.3 p 49.29 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.493 2.317 . . . . 0.0 114.099 -162.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.9 55.01 19.98 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.503 1.525 . . . . 0.0 113.117 168.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.1 p -79.48 -82.48 0.1 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.389 1.476 . . . . 0.0 112.763 -161.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.09 -11.95 71.92 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.003 0.811 . . . . 0.0 112.949 163.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.404 ' CZ3' ' HB2' ' A' ' 62' ' ' SER . 37.9 t90 -97.03 105.71 26.01 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.432 1.493 . . . . 0.0 111.056 -175.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -84.96 123.36 2.74 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.393 2.062 . . . . 0.0 111.879 -170.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 60' ' ' TRP . 28.6 t -149.58 155.61 40.58 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 111.547 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.66 115.25 4.85 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.559 1.544 . . . . 0.0 109.253 -159.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -72.26 -16.76 61.93 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -146.94 155.54 42.36 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.929 0.892 . . . . 0.0 112.399 166.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.04 108.02 3.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 142.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -112.98 152.7 29.1 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.86 1.664 . . . . 0.0 111.871 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.48 -30.4 4.9 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.611 1.101 . . . . 0.0 111.526 -156.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 p -107.62 133.28 52.3 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.345 1.858 . . . . 0.0 112.868 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -148.85 132.21 16.57 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.349 2.259 . . . . 0.0 110.613 174.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.76 -81.46 0.01 OUTLIER Glycine 0 N--CA 1.47 0.944 0 C-N-CA 127.257 2.361 . . . . 0.0 114.761 157.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -28.1 40.14 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.429 1.492 . . . . 0.0 112.278 168.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.84 4.67 53.54 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.02 -12.61 60.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.186 1.395 . . . . 0.0 113.255 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -103.0 -30.62 10.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.451 0.569 . . . . 0.0 112.053 163.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -73.75 -25.59 60.25 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.74 -30.64 56.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.427 1.491 . . . . 0.0 112.362 167.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.18 73.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.662 1.125 . . . . 0.0 112.73 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.16 166.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 123.176 1.465 . . . . 0.0 111.995 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -133.87 176.36 8.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.88 2.072 . . . . 0.0 108.792 166.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.568 ' H ' HD23 ' A' ' 80' ' ' LEU . 7.0 ptt180 -147.3 146.7 29.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.9 0.88 . . . . 0.0 112.967 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.86 108.63 7.05 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.191 1.796 . . . . 0.0 109.205 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -89.69 149.22 22.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.393 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.52 120.01 6.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.659 1.184 . . . . 0.0 109.205 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -130.08 35.27 4.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.218 1.007 . . . . 0.0 110.605 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -130.92 -6.47 3.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.736 2.015 . . . . 0.0 114.606 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.21 24.39 1.88 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.702 2.001 . . . . 0.0 111.806 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.66 -10.27 46.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.636 2.065 . . . . 0.0 114.155 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.8 t -145.83 130.9 9.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.788 1.235 . . . . 0.0 109.807 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.25 133.01 23.7 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.094 2.53 . . . . 0.0 112.88 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -138.6 157.87 45.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.829 2.852 . . . . 0.0 111.741 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.3 mtt -138.76 128.03 24.24 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.392 2.277 . . . . 0.0 107.915 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.89 153.29 47.63 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.205 1.002 . . . . 0.0 111.325 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.76 141.32 44.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.206 1.402 . . . . 0.0 111.827 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -117.52 152.03 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.186 1.394 . . . . 0.0 109.591 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.4 t -93.02 120.91 33.81 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 165.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.56 -14.96 41.4 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 114.411 169.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -65.42 -38.36 89.7 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.691 0.796 . . . . 0.0 112.447 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.55 -12.22 10.38 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 127.604 2.361 . . . . 0.0 114.888 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.362 56.5 mt-10 62.19 64.1 1.0 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.912 2.485 . . . . 0.0 115.213 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.28 136.82 32.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -78.45 109.16 12.37 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.988 165.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.297 2.7 pp -141.27 -1.41 1.35 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 -172.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.0 142.04 13.5 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.746 1.641 . . . . 0.0 111.515 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.17 160.18 43.45 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.753 -0.851 . . . . 0.0 111.308 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.35 139.11 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 125.138 1.375 . . . . 0.0 111.125 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -145.87 154.11 50.89 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.869 1.268 . . . . 0.0 114.007 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -84.38 141.01 8.79 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.574 2.849 . . . . 0.0 111.27 171.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.36 28.86 4.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.352 1.461 . . . . 0.0 113.158 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.42 -50.96 0.82 Allowed Glycine 0 CA--C 1.542 1.748 0 C-N-CA 126.542 2.02 . . . . 0.0 115.241 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -87.72 -165.38 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.175 3.25 . . . . 0.0 112.295 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -56.28 149.13 38.91 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.819 1.648 . . . . 0.0 113.064 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -66.68 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 124.791 3.661 . . . . 0.0 115.261 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -31.51 62.09 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.85 -1.156 . . . . 0.0 112.373 162.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.0 14.12 65.17 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.88 150.57 28.2 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -165.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -105.42 137.73 42.77 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.902 1.681 . . . . 0.0 108.652 170.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -90.48 160.82 15.81 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 123.824 0.85 . . . . 0.0 109.721 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.9 p -150.3 155.76 40.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.057 1.343 . . . . 0.0 110.834 166.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 mm -118.85 165.81 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.36 1.864 . . . . 0.0 109.368 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.85 103.84 6.28 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.305 -1.497 . . . . 0.0 113.622 150.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -74.73 21.23 0.11 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.31 -19.71 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.067 1.747 . . . . 0.0 114.895 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.11 17.53 10.8 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.304 1.842 . . . . 0.0 114.923 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 61.5 mt -120.69 157.52 29.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.324 1.059 . . . . 0.0 113.174 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -104.57 161.9 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.267 2.227 . . . . 0.0 111.288 163.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -142.46 145.5 33.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 111.003 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -148.99 151.67 35.04 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.019 1.328 . . . . 0.0 112.144 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.91 170.31 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.801 2.334 . . . . 0.0 113.288 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.618 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.8 OUTLIER -86.18 -44.25 12.35 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.836 1.303 . . . . 0.0 112.532 -178.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -64.26 148.18 96.12 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 126.252 1.821 . . . . 0.0 112.016 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.18 -179.97 2.08 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.7 2.267 . . . . 0.0 112.566 168.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.96 32.16 15.74 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.183 1.393 . . . . 0.0 113.756 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.24 -19.85 57.97 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.55 1.14 . . . . 0.0 112.897 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.15 145.38 25.95 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.361 1.064 . . . . 0.0 110.881 167.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.86 35.34 2.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.461 1.505 . . . . 0.0 111.904 -166.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -58.76 -9.47 1.79 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.546 1.538 . . . . 0.0 114.901 -174.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -63.32 -21.85 66.51 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.94 172.17 9.47 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.267 1.427 . . . . 0.0 112.96 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -148.57 131.48 16.16 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.422 -0.799 . . . . 0.0 111.049 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 49.49 -179.36 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 128.964 2.906 . . . . 0.0 117.953 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -125.76 166.97 15.82 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.364 1.866 . . . . 0.0 108.953 165.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 . . . . . 0 C--O 1.251 1.161 0 C-N-CA 124.897 1.279 . . . . 0.0 112.235 178.821 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 ttm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 118.119 -0.944 . . . . 0.0 108.907 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.63 29.97 10.16 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -135.63 168.34 19.45 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.889 2.076 . . . . 0.0 110.207 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -118.28 -40.14 2.97 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 169.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -57.7 8.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.051 1.34 . . . . 0.0 110.919 -172.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -64.24 -25.87 68.25 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.262 1.025 . . . . 0.0 112.956 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -74.19 -39.91 62.85 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.84 -21.75 54.57 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.121 1.368 . . . . 0.0 114.478 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.6 t -126.81 64.4 58.71 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.092 1.357 . . . . 0.0 111.551 171.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.12 131.84 5.17 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.666 2.244 . . . . 0.0 114.452 -168.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -82.13 -60.23 2.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.777 -158.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -27.39 50.57 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.198 1.399 . . . . 0.0 113.353 170.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.4 -12.12 35.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.382 1.873 . . . . 0.0 113.3 -176.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -106.21 -41.92 5.21 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.387 1.075 . . . . 0.0 113.602 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -50.87 -33.66 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.796 0.838 . . . . 0.0 111.532 173.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 p -79.01 -19.55 51.28 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 128.83 2.852 . . . . 0.0 114.738 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -82.68 -43.22 17.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.618 1.567 . . . . 0.0 110.241 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -92.41 -46.13 7.82 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.482 -174.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.44 12.3 ptpt 42.54 24.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 1 N-CA-C 122.18 4.141 . . . . 0.0 122.18 171.782 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.7 46.87 0.14 Allowed Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.276 0.941 . . . . 0.0 111.921 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 t -122.51 101.38 7.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.114 1.366 . . . . 0.0 113.982 -161.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.06 144.77 30.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.902 0.881 . . . . 0.0 111.008 161.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.77 155.3 19.95 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.555 1.542 . . . . 0.0 110.833 -176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.76 94.85 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.225 1.95 . . . . 0.0 112.479 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -143.05 -87.09 0.14 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.84 2.056 . . . . 0.0 110.644 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.4 t 69.0 -42.53 0.49 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.0 2.12 . . . . 0.0 111.543 -163.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.93 -107.95 0.64 Allowed Glycine 0 C--O 1.224 -0.483 0 C-N-CA 126.619 2.057 . . . . 0.0 114.281 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.1 ttm -57.43 -21.04 34.18 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.159 0.984 . . . . 0.0 113.311 173.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.92 9.05 40.76 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 175.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.29 38.46 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.072 1.349 . . . . 0.0 114.473 169.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -115.61 174.7 5.88 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.007 2.523 . . . . 0.0 111.648 -177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -74.67 43.12 0.18 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 122.591 1.186 . . . . 0.0 112.863 165.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.273 40.3 mmtm 55.3 86.29 0.06 Allowed 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 130.963 3.705 . . . . 0.0 115.059 168.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -81.88 168.48 17.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 112.109 -2.314 . . . . 0.0 112.762 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m -120.65 163.18 18.45 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 125.79 1.636 . . . . 0.0 110.082 -160.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.68 -160.2 23.89 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 114.125 0.41 . . . . 0.0 114.125 174.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.9 ptp -151.29 156.2 40.32 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.139 0.976 . . . . 0.0 113.052 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -104.4 140.72 37.52 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.464 2.706 . . . . 0.0 110.974 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -144.12 158.75 43.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.718 2.007 . . . . 0.0 110.861 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 1.3 t -72.86 168.39 19.0 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.833 1.778 . . . . 0.0 115.144 -172.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.72 3.97 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.774 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.9 t -117.57 -44.82 2.73 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 111.156 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 4.3 p -90.21 -104.46 0.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.963 1.705 . . . . 0.0 108.239 162.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -156.8 -50.07 0.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.799 1.64 . . . . 0.0 114.147 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 154.96 53.9 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -149.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.49 135.51 36.57 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.613 2.209 . . . . 0.0 111.037 162.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -22.89 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.42 120.41 10.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.997 -0.439 . . . . 0.0 110.8 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -86.04 135.08 33.77 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 123.565 1.65 . . . . 0.0 112.421 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -5.72 6.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.047 2.139 . . . . 0.0 112.885 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -23.69 57.86 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.705 1.202 . . . . 0.0 112.948 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.23 -1.13 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.652 1.181 . . . . 0.0 114.002 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -79.66 123.04 27.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.089 0.956 . . . . 0.0 111.143 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -77.61 70.14 3.95 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 122.426 1.108 . . . . 0.0 111.285 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.92 -6.03 59.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 p -71.6 45.73 0.11 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.855 2.862 . . . . 0.0 114.329 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.38 -63.86 0.19 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.287 0.946 . . . . 0.0 113.248 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -101.74 -9.81 20.51 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.542 0.671 . . . . 0.0 112.456 -161.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.43 11.12 46.31 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.102 0.858 . . . . 0.0 114.011 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -79.84 147.46 66.5 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -157.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.53 89.49 1.32 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.062 2.508 . . . . 0.0 114.888 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -149.78 163.58 37.62 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.984 2.514 . . . . 0.0 111.443 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -154.98 145.39 22.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.924 2.09 . . . . 0.0 108.838 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -73.62 -34.04 64.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.112 167.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -153.94 165.21 36.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.289 1.435 . . . . 0.0 110.973 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.58 92.22 6.5 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 148.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.37 130.18 45.33 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 165.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.44 -28.9 1.63 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.093 1.33 . . . . 0.0 111.723 -166.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.7 p -134.25 147.27 50.65 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.986 1.315 . . . . 0.0 114.506 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -148.81 110.58 4.53 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 126.63 1.972 . . . . 0.0 110.055 175.286 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.17 -81.37 0.01 OUTLIER Glycine 0 N--CA 1.479 1.56 0 C-N-CA 126.747 2.118 . . . . 0.0 114.799 167.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.0 m -45.25 -34.68 2.96 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.109 1.763 . . . . 0.0 113.037 164.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 70' ' ' LYS . 35.9 m-20 -107.71 9.88 29.04 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -54.03 -39.76 66.46 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 112.245 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.99 -11.43 24.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.173 1.389 . . . . 0.0 112.388 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -66.87 -25.44 66.41 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.388 -0.82 . . . . 0.0 112.0 171.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.7 p -49.97 -45.56 51.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.75 2.02 . . . . 0.0 114.049 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.23 24.94 76.46 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.384 -0.676 . . . . 0.0 112.296 -160.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.781 1.277 . . . . 0.0 112.417 174.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.12 177.73 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 128.576 2.751 . . . . 0.0 109.134 -173.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 154.9 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.74 105.93 6.35 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 126.488 1.915 . . . . 0.0 109.222 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.78 154.42 19.53 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.933 0.893 . . . . 0.0 111.064 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -143.06 113.89 7.6 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.713 1.205 . . . . 0.0 108.444 166.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -129.33 37.57 4.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.889 1.328 . . . . 0.0 110.269 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.8 t -113.79 -17.93 11.95 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 113.973 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.44 22.14 5.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.355 2.262 . . . . 0.0 111.847 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.68 -12.01 54.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.634 2.064 . . . . 0.0 114.761 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.09 130.23 23.4 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.219 1.408 . . . . 0.0 110.025 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.29 128.36 11.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.402 2.068 . . . . 0.0 112.12 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -133.18 155.95 48.38 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 128.08 2.552 . . . . 0.0 109.904 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.3 mtt -141.27 130.81 23.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.06 1.744 . . . . 0.0 109.423 -172.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -133.42 153.67 51.41 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.29 1.436 . . . . 0.0 110.735 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.94 145.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.239 1.016 . . . . 0.0 111.217 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.38 138.7 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.593 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.7 t -79.02 108.76 12.74 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -79.89 -7.71 58.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.285 1.034 . . . . 0.0 113.272 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.89 -39.5 94.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.323 1.049 . . . . 0.0 112.073 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.5 p -134.77 -5.83 2.47 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.361 43.3 mt-10 71.33 53.25 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.613 2.365 . . . . 0.0 114.051 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.74 134.04 51.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.833 1.653 . . . . 0.0 113.207 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -78.88 76.59 5.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.355 1.462 . . . . 0.0 112.307 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 3.24 6.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -171.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.9 172.41 19.31 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 122.825 1.236 . . . . 0.0 116.128 160.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -137.48 160.36 39.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 p -125.68 123.68 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.651 1.98 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.58 149.15 61.06 Favored Pre-proline 0 C--O 1.241 0.654 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.192 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.69 152.32 53.09 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.288 2.658 . . . . 0.0 112.347 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -100.63 -0.46 37.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.51 1.924 . . . . 0.0 115.129 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.94 -61.48 0.66 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.437 1.494 . . . . 0.0 115.098 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.47 -157.94 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 124.795 3.663 . . . . 0.0 112.902 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 150.53 31.1 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.758 1.223 . . . . 0.0 112.304 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.21 2.17 2.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.138 3.226 . . . . 0.0 114.464 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -59.48 -24.01 63.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.312 -0.868 . . . . 0.0 113.141 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.59 0.66 85.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.579 1.392 . . . . 0.0 116.579 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -60.39 146.11 45.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.669 1.235 . . . . 0.0 113.422 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.0 149.59 28.33 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.258 1.823 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -82.45 144.74 30.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.672 0.748 . . . . 0.0 111.834 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.3 p -129.49 134.63 47.89 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.57 2.748 . . . . 0.0 108.478 168.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.3 tp -127.85 126.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.358 -0.839 . . . . 0.0 112.265 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -119.68 3.05 11.17 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m -134.17 39.44 3.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.132 1.773 . . . . 0.0 111.766 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.24 -39.73 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -163.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.95 -11.76 0.53 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.588 2.755 . . . . 0.0 117.516 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.4 pp -126.24 176.47 7.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.547 1.939 . . . . 0.0 114.094 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.07 178.97 4.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 114.589 -165.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.59 160.92 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.766 1.226 . . . . 0.0 113.821 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.7 152.74 79.22 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.914 1.686 . . . . 0.0 110.663 160.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.56 167.88 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.595 1.53 . . . . 0.0 111.284 160.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.35 -45.18 9.19 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 112.507 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.65 160.26 62.1 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 127.149 2.18 . . . . 0.0 113.469 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.87 -177.33 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.92 3.08 . . . . 0.0 113.44 167.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 58.4 37.94 25.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.36 1.464 . . . . 0.0 113.131 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.47 -14.63 56.79 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.657 1.983 . . . . 0.0 113.447 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.31 -177.77 6.85 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.99 1.316 . . . . 0.0 111.262 168.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.0 tp 68.33 47.76 0.94 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.866 1.266 . . . . 0.0 111.406 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.66 -27.27 66.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.589 1.156 . . . . 0.0 113.03 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -89.64 173.3 8.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.271 1.029 . . . . 0.0 110.908 165.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -63.97 161.57 15.54 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -75.66 -147.22 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.04 2.136 . . . . 0.0 109.846 165.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 59.3 t60 56.72 30.62 17.91 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 172.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -78.54 54.57 1.48 Allowed 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.013 -1.68 . . . . 0.0 113.102 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 . . . . . 0 C--O 1.252 1.189 0 C-N-CA 127.934 2.493 . . . . 0.0 110.942 -177.955 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 118.558 -0.734 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.31 -79.78 0.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.238 1.015 . . . . 0.0 110.155 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.47 154.46 40.19 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -115.11 -31.05 6.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.432 1.493 . . . . 0.0 111.773 167.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -58.23 -65.26 0.68 Allowed 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 127.712 2.405 . . . . 0.0 111.655 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -67.99 -25.09 65.24 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 125.616 1.567 . . . . 0.0 112.995 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -66.47 -39.63 88.9 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.697 1.599 . . . . 0.0 112.715 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.27 -24.53 17.41 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -139.66 85.46 14.75 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.718 1.207 . . . . 0.0 111.187 170.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.16 161.42 32.39 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.167 2.578 . . . . 0.0 113.243 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.64 -71.29 0.76 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.073 0.549 . . . . 0.0 110.837 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -62.86 -30.55 71.6 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.729 -0.607 . . . . 0.0 111.685 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -19.45 45.5 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -77.73 -54.22 6.62 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.535 1.061 . . . . 0.0 110.433 165.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 t -50.17 -50.92 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.764 1.226 . . . . 0.0 112.108 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.7 p -63.44 -25.79 68.43 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.33 1.052 . . . . 0.0 112.897 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -67.68 -17.19 64.5 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.179 1.792 . . . . 0.0 112.801 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -122.95 -8.12 8.36 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.249 1.019 . . . . 0.0 112.822 171.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -70.28 71.8 0.44 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.532 2.333 . . . . 0.0 113.474 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.16 12.05 71.51 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 113.772 -1.558 . . . . 0.0 114.496 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 t -123.68 162.68 22.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.373 2.269 . . . . 0.0 106.647 160.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -109.31 149.53 29.33 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.059 0.943 . . . . 0.0 110.092 170.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.63 156.78 48.61 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.184 0.993 . . . . 0.0 112.968 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.37 83.4 2.23 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.538 2.159 . . . . 0.0 112.95 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -117.58 -23.09 7.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.03 -2.35 . . . . 0.0 113.372 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.14 19.64 2.21 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 162.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.64 -46.35 38.32 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 120.728 -1.232 . . . . 0.0 115.412 -168.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.7 mtp -66.69 -10.49 47.12 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -104.61 -5.85 21.06 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 128.494 2.718 . . . . 0.0 112.879 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.1 mt -112.86 -15.29 12.94 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.746 1.618 . . . . 0.0 112.729 -177.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.87 18.95 13.44 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -173.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.25 50.3 m-20 51.04 -149.51 0.31 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.707 -151.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -115.5 10.6 15.72 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.917 1.69 . . . . 0.0 115.504 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -177.4 0.1 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.179 2.592 . . . . 0.0 115.112 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -126.26 153.63 44.51 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.298 1.439 . . . . 0.0 109.987 -164.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.31 -165.71 31.25 Favored Glycine 0 N--CA 1.474 1.22 0 O-C-N 119.914 -1.741 . . . . 0.0 116.013 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -155.57 161.25 40.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.502 1.121 . . . . 0.0 113.78 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.06 143.8 39.57 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 129.278 3.031 . . . . 0.0 111.018 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -136.76 165.19 26.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.968 2.107 . . . . 0.0 109.771 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.72 158.57 10.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.76 1.267 . . . . 0.0 111.311 170.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 p -92.09 12.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.653 156.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.0 m -121.18 -43.61 2.42 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -162.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.6 p -103.78 -92.89 0.34 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.283 1.401 . . . . 0.0 113.679 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -160.73 -49.13 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.055 2.142 . . . . 0.0 113.7 -172.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p -113.02 156.71 42.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -158.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.82 152.49 16.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.73 2.953 . . . . 0.0 113.333 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.5 -26.39 1.84 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.262 1.025 . . . . 0.0 113.601 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.09 122.01 25.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.629 0.65 . . . . 0.0 112.041 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 p -85.3 130.92 34.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.947 -1.096 . . . . 0.0 109.55 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -9.75 24.08 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 123.135 1.445 . . . . 0.0 112.331 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.8 tt0 -58.18 -33.1 68.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.807 1.243 . . . . 0.0 114.144 166.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 8.1 mmpt? -83.28 0.65 44.74 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.961 1.704 . . . . 0.0 113.092 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 117.44 7.71 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 120.097 1.317 . . . . 0.0 110.154 -169.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.8 135.19 54.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -164.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 72.4 m -58.51 163.34 3.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.656 1.583 . . . . 0.0 113.753 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.279 97.6 p 57.07 -6.63 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.706 2.802 . . . . 0.0 117.941 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.78 111.75 3.69 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 119.939 1.245 . . . . 0.0 110.857 164.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.5 p -71.9 -63.42 1.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.606 1.162 . . . . 0.0 113.645 -162.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.75 -22.51 53.08 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.858 0.742 . . . . 0.0 112.375 153.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.78 111.01 3.07 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -155.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.18 114.84 3.4 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.874 2.383 . . . . 0.0 111.661 -168.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 p -158.38 153.2 24.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.403 1.481 . . . . 0.0 111.089 -164.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.84 148.65 45.63 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.769 2.028 . . . . 0.0 109.379 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.6 p -84.1 -25.9 29.38 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.053 1.741 . . . . 0.0 113.516 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -153.95 162.74 40.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.165 1.386 . . . . 0.0 112.146 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.54 52.5 2.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.752 1.221 . . . . 0.0 110.377 163.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -74.98 112.46 11.24 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.664 0.745 . . . . 0.0 111.302 -169.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.14 -41.26 1.07 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 127.273 2.368 . . . . 0.0 108.205 -153.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.2 p -91.16 161.29 15.14 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.182 1.793 . . . . 0.0 112.369 155.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -157.76 106.19 2.05 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.936 2.494 . . . . 0.0 112.636 169.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.58 -73.76 0.01 OUTLIER Glycine 0 N--CA 1.474 1.181 0 C-N-CA 128.503 2.954 . . . . 0.0 115.735 160.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.9 -24.9 66.15 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.715 1.606 . . . . 0.0 111.59 170.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.35 3.0 4.07 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 -165.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -80.72 3.25 22.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.289 1.836 . . . . 0.0 114.06 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t -105.22 -15.15 15.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.332 1.053 . . . . 0.0 111.813 160.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -99.3 -34.22 10.41 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -168.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -18.39 65.26 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -168.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.74 16.16 71.89 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.584 -0.697 . . . . 0.0 112.912 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.84 167.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.248 1.419 . . . . 0.0 112.204 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.69 173.62 11.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.14 1.776 . . . . 0.0 110.575 169.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 163.53 36.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.58 1.152 . . . . 0.0 113.157 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.73 118.23 6.51 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 127.147 2.179 . . . . 0.0 108.995 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.85 147.41 41.12 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.615 0.766 . . . . 0.0 110.579 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -129.4 51.86 2.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 123.961 1.839 . . . . 0.0 111.215 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.3 p -79.51 47.97 0.87 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.765 2.026 . . . . 0.0 110.72 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.93 -1.22 2.22 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.6 mt -90.07 10.84 22.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.675 1.19 . . . . 0.0 113.043 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.67 -9.31 6.31 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.209 1.385 . . . . 0.0 113.967 -166.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.73 109.75 20.55 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 126.578 1.951 . . . . 0.0 108.129 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.62 126.44 12.1 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.374 2.049 . . . . 0.0 112.849 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -122.95 151.7 41.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.209 1.803 . . . . 0.0 109.183 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 35.3 mtp -112.72 128.23 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.023 2.129 . . . . 0.0 105.77 164.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -124.9 144.94 50.07 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.804 -1.185 . . . . 0.0 111.943 172.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -145.48 138.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.31 1.053 . . . . 0.0 112.304 -156.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 103' ' ' LEU . 2.8 m -149.43 173.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.83 -1.169 . . . . 0.0 111.022 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.6 t -94.14 150.32 20.43 Favored 'General case' 0 N--CA 1.404 -2.773 0 C-N-CA 127.398 2.279 . . . . 0.0 106.575 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -110.27 -18.09 13.36 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 127.762 2.425 . . . . 0.0 112.795 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.56 -44.94 96.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.569 1.148 . . . . 0.0 112.209 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -96.71 -29.57 13.72 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.411 2.284 . . . . 0.0 111.462 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 67.37 124.44 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.61 1.195 . . . . 0.0 111.041 -154.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 71.96 85.26 0.12 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.956 2.102 . . . . 0.0 114.515 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.308 2.7 t60 -74.85 -14.6 60.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.514 ' H ' HG12 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 38.89 52.21 1.91 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.515 2.326 . . . . 0.0 113.591 -172.32 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.97 156.45 22.38 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 111.527 -2.579 . . . . 0.0 109.383 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.53 156.37 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.098 0.959 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.2 t -139.82 126.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 123.799 0.84 . . . . 0.0 109.487 -174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -133.59 152.26 78.71 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.015 0.926 . . . . 0.0 111.496 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.46 140.38 15.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.77 2.313 . . . . 0.0 110.33 160.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.57 -5.61 59.26 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.12 -46.35 0.48 Allowed Glycine 0 CA--C 1.542 1.758 0 C-N-CA 126.891 2.186 . . . . 0.0 113.991 -162.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.93 179.04 6.88 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 CA-C-N 120.981 2.391 . . . . 0.0 113.768 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.67 162.69 4.61 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.707 1.603 . . . . 0.0 111.819 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.25 -3.23 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.168 3.245 . . . . 0.0 116.088 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 t -81.09 -21.54 39.88 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.982 1.713 . . . . 0.0 114.319 170.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.66 16.29 59.88 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 127.346 2.403 . . . . 0.0 115.443 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -70.9 159.52 34.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -167.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -118.75 129.27 55.16 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 107.322 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -84.68 130.36 34.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.8 m -115.27 129.27 56.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.644 1.978 . . . . 0.0 108.784 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.32 175.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 120.434 1.47 . . . . 0.0 110.054 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.51 139.97 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.893 -1.129 . . . . 0.0 111.874 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.1 m -76.0 28.89 0.11 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -165.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.94 -30.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.83 41.56 0.77 Allowed 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.8 mt -132.06 153.64 50.22 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.056 -1.028 . . . . 0.0 112.947 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.58 153.72 35.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.316 1.846 . . . . 0.0 111.328 164.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -151.02 130.65 13.07 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.472 -0.767 . . . . 0.0 112.577 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -142.25 159.17 59.39 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 126.156 1.783 . . . . 0.0 111.702 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.46 164.63 33.53 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.613 2.209 . . . . 0.0 114.22 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.3 t -102.6 -66.79 0.91 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.257 2.623 . . . . 0.0 109.383 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.48 179.25 1.35 Allowed Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 129.492 3.117 . . . . 0.0 112.127 171.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -106.87 -178.96 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 124.383 3.389 . . . . 0.0 113.594 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 76.97 21.61 1.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.383 2.273 . . . . 0.0 116.323 169.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.19 -31.75 73.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.553 0.741 . . . . 0.0 111.813 167.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.54 179.47 0.07 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.547 2.339 . . . . 0.0 115.685 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.17 31.79 0.39 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -171.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.43 -53.78 42.92 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -149.88 158.0 43.73 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -170.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -68.1 160.38 29.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.312 1.445 . . . . 0.0 112.789 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -46.7 137.93 6.54 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.314 1.446 . . . . 0.0 112.653 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -83.1 172.88 12.23 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -59.5 134.12 56.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.18 0.592 . . . . 0.0 110.458 164.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 124.056 0.942 . . . . 0.0 112.474 -178.768 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.061 -0.019 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.65 26.14 0.33 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.977 1.311 . . . . 0.0 112.425 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -161.02 175.41 12.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.544 1.538 . . . . 0.0 111.367 -153.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.3 m95 -98.99 -34.02 10.59 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.194 0.997 . . . . 0.0 111.855 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -62.29 -51.21 68.59 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.003 0.921 . . . . 0.0 111.309 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -67.34 -25.13 65.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -78.08 -32.91 50.97 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.875 2.07 . . . . 0.0 112.983 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.273 3.6 pp -87.24 -24.04 24.52 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 174.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -120.57 60.91 8.33 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 119.596 1.089 . . . . 0.0 113.489 166.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.45 130.05 9.73 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.845 1.697 . . . . 0.0 113.411 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -78.51 -57.96 3.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.953 -153.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -64.41 -10.83 27.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.89 1.676 . . . . 0.0 114.129 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -99.27 -12.66 20.17 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.614 2.365 . . . . 0.0 115.352 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -110.44 -48.8 3.12 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.419 1.488 . . . . 0.0 113.233 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -63.12 -28.05 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.284 -0.885 . . . . 0.0 110.869 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -5.04 1.0 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 130.816 3.646 . . . . 0.0 114.716 170.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -71.74 -17.53 62.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 117.453 -1.26 . . . . 0.0 111.961 164.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.84 -7.85 0.1 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 171.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 11.64 86.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.731 2.812 . . . . 0.0 114.885 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.83 42.02 0.72 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 128.11 2.767 . . . . 0.0 116.433 -169.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -80.38 105.84 11.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.299 1.44 . . . . 0.0 112.083 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -55.92 154.41 7.37 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.675 1.99 . . . . 0.0 113.173 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.42 155.79 80.85 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 127.197 2.199 . . . . 0.0 112.707 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.31 177.94 2.87 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.488 3.459 . . . . 0.0 112.956 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 64.81 -7.89 0.25 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.4 m -51.9 26.15 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.81 1 C-N-CA 132.211 4.204 . . . . 0.0 114.472 149.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.07 -28.97 19.68 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -166.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.5 mtp -75.83 -23.42 55.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.755 1.264 . . . . 0.0 114.279 171.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.32 -10.8 40.0 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 128.621 2.768 . . . . 0.0 112.05 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -98.41 66.09 1.7 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.268 1.827 . . . . 0.0 107.823 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -134.21 -151.95 0.46 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.628 1.571 . . . . 0.0 112.86 -152.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 34' ' ' GLU . 6.5 m-20 -67.7 76.34 0.19 Allowed 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.015 -1.053 . . . . 0.0 110.852 164.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -67.29 12.45 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 126.74 2.016 . . . . 0.0 115.323 176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 32' ' ' ASN . 2.6 tt0 46.51 -169.52 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 131.08 3.752 . . . . 0.0 115.176 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -142.44 157.69 44.49 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.118 1.367 . . . . 0.0 110.172 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.58 -141.8 8.23 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.469 1.509 . . . . 0.0 111.584 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.6 ptp -144.54 162.46 36.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.402 1.081 . . . . 0.0 112.198 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.88 134.18 52.35 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 109.921 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -135.9 163.21 30.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 0.0 110.441 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.59 172.71 6.96 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 124.213 1.959 . . . . 0.0 114.802 -169.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.9 1.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 112.715 -2.038 . . . . 0.0 112.512 165.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.7 m -115.04 -26.89 7.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.177 1.391 . . . . 0.0 112.364 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.9 p -115.83 -98.11 0.45 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.608 1.963 . . . . 0.0 111.337 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.25 -50.18 0.07 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 p -95.62 160.01 31.31 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 116.563 2.061 . . . . 0.0 116.563 -150.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.35 132.83 40.24 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.841 2.361 . . . . 0.0 112.276 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -33.65 5.74 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.902 1.281 . . . . 0.0 111.66 -166.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.34 158.64 30.06 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.373 -0.83 . . . . 0.0 112.712 168.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 p -94.96 132.87 39.33 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 122.677 1.227 . . . . 0.0 110.953 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -4.83 24.12 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.11 0.964 . . . . 0.0 113.405 172.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.91 -29.36 64.24 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.578 1.951 . . . . 0.0 113.576 170.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.01 1.74 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.952 1.301 . . . . 0.0 113.621 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -69.89 121.43 17.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.315 1.846 . . . . 0.0 114.304 -167.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -83.74 79.5 9.44 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.9 t 68.96 135.12 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.708 2.803 . . . . 0.0 117.107 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.4 p -85.22 -6.66 59.26 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.7 -25.26 68.81 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 119.425 1.011 . . . . 0.0 114.541 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 m -109.89 -5.53 15.48 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.376 1.47 . . . . 0.0 111.14 166.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.07 -7.61 15.44 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 126.879 2.18 . . . . 0.0 114.672 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -90.22 133.97 32.31 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -138.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.9 103.75 1.23 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.766 2.311 . . . . 0.0 113.979 -168.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.7 p -158.55 142.29 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.798 2.439 . . . . 0.0 109.533 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -155.3 132.32 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.794 2.038 . . . . 0.0 107.733 -170.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 p -68.96 -24.32 64.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -139.82 142.55 36.64 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.479 0.657 . . . . 0.0 112.13 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.64 39.35 0.61 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.186 1.395 . . . . 0.0 111.555 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -78.18 119.37 21.47 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.421 -1.424 . . . . 0.0 110.742 -173.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.71 -34.09 0.17 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.215 1.388 . . . . 0.0 111.921 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.55 125.19 28.8 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.029 1.332 . . . . 0.0 109.766 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -135.77 119.03 16.65 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.266 1.426 . . . . 0.0 113.46 -162.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.34 -78.63 1.27 Allowed Glycine 0 N--CA 1.464 0.5 0 C-N-CA 124.722 1.154 . . . . 0.0 111.815 172.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -29.28 55.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.289 1.036 . . . . 0.0 113.311 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -105.64 -9.05 17.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.792 1.282 . . . . 0.0 113.526 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.51 4.55 38.71 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 127.098 2.159 . . . . 0.0 110.862 -171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.0 t -70.14 -32.43 70.42 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 165.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -129.98 -73.6 0.56 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.686 1.194 . . . . 0.0 113.303 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.2 p -167.04 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.019 1.728 . . . . 0.0 113.592 -165.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.2 -10.67 7.51 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.968 1.27 . . . . 0.0 113.784 -162.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.87 178.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.712 2.005 . . . . 0.0 111.874 -172.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.42 -177.59 4.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.186 2.194 . . . . 0.0 108.915 166.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -139.39 155.0 47.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.273 1.829 . . . . 0.0 110.742 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 118.57 10.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.85 2.06 . . . . 0.0 107.149 168.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.97 138.53 33.76 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.269 -0.895 . . . . 0.0 111.338 172.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.3 23.01 14.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.739 1.216 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.2 t -71.1 38.65 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.81 2.444 . . . . 0.0 113.362 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.27 10.89 6.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.475 2.71 . . . . 0.0 112.387 -174.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.96 14.42 14.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.238 1.815 . . . . 0.0 112.462 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.28 -12.22 7.55 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 126.019 1.771 . . . . 0.0 113.561 -171.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.9 t -102.22 107.05 51.56 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 108.616 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.19 126.96 12.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.554 1.503 . . . . 0.0 110.623 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -147.89 156.03 42.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.478 2.711 . . . . 0.0 109.629 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.2 mtt -125.99 125.93 43.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.63 2.372 . . . . 0.0 106.994 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -116.39 154.46 30.23 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 110.926 173.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.16 137.24 55.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 125.408 1.483 . . . . 0.0 110.514 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.73 143.4 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.436 0.636 . . . . 0.0 111.516 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.7 t -70.05 108.02 3.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 160.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -63.72 -22.12 66.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.055 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -83.01 -39.5 21.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 112.574 -167.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 18.3 p -115.36 6.04 14.76 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.963 1.705 . . . . 0.0 114.249 172.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.36 60.34 3.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.497 . . . . 0.0 114.616 174.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -150.01 148.77 29.45 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -69.6 136.35 51.14 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.871 0.868 . . . . 0.0 111.263 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.31 -20.99 1.39 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.0 151.56 23.77 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 127.078 2.275 . . . . 0.0 112.52 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.66 166.71 22.91 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 126.141 1.776 . . . . 0.0 111.557 172.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.9 t -143.54 136.17 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.396 1.879 . . . . 0.0 108.212 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -148.57 153.97 40.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.42 1.088 . . . . 0.0 113.069 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.91 135.43 7.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.996 2.464 . . . . 0.0 109.91 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.37 -1.5 45.72 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.22 -40.8 0.51 Allowed Glycine 0 CA--C 1.542 1.749 0 CA-C-O 117.376 -1.791 . . . . 0.0 116.559 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.68 -167.59 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.451 2.767 . . . . 0.0 113.446 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -55.45 160.71 3.48 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.752 1.621 . . . . 0.0 112.345 171.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -59.93 -9.43 9.83 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.659 2.906 . . . . 0.0 114.136 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -22.64 62.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.507 1.523 . . . . 0.0 113.087 170.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.65 19.05 54.06 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 126.405 1.955 . . . . 0.0 115.893 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -73.34 146.72 45.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -110.13 144.53 38.62 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.197 1.399 . . . . 0.0 109.308 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -91.39 137.66 32.19 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.009 1.724 . . . . 0.0 110.068 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.7 p -132.01 132.28 43.29 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.04 1.736 . . . . 0.0 112.769 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 122' ' ' SER . 10.2 mm -80.92 154.99 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.115 1.366 . . . . 0.0 110.611 174.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -91.22 -13.12 33.39 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 120' ' ' ILE . 68.7 m 57.14 82.68 0.11 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.067 2.147 . . . . 0.0 114.417 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 124' ' ' ALA 0.299 3.4 p -93.57 -96.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 111.529 167.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.43 ' H ' HG13 ' A' ' 123' ' ' VAL . . . -157.07 20.92 0.31 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -166.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.99 173.98 6.79 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.687 1.585 . . . . 0.0 113.166 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.26 163.17 12.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.202 1.801 . . . . 0.0 112.735 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -150.79 148.16 28.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.169 1.387 . . . . 0.0 111.861 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -140.4 149.87 59.04 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.069 1.348 . . . . 0.0 111.525 170.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.83 171.32 10.73 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.081 2.521 . . . . 0.0 114.533 -165.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.02 -40.5 11.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.065 1.346 . . . . 0.0 113.903 -173.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -95.64 157.41 36.12 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 127.598 2.359 . . . . 0.0 113.76 -169.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.05 173.92 3.56 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.007 2.472 . . . . 0.0 113.669 164.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 64.78 0.66 1.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.52 2.728 . . . . 0.0 114.558 -170.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -115.38 7.14 15.0 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.749 2.02 . . . . 0.0 113.702 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -140.99 163.32 33.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.249 1.819 . . . . 0.0 110.917 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -148.79 30.53 0.81 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -170.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -55.72 -27.95 53.17 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.931 1.692 . . . . 0.0 114.525 -173.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -65.73 -20.74 66.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.193 1.797 . . . . 0.0 115.239 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 12.3 m170 57.24 170.38 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.611 2.364 . . . . 0.0 114.932 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -56.56 117.15 3.59 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.688 1.595 . . . . 0.0 111.903 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -125.17 174.24 8.21 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.336 1.454 . . . . 0.0 113.02 -173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -61.44 153.89 25.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.992 0.901 . . . . 0.0 112.414 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.376 1.87 . . . . 0.0 108.259 171.745 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 119.304 -0.379 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.05 8.49 1.48 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.163 1.785 . . . . 0.0 115.589 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -94.14 167.0 11.85 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.618 1.967 . . . . 0.0 112.77 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -91.15 -26.49 19.06 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.537 1.135 . . . . 0.0 111.452 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -58.4 -46.65 86.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 124.674 1.19 . . . . 0.0 110.336 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.63 -36.18 82.96 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -67.42 -36.54 81.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.879 0.872 . . . . 0.0 113.118 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -83.36 -11.41 57.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.717 2.407 . . . . 0.0 114.49 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.4 p -115.58 57.04 1.2 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.193 1.397 . . . . 0.0 114.36 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.0 -177.85 3.18 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.596 2.197 . . . . 0.0 113.434 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -49.24 -49.07 44.91 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.321 -1.487 . . . . 0.0 113.596 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.07 -34.1 67.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.595 1.158 . . . . 0.0 112.923 176.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -84.47 -35.24 23.11 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.46 1.504 . . . . 0.0 111.11 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -41.37 85.67 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.798 -1.189 . . . . 0.0 110.986 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.97 -35.13 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.157 1.383 . . . . 0.0 112.513 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 p -89.41 -22.86 22.34 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.851 1.26 . . . . 0.0 113.303 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -63.22 -44.06 96.37 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.838 1.655 . . . . 0.0 110.944 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -111.26 -21.89 11.65 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 tptm 15.21 72.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.016 2.527 . . . . 0.0 116.475 165.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.33 47.76 0.63 Allowed Glycine 0 N--CA 1.47 0.942 0 CA-C-N 113.352 -1.749 . . . . 0.0 113.291 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 t -117.98 174.31 6.27 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.78 1.632 . . . . 0.0 112.259 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -121.63 149.52 43.07 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 128.298 2.639 . . . . 0.0 111.963 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.73 144.67 12.33 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.756 0.822 . . . . 0.0 112.241 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.75 129.84 7.38 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.241 2.627 . . . . 0.0 111.573 175.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -136.6 -22.69 1.26 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 117.535 2.42 . . . . 0.0 117.535 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.21 -17.43 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 119.984 1.266 . . . . 0.0 114.404 -167.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.42 -108.69 2.52 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.896 1.226 . . . . 0.0 112.946 172.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.0 mtp -57.58 -31.1 65.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 167.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -3.61 49.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.38 -0.825 . . . . 0.0 112.607 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -89.36 -24.5 21.95 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.415 1.086 . . . . 0.0 112.468 170.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.24 -30.39 19.72 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.724 1.147 . . . . 0.0 112.47 166.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 57.53 -68.11 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.094 2.958 . . . . 0.0 118.545 164.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -160.44 117.91 2.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.255 2.622 . . . . 0.0 108.766 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.38 1.1 mp0 51.13 -147.46 0.41 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 149.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 130' ' ' SER . 1.2 t -100.15 178.41 4.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.455 1.102 . . . . 0.0 111.545 170.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.71 -153.12 14.22 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.124 0.868 . . . . 0.0 114.47 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.7 ptp -154.12 161.05 42.15 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.329 1.061 . . . . 0.0 112.895 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -120.0 148.37 43.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.787 2.435 . . . . 0.0 110.553 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.35 159.87 42.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.812 2.045 . . . . 0.0 109.503 -167.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.7 m -74.11 165.7 24.7 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.158 1.456 . . . . 0.0 111.802 158.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.62 -9.98 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.853 -1.522 . . . . 0.0 113.948 154.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 t -83.24 -46.34 12.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 112.441 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 p -85.15 -87.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.895 1.278 . . . . 0.0 111.337 170.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -148.9 -57.02 0.21 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.0 p -130.14 156.0 79.93 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -135.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.69 139.45 40.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.502 2.801 . . . . 0.0 112.732 164.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 mt -143.94 -18.78 0.58 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -135.2 134.71 40.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.317 1.417 . . . . 0.0 111.313 -167.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -101.51 122.06 43.11 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.959 1.303 . . . . 0.0 111.007 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -60.15 -15.45 24.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.475 1.51 . . . . 0.0 113.578 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.415 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.51 -31.27 67.73 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 130.252 3.421 . . . . 0.0 113.269 178.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -74.25 4.09 6.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.828 1.251 . . . . 0.0 111.793 177.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -62.61 134.72 56.75 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 120.661 -1.275 . . . . 0.0 114.018 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -129.88 132.12 46.31 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.179 2.192 . . . . 0.0 111.519 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.8 t 37.68 37.82 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 129.45 3.1 . . . . 0.0 117.489 170.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 p -121.48 -67.0 1.0 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.672 1.189 . . . . 0.0 113.102 -166.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.07 -74.94 0.08 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.044 1.307 . . . . 0.0 112.674 -174.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 m -139.17 -36.06 0.54 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.332 2.253 . . . . 0.0 111.656 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.93 -31.61 61.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.039 0.828 . . . . 0.0 114.752 -167.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.29 134.21 5.61 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.655 0.782 . . . . 0.0 111.315 164.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.61 121.17 4.58 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.606 2.204 . . . . 0.0 115.206 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -129.91 178.51 6.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.78 142.35 17.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.821 3.649 . . . . 0.0 106.801 159.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 p -73.75 -35.1 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 111.402 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -146.33 157.32 43.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.718 1.247 . . . . 0.0 114.195 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.15 69.4 10.11 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.939 1.696 . . . . 0.0 110.113 166.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HB3' ' HE3' ' A' ' 52' ' ' LYS . 23.1 t80 -79.47 130.27 35.25 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.343 -0.848 . . . . 0.0 112.094 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.71 -37.04 0.07 OUTLIER Glycine 0 CA--C 1.536 1.388 0 C-N-CA 127.27 2.367 . . . . 0.0 111.292 167.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.2 p -125.05 140.85 52.54 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.19 1.396 . . . . 0.0 114.608 -173.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -137.51 135.94 37.22 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.914 2.486 . . . . 0.0 111.007 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.44 -80.69 0.11 Allowed Glycine 0 N--CA 1.468 0.822 0 C-N-CA 127.103 2.287 . . . . 0.0 113.249 157.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.2 m -45.69 -38.49 6.89 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.094 2.158 . . . . 0.0 112.774 167.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -119.04 19.08 13.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -164.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -65.74 -34.68 78.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.789 0.836 . . . . 0.0 112.794 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.1 t -92.51 -23.08 19.22 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.426 1.091 . . . . 0.0 111.803 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -71.45 -13.13 61.73 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.162 1.385 . . . . 0.0 113.682 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.7 p -48.63 -39.54 24.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.853 1.661 . . . . 0.0 112.605 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.24 17.69 76.11 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.011 -167.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 pt -117.54 155.98 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.868 1.834 . . . . 0.0 114.564 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -136.08 176.62 8.52 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.595 2.758 . . . . 0.0 110.733 177.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.629 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -138.43 141.91 39.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.036 1.334 . . . . 0.0 113.375 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.42 112.7 10.53 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 108.314 173.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.6 mp -80.6 157.28 26.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 125.886 1.674 . . . . 0.0 111.076 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -131.18 108.89 10.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 t -118.44 24.5 10.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.032 1.396 . . . . 0.0 109.836 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.62 -6.71 9.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.393 1.877 . . . . 0.0 113.682 -154.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.5 mt -105.26 18.66 21.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.071 2.148 . . . . 0.0 112.689 170.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -7.01 64.45 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.061 1.315 . . . . 0.0 115.392 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 52.4 t -127.79 112.99 20.59 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.892 1.677 . . . . 0.0 109.648 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.68 125.88 7.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.778 2.319 . . . . 0.0 114.039 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -129.42 154.2 47.18 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.129 2.572 . . . . 0.0 110.222 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mtm -127.49 127.13 43.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.364 1.866 . . . . 0.0 108.224 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -123.25 144.59 49.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.813 0.816 . . . . 0.0 109.776 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.55 144.5 21.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.471 1.108 . . . . 0.0 109.608 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.4 m -128.28 151.82 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 0.0 111.301 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.2 t -93.02 119.04 31.86 Favored 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 126.71 2.004 . . . . 0.0 105.886 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -69.5 -16.77 63.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.606 1.962 . . . . 0.0 111.974 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -83.95 -45.84 12.72 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.2 p -106.78 -7.59 17.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.601 1.961 . . . . 0.0 113.835 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 63.15 40.76 8.64 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.24 1.816 . . . . 0.0 113.066 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.92 154.46 51.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.451 1.5 . . . . 0.0 111.907 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -80.98 90.06 5.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.145 0.978 . . . . 0.0 113.149 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -74.3 8.59 2.1 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -175.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.68 179.63 30.06 Favored Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.002 -1.061 . . . . 0.0 114.065 165.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 156.49 44.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 111.684 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.03 137.47 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.316 1.055 . . . . 0.0 111.751 -173.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.83 151.2 45.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 113.063 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.53 133.44 10.55 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.043 2.495 . . . . 0.0 109.305 162.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -93.87 1.57 56.35 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.43 -62.19 0.28 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.387 -1.229 . . . . 0.0 114.396 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.37 -177.12 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.549 2.832 . . . . 0.0 112.967 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.77 149.83 4.23 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.254 1.022 . . . . 0.0 111.506 170.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.51 -3.77 9.64 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.975 2.45 . . . . 0.0 114.149 -171.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.9 p -54.92 -30.94 59.62 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.639 -0.663 . . . . 0.0 111.943 162.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.9 10.13 74.91 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.882 2.182 . . . . 0.0 117.091 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -50.96 148.81 3.93 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.209 1.504 . . . . 0.0 113.957 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.7 132.02 43.57 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.695 1.198 . . . . 0.0 110.828 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.7 125.35 45.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.105 1.362 . . . . 0.0 110.275 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.5 p -108.13 126.06 52.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.897 2.079 . . . . 0.0 109.618 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -92.41 156.8 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.844 0.831 . . . . 0.0 109.845 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -126.92 163.0 24.62 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.461 1.905 . . . . 0.0 109.957 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 m -96.42 18.43 13.97 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 p -47.39 -48.93 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -159.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.61 24.07 0.34 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.2 mt -125.07 154.92 40.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.426 1.09 . . . . 0.0 112.16 -161.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -128.01 157.14 41.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.779 2.032 . . . . 0.0 113.917 -171.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.4 143.16 33.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -167.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -137.94 152.98 73.23 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.597 1.559 . . . . 0.0 110.875 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.02 179.59 5.59 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.538 2.159 . . . . 0.0 112.022 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.497 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 5.8 t -102.59 -57.7 2.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.967 1.707 . . . . 0.0 111.469 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.497 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 9.3 mmpt? -70.0 157.77 88.96 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 126.419 1.888 . . . . 0.0 112.976 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.4 -173.23 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.97 3.114 . . . . 0.0 113.639 167.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 59.74 29.48 19.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.988 1.715 . . . . 0.0 113.903 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -155.29 44.35 0.47 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.493 2.317 . . . . 0.0 110.906 -171.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.12 36.4 25.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.724 2.01 . . . . 0.0 114.174 -174.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.7 tp -148.15 37.74 0.87 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.269 1.828 . . . . 0.0 111.552 -171.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -73.11 0.34 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.743 1.217 . . . . 0.0 111.832 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -169.98 -172.11 1.29 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.737 2.015 . . . . 0.0 110.813 172.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 59.05 86.3 0.09 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.185 1.794 . . . . 0.0 114.685 163.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -122.84 25.61 8.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.811 1.244 . . . . 0.0 112.742 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -155.78 126.71 6.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.314 1.046 . . . . 0.0 111.384 -165.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.402 ' CG ' ' H ' ' A' ' 143' ' ' HIS . 2.5 t-80 53.52 -162.05 0.11 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.881 1.672 . . . . 0.0 113.994 177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.402 ' H ' ' CG ' ' A' ' 142' ' ' HIS . 11.9 t-160 . . . . . 0 C--O 1.251 1.145 0 C-N-CA 126.62 1.968 . . . . 0.0 113.178 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.08 19.87 7.76 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -171.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -139.0 176.33 8.78 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.07 1.748 . . . . 0.0 112.673 -168.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -115.82 -32.35 5.49 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 164.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -63.51 -59.99 3.93 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -173.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -63.34 -29.17 70.53 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.659 1.584 . . . . 0.0 112.244 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -71.76 -42.6 66.99 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.754 2.022 . . . . 0.0 112.058 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.1 mt -77.97 -33.42 51.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.841 1.256 . . . . 0.0 112.796 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.275 12.2 t -128.73 76.77 78.48 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.33 160.58 46.64 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.023 3.149 . . . . 0.0 113.299 170.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.48 -66.47 1.04 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.569 1.148 . . . . 0.0 110.706 174.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -53.2 -26.06 16.09 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.164 1.785 . . . . 0.0 113.722 175.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.58 -16.98 21.75 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.229 1.412 . . . . 0.0 113.829 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.48 -54.47 3.78 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 111.506 175.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.49 -23.29 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 O-C-N 120.314 -1.491 . . . . 0.0 111.964 -172.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -68.25 -23.73 64.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.087 2.155 . . . . 0.0 112.649 172.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -67.4 -48.31 67.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.145 1.378 . . . . 0.0 110.369 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -73.13 -25.9 61.02 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.837 0.855 . . . . 0.0 111.095 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -71.56 61.28 0.35 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.388 1.875 . . . . 0.0 112.935 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.06 -6.98 0.12 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.509 1.528 . . . . 0.0 116.637 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 t -139.89 178.82 6.98 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.421 1.488 . . . . 0.0 110.987 -174.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -105.21 149.95 25.51 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.98 1.712 . . . . 0.0 111.811 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.61 154.32 44.1 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.792 1.237 . . . . 0.0 112.379 -173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.48 142.35 48.91 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.331 2.687 . . . . 0.0 111.527 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -80.75 45.14 0.78 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.1 m -67.69 24.96 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 128.712 2.805 . . . . 0.0 114.559 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.23 -56.17 5.49 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 126.599 2.047 . . . . 0.0 117.254 -165.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.2 ttm -64.2 -16.06 61.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.486 1.143 . . . . 0.0 114.077 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.9 -2.66 34.2 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.601 2.76 . . . . 0.0 112.159 176.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.7 mt -103.7 -9.46 19.11 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.18 1.792 . . . . 0.0 112.801 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -154.43 -32.89 0.1 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.742 1.617 . . . . 0.0 113.694 164.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.3 t30 55.04 -81.6 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.16 1.784 . . . . 0.0 112.718 -166.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -151.01 4.35 0.47 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -69.31 175.22 4.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 123.439 1.59 . . . . 0.0 113.104 173.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m -146.63 154.46 41.5 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.496 1.518 . . . . 0.0 109.788 -166.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.62 -158.52 20.82 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 172.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ptp -155.2 167.55 29.99 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.436 1.494 . . . . 0.0 112.647 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.98 151.17 40.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 112.253 157.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -138.16 164.59 28.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.039 2.136 . . . . 0.0 109.834 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.445 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 59.4 m -62.16 169.72 2.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 124.085 1.898 . . . . 0.0 114.712 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 p -115.6 -2.37 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.952 -2.385 . . . . 0.0 112.301 169.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.2 m -124.57 -18.35 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -169.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 12.7 p -125.9 -101.29 0.37 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.137 1.375 . . . . 0.0 112.008 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -159.71 -35.77 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.404 2.282 . . . . 0.0 113.538 -170.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.44 124.32 87.96 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -157.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.43 127.02 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.066 1.844 . . . . 0.0 110.363 156.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.72 -45.07 1.63 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.931 -158.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -126.31 121.12 31.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.825 -171.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 p -82.28 131.13 35.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.185 0.993 . . . . 0.0 108.903 166.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -58.45 -13.95 6.66 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.236 1.815 . . . . 0.0 112.321 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.11 -43.6 87.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 127.098 2.159 . . . . 0.0 114.548 168.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.8 mmpt? -72.83 -2.09 19.27 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.215 1.406 . . . . 0.0 113.222 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -78.36 137.5 38.06 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.628 1.971 . . . . 0.0 110.522 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -84.29 61.85 6.81 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 123.0 1.381 . . . . 0.0 111.571 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.8 t -101.35 109.5 21.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.181 0.992 . . . . 0.0 110.471 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.7 p -157.78 -40.47 0.07 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.557 1.143 . . . . 0.0 112.416 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.39 -49.67 0.39 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.305 1.431 . . . . 0.0 113.503 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.7 m -112.06 -20.56 11.91 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.302 1.041 . . . . 0.0 111.078 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.15 6.15 6.92 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.543 1.068 . . . . 0.0 114.483 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -65.58 142.61 98.35 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.663 1.185 . . . . 0.0 111.043 -170.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.04 96.84 0.63 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 CA-C-O 124.618 1.841 . . . . 0.0 113.887 -164.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.1 p -152.0 161.82 42.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 128.599 2.76 . . . . 0.0 110.427 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -157.15 168.29 27.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.365 2.266 . . . . 0.0 106.559 -169.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -127.55 -7.07 5.73 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 164.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -135.12 147.9 49.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 122.139 0.971 . . . . 0.0 111.858 160.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.57 108.97 4.65 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.689 1.995 . . . . 0.0 105.811 165.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -30.08 95.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 129.803 3.241 . . . . 0.0 112.408 172.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.1 19.06 35.58 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.181 1.372 . . . . 0.0 114.109 -162.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -55.95 143.69 31.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.071 2.548 . . . . 0.0 115.125 -171.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.4 mmpt? -139.23 142.43 37.84 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 128.456 2.702 . . . . 0.0 111.342 172.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.88 -57.37 3.09 Favored Glycine 0 N--CA 1.478 1.476 0 C-N-CA 126.516 2.008 . . . . 0.0 114.82 163.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -25.92 64.91 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.0 1.32 . . . . 0.0 112.72 160.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -146.17 136.29 23.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.342 2.257 . . . . 0.0 109.811 167.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -139.74 7.02 2.28 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.497 1.519 . . . . 0.0 114.702 152.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 t -96.32 -41.32 8.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.719 1.208 . . . . 0.0 113.148 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -77.38 -32.98 55.27 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.906 1.682 . . . . 0.0 113.442 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.7 p -116.16 -54.57 2.47 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.037 1.735 . . . . 0.0 108.823 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.96 18.17 32.29 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.198 1.38 . . . . 0.0 113.914 -173.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -74.12 178.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 122.766 1.27 . . . . 0.0 113.091 -171.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.55 171.87 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.707 1.603 . . . . 0.0 110.152 174.136 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.629 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -160.79 157.78 27.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.766 1.627 . . . . 0.0 111.512 177.282 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -149.94 123.7 9.24 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.005 2.122 . . . . 0.0 107.916 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.03 147.35 42.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.745 161.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.04 23.27 11.47 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.201 1.001 . . . . 0.0 113.311 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.4 m -71.25 41.77 0.07 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.281 3.032 . . . . 0.0 112.876 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.88 -1.25 2.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 127.091 2.156 . . . . 0.0 113.438 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.9 mt -102.46 20.29 17.3 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.713 2.005 . . . . 0.0 112.224 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -9.11 60.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.049 1.309 . . . . 0.0 114.75 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.2 t -136.37 134.41 19.88 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 110.608 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 140.89 37.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.149 2.566 . . . . 0.0 113.366 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.2 mmt-85 -146.34 156.04 43.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.631 1.972 . . . . 0.0 111.308 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.25 119.81 20.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.608 1.563 . . . . 0.0 108.928 171.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -137.71 148.34 45.58 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.631 -0.668 . . . . 0.0 112.207 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.18 142.8 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.316 1.446 . . . . 0.0 112.296 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.91 157.43 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.807 1.243 . . . . 0.0 110.353 -172.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 49.1 t -92.98 128.43 38.85 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 123.008 1.385 . . . . 0.0 107.517 163.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -20.09 21.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.575 1.95 . . . . 0.0 112.166 170.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.82 -39.31 93.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.152 0.887 . . . . 0.0 112.616 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.05 -2.59 10.75 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.702 2.001 . . . . 0.0 114.856 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 52.43 63.67 2.15 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.461 1.505 . . . . 0.0 112.141 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -129.91 131.49 46.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.337 1.055 . . . . 0.0 112.04 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -90.87 103.29 16.02 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.194 -0.941 . . . . 0.0 109.578 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.0 mt -103.36 -40.49 6.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -160.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.51 148.63 20.02 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.873 1.702 . . . . 0.0 113.763 -161.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 159.35 42.95 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.468 1.107 . . . . 0.0 111.831 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.04 139.82 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 122.634 1.207 . . . . 0.0 111.37 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -147.95 154.98 44.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.572 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.39 135.79 13.61 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.681 2.921 . . . . 0.0 111.361 171.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -74.7 -4.61 38.44 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.95 -62.65 0.24 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.985 1.755 . . . . 0.0 114.213 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.12 -156.27 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.007 3.138 . . . . 0.0 112.707 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.96 160.51 0.81 Allowed Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 125.085 1.354 . . . . 0.0 112.217 170.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -58.34 -6.08 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.651 2.901 . . . . 0.0 114.949 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -30.17 67.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.011 0.924 . . . . 0.0 112.446 164.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.3 30.85 6.42 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 126.664 2.078 . . . . 0.0 114.995 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -72.37 143.23 48.66 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.313 1.045 . . . . 0.0 112.923 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -131.06 127.0 37.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.366 1.066 . . . . 0.0 109.629 169.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.25 127.77 38.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.035 0.534 . . . . 0.0 109.978 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 m -126.06 134.22 51.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.953 1.701 . . . . 0.0 110.081 -171.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.9 tt -131.61 164.2 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.142 . . . . 0.0 110.624 -171.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.02 -55.41 1.28 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 m 45.85 34.66 1.97 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.77 -24.67 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -157.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -139.63 17.17 2.53 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.773 1.629 . . . . 0.0 114.415 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.93 179.55 7.52 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.918 -1.114 . . . . 0.0 111.192 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -101.67 134.39 44.88 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.244 -0.91 . . . . 0.0 111.405 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -139.27 137.72 36.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.454 -171.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -144.26 143.49 22.43 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.718 1.207 . . . . 0.0 110.831 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.12 168.53 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.472 1.448 . . . . 0.0 110.955 164.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.28 -44.68 5.34 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.666 1.186 . . . . 0.0 112.705 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.43 148.06 1.78 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.524 1.13 . . . . 0.0 112.488 167.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.38 -175.41 1.3 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.011 2.474 . . . . 0.0 113.243 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . 0.258 . . 69.2 32.2 3.72 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.987 2.115 . . . . 0.0 114.532 -166.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.65 -20.24 29.74 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.032 1.333 . . . . 0.0 114.067 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 52.99 44.04 30.96 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.836 1.654 . . . . 0.0 114.916 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.4 tp -139.95 40.08 1.97 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.885 1.326 . . . . 0.0 111.716 -164.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.39 -42.83 70.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.285 1.434 . . . . 0.0 114.099 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -139.06 170.61 15.66 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.061 1.345 . . . . 0.0 111.86 -176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -132.28 -153.19 0.54 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.926 1.29 . . . . 0.0 110.298 -170.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -110.78 -41.73 4.2 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.184 -0.947 . . . . 0.0 113.225 166.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 55.73 174.25 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.447 1.099 . . . . 0.0 113.021 -164.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -127.92 158.08 38.8 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.414 1.486 . . . . 0.0 109.174 167.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.801 1.24 . . . . 0.0 112.005 172.613 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.34 -150.51 21.0 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.457 -0.777 . . . . 0.0 112.068 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.13 169.81 20.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.072 1.349 . . . . 0.0 112.645 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.56 144.71 50.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.247 2.619 . . . . 0.0 110.764 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -147.08 160.55 42.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 111.327 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 59.9 m -64.6 154.21 36.98 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 123.056 1.408 . . . . 0.0 112.077 171.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.269 9.0 p -113.8 27.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.808 153.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.21 -41.4 3.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.534 1.534 . . . . 0.0 112.104 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 17.5 p -109.99 -103.53 0.38 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.674 1.59 . . . . 0.0 112.444 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.55 -40.51 0.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.878 2.471 . . . . 0.0 113.37 -163.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -98.02 137.15 20.85 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -152.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.85 139.65 15.69 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.094 2.529 . . . . 0.0 111.531 161.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.19 -29.71 0.88 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -165.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -132.04 126.97 35.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.559 1.072 . . . . 0.0 111.548 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.1 m -86.82 133.23 33.66 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 120.659 -1.276 . . . . 0.0 110.798 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -11.93 23.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.124 1.37 . . . . 0.0 112.931 171.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -35.81 71.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.22 7.49 24.97 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.227 1.011 . . . . 0.0 112.465 176.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -61.37 131.97 52.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.068 0.849 . . . . 0.0 109.658 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 122.716 1.245 . . . . 0.0 112.582 174.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo . . . . . 0 CA--C 1.54 0.802 0 CA-C-O 125.185 2.077 . . . . 0.0 116.392 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -135.28 154.31 51.59 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 128.516 2.726 . . . . 0.0 110.806 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -138.45 107.04 5.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.885 1.674 . . . . 0.0 111.014 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.7 p -63.99 -15.07 58.48 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.25 160.62 40.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.373 0.669 . . . . 0.0 109.387 138.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 124.314 1.046 . . . . 0.0 109.259 166.077 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.988 0 CA-C-O 119.238 -0.757 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -96.27 148.86 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.048 0.924 . . . . 0.0 111.232 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.43 174.12 8.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.821 2.848 . . . . 0.0 110.197 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.08 156.84 33.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.003 1.321 . . . . 0.0 112.144 -167.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.95 121.89 3.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.405 1.882 . . . . 0.0 110.083 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -97.24 154.07 17.63 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.338 1.855 . . . . 0.0 112.237 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -147.99 111.15 4.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.729 1.212 . . . . 0.0 110.21 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.7 t -118.95 19.85 12.91 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.811 1.767 . . . . 0.0 112.834 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 -15.15 28.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.252 1.421 . . . . 0.0 114.009 -154.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.0 mt -84.94 10.61 11.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.806 1.642 . . . . 0.0 112.914 166.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.16 -5.01 81.41 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.63 1.586 . . . . 0.0 114.653 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 10.0 t -137.19 129.65 16.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.258 1.023 . . . . 0.0 111.401 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.57 135.11 12.82 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.126 2.551 . . . . 0.0 114.373 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.6 mmt-85 -127.77 157.3 40.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 129.967 3.307 . . . . 0.0 109.315 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.4 mtm -133.44 132.84 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.355 1.862 . . . . 0.0 108.308 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -139.26 149.36 44.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 112.151 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.11 150.69 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.283 1.433 . . . . 0.0 111.916 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.42 155.02 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 109.927 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 1.232 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 7.6 t -92.6 128.41 38.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 158.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -84.02 -24.24 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.253 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -64.74 -43.95 91.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.854 0.862 . . . . 0.0 112.447 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.232 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.8 OUTLIER -99.98 -15.07 18.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.66 2.384 . . . . 0.0 113.238 178.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.303 42.5 mt-10 64.31 24.82 13.38 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.935 2.094 . . . . 0.0 112.799 -168.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.82 98.32 8.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.796 2.039 . . . . 0.0 112.848 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -89.12 68.87 8.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.949 1.7 . . . . 0.0 112.345 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.59 -5.09 8.7 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -159.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.56 135.97 12.44 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.707 2.099 . . . . 0.0 112.171 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.49 152.8 33.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.09 0.956 . . . . 0.0 111.39 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.12 125.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 122.322 1.058 . . . . 0.0 112.834 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -129.76 145.06 55.48 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.802 1.241 . . . . 0.0 111.76 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.57 167.21 27.07 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.48 2.787 . . . . 0.0 112.419 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -109.14 -8.49 15.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.453 1.901 . . . . 0.0 115.336 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.1 -56.31 0.71 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.661 1.6 . . . . 0.0 114.512 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.75 -157.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 124.65 3.567 . . . . 0.0 113.271 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 154.98 13.56 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.661 1.584 . . . . 0.0 111.406 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -61.56 -7.48 8.99 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.443 2.762 . . . . 0.0 114.283 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 p -57.74 -26.78 62.3 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.876 1.27 . . . . 0.0 113.762 165.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.34 4.46 86.04 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.193 1.377 . . . . 0.0 116.054 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.94 149.88 8.48 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.98 127.39 50.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 110.99 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.37 103.14 12.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.253 1.421 . . . . 0.0 109.484 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.1 p -92.9 136.85 32.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.436 2.294 . . . . 0.0 110.55 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.05 133.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.158 -0.964 . . . . 0.0 109.239 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -110.48 133.04 53.65 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.0 m -82.71 16.37 2.23 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -164.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.66 -23.72 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.95 22.38 3.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.851 1.66 . . . . 0.0 113.576 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.4 mt -122.02 140.58 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.155 0.982 . . . . 0.0 112.993 -170.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -115.54 178.05 4.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.404 2.682 . . . . 0.0 112.15 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -150.63 148.31 28.47 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.467 1.107 . . . . 0.0 112.29 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -131.16 134.11 25.45 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.37 1.468 . . . . 0.0 109.41 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.86 171.57 15.28 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.185 2.59 . . . . 0.0 113.107 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -42.5 18.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.921 0.888 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt . . . . . 0 CA--C 1.55 0.978 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 -167.638 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.783 0.802 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 129' ' ' PRO . . . 145.81 -154.53 26.0 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 125.369 1.461 . . . . 0.0 112.266 -175.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 21.8 ptm -158.08 162.97 38.1 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -125.84 142.12 51.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.664 2.786 . . . . 0.0 110.77 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -154.91 166.23 34.18 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.343 1.857 . . . . 0.0 110.428 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 4.5 t -80.98 172.84 13.24 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.132 1.444 . . . . 0.0 113.298 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.07 -9.06 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.173 1.789 . . . . 0.0 112.908 163.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 92.4 m -103.99 -33.45 8.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.959 1.303 . . . . 0.0 113.648 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -99.32 -100.49 0.23 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.759 1.223 . . . . 0.0 111.619 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -165.09 -62.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.36 145.12 29.13 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -161.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.43 151.58 70.95 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.236 2.624 . . . . 0.0 111.214 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.2 tp -137.83 -33.81 0.7 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -166.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -144.98 140.27 28.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.161 1.346 . . . . 0.0 114.205 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -98.56 144.41 27.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.011 0.925 . . . . 0.0 112.965 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -13.21 40.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.161 1.384 . . . . 0.0 113.407 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -24.87 66.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -87.19 -3.08 59.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.828 2.451 . . . . 0.0 113.312 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 127.76 33.7 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.992 1.317 . . . . 0.0 110.864 -170.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -166.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 CA--C 1.534 0.501 0 CA-C-O 124.311 1.713 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.2 p -158.74 156.56 30.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.695 2.798 . . . . 0.0 110.016 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.08 158.78 43.57 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 108.072 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.2 p -91.62 -20.13 21.97 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 127.243 2.217 . . . . 0.0 112.71 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -150.87 152.96 34.45 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.591 1.156 . . . . 0.0 112.199 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 125.033 1.333 . . . . 0.0 109.588 166.085 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.19 0 CA-C-O 121.801 0.667 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.59 164.97 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.471 1.909 . . . . 0.0 112.494 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.09 177.8 4.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.579 1.552 . . . . 0.0 109.408 158.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.28 155.96 38.72 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.657 -174.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -151.98 121.16 6.71 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.262 1.825 . . . . 0.0 108.49 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.51 135.69 38.25 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.55 -0.719 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -94.01 25.53 3.66 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 122.389 1.09 . . . . 0.0 111.195 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -75.8 45.99 0.36 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.816 2.446 . . . . 0.0 111.305 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -127.19 -13.16 5.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.128 2.171 . . . . 0.0 113.287 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.14 18.39 21.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.941 2.496 . . . . 0.0 112.633 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.91 -6.67 54.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.686 1.136 . . . . 0.0 114.643 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.3 t -133.53 133.61 22.8 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.885 1.674 . . . . 0.0 110.628 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.38 152.48 60.79 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.623 2.882 . . . . 0.0 114.214 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -146.26 164.21 33.03 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 128.859 2.864 . . . . 0.0 109.763 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.4 ttp -119.0 135.33 54.67 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 151.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 153.16 42.41 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.714 1.206 . . . . 0.0 110.709 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.41 148.49 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 122.103 0.954 . . . . 0.0 112.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.82 148.87 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.431 1.093 . . . . 0.0 112.327 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.72 107.95 10.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.429 2.292 . . . . 0.0 104.898 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -74.99 -14.2 60.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 168.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -61.58 -40.13 93.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 112.205 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.8 p -124.76 -5.46 7.51 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 9.4 tt0 73.38 53.71 0.12 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.215 2.206 . . . . 0.0 116.118 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.0 153.43 41.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 113.922 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 134.96 55.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.65 1.58 . . . . 0.0 113.064 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 tp -123.98 -15.48 6.85 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -165.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.82 179.55 34.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.731 2.11 . . . . 0.0 112.486 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -179.48 6.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.495 1.141 . . . . 0.0 113.816 -167.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.2 137.17 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.73 2.012 . . . . 0.0 109.576 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.26 149.42 48.26 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.315 1.446 . . . . 0.0 112.249 -172.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.88 143.46 16.44 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.826 2.35 . . . . 0.0 109.805 160.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.84 22.94 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.838 -1.164 . . . . 0.0 113.557 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.59 -46.34 1.15 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 127.157 2.313 . . . . 0.0 115.887 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -83.53 -163.48 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.34 2.693 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 151.9 63.49 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 113.258 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.28 -15.84 50.74 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.189 2.593 . . . . 0.0 113.215 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 p -56.67 -23.4 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.022 1.329 . . . . 0.0 113.186 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 9.76 64.9 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.463 2.459 . . . . 0.0 116.603 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -53.03 152.32 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.302 1.551 . . . . 0.0 114.246 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -136.94 154.44 50.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.883 2.073 . . . . 0.0 108.957 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -92.94 142.5 27.23 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.524 0.73 . . . . 0.0 110.498 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.5 p -121.0 143.2 49.17 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.744 1.618 . . . . 0.0 112.561 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.35 165.3 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.21 -0.931 . . . . 0.0 112.755 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.89 126.41 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.063 1.345 . . . . 0.0 114.162 -165.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -77.62 46.52 0.55 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.173 1.789 . . . . 0.0 112.954 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.18 -47.28 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.465 1.506 . . . . 0.0 113.398 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.29 4.66 0.05 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.565 1.546 . . . . 0.0 114.058 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.0 mt -85.8 159.59 19.69 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.746 1.619 . . . . 0.0 110.382 -164.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -103.95 133.68 48.5 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.142 0.977 . . . . 0.0 112.989 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.1 138.94 14.26 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.36 -0.838 . . . . 0.0 111.773 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -138.31 153.32 72.83 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.891 1.277 . . . . 0.0 111.997 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.436 ' HA ' ' HA3' ' A' ' 36' ' ' GLY . 87.1 Cg_endo -75.16 170.6 20.02 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.972 2.448 . . . . 0.0 112.859 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.44 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -91.74 -43.06 9.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.812 0.845 . . . . 0.0 111.73 -176.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 8.4 mmpt? . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 125.678 1.591 . . . . 0.0 114.767 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.7 m . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.92 -144.45 10.73 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.088 1.328 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ptm -132.74 162.75 30.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 112.517 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.96 139.76 52.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.962 2.905 . . . . 0.0 109.54 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.41 168.05 23.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.564 1.945 . . . . 0.0 109.423 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.0 OUTLIER -63.91 173.93 1.66 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 123.28 1.514 . . . . 0.0 112.578 176.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 p -122.98 -6.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.444 151.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.2 m -108.93 -27.73 9.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -168.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 13.8 p -109.28 -95.25 0.4 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.753 1.621 . . . . 0.0 112.017 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -157.37 -55.43 0.08 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.8 154.5 50.27 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 -154.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.37 143.86 71.69 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.169 1.913 . . . . 0.0 110.889 161.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.85 -51.93 2.64 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.374 1.07 . . . . 0.0 111.888 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -145.66 158.69 43.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.826 0.822 . . . . 0.0 112.033 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 p -85.63 135.05 33.95 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.441 1.096 . . . . 0.0 108.813 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -6.79 12.52 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.233 -0.917 . . . . 0.0 112.871 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -44.33 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 160.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -67.01 -10.5 50.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.862 1.665 . . . . 0.0 113.132 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -78.55 127.71 32.53 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.655 1.982 . . . . 0.0 110.969 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--N 1.326 -0.438 0 C-N-CA 127.052 2.141 . . . . 0.0 105.976 170.66 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 CA--C 1.532 0.381 0 CA-C-O 123.581 1.409 . . . . 0.0 114.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.9 p -140.95 158.12 44.38 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.215 1.806 . . . . 0.0 110.881 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.23 114.62 6.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.141 0.976 . . . . 0.0 108.976 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -73.07 -20.84 60.88 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.387 -0.821 . . . . 0.0 112.925 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -145.06 148.54 33.8 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.137 -0.977 . . . . 0.0 112.441 -174.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 124.992 1.317 . . . . 0.0 109.45 174.449 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.405 0 N-CA-C 113.968 0.347 . . . . 0.0 113.968 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.97 178.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 127.124 2.17 . . . . 0.0 110.455 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.51 175.2 8.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.857 2.063 . . . . 0.0 107.948 159.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.495 HH11 HD13 ' A' ' 83' ' ' LEU . 1.9 ppt_? -147.03 140.67 25.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -126.46 93.18 3.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.226 1.488 . . . . 0.0 112.108 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD13 HH11 ' A' ' 81' ' ' ARG . 6.5 mp -62.97 144.03 57.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.29 -0.881 . . . . 0.0 108.7 155.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -146.24 52.27 1.14 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.294 1.521 . . . . 0.0 112.363 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -73.3 30.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.244 1.818 . . . . 0.0 114.529 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -109.8 0.31 18.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.333 1.453 . . . . 0.0 113.615 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.1 mt -80.16 6.66 11.11 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.267 1.027 . . . . 0.0 112.394 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -6.63 52.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.433 1.492 . . . . 0.0 113.941 -163.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.4 t -130.39 131.58 23.47 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.84 . . . . 0.0 110.09 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.39 131.43 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.088 2.525 . . . . 0.0 113.115 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -133.02 157.65 44.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.448 1.899 . . . . 0.0 109.788 166.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.2 mtm -131.61 136.02 47.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.777 2.031 . . . . 0.0 108.526 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.17 153.15 52.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 124.732 1.213 . . . . 0.0 110.828 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.25 144.44 28.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.346 1.058 . . . . 0.0 112.209 162.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 102' ' ' HIS . 2.8 m -111.82 146.43 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.825 1.25 . . . . 0.0 110.979 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.715 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.2 t -74.79 112.17 10.73 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 124.039 1.876 . . . . 0.0 107.198 169.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -63.37 -24.56 67.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 112.422 -2.172 . . . . 0.0 112.04 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.16 -45.21 18.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.203 1.401 . . . . 0.0 114.419 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.715 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 8.2 p -113.53 -3.74 13.63 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.898 1.679 . . . . 0.0 115.195 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 71.31 46.29 0.44 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.677 1.991 . . . . 0.0 115.53 167.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.93 144.46 37.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.406 ' HB3' HG12 ' A' ' 95' ' ' VAL . 13.9 p-80 -75.7 118.72 18.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.712 1.205 . . . . 0.0 110.416 170.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.61 -29.01 1.57 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -168.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.93 127.57 6.55 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 127.289 2.376 . . . . 0.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.97 146.34 35.51 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.025 -0.691 . . . . 0.0 111.083 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.98 142.07 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.526 1.531 . . . . 0.0 111.141 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -145.47 156.66 53.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.3 147.79 12.86 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.974 3.116 . . . . 0.0 112.804 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -97.82 -1.05 44.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.8 -55.15 0.77 Allowed Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.953 1.739 . . . . 0.0 116.103 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 -156.98 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 125.202 3.935 . . . . 0.0 113.54 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -51.93 159.57 1.37 Allowed Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.76 1.624 . . . . 0.0 112.097 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.34 -8.91 7.46 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.429 2.752 . . . . 0.0 114.665 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.7 p -55.26 -34.06 63.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.339 1.456 . . . . 0.0 112.914 165.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.97 3.98 86.22 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -57.3 138.21 55.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.703 1.252 . . . . 0.0 113.764 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -115.25 128.67 56.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.103 1.761 . . . . 0.0 108.893 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -111.17 109.9 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.729 1.211 . . . . 0.0 109.334 -169.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.5 m -95.7 148.61 22.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.183 2.193 . . . . 0.0 111.288 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -134.0 144.9 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.137 0.975 . . . . 0.0 109.882 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.25 107.31 9.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.306 1.051 . . . . 0.0 113.219 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.9 m -79.22 38.04 0.34 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.51 -27.88 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.05 -1.031 . . . . 0.0 112.096 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 15.86 7.84 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.032 2.133 . . . . 0.0 113.351 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.463 1.505 . . . . 0.0 111.945 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -112.26 160.71 17.37 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.43 1.492 . . . . 0.0 111.573 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.59 149.67 50.63 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.47 -0.769 . . . . 0.0 112.375 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -136.61 133.97 19.33 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.458 1.503 . . . . 0.0 108.938 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.77 170.28 14.26 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.883 2.389 . . . . 0.0 113.404 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -39.59 54.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.045 0.926 . . . . 0.0 112.42 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm . . . . . 0 CA--C 1.548 0.89 0 C-N-CA 125.093 1.357 . . . . 0.0 113.152 -171.715 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.61 -154.26 16.01 Favored Glycine 0 N--CA 1.465 0.627 0 C-N-CA 124.464 1.03 . . . . 0.0 113.814 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptp -156.05 163.59 39.49 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.036 1.334 . . . . 0.0 112.302 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.75 144.21 41.41 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 127.914 2.486 . . . . 0.0 111.014 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -141.81 161.68 37.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.004 1.721 . . . . 0.0 111.264 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 64.0 m -66.07 162.7 18.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 123.354 1.549 . . . . 0.0 113.235 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.29 1.44 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.963 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.7 m -129.4 -39.09 1.52 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -167.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 17.5 p -94.67 -85.34 0.31 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.587 1.085 . . . . 0.0 112.549 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.98 -74.51 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 p -110.46 155.65 41.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -151.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.95 138.39 33.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.294 1.996 . . . . 0.0 111.771 165.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.0 mt -135.35 -11.53 2.15 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.98 120.29 23.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.425 1.011 . . . . 0.0 111.534 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -92.8 131.6 37.7 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.812 1.768 . . . . 0.0 112.054 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -67.67 -7.53 27.54 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.742 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.35 -28.95 63.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 113.976 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 5.48 51.64 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 171.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -78.22 136.44 37.79 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.691 0.678 . . . . 0.0 109.439 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 CA--C 1.545 0.756 0 C-N-CA 123.611 0.764 . . . . 0.0 112.686 175.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo . . . . . 0 CA--C 1.538 0.681 0 CA-C-O 123.294 1.289 . . . . 0.0 114.259 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -159.33 148.61 18.39 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.532 1.933 . . . . 0.0 110.767 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -148.08 128.05 13.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.555 1.942 . . . . 0.0 109.59 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 p -73.35 -20.29 60.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -126.61 143.88 51.08 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.986 1.85 . . . . 0.0 113.897 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.794 0 CA-C-N 110.969 -2.832 . . . . 0.0 107.469 -177.954 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.182 0 CA-C-O 119.813 -0.437 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -98.47 163.41 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.841 0.829 . . . . 0.0 111.693 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.56 176.62 8.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.791 2.036 . . . . 0.0 112.502 -169.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.555 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -145.86 151.46 37.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.295 1.438 . . . . 0.0 112.875 -171.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.73 112.74 5.17 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.528 1.931 . . . . 0.0 108.82 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.04 131.6 37.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.963 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -98.82 17.42 19.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.015 1.326 . . . . 0.0 112.084 -168.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -70.33 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.891 2.876 . . . . 0.0 114.767 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -125.05 0.39 7.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.983 1.713 . . . . 0.0 113.766 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.9 mt -100.08 15.53 27.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 113.273 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.29 -9.43 54.48 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.408 1.48 . . . . 0.0 114.328 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.6 t -118.81 121.45 30.62 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.441 1.496 . . . . 0.0 110.224 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 125.01 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.332 2.022 . . . . 0.0 111.804 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -144.62 159.85 42.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.722 2.009 . . . . 0.0 109.909 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.8 mtp -128.51 127.13 41.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.938 2.095 . . . . 0.0 107.975 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.56 151.98 51.47 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.161 0.984 . . . . 0.0 110.677 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 m -133.82 148.8 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.993 1.317 . . . . 0.0 110.84 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.25 156.16 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.27 0.628 . . . . 0.0 111.432 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.841 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.3 t -92.61 118.91 31.51 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -83.59 -14.87 51.09 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.861 171.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -70.01 -51.01 35.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.064 0.945 . . . . 0.0 112.811 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.841 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 2.6 p -107.4 -7.75 16.53 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.833 1.653 . . . . 0.0 115.033 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 61.26 56.29 2.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.109 2.164 . . . . 0.0 114.039 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.79 146.13 43.2 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.693 1.197 . . . . 0.0 111.796 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.06 126.61 30.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.19 -0.944 . . . . 0.0 111.18 172.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.38 6.66 36.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.487 1.915 . . . . 0.0 113.216 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.8 -168.77 13.04 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 127.22 2.343 . . . . 0.0 112.584 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.23 163.85 36.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 123.012 1.386 . . . . 0.0 113.577 -165.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.64 135.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.28 1.832 . . . . 0.0 110.031 -165.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -148.13 154.17 42.4 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.021 1.329 . . . . 0.0 113.53 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.22 129.79 6.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.402 2.734 . . . . 0.0 109.763 163.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.31 -3.0 54.5 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.06 -54.64 0.38 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.238 1.399 . . . . 0.0 114.797 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.88 -165.02 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.469 2.779 . . . . 0.0 112.736 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 157.75 2.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.322 1.449 . . . . 0.0 111.862 173.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -57.44 -17.82 28.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.946 2.431 . . . . 0.0 113.479 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -23.24 36.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.599 1.56 . . . . 0.0 113.269 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.69 17.89 51.8 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 127.773 2.606 . . . . 0.0 115.427 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.02 140.1 56.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.413 1.107 . . . . 0.0 112.584 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -124.76 146.91 48.96 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.198 1.799 . . . . 0.0 110.318 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.48 129.58 42.6 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.269 1.427 . . . . 0.0 109.148 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.9 p -120.78 144.39 48.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.014 1.326 . . . . 0.0 111.055 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.2 tp -123.42 155.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 0.0 111.091 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -126.8 134.16 50.64 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.989 1.716 . . . . 0.0 107.448 161.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.4 m -81.7 50.67 1.55 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -163.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -50.99 -59.89 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.902 2.481 . . . . 0.0 115.236 -164.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.13 27.1 0.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.727 1.211 . . . . 0.0 114.024 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.3 mt -117.19 157.01 26.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.823 1.249 . . . . 0.0 110.358 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 166.42 10.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.825 1.65 . . . . 0.0 112.19 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -144.63 153.21 41.53 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.557 1.143 . . . . 0.0 112.203 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 151.97 67.42 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.442 1.897 . . . . 0.0 109.946 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.13 170.69 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.62 2.213 . . . . 0.0 112.921 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.55 -45.73 8.75 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.877 0.871 . . . . 0.0 111.95 -170.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt . . . . . 0 CA--C 1.546 0.809 0 C-N-CA 127.23 2.212 . . . . 0.0 112.371 179.001 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.428 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.6 m . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.91 -167.3 39.99 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 118.863 0.756 . . . . 0.0 113.119 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.7 ptp -156.2 159.44 38.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.256 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.89 144.47 50.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.134 2.573 . . . . 0.0 111.044 -170.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.53 155.7 37.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.655 1.982 . . . . 0.0 109.184 -168.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.857 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 1.8 t -77.79 167.65 21.2 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.808 1.766 . . . . 0.0 113.486 -176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -137.56 5.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 112.66 -2.064 . . . . 0.0 112.102 166.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 99' ' ' CYS . 91.3 m -119.56 -31.37 4.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.782 1.633 . . . . 0.0 112.219 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.857 ' HG ' ' HG ' ' A' ' 40' ' ' CYS . 11.3 p -100.65 -103.24 0.24 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.509 1.523 . . . . 0.0 108.534 158.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.88 -31.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 p -81.64 155.71 70.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -161.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.45 136.97 45.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.166 1.911 . . . . 0.0 110.237 156.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.5 -39.13 0.82 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -157.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -157.47 152.6 25.89 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.444 1.02 . . . . 0.0 111.823 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -97.27 142.98 28.5 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.559 -1.338 . . . . 0.0 112.151 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 t -66.89 -10.32 47.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -42.36 64.35 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.937 1.695 . . . . 0.0 114.093 165.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.04 -1.36 28.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.289 1.435 . . . . 0.0 113.155 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -76.58 141.91 40.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.431 0.634 . . . . 0.0 111.334 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 . . . . . 0 C--N 1.319 -0.747 0 C-N-CA 124.782 1.233 . . . . 0.0 112.111 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.539 0.737 0 CA-C-O 122.183 0.826 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 p -153.07 139.23 18.34 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.217 1.407 . . . . 0.0 109.874 -165.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -155.11 114.13 3.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.852 0.861 . . . . 0.0 110.524 -154.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 p -75.79 -19.97 58.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -146.83 156.99 43.54 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.411 1.084 . . . . 0.0 111.269 173.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 125.073 1.349 . . . . 0.0 111.711 169.936 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.682 0 N-CA-C 113.613 0.205 . . . . 0.0 113.613 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.63 173.79 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.812 2.045 . . . . 0.0 112.404 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.66 -179.79 4.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.191 2.197 . . . . 0.0 110.083 -178.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.619 ' H ' HD23 ' A' ' 80' ' ' LEU . 24.6 mmt85 -141.25 146.09 36.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.841 1.656 . . . . 0.0 109.832 -170.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -144.03 102.35 3.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.283 1.433 . . . . 0.0 111.496 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.42 149.87 35.09 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.018 -1.051 . . . . 0.0 111.233 165.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -134.38 29.63 3.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.8 1.286 . . . . 0.0 112.598 -170.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -73.63 35.52 0.09 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.535 1.934 . . . . 0.0 113.939 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.85 2.57 4.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.552 1.941 . . . . 0.0 112.797 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.3 15.08 5.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.394 1.878 . . . . 0.0 112.78 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.11 -3.53 65.51 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.8 1.191 . . . . 0.0 114.388 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 t -140.72 141.28 24.27 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 127.908 2.483 . . . . 0.0 110.164 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.67 129.33 16.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.809 2.339 . . . . 0.0 112.691 170.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -139.45 159.32 42.44 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.159 2.584 . . . . 0.0 108.515 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.9 ttm -143.35 134.68 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.575 1.55 . . . . 0.0 110.232 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -139.23 166.57 24.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.57 138.33 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.659 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.66 145.9 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 44.0 t -77.87 103.32 7.73 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.257 1.423 . . . . 0.0 107.551 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -57.4 -18.46 17.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.159 1.783 . . . . 0.0 112.562 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.82 -37.41 13.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 113.316 -167.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 12.3 p -121.15 1.88 10.33 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.645 1.978 . . . . 0.0 114.524 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.274 4.5 tt0 59.98 57.82 2.93 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.526 2.33 . . . . 0.0 113.294 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.4 129.67 35.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.747 1.219 . . . . 0.0 113.621 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.03 116.63 16.93 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.154 -0.966 . . . . 0.0 110.371 164.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -120.56 -36.44 3.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -169.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.39 146.31 18.33 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 128.24 2.829 . . . . 0.0 111.846 -166.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 158.64 38.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.377 0.671 . . . . 0.0 111.809 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.27 139.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.701 1.238 . . . . 0.0 111.45 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.99 150.29 38.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.39 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.59 133.85 19.48 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.321 2.681 . . . . 0.0 110.905 169.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.67 7.64 29.09 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.17 -49.94 0.55 Allowed Glycine 0 CA--C 1.541 1.657 0 C-N-CA 126.012 1.767 . . . . 0.0 114.777 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.09 -154.97 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.55 3.5 . . . . 0.0 112.108 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.29 157.83 3.04 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 126.493 1.917 . . . . 0.0 112.325 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -62.8 -8.86 14.51 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.378 2.719 . . . . 0.0 114.093 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.0 p -63.74 -24.14 67.65 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.813 -1.179 . . . . 0.0 112.261 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.22 20.49 33.29 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.844 2.64 . . . . 0.0 115.91 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -63.53 135.3 56.75 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.041 -1.27 . . . . 0.0 112.238 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -112.11 138.94 48.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 127.117 2.167 . . . . 0.0 108.503 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -107.03 128.31 54.25 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.468 1.107 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.7 p -121.76 149.1 43.78 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.617 1.567 . . . . 0.0 110.063 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.6 tt -131.65 164.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.546 -1.346 . . . . 0.0 109.76 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.1 124.54 24.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.21 -0.931 . . . . 0.0 112.528 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.1 m -79.91 36.44 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.974 1.309 . . . . 0.0 114.038 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.03 -37.91 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.168 1.787 . . . . 0.0 113.586 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.15 60.02 0.15 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.061 1.344 . . . . 0.0 113.125 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.27 171.68 13.72 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.761 1.625 . . . . 0.0 113.444 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 mmpt? -120.83 156.39 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.363 1.865 . . . . 0.0 114.609 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.12 150.99 22.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.452 1.501 . . . . 0.0 111.747 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.1 146.86 56.32 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.738 2.015 . . . . 0.0 111.551 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.72 169.67 19.58 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.265 1.976 . . . . 0.0 111.264 165.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 -38.53 7.08 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 111.904 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HE3' ' HB ' ' A' ' 35' ' ' THR . 10.4 mmpt? . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 126.193 1.797 . . . . 0.0 112.442 161.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 C--O 1.224 -0.245 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.96 -142.35 10.25 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 121.012 -1.055 . . . . 0.0 111.263 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.3 ptp -155.66 157.2 36.29 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.625 1.202 . . . . 0.0 113.746 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -112.8 130.05 56.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 128.15 2.58 . . . . 0.0 107.652 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -151.58 168.33 25.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.736 1.214 . . . . 0.0 112.376 -161.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.944 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -74.89 172.14 12.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 123.648 1.69 . . . . 0.0 114.379 -178.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.67 0.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.409 157.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 97.7 m -112.62 -48.65 2.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.414 1.486 . . . . 0.0 112.345 -168.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.944 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 7.5 p -86.88 -80.63 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.742 1.217 . . . . 0.0 111.99 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.05 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.313 1.445 . . . . 0.0 114.645 163.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.1 p -101.68 159.01 30.67 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -158.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.68 155.56 49.39 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.961 3.107 . . . . 0.0 112.512 163.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.61 -31.15 0.57 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -172.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -132.04 122.23 25.14 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.889 -1.132 . . . . 0.0 108.717 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -82.9 136.46 34.58 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 120.388 -1.445 . . . . 0.0 109.241 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 t -58.54 -18.86 32.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.504 1.122 . . . . 0.0 112.76 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 3.5 tt0 -60.83 -42.03 96.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.897 1.279 . . . . 0.0 113.813 175.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.1 mmpt? -74.45 -4.16 34.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.817 0.847 . . . . 0.0 112.706 174.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -74.54 135.15 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.337 1.055 . . . . 0.0 109.504 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.957 -163.587 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo . . . . . 0 CA--C 1.539 0.767 0 CA-C-O 122.82 1.092 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -138.5 152.79 48.57 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.042 1.737 . . . . 0.0 110.109 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -141.32 130.74 23.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 p -78.98 -12.66 60.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.32 150.72 50.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.799 1.285 . . . . 0.0 112.144 160.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 107.415 179.297 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.361 0 CA-C-O 118.98 -0.9 . . . . 0.0 114.383 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.1 pt -59.43 162.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -145.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tt -121.63 158.59 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.735 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.75 153.37 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.856 1.262 . . . . 0.0 111.673 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.45 133.31 13.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.464 1.906 . . . . 0.0 108.937 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.73 156.12 39.26 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.784 1.634 . . . . 0.0 112.055 163.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -133.55 118.61 18.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 164.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 t -115.53 20.95 14.39 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 122.136 0.97 . . . . 0.0 111.922 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -84.79 -6.3 59.35 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.703 2.401 . . . . 0.0 113.324 -168.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -86.83 10.29 16.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.028 2.131 . . . . 0.0 112.733 164.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.79 -0.17 57.89 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 124.67 1.129 . . . . 0.0 114.732 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.46 128.72 11.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.674 1.59 . . . . 0.0 110.211 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.89 139.39 19.51 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.674 2.249 . . . . 0.0 113.569 -170.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -134.49 165.67 24.64 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 130.665 3.586 . . . . 0.0 109.928 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mtm -132.62 133.95 44.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.192 2.197 . . . . 0.0 109.955 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -133.18 145.54 50.71 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.15 0.98 . . . . 0.0 112.955 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.56 146.17 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.42 1.888 . . . . 0.0 111.331 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 m -141.77 147.04 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.401 -0.812 . . . . 0.0 111.799 -169.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.643 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 48.2 t -74.51 97.9 3.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 123.69 1.709 . . . . 0.0 108.892 170.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -24.2 2.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.576 1.951 . . . . 0.0 112.69 165.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -83.79 -41.11 17.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.862 1.665 . . . . 0.0 114.456 -172.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.643 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 24.7 p -126.97 1.08 6.58 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -175.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.258 13.1 mt-10 72.95 22.0 3.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.272 2.629 . . . . 0.0 115.068 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.0 94.53 9.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.338 1.055 . . . . 0.0 113.431 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.48 53.75 2.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.64 -7.24 38.15 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -160.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.01 130.27 8.33 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 126.662 2.077 . . . . 0.0 113.04 -167.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.82 153.36 36.64 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.904 -0.762 . . . . 0.0 110.802 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.97 128.82 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.795 0.838 . . . . 0.0 111.672 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -127.99 141.12 40.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.576 1.15 . . . . 0.0 112.502 -169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -73.21 162.57 40.24 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.62 2.88 . . . . 0.0 111.506 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -116.8 -0.84 12.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.71 -62.5 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.825 1.678 . . . . 0.0 114.822 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -69.6 -162.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.262 1 C-N-CA 125.714 4.276 . . . . 0.0 114.099 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -56.43 163.07 2.73 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 126.171 1.788 . . . . 0.0 113.057 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -59.21 -11.58 13.5 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 0.0 114.436 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 p -58.78 -23.87 60.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.029 1.332 . . . . 0.0 113.892 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.6 -3.61 62.62 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.908 1.718 . . . . 0.0 116.262 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -59.37 145.34 43.85 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.713 1.257 . . . . 0.0 112.426 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 128.9 55.55 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.265 1.026 . . . . 0.0 109.327 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -99.09 110.49 23.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.812 1.245 . . . . 0.0 109.935 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.9 m -113.48 112.43 23.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.242 2.217 . . . . 0.0 108.685 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.7 tt -136.46 118.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.51 0.724 . . . . 0.0 112.544 -167.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -80.56 -9.27 59.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.9 m -16.73 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.358 2.663 . . . . 0.0 116.262 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 -33.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.954 2.102 . . . . 0.0 112.126 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.18 2.46 5.87 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.665 1.586 . . . . 0.0 114.423 165.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.54 -174.19 2.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.921 2.888 . . . . 0.0 110.628 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.91 163.66 12.78 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.575 -1.328 . . . . 0.0 114.524 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.47 155.87 42.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.852 1.261 . . . . 0.0 112.397 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -149.13 150.11 31.26 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.825 1.65 . . . . 0.0 111.78 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.84 173.54 13.44 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.141 2.56 . . . . 0.0 113.17 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.02 -40.22 6.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -172.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.31 -157.72 25.65 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ptp -146.07 161.87 39.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.914 1.286 . . . . 0.0 113.862 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 127' ' ' PHE . 46.6 m-85 -125.38 131.04 53.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.085 2.554 . . . . 0.0 109.838 171.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -137.2 173.67 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.497 1.519 . . . . 0.0 110.056 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 1.016 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 4.5 t -65.92 158.79 27.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 123.217 1.484 . . . . 0.0 113.308 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.96 -3.59 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.096 168.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.8 m -125.01 -22.01 4.55 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.404 1.482 . . . . 0.0 114.629 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 1.016 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 7.5 p -122.11 -88.57 0.62 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.403 1.481 . . . . 0.0 113.104 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -152.6 -46.59 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -127.43 161.23 55.92 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -140.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.43 150.45 41.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.081 3.187 . . . . 0.0 113.34 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -137.36 -34.54 0.7 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -152.72 146.73 25.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.445 1.02 . . . . 0.0 112.474 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.5 p -81.66 145.82 30.36 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.644 -1.285 . . . . 0.0 111.356 169.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -61.4 -17.98 56.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.29 -34.83 66.85 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.897 1.679 . . . . 0.0 113.396 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -9.44 51.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.574 1.15 . . . . 0.0 112.216 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -70.58 108.17 4.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.187 0.903 . . . . 0.0 109.979 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 CA--C 1.541 0.607 0 C-N-CA 125.105 1.362 . . . . 0.0 114.577 -153.339 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.533 0.439 0 CA-C-O 123.3 1.292 . . . . 0.0 114.382 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.04 149.96 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.052 1.741 . . . . 0.0 110.628 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.97 108.74 8.56 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.293 1.837 . . . . 0.0 108.79 -162.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.3 p -67.1 -18.47 65.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.84 154.35 39.38 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.149 0.98 . . . . 0.0 110.988 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 123.734 0.813 . . . . 0.0 109.069 166.01 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 CA-C-O 119.959 -0.356 . . . . 0.0 113.771 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.21 167.2 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 122.441 1.115 . . . . 0.0 111.554 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.23 176.94 8.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.093 1.757 . . . . 0.0 110.469 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.542 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -157.7 163.57 38.03 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.913 1.685 . . . . 0.0 111.796 -167.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.9 156.64 20.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.911 2.884 . . . . 0.0 105.348 -157.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -124.47 151.64 44.33 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 127.283 2.233 . . . . 0.0 111.074 169.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.84 21.35 5.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.203 1.801 . . . . 0.0 111.422 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.7 t -69.57 32.51 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.494 2.318 . . . . 0.0 114.767 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 t -138.2 12.31 2.82 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.796 3.238 . . . . 0.0 111.032 -174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -109.18 22.98 15.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.876 2.47 . . . . 0.0 112.187 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.89 -16.33 58.67 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 125.064 1.316 . . . . 0.0 114.406 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 t -143.15 143.88 26.44 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.794 1.238 . . . . 0.0 110.608 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.88 133.79 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.477 2.118 . . . . 0.0 112.909 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -148.55 154.1 39.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 129.181 2.992 . . . . 0.0 109.25 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.2 mtt -135.0 145.67 48.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.496 2.319 . . . . 0.0 108.215 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -139.47 138.27 36.27 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.197 0.999 . . . . 0.0 111.37 -169.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.85 139.22 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 122.314 1.054 . . . . 0.0 112.092 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.43 152.4 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.848 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 40.1 t -89.54 121.21 31.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 164.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.41 -18.6 31.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.534 1.934 . . . . 0.0 111.883 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -67.8 -28.58 67.71 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 7.1 p -129.61 -3.82 4.76 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 126.225 1.81 . . . . 0.0 115.042 177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.272 11.6 mt-10 62.27 42.35 9.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 127.279 2.232 . . . . 0.0 113.761 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.89 52.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.608 1.963 . . . . 0.0 112.573 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 115.2 17.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 165.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.32 -35.42 3.8 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -170.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.87 132.82 5.74 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 127.005 2.241 . . . . 0.0 112.004 -164.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.51 28.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.086 0.946 . . . . 0.0 110.994 -172.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.49 127.92 32.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.147 -0.97 . . . . 0.0 109.577 -149.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -148.6 150.22 33.09 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.92 132.84 25.59 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.876 2.384 . . . . 0.0 110.174 156.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.04 11.92 10.6 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.22 -67.24 0.34 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.955 1.74 . . . . 0.0 112.311 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.38 -164.34 0.19 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.113 3.209 . . . . 0.0 112.192 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -61.0 143.84 91.44 Favored Pre-proline 0 N--CA 1.473 0.696 0 O-C-N 120.286 -1.509 . . . . 0.0 112.555 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.5 -2.42 8.3 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.904 3.069 . . . . 0.0 114.127 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -50.15 -35.4 25.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.159 1.345 . . . . 0.0 110.897 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -90.59 16.2 58.5 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.216 2.341 . . . . 0.0 117.098 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.59 149.11 11.19 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -116.68 139.66 50.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.721 1.608 . . . . 0.0 110.022 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.6 100.19 11.78 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 174.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.9 t -74.77 143.77 43.9 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.656 -0.652 . . . . 0.0 110.871 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.9 mt -140.61 132.58 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.021 0.528 . . . . 0.0 110.266 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.84 99.3 12.19 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -173.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.3 p -52.19 -31.16 30.4 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.2 p -46.68 -29.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.861 2.064 . . . . 0.0 115.258 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.96 10.7 40.81 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.3 170.86 15.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.174 1.789 . . . . 0.0 111.702 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 129.97 52.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 110.325 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 43.8 p90 -142.82 145.87 33.63 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 112.753 -171.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -154.65 150.42 21.7 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.01 1.324 . . . . 0.0 112.175 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.04 169.1 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.069 1.846 . . . . 0.0 111.613 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.67 -42.67 9.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.826 1.25 . . . . 0.0 111.683 176.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt . . . . . 0 CA--C 1.551 0.996 0 C-N-CA 127.358 2.263 . . . . 0.0 113.235 -178.625 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.87 -155.5 20.88 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.103 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 ptp -159.99 166.97 28.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -127.78 135.79 50.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.457 2.703 . . . . 0.0 109.629 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -144.96 155.68 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 0.0 110.753 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 m -68.3 167.17 14.98 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 123.401 1.572 . . . . 0.0 112.543 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.26 -8.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 113.504 -1.68 . . . . 0.0 111.927 152.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -97.2 -18.63 19.14 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.16 1.784 . . . . 0.0 114.73 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.1 p -118.73 -105.09 0.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.315 2.246 . . . . 0.0 109.013 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -163.36 -38.87 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.84 2.056 . . . . 0.0 113.699 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.21 140.5 24.45 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -165.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.95 146.66 65.95 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.388 2.059 . . . . 0.0 111.101 170.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.61 -27.87 2.32 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -134.52 127.11 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.426 -0.796 . . . . 0.0 112.324 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 p -84.44 141.12 31.04 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.696 -1.253 . . . . 0.0 110.196 164.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -18.32 23.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.111 0.964 . . . . 0.0 113.436 170.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.52 -41.79 61.27 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.92 1.688 . . . . 0.0 114.262 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -71.4 -8.92 56.96 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.592 1.557 . . . . 0.0 112.841 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -81.01 129.64 34.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.247 0.546 . . . . 0.0 112.019 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 160.878 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.537 0.641 0 CA-C-O 122.423 0.926 . . . . 0.0 114.321 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 t -154.81 153.67 31.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.466 1.507 . . . . 0.0 111.379 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.73 119.22 22.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.195 2.198 . . . . 0.0 107.471 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 p -70.31 -14.46 62.59 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -153.42 161.16 42.57 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.671 0 C-N-CA 126.145 1.778 . . . . 0.0 110.024 171.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 CA-C-O 118.705 -1.053 . . . . 0.0 113.232 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -96.72 159.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.355 1.077 . . . . 0.0 110.14 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -144.1 164.54 30.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.315 1.446 . . . . 0.0 111.029 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.98 158.87 43.43 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.42 112.2 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.169 2.587 . . . . 0.0 107.37 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.35 154.9 28.71 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.07 0.948 . . . . 0.0 110.861 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -141.01 34.96 1.74 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.828 0.823 . . . . 0.0 112.961 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -71.95 55.19 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 124.051 1.881 . . . . 0.0 109.629 157.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -142.18 8.36 1.83 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.038 2.535 . . . . 0.0 112.351 -167.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.4 mt -128.04 20.24 6.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.647 1.979 . . . . 0.0 112.571 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.42 2.17 73.24 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 120.976 -1.077 . . . . 0.0 115.588 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.6 t -135.39 138.91 29.91 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 127.327 2.251 . . . . 0.0 110.085 168.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.13 135.61 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.501 2.801 . . . . 0.0 114.658 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -144.68 158.42 43.79 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.298 2.639 . . . . 0.0 110.628 167.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.4 mtp -141.92 125.85 17.18 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.388 2.675 . . . . 0.0 107.864 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -133.18 146.48 51.57 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.872 -1.142 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.61 153.32 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.241 1.416 . . . . 0.0 110.962 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.03 140.63 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.259 1.424 . . . . 0.0 109.144 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 1.225 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 42.9 t -76.72 97.37 4.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 124.085 1.897 . . . . 0.0 106.604 160.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -66.83 -14.72 63.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.727 -1.578 . . . . 0.0 111.545 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -66.53 -50.48 63.05 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.885 1.274 . . . . 0.0 112.426 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.225 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.7 OUTLIER -100.89 -11.99 19.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.009 2.123 . . . . 0.0 114.281 -173.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 68.02 17.91 9.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.395 1.878 . . . . 0.0 113.994 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . . . -75.7 86.11 2.73 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.057 1.408 . . . . 0.0 112.229 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -89.78 67.58 7.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.827 1.651 . . . . 0.0 113.404 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.275 0.0 OUTLIER -135.02 5.88 3.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 118.528 2.788 . . . . 0.0 118.528 -170.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.06 129.3 9.0 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.47 1.032 . . . . 0.0 112.679 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -147.71 160.74 42.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.8 142.45 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 123.692 1.71 . . . . 0.0 112.745 -171.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -149.1 156.59 40.26 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 127.322 2.249 . . . . 0.0 110.435 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.38 142.49 54.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.292 1.995 . . . . 0.0 109.444 165.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.94 18.05 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 113.583 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.64 -64.15 0.6 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.529 2.49 . . . . 0.0 112.739 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -86.53 -153.65 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.544 4.162 . . . . 0.0 113.516 -174.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.83 149.41 2.31 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 127.597 2.359 . . . . 0.0 113.712 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.81 -7.9 19.78 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.411 2.741 . . . . 0.0 114.498 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.1 p -58.87 -27.12 64.87 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.182 -0.949 . . . . 0.0 112.131 165.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -88.16 5.9 84.21 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.202 1.858 . . . . 0.0 116.324 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -58.88 127.3 31.52 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 1.428 . . . . 0.0 111.876 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -109.23 120.18 41.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.37 1.068 . . . . 0.0 109.583 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -90.37 76.19 6.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.825 1.298 . . . . 0.0 110.117 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.4 t -66.31 131.03 45.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.533 1.635 . . . . 0.0 111.59 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.3 tt -148.41 166.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.679 -1.601 . . . . 0.0 109.086 -168.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.44 134.56 46.33 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.256 -1.527 . . . . 0.0 113.889 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -81.04 -32.56 34.04 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.24 -33.56 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.86 2.56 14.22 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.3 mt -135.19 171.94 13.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.002 2.521 . . . . 0.0 110.034 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 9.7 mmpt? -109.82 159.38 17.25 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.933 -1.105 . . . . 0.0 112.694 168.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -148.59 153.0 37.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -146.33 145.97 25.92 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 125.797 1.639 . . . . 0.0 111.491 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.73 173.43 14.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.655 2.237 . . . . 0.0 112.072 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.6 t -100.06 -54.93 2.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.233 1.013 . . . . 0.0 111.28 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 126.542 1.937 . . . . 0.0 114.555 -174.1 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.38 -152.51 18.15 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptp -155.25 174.58 15.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.897 1.679 . . . . 0.0 113.011 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.47 148.28 52.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.715 1.606 . . . . 0.0 112.378 163.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -137.17 169.37 17.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.826 2.051 . . . . 0.0 111.758 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.81 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -76.21 168.4 20.12 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 123.781 1.753 . . . . 0.0 114.05 -177.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.54 26.33 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 127.352 2.261 . . . . 0.0 111.409 164.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.62 -41.08 2.03 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.508 1.523 . . . . 0.0 111.103 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.81 ' HG ' ' HG ' ' A' ' 40' ' ' CYS . 21.3 p -97.33 -99.16 0.2 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.139 1.376 . . . . 0.0 110.85 166.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.08 -49.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.021 1.328 . . . . 0.0 114.202 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -99.66 154.07 37.45 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -142.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.0 142.17 99.12 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.933 1.756 . . . . 0.0 110.336 158.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.33 -34.93 1.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.673 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -135.87 134.76 39.14 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 p -91.13 127.55 36.6 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.312 1.053 . . . . 0.0 109.46 164.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.46 -7.21 29.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 113.383 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 4.9 mt-10 -59.05 -33.13 70.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.663 167.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 6.9 mmpt? -75.69 7.81 3.5 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.149 0.979 . . . . 0.0 111.955 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . 16.0 ttpp -52.69 132.85 36.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.42 0.629 . . . . 0.0 111.432 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.5 t80 . . . . . 0 CA--C 1.547 0.847 0 C-N-CA 124.902 1.281 . . . . 0.0 111.802 178.7 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.531 0.373 0 CA-C-O 123.063 1.193 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -157.83 144.92 18.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.643 1.977 . . . . 0.0 110.605 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -143.58 117.15 9.17 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.094 1.357 . . . . 0.0 109.832 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.4 p -69.19 -23.68 63.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -145.44 158.22 43.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.944 0.897 . . . . 0.0 112.006 162.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 124.335 1.054 . . . . 0.0 109.322 162.597 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.227 0 CA-C-O 118.952 -0.915 . . . . 0.0 114.592 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -93.74 161.87 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.816 1.77 . . . . 0.0 114.901 -171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -134.57 -178.07 4.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.513 2.325 . . . . 0.0 109.221 168.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.583 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -151.74 161.74 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.676 1.19 . . . . 0.0 113.482 -171.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.24 117.44 8.97 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 129.113 2.965 . . . . 0.0 106.487 -175.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.85 148.92 25.04 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.032 1.333 . . . . 0.0 112.314 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.56 36.88 3.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.957 1.303 . . . . 0.0 112.537 -163.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p -68.3 22.38 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.918 2.087 . . . . 0.0 115.492 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.3 t -126.66 -2.81 6.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.8 2.04 . . . . 0.0 113.455 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.54 12.37 7.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.544 1.538 . . . . 0.0 112.771 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.01 -9.59 65.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.49 1.519 . . . . 0.0 113.856 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.7 t -139.71 143.27 34.39 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.661 1.984 . . . . 0.0 109.683 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.71 133.62 43.08 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.041 1.827 . . . . 0.0 112.039 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -137.05 154.76 50.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.442 1.897 . . . . 0.0 109.475 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 ttm -133.47 134.65 43.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.54 1.536 . . . . 0.0 108.881 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -134.98 147.46 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.475 1.51 . . . . 0.0 110.575 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.61 146.9 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.188 1.395 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.71 144.4 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.218 1.007 . . . . 0.0 111.71 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 40.6 t -79.07 105.12 10.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 166.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -77.04 -7.7 56.14 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -69.0 -51.59 37.66 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.453 1.901 . . . . 0.0 112.03 172.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 17.5 p -112.09 -5.95 14.21 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.179 1.791 . . . . 0.0 114.453 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 62.4 63.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.028 2.531 . . . . 0.0 113.766 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.52 152.93 43.13 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -77.48 80.59 3.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.302 1.841 . . . . 0.0 112.511 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 103' ' ' LEU 0.255 3.4 mm? -91.63 48.13 1.43 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 124.121 1.915 . . . . 0.0 114.559 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.36 163.63 10.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 111.123 -2.762 . . . . 0.0 115.611 150.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.79 163.0 40.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.668 0.787 . . . . 0.0 111.255 -174.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.34 142.21 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.166 1.386 . . . . 0.0 112.049 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.22 153.54 73.19 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.098 1.759 . . . . 0.0 113.872 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.19 135.3 7.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.961 3.108 . . . . 0.0 112.006 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -118.61 4.78 11.65 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -162.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.62 -38.36 1.0 Allowed Glycine 0 CA--C 1.544 1.85 0 CA-C-O 117.458 -1.746 . . . . 0.0 116.347 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -101.24 -172.91 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.153 3.235 . . . . 0.0 113.226 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -51.51 156.99 1.91 Allowed Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 125.751 1.62 . . . . 0.0 112.363 163.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.93 -4.02 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.698 2.932 . . . . 0.0 114.359 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -20.37 65.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.207 1.403 . . . . 0.0 113.58 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.98 -90.38 0.47 Allowed Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.658 1.599 . . . . 0.0 112.765 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 50.28 140.45 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 131.581 3.952 . . . . 0.0 119.009 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -110.81 126.51 54.71 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.981 -1.074 . . . . 0.0 109.913 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -90.05 122.56 33.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.064 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.6 p -105.83 122.8 46.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.594 1.558 . . . . 0.0 110.488 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.09 166.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.884 1.674 . . . . 0.0 109.591 -175.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.42 108.63 2.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.512 1.125 . . . . 0.0 113.341 173.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.3 m -75.1 56.14 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.431 1.492 . . . . 0.0 111.48 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -41.38 -46.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 128.521 2.728 . . . . 0.0 114.641 -162.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.98 38.92 1.2 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.463 1.905 . . . . 0.0 110.491 166.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.8 mt -110.76 165.75 11.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.559 1.544 . . . . 0.0 111.014 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.8 mmpt? -94.82 146.09 24.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -163.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -141.32 149.28 41.0 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.202 -0.936 . . . . 0.0 112.353 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -144.73 148.51 39.84 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 124.947 1.299 . . . . 0.0 111.644 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.2 174.86 8.4 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.824 1.683 . . . . 0.0 110.023 163.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.87 -38.95 18.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.714 0.768 . . . . 0.0 112.003 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 127.651 2.38 . . . . 0.0 115.191 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.433 HG23 ' CB ' ' A' ' 130' ' ' SER . 6.9 t . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.537 0.208 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.0 -160.85 31.83 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.654 1.121 . . . . 0.0 114.91 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -160.19 163.63 33.48 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.863 1.265 . . . . 0.0 113.861 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -95.85 145.5 25.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 128.475 2.71 . . . . 0.0 110.987 167.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -153.67 164.27 38.57 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.825 1.65 . . . . 0.0 112.307 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 69.3 m -67.12 166.13 14.53 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 123.893 1.806 . . . . 0.0 113.788 170.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.67 16.17 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 126.486 1.915 . . . . 0.0 112.69 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 47.7 t -127.38 -49.51 1.41 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.37 1.068 . . . . 0.0 112.493 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 9.1 p -96.68 -96.54 0.19 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.892 1.277 . . . . 0.0 112.919 -174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -155.26 -36.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.398 2.279 . . . . 0.0 113.563 -165.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p -82.23 118.23 71.21 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -160.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.31 153.69 77.06 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 120.997 1.132 . . . . 0.0 110.051 136.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.4 tp -152.14 -47.98 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -120.81 122.47 40.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.19 0.904 . . . . 0.0 110.657 -169.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.3 p -75.88 145.62 40.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 123.229 1.49 . . . . 0.0 111.041 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -75.86 -10.07 59.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.484 169.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.79 -40.06 78.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.439 1.496 . . . . 0.0 114.779 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.26 -0.1 53.62 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.342 1.026 . . . . 0.0 113.608 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -99.61 128.1 45.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -159.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.856 0.836 . . . . 0.0 111.688 168.746 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.535 0.56 0 CA-C-O 124.313 1.714 . . . . 0.0 115.876 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -149.54 155.52 40.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.247 2.219 . . . . 0.0 110.581 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.85 122.11 12.27 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.311 1.844 . . . . 0.0 108.374 -168.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -76.12 -7.61 55.15 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -164.55 154.42 13.95 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 157.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.835 0 C-N-CA 126.445 1.898 . . . . 0.0 113.026 175.869 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.948 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.8 178.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 122.595 1.188 . . . . 0.0 112.685 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -143.99 173.98 11.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.536 1.935 . . . . 0.0 111.611 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.549 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -146.62 147.71 31.34 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 113.868 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.07 109.71 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.628 1.971 . . . . 0.0 108.747 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.21 150.16 20.57 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.395 1.878 . . . . 0.0 109.069 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.11 120.54 4.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.151 0.887 . . . . 0.0 110.86 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -121.88 32.71 5.74 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.233 1.016 . . . . 0.0 110.423 164.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.5 m -107.36 -13.94 14.99 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 128.156 2.582 . . . . 0.0 113.47 -161.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.45 16.96 5.73 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 127.453 2.301 . . . . 0.0 111.955 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.28 -6.03 52.73 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.1 t -138.57 131.44 16.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.264 2.226 . . . . 0.0 108.999 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.33 144.15 25.75 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.081 2.52 . . . . 0.0 113.776 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -148.27 160.74 42.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 129.406 3.082 . . . . 0.0 112.315 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mtp -143.62 132.27 22.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.108 1.763 . . . . 0.0 109.017 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -138.16 150.09 46.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.125 0.875 . . . . 0.0 112.741 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 141.58 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 110.574 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.65 155.1 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 110.276 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 36.9 t -97.49 112.94 24.58 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 122.631 1.205 . . . . 0.0 108.111 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -67.33 -18.02 65.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.868 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -85.63 -38.56 18.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.553 1.141 . . . . 0.0 112.911 -171.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.807 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 2.6 p -112.21 -13.41 13.5 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 127.709 2.403 . . . . 0.0 114.566 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 6.8 tt0 70.83 53.86 0.27 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.673 2.389 . . . . 0.0 116.151 173.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.34 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.707 1.203 . . . . 0.0 113.065 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.8 40.98 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.381 -0.825 . . . . 0.0 111.046 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.29 -27.13 19.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.079 1.419 . . . . 0.0 113.626 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.02 176.03 32.68 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 126.71 2.1 . . . . 0.0 113.634 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -153.3 167.24 30.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.653 1.216 . . . . 0.0 113.518 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.45 134.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 125.467 1.507 . . . . 0.0 109.024 -161.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.7 159.06 72.8 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.938 1.295 . . . . 0.0 111.999 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -67.11 146.15 75.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.354 2.036 . . . . 0.0 110.668 163.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -114.33 16.02 17.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.612 1.165 . . . . 0.0 113.79 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.46 -71.32 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.988 1.756 . . . . 0.0 112.495 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.51 179.53 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.609 2.873 . . . . 0.0 112.694 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -58.03 151.5 44.9 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.734 1.613 . . . . 0.0 112.735 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.57 -3.43 4.34 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.133 3.222 . . . . 0.0 115.264 -172.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -57.41 -29.12 63.86 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.666 -0.646 . . . . 0.0 112.088 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.41 16.19 60.2 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.19 2.328 . . . . 0.0 116.455 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -47.49 139.9 6.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.618 1.167 . . . . 0.0 113.958 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -114.97 136.21 53.38 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.106 1.762 . . . . 0.0 110.073 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.61 114.73 29.08 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.75 1.62 . . . . 0.0 110.82 -167.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 54.6 m -99.5 142.98 30.28 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.428 2.691 . . . . 0.0 111.504 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.7 mm -107.73 154.81 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.96 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.57 122.39 39.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.101 0.961 . . . . 0.0 112.183 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.7 m -77.39 49.5 0.72 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.391 1.076 . . . . 0.0 113.377 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.35 -55.5 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.28 -0.888 . . . . 0.0 112.633 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.08 -0.53 0.44 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.92 162.62 29.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.58 1.552 . . . . 0.0 110.703 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -108.53 160.81 15.61 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.276 1.43 . . . . 0.0 112.841 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -149.56 143.21 25.45 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.172 1.389 . . . . 0.0 110.449 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -135.17 155.72 78.71 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.243 1.417 . . . . 0.0 111.197 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.37 167.94 25.97 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.027 1.818 . . . . 0.0 112.047 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.433 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -95.58 -35.29 11.69 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.258 1.423 . . . . 0.0 112.723 -177.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt . . . . . 0 CA--C 1.549 0.906 0 C-N-CA 126.105 1.762 . . . . 0.0 114.591 -176.026 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.54 -147.65 10.02 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.372 1.309 . . . . 0.0 116.372 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 ptp -134.54 179.89 6.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.251 1.82 . . . . 0.0 114.048 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.02 144.85 48.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 129.968 3.307 . . . . 0.0 108.695 159.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -144.88 151.13 38.24 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 110.931 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 74.1 m -71.38 161.76 30.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.134 1.445 . . . . 0.0 111.556 175.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.25 6.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.711 163.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.3 m -115.48 -57.24 2.26 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.907 1.283 . . . . 0.0 112.405 -165.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 1.7 p -81.19 -81.28 0.14 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.315 1.046 . . . . 0.0 111.928 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.72 -59.77 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.278 1.431 . . . . 0.0 113.218 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 p -96.85 165.92 14.96 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -154.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -59.36 152.39 61.16 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 120.66 0.906 . . . . 0.0 111.344 150.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 -31.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -128.11 132.77 48.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.58 -0.7 . . . . 0.0 110.935 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.6 m -76.66 140.53 40.96 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.023 -1.048 . . . . 0.0 109.705 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -64.85 -10.97 32.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.967 0.907 . . . . 0.0 112.521 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -87.68 -1.97 58.31 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.228 1.411 . . . . 0.0 113.666 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -95.29 130.12 42.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.594 1.158 . . . . 0.0 109.575 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 122.207 0.203 . . . . 0.0 110.576 -175.269 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo . . . . . 0 CA--C 1.548 1.209 0 N-CA-C 114.695 0.998 . . . . 0.0 114.695 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 157.72 43.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.184 2.194 . . . . 0.0 109.904 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -153.1 116.44 4.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.978 1.311 . . . . 0.0 110.058 -169.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.4 p -72.05 -23.91 61.45 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.19 166.66 20.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 113.335 172.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 124.414 1.085 . . . . 0.0 110.334 162.435 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.003 1.402 . . . . 0.0 111.485 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.91 177.24 8.03 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.97 1.708 . . . . 0.0 111.869 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 155.44 38.33 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.329 1.451 . . . . 0.0 112.903 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 118.59 5.53 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.779 2.832 . . . . 0.0 107.29 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -75.02 149.8 39.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 111.4 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -136.7 96.5 3.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.732 0.777 . . . . 0.0 111.29 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.3 t -111.03 21.95 15.84 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.603 1.161 . . . . 0.0 112.217 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -5.94 58.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -162.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -98.35 14.08 29.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.623 1.969 . . . . 0.0 111.712 164.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.48 -4.17 64.99 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.988 1.756 . . . . 0.0 115.279 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.0 t -123.52 109.42 30.77 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.166 1.387 . . . . 0.0 109.767 -175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.74 125.6 9.57 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.044 2.496 . . . . 0.0 113.158 -166.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 165.95 13.02 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.169 2.187 . . . . 0.0 109.881 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.37 122.81 44.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.444 1.498 . . . . 0.0 108.021 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -120.32 137.87 54.02 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.981 0.913 . . . . 0.0 109.802 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.55 145.67 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 121.241 -0.912 . . . . 0.0 111.497 -165.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.44 138.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.041 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 42.2 t -72.72 98.63 2.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 123.41 1.576 . . . . 0.0 107.843 161.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.54 -16.66 57.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.884 1.274 . . . . 0.0 111.924 167.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -71.09 -45.61 63.38 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.851 1.205 . . . . 0.0 113.619 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 3.9 p -123.42 8.81 9.04 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.093 2.157 . . . . 0.0 115.424 -169.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.56 15.7 9.81 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.73 2.012 . . . . 0.0 114.821 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . . . -75.46 83.45 2.54 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.481 -1.387 . . . . 0.0 112.956 -175.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -83.17 58.1 4.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.123 1.769 . . . . 0.0 113.81 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.05 7.97 2.71 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -162.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.43 135.4 12.67 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.056 1.789 . . . . 0.0 110.925 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 157.18 42.83 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.559 -0.965 . . . . 0.0 111.312 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.91 137.85 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.685 1.594 . . . . 0.0 111.505 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.31 149.46 54.96 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.0 1.32 . . . . 0.0 113.112 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.67 146.36 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.573 2.182 . . . . 0.0 110.019 157.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.65 12.5 18.46 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.13 -64.65 0.2 Allowed Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.646 1.117 . . . . 0.0 115.043 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.84 -172.76 1.42 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.935 3.09 . . . . 0.0 113.396 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.95 162.76 0.46 Allowed Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 125.188 1.395 . . . . 0.0 112.507 171.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -60.33 -5.64 4.37 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.138 2.559 . . . . 0.0 114.378 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 18.03 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.635 1.974 . . . . 0.0 113.019 163.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -154.15 19.0 0.64 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.428 1.966 . . . . 0.0 116.535 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.71 161.33 29.74 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.489 1.145 . . . . 0.0 113.966 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -128.44 132.07 48.43 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.042 1.737 . . . . 0.0 109.368 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -99.64 130.85 45.9 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.033 0.933 . . . . 0.0 109.916 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.58 139.97 52.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.326 1.85 . . . . 0.0 109.844 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.8 tt -127.04 170.66 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 109.562 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.78 129.48 50.54 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.74 -1.225 . . . . 0.0 111.643 164.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -83.79 39.42 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.735 1.214 . . . . 0.0 114.251 -167.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -44.57 -36.61 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 -151.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.24 22.51 0.94 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.966 1.706 . . . . 0.0 112.093 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.8 mt -98.5 157.85 15.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 120.666 -1.271 . . . . 0.0 111.678 -155.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 142.65 36.86 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.746 1.26 . . . . 0.0 113.753 -161.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -153.21 144.18 22.91 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 120.321 -1.487 . . . . 0.0 111.215 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -140.08 153.38 69.22 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.921 1.688 . . . . 0.0 111.002 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.27 171.66 17.18 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.885 2.39 . . . . 0.0 112.296 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -38.1 14.22 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.318 1.447 . . . . 0.0 110.622 170.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 128.31 2.644 . . . . 0.0 112.48 -171.045 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.18 -149.93 16.0 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 114.394 0.517 . . . . 0.0 114.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.6 ptp -155.06 168.27 27.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.384 1.074 . . . . 0.0 113.262 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -122.18 139.17 54.07 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 128.809 2.844 . . . . 0.0 109.574 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.69 157.5 43.29 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.561 1.544 . . . . 0.0 110.871 -172.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 2.1 t -79.04 170.17 17.09 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.486 1.612 . . . . 0.0 114.238 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.28 13.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.496 1.918 . . . . 0.0 112.008 161.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.8 t -121.42 -33.22 3.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.09 1.356 . . . . 0.0 112.846 -173.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 3.6 p -102.29 -86.4 0.42 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.715 1.606 . . . . 0.0 111.348 167.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.1 -41.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 p -111.47 161.39 25.58 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -146.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.72 139.86 31.46 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.184 2.589 . . . . 0.0 111.888 159.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.5 mt -136.92 -23.31 1.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -135.83 141.89 44.75 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.524 1.057 . . . . 0.0 111.285 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.4 p -116.36 132.03 56.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.799 1.285 . . . . 0.0 112.123 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -5.04 19.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.997 1.319 . . . . 0.0 113.53 175.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.46 -26.8 68.12 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.793 -1.192 . . . . 0.0 112.419 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -90.67 5.97 45.9 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.824 1.25 . . . . 0.0 114.32 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 2.9 ttpt -59.43 131.91 52.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.046 0.938 . . . . 0.0 110.472 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.418 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 32.6 t80 . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 124.764 1.226 . . . . 0.0 112.397 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 CA--C 1.535 0.559 0 CA-C-O 122.774 1.072 . . . . 0.0 113.048 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.1 p -151.44 165.96 32.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.064 2.146 . . . . 0.0 111.292 -167.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.71 148.88 26.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.781 1.632 . . . . 0.0 109.641 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.6 p -96.56 -27.2 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.267 1.827 . . . . 0.0 113.068 169.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -145.92 155.09 42.63 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.449 1.499 . . . . 0.0 109.524 158.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.389 168.869 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 CA-C-O 119.463 -0.632 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.51 -177.81 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 122.066 0.936 . . . . 0.0 112.104 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.43 -179.3 6.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.63 1.972 . . . . 0.0 109.171 175.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.637 ' H ' HD23 ' A' ' 80' ' ' LEU . 9.6 mmt180 -140.3 154.43 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.957 1.703 . . . . 0.0 109.316 -171.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -152.63 123.8 7.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.756 1.222 . . . . 0.0 110.241 165.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.23 159.03 18.97 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.752 1.621 . . . . 0.0 111.648 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -130.56 111.83 12.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -123.07 19.92 9.94 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 123.114 1.435 . . . . 0.0 111.488 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.88 -18.8 13.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -142.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.66 8.03 45.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 113.025 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.39 -10.03 73.61 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.854 1.693 . . . . 0.0 114.751 -173.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -109.65 126.68 28.61 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 0.0 110.717 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.79 127.37 2.66 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.414 2.743 . . . . 0.0 112.99 175.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -133.66 155.43 49.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.305 3.042 . . . . 0.0 108.717 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 42.5 mtp -140.48 124.02 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.414 1.485 . . . . 0.0 110.736 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -126.42 153.74 44.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.305 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.03 138.45 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.835 1.254 . . . . 0.0 110.759 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.77 148.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 122.103 0.954 . . . . 0.0 111.412 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 53.5 t -82.58 99.08 9.32 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.63 -20.47 66.3 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.687 -0.633 . . . . 0.0 111.566 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -64.25 -35.0 79.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.248 1.019 . . . . 0.0 111.79 -175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 26.4 p -131.8 -7.05 3.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.023 2.129 . . . . 0.0 115.464 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 69.34 59.62 0.32 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.89 2.876 . . . . 0.0 115.614 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.4 38.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 113.416 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.13 141.67 58.02 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 166.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.1 mt -108.48 -32.91 7.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.46 -169.62 35.59 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 127.487 2.47 . . . . 0.0 114.043 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -153.67 -179.48 7.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -152.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.22 145.92 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.805 1.642 . . . . 0.0 112.012 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.27 153.69 44.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.524 1.53 . . . . 0.0 111.965 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.81 137.0 15.57 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.524 2.816 . . . . 0.0 111.035 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.88 -0.07 41.97 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.52 -55.28 0.26 Allowed Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.05 1.786 . . . . 0.0 114.998 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -93.74 -153.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.279 3.319 . . . . 0.0 112.433 -169.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.45 171.22 0.29 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.327 2.251 . . . . 0.0 113.196 172.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -58.84 -5.98 3.08 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.954 2.436 . . . . 0.0 115.074 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -61.32 -26.42 67.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.71 1.204 . . . . 0.0 113.271 163.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.67 12.69 62.83 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.819 2.152 . . . . 0.0 115.765 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.92 132.61 49.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.335 1.067 . . . . 0.0 112.398 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -126.24 134.95 51.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.364 1.466 . . . . 0.0 108.711 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.89 138.58 41.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.052 0.941 . . . . 0.0 110.982 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 57.9 m -122.57 136.99 55.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.926 2.09 . . . . 0.0 109.466 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.0 tt -137.55 169.05 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.592 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.01 166.31 24.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -170.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -133.87 36.5 3.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.944 1.297 . . . . 0.0 113.356 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.06 -47.63 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.586 -1.321 . . . . 0.0 112.6 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 23.62 4.03 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.84 1.656 . . . . 0.0 112.781 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.9 mt -133.88 155.21 50.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.577 1.951 . . . . 0.0 110.13 -165.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -104.55 156.38 18.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.967 0.889 . . . . 0.0 113.359 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.11 153.31 33.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 111.426 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -139.0 150.87 66.72 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.538 . . . . 0.0 111.456 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.71 171.51 18.07 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.602 2.201 . . . . 0.0 112.559 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.33 -46.27 5.07 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.533 1.133 . . . . 0.0 112.011 -175.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.872 0 C-N-CA 127.631 2.372 . . . . 0.0 115.629 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.69 -153.7 19.33 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.432 ' HA ' ' H ' ' A' ' 50' ' ' SER . 1.8 pmm? -151.52 165.68 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.958 1.303 . . . . 0.0 113.965 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.31 153.23 37.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.66 2.384 . . . . 0.0 111.342 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 161.57 37.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.906 1.682 . . . . 0.0 109.979 173.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.87 154.21 9.74 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 122.737 1.256 . . . . 0.0 110.16 164.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.51 -10.75 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.656 157.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 89.9 m -92.49 -46.71 7.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.23 -101.45 0.16 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.051 1.34 . . . . 0.0 110.248 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -159.47 -47.26 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.609 1.964 . . . . 0.0 112.98 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.04 153.62 38.45 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 125.923 1.689 . . . . 0.0 115.258 -157.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 135.97 15.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.342 2.028 . . . . 0.0 113.594 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.06 -30.44 12.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.432 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -157.09 157.95 35.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 112.162 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -101.65 147.22 26.7 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.274 -0.891 . . . . 0.0 111.412 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -64.67 -17.27 63.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.482 1.113 . . . . 0.0 112.232 172.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -35.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.476 1.91 . . . . 0.0 113.747 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.56 -1.35 30.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.812 2.045 . . . . 0.0 112.53 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.58 116.96 8.89 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.784 0.802 . . . . 0.0 111.344 -171.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.5 t80 . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 124.956 1.302 . . . . 0.0 110.461 172.252 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 CA--C 1.541 0.853 0 CA-C-O 122.727 1.053 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.7 p -141.16 169.33 17.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.13 1.772 . . . . 0.0 111.256 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -149.41 141.32 23.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.85 1.26 . . . . 0.0 108.778 161.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -85.7 -16.83 37.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 0.0 113.799 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -158.38 159.8 36.2 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.068 1.747 . . . . 0.0 111.014 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.297 1.439 . . . . 0.0 109.408 -178.474 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.728 0 N-CA-C 114.784 0.673 . . . . 0.0 114.784 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.68 177.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 127.411 2.284 . . . . 0.0 111.12 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.91 170.35 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.588 1.555 . . . . 0.0 110.141 170.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.46 158.44 34.11 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -148.87 108.52 4.0 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 128.097 2.559 . . . . 0.0 108.699 -166.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.5 144.82 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.101 -0.999 . . . . 0.0 111.02 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -117.26 19.52 14.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.764 1.225 . . . . 0.0 112.486 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t -70.3 35.18 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.453 2.301 . . . . 0.0 114.211 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -110.74 -23.64 10.93 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.324 2.25 . . . . 0.0 113.562 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -97.28 14.95 24.31 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.45 1.9 . . . . 0.0 113.164 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.66 48.68 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.516 1.532 . . . . 0.0 114.836 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 37.7 t -111.06 103.53 54.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.341 1.857 . . . . 0.0 109.648 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.47 125.76 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.759 1.639 . . . . 0.0 111.613 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -151.26 156.96 41.92 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.807 2.443 . . . . 0.0 111.609 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.4 mtm -115.95 98.96 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.024 2.53 . . . . 0.0 107.407 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -83.06 148.6 27.43 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.118 -1.614 . . . . 0.0 108.974 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 m -138.22 145.47 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 122.343 1.068 . . . . 0.0 112.879 -167.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.656 HG12 ' H ' ' A' ' 103' ' ' LEU . 6.1 m -139.86 156.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.067 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.879 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 48.9 t -80.11 155.37 27.53 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-O 124.079 1.895 . . . . 0.0 108.517 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -114.67 -18.22 11.45 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 110.906 -2.861 . . . . 0.0 113.497 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.63 -41.79 95.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.77 0.828 . . . . 0.0 112.185 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.879 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -110.85 -20.66 12.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.859 2.464 . . . . 0.0 113.369 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 64.8 122.51 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.06 1.744 . . . . 0.0 112.27 -162.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 75.47 77.88 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.694 1.998 . . . . 0.0 115.765 164.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.579 ' HB2' ' H ' ' A' ' 96' ' ' CYS 0.332 2.9 t60 -85.57 -21.44 28.52 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.656 ' H ' HG12 ' A' ' 95' ' ' VAL . 3.2 tp 53.16 27.84 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.308 2.643 . . . . 0.0 116.023 163.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.8 -179.55 52.96 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 123.103 1.391 . . . . 0.0 109.817 159.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.06 162.87 40.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.44 1.59 . . . . 0.0 113.393 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.05 139.59 42.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.488 -169.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.41 144.25 52.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.49 142.72 49.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.204 2.603 . . . . 0.0 110.12 162.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -107.98 -3.13 19.08 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.57 -64.28 0.61 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.897 1.713 . . . . 0.0 114.215 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.01 -170.96 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 124.584 3.523 . . . . 0.0 114.438 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -50.02 159.82 0.74 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.761 1.624 . . . . 0.0 111.985 169.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.62 -5.42 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.861 2.374 . . . . 0.0 114.758 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -65.41 -10.88 37.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.753 1.621 . . . . 0.0 114.519 164.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.43 -9.17 48.06 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.831 1.682 . . . . 0.0 116.359 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -56.51 143.14 36.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.973 1.309 . . . . 0.0 113.061 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -129.67 133.94 47.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 110.283 -166.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -104.8 129.02 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.634 1.174 . . . . 0.0 110.047 -174.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.7 p -131.17 129.27 41.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.391 1.077 . . . . 0.0 111.969 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 122' ' ' SER . 7.0 tp -109.34 161.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.31 1.044 . . . . 0.0 110.631 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -93.06 -21.51 19.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.83 1.252 . . . . 0.0 113.292 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.464 ' H ' HG13 ' A' ' 120' ' ' ILE . 50.6 m 58.25 19.67 6.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 p -71.85 -17.69 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.77 43.66 1.26 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.436 1.495 . . . . 0.0 113.167 -163.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.5 mt -117.55 156.01 28.82 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.759 1.266 . . . . 0.0 114.181 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -102.1 152.33 21.11 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.396 2.278 . . . . 0.0 109.76 157.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -146.32 145.59 30.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.81 0.844 . . . . 0.0 111.715 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -140.75 153.54 67.92 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.82 1.648 . . . . 0.0 110.553 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.38 171.9 14.28 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.373 2.049 . . . . 0.0 112.765 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.47 -37.89 22.55 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 128.932 2.893 . . . . 0.0 113.663 -174.663 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.512 -0.5 0 CA-C-O 121.235 0.54 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.21 -145.66 14.18 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.734 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.5 ptp -149.88 159.33 44.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 153.41 19.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.497 152.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -147.52 155.74 42.16 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.89 1.276 . . . . 0.0 109.785 158.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.45 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 71.5 m -61.57 165.86 4.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 124.134 1.921 . . . . 0.0 112.435 168.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.19 29.3 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.263 167.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 35.0 t -135.23 -47.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.107 1.363 . . . . 0.0 113.312 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.45 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 5.2 p -84.48 -84.57 0.14 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.854 1.262 . . . . 0.0 112.065 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -153.5 -48.94 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.5 p -145.02 165.07 23.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -139.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 144.4 46.87 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.409 2.74 . . . . 0.0 113.44 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -144.35 -4.63 0.79 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.38 129.05 21.53 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.525 -1.359 . . . . 0.0 110.299 169.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 p -94.48 142.45 27.42 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.164 -0.96 . . . . 0.0 111.488 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.17 -11.22 28.59 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.084 0.945 . . . . 0.0 113.336 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -38.92 72.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.43 -1.419 . . . . 0.0 114.054 163.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -73.32 -3.56 27.86 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.513 1.525 . . . . 0.0 112.619 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -65.56 130.72 44.3 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.275 1.03 . . . . 0.0 110.26 -173.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 61.6 t80 . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 126.961 2.104 . . . . 0.0 112.163 -170.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo . . . . . 0 CA--C 1.537 0.661 0 N-CA-C 115.486 1.302 . . . . 0.0 115.486 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.1 m -159.68 172.29 18.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.72 2.008 . . . . 0.0 110.271 169.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -140.19 121.76 15.21 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.393 1.877 . . . . 0.0 107.16 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -84.97 -10.8 56.67 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -160.93 164.1 31.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.106 0.962 . . . . 0.0 112.926 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 125.682 1.593 . . . . 0.0 109.331 172.222 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.387 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -108.02 149.44 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.502 1.651 . . . . 0.0 110.253 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 mp -125.56 167.56 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.668 1.587 . . . . 0.0 111.499 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.93 150.42 36.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.366 1.466 . . . . 0.0 111.391 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.98 117.79 4.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.918 1.687 . . . . 0.0 108.351 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.29 144.66 35.92 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.599 1.16 . . . . 0.0 111.416 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -124.8 34.45 4.99 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 123.009 1.385 . . . . 0.0 111.083 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -70.2 42.92 0.06 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 129.612 3.165 . . . . 0.0 112.48 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 t -126.08 -12.77 6.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.977 2.111 . . . . 0.0 113.277 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -98.14 16.89 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.953 2.101 . . . . 0.0 113.598 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.14 5.52 89.61 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 124.054 0.835 . . . . 0.0 115.019 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 31.9 t -141.74 135.62 14.76 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.742 2.417 . . . . 0.0 110.284 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.5 125.77 11.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.336 2.691 . . . . 0.0 112.569 173.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -136.17 156.37 48.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.637 2.375 . . . . 0.0 109.89 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.2 mtt -133.77 131.19 39.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.386 2.274 . . . . 0.0 108.527 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -132.43 148.66 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 121.163 -0.961 . . . . 0.0 111.898 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.73 147.93 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.077 1.351 . . . . 0.0 112.513 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.54 152.11 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.198 1.399 . . . . 0.0 111.495 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 1.248 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 43.6 t -90.07 117.55 28.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 164.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -97.55 -0.87 45.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.043 1.737 . . . . 0.0 113.188 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HB2' ' SG ' ' A' ' 96' ' ' CYS . 30.8 mt-30 -63.21 -45.25 92.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.194 1.398 . . . . 0.0 110.404 162.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.248 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 1.7 p -125.4 -14.09 6.48 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.329 2.252 . . . . 0.0 115.197 -169.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.275 75.5 mt-10 74.61 60.11 0.07 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.887 2.475 . . . . 0.0 115.656 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.44 141.11 28.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.8 115.2 7.86 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.147 -0.97 . . . . 0.0 111.672 172.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 tp -97.68 -36.1 10.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.455 1.121 . . . . 0.0 113.774 -159.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.34 155.85 26.46 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 127.399 2.428 . . . . 0.0 112.876 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.44 146.16 29.46 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.745 0.818 . . . . 0.0 111.595 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.22 135.22 44.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 110.453 -155.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.49 152.07 41.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.21 156.48 25.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.502 3.468 . . . . 0.0 112.182 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -123.81 5.17 8.77 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -164.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.75 -59.82 0.68 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 117.839 -1.534 . . . . 0.0 115.682 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -62.59 -166.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.83 3.02 . . . . 0.0 112.58 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -55.52 159.33 4.87 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 110.602 169.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -57.9 -8.19 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.224 2.616 . . . . 0.0 114.283 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -24.63 15.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.019 1.328 . . . . 0.0 113.487 163.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.85 2.4 76.26 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.655 1.598 . . . . 0.0 116.275 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -51.0 139.56 17.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.59 1.195 . . . . 0.0 112.964 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -109.81 126.94 54.32 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.768 1.227 . . . . 0.0 108.534 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.83 98.04 8.34 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.886 0.875 . . . . 0.0 109.267 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.18 148.29 35.99 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.09 0.956 . . . . 0.0 110.626 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.98 157.17 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.467 1.107 . . . . 0.0 110.062 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 159.28 35.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 112.879 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -123.04 19.41 10.01 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.1 p -44.29 -39.72 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 126.243 1.817 . . . . 0.0 115.868 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.29 30.27 0.62 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.475 1.51 . . . . 0.0 112.804 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.43 173.24 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.591 1.556 . . . . 0.0 109.946 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -115.29 149.61 37.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 122.429 1.109 . . . . 0.0 113.257 173.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -159.21 133.11 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.591 1.156 . . . . 0.0 110.001 -168.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -145.06 152.13 50.46 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 124.796 1.238 . . . . 0.0 112.1 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.67 168.97 23.61 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.135 1.89 . . . . 0.0 112.402 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -41.11 12.83 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.339 1.056 . . . . 0.0 111.776 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 CA--C 1.547 0.827 0 C-N-CA 124.192 0.997 . . . . 0.0 111.652 177.334 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.618 HG23 ' HB2' ' A' ' 130' ' ' SER . 1.3 t . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.48 -140.51 6.37 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.56 1.076 . . . . 0.0 114.638 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -155.33 161.8 40.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.473 1.13 . . . . 0.0 112.564 173.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -133.52 145.7 50.38 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.999 1.32 . . . . 0.0 111.336 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.63 164.04 38.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.583 1.153 . . . . 0.0 111.648 -161.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 69.7 m -59.07 157.58 9.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 123.451 1.596 . . . . 0.0 113.874 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.259 8.7 p -125.73 41.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.557 158.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.3 t -135.64 -48.01 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.706 1.202 . . . . 0.0 112.945 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 9.4 p -96.42 -89.96 0.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.522 1.529 . . . . 0.0 113.844 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.32 -30.75 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.043 2.137 . . . . 0.0 113.114 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.3 p -85.37 125.69 69.06 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -161.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.16 138.8 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.046 1.831 . . . . 0.0 111.403 160.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.17 -27.9 4.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.372 -163.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.68 137.99 18.46 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -84.07 136.46 34.01 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.299 -0.875 . . . . 0.0 109.693 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.8 m -62.38 -12.42 21.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.964 1.706 . . . . 0.0 114.387 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -29.54 69.03 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.611 0.764 . . . . 0.0 111.322 172.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -74.68 -2.99 28.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.186 0.994 . . . . 0.0 113.497 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 16.2 ttpp -53.45 128.25 28.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.774 0.716 . . . . 0.0 109.84 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 CA--C 1.537 0.657 0 CA-C-O 121.697 0.624 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.6 t -149.58 155.61 40.58 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 111.547 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.66 115.25 4.85 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.559 1.544 . . . . 0.0 109.253 -159.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -72.26 -16.76 61.93 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -146.94 155.54 42.36 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.929 0.892 . . . . 0.0 112.399 166.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 142.326 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.16 166.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 123.176 1.465 . . . . 0.0 111.995 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -133.87 176.36 8.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.88 2.072 . . . . 0.0 108.792 166.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.568 ' H ' HD23 ' A' ' 80' ' ' LEU . 7.0 ptt180 -147.3 146.7 29.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.9 0.88 . . . . 0.0 112.967 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.86 108.63 7.05 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.191 1.796 . . . . 0.0 109.205 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -89.69 149.22 22.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.393 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.52 120.01 6.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.659 1.184 . . . . 0.0 109.205 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -130.08 35.27 4.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.218 1.007 . . . . 0.0 110.605 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -130.92 -6.47 3.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.736 2.015 . . . . 0.0 114.606 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.21 24.39 1.88 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.702 2.001 . . . . 0.0 111.806 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.66 -10.27 46.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.636 2.065 . . . . 0.0 114.155 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.8 t -145.83 130.9 9.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.788 1.235 . . . . 0.0 109.807 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.25 133.01 23.7 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.094 2.53 . . . . 0.0 112.88 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -138.6 157.87 45.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.829 2.852 . . . . 0.0 111.741 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.3 mtt -138.76 128.03 24.24 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.392 2.277 . . . . 0.0 107.915 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.89 153.29 47.63 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.205 1.002 . . . . 0.0 111.325 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.76 141.32 44.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.206 1.402 . . . . 0.0 111.827 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -117.52 152.03 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.186 1.394 . . . . 0.0 109.591 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 1.067 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 40.4 t -93.02 120.91 33.81 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 165.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.56 -14.96 41.4 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 114.411 169.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -65.42 -38.36 89.7 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.691 0.796 . . . . 0.0 112.447 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.067 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 1.7 p -117.55 -12.22 10.38 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 127.604 2.361 . . . . 0.0 114.888 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.362 56.5 mt-10 62.19 64.1 1.0 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.912 2.485 . . . . 0.0 115.213 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.28 136.82 32.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -78.45 109.16 12.37 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.988 165.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.297 2.7 pp -141.27 -1.41 1.35 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 -172.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.0 142.04 13.5 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.746 1.641 . . . . 0.0 111.515 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.17 160.18 43.45 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.753 -0.851 . . . . 0.0 111.308 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.35 139.11 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 125.138 1.375 . . . . 0.0 111.125 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -145.87 154.11 50.89 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.869 1.268 . . . . 0.0 114.007 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -84.38 141.01 8.79 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.574 2.849 . . . . 0.0 111.27 171.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.36 28.86 4.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.352 1.461 . . . . 0.0 113.158 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.42 -50.96 0.82 Allowed Glycine 0 CA--C 1.542 1.748 0 C-N-CA 126.542 2.02 . . . . 0.0 115.241 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -87.72 -165.38 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.175 3.25 . . . . 0.0 112.295 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -56.28 149.13 38.91 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.819 1.648 . . . . 0.0 113.064 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -66.68 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 124.791 3.661 . . . . 0.0 115.261 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -31.51 62.09 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.85 -1.156 . . . . 0.0 112.373 162.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.0 14.12 65.17 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.88 150.57 28.2 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -165.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -105.42 137.73 42.77 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.902 1.681 . . . . 0.0 108.652 170.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -90.48 160.82 15.81 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 123.824 0.85 . . . . 0.0 109.721 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.9 p -150.3 155.76 40.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.057 1.343 . . . . 0.0 110.834 166.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 mm -118.85 165.81 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.36 1.864 . . . . 0.0 109.368 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.85 103.84 6.28 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.305 -1.497 . . . . 0.0 113.622 150.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -74.73 21.23 0.11 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.31 -19.71 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.067 1.747 . . . . 0.0 114.895 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.11 17.53 10.8 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.304 1.842 . . . . 0.0 114.923 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 61.5 mt -120.69 157.52 29.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.324 1.059 . . . . 0.0 113.174 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -104.57 161.9 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.267 2.227 . . . . 0.0 111.288 163.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -142.46 145.5 33.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 111.003 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -148.99 151.67 35.04 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.019 1.328 . . . . 0.0 112.144 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.91 170.31 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.801 2.334 . . . . 0.0 113.288 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.618 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.8 OUTLIER -86.18 -44.25 12.35 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.836 1.303 . . . . 0.0 112.532 -178.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 126.252 1.821 . . . . 0.0 112.016 -178.612 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.216 0.531 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.68 -160.2 23.89 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 114.125 0.41 . . . . 0.0 114.125 174.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.9 ptp -151.29 156.2 40.32 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.139 0.976 . . . . 0.0 113.052 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -104.4 140.72 37.52 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.464 2.706 . . . . 0.0 110.974 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -144.12 158.75 43.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.718 2.007 . . . . 0.0 110.861 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 1.3 t -72.86 168.39 19.0 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.833 1.778 . . . . 0.0 115.144 -172.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.72 3.97 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.774 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.9 t -117.57 -44.82 2.73 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 111.156 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 4.3 p -90.21 -104.46 0.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.963 1.705 . . . . 0.0 108.239 162.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -156.8 -50.07 0.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.799 1.64 . . . . 0.0 114.147 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 154.96 53.9 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -149.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.49 135.51 36.57 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.613 2.209 . . . . 0.0 111.037 162.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -22.89 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.42 120.41 10.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.997 -0.439 . . . . 0.0 110.8 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -86.04 135.08 33.77 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 123.565 1.65 . . . . 0.0 112.421 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -5.72 6.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.047 2.139 . . . . 0.0 112.885 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -23.69 57.86 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.705 1.202 . . . . 0.0 112.948 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.23 -1.13 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.652 1.181 . . . . 0.0 114.002 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -79.66 123.04 27.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.089 0.956 . . . . 0.0 111.143 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 122.426 1.108 . . . . 0.0 111.285 170.191 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 CA--C 1.538 0.711 0 CA-C-O 124.71 1.879 . . . . 0.0 114.888 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -149.78 163.58 37.62 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.984 2.514 . . . . 0.0 111.443 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -154.98 145.39 22.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.924 2.09 . . . . 0.0 108.838 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -73.62 -34.04 64.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.112 167.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -153.94 165.21 36.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.289 1.435 . . . . 0.0 110.973 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 148.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 119.384 -0.676 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.781 1.277 . . . . 0.0 112.417 174.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.12 177.73 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 128.576 2.751 . . . . 0.0 109.134 -173.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 154.9 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.74 105.93 6.35 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 126.488 1.915 . . . . 0.0 109.222 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.78 154.42 19.53 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.933 0.893 . . . . 0.0 111.064 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -143.06 113.89 7.6 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.713 1.205 . . . . 0.0 108.444 166.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -129.33 37.57 4.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.889 1.328 . . . . 0.0 110.269 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.8 t -113.79 -17.93 11.95 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 113.973 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.44 22.14 5.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.355 2.262 . . . . 0.0 111.847 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.68 -12.01 54.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.634 2.064 . . . . 0.0 114.761 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.09 130.23 23.4 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.219 1.408 . . . . 0.0 110.025 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.29 128.36 11.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.402 2.068 . . . . 0.0 112.12 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -133.18 155.95 48.38 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 128.08 2.552 . . . . 0.0 109.904 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.3 mtt -141.27 130.81 23.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.06 1.744 . . . . 0.0 109.423 -172.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -133.42 153.67 51.41 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.29 1.436 . . . . 0.0 110.735 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.94 145.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.239 1.016 . . . . 0.0 111.217 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.38 138.7 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.593 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.5 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 8.7 t -79.02 108.76 12.74 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 174.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -79.89 -7.71 58.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.285 1.034 . . . . 0.0 113.272 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.89 -39.5 94.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.323 1.049 . . . . 0.0 112.073 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.5 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 25.5 p -134.77 -5.83 2.47 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 -178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.361 43.3 mt-10 71.33 53.25 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.613 2.365 . . . . 0.0 114.051 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.74 134.04 51.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.833 1.653 . . . . 0.0 113.207 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -78.88 76.59 5.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.355 1.462 . . . . 0.0 112.307 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 3.24 6.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -171.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.9 172.41 19.31 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 122.825 1.236 . . . . 0.0 116.128 160.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -137.48 160.36 39.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 p -125.68 123.68 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.651 1.98 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.58 149.15 61.06 Favored Pre-proline 0 C--O 1.241 0.654 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.192 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.69 152.32 53.09 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.288 2.658 . . . . 0.0 112.347 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -100.63 -0.46 37.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.51 1.924 . . . . 0.0 115.129 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.94 -61.48 0.66 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.437 1.494 . . . . 0.0 115.098 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.47 -157.94 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 124.795 3.663 . . . . 0.0 112.902 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 150.53 31.1 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.758 1.223 . . . . 0.0 112.304 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.21 2.17 2.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.138 3.226 . . . . 0.0 114.464 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -59.48 -24.01 63.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.312 -0.868 . . . . 0.0 113.141 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.59 0.66 85.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.579 1.392 . . . . 0.0 116.579 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -60.39 146.11 45.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.669 1.235 . . . . 0.0 113.422 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.0 149.59 28.33 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.258 1.823 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -82.45 144.74 30.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.672 0.748 . . . . 0.0 111.834 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.3 p -129.49 134.63 47.89 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.57 2.748 . . . . 0.0 108.478 168.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.3 tp -127.85 126.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.358 -0.839 . . . . 0.0 112.265 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -119.68 3.05 11.17 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m -134.17 39.44 3.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.132 1.773 . . . . 0.0 111.766 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.24 -39.73 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -163.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.95 -11.76 0.53 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.588 2.755 . . . . 0.0 117.516 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.4 pp -126.24 176.47 7.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.547 1.939 . . . . 0.0 114.094 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.07 178.97 4.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 114.589 -165.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.59 160.92 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.766 1.226 . . . . 0.0 113.821 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.7 152.74 79.22 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.914 1.686 . . . . 0.0 110.663 160.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.56 167.88 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.595 1.53 . . . . 0.0 111.284 160.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.35 -45.18 9.19 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 112.507 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.546 0.815 0 C-N-CA 127.149 2.18 . . . . 0.0 113.469 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.223 -0.309 0 CA-C-O 121.537 0.684 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.31 -165.71 31.25 Favored Glycine 0 N--CA 1.474 1.22 0 O-C-N 119.914 -1.741 . . . . 0.0 116.013 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -155.57 161.25 40.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.502 1.121 . . . . 0.0 113.78 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.06 143.8 39.57 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 129.278 3.031 . . . . 0.0 111.018 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -136.76 165.19 26.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.968 2.107 . . . . 0.0 109.771 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 57.1 m -59.72 158.57 10.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.76 1.267 . . . . 0.0 111.311 170.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 p -92.09 12.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.653 156.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.0 m -121.18 -43.61 2.42 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -162.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 8.6 p -103.78 -92.89 0.34 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.283 1.401 . . . . 0.0 113.679 -175.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -160.73 -49.13 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.055 2.142 . . . . 0.0 113.7 -172.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p -113.02 156.71 42.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -158.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.82 152.49 16.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.73 2.953 . . . . 0.0 113.333 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.5 -26.39 1.84 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.262 1.025 . . . . 0.0 113.601 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.09 122.01 25.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.629 0.65 . . . . 0.0 112.041 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 p -85.3 130.92 34.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.947 -1.096 . . . . 0.0 109.55 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -9.75 24.08 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 123.135 1.445 . . . . 0.0 112.331 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.8 tt0 -58.18 -33.1 68.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.807 1.243 . . . . 0.0 114.144 166.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 8.1 mmpt? -83.28 0.65 44.74 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.961 1.704 . . . . 0.0 113.092 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 117.44 7.71 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 120.097 1.317 . . . . 0.0 110.154 -169.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -164.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 CA-C-O 122.873 1.114 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 p -158.38 153.2 24.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.403 1.481 . . . . 0.0 111.089 -164.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.84 148.65 45.63 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.769 2.028 . . . . 0.0 109.379 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.6 p -84.1 -25.9 29.38 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.053 1.741 . . . . 0.0 113.516 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -153.95 162.74 40.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.165 1.386 . . . . 0.0 112.146 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 124.752 1.221 . . . . 0.0 110.377 163.829 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 CA-C-O 119.503 -0.61 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.84 167.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.248 1.419 . . . . 0.0 112.204 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.69 173.62 11.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.14 1.776 . . . . 0.0 110.575 169.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 163.53 36.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.58 1.152 . . . . 0.0 113.157 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.73 118.23 6.51 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 127.147 2.179 . . . . 0.0 108.995 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.85 147.41 41.12 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.615 0.766 . . . . 0.0 110.579 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -129.4 51.86 2.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 123.961 1.839 . . . . 0.0 111.215 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.3 p -79.51 47.97 0.87 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.765 2.026 . . . . 0.0 110.72 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.93 -1.22 2.22 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.6 mt -90.07 10.84 22.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.675 1.19 . . . . 0.0 113.043 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.67 -9.31 6.31 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.209 1.385 . . . . 0.0 113.967 -166.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.73 109.75 20.55 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 126.578 1.951 . . . . 0.0 108.129 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.62 126.44 12.1 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.374 2.049 . . . . 0.0 112.849 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -122.95 151.7 41.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.209 1.803 . . . . 0.0 109.183 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 35.3 mtp -112.72 128.23 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.023 2.129 . . . . 0.0 105.77 164.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -124.9 144.94 50.07 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.804 -1.185 . . . . 0.0 111.943 172.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -145.48 138.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.31 1.053 . . . . 0.0 112.304 -156.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 103' ' ' LEU . 2.8 m -149.43 173.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.83 -1.169 . . . . 0.0 111.022 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 34.6 t -94.14 150.32 20.43 Favored 'General case' 0 N--CA 1.404 -2.773 0 C-N-CA 127.398 2.279 . . . . 0.0 106.575 168.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -110.27 -18.09 13.36 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 127.762 2.425 . . . . 0.0 112.795 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.56 -44.94 96.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.569 1.148 . . . . 0.0 112.209 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -96.71 -29.57 13.72 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.411 2.284 . . . . 0.0 111.462 175.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 67.37 124.44 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.61 1.195 . . . . 0.0 111.041 -154.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 71.96 85.26 0.12 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.956 2.102 . . . . 0.0 114.515 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.308 2.7 t60 -74.85 -14.6 60.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.514 ' H ' HG12 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 38.89 52.21 1.91 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.515 2.326 . . . . 0.0 113.591 -172.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.97 156.45 22.38 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 111.527 -2.579 . . . . 0.0 109.383 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.53 156.37 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.098 0.959 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.2 t -139.82 126.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 123.799 0.84 . . . . 0.0 109.487 -174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -133.59 152.26 78.71 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.015 0.926 . . . . 0.0 111.496 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.46 140.38 15.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.77 2.313 . . . . 0.0 110.33 160.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.57 -5.61 59.26 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.12 -46.35 0.48 Allowed Glycine 0 CA--C 1.542 1.758 0 C-N-CA 126.891 2.186 . . . . 0.0 113.991 -162.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.93 179.04 6.88 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 CA-C-N 120.981 2.391 . . . . 0.0 113.768 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.67 162.69 4.61 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.707 1.603 . . . . 0.0 111.819 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.25 -3.23 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.168 3.245 . . . . 0.0 116.088 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 t -81.09 -21.54 39.88 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.982 1.713 . . . . 0.0 114.319 170.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.66 16.29 59.88 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 127.346 2.403 . . . . 0.0 115.443 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -70.9 159.52 34.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -167.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -118.75 129.27 55.16 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 107.322 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -84.68 130.36 34.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.8 m -115.27 129.27 56.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.644 1.978 . . . . 0.0 108.784 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.32 175.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 120.434 1.47 . . . . 0.0 110.054 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.51 139.97 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.893 -1.129 . . . . 0.0 111.874 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.1 m -76.0 28.89 0.11 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -165.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.94 -30.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.83 41.56 0.77 Allowed 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.8 mt -132.06 153.64 50.22 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.056 -1.028 . . . . 0.0 112.947 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.58 153.72 35.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.316 1.846 . . . . 0.0 111.328 164.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -151.02 130.65 13.07 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.472 -0.767 . . . . 0.0 112.577 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -142.25 159.17 59.39 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 126.156 1.783 . . . . 0.0 111.702 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.46 164.63 33.53 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.613 2.209 . . . . 0.0 114.22 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.3 t -102.6 -66.79 0.91 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.257 2.623 . . . . 0.0 109.383 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.802 0 C-N-CA 129.492 3.117 . . . . 0.0 112.127 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.58 -141.8 8.23 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.469 1.509 . . . . 0.0 111.584 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.6 ptp -144.54 162.46 36.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.402 1.081 . . . . 0.0 112.198 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.88 134.18 52.35 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 109.921 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -135.9 163.21 30.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 0.0 110.441 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.854 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 2.0 t -69.59 172.71 6.96 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 124.213 1.959 . . . . 0.0 114.802 -169.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.9 1.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 112.715 -2.038 . . . . 0.0 112.512 165.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.7 m -115.04 -26.89 7.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.177 1.391 . . . . 0.0 112.364 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.854 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 11.9 p -115.83 -98.11 0.45 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.608 1.963 . . . . 0.0 111.337 173.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.25 -50.18 0.07 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 p -95.62 160.01 31.31 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 116.563 2.061 . . . . 0.0 116.563 -150.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.35 132.83 40.24 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.841 2.361 . . . . 0.0 112.276 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -33.65 5.74 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.902 1.281 . . . . 0.0 111.66 -166.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.34 158.64 30.06 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.373 -0.83 . . . . 0.0 112.712 168.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 p -94.96 132.87 39.33 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 122.677 1.227 . . . . 0.0 110.953 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -4.83 24.12 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.11 0.964 . . . . 0.0 113.405 172.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.91 -29.36 64.24 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.578 1.951 . . . . 0.0 113.576 170.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.01 1.74 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.952 1.301 . . . . 0.0 113.621 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -69.89 121.43 17.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.315 1.846 . . . . 0.0 114.304 -167.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.417 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 CA--C 1.535 0.555 0 CA-C-O 123.961 1.567 . . . . 0.0 113.979 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.7 p -158.55 142.29 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.798 2.439 . . . . 0.0 109.533 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -155.3 132.32 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.794 2.038 . . . . 0.0 107.733 -170.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 p -68.96 -24.32 64.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -139.82 142.55 36.64 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.479 0.657 . . . . 0.0 112.13 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.829 0 C-N-CA 125.186 1.395 . . . . 0.0 111.555 173.893 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.554 0 CA-C-O 121.131 0.295 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.87 178.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.712 2.005 . . . . 0.0 111.874 -172.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.42 -177.59 4.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.186 2.194 . . . . 0.0 108.915 166.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -139.39 155.0 47.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.273 1.829 . . . . 0.0 110.742 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 118.57 10.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.85 2.06 . . . . 0.0 107.149 168.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.97 138.53 33.76 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.269 -0.895 . . . . 0.0 111.338 172.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.3 23.01 14.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.739 1.216 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.2 t -71.1 38.65 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.81 2.444 . . . . 0.0 113.362 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.27 10.89 6.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.475 2.71 . . . . 0.0 112.387 -174.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.96 14.42 14.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.238 1.815 . . . . 0.0 112.462 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.28 -12.22 7.55 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 126.019 1.771 . . . . 0.0 113.561 -171.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.9 t -102.22 107.05 51.56 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 108.616 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.19 126.96 12.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.554 1.503 . . . . 0.0 110.623 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -147.89 156.03 42.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.478 2.711 . . . . 0.0 109.629 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.2 mtt -125.99 125.93 43.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.63 2.372 . . . . 0.0 106.994 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -116.39 154.46 30.23 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 110.926 173.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.16 137.24 55.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 125.408 1.483 . . . . 0.0 110.514 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.73 143.4 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.436 0.636 . . . . 0.0 111.516 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 39.7 t -70.05 108.02 3.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 160.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -63.72 -22.12 66.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.055 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -83.01 -39.5 21.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 112.574 -167.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.487 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 18.3 p -115.36 6.04 14.76 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.963 1.705 . . . . 0.0 114.249 172.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.36 60.34 3.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.497 . . . . 0.0 114.616 174.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -150.01 148.77 29.45 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -69.6 136.35 51.14 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.871 0.868 . . . . 0.0 111.263 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.31 -20.99 1.39 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.0 151.56 23.77 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 127.078 2.275 . . . . 0.0 112.52 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.66 166.71 22.91 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 126.141 1.776 . . . . 0.0 111.557 172.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.9 t -143.54 136.17 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.396 1.879 . . . . 0.0 108.212 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -148.57 153.97 40.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.42 1.088 . . . . 0.0 113.069 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.91 135.43 7.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.996 2.464 . . . . 0.0 109.91 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.37 -1.5 45.72 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.22 -40.8 0.51 Allowed Glycine 0 CA--C 1.542 1.749 0 CA-C-O 117.376 -1.791 . . . . 0.0 116.559 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.68 -167.59 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.451 2.767 . . . . 0.0 113.446 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -55.45 160.71 3.48 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.752 1.621 . . . . 0.0 112.345 171.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -59.93 -9.43 9.83 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.659 2.906 . . . . 0.0 114.136 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -22.64 62.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.507 1.523 . . . . 0.0 113.087 170.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.65 19.05 54.06 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 126.405 1.955 . . . . 0.0 115.893 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -73.34 146.72 45.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -110.13 144.53 38.62 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.197 1.399 . . . . 0.0 109.308 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -91.39 137.66 32.19 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.009 1.724 . . . . 0.0 110.068 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.7 p -132.01 132.28 43.29 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.04 1.736 . . . . 0.0 112.769 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 122' ' ' SER . 10.2 mm -80.92 154.99 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.115 1.366 . . . . 0.0 110.611 174.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -91.22 -13.12 33.39 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 120' ' ' ILE . 68.7 m 57.14 82.68 0.11 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.067 2.147 . . . . 0.0 114.417 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 124' ' ' ALA 0.299 3.4 p -93.57 -96.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 111.529 167.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.43 ' H ' HG13 ' A' ' 123' ' ' VAL . . . -157.07 20.92 0.31 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -166.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.99 173.98 6.79 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.687 1.585 . . . . 0.0 113.166 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.26 163.17 12.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.202 1.801 . . . . 0.0 112.735 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -150.79 148.16 28.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.169 1.387 . . . . 0.0 111.861 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -140.4 149.87 59.04 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.069 1.348 . . . . 0.0 111.525 170.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.83 171.32 10.73 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.081 2.521 . . . . 0.0 114.533 -165.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.02 -40.5 11.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.065 1.346 . . . . 0.0 113.903 -173.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 127.598 2.359 . . . . 0.0 113.76 -169.822 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 130' ' ' SER . 1.2 t . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.128 0.489 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.71 -153.12 14.22 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.124 0.868 . . . . 0.0 114.47 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.7 ptp -154.12 161.05 42.15 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.329 1.061 . . . . 0.0 112.895 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -120.0 148.37 43.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.787 2.435 . . . . 0.0 110.553 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.35 159.87 42.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.812 2.045 . . . . 0.0 109.503 -167.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 83.7 m -74.11 165.7 24.7 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.158 1.456 . . . . 0.0 111.802 158.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.62 -9.98 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.853 -1.522 . . . . 0.0 113.948 154.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 t -83.24 -46.34 12.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 112.441 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 15.1 p -85.15 -87.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.895 1.278 . . . . 0.0 111.337 170.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -148.9 -57.02 0.21 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.0 p -130.14 156.0 79.93 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -135.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.69 139.45 40.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.502 2.801 . . . . 0.0 112.732 164.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 mt -143.94 -18.78 0.58 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -135.2 134.71 40.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.317 1.417 . . . . 0.0 111.313 -167.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -101.51 122.06 43.11 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.959 1.303 . . . . 0.0 111.007 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -60.15 -15.45 24.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.475 1.51 . . . . 0.0 113.578 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.415 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.51 -31.27 67.73 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 130.252 3.421 . . . . 0.0 113.269 178.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -74.25 4.09 6.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.828 1.251 . . . . 0.0 111.793 177.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -62.61 134.72 56.75 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 120.661 -1.275 . . . . 0.0 114.018 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 CA--C 1.543 0.681 0 C-N-CA 127.179 2.192 . . . . 0.0 111.519 -176.617 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.54 0.82 0 N-CA-C 115.206 1.195 . . . . 0.0 115.206 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -129.91 178.51 6.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.78 142.35 17.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.821 3.649 . . . . 0.0 106.801 159.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 p -73.75 -35.1 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 111.402 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -146.33 157.32 43.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.718 1.247 . . . . 0.0 114.195 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 125.939 1.696 . . . . 0.0 110.113 166.576 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.992 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 pt -117.54 155.98 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.868 1.834 . . . . 0.0 114.564 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -136.08 176.62 8.52 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.595 2.758 . . . . 0.0 110.733 177.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.629 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -138.43 141.91 39.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.036 1.334 . . . . 0.0 113.375 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.42 112.7 10.53 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 108.314 173.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.6 mp -80.6 157.28 26.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 125.886 1.674 . . . . 0.0 111.076 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -131.18 108.89 10.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 t -118.44 24.5 10.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.032 1.396 . . . . 0.0 109.836 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.62 -6.71 9.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.393 1.877 . . . . 0.0 113.682 -154.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.5 mt -105.26 18.66 21.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.071 2.148 . . . . 0.0 112.689 170.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -7.01 64.45 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.061 1.315 . . . . 0.0 115.392 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 52.4 t -127.79 112.99 20.59 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.892 1.677 . . . . 0.0 109.648 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.68 125.88 7.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.778 2.319 . . . . 0.0 114.039 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -129.42 154.2 47.18 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.129 2.572 . . . . 0.0 110.222 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mtm -127.49 127.13 43.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.364 1.866 . . . . 0.0 108.224 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -123.25 144.59 49.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.813 0.816 . . . . 0.0 109.776 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.55 144.5 21.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.471 1.108 . . . . 0.0 109.608 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.4 m -128.28 151.82 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 0.0 111.301 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.744 ' HG ' ' HG ' ' A' ' 99' ' ' CYS . 43.2 t -93.02 119.04 31.86 Favored 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 126.71 2.004 . . . . 0.0 105.886 174.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -69.5 -16.77 63.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.606 1.962 . . . . 0.0 111.974 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -83.95 -45.84 12.72 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.744 ' HG ' ' HG ' ' A' ' 96' ' ' CYS . 2.2 p -106.78 -7.59 17.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.601 1.961 . . . . 0.0 113.835 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 63.15 40.76 8.64 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.24 1.816 . . . . 0.0 113.066 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.92 154.46 51.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.451 1.5 . . . . 0.0 111.907 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -80.98 90.06 5.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.145 0.978 . . . . 0.0 113.149 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -74.3 8.59 2.1 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -175.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.68 179.63 30.06 Favored Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.002 -1.061 . . . . 0.0 114.065 165.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 156.49 44.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 111.684 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.03 137.47 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.316 1.055 . . . . 0.0 111.751 -173.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.83 151.2 45.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 113.063 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.53 133.44 10.55 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.043 2.495 . . . . 0.0 109.305 162.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -93.87 1.57 56.35 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.43 -62.19 0.28 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.387 -1.229 . . . . 0.0 114.396 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.37 -177.12 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.549 2.832 . . . . 0.0 112.967 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.77 149.83 4.23 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.254 1.022 . . . . 0.0 111.506 170.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.51 -3.77 9.64 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.975 2.45 . . . . 0.0 114.149 -171.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.9 p -54.92 -30.94 59.62 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.639 -0.663 . . . . 0.0 111.943 162.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.9 10.13 74.91 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.882 2.182 . . . . 0.0 117.091 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -50.96 148.81 3.93 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.209 1.504 . . . . 0.0 113.957 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.7 132.02 43.57 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.695 1.198 . . . . 0.0 110.828 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.7 125.35 45.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.105 1.362 . . . . 0.0 110.275 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.5 p -108.13 126.06 52.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.897 2.079 . . . . 0.0 109.618 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -92.41 156.8 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.844 0.831 . . . . 0.0 109.845 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -126.92 163.0 24.62 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.461 1.905 . . . . 0.0 109.957 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 m -96.42 18.43 13.97 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 p -47.39 -48.93 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -159.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.61 24.07 0.34 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.2 mt -125.07 154.92 40.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.426 1.09 . . . . 0.0 112.16 -161.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -128.01 157.14 41.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.779 2.032 . . . . 0.0 113.917 -171.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.4 143.16 33.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -167.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -137.94 152.98 73.23 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.597 1.559 . . . . 0.0 110.875 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.02 179.59 5.59 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.538 2.159 . . . . 0.0 112.022 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.497 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 5.8 t -102.59 -57.7 2.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.967 1.707 . . . . 0.0 111.469 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.497 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 9.3 mmpt? . . . . . 0 CA--C 1.554 1.102 0 C-N-CA 126.419 1.888 . . . . 0.0 112.976 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.62 -158.52 20.82 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 172.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ptp -155.2 167.55 29.99 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.436 1.494 . . . . 0.0 112.647 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.98 151.17 40.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 112.253 157.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -138.16 164.59 28.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.039 2.136 . . . . 0.0 109.834 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 59.4 m -62.16 169.72 2.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 124.085 1.898 . . . . 0.0 114.712 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 p -115.6 -2.37 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.952 -2.385 . . . . 0.0 112.301 169.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.2 m -124.57 -18.35 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -169.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 12.7 p -125.9 -101.29 0.37 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.137 1.375 . . . . 0.0 112.008 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -159.71 -35.77 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.404 2.282 . . . . 0.0 113.538 -170.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.44 124.32 87.96 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -157.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.43 127.02 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.066 1.844 . . . . 0.0 110.363 156.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.72 -45.07 1.63 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.931 -158.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -126.31 121.12 31.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.825 -171.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 p -82.28 131.13 35.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.185 0.993 . . . . 0.0 108.903 166.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -58.45 -13.95 6.66 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.236 1.815 . . . . 0.0 112.321 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.11 -43.6 87.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 127.098 2.159 . . . . 0.0 114.548 168.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.8 mmpt? -72.83 -2.09 19.27 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.215 1.406 . . . . 0.0 113.222 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -78.36 137.5 38.06 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.628 1.971 . . . . 0.0 110.522 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 CA--C 1.541 0.625 0 CA-C-O 123.0 1.381 . . . . 0.0 111.571 179.633 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.533 0.442 0 CA-C-O 124.618 1.841 . . . . 0.0 113.887 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.1 p -152.0 161.82 42.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 128.599 2.76 . . . . 0.0 110.427 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -157.15 168.29 27.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.365 2.266 . . . . 0.0 106.559 -169.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -127.55 -7.07 5.73 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 164.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -135.12 147.9 49.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 122.139 0.971 . . . . 0.0 111.858 160.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.461 0 C-N-CA 126.689 1.995 . . . . 0.0 105.811 165.358 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.616 0 CA-C-O 119.844 -0.42 . . . . 0.0 113.914 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -74.12 178.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 122.766 1.27 . . . . 0.0 113.091 -171.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.55 171.87 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.707 1.603 . . . . 0.0 110.152 174.136 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.629 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -160.79 157.78 27.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.766 1.627 . . . . 0.0 111.512 177.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -149.94 123.7 9.24 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.005 2.122 . . . . 0.0 107.916 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.03 147.35 42.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.745 161.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.04 23.27 11.47 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.201 1.001 . . . . 0.0 113.311 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.4 m -71.25 41.77 0.07 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.281 3.032 . . . . 0.0 112.876 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.88 -1.25 2.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 127.091 2.156 . . . . 0.0 113.438 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.9 mt -102.46 20.29 17.3 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.713 2.005 . . . . 0.0 112.224 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -9.11 60.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.049 1.309 . . . . 0.0 114.75 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.2 t -136.37 134.41 19.88 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 110.608 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 140.89 37.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.149 2.566 . . . . 0.0 113.366 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.2 mmt-85 -146.34 156.04 43.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.631 1.972 . . . . 0.0 111.308 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.25 119.81 20.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.608 1.563 . . . . 0.0 108.928 171.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -137.71 148.34 45.58 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.631 -0.668 . . . . 0.0 112.207 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.18 142.8 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.316 1.446 . . . . 0.0 112.296 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.91 157.43 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.807 1.243 . . . . 0.0 110.353 -172.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 1.043 ' SG ' ' SG ' ' A' ' 99' ' ' CYS . 49.1 t -92.98 128.43 38.85 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 123.008 1.385 . . . . 0.0 107.517 163.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -20.09 21.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.575 1.95 . . . . 0.0 112.166 170.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.82 -39.31 93.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.152 0.887 . . . . 0.0 112.616 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 1.043 ' SG ' ' SG ' ' A' ' 96' ' ' CYS . 1.6 p -119.05 -2.59 10.75 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.702 2.001 . . . . 0.0 114.856 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 52.43 63.67 2.15 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.461 1.505 . . . . 0.0 112.141 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -129.91 131.49 46.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.337 1.055 . . . . 0.0 112.04 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -90.87 103.29 16.02 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.194 -0.941 . . . . 0.0 109.578 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.0 mt -103.36 -40.49 6.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -160.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.51 148.63 20.02 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.873 1.702 . . . . 0.0 113.763 -161.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 159.35 42.95 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.468 1.107 . . . . 0.0 111.831 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.04 139.82 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 122.634 1.207 . . . . 0.0 111.37 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -147.95 154.98 44.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.572 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.39 135.79 13.61 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.681 2.921 . . . . 0.0 111.361 171.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -74.7 -4.61 38.44 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.95 -62.65 0.24 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.985 1.755 . . . . 0.0 114.213 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.12 -156.27 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.007 3.138 . . . . 0.0 112.707 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.96 160.51 0.81 Allowed Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 125.085 1.354 . . . . 0.0 112.217 170.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -58.34 -6.08 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.651 2.901 . . . . 0.0 114.949 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -30.17 67.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.011 0.924 . . . . 0.0 112.446 164.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.3 30.85 6.42 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 126.664 2.078 . . . . 0.0 114.995 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -72.37 143.23 48.66 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.313 1.045 . . . . 0.0 112.923 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -131.06 127.0 37.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.366 1.066 . . . . 0.0 109.629 169.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.25 127.77 38.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.035 0.534 . . . . 0.0 109.978 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 m -126.06 134.22 51.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.953 1.701 . . . . 0.0 110.081 -171.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.9 tt -131.61 164.2 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.142 . . . . 0.0 110.624 -171.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.02 -55.41 1.28 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 m 45.85 34.66 1.97 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.77 -24.67 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -157.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -139.63 17.17 2.53 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.773 1.629 . . . . 0.0 114.415 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.93 179.55 7.52 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.918 -1.114 . . . . 0.0 111.192 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -101.67 134.39 44.88 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.244 -0.91 . . . . 0.0 111.405 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -139.27 137.72 36.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.454 -171.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -144.26 143.49 22.43 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.718 1.207 . . . . 0.0 110.831 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.12 168.53 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.472 1.448 . . . . 0.0 110.955 164.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.28 -44.68 5.34 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.666 1.186 . . . . 0.0 112.705 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 124.524 1.13 . . . . 0.0 112.488 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 119.333 -0.365 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.43 23.11 8.65 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.586 1.954 . . . . 0.0 115.048 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -135.22 174.92 10.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.292 1.437 . . . . 0.0 114.327 -162.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -121.86 -25.81 4.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.821 1.248 . . . . 0.0 113.6 153.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -58.58 -64.28 0.98 Allowed 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 128.481 2.712 . . . . 0.0 111.965 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -64.21 -24.64 67.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.962 1.705 . . . . 0.0 113.302 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -74.47 -35.42 63.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.634 1.574 . . . . 0.0 112.849 172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.2 mt -87.1 -27.07 23.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.719 1.208 . . . . 0.0 113.41 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -138.73 68.84 44.36 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 125.245 1.418 . . . . 0.0 111.67 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.27 157.57 49.25 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.295 2.663 . . . . 0.0 112.952 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -120.1 -78.61 0.59 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.247 1.019 . . . . 0.0 111.342 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -60.73 -28.08 68.41 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -85.95 -16.78 37.31 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.62 1.568 . . . . 0.0 113.832 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -89.24 -52.13 5.22 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.703 -0.623 . . . . 0.0 112.496 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.9 -33.91 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 O-C-N 121.723 -0.611 . . . . 0.0 111.409 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 p -66.22 -18.82 65.59 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.717 2.007 . . . . 0.0 115.38 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -87.62 -37.48 16.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.123 1.369 . . . . 0.0 112.37 164.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.21 -14.47 62.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.513 0.725 . . . . 0.0 112.454 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -66.04 54.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.442 1.897 . . . . 0.0 113.39 166.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.0 -4.66 0.04 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 169.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.2 t -140.04 159.99 40.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 123.635 1.683 . . . . 0.0 113.523 -169.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.15 163.36 12.32 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 127.465 2.306 . . . . 0.0 109.569 156.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -141.04 144.14 33.95 Favored Pre-proline 0 CA--C 1.551 1.001 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.65 178.68 6.81 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.243 3.295 . . . . 0.0 111.225 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.5 t80 56.07 25.38 8.86 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 123.865 1.793 . . . . 0.0 113.402 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.29 -23.57 0.94 Allowed 'General case' 0 N--CA 1.469 0.488 1 C-N-CA 131.806 4.042 . . . . 0.0 114.332 -178.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.1 -101.91 0.31 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.75 1.643 . . . . 0.0 113.508 164.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.4 mtp -58.36 -18.5 28.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.07 -2.41 58.1 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.694 1.198 . . . . 0.0 113.566 172.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.51 -13.25 49.61 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 119.715 -1.865 . . . . 0.0 115.069 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -91.55 -163.46 1.04 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.643 1.577 . . . . 0.0 112.84 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -68.28 160.97 28.3 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.22 -0.925 . . . . 0.0 111.434 170.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -135.44 112.52 10.36 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.253 1.421 . . . . 0.0 110.083 168.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.06 177.23 0.13 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.7 m -85.54 164.78 17.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.02 168.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.34 -150.51 21.0 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.457 -0.777 . . . . 0.0 112.068 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.2 ptp -150.13 169.81 20.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.072 1.349 . . . . 0.0 112.645 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -126.56 144.71 50.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.247 2.619 . . . . 0.0 110.764 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -147.08 160.55 42.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.387 1.875 . . . . 0.0 111.327 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.9 m -64.6 154.21 36.98 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 123.056 1.408 . . . . 0.0 112.077 171.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.269 9.0 p -113.8 27.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.138 -1.392 . . . . 0.0 111.808 153.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.5 t -116.21 -41.4 3.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.534 1.534 . . . . 0.0 112.104 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.5 p -109.99 -103.53 0.38 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.674 1.59 . . . . 0.0 112.444 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.55 -40.51 0.14 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.878 2.471 . . . . 0.0 113.37 -163.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.7 p -98.02 137.15 20.85 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -152.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.85 139.65 15.69 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.094 2.529 . . . . 0.0 111.531 161.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.19 -29.71 0.88 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -165.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -132.04 126.97 35.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.559 1.072 . . . . 0.0 111.548 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.1 m -86.82 133.23 33.66 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 120.659 -1.276 . . . . 0.0 110.798 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -11.93 23.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.124 1.37 . . . . 0.0 112.931 171.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -35.81 71.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.22 7.49 24.97 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.227 1.011 . . . . 0.0 112.465 176.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -61.37 131.97 52.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.068 0.849 . . . . 0.0 109.658 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -66.62 68.87 0.06 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 122.716 1.245 . . . . 0.0 112.582 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 7.2 t -73.18 172.65 10.7 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.35 1.46 . . . . 0.0 110.787 168.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.316 11.7 p 50.78 10.78 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 117.635 2.457 . . . . 0.0 117.635 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.92 -69.98 0.49 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 127.011 2.243 . . . . 0.0 110.241 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.84 -17.69 3.53 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.584 0.754 . . . . 0.0 112.784 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.09 -0.74 13.75 Favored Glycine 0 CA--C 1.538 1.525 0 O-C-N 120.498 -1.376 . . . . 0.0 114.448 -173.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.44 ' CG ' ' HD2' ' A' ' 61' ' ' PRO . 74.6 t90 -65.71 162.14 46.62 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 128.754 2.822 . . . . 0.0 112.102 -172.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 60' ' ' TRP . 71.4 Cg_endo -75.15 81.42 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.578 2.185 . . . . 0.0 116.392 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -135.28 154.31 51.59 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 128.516 2.726 . . . . 0.0 110.806 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -138.45 107.04 5.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.885 1.674 . . . . 0.0 111.014 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.7 p -63.99 -15.07 58.48 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -143.25 160.62 40.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.373 0.669 . . . . 0.0 109.387 138.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.82 72.73 1.09 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.314 1.046 . . . . 0.0 109.259 166.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -94.67 128.6 41.45 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -154.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.23 -24.85 0.15 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 126.229 1.871 . . . . 0.0 113.698 173.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.7 p -142.42 154.27 44.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.405 1.482 . . . . 0.0 112.979 -168.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 132.46 18.83 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.627 1.571 . . . . 0.0 112.909 -170.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.58 -81.39 0.06 OUTLIER Glycine 0 N--CA 1.47 0.933 0 C-N-CA 126.957 2.218 . . . . 0.0 114.067 155.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -54.54 -30.93 55.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.763 1.225 . . . . 0.0 111.917 168.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -87.46 -2.01 58.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -74.8 -14.16 60.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.644 1.178 . . . . 0.0 113.344 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.5 t -95.31 -36.21 11.49 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.824 1.249 . . . . 0.0 111.271 163.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -68.57 -38.03 80.36 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.052 -1.03 . . . . 0.0 113.485 -173.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -32.98 65.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.928 2.091 . . . . 0.0 113.639 -175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.17 16.69 75.29 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.238 -0.757 . . . . 0.0 112.33 -172.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -96.27 148.86 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.048 0.924 . . . . 0.0 111.232 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -126.43 174.12 8.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.821 2.848 . . . . 0.0 110.197 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.08 156.84 33.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.003 1.321 . . . . 0.0 112.144 -167.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.95 121.89 3.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.405 1.882 . . . . 0.0 110.083 -175.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -97.24 154.07 17.63 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.338 1.855 . . . . 0.0 112.237 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -147.99 111.15 4.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.729 1.212 . . . . 0.0 110.21 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.7 t -118.95 19.85 12.91 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 123.811 1.767 . . . . 0.0 112.834 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.14 -15.15 28.06 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.252 1.421 . . . . 0.0 114.009 -154.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 68.0 mt -84.94 10.61 11.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.806 1.642 . . . . 0.0 112.914 166.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.16 -5.01 81.41 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.63 1.586 . . . . 0.0 114.653 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 10.0 t -137.19 129.65 16.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.258 1.023 . . . . 0.0 111.401 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.57 135.11 12.82 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.126 2.551 . . . . 0.0 114.373 -170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.6 mmt-85 -127.77 157.3 40.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 129.967 3.307 . . . . 0.0 109.315 171.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.4 mtm -133.44 132.84 41.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.355 1.862 . . . . 0.0 108.308 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -139.26 149.36 44.21 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.357 0.599 . . . . 0.0 112.151 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.11 150.69 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.283 1.433 . . . . 0.0 111.916 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.42 155.02 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.779 0.832 . . . . 0.0 109.927 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 7.6 t -92.6 128.41 38.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 158.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -84.02 -24.24 30.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.064 -1.426 . . . . 0.0 112.253 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -64.74 -43.95 91.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.854 0.862 . . . . 0.0 112.447 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.98 -15.07 18.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.66 2.384 . . . . 0.0 113.238 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.303 42.5 mt-10 64.31 24.82 13.38 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.935 2.094 . . . . 0.0 112.799 -168.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.82 98.32 8.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.796 2.039 . . . . 0.0 112.848 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -89.12 68.87 8.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.949 1.7 . . . . 0.0 112.345 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.59 -5.09 8.7 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -159.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.56 135.97 12.44 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.707 2.099 . . . . 0.0 112.171 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.49 152.8 33.48 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.09 0.956 . . . . 0.0 111.39 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.12 125.85 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 122.322 1.058 . . . . 0.0 112.834 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -129.76 145.06 55.48 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.802 1.241 . . . . 0.0 111.76 -170.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.57 167.21 27.07 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.48 2.787 . . . . 0.0 112.419 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -109.14 -8.49 15.14 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.453 1.901 . . . . 0.0 115.336 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.1 -56.31 0.71 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.661 1.6 . . . . 0.0 114.512 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.75 -157.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 124.65 3.567 . . . . 0.0 113.271 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.15 154.98 13.56 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 125.661 1.584 . . . . 0.0 111.406 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -61.56 -7.48 8.99 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.443 2.762 . . . . 0.0 114.283 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.3 p -57.74 -26.78 62.3 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.876 1.27 . . . . 0.0 113.762 165.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.34 4.46 86.04 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.193 1.377 . . . . 0.0 116.054 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -53.94 149.88 8.48 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.98 127.39 50.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 110.99 170.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.37 103.14 12.42 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.253 1.421 . . . . 0.0 109.484 -175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 6.1 p -92.9 136.85 32.88 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.436 2.294 . . . . 0.0 110.55 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.05 133.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.158 -0.964 . . . . 0.0 109.239 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -110.48 133.04 53.65 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.0 m -82.71 16.37 2.23 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -164.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.66 -23.72 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.95 22.38 3.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.851 1.66 . . . . 0.0 113.576 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.4 mt -122.02 140.58 52.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.155 0.982 . . . . 0.0 112.993 -170.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -115.54 178.05 4.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.404 2.682 . . . . 0.0 112.15 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -150.63 148.31 28.47 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.467 1.107 . . . . 0.0 112.29 -167.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -131.16 134.11 25.45 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.37 1.468 . . . . 0.0 109.41 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.86 171.57 15.28 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.185 2.59 . . . . 0.0 113.107 -173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -42.5 18.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.921 0.888 . . . . 0.0 112.775 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -92.4 148.1 35.76 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.112 0.965 . . . . 0.0 113.473 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.94 174.85 6.18 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.164 3.243 . . . . 0.0 114.889 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 64.49 3.17 1.8 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.417 2.287 . . . . 0.0 115.071 -165.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.26 -36.61 0.48 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.749 2.02 . . . . 0.0 110.785 161.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.25 132.32 42.02 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.279 -0.888 . . . . 0.0 110.49 155.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.1 tp -160.74 48.33 0.23 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.444 1.898 . . . . 0.0 109.523 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -47.79 40.25 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -160.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -92.3 163.38 13.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.869 0.868 . . . . 0.0 111.809 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -62.86 152.64 35.63 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.651 -0.656 . . . . 0.0 112.26 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -124.2 21.68 8.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.769 0.827 . . . . 0.0 112.979 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -103.95 172.69 6.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.983 1.313 . . . . 0.0 112.656 -160.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.66 -171.76 3.4 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.768 0.827 . . . . 0.0 111.947 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 . . . . . 0 C--O 1.249 1.028 0 C-N-CA 125.93 1.692 . . . . 0.0 115.407 -176.081 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.38 32.89 14.64 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.038 1.335 . . . . 0.0 114.111 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.79 -175.45 3.17 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.776 2.43 . . . . 0.0 111.26 172.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -113.09 -25.52 8.89 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.079 0.952 . . . . 0.0 112.672 159.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -59.31 -54.49 46.24 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.984 1.714 . . . . 0.0 112.966 -169.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -75.07 -24.91 58.26 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -63.85 -37.37 87.14 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.891 0.877 . . . . 0.0 112.156 165.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.7 mt -88.23 -20.85 24.96 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.838 1.655 . . . . 0.0 114.161 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 11.9 t -137.37 76.94 42.32 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 124.528 1.131 . . . . 0.0 112.371 168.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.26 178.07 8.09 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.029 3.153 . . . . 0.0 114.427 175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -50.19 -46.45 54.4 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.57 -1.331 . . . . 0.0 112.956 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -58.08 -29.04 65.13 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -84.79 -26.24 27.64 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.548 1.539 . . . . 0.0 113.468 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.73 -45.84 23.55 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.996 1.319 . . . . 0.0 111.144 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.44 -19.71 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.205 1.402 . . . . 0.0 112.748 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.0 p -91.65 -31.28 15.91 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.163 2.185 . . . . 0.0 113.285 170.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -64.67 -49.06 72.43 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.338 1.455 . . . . 0.0 111.829 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.02 -4.39 49.64 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.32 1.048 . . . . 0.0 111.988 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -27.08 83.24 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 130.525 3.53 . . . . 0.0 116.141 -175.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.44 55.72 0.24 Allowed Glycine 0 N--CA 1.467 0.735 0 CA-C-N 111.477 -2.601 . . . . 0.0 111.773 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.3 t -110.24 128.9 55.75 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.755 1.622 . . . . 0.0 111.436 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -107.54 138.19 44.21 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.559 2.743 . . . . 0.0 107.43 162.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.59 150.33 14.38 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -171.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.99 179.7 5.83 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.525 2.816 . . . . 0.0 111.272 162.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 64.1 28.1 14.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.225 1.81 . . . . 0.0 114.887 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.55 -30.39 2.23 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 128.608 2.763 . . . . 0.0 114.674 164.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.63 -104.96 0.29 Allowed Glycine 0 N--CA 1.467 0.715 0 CA-C-N 119.967 1.258 . . . . 0.0 114.25 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 10.5 ttm -56.83 -23.03 40.98 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.272 1.029 . . . . 0.0 113.495 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -85.05 -6.59 59.32 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 117.958 -1.02 . . . . 0.0 113.496 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -79.64 47.95 0.89 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 121.135 1.789 . . . . 0.0 113.692 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -139.71 172.65 12.49 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.058 1.743 . . . . 0.0 113.071 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -68.58 158.51 33.83 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.598 0.759 . . . . 0.0 112.121 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -122.2 99.14 6.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.085 -1.009 . . . . 0.0 111.427 -159.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.03 170.19 15.95 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 -167.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -76.77 164.63 25.67 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 113.57 -1.65 . . . . 0.0 110.081 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 129' ' ' PRO . . . 145.81 -154.53 26.0 Favored Glycine 0 N--CA 1.467 0.751 0 C-N-CA 125.369 1.461 . . . . 0.0 112.266 -175.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 21.8 ptm -158.08 162.97 38.1 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -125.84 142.12 51.67 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.664 2.786 . . . . 0.0 110.77 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -154.91 166.23 34.18 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.343 1.857 . . . . 0.0 110.428 -173.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 4.5 t -80.98 172.84 13.24 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.132 1.444 . . . . 0.0 113.298 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.07 -9.06 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.173 1.789 . . . . 0.0 112.908 163.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 92.4 m -103.99 -33.45 8.81 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.959 1.303 . . . . 0.0 113.648 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.462 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -99.32 -100.49 0.23 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.759 1.223 . . . . 0.0 111.619 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -165.09 -62.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.36 145.12 29.13 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -161.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.43 151.58 70.95 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.236 2.624 . . . . 0.0 111.214 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.2 tp -137.83 -33.81 0.7 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -166.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -144.98 140.27 28.09 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 120.161 1.346 . . . . 0.0 114.205 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.1 m -98.56 144.41 27.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.011 0.925 . . . . 0.0 112.965 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -13.21 40.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.161 1.384 . . . . 0.0 113.407 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -24.87 66.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -87.19 -3.08 59.04 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.828 2.451 . . . . 0.0 113.312 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 127.76 33.7 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.992 1.317 . . . . 0.0 110.864 -170.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.88 117.08 10.1 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -166.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.5 m -84.65 56.09 3.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.5 1.12 . . . . 0.0 113.659 -175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.0 p -70.91 164.48 25.31 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.495 -0.753 . . . . 0.0 111.87 168.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.86 -1.82 26.81 Favored Glycine 0 CA--C 1.541 1.694 0 O-C-N 121.139 -0.976 . . . . 0.0 114.908 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.68 -25.45 13.85 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.017 1.727 . . . . 0.0 112.17 169.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.57 6.01 61.53 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.295 1.426 . . . . 0.0 113.598 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.422 ' CD1' ' HD2' ' A' ' 61' ' ' PRO . 91.8 t90 -50.56 144.49 12.36 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.193 1.797 . . . . 0.0 113.646 -166.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 60' ' ' TRP . 37.5 Cg_endo -65.58 100.33 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.173 2.582 . . . . 0.0 114.166 -171.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.2 p -158.74 156.56 30.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.695 2.798 . . . . 0.0 110.016 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -139.08 158.78 43.57 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 108.072 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.2 p -91.62 -20.13 21.97 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 127.243 2.217 . . . . 0.0 112.71 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -150.87 152.96 34.45 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.591 1.156 . . . . 0.0 112.199 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.62 91.65 3.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.033 1.333 . . . . 0.0 109.588 166.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -133.81 129.66 36.86 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.441 1.496 . . . . 0.0 108.871 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.96 -28.0 0.12 Allowed Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.814 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' HE2' ' A' ' 70' ' ' LYS . 92.4 p -86.96 150.13 24.29 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.059 1.429 . . . . 0.0 111.064 163.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -151.94 141.61 21.81 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 129.134 2.974 . . . . 0.0 111.798 -175.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.68 -79.08 0.09 OUTLIER Glycine 0 N--CA 1.472 1.068 0 C-N-CA 126.676 2.084 . . . . 0.0 115.03 155.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.85 -27.71 65.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.542 0.737 . . . . 0.0 112.651 167.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -121.6 108.55 13.71 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.708 0.766 . . . . 0.0 109.27 156.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -172.17 13.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.789 2.036 . . . . 0.0 111.992 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.5 t -74.98 -34.85 62.05 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.194 -0.941 . . . . 0.0 109.74 -170.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -127.75 -60.15 1.18 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.434 1.094 . . . . 0.0 113.9 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.1 p -167.06 -37.3 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -161.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.33 -33.15 2.75 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 125.557 1.551 . . . . 0.0 112.507 -164.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.6 pt -121.59 164.97 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.471 1.909 . . . . 0.0 112.494 -171.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.09 177.8 4.58 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.579 1.552 . . . . 0.0 109.408 158.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.28 155.96 38.72 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.548 1.139 . . . . 0.0 112.657 -174.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -151.98 121.16 6.71 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.262 1.825 . . . . 0.0 108.49 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.51 135.69 38.25 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.55 -0.719 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -94.01 25.53 3.66 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 122.389 1.09 . . . . 0.0 111.195 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -75.8 45.99 0.36 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.816 2.446 . . . . 0.0 111.305 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -127.19 -13.16 5.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.128 2.171 . . . . 0.0 113.287 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.14 18.39 21.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.941 2.496 . . . . 0.0 112.633 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.91 -6.67 54.81 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.686 1.136 . . . . 0.0 114.643 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.3 t -133.53 133.61 22.8 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.885 1.674 . . . . 0.0 110.628 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.38 152.48 60.79 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.623 2.882 . . . . 0.0 114.214 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -146.26 164.21 33.03 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 128.859 2.864 . . . . 0.0 109.763 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.4 ttp -119.0 135.33 54.67 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 151.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.46 153.16 42.41 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.714 1.206 . . . . 0.0 110.709 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.41 148.49 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 122.103 0.954 . . . . 0.0 112.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.82 148.87 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.431 1.093 . . . . 0.0 112.327 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.3 t -77.72 107.95 10.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.429 2.292 . . . . 0.0 104.898 169.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -74.99 -14.2 60.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 168.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -61.58 -40.13 93.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.438 1.895 . . . . 0.0 112.205 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 22.8 p -124.76 -5.46 7.51 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 9.4 tt0 73.38 53.71 0.12 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.215 2.206 . . . . 0.0 116.118 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.0 153.43 41.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 113.922 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.16 134.96 55.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.65 1.58 . . . . 0.0 113.064 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.4 tp -123.98 -15.48 6.85 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -165.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.82 179.55 34.69 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.731 2.11 . . . . 0.0 112.486 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.7 -179.48 6.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.495 1.141 . . . . 0.0 113.816 -167.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.1 t -145.2 137.17 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.73 2.012 . . . . 0.0 109.576 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.26 149.42 48.26 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.315 1.446 . . . . 0.0 112.249 -172.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.88 143.46 16.44 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.826 2.35 . . . . 0.0 109.805 160.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.84 22.94 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 120.838 -1.164 . . . . 0.0 113.557 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 118.59 -46.34 1.15 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 127.157 2.313 . . . . 0.0 115.887 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -83.53 -163.48 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.34 2.693 . . . . 0.0 111.812 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 151.9 63.49 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.11 1.364 . . . . 0.0 113.258 -173.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.28 -15.84 50.74 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.189 2.593 . . . . 0.0 113.215 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 p -56.67 -23.4 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.022 1.329 . . . . 0.0 113.186 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 9.76 64.9 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.463 2.459 . . . . 0.0 116.603 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -53.03 152.32 4.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.302 1.551 . . . . 0.0 114.246 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -136.94 154.44 50.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.883 2.073 . . . . 0.0 108.957 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -92.94 142.5 27.23 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.524 0.73 . . . . 0.0 110.498 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.5 p -121.0 143.2 49.17 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.744 1.618 . . . . 0.0 112.561 174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tp -138.35 165.3 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.21 -0.931 . . . . 0.0 112.755 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.89 126.41 18.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.063 1.345 . . . . 0.0 114.162 -165.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -77.62 46.52 0.55 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.173 1.789 . . . . 0.0 112.954 174.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.18 -47.28 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.465 1.506 . . . . 0.0 113.398 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -162.29 4.66 0.05 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.565 1.546 . . . . 0.0 114.058 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 50.0 mt -85.8 159.59 19.69 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.746 1.619 . . . . 0.0 110.382 -164.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -103.95 133.68 48.5 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.142 0.977 . . . . 0.0 112.989 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -157.1 138.94 14.26 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.36 -0.838 . . . . 0.0 111.773 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -138.31 153.32 72.83 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.891 1.277 . . . . 0.0 111.997 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.436 ' HA ' ' HA3' ' A' ' 36' ' ' GLY . 87.1 Cg_endo -75.16 170.6 20.02 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.972 2.448 . . . . 0.0 112.859 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.44 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 0.2 OUTLIER -91.74 -43.06 9.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.812 0.845 . . . . 0.0 111.73 -176.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 8.4 mmpt? -66.06 150.03 97.1 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.678 1.591 . . . . 0.0 114.767 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -66.37 177.65 3.09 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.484 2.79 . . . . 0.0 113.319 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 61.15 17.4 8.07 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.337 1.855 . . . . 0.0 114.242 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.93 1.27 1.65 Allowed 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.49 162.26 37.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.067 1.347 . . . . 0.0 111.586 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.2 tp -157.48 60.95 0.49 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.237 1.815 . . . . 0.0 108.406 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -72.98 -55.12 7.0 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.855 1.662 . . . . 0.0 114.172 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.66 162.74 25.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.016 1.28 . . . . 0.0 114.247 -176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -66.82 136.45 55.45 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.423 -0.798 . . . . 0.0 110.024 160.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -96.3 -150.57 0.33 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -156.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 56.23 33.29 21.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.308 1.843 . . . . 0.0 115.611 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -141.73 176.3 9.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.846 1.258 . . . . 0.0 110.213 168.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 125.192 1.397 . . . . 0.0 110.485 172.368 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.88 29.8 2.29 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.035 0.934 . . . . 0.0 112.902 -175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -142.62 162.44 35.46 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.383 1.473 . . . . 0.0 111.321 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -87.97 -26.93 22.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.487 0.715 . . . . 0.0 111.691 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -56.65 -41.23 76.82 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.506 1.522 . . . . 0.0 110.386 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 mmtm -68.27 -33.76 74.95 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.868 1.267 . . . . 0.0 113.708 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -75.66 -39.87 56.96 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.051 0.94 . . . . 0.0 112.115 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 pp -85.49 -21.06 28.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.2 1.0 . . . . 0.0 112.971 -177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.33 78.13 76.37 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.959 1.703 . . . . 0.0 109.17 169.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.9 -173.19 1.66 Allowed 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.247 3.298 . . . . 0.0 114.181 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -51.26 -49.49 61.08 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.58 1.952 . . . . 0.0 114.289 -171.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -58.0 -38.36 75.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.311 0.644 . . . . 0.0 112.054 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -72.23 -40.72 67.56 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.303 0.641 . . . . 0.0 112.017 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -45.8 87.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.893 1.277 . . . . 0.0 110.492 173.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.29 -39.1 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.574 0.749 . . . . 0.0 112.481 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 p -84.15 -22.62 30.96 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 119.696 1.135 . . . . 0.0 113.625 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -67.43 -40.5 85.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.069 2.148 . . . . 0.0 110.074 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -94.71 -54.66 3.41 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.874 0.734 . . . . 0.0 111.357 173.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.9 tptp 42.58 6.75 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 121.795 3.998 . . . . 0.0 121.795 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.01 -17.83 0.88 Allowed Glycine 0 C--N 1.305 -1.192 0 C-N-CA 127.688 2.566 . . . . 0.0 114.193 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 t -147.88 169.54 19.61 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.383 1.873 . . . . 0.0 110.567 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -112.92 173.18 6.51 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.431 148.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.09 150.97 66.83 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 124.397 1.079 . . . . 0.0 110.766 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.15 96.37 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.355 2.037 . . . . 0.0 111.721 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -76.62 15.17 0.67 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 -173.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 178.13 -24.34 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 128.546 2.738 . . . . 0.0 112.741 -172.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' H ' HD12 ' A' ' 30' ' ' LEU . . . 57.67 -98.91 0.09 OUTLIER Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.82 1.2 . . . . 0.0 114.527 171.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 29.6 mtm -57.47 -17.68 14.63 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 169.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.62 7.35 45.29 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.663 1.585 . . . . 0.0 113.864 172.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 27' ' ' GLY . 10.0 mt -116.18 -4.24 11.95 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.87 -9.91 58.99 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -171.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -4.42 32.76 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -162.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.59 117.29 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 129.419 3.088 . . . . 0.0 115.993 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -76.19 165.52 24.79 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 169.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.7 m -144.01 158.07 43.94 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.68 2.792 . . . . 0.0 108.629 168.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.92 -144.45 10.73 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.088 1.328 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ptm -132.74 162.75 30.62 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 112.517 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -127.96 139.76 52.39 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 128.962 2.905 . . . . 0.0 109.54 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.41 168.05 23.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 126.564 1.945 . . . . 0.0 109.423 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.91 173.93 1.66 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 123.28 1.514 . . . . 0.0 112.578 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 p -122.98 -6.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 114.03 -1.441 . . . . 0.0 112.444 151.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.2 m -108.93 -27.73 9.52 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -168.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.8 p -109.28 -95.25 0.4 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.753 1.621 . . . . 0.0 112.017 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -157.37 -55.43 0.08 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.8 154.5 50.27 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 116.191 1.922 . . . . 0.0 116.191 -154.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.37 143.86 71.69 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.169 1.913 . . . . 0.0 110.889 161.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -115.85 -51.93 2.64 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.374 1.07 . . . . 0.0 111.888 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -145.66 158.69 43.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.826 0.822 . . . . 0.0 112.033 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 p -85.63 135.05 33.95 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.441 1.096 . . . . 0.0 108.813 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -6.79 12.52 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.233 -0.917 . . . . 0.0 112.871 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -44.33 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 160.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -67.01 -10.5 50.43 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.862 1.665 . . . . 0.0 113.132 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -78.55 127.71 32.53 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.655 1.982 . . . . 0.0 110.969 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -109.89 117.68 34.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.052 2.141 . . . . 0.0 105.976 170.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 10.3 t -171.08 152.42 3.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 111.736 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.6 p -150.77 28.33 0.7 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.535 1.534 . . . . 0.0 111.957 161.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.86 -65.21 2.94 Favored Glycine 0 CA--C 1.532 1.107 0 O-C-N 120.637 -1.289 . . . . 0.0 111.176 -163.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.05 -32.12 61.46 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.375 1.07 . . . . 0.0 112.235 170.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -19.6 59.2 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 117.941 -1.477 . . . . 0.0 114.254 165.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.3 t90 58.93 134.77 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.352 0 N-CA-C 118.079 2.622 . . . . 0.0 118.079 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.71 107.1 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.874 2.383 . . . . 0.0 114.479 -163.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.9 p -140.95 158.12 44.38 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.215 1.806 . . . . 0.0 110.881 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.23 114.62 6.3 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.141 0.976 . . . . 0.0 108.976 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -73.07 -20.84 60.88 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.387 -0.821 . . . . 0.0 112.925 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -145.06 148.54 33.8 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.137 -0.977 . . . . 0.0 112.441 -174.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.34 85.19 2.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.992 1.317 . . . . 0.0 109.45 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -135.11 113.99 11.94 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.318 1.047 . . . . 0.0 110.67 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 167.91 -37.44 0.22 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.005 1.764 . . . . 0.0 111.431 -170.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -69.85 148.5 48.98 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 142.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.91 145.13 6.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.143 2.177 . . . . 0.0 113.108 158.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.29 -92.83 1.01 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.976 1.75 . . . . 0.0 111.332 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -45.68 -39.09 7.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.724 2.01 . . . . 0.0 115.243 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.37 -31.19 65.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.745 2.018 . . . . 0.0 115.367 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -100.48 20.46 14.91 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 127.114 2.166 . . . . 0.0 111.353 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -77.53 -34.63 53.87 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 113.76 -1.564 . . . . 0.0 108.302 152.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -137.47 -66.29 0.51 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -171.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.1 p -164.42 -44.3 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 128.715 2.806 . . . . 0.0 111.47 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.95 -14.89 24.21 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 126.566 2.031 . . . . 0.0 113.968 -167.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.97 178.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 127.124 2.17 . . . . 0.0 110.455 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.51 175.2 8.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.857 2.063 . . . . 0.0 107.948 159.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.495 HH11 HD13 ' A' ' 83' ' ' LEU . 1.9 ppt_? -147.03 140.67 25.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -126.46 93.18 3.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.226 1.488 . . . . 0.0 112.108 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD13 HH11 ' A' ' 81' ' ' ARG . 6.5 mp -62.97 144.03 57.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.29 -0.881 . . . . 0.0 108.7 155.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -146.24 52.27 1.14 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.294 1.521 . . . . 0.0 112.363 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -73.3 30.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.244 1.818 . . . . 0.0 114.529 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -109.8 0.31 18.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.333 1.453 . . . . 0.0 113.615 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.1 mt -80.16 6.66 11.11 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.267 1.027 . . . . 0.0 112.394 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -6.63 52.3 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.433 1.492 . . . . 0.0 113.941 -163.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.4 t -130.39 131.58 23.47 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.301 1.84 . . . . 0.0 110.09 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.39 131.43 15.05 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.088 2.525 . . . . 0.0 113.115 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -133.02 157.65 44.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.448 1.899 . . . . 0.0 109.788 166.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.2 mtm -131.61 136.02 47.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.777 2.031 . . . . 0.0 108.526 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.17 153.15 52.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 124.732 1.213 . . . . 0.0 110.828 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.0 m -120.25 144.44 28.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.346 1.058 . . . . 0.0 112.209 162.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 102' ' ' HIS . 2.8 m -111.82 146.43 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.825 1.25 . . . . 0.0 110.979 173.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.79 112.17 10.73 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 124.039 1.876 . . . . 0.0 107.198 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -63.37 -24.56 67.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 112.422 -2.172 . . . . 0.0 112.04 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -80.16 -45.21 18.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.203 1.401 . . . . 0.0 114.419 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.2 p -113.53 -3.74 13.63 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.898 1.679 . . . . 0.0 115.195 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 71.31 46.29 0.44 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.677 1.991 . . . . 0.0 115.53 167.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.93 144.46 37.11 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.406 ' HB3' HG12 ' A' ' 95' ' ' VAL . 13.9 p-80 -75.7 118.72 18.83 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.712 1.205 . . . . 0.0 110.416 170.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -132.61 -29.01 1.57 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 -168.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.93 127.57 6.55 Favored Glycine 0 C--N 1.319 -0.416 0 C-N-CA 127.289 2.376 . . . . 0.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.97 146.34 35.51 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 122.025 -0.691 . . . . 0.0 111.083 -172.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.98 142.07 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.526 1.531 . . . . 0.0 111.141 -169.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -145.47 156.66 53.18 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -83.3 147.79 12.86 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.974 3.116 . . . . 0.0 112.804 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -97.82 -1.05 44.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.8 -55.15 0.77 Allowed Glycine 0 CA--C 1.544 1.851 0 C-N-CA 125.953 1.739 . . . . 0.0 116.103 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 -156.98 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.314 0 C-N-CA 125.202 3.935 . . . . 0.0 113.54 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -51.93 159.57 1.37 Allowed Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.76 1.624 . . . . 0.0 112.097 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -59.34 -8.91 7.46 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.429 2.752 . . . . 0.0 114.665 174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.7 p -55.26 -34.06 63.72 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.339 1.456 . . . . 0.0 112.914 165.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -84.97 3.98 86.22 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -57.3 138.21 55.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.703 1.252 . . . . 0.0 113.764 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -115.25 128.67 56.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.103 1.761 . . . . 0.0 108.893 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -111.17 109.9 20.16 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.729 1.211 . . . . 0.0 109.334 -169.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.5 m -95.7 148.61 22.37 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.183 2.193 . . . . 0.0 111.288 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -134.0 144.9 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.137 0.975 . . . . 0.0 109.882 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.25 107.31 9.89 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.306 1.051 . . . . 0.0 113.219 176.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.9 m -79.22 38.04 0.34 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.51 -27.88 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 O-C-N 121.05 -1.031 . . . . 0.0 112.096 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 15.86 7.84 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.032 2.133 . . . . 0.0 113.351 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.463 1.505 . . . . 0.0 111.945 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -112.26 160.71 17.37 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.43 1.492 . . . . 0.0 111.573 172.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -134.59 149.67 50.63 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.47 -0.769 . . . . 0.0 112.375 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -136.61 133.97 19.33 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.458 1.503 . . . . 0.0 108.938 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.77 170.28 14.26 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.883 2.389 . . . . 0.0 113.404 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -39.59 54.33 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.045 0.926 . . . . 0.0 112.42 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -73.88 144.66 82.94 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.093 1.357 . . . . 0.0 113.152 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.26 175.68 6.48 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.646 2.897 . . . . 0.0 113.896 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 67.84 -10.88 0.37 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.277 3.031 . . . . 0.0 114.414 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -98.75 -7.68 27.25 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.628 2.371 . . . . 0.0 113.094 170.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -119.41 143.14 47.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.874 1.67 . . . . 0.0 107.51 156.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -155.17 42.04 0.44 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.748 1.261 . . . . 0.0 111.048 -166.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -78.28 29.18 0.18 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.703 2.001 . . . . 0.0 113.312 -176.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.69 139.94 24.89 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.84 1.656 . . . . 0.0 113.522 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -128.08 34.49 4.58 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.941 -1.099 . . . . 0.0 113.523 -169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -133.5 -31.66 1.2 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.411 ' CG ' ' H ' ' A' ' 142' ' ' HIS . 13.5 t-80 50.81 -164.5 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.248 1.819 . . . . 0.0 114.266 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.411 ' H ' ' CG ' ' A' ' 141' ' ' HIS . 90.8 m-70 -99.97 150.99 21.85 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.426 1.49 . . . . 0.0 109.592 159.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.3 t60 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 124.421 1.088 . . . . 0.0 111.435 -168.245 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ppp? . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.96 -68.68 0.42 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.164 1.385 . . . . 0.0 110.88 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.27 177.76 9.92 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.291 1.436 . . . . 0.0 111.604 161.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -106.51 -35.33 7.11 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 161.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -60.44 -59.88 4.7 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 124.791 1.236 . . . . 0.0 111.001 -166.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -66.65 -31.51 72.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.845 1.258 . . . . 0.0 112.763 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -69.15 -35.89 76.84 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.587 0.755 . . . . 0.0 112.545 175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.88 -26.15 34.41 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.5 p -121.88 64.99 18.73 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.272 1.429 . . . . 0.0 113.448 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.9 -168.41 0.62 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.541 2.161 . . . . 0.0 115.163 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -50.46 -47.84 56.83 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.35 1.86 . . . . 0.0 114.338 -168.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -61.38 -28.34 69.17 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -78.83 -35.16 44.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.149 0.98 . . . . 0.0 112.221 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -62.73 -55.03 30.33 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.699 0.761 . . . . 0.0 111.257 171.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.4 t -62.58 -38.5 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.684 0.794 . . . . 0.0 110.953 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 p -70.11 -26.04 63.78 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.297 -0.877 . . . . 0.0 113.122 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -39.92 75.96 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.318 1.047 . . . . 0.0 110.848 174.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -72.03 -30.84 65.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.499 0.32 . . . . 0.0 111.417 170.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.38 33.49 0.09 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.819 2.047 . . . . 0.0 113.783 166.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.88 24.39 0.72 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 128.408 2.909 . . . . 0.0 113.087 -172.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 t -106.97 110.71 22.93 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.944 1.697 . . . . 0.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -146.66 -164.86 2.08 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 128.933 2.893 . . . . 0.0 108.349 174.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 69.98 157.3 0.16 Allowed Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 127.038 2.135 . . . . 0.0 116.1 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.59 127.98 5.9 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.783 2.322 . . . . 0.0 111.941 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -91.1 -96.11 0.12 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.214 1.006 . . . . 0.0 110.933 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.74 -28.63 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.941 2.896 . . . . 0.0 109.942 -163.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.39 -117.93 10.23 Favored Glycine 0 C--N 1.339 0.701 0 O-C-N 120.542 -1.349 . . . . 0.0 111.235 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.6 mtm -55.41 -30.91 61.31 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.25 0.62 . . . . 0.0 112.087 169.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -8.15 55.52 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.0 mt -68.06 -32.18 72.35 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.765 -1.209 . . . . 0.0 113.029 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -162.21 -58.53 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.814 0.733 . . . . 0.0 112.583 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.6 -35.48 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.765 2.826 . . . . 0.0 109.39 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.312 14.3 mmtm 66.74 129.4 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 130.073 3.349 . . . . 0.0 116.363 -173.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -124.81 171.42 10.15 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.299 2.24 . . . . 0.0 112.254 -166.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -126.82 154.35 44.44 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.81 1.244 . . . . 0.0 109.619 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.61 -154.26 16.01 Favored Glycine 0 N--CA 1.465 0.627 0 C-N-CA 124.464 1.03 . . . . 0.0 113.814 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptp -156.05 163.59 39.49 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.036 1.334 . . . . 0.0 112.302 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.75 144.21 41.41 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 127.914 2.486 . . . . 0.0 111.014 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -141.81 161.68 37.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.004 1.721 . . . . 0.0 111.264 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 64.0 m -66.07 162.7 18.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 123.354 1.549 . . . . 0.0 113.235 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.29 1.44 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.963 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.7 m -129.4 -39.09 1.52 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -167.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.5 p -94.67 -85.34 0.31 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.587 1.085 . . . . 0.0 112.549 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.98 -74.51 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.1 p -110.46 155.65 41.69 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -151.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.95 138.39 33.96 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.294 1.996 . . . . 0.0 111.771 165.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.0 mt -135.35 -11.53 2.15 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -130.98 120.29 23.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.425 1.011 . . . . 0.0 111.534 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -92.8 131.6 37.7 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.812 1.768 . . . . 0.0 112.054 176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -67.67 -7.53 27.54 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.005 -1.452 . . . . 0.0 112.742 170.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -57.35 -28.95 63.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 113.976 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 5.48 51.64 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 171.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -78.22 136.44 37.79 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.691 0.678 . . . . 0.0 109.439 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -75.69 57.26 0.98 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.611 0.764 . . . . 0.0 112.686 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 72.2 m -58.8 -35.53 72.98 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.917 1.687 . . . . 0.0 112.552 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 p -86.01 -5.38 59.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.921 2.488 . . . . 0.0 114.225 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.14 -124.99 2.22 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.831 1.205 . . . . 0.0 112.829 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 m -67.98 -19.39 64.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.629 1.572 . . . . 0.0 113.334 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.68 7.58 88.1 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.784 1.183 . . . . 0.0 113.347 -165.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 62.6 t90 -101.94 137.27 19.47 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.818 2.047 . . . . 0.0 110.811 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.54 111.31 2.99 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.329 2.019 . . . . 0.0 114.259 -160.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -159.33 148.61 18.39 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.532 1.933 . . . . 0.0 110.767 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -148.08 128.05 13.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.555 1.942 . . . . 0.0 109.59 -174.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.0 p -73.35 -20.29 60.81 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -126.61 143.88 51.08 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.986 1.85 . . . . 0.0 113.897 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.31 111.8 8.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 110.969 -2.832 . . . . 0.0 107.469 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -62.82 28.61 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.563 2.745 . . . . 0.0 114.655 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -99.39 37.7 3.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.41 2.433 . . . . 0.0 113.518 -168.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.3 t -51.76 156.39 1.44 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 123.029 1.395 . . . . 0.0 112.821 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.43 135.27 55.07 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.85 2.46 . . . . 0.0 112.032 -162.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.09 -70.33 1.83 Allowed Glycine 0 N--CA 1.469 0.85 0 C-N-CA 126.144 1.83 . . . . 0.0 114.019 167.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 m -50.16 -33.61 19.62 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.999 2.52 . . . . 0.0 112.622 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -138.42 126.88 23.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 152.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -139.18 19.99 2.6 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.023 1.329 . . . . 0.0 112.773 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -119.61 -37.55 3.12 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 127.161 2.184 . . . . 0.0 112.256 -173.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -83.84 -28.34 28.09 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.349 1.46 . . . . 0.0 112.517 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.8 p -85.02 -56.04 3.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.978 166.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.41 22.01 55.34 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.291 0.948 . . . . 0.0 112.536 -167.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -98.47 163.41 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.841 0.829 . . . . 0.0 111.693 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.56 176.62 8.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.791 2.036 . . . . 0.0 112.502 -169.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.555 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -145.86 151.46 37.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.295 1.438 . . . . 0.0 112.875 -171.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.73 112.74 5.17 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.528 1.931 . . . . 0.0 108.82 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.04 131.6 37.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.963 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -98.82 17.42 19.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.015 1.326 . . . . 0.0 112.084 -168.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -70.33 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.891 2.876 . . . . 0.0 114.767 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -125.05 0.39 7.9 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.983 1.713 . . . . 0.0 113.766 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.9 mt -100.08 15.53 27.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 113.273 175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.29 -9.43 54.48 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.408 1.48 . . . . 0.0 114.328 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.6 t -118.81 121.45 30.62 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.441 1.496 . . . . 0.0 110.224 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.14 125.01 7.6 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.332 2.022 . . . . 0.0 111.804 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -144.62 159.85 42.12 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.722 2.009 . . . . 0.0 109.909 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.8 mtp -128.51 127.13 41.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.938 2.095 . . . . 0.0 107.975 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.56 151.98 51.47 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.161 0.984 . . . . 0.0 110.677 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 m -133.82 148.8 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.993 1.317 . . . . 0.0 110.84 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.25 156.16 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.27 0.628 . . . . 0.0 111.432 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.3 t -92.61 118.91 31.51 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -83.59 -14.87 51.09 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.861 171.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -70.01 -51.01 35.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.064 0.945 . . . . 0.0 112.811 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.6 p -107.4 -7.75 16.53 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.833 1.653 . . . . 0.0 115.033 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 61.26 56.29 2.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.109 2.164 . . . . 0.0 114.039 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.79 146.13 43.2 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.693 1.197 . . . . 0.0 111.796 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.06 126.61 30.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.19 -0.944 . . . . 0.0 111.18 172.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 80.9 mt -88.38 6.66 36.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.487 1.915 . . . . 0.0 113.216 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.8 -168.77 13.04 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 127.22 2.343 . . . . 0.0 112.584 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.23 163.85 36.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 123.012 1.386 . . . . 0.0 113.577 -165.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.2 t -140.64 135.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.28 1.832 . . . . 0.0 110.031 -165.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -148.13 154.17 42.4 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.021 1.329 . . . . 0.0 113.53 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.22 129.79 6.93 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.402 2.734 . . . . 0.0 109.763 163.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -82.31 -3.0 54.5 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -174.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.06 -54.64 0.38 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.238 1.399 . . . . 0.0 114.797 -171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.88 -165.02 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.469 2.779 . . . . 0.0 112.736 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.11 157.75 2.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.322 1.449 . . . . 0.0 111.862 173.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -57.44 -17.82 28.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.946 2.431 . . . . 0.0 113.479 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.39 -23.24 36.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.599 1.56 . . . . 0.0 113.269 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.69 17.89 51.8 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 127.773 2.606 . . . . 0.0 115.427 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.02 140.1 56.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.413 1.107 . . . . 0.0 112.584 172.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -124.76 146.91 48.96 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.198 1.799 . . . . 0.0 110.318 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.48 129.58 42.6 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.269 1.427 . . . . 0.0 109.148 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.9 p -120.78 144.39 48.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.014 1.326 . . . . 0.0 111.055 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.2 tp -123.42 155.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.108 0.963 . . . . 0.0 111.091 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -126.8 134.16 50.64 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.989 1.716 . . . . 0.0 107.448 161.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.4 m -81.7 50.67 1.55 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -163.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -50.99 -59.89 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.902 2.481 . . . . 0.0 115.236 -164.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.13 27.1 0.78 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.727 1.211 . . . . 0.0 114.024 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 49.3 mt -117.19 157.01 26.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.823 1.249 . . . . 0.0 110.358 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 166.42 10.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.825 1.65 . . . . 0.0 112.19 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -144.63 153.21 41.53 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.557 1.143 . . . . 0.0 112.203 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -139.66 151.97 67.42 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.442 1.897 . . . . 0.0 109.946 175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.13 170.69 19.84 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.62 2.213 . . . . 0.0 112.921 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.55 -45.73 8.75 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.877 0.871 . . . . 0.0 111.95 -170.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.7 mmmt -78.79 158.52 75.36 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.23 2.212 . . . . 0.0 112.371 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.67 -177.55 1.9 Allowed 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.809 2.339 . . . . 0.0 112.447 161.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.2 22.92 13.49 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.796 1.638 . . . . 0.0 114.414 169.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.31 -13.55 58.29 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.772 1.629 . . . . 0.0 114.005 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 71.66 146.08 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.546 2.738 . . . . 0.0 114.7 -170.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . 0.276 1.1 pt? -94.42 12.7 26.24 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -63.28 -26.82 68.95 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 127.896 2.478 . . . . 0.0 111.99 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -62.87 -14.66 48.93 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -75.54 -13.01 60.34 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.509 1.524 . . . . 0.0 114.496 171.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -67.19 174.52 3.14 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.984 1.714 . . . . 0.0 113.685 -172.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -70.47 64.19 0.27 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.701 2.4 . . . . 0.0 111.647 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -136.03 55.51 1.86 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 128.554 2.741 . . . . 0.0 106.837 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 3.7 m80 . . . . . 0 C--O 1.253 1.284 0 C-N-CA 126.464 1.906 . . . . 0.0 111.873 -163.24 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.406 0.146 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.87 -25.29 67.83 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.367 -0.833 . . . . 0.0 111.895 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -138.57 173.52 11.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.818 2.047 . . . . 0.0 110.516 159.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 15.3 m95 -94.15 -31.98 13.92 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.02 1.328 . . . . 0.0 111.63 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -57.13 -46.23 82.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.111 0.964 . . . . 0.0 111.001 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -60.28 -30.31 69.38 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.312 1.045 . . . . 0.0 113.332 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -90.8 -31.73 16.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.441 1.896 . . . . 0.0 113.243 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.54 -39.24 81.2 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.282 1.833 . . . . 0.0 111.395 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 p -122.74 74.2 45.13 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.396 1.478 . . . . 0.0 111.27 177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.94 147.24 89.08 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.41 2.074 . . . . 0.0 113.579 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -82.01 -50.05 9.54 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -159.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -60.5 -33.53 72.75 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.359 171.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -65.93 -51.18 60.87 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 122.725 0.41 . . . . 0.0 110.483 172.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -61.03 -40.39 93.41 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.218 0.532 . . . . 0.0 111.402 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.93 -49.93 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.125 0.97 . . . . 0.0 112.704 171.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.4 p -77.92 -13.01 60.03 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.789 1.636 . . . . 0.0 115.259 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.7 tpt85 -77.81 -8.31 57.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.912 2.885 . . . . 0.0 110.776 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -134.71 -56.21 0.83 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.379 0.609 . . . . 0.0 112.314 161.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.94 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 118.141 2.645 . . . . 0.0 118.141 -165.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.67 15.02 1.4 Allowed Glycine 0 CA--C 1.537 1.452 0 C-N-CA 126.979 2.228 . . . . 0.0 115.611 -171.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -83.63 79.35 9.48 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 123.109 1.433 . . . . 0.0 113.973 -165.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -76.84 136.76 38.93 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.266 -1.521 . . . . 0.0 109.378 167.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.42 144.91 29.77 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.089 0.955 . . . . 0.0 112.26 -173.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -91.09 -174.61 0.67 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 121.971 1.781 . . . . 0.0 115.502 -158.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -45.46 4.79 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 1 C-N-CA 134.611 5.165 . . . . 0.0 119.145 175.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 74.4 m -137.97 17.71 2.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 118.875 2.917 . . . . 0.0 118.875 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -132.17 -66.57 0.09 OUTLIER Glycine 0 N--CA 1.469 0.862 0 O-C-N 120.916 -1.115 . . . . 0.0 112.604 166.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.4 mtp -69.52 -9.19 52.82 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -19.49 25.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 170.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.78 51.83 0.97 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.495 1.043 . . . . 0.0 111.23 -164.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -130.25 147.33 51.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 117.655 2.465 . . . . 0.0 117.655 -160.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -103.62 -136.56 0.34 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.735 2.014 . . . . 0.0 109.267 162.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -150.05 115.65 5.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.952 1.701 . . . . 0.0 111.055 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.89 179.96 1.01 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.763 1.268 . . . . 0.0 112.016 161.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.428 ' HB ' ' HE3' ' A' ' 131' ' ' LYS . 1.6 m -137.59 151.04 47.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.385 1.874 . . . . 0.0 108.535 177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.91 -167.3 39.99 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 118.863 0.756 . . . . 0.0 113.119 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.7 ptp -156.2 159.44 38.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.323 1.059 . . . . 0.0 113.256 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -124.89 144.47 50.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.134 2.573 . . . . 0.0 111.044 -170.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.53 155.7 37.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.655 1.982 . . . . 0.0 109.184 -168.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.79 167.65 21.2 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 123.808 1.766 . . . . 0.0 113.486 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -137.56 5.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 112.66 -2.064 . . . . 0.0 112.102 166.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 99' ' ' CYS . 91.3 m -119.56 -31.37 4.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.782 1.633 . . . . 0.0 112.219 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.3 p -100.65 -103.24 0.24 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.509 1.523 . . . . 0.0 108.534 158.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.88 -31.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 p -81.64 155.71 70.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -161.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.45 136.97 45.11 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.166 1.911 . . . . 0.0 110.237 156.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -134.5 -39.13 0.82 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -157.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -157.47 152.6 25.89 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.444 1.02 . . . . 0.0 111.823 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -97.27 142.98 28.5 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.559 -1.338 . . . . 0.0 112.151 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 t -66.89 -10.32 47.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.55 -42.36 64.35 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.937 1.695 . . . . 0.0 114.093 165.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.04 -1.36 28.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.289 1.435 . . . . 0.0 113.155 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -76.58 141.91 40.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.431 0.634 . . . . 0.0 111.334 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -82.47 129.23 34.86 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.782 1.233 . . . . 0.0 112.111 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.1 m 47.06 -145.73 0.24 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.853 2.061 . . . . 0.0 113.649 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.9 p -72.07 -34.67 68.9 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.454 -1.404 . . . . 0.0 113.059 169.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 56.33 40.93 86.52 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-O 119.125 -0.819 . . . . 0.0 113.41 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.4 m -54.57 -38.28 66.49 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.189 1.796 . . . . 0.0 115.192 -164.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.28 -5.46 14.71 Favored Glycine 0 N--CA 1.474 1.233 0 C-N-CA 124.124 0.868 . . . . 0.0 113.03 163.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 119' ' ' CYS . 0.6 OUTLIER -134.91 73.95 65.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.885 -0.773 . . . . 0.0 112.239 -155.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -65.92 131.8 28.36 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.366 2.044 . . . . 0.0 110.766 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 p -153.07 139.23 18.34 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.217 1.407 . . . . 0.0 109.874 -165.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -155.11 114.13 3.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.852 0.861 . . . . 0.0 110.524 -154.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 p -75.79 -19.97 58.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -146.83 156.99 43.54 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.411 1.084 . . . . 0.0 111.269 173.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.55 39.14 1.0 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.073 1.349 . . . . 0.0 111.711 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -75.96 104.24 6.4 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.626 -1.296 . . . . 0.0 110.389 -174.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.34 -11.81 0.08 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.587 -1.118 . . . . 0.0 114.963 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.4 p -74.14 149.01 41.22 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.062 1.345 . . . . 0.0 112.04 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 128.38 18.9 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.714 1.206 . . . . 0.0 113.804 -158.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.91 -70.98 0.57 Allowed Glycine 0 N--CA 1.472 1.098 0 C-N-CA 128.42 2.914 . . . . 0.0 114.682 158.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 m -74.53 -31.99 62.33 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.454 1.502 . . . . 0.0 110.62 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.07 25.67 11.32 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 124.181 1.943 . . . . 0.0 110.576 -168.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -144.69 -1.67 0.88 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.34 3.056 . . . . 0.0 109.631 -168.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -68.43 -37.25 80.1 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.796 0.807 . . . . 0.0 109.825 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -143.47 -46.55 0.29 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.919 0.888 . . . . 0.0 113.337 166.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.2 p -161.92 -41.35 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.415 1.486 . . . . 0.0 113.776 -172.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.76 -22.65 0.87 Allowed Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.528 1.061 . . . . 0.0 113.613 -161.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 pt -118.63 173.79 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.812 2.045 . . . . 0.0 112.404 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -124.66 -179.79 4.65 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.191 2.197 . . . . 0.0 110.083 -178.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.619 ' H ' HD23 ' A' ' 80' ' ' LEU . 24.6 mmt85 -141.25 146.09 36.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.841 1.656 . . . . 0.0 109.832 -170.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -144.03 102.35 3.87 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.283 1.433 . . . . 0.0 111.496 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.42 149.87 35.09 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.018 -1.051 . . . . 0.0 111.233 165.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -134.38 29.63 3.61 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.8 1.286 . . . . 0.0 112.598 -170.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -73.63 35.52 0.09 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.535 1.934 . . . . 0.0 113.939 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.85 2.57 4.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.552 1.941 . . . . 0.0 112.797 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -86.3 15.08 5.62 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.394 1.878 . . . . 0.0 112.78 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.11 -3.53 65.51 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.8 1.191 . . . . 0.0 114.388 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 t -140.72 141.28 24.27 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 127.908 2.483 . . . . 0.0 110.164 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.67 129.33 16.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.809 2.339 . . . . 0.0 112.691 170.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -139.45 159.32 42.44 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.159 2.584 . . . . 0.0 108.515 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.9 ttm -143.35 134.68 26.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.575 1.55 . . . . 0.0 110.232 -175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -139.23 166.57 24.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.57 138.33 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.931 1.692 . . . . 0.0 110.659 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.66 145.9 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 44.0 t -77.87 103.32 7.73 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.257 1.423 . . . . 0.0 107.551 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -57.4 -18.46 17.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.159 1.783 . . . . 0.0 112.562 167.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.82 -37.41 13.64 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.708 1.603 . . . . 0.0 113.316 -167.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 42' ' ' CYS . 12.3 p -121.15 1.88 10.33 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 126.645 1.978 . . . . 0.0 114.524 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.274 4.5 tt0 59.98 57.82 2.93 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.526 2.33 . . . . 0.0 113.294 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.4 129.67 35.69 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.747 1.219 . . . . 0.0 113.621 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.03 116.63 16.93 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.154 -0.966 . . . . 0.0 110.371 164.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.7 mt -120.56 -36.44 3.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -169.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -135.39 146.31 18.33 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 128.24 2.829 . . . . 0.0 111.846 -166.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.69 158.64 38.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.377 0.671 . . . . 0.0 111.809 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.27 139.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.701 1.238 . . . . 0.0 111.45 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -146.99 150.29 38.28 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.39 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.59 133.85 19.48 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.321 2.681 . . . . 0.0 110.905 169.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.67 7.64 29.09 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.17 -49.94 0.55 Allowed Glycine 0 CA--C 1.541 1.657 0 C-N-CA 126.012 1.767 . . . . 0.0 114.777 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.09 -154.97 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.55 3.5 . . . . 0.0 112.108 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.29 157.83 3.04 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 126.493 1.917 . . . . 0.0 112.325 170.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -62.8 -8.86 14.51 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.378 2.719 . . . . 0.0 114.093 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.0 p -63.74 -24.14 67.65 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.813 -1.179 . . . . 0.0 112.261 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.22 20.49 33.29 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 127.844 2.64 . . . . 0.0 115.91 169.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -63.53 135.3 56.75 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.041 -1.27 . . . . 0.0 112.238 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -112.11 138.94 48.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 127.117 2.167 . . . . 0.0 108.503 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -107.03 128.31 54.25 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.468 1.107 . . . . 0.0 109.058 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.483 ' HB3' ' CH2' ' A' ' 60' ' ' TRP . 31.7 p -121.76 149.1 43.78 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.617 1.567 . . . . 0.0 110.063 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.6 tt -131.65 164.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 120.546 -1.346 . . . . 0.0 109.76 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.1 124.54 24.87 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.21 -0.931 . . . . 0.0 112.528 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.1 m -79.91 36.44 0.34 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.974 1.309 . . . . 0.0 114.038 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.03 -37.91 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.168 1.787 . . . . 0.0 113.586 -169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -164.15 60.02 0.15 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.061 1.344 . . . . 0.0 113.125 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -142.27 171.68 13.72 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.761 1.625 . . . . 0.0 113.444 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.7 mmpt? -120.83 156.39 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.363 1.865 . . . . 0.0 114.609 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.12 150.99 22.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.452 1.501 . . . . 0.0 111.747 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.1 146.86 56.32 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.738 2.015 . . . . 0.0 111.551 160.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.72 169.67 19.58 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.265 1.976 . . . . 0.0 111.264 165.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.59 -38.53 7.08 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 111.904 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.428 ' HE3' ' HB ' ' A' ' 35' ' ' THR . 10.4 mmpt? -45.93 148.25 1.47 Allowed Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.193 1.797 . . . . 0.0 112.442 161.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.15 172.55 7.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.441 2.094 . . . . 0.0 113.495 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 56.56 55.59 6.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.356 1.462 . . . . 0.0 110.826 -172.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.82 -32.74 72.66 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.693 0.797 . . . . 0.0 111.724 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 62.58 159.57 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.525 1.93 . . . . 0.0 113.816 -172.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.3 tt 55.64 38.76 30.58 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 123.015 1.388 . . . . 0.0 109.87 -159.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -69.08 -58.63 3.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.703 2.001 . . . . 0.0 112.114 -162.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -152.98 166.3 32.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.654 1.982 . . . . 0.0 110.242 165.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -80.12 172.34 13.89 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.339 1.056 . . . . 0.0 113.208 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -55.47 140.19 41.14 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.964 -1.085 . . . . 0.0 111.449 171.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.73 159.46 41.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.494 0.717 . . . . 0.0 111.942 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -65.34 133.41 51.32 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.792 0.837 . . . . 0.0 111.386 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 . . . . . 0 C--O 1.255 1.349 0 C-N-CA 124.811 1.244 . . . . 0.0 109.71 177.706 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.25 46.89 0.16 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.678 1.191 . . . . 0.0 113.312 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -141.51 156.79 45.71 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.365 -1.459 . . . . 0.0 113.523 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.6 m95 -83.9 -31.92 25.43 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.045 0.938 . . . . 0.0 112.594 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -62.83 -38.91 92.64 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 123.662 0.785 . . . . 0.0 110.644 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -29.13 56.44 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.29 1.036 . . . . 0.0 113.504 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -80.61 -45.89 16.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.33 1.452 . . . . 0.0 111.464 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.61 -46.77 71.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.942 0.897 . . . . 0.0 111.982 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.27 78.73 35.13 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.932 2.493 . . . . 0.0 110.018 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.07 177.19 4.59 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.376 2.717 . . . . 0.0 113.82 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -52.6 -45.12 66.41 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 119.98 -1.7 . . . . 0.0 114.035 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -65.47 -20.01 66.18 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -84.09 -39.2 19.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.963 1.305 . . . . 0.0 111.474 166.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -64.17 -40.86 97.01 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.891 -1.756 . . . . 0.0 111.562 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.485 ' CG1' HG11 ' A' ' 123' ' ' VAL . 77.2 t -72.5 -0.17 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.98 2.512 . . . . 0.0 113.175 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 p -109.07 -34.69 6.53 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.561 -1.337 . . . . 0.0 112.94 161.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.53 -46.57 53.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.436 1.095 . . . . 0.0 111.912 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.42 -31.65 70.59 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.268 0.627 . . . . 0.0 111.037 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -89.2 30.12 1.0 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.698 1.199 . . . . 0.0 113.336 -172.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.59 23.46 0.16 Allowed Glycine 0 CA--C 1.53 1.006 0 N-CA-C 115.917 1.127 . . . . 0.0 115.917 -169.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -133.05 135.19 45.22 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.622 1.569 . . . . 0.0 110.833 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -115.99 138.99 50.7 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.823 1.649 . . . . 0.0 112.425 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.01 149.71 17.07 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 125.577 1.551 . . . . 0.0 113.398 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.88 136.68 3.1 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.25 3.3 . . . . 0.0 113.679 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -147.37 -82.25 0.13 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.15 -34.26 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 129.179 2.992 . . . . 0.0 108.957 -157.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.0 -102.64 0.6 Allowed Glycine 0 C--N 1.339 0.7 0 O-C-N 120.475 -1.391 . . . . 0.0 113.442 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.7 mtp -53.16 -37.24 61.69 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.634 -0.333 . . . . 0.0 111.504 167.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -80.08 2.04 25.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.734 1.213 . . . . 0.0 113.535 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.3 mt -77.1 -47.88 19.3 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.814 1.188 . . . . 0.0 111.473 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -169.53 0.43 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.0 t30 58.27 162.5 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -171.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -153.89 121.48 5.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.608 2.363 . . . . 0.0 108.28 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.38 171.15 2.02 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 119.39 3.107 . . . . 0.0 119.39 -166.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.4 m -73.84 164.81 26.15 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 127.59 2.356 . . . . 0.0 107.781 163.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.96 -142.35 10.25 Favored Glycine 0 N--CA 1.463 0.453 0 O-C-N 121.012 -1.055 . . . . 0.0 111.263 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.3 ptp -155.66 157.2 36.29 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.625 1.202 . . . . 0.0 113.746 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -112.8 130.05 56.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 128.15 2.58 . . . . 0.0 107.652 172.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -151.58 168.33 25.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.736 1.214 . . . . 0.0 112.376 -161.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 172.14 12.77 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 123.648 1.69 . . . . 0.0 114.379 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.67 0.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 112.063 -2.335 . . . . 0.0 112.409 157.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 97.7 m -112.62 -48.65 2.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.414 1.486 . . . . 0.0 112.345 -168.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.5 p -86.88 -80.63 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.742 1.217 . . . . 0.0 111.99 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.05 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.313 1.445 . . . . 0.0 114.645 163.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.1 p -101.68 159.01 30.67 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -158.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.68 155.56 49.39 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.961 3.107 . . . . 0.0 112.512 163.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.61 -31.15 0.57 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -172.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -132.04 122.23 25.14 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.889 -1.132 . . . . 0.0 108.717 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -82.9 136.46 34.58 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 120.388 -1.445 . . . . 0.0 109.241 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.4 t -58.54 -18.86 32.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.504 1.122 . . . . 0.0 112.76 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 3.5 tt0 -60.83 -42.03 96.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.897 1.279 . . . . 0.0 113.813 175.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.1 mmpt? -74.45 -4.16 34.96 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.817 0.847 . . . . 0.0 112.706 174.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -74.54 135.15 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.337 1.055 . . . . 0.0 109.504 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.68 119.77 13.62 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.957 -163.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.1 m 58.4 -66.67 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.616 2.367 . . . . 0.0 113.962 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.5 p -160.13 -9.29 0.05 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.877 2.071 . . . . 0.0 113.057 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.95 97.45 0.04 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.952 1.739 . . . . 0.0 113.9 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.02 -9.99 35.62 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.503 1.921 . . . . 0.0 115.171 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.59 -28.26 7.54 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.457 1.98 . . . . 0.0 110.496 -155.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.63 121.25 84.71 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 161.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -105.0 109.26 0.03 OUTLIER 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.458 2.106 . . . . 0.0 114.218 -173.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -138.5 152.79 48.57 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.042 1.737 . . . . 0.0 110.109 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -141.32 130.74 23.76 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.6 p -78.98 -12.66 60.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.32 150.72 50.04 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.799 1.285 . . . . 0.0 112.144 160.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.91 103.3 5.33 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.532 1.933 . . . . 0.0 107.415 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -53.86 85.31 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.558 1.943 . . . . 0.0 112.57 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.17 32.0 6.59 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.356 1.455 . . . . 0.0 114.281 -169.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.7 m -48.56 141.12 7.31 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.903 1.335 . . . . 0.0 114.126 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -131.65 148.66 52.61 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 130.184 3.393 . . . . 0.0 108.341 170.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.15 -87.4 0.68 Allowed Glycine 0 N--CA 1.466 0.656 0 C-N-CA 125.456 1.503 . . . . 0.0 112.781 168.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 m -46.63 -32.1 3.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.508 1.923 . . . . 0.0 113.897 172.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -147.45 126.45 12.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 160.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -132.61 -0.89 3.5 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 124.715 1.206 . . . . 0.0 111.606 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.4 t -97.01 -23.97 16.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.647 1.179 . . . . 0.0 111.543 -170.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -75.3 -33.93 61.24 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 p -109.77 -50.35 2.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.988 2.115 . . . . 0.0 111.15 -165.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.98 -17.29 0.14 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.88 1.705 . . . . 0.0 114.383 -164.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.1 pt -59.43 162.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -145.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 tt -121.63 158.59 28.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.735 171.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.75 153.37 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.856 1.262 . . . . 0.0 111.673 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.45 133.31 13.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.464 1.906 . . . . 0.0 108.937 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.73 156.12 39.26 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 125.784 1.634 . . . . 0.0 112.055 163.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -133.55 118.61 18.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 164.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 t -115.53 20.95 14.39 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 122.136 0.97 . . . . 0.0 111.922 166.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -84.79 -6.3 59.35 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.703 2.401 . . . . 0.0 113.324 -168.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -86.83 10.29 16.47 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.028 2.131 . . . . 0.0 112.733 164.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.79 -0.17 57.89 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 124.67 1.129 . . . . 0.0 114.732 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.2 t -141.46 128.72 11.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.674 1.59 . . . . 0.0 110.211 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.89 139.39 19.51 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.674 2.249 . . . . 0.0 113.569 -170.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -134.49 165.67 24.64 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 130.665 3.586 . . . . 0.0 109.928 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 13.2 mtm -132.62 133.95 44.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.192 2.197 . . . . 0.0 109.955 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -133.18 145.54 50.71 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.15 0.98 . . . . 0.0 112.955 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.56 146.17 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.42 1.888 . . . . 0.0 111.331 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.9 m -141.77 147.04 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.401 -0.812 . . . . 0.0 111.799 -169.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 48.2 t -74.51 97.9 3.22 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 123.69 1.709 . . . . 0.0 108.892 170.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.43 -24.2 2.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.576 1.951 . . . . 0.0 112.69 165.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -83.79 -41.11 17.93 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.862 1.665 . . . . 0.0 114.456 -172.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 24.7 p -126.97 1.08 6.58 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.258 13.1 mt-10 72.95 22.0 3.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.272 2.629 . . . . 0.0 115.068 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.0 94.53 9.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.338 1.055 . . . . 0.0 113.431 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.48 53.75 2.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.64 -7.24 38.15 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -160.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -120.01 130.27 8.33 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 126.662 2.077 . . . . 0.0 113.04 -167.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.82 153.36 36.64 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.904 -0.762 . . . . 0.0 110.802 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.97 128.82 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.795 0.838 . . . . 0.0 111.672 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -127.99 141.12 40.19 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.576 1.15 . . . . 0.0 112.502 -169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -73.21 162.57 40.24 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.62 2.88 . . . . 0.0 111.506 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -116.8 -0.84 12.18 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 134.71 -62.5 0.62 Allowed Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.825 1.678 . . . . 0.0 114.822 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -69.6 -162.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.549 1.262 1 C-N-CA 125.714 4.276 . . . . 0.0 114.099 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -56.43 163.07 2.73 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 126.171 1.788 . . . . 0.0 113.057 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -59.21 -11.58 13.5 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 0.0 114.436 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 p -58.78 -23.87 60.85 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.029 1.332 . . . . 0.0 113.892 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -94.6 -3.61 62.62 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.908 1.718 . . . . 0.0 116.262 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -59.37 145.34 43.85 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.713 1.257 . . . . 0.0 112.426 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 128.9 55.55 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.265 1.026 . . . . 0.0 109.327 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -99.09 110.49 23.07 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.812 1.245 . . . . 0.0 109.935 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.9 m -113.48 112.43 23.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.242 2.217 . . . . 0.0 108.685 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.7 tt -136.46 118.38 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.51 0.724 . . . . 0.0 112.544 -167.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -80.56 -9.27 59.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.9 m -16.73 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.358 2.663 . . . . 0.0 116.262 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.485 HG11 ' CG1' ' A' ' 15' ' ' VAL . 7.6 p -132.68 -33.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.954 2.102 . . . . 0.0 112.126 -173.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.18 2.46 5.87 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.665 1.586 . . . . 0.0 114.423 165.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.4 mt -119.54 -174.19 2.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.921 2.888 . . . . 0.0 110.628 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.91 163.66 12.78 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.575 -1.328 . . . . 0.0 114.524 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.47 155.87 42.31 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.852 1.261 . . . . 0.0 112.397 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -149.13 150.11 31.26 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 125.825 1.65 . . . . 0.0 111.78 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.84 173.54 13.44 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.141 2.56 . . . . 0.0 113.17 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.02 -40.22 6.58 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 153.19 94.78 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -172.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.05 176.38 2.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.333 2.689 . . . . 0.0 113.442 166.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 59.43 25.7 14.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.827 1.651 . . . . 0.0 114.316 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -104.51 7.28 35.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.251 2.221 . . . . 0.0 113.537 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.1 90.04 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.87 1.668 . . . . 0.0 112.95 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -143.34 37.0 1.36 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.034 2.134 . . . . 0.0 110.429 -170.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.66 -57.98 4.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.962 2.505 . . . . 0.0 111.269 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -162.96 -169.6 2.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.559 2.344 . . . . 0.0 108.085 153.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -140.06 162.56 34.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.499 1.12 . . . . 0.0 111.056 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -73.38 64.51 0.83 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.005 1.322 . . . . 0.0 112.24 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.91 162.56 29.39 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.891 1.676 . . . . 0.0 112.939 -176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 67.5 m80 64.37 155.14 0.06 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.171 2.188 . . . . 0.0 115.224 -176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 5.0 p80 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 126.072 1.749 . . . . 0.0 110.151 176.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.33 -37.86 0.1 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -145.13 175.72 10.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.42 1.088 . . . . 0.0 113.838 -166.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -108.09 -38.0 5.9 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.228 1.011 . . . . 0.0 112.547 159.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -63.52 -59.92 4.02 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.906 1.283 . . . . 0.0 111.437 -164.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -57.65 -31.4 66.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.032 1.333 . . . . 0.0 112.472 175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -73.07 -36.24 66.81 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.312 1.445 . . . . 0.0 111.831 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pp -92.93 -22.92 18.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 t -127.66 64.06 62.35 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.372 1.069 . . . . 0.0 113.768 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.83 153.77 72.29 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 124.162 3.241 . . . . 0.0 113.999 167.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -92.12 -66.82 0.9 Allowed 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.723 -0.61 . . . . 0.0 111.601 164.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -55.59 -32.71 63.31 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -77.23 -17.15 58.68 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.559 1.544 . . . . 0.0 114.439 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -99.37 -42.69 6.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.13 0.972 . . . . 0.0 112.472 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.85 -23.31 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.039 1.736 . . . . 0.0 111.829 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.19 -25.7 62.64 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.593 1.557 . . . . 0.0 112.909 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -79.8 -22.39 43.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.635 1.174 . . . . 0.0 113.014 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -130.2 -26.27 2.37 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? 30.46 75.98 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.749 2.42 . . . . 0.0 115.572 166.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.45 5.9 Favored Glycine 0 N--CA 1.472 1.039 0 CA-C-N 114.224 -1.353 . . . . 0.0 115.052 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -89.91 173.82 8.02 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 123.219 1.485 . . . . 0.0 111.96 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -115.64 162.1 17.73 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 127.264 2.226 . . . . 0.0 111.662 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 66.95 153.09 0.13 Allowed Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 128.591 2.756 . . . . 0.0 115.53 -170.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -94.79 127.93 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.858 3.039 . . . . 0.0 111.229 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -71.62 0.29 9.01 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 117.422 2.379 . . . . 0.0 117.422 -170.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.23 -23.68 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 128.118 2.567 . . . . 0.0 112.021 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.83 -104.88 0.64 Allowed Glycine 0 C--N 1.34 0.788 0 O-C-N 120.879 -1.138 . . . . 0.0 112.146 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.7 ttm -55.65 -23.9 30.67 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 171.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.74 6.62 47.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.1 mt -120.65 -25.63 5.47 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.825 2.45 . . . . 0.0 112.865 168.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -158.83 159.41 35.05 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -169.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.87 -157.84 0.63 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.937 1.695 . . . . 0.0 110.146 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -130.29 109.96 11.16 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.278 2.231 . . . . 0.0 108.118 172.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -116.49 168.52 10.09 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 126.896 2.079 . . . . 0.0 112.82 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -109.13 144.11 37.62 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.534 1.534 . . . . 0.0 107.692 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.31 -157.72 25.65 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ptp -146.07 161.87 39.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.914 1.286 . . . . 0.0 113.862 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 127' ' ' PHE . 46.6 m-85 -125.38 131.04 53.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.085 2.554 . . . . 0.0 109.838 171.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -137.2 173.67 11.43 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.497 1.519 . . . . 0.0 110.056 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.92 158.79 27.12 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 123.217 1.484 . . . . 0.0 113.308 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 p -115.96 -3.59 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 112.681 -2.054 . . . . 0.0 112.096 168.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.8 m -125.01 -22.01 4.55 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.404 1.482 . . . . 0.0 114.629 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.5 p -122.11 -88.57 0.62 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.403 1.481 . . . . 0.0 113.104 -177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -152.6 -46.59 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 -171.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -127.43 161.23 55.92 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -140.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.43 150.45 41.13 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.081 3.187 . . . . 0.0 113.34 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -137.36 -34.54 0.7 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -152.72 146.73 25.35 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.445 1.02 . . . . 0.0 112.474 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 67' ' ' TYR . 85.5 p -81.66 145.82 30.36 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.644 -1.285 . . . . 0.0 111.356 169.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t -61.4 -17.98 56.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -56.29 -34.83 66.85 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.897 1.679 . . . . 0.0 113.396 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -9.44 51.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.574 1.15 . . . . 0.0 112.216 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -70.58 108.17 4.22 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.187 0.903 . . . . 0.0 109.979 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -54.05 149.8 8.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.105 1.362 . . . . 0.0 114.577 -153.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 2.7 t -86.08 45.29 1.21 Allowed 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.925 -1.109 . . . . 0.0 112.494 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.1 p -79.09 160.78 26.92 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.784 -0.573 . . . . 0.0 111.809 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.32 4.04 5.28 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 171.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 p -112.37 -35.78 5.48 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.143 1.472 . . . . 0.0 113.335 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.08 8.06 64.03 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 123.857 0.741 . . . . 0.0 113.326 -165.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 74.2 t90 -63.39 137.83 97.19 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.138 0.975 . . . . 0.0 110.666 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.58 104.65 1.91 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.112 1.875 . . . . 0.0 114.382 -157.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.3 t -144.04 149.96 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.052 1.741 . . . . 0.0 110.628 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -133.97 108.74 8.56 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.293 1.837 . . . . 0.0 108.79 -162.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.3 p -67.1 -18.47 65.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.84 154.35 39.38 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.149 0.98 . . . . 0.0 110.988 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.93 74.27 10.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.734 0.813 . . . . 0.0 109.069 166.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.433 ' HB3' ' H ' ' A' ' 49' ' ' SER . 14.7 t80 -74.13 84.15 1.82 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.411 1.1 . . . . 0.0 112.234 -169.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.28 -21.6 0.07 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.943 2.211 . . . . 0.0 112.252 -167.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 t -108.37 142.77 38.21 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.597 1.198 . . . . 0.0 112.712 161.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 1.4 tptt -148.1 98.12 2.88 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.681 1.992 . . . . 0.0 113.611 -169.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.92 -66.21 0.47 Allowed Glycine 0 N--CA 1.473 1.113 0 C-N-CA 127.928 2.68 . . . . 0.0 115.633 159.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -27.83 26.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.646 1.578 . . . . 0.0 112.294 165.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.542 ' HB2' ' H ' ' A' ' 70' ' ' LYS . 31.9 m-20 -86.11 30.9 0.65 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.656 1.217 . . . . 0.0 113.818 -161.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -78.14 -15.44 58.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.174 1.789 . . . . 0.0 114.032 -161.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.83 -11.88 7.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.328 1.051 . . . . 0.0 112.669 171.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -65.1 -23.59 67.2 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.405 1.082 . . . . 0.0 113.443 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.17 -29.35 63.58 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.695 2.398 . . . . 0.0 115.072 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.19 14.07 76.59 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.781 0.705 . . . . 0.0 113.771 -173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.21 167.2 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 122.441 1.115 . . . . 0.0 111.554 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -142.23 176.94 8.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.093 1.757 . . . . 0.0 110.469 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.542 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -157.7 163.57 38.03 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.913 1.685 . . . . 0.0 111.796 -167.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.9 156.64 20.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 128.911 2.884 . . . . 0.0 105.348 -157.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -124.47 151.64 44.33 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 127.283 2.233 . . . . 0.0 111.074 169.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.84 21.35 5.44 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.203 1.801 . . . . 0.0 111.422 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.7 t -69.57 32.51 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 127.494 2.318 . . . . 0.0 114.767 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 t -138.2 12.31 2.82 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.796 3.238 . . . . 0.0 111.032 -174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -109.18 22.98 15.16 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.876 2.47 . . . . 0.0 112.187 176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.89 -16.33 58.67 Favored Glycine 0 N--CA 1.473 1.132 0 C-N-CA 125.064 1.316 . . . . 0.0 114.406 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 t -143.15 143.88 26.44 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 124.794 1.238 . . . . 0.0 110.608 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.88 133.79 49.75 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.477 2.118 . . . . 0.0 112.909 175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -148.55 154.1 39.31 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 129.181 2.992 . . . . 0.0 109.25 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.2 mtt -135.0 145.67 48.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.496 2.319 . . . . 0.0 108.215 177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -139.47 138.27 36.27 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.197 0.999 . . . . 0.0 111.37 -169.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.85 139.22 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 122.314 1.054 . . . . 0.0 112.092 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.43 152.4 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.848 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.1 t -89.54 121.21 31.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 164.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.41 -18.6 31.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.534 1.934 . . . . 0.0 111.883 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -67.8 -28.58 67.71 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.1 p -129.61 -3.82 4.76 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 126.225 1.81 . . . . 0.0 115.042 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.272 11.6 mt-10 62.27 42.35 9.44 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 127.279 2.232 . . . . 0.0 113.761 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.89 52.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.608 1.963 . . . . 0.0 112.573 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.62 115.2 17.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 165.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.32 -35.42 3.8 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -170.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.87 132.82 5.74 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 127.005 2.241 . . . . 0.0 112.004 -164.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.51 28.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 122.086 0.946 . . . . 0.0 110.994 -172.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.49 127.92 32.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 121.147 -0.97 . . . . 0.0 109.577 -149.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -148.6 150.22 33.09 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.92 132.84 25.59 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.876 2.384 . . . . 0.0 110.174 156.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.04 11.92 10.6 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.22 -67.24 0.34 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.955 1.74 . . . . 0.0 112.311 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.38 -164.34 0.19 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 124.113 3.209 . . . . 0.0 112.192 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -61.0 143.84 91.44 Favored Pre-proline 0 N--CA 1.473 0.696 0 O-C-N 120.286 -1.509 . . . . 0.0 112.555 -177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.5 -2.42 8.3 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.904 3.069 . . . . 0.0 114.127 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -50.15 -35.4 25.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.159 1.345 . . . . 0.0 110.897 158.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -90.59 16.2 58.5 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 127.216 2.341 . . . . 0.0 117.098 174.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.59 149.11 11.19 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -116.68 139.66 50.29 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.721 1.608 . . . . 0.0 110.022 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.6 100.19 11.78 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.099 174.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.9 t -74.77 143.77 43.9 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.656 -0.652 . . . . 0.0 110.871 173.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.9 mt -140.61 132.58 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.021 0.528 . . . . 0.0 110.266 169.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.84 99.3 12.19 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -173.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.3 p -52.19 -31.16 30.4 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.2 p -46.68 -29.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.861 2.064 . . . . 0.0 115.258 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.96 10.7 40.81 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mp -134.3 170.86 15.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.174 1.789 . . . . 0.0 111.702 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.62 129.97 52.68 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 110.325 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 43.8 p90 -142.82 145.87 33.63 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 112.753 -171.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -154.65 150.42 21.7 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.01 1.324 . . . . 0.0 112.175 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.04 169.1 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.069 1.846 . . . . 0.0 111.613 169.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.67 -42.67 9.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.826 1.25 . . . . 0.0 111.683 176.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -57.21 152.43 30.83 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.358 2.263 . . . . 0.0 113.235 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.17 -178.81 1.2 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.667 2.911 . . . . 0.0 113.481 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.18 14.7 6.86 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.377 1.871 . . . . 0.0 114.618 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -147.35 -60.81 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.515 1.526 . . . . 0.0 111.569 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.91 35.77 0.59 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.197 -0.939 . . . . 0.0 113.344 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 16.1 tp -153.57 37.25 0.46 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.033 1.333 . . . . 0.0 113.17 -172.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -83.08 37.96 0.57 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.024 2.13 . . . . 0.0 112.967 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -58.19 164.3 2.48 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.711 2.804 . . . . 0.0 115.155 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -134.16 93.84 3.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.937 1.695 . . . . 0.0 109.313 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -123.68 44.39 2.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.591 1.156 . . . . 0.0 112.325 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -148.97 151.31 34.35 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.232 1.813 . . . . 0.0 110.244 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.85 154.55 50.48 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.725 1.61 . . . . 0.0 111.301 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.9 p80 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.701 1.6 . . . . 0.0 114.414 178.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.825 0.345 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.19 -9.87 0.15 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.545 2.338 . . . . 0.0 115.121 -172.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.25 170.4 16.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.116 1.767 . . . . 0.0 111.347 163.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -98.96 -28.55 13.38 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.923 0.889 . . . . 0.0 112.918 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -52.77 -48.82 66.53 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.428 1.091 . . . . 0.0 112.174 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -74.89 -29.46 61.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.704 1.202 . . . . 0.0 112.573 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -69.67 -41.01 76.07 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.915 1.286 . . . . 0.0 112.415 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -93.72 -24.8 17.7 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.715 1.206 . . . . 0.0 114.009 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.34 58.67 32.35 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.109 1.763 . . . . 0.0 111.103 176.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.04 133.29 37.75 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.239 1.96 . . . . 0.0 112.65 -174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -92.84 -51.97 4.83 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.701 -1.591 . . . . 0.0 111.586 -148.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -59.47 -29.99 68.21 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 167.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -77.17 -24.36 51.47 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.749 2.02 . . . . 0.0 114.216 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -83.27 -42.38 17.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.457 1.503 . . . . 0.0 111.072 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.96 -30.66 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.457 1.103 . . . . 0.0 113.52 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -72.96 -25.77 61.13 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.08 1.352 . . . . 0.0 112.933 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -27.32 68.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.14 2.176 . . . . 0.0 110.545 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -130.21 -19.12 3.19 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.4 tptm 6.82 67.56 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.687 3.195 . . . . 0.0 119.023 168.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 139.1 -12.64 3.32 Favored Glycine 0 N--CA 1.471 0.985 0 CA-C-N 114.315 -1.311 . . . . 0.0 114.712 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 t -47.84 135.9 11.59 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 126.266 1.826 . . . . 0.0 111.368 172.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -130.86 140.56 50.24 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 112.796 -2.002 . . . . 0.0 113.521 171.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.25 153.68 15.33 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.874 2.47 . . . . 0.0 108.468 171.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.38 101.71 1.29 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 121.995 1.797 . . . . 0.0 112.354 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -142.6 -24.68 0.64 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 29' ' ' TYR . 5.6 m -65.8 -15.88 63.29 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.34 1.856 . . . . 0.0 114.594 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.94 -108.41 0.95 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.388 1.47 . . . . 0.0 112.753 176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 9.4 mtm -62.25 -12.83 22.66 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 26' ' ' SER . 0.2 OUTLIER -99.94 4.1 44.78 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.655 1.582 . . . . 0.0 114.498 171.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.86 -41.38 17.53 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.368 1.44 . . . . 0.0 113.388 169.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -101.92 151.54 21.98 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.048 0.939 . . . . 0.0 112.878 -174.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 50.2 -162.38 0.05 Allowed 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.028 1.331 . . . . 0.0 113.656 -169.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' A' ' 29' ' ' TYR . 19.2 mmtt -178.74 144.93 0.28 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.429 1.091 . . . . 0.0 112.106 119.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -46.38 173.8 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.977 2.911 . . . . 0.0 117.068 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.19 142.93 26.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.316 1.846 . . . . 0.0 107.397 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.87 -155.5 20.88 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-O 119.098 -0.835 . . . . 0.0 113.103 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 ptp -159.99 166.97 28.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -127.78 135.79 50.59 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.457 2.703 . . . . 0.0 109.629 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -144.96 155.68 43.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.149 1.38 . . . . 0.0 110.753 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 m -68.3 167.17 14.98 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 123.401 1.572 . . . . 0.0 112.543 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.26 -8.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 113.504 -1.68 . . . . 0.0 111.927 152.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 98.1 m -97.2 -18.63 19.14 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.16 1.784 . . . . 0.0 114.73 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.1 p -118.73 -105.09 0.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.315 2.246 . . . . 0.0 109.013 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -163.36 -38.87 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.84 2.056 . . . . 0.0 113.699 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.21 140.5 24.45 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -165.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.95 146.66 65.95 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.388 2.059 . . . . 0.0 111.101 170.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.61 -27.87 2.32 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -134.52 127.11 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.426 -0.796 . . . . 0.0 112.324 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 p -84.44 141.12 31.04 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 120.696 -1.253 . . . . 0.0 110.196 164.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.0 -18.32 23.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.111 0.964 . . . . 0.0 113.436 170.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.52 -41.79 61.27 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.92 1.688 . . . . 0.0 114.262 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -71.4 -8.92 56.96 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.592 1.557 . . . . 0.0 112.841 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 ttpp -81.01 129.64 34.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.247 0.546 . . . . 0.0 112.019 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -68.44 138.26 55.14 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 160.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.1 t -158.98 -32.16 0.07 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 p -44.18 90.86 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.574 2.75 . . . . 0.0 115.227 -169.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.77 -1.72 71.83 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 117.993 -1.448 . . . . 0.0 116.459 170.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.8 m -135.48 -10.43 2.16 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.079 1.94 . . . . 0.0 111.805 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.97 -8.7 5.96 Favored Glycine 0 CA--C 1.537 1.411 0 O-C-N 120.669 -1.269 . . . . 0.0 115.152 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -63.17 144.39 97.39 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -155.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -90.82 107.46 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.201 1.934 . . . . 0.0 114.321 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.1 t -154.81 153.67 31.56 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.466 1.507 . . . . 0.0 111.379 166.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -130.73 119.22 22.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.195 2.198 . . . . 0.0 107.471 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 p -70.31 -14.46 62.59 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -153.42 161.16 42.57 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.945 0.898 . . . . 0.0 113.374 174.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.41 69.14 1.1 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.145 1.778 . . . . 0.0 110.024 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.34 100.92 0.87 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.298 1.047 . . . . 0.0 110.969 -175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.19 -12.9 2.09 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.772 1.177 . . . . 0.0 112.208 -158.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.1 p -107.3 147.26 30.49 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.851 1.261 . . . . 0.0 110.865 145.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.25 59.31 1.16 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.997 1.719 . . . . 0.0 115.591 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.66 -62.04 0.05 OUTLIER Glycine 0 N--CA 1.476 1.364 0 C-N-CA 127.553 2.501 . . . . 0.0 115.464 169.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 t -49.51 -42.65 44.19 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.754 2.021 . . . . 0.0 110.953 159.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -113.37 94.67 4.98 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.618 1.567 . . . . 0.0 108.937 174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -133.43 -38.58 0.93 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.556 1.542 . . . . 0.0 110.628 175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.9 t -73.84 -34.31 64.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.394 1.478 . . . . 0.0 110.947 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -62.99 -28.89 70.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -20.75 63.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.576 1.151 . . . . 0.0 112.908 -173.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.48 12.46 58.8 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.705 -1.053 . . . . 0.0 113.232 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -96.72 159.91 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.355 1.077 . . . . 0.0 110.14 170.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.9 tt -144.1 164.54 30.37 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.315 1.446 . . . . 0.0 111.029 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.98 158.87 43.43 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.42 112.2 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.169 2.587 . . . . 0.0 107.37 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.35 154.9 28.71 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.07 0.948 . . . . 0.0 110.861 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -141.01 34.96 1.74 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.828 0.823 . . . . 0.0 112.961 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 t -71.95 55.19 0.29 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 124.051 1.881 . . . . 0.0 109.629 157.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -142.18 8.36 1.83 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.038 2.535 . . . . 0.0 112.351 -167.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.4 mt -128.04 20.24 6.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.647 1.979 . . . . 0.0 112.571 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.42 2.17 73.24 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 120.976 -1.077 . . . . 0.0 115.588 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 21.6 t -135.39 138.91 29.91 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 127.327 2.251 . . . . 0.0 110.085 168.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.13 135.61 17.25 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.501 2.801 . . . . 0.0 114.658 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -144.68 158.42 43.79 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 128.298 2.639 . . . . 0.0 110.628 167.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.4 mtp -141.92 125.85 17.18 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.388 2.675 . . . . 0.0 107.864 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -133.18 146.48 51.57 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 120.872 -1.142 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -127.61 153.32 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.241 1.416 . . . . 0.0 110.962 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.03 140.63 47.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.259 1.424 . . . . 0.0 109.144 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 42.9 t -76.72 97.37 4.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 124.085 1.897 . . . . 0.0 106.604 160.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -66.83 -14.72 63.0 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 113.727 -1.578 . . . . 0.0 111.545 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -66.53 -50.48 63.05 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.885 1.274 . . . . 0.0 112.426 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -100.89 -11.99 19.34 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.009 2.123 . . . . 0.0 114.281 -173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 68.02 17.91 9.5 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.395 1.878 . . . . 0.0 113.994 -161.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . . . -75.7 86.11 2.73 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.057 1.408 . . . . 0.0 112.229 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -89.78 67.58 7.33 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.827 1.651 . . . . 0.0 113.404 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.275 0.0 OUTLIER -135.02 5.88 3.34 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 118.528 2.788 . . . . 0.0 118.528 -170.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.06 129.3 9.0 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.47 1.032 . . . . 0.0 112.679 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -147.71 160.74 42.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.8 142.45 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 123.692 1.71 . . . . 0.0 112.745 -171.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -149.1 156.59 40.26 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 127.322 2.249 . . . . 0.0 110.435 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.38 142.49 54.73 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.292 1.995 . . . . 0.0 109.444 165.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.94 18.05 2.18 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 113.583 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 133.64 -64.15 0.6 Allowed Glycine 0 CA--C 1.54 1.605 0 C-N-CA 127.529 2.49 . . . . 0.0 112.739 -176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -86.53 -153.65 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.544 4.162 . . . . 0.0 113.516 -174.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.83 149.41 2.31 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 127.597 2.359 . . . . 0.0 113.712 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.81 -7.9 19.78 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.411 2.741 . . . . 0.0 114.498 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.1 p -58.87 -27.12 64.87 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.182 -0.949 . . . . 0.0 112.131 165.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -88.16 5.9 84.21 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.202 1.858 . . . . 0.0 116.324 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -58.88 127.3 31.52 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.057 1.428 . . . . 0.0 111.876 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -109.23 120.18 41.74 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.37 1.068 . . . . 0.0 109.583 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -90.37 76.19 6.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.825 1.298 . . . . 0.0 110.117 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.4 t -66.31 131.03 45.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.533 1.635 . . . . 0.0 111.59 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.3 tt -148.41 166.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 113.679 -1.601 . . . . 0.0 109.086 -168.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.44 134.56 46.33 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.256 -1.527 . . . . 0.0 113.889 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -81.04 -32.56 34.04 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.24 -33.56 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -168.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.86 2.56 14.22 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.3 mt -135.19 171.94 13.72 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.002 2.521 . . . . 0.0 110.034 -176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 9.7 mmpt? -109.82 159.38 17.25 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.933 -1.105 . . . . 0.0 112.694 168.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -148.59 153.0 37.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -146.33 145.97 25.92 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 125.797 1.639 . . . . 0.0 111.491 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.73 173.43 14.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.655 2.237 . . . . 0.0 112.072 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.6 t -100.06 -54.93 2.76 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.233 1.013 . . . . 0.0 111.28 172.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -51.12 139.93 23.18 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.542 1.937 . . . . 0.0 114.555 -174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.28 171.72 17.73 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.717 2.278 . . . . 0.0 113.999 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 61.75 22.47 13.01 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.999 2.119 . . . . 0.0 114.365 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.8 -17.59 40.53 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.504 1.522 . . . . 0.0 113.846 -173.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.83 173.51 0.27 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.905 2.482 . . . . 0.0 115.923 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.5 tp -164.13 57.94 0.15 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.557 2.343 . . . . 0.0 107.922 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.01 -37.19 8.81 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.777 2.431 . . . . 0.0 114.376 -169.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -156.18 148.66 23.67 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.161 1.384 . . . . 0.0 109.895 159.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -82.66 -11.15 58.57 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -165.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -150.87 127.29 10.7 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.899 1.227 . . . . 0.0 114.091 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -156.2 159.81 39.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.96 1.304 . . . . 0.0 112.773 162.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -158.56 152.2 23.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.385 2.274 . . . . 0.0 107.565 159.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 N--CA 1.48 1.058 0 CA-C-N 119.796 1.18 . . . . 0.0 111.673 166.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mpp? . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.6 2.12 18.48 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.909 1.284 . . . . 0.0 113.206 169.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -97.08 139.11 33.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.105 2.162 . . . . 0.0 113.649 -173.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -75.75 -27.9 58.29 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.998 1.719 . . . . 0.0 110.925 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -51.84 -52.26 50.65 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.949 1.3 . . . . 0.0 110.385 172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -74.66 -31.37 61.91 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -67.53 -37.62 83.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.744 0.818 . . . . 0.0 111.836 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.8 mt -88.8 -26.55 21.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.151 1.38 . . . . 0.0 113.378 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.258 11.8 t -135.12 85.45 33.89 Favored Pre-proline 0 N--CA 1.478 0.941 0 CA-C-N 119.641 1.11 . . . . 0.0 113.219 167.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.31 -179.25 5.28 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.352 2.701 . . . . 0.0 114.564 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -47.7 -48.84 29.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.284 1.434 . . . . 0.0 112.904 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -61.23 -32.17 71.95 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.582 0.753 . . . . 0.0 112.022 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -78.76 -36.62 42.78 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.292 1.037 . . . . 0.0 111.61 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -71.79 -43.48 65.62 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.604 1.093 . . . . 0.0 110.843 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.96 -37.47 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 120.993 -1.067 . . . . 0.0 111.739 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 p -68.54 -29.04 67.53 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.399 1.454 . . . . 0.0 112.388 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -62.88 -39.08 93.35 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.429 0.558 . . . . 0.0 110.979 173.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -75.48 -28.35 59.19 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 121.481 0.658 . . . . 0.0 111.166 171.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -74.74 22.99 0.1 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.7 -18.96 1.07 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 127.024 2.25 . . . . 0.0 115.025 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -90.95 105.09 17.59 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 123.271 1.51 . . . . 0.0 111.897 -172.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 143.59 45.38 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.218 149.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -166.82 153.81 8.41 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.16 -177.44 2.65 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.372 3.381 . . . . 0.0 112.001 163.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.1 t80 61.67 -8.1 0.1 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 p -30.6 -44.24 0.05 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.53 1.932 . . . . 0.0 112.259 137.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.95 -99.79 0.52 Allowed Glycine 0 N--CA 1.466 0.684 0 O-C-N 121.116 -0.99 . . . . 0.0 113.438 160.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.1 ttm -54.91 -33.7 62.38 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.114 -0.639 . . . . 0.0 111.225 167.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -11.02 60.66 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.1 mt -86.26 -15.82 39.53 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.838 1.255 . . . . 0.0 112.134 172.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -138.79 4.83 2.35 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.8 110.45 4.27 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.42 -1.425 . . . . 0.0 112.607 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 4.0 mmpt? -152.19 130.98 12.42 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 128.371 2.668 . . . . 0.0 107.456 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -68.3 169.67 10.14 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 128.309 2.644 . . . . 0.0 115.409 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 m -85.52 152.01 23.5 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.414 1.086 . . . . 0.0 108.167 165.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.38 -152.51 18.15 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptp -155.25 174.58 15.01 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.897 1.679 . . . . 0.0 113.011 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.47 148.28 52.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.715 1.606 . . . . 0.0 112.378 163.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -137.17 169.37 17.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.826 2.051 . . . . 0.0 111.758 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -76.21 168.4 20.12 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 123.781 1.753 . . . . 0.0 114.05 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 p -144.54 26.33 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 127.352 2.261 . . . . 0.0 111.409 164.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.62 -41.08 2.03 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.508 1.523 . . . . 0.0 111.103 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.3 p -97.33 -99.16 0.2 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.139 1.376 . . . . 0.0 110.85 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.08 -49.16 0.09 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.021 1.328 . . . . 0.0 114.202 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -99.66 154.07 37.45 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -142.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.0 142.17 99.12 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.933 1.756 . . . . 0.0 110.336 158.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.33 -34.93 1.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.673 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -135.87 134.76 39.14 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 p -91.13 127.55 36.6 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 122.312 1.053 . . . . 0.0 109.46 164.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.46 -7.21 29.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 113.383 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 4.9 mt-10 -59.05 -33.13 70.41 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.663 167.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 6.9 mmpt? -75.69 7.81 3.5 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.149 0.979 . . . . 0.0 111.955 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 53' ' ' LYS . 16.0 ttpp -52.69 132.85 36.65 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.42 0.629 . . . . 0.0 111.432 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -73.22 143.79 47.01 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.902 1.281 . . . . 0.0 111.802 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.4 m 47.55 -164.45 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.597 1.959 . . . . 0.0 114.558 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.6 p -101.8 -93.35 0.3 Allowed 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.345 -1.472 . . . . 0.0 112.204 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.59 25.95 6.89 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 117.542 1.777 . . . . 0.0 117.542 -157.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.88 -13.1 54.43 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.394 2.097 . . . . 0.0 111.146 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.55 1.29 4.48 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.364 1.459 . . . . 0.0 114.358 -170.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -93.95 134.65 25.75 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 118.629 1.215 . . . . 0.0 114.161 -152.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.58 105.11 1.7 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.983 2.455 . . . . 0.0 112.92 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 p -157.83 144.92 18.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.643 1.977 . . . . 0.0 110.605 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -143.58 117.15 9.17 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.094 1.357 . . . . 0.0 109.832 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 78.4 p -69.19 -23.68 63.95 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -145.44 158.22 43.88 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.944 0.897 . . . . 0.0 112.006 162.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.03 71.28 5.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.335 1.054 . . . . 0.0 109.322 162.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -79.97 100.24 8.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.862 0.839 . . . . 0.0 111.065 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.34 -34.14 0.02 OUTLIER Glycine 0 CA--C 1.537 1.446 0 C-N-CA 128.818 3.104 . . . . 0.0 110.068 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.5 p -125.05 144.15 50.55 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.094 1.757 . . . . 0.0 113.482 174.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -139.05 134.98 33.71 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.947 2.099 . . . . 0.0 110.367 170.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.71 -79.1 0.01 OUTLIER Glycine 0 N--CA 1.476 1.318 0 C-N-CA 128.81 3.1 . . . . 0.0 115.232 162.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.8 m -50.12 -27.46 5.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.101 2.16 . . . . 0.0 114.247 165.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.54 15.39 10.34 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -166.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -62.29 -35.23 78.39 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.284 -1.51 . . . . 0.0 112.012 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.8 t -81.85 -24.28 35.89 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.211 0.604 . . . . 0.0 111.565 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -66.58 -21.0 66.14 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.68 -22.63 67.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.703 1.201 . . . . 0.0 112.933 169.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.95 6.04 54.81 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.952 -0.915 . . . . 0.0 114.592 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -93.74 161.87 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 123.816 1.77 . . . . 0.0 114.901 -171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -134.57 -178.07 4.9 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.513 2.325 . . . . 0.0 109.221 168.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.583 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -151.74 161.74 42.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.676 1.19 . . . . 0.0 113.482 -171.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.24 117.44 8.97 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 129.113 2.965 . . . . 0.0 106.487 -175.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.85 148.92 25.04 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.032 1.333 . . . . 0.0 112.314 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.56 36.88 3.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.957 1.303 . . . . 0.0 112.537 -163.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.6 p -68.3 22.38 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.918 2.087 . . . . 0.0 115.492 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.3 t -126.66 -2.81 6.67 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.8 2.04 . . . . 0.0 113.455 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.54 12.37 7.13 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.544 1.538 . . . . 0.0 112.771 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.01 -9.59 65.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.49 1.519 . . . . 0.0 113.856 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.7 t -139.71 143.27 34.39 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.661 1.984 . . . . 0.0 109.683 175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.71 133.62 43.08 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.041 1.827 . . . . 0.0 112.039 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mmt85 -137.05 154.76 50.28 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.442 1.897 . . . . 0.0 109.475 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.8 ttm -133.47 134.65 43.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.54 1.536 . . . . 0.0 108.881 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -134.98 147.46 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.475 1.51 . . . . 0.0 110.575 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.61 146.9 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.188 1.395 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.71 144.4 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.218 1.007 . . . . 0.0 111.71 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.6 t -79.07 105.12 10.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 166.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -77.04 -7.7 56.14 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -69.0 -51.59 37.66 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 126.453 1.901 . . . . 0.0 112.03 172.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 17.5 p -112.09 -5.95 14.21 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.179 1.791 . . . . 0.0 114.453 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 62.4 63.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.028 2.531 . . . . 0.0 113.766 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.52 152.93 43.13 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -77.48 80.59 3.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.302 1.841 . . . . 0.0 112.511 -177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 103' ' ' LEU 0.255 3.4 mm? -91.63 48.13 1.43 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 124.121 1.915 . . . . 0.0 114.559 178.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.36 163.63 10.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 111.123 -2.762 . . . . 0.0 115.611 150.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.79 163.0 40.12 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.668 0.787 . . . . 0.0 111.255 -174.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.34 142.21 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.166 1.386 . . . . 0.0 112.049 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -138.22 153.54 73.19 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.098 1.759 . . . . 0.0 113.872 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.19 135.3 7.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.961 3.108 . . . . 0.0 112.006 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -118.61 4.78 11.65 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -162.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.62 -38.36 1.0 Allowed Glycine 0 CA--C 1.544 1.85 0 CA-C-O 117.458 -1.746 . . . . 0.0 116.347 -173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -101.24 -172.91 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.153 3.235 . . . . 0.0 113.226 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -51.51 156.99 1.91 Allowed Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 125.751 1.62 . . . . 0.0 112.363 163.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.93 -4.02 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.698 2.932 . . . . 0.0 114.359 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.79 -20.37 65.19 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.207 1.403 . . . . 0.0 113.58 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -79.98 -90.38 0.47 Allowed Glycine 0 N--CA 1.471 0.981 0 C-N-CA 125.658 1.599 . . . . 0.0 112.765 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 50.28 140.45 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 131.581 3.952 . . . . 0.0 119.009 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -110.81 126.51 54.71 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.981 -1.074 . . . . 0.0 109.913 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -90.05 122.56 33.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.064 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 26.6 p -105.83 122.8 46.85 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.594 1.558 . . . . 0.0 110.488 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.09 166.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.884 1.674 . . . . 0.0 109.591 -175.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.42 108.63 2.77 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.512 1.125 . . . . 0.0 113.341 173.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.3 m -75.1 56.14 0.77 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.431 1.492 . . . . 0.0 111.48 168.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -41.38 -46.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 128.521 2.728 . . . . 0.0 114.641 -162.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.98 38.92 1.2 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.463 1.905 . . . . 0.0 110.491 166.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.8 mt -110.76 165.75 11.58 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.559 1.544 . . . . 0.0 111.014 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 6.8 mmpt? -94.82 146.09 24.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -163.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -141.32 149.28 41.0 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.202 -0.936 . . . . 0.0 112.353 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -144.73 148.51 39.84 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 124.947 1.299 . . . . 0.0 111.644 171.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.2 174.86 8.4 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.824 1.683 . . . . 0.0 110.023 163.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.87 -38.95 18.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.714 0.768 . . . . 0.0 112.003 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.62 155.77 19.74 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.651 2.38 . . . . 0.0 115.191 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.63 179.0 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.907 3.071 . . . . 0.0 113.47 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.88 2.92 1.07 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.467 2.307 . . . . 0.0 114.163 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.08 -31.54 0.2 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.89 1.676 . . . . 0.0 113.031 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -96.15 154.94 16.98 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.918 0.887 . . . . 0.0 111.461 155.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.9 tp -157.99 44.91 0.33 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.735 1.614 . . . . 0.0 110.207 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.71 -34.07 76.4 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -161.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -151.16 170.99 18.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.45 1.1 . . . . 0.0 111.964 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -70.61 138.69 51.02 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.877 -0.515 . . . . 0.0 109.837 160.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -120.01 155.33 33.08 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.706 0.802 . . . . 0.0 112.108 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -47.16 -41.14 17.25 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 32.7 m80 44.19 47.11 7.6 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . 0.347 0.3 OUTLIER . . . . . 0 C--O 1.247 0.939 0 C-N-CA 128.209 2.604 . . . . 0.0 117.571 168.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 119.557 -0.258 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.33 -51.43 0.14 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.467 0.707 . . . . 0.0 111.762 169.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -157.08 171.25 20.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.447 1.499 . . . . 0.0 111.223 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -90.32 -30.77 17.26 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.469 1.108 . . . . 0.0 111.37 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -61.86 -46.34 89.84 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.543 0.737 . . . . 0.0 109.67 -172.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -57.9 -31.98 67.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.771 1.228 . . . . 0.0 113.882 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -82.39 -36.71 26.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.25 1.82 . . . . 0.0 112.619 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.72 -38.65 67.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.147 1.779 . . . . 0.0 112.609 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.26 69.48 80.25 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.848 1.659 . . . . 0.0 111.514 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.94 -178.8 2.19 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.31 2.674 . . . . 0.0 113.602 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -49.75 -50.15 45.47 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.241 -1.537 . . . . 0.0 113.71 -167.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -61.69 -31.77 71.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.303 0.641 . . . . 0.0 112.239 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -77.62 -37.51 49.98 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.601 1.161 . . . . 0.0 111.756 176.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -71.47 -44.99 63.74 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.246 1.018 . . . . 0.0 111.126 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.5 t -71.15 -32.43 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.092 1.357 . . . . 0.0 111.995 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 p -69.03 -16.04 63.61 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 121.364 1.893 . . . . 0.0 113.93 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -44.54 13.48 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.079 0.952 . . . . 0.0 110.34 164.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -19.19 62.47 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -75.71 28.84 0.11 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 120.615 -1.303 . . . . 0.0 113.257 165.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.56 27.51 0.1 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.101 1.334 . . . . 0.0 113.918 -167.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 t -134.82 173.54 11.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.614 1.566 . . . . 0.0 111.118 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -121.27 160.75 23.26 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 127.045 2.138 . . . . 0.0 112.376 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.63 159.85 27.99 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 124.816 1.246 . . . . 0.0 111.636 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.27 155.5 67.38 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.893 2.395 . . . . 0.0 115.478 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.53 -34.47 75.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.89 1.676 . . . . 0.0 113.023 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 56.0 m 62.92 -37.66 0.15 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 131.61 3.964 . . . . 0.0 114.616 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.76 -106.34 0.68 Allowed Glycine 0 C--O 1.224 -0.472 0 C-N-CA 126.412 1.958 . . . . 0.0 112.922 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.1 mtt -57.43 -27.35 62.33 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.329 0.651 . . . . 0.0 112.396 170.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -80.12 6.71 10.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.864 1.266 . . . . 0.0 114.054 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.1 mt -82.95 12.27 5.14 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.297 1.039 . . . . 0.0 112.753 156.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -70.79 -23.96 62.49 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.786 -1.196 . . . . 0.0 114.211 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -144.92 108.07 4.55 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.633 0.773 . . . . 0.0 112.363 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -140.82 113.92 8.48 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.038 1.735 . . . . 0.0 108.537 165.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -93.89 179.34 5.38 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.24 1.816 . . . . 0.0 112.944 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.433 HG23 ' CB ' ' A' ' 130' ' ' SER . 6.9 t -83.58 166.13 18.47 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.127 1.371 . . . . 0.0 111.003 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.0 -160.85 31.83 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.654 1.121 . . . . 0.0 114.91 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -160.19 163.63 33.48 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.863 1.265 . . . . 0.0 113.861 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -95.85 145.5 25.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 128.475 2.71 . . . . 0.0 110.987 167.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -153.67 164.27 38.57 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.825 1.65 . . . . 0.0 112.307 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 69.3 m -67.12 166.13 14.53 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 123.893 1.806 . . . . 0.0 113.788 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.67 16.17 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 126.486 1.915 . . . . 0.0 112.69 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 47.7 t -127.38 -49.51 1.41 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.37 1.068 . . . . 0.0 112.493 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 9.1 p -96.68 -96.54 0.19 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.892 1.277 . . . . 0.0 112.919 -174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -155.26 -36.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.398 2.279 . . . . 0.0 113.563 -165.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p -82.23 118.23 71.21 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -160.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.31 153.69 77.06 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 120.997 1.132 . . . . 0.0 110.051 136.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.4 tp -152.14 -47.98 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -120.81 122.47 40.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.19 0.904 . . . . 0.0 110.657 -169.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 95.3 p -75.88 145.62 40.4 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 123.229 1.49 . . . . 0.0 111.041 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -75.86 -10.07 59.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.484 169.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.79 -40.06 78.95 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.439 1.496 . . . . 0.0 114.779 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.26 -0.1 53.62 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.342 1.026 . . . . 0.0 113.608 171.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -99.61 128.1 45.71 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -159.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -57.8 130.95 48.81 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.856 0.836 . . . . 0.0 111.688 168.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 98.1 m -125.62 -1.11 7.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.796 1.238 . . . . 0.0 113.876 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.5 p -78.44 131.32 36.85 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 156.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.47 -22.21 76.39 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.859 -1.151 . . . . 0.0 114.579 -175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 p -72.71 -37.28 67.85 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.053 2.541 . . . . 0.0 113.52 170.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.1 -27.42 73.71 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.395 0.998 . . . . 0.0 112.446 166.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 18.0 t90 65.6 141.04 0.06 OUTLIER Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 129.292 3.037 . . . . 0.0 113.72 169.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.94 98.86 0.26 Allowed 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.932 2.421 . . . . 0.0 115.876 -163.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.9 p -149.54 155.52 40.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.247 2.219 . . . . 0.0 110.581 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -143.85 122.11 12.27 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.311 1.844 . . . . 0.0 108.374 -168.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -76.12 -7.61 55.15 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -164.55 154.42 13.95 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 157.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.07 58.98 0.92 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.445 1.898 . . . . 0.0 113.026 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -80.02 120.2 23.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.331 1.052 . . . . 0.0 110.903 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.82 -34.29 0.08 OUTLIER Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.026 1.774 . . . . 0.0 111.866 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.1 m -144.89 149.06 34.65 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.834 2.053 . . . . 0.0 110.07 168.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -139.32 130.55 26.72 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.744 2.018 . . . . 0.0 112.137 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.75 -70.85 0.71 Allowed Glycine 0 N--CA 1.474 1.222 0 C-N-CA 125.814 1.673 . . . . 0.0 114.664 165.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -47.81 -35.4 10.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.597 2.359 . . . . 0.0 112.905 169.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -154.06 114.9 4.02 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.639 0.775 . . . . 0.0 110.644 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -136.66 28.63 2.96 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.466 1.507 . . . . 0.0 112.186 161.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 t -158.34 -21.62 0.08 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.19 -7.52 51.79 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.464 1.906 . . . . 0.0 113.547 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.7 p -49.14 -38.58 25.79 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 128.635 2.774 . . . . 0.0 113.758 157.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.55 13.81 79.44 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.437 1.017 . . . . 0.0 112.948 -175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.8 178.69 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-O 122.595 1.188 . . . . 0.0 112.685 171.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -143.99 173.98 11.25 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.536 1.935 . . . . 0.0 111.611 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.549 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -146.62 147.71 31.34 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 124.733 1.213 . . . . 0.0 113.868 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.07 109.71 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.628 1.971 . . . . 0.0 108.747 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.21 150.16 20.57 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.395 1.878 . . . . 0.0 109.069 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.11 120.54 4.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.151 0.887 . . . . 0.0 110.86 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.1 t -121.88 32.71 5.74 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.233 1.016 . . . . 0.0 110.423 164.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.5 m -107.36 -13.94 14.99 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 128.156 2.582 . . . . 0.0 113.47 -161.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.45 16.96 5.73 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 127.453 2.301 . . . . 0.0 111.955 170.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.28 -6.03 52.73 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 38.1 t -138.57 131.44 16.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.264 2.226 . . . . 0.0 108.999 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.33 144.15 25.75 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.081 2.52 . . . . 0.0 113.776 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -148.27 160.74 42.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 129.406 3.082 . . . . 0.0 112.315 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.0 mtp -143.62 132.27 22.45 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.108 1.763 . . . . 0.0 109.017 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -138.16 150.09 46.47 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 119.125 0.875 . . . . 0.0 112.741 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.7 m -124.2 141.58 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 110.574 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.65 155.1 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 110.276 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 36.9 t -97.49 112.94 24.58 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-O 122.631 1.205 . . . . 0.0 108.111 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -67.33 -18.02 65.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.868 164.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -85.63 -38.56 18.27 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.553 1.141 . . . . 0.0 112.911 -171.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.6 p -112.21 -13.41 13.5 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 127.709 2.403 . . . . 0.0 114.566 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.319 6.8 tt0 70.83 53.86 0.27 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.673 2.389 . . . . 0.0 116.151 173.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.34 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.707 1.203 . . . . 0.0 113.065 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 129.8 40.98 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.381 -0.825 . . . . 0.0 111.046 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.29 -27.13 19.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.079 1.419 . . . . 0.0 113.626 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.02 176.03 32.68 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 126.71 2.1 . . . . 0.0 113.634 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -153.3 167.24 30.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 122.653 1.216 . . . . 0.0 113.518 -160.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.45 134.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 125.467 1.507 . . . . 0.0 109.024 -161.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.7 159.06 72.8 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.938 1.295 . . . . 0.0 111.999 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -67.11 146.15 75.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.354 2.036 . . . . 0.0 110.668 163.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -114.33 16.02 17.93 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.612 1.165 . . . . 0.0 113.79 -173.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.46 -71.32 0.46 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.988 1.756 . . . . 0.0 112.495 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.51 179.53 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.609 2.873 . . . . 0.0 112.694 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -58.03 151.5 44.9 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.734 1.613 . . . . 0.0 112.735 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.57 -3.43 4.34 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.133 3.222 . . . . 0.0 115.264 -172.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -57.41 -29.12 63.86 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.666 -0.646 . . . . 0.0 112.088 163.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.41 16.19 60.2 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 127.19 2.328 . . . . 0.0 116.455 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -47.49 139.9 6.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.618 1.167 . . . . 0.0 113.958 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -114.97 136.21 53.38 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.106 1.762 . . . . 0.0 110.073 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.61 114.73 29.08 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.75 1.62 . . . . 0.0 110.82 -167.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 54.6 m -99.5 142.98 30.28 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.428 2.691 . . . . 0.0 111.504 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.7 mm -107.73 154.81 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 121.292 -0.88 . . . . 0.0 109.96 169.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.57 122.39 39.55 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.101 0.961 . . . . 0.0 112.183 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.7 m -77.39 49.5 0.72 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.391 1.076 . . . . 0.0 113.377 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.35 -55.5 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 121.28 -0.888 . . . . 0.0 112.633 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.08 -0.53 0.44 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 22.1 mt -71.92 162.62 29.19 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.58 1.552 . . . . 0.0 110.703 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -108.53 160.81 15.61 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.276 1.43 . . . . 0.0 112.841 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -149.56 143.21 25.45 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.172 1.389 . . . . 0.0 110.449 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -135.17 155.72 78.71 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.243 1.417 . . . . 0.0 111.197 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.37 167.94 25.97 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.027 1.818 . . . . 0.0 112.047 168.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.433 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -95.58 -35.29 11.69 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.258 1.423 . . . . 0.0 112.723 -177.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.434 ' HE3' ' HD2' ' A' ' 132' ' ' PRO . 25.0 mmmt -67.54 144.88 98.06 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 126.105 1.762 . . . . 0.0 114.591 -176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.434 ' HD2' ' HE3' ' A' ' 131' ' ' LYS . 38.0 Cg_endo -60.97 171.85 3.45 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.836 2.358 . . . . 0.0 112.876 158.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 58.4 16.91 4.41 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.298 1.839 . . . . 0.0 114.024 -170.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.67 37.7 1.34 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.421 2.288 . . . . 0.0 111.139 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 61.8 41.7 11.41 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.572 1.549 . . . . 0.0 114.859 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.06 43.39 1.32 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.218 1.407 . . . . 0.0 111.566 162.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.7 13.87 9.65 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -49.44 144.9 5.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.144 1.777 . . . . 0.0 115.118 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -157.41 163.91 38.06 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.226 1.01 . . . . 0.0 111.361 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.64 -157.19 0.24 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 122.821 0.449 . . . . 0.0 110.891 161.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.52 149.22 4.5 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.766 -1.209 . . . . 0.0 112.283 173.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -142.51 171.77 13.61 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.839 2.056 . . . . 0.0 109.294 -170.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 13.3 m170 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.761 -1.114 . . . . 0.0 112.04 170.448 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 tmm? . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.94 67.15 0.54 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.255 1.422 . . . . 0.0 112.845 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.99 165.37 25.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.272 156.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -112.93 -27.25 8.16 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.025 0.93 . . . . 0.0 113.352 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.278 0.0 OUTLIER -56.19 -54.41 45.54 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.968 2.907 . . . . 0.0 111.863 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -62.89 -27.73 69.56 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -76.47 -36.63 57.77 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.237 1.815 . . . . 0.0 113.721 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.6 mt -82.37 -20.36 37.34 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.887 1.275 . . . . 0.0 113.916 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 14.0 t -140.72 50.14 1.94 Allowed Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 146.28 67.59 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.999 3.132 . . . . 0.0 115.055 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -95.25 -57.38 2.43 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.414 1.086 . . . . 0.0 112.348 -163.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -59.87 -32.19 70.47 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.196 174.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.92 -45.35 71.07 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 124.156 0.982 . . . . 0.0 111.675 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -65.86 -41.75 91.28 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.001 1.273 . . . . 0.0 112.218 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.06 -38.87 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.902 -1.047 . . . . 0.0 112.49 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 p -80.4 -32.65 37.49 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.354 1.461 . . . . 0.0 112.388 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -52.18 66.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.213 1.005 . . . . 0.0 109.385 170.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -11.27 59.86 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.135 0.493 . . . . 0.0 111.945 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 59.09 1.4 Allowed 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.318 -2.113 . . . . 0.0 113.66 161.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.95 -6.35 0.22 Allowed Glycine 0 N--CA 1.465 0.621 0 N-CA-C 117.292 1.677 . . . . 0.0 117.292 -168.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.7 t -144.59 133.18 22.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.678 1.239 . . . . 0.0 111.932 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -121.59 145.98 47.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.483 1.913 . . . . 0.0 110.426 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.08 155.51 80.01 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -166.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.22 179.81 5.78 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.32 3.347 . . . . 0.0 112.735 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -49.14 -29.58 5.55 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 57.1 m 68.1 -28.63 0.15 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.241 2.617 . . . . 0.0 114.572 172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.25 -102.71 0.11 Allowed Glycine 0 N--CA 1.468 0.801 0 C-N-CA 126.146 1.831 . . . . 0.0 114.147 170.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.8 mtt -55.93 -25.61 44.06 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 171.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -84.34 -1.74 55.92 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.016 1.327 . . . . 0.0 112.997 175.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.22 89.39 3.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.946 1.298 . . . . 0.0 109.602 160.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -53.71 159.55 1.58 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 163.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -56.27 161.92 2.28 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -147.38 117.44 7.27 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-O 122.173 0.987 . . . . 0.0 112.313 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.03 176.1 0.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.146 2.178 . . . . 0.0 113.283 157.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.36 -176.06 2.83 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -163.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.54 -147.65 10.02 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 116.372 1.309 . . . . 0.0 116.372 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 ptp -134.54 179.89 6.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.251 1.82 . . . . 0.0 114.048 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -134.02 144.85 48.95 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 129.968 3.307 . . . . 0.0 108.695 159.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -144.88 151.13 38.24 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 110.931 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.38 161.76 30.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.134 1.445 . . . . 0.0 111.556 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.25 6.32 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.711 163.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.3 m -115.48 -57.24 2.26 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.907 1.283 . . . . 0.0 112.405 -165.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.7 p -81.19 -81.28 0.14 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.315 1.046 . . . . 0.0 111.928 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -164.72 -59.77 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.278 1.431 . . . . 0.0 113.218 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 p -96.85 165.92 14.96 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -154.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -59.36 152.39 61.16 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 120.66 0.906 . . . . 0.0 111.344 150.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 -31.74 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -128.11 132.77 48.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.58 -0.7 . . . . 0.0 110.935 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.6 m -76.66 140.53 40.96 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.023 -1.048 . . . . 0.0 109.705 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 t -64.85 -10.97 32.3 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.967 0.907 . . . . 0.0 112.521 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -87.68 -1.97 58.31 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.228 1.411 . . . . 0.0 113.666 170.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -95.29 130.12 42.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.594 1.158 . . . . 0.0 109.575 -171.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -67.84 117.87 10.31 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.207 0.203 . . . . 0.0 110.576 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 66.4 m 57.01 -62.7 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.648 2.779 . . . . 0.0 116.699 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.7 p 61.57 162.29 0.07 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.17 1.788 . . . . 0.0 113.645 -158.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.12 2.11 45.44 Favored Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.613 -1.304 . . . . 0.0 115.264 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.17 -7.16 29.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.447 1.899 . . . . 0.0 112.618 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.85 -9.62 10.92 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.959 1.266 . . . . 0.0 114.673 -169.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.23 127.53 27.74 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.168 1.387 . . . . 0.0 111.131 -175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -111.65 125.36 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 122.986 2.458 . . . . 0.0 114.695 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -146.43 157.72 43.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.184 2.194 . . . . 0.0 109.904 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -153.1 116.44 4.65 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.978 1.311 . . . . 0.0 110.058 -169.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.4 p -72.05 -23.91 61.45 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.19 166.66 20.89 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 113.335 172.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.57 78.63 9.14 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.414 1.085 . . . . 0.0 110.334 162.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -72.2 140.07 48.53 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.399 -0.813 . . . . 0.0 112.171 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.07 -32.55 2.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 126.401 1.953 . . . . 0.0 111.604 175.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.3 134.04 55.35 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 128.03 2.532 . . . . 0.0 112.757 -175.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.85 130.35 31.66 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.521 1.928 . . . . 0.0 112.401 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.88 -77.98 0.1 Allowed Glycine 0 N--CA 1.474 1.181 0 C-N-CA 125.962 1.744 . . . . 0.0 115.009 159.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.71 -29.55 68.19 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.976 1.311 . . . . 0.0 111.76 167.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -89.34 9.17 27.09 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -165.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -82.69 2.17 34.93 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -169.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.2 t -103.01 -29.89 11.11 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.904 1.282 . . . . 0.0 111.78 153.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.52 -23.49 63.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.499 1.52 . . . . 0.0 113.677 -169.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.8 p -51.51 -38.11 52.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.373 1.869 . . . . 0.0 113.189 169.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.28 13.71 70.75 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.198 -170.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.03 159.73 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 119.003 1.402 . . . . 0.0 111.485 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.91 177.24 8.03 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.97 1.708 . . . . 0.0 111.869 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 155.44 38.33 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.329 1.451 . . . . 0.0 112.903 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.42 118.59 5.53 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.779 2.832 . . . . 0.0 107.29 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -75.02 149.8 39.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.448 0.642 . . . . 0.0 111.4 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -136.7 96.5 3.34 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.732 0.777 . . . . 0.0 111.29 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.3 t -111.03 21.95 15.84 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.603 1.161 . . . . 0.0 112.217 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.62 -5.94 58.5 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -162.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.3 mt -98.35 14.08 29.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.623 1.969 . . . . 0.0 111.712 164.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.48 -4.17 64.99 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.988 1.756 . . . . 0.0 115.279 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 50.0 t -123.52 109.42 30.77 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.166 1.387 . . . . 0.0 109.767 -175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.74 125.6 9.57 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.044 2.496 . . . . 0.0 113.158 -166.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.74 165.95 13.02 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.169 2.187 . . . . 0.0 109.881 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.37 122.81 44.87 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.444 1.498 . . . . 0.0 108.021 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -120.32 137.87 54.02 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.981 0.913 . . . . 0.0 109.802 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.55 145.67 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 121.241 -0.912 . . . . 0.0 111.497 -165.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.44 138.73 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.041 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 42.2 t -72.72 98.63 2.42 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 123.41 1.576 . . . . 0.0 107.843 161.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.54 -16.66 57.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.884 1.274 . . . . 0.0 111.924 167.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -71.09 -45.61 63.38 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.851 1.205 . . . . 0.0 113.619 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 3.9 p -123.42 8.81 9.04 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 127.093 2.157 . . . . 0.0 115.424 -169.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 64.56 15.7 9.81 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.73 2.012 . . . . 0.0 114.821 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 96' ' ' CYS . . . -75.46 83.45 2.54 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.481 -1.387 . . . . 0.0 112.956 -175.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -83.17 58.1 4.28 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.123 1.769 . . . . 0.0 113.81 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.05 7.97 2.71 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -162.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.43 135.4 12.67 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.056 1.789 . . . . 0.0 110.925 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.17 157.18 42.83 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.559 -0.965 . . . . 0.0 111.312 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.6 p -143.91 137.85 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.685 1.594 . . . . 0.0 111.505 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.31 149.46 54.96 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.0 1.32 . . . . 0.0 113.112 -171.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.67 146.36 26.83 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.573 2.182 . . . . 0.0 110.019 157.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -113.65 12.5 18.46 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.13 -64.65 0.2 Allowed Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.646 1.117 . . . . 0.0 115.043 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.84 -172.76 1.42 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.935 3.09 . . . . 0.0 113.396 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.95 162.76 0.46 Allowed Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 125.188 1.395 . . . . 0.0 112.507 171.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -60.33 -5.64 4.37 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.138 2.559 . . . . 0.0 114.378 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 18.03 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.635 1.974 . . . . 0.0 113.019 163.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -154.15 19.0 0.64 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.428 1.966 . . . . 0.0 116.535 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.71 161.33 29.74 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.489 1.145 . . . . 0.0 113.966 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -128.44 132.07 48.43 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.042 1.737 . . . . 0.0 109.368 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -99.64 130.85 45.9 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.033 0.933 . . . . 0.0 109.916 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 70.9 m -127.58 139.97 52.42 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.326 1.85 . . . . 0.0 109.844 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.8 tt -127.04 170.66 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.286 0.634 . . . . 0.0 109.562 174.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.78 129.48 50.54 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.74 -1.225 . . . . 0.0 111.643 164.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -83.79 39.42 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.735 1.214 . . . . 0.0 114.251 -167.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -44.57 -36.61 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 116.747 2.128 . . . . 0.0 116.747 -151.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.24 22.51 0.94 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.966 1.706 . . . . 0.0 112.093 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.8 mt -98.5 157.85 15.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 120.666 -1.271 . . . . 0.0 111.678 -155.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.37 142.65 36.86 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.746 1.26 . . . . 0.0 113.753 -161.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -153.21 144.18 22.91 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 120.321 -1.487 . . . . 0.0 111.215 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -140.08 153.38 69.22 Favored Pre-proline 0 N--CA 1.473 0.688 0 C-N-CA 125.921 1.688 . . . . 0.0 111.002 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.27 171.66 17.18 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.885 2.39 . . . . 0.0 112.296 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -38.1 14.22 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.318 1.447 . . . . 0.0 110.622 170.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -89.33 144.29 32.09 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 128.31 2.644 . . . . 0.0 112.48 -171.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.34 -164.9 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.263 3.309 . . . . 0.0 113.068 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 61.41 38.52 16.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.705 1.602 . . . . 0.0 113.314 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.27 -10.23 52.95 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.34 1.456 . . . . 0.0 113.732 -173.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -95.19 125.03 39.55 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.519 1.528 . . . . 0.0 111.545 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.2 tp -161.77 55.17 0.26 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.686 1.594 . . . . 0.0 110.055 -176.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -48.72 -40.12 27.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.1 1.76 . . . . 0.0 113.66 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -149.76 152.81 35.85 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.138 2.175 . . . . 0.0 110.1 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.4 167.99 20.86 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -85.24 165.76 17.08 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.33 -0.857 . . . . 0.0 111.419 169.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.8 177.99 7.45 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -145.98 155.26 42.71 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.48 2.312 . . . . 0.0 109.42 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 . . . . . 0 C--O 1.251 1.183 0 C-N-CA 125.943 1.697 . . . . 0.0 112.059 -169.931 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 ttp . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.965 0.412 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.83 -37.07 0.12 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.675 1.19 . . . . 0.0 110.892 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -104.84 170.67 7.74 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.555 2.342 . . . . 0.0 113.449 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -112.27 -25.18 9.4 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 147.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -65.24 -48.1 74.46 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.68 1.192 . . . . 0.0 113.106 -168.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -68.43 -29.65 68.35 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.654 1.182 . . . . 0.0 112.823 174.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -75.12 -38.5 61.06 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.681 1.192 . . . . 0.0 112.15 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -83.49 -23.38 32.19 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -136.47 86.12 24.34 Favored Pre-proline 0 N--CA 1.474 0.728 0 CA-C-N 118.829 0.74 . . . . 0.0 111.516 166.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.59 166.66 17.09 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.645 2.23 . . . . 0.0 113.422 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.14 -37.63 87.97 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 119.868 -1.77 . . . . 0.0 113.943 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -58.01 -39.57 78.63 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 166.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -69.01 -39.1 79.51 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.67 -1.269 . . . . 0.0 111.322 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -64.55 -44.28 91.29 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.804 1.242 . . . . 0.0 111.738 177.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.73 -53.04 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.089 173.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 p -61.39 -31.6 71.51 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.679 1.127 . . . . 0.0 112.249 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.73 -29.76 70.91 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.926 0.891 . . . . 0.0 112.053 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -104.75 -11.95 16.57 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.259 0.623 . . . . 0.0 112.617 174.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -64.67 -3.62 3.39 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 117.989 2.588 . . . . 0.0 117.989 -170.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.41 11.86 9.04 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 128.998 3.19 . . . . 0.0 116.099 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 t -81.56 108.1 14.86 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.824 1.312 . . . . 0.0 109.926 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.45 147.23 40.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.705 2.002 . . . . 0.0 111.396 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -143.58 145.77 32.74 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.622 1.569 . . . . 0.0 111.826 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.48 179.13 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.048 3.165 . . . . 0.0 112.825 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.8 t80 67.2 -37.81 0.32 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 129.022 2.929 . . . . 0.0 115.724 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t 67.3 -40.93 0.41 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 127.991 2.516 . . . . 0.0 113.186 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 47.93 -100.92 0.03 OUTLIER Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.503 2.001 . . . . 0.0 114.791 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.4 mtm -60.28 -16.03 30.48 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.452 ' CZ ' ' HE3' ' A' ' 33' ' ' LYS . 3.0 m-30 -99.92 2.96 44.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.561 1.944 . . . . 0.0 112.799 175.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.46 -30.36 64.5 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 120.422 1.465 . . . . 0.0 114.358 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -93.43 -165.71 1.38 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.789 1.235 . . . . 0.0 109.372 164.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 61.3 -162.41 0.27 Allowed 'General case' 0 CA--C 1.556 1.184 0 O-C-N 121.611 -0.681 . . . . 0.0 111.943 166.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HE3' ' CZ ' ' A' ' 29' ' ' TYR . 68.6 mmtt 54.33 35.84 23.86 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.298 1.839 . . . . 0.0 115.137 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -63.37 -175.66 0.12 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 130.843 3.657 . . . . 0.0 115.049 -173.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.59 156.37 35.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.476 1.51 . . . . 0.0 107.9 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.18 -149.93 16.0 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 114.394 0.517 . . . . 0.0 114.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.6 ptp -155.06 168.27 27.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.384 1.074 . . . . 0.0 113.262 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -122.18 139.17 54.07 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 128.809 2.844 . . . . 0.0 109.574 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.69 157.5 43.29 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.561 1.544 . . . . 0.0 110.871 -172.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.1 t -79.04 170.17 17.09 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 123.486 1.612 . . . . 0.0 114.238 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.9 p -134.28 13.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.496 1.918 . . . . 0.0 112.008 161.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.8 t -121.42 -33.22 3.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.09 1.356 . . . . 0.0 112.846 -173.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.6 p -102.29 -86.4 0.42 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.715 1.606 . . . . 0.0 111.348 167.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.1 -41.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.2 p -111.47 161.39 25.58 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 -146.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.72 139.86 31.46 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.184 2.589 . . . . 0.0 111.888 159.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.5 mt -136.92 -23.31 1.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -135.83 141.89 44.75 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.524 1.057 . . . . 0.0 111.285 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.4 p -116.36 132.03 56.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.799 1.285 . . . . 0.0 112.123 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.09 -5.04 19.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.997 1.319 . . . . 0.0 113.53 175.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.46 -26.8 68.12 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.793 -1.192 . . . . 0.0 112.419 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -90.67 5.97 45.9 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.824 1.25 . . . . 0.0 114.32 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 2.9 ttpt -59.43 131.91 52.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.046 0.938 . . . . 0.0 110.472 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.418 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 32.6 t80 -83.17 156.9 22.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.764 1.226 . . . . 0.0 112.397 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 2.5 t 63.55 -166.72 0.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.155 1.782 . . . . 0.0 113.916 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.9 p -94.88 -151.02 0.32 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.447 2.299 . . . . 0.0 112.321 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.97 88.09 0.02 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 151.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -129.3 -9.94 4.68 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.87 1.668 . . . . 0.0 110.48 174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.36 3.9 5.86 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.182 1.849 . . . . 0.0 115.725 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -90.99 120.08 68.73 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 118.5 1.15 . . . . 0.0 112.341 -162.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.9 109.2 2.62 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.079 2.519 . . . . 0.0 113.048 -168.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 46.1 p -151.44 165.96 32.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.064 2.146 . . . . 0.0 111.292 -167.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.71 148.88 26.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.781 1.632 . . . . 0.0 109.641 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.6 p -96.56 -27.2 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.267 1.827 . . . . 0.0 113.068 169.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -145.92 155.09 42.63 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.449 1.499 . . . . 0.0 109.524 158.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.31 77.14 9.14 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.389 168.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -74.54 134.52 42.19 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.949 -1.095 . . . . 0.0 111.67 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.76 -38.78 1.33 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 128.005 2.717 . . . . 0.0 109.946 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 p -112.86 148.36 35.07 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 128.454 2.702 . . . . 0.0 111.322 169.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.7 123.25 10.43 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.809 1.644 . . . . 0.0 112.422 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.41 -83.05 0.03 OUTLIER Glycine 0 N--CA 1.472 1.08 0 C-N-CA 127.174 2.321 . . . . 0.0 114.197 163.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.9 m -58.45 -25.17 61.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.931 1.292 . . . . 0.0 112.317 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -85.04 2.52 42.85 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 122.307 1.051 . . . . 0.0 112.95 -167.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.27 -18.48 64.55 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.405 1.482 . . . . 0.0 114.61 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.7 t -100.75 -36.44 9.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.849 1.659 . . . . 0.0 111.446 167.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -70.68 -26.7 63.55 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 -167.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.28 -32.04 64.18 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.397 2.279 . . . . 0.0 112.619 170.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.39 18.35 69.5 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.59 1.091 . . . . 0.0 112.696 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.51 -177.81 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 122.066 0.936 . . . . 0.0 112.104 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.43 -179.3 6.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.63 1.972 . . . . 0.0 109.171 175.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.637 ' H ' HD23 ' A' ' 80' ' ' LEU . 9.6 mmt180 -140.3 154.43 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.957 1.703 . . . . 0.0 109.316 -171.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -152.63 123.8 7.58 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.756 1.222 . . . . 0.0 110.241 165.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.8 mp -87.23 159.03 18.97 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.752 1.621 . . . . 0.0 111.648 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -130.56 111.83 12.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 t -123.07 19.92 9.94 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 123.114 1.435 . . . . 0.0 111.488 -177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.88 -18.8 13.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -142.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.3 mt -98.66 8.03 45.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 113.025 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.39 -10.03 73.61 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.854 1.693 . . . . 0.0 114.751 -173.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.3 t -109.65 126.68 28.61 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.283 1.433 . . . . 0.0 110.717 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.79 127.37 2.66 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.414 2.743 . . . . 0.0 112.99 175.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -133.66 155.43 49.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 129.305 3.042 . . . . 0.0 108.717 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 42.5 mtp -140.48 124.02 17.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.414 1.485 . . . . 0.0 110.736 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -126.42 153.74 44.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.305 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.03 138.45 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.835 1.254 . . . . 0.0 110.759 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 m -122.77 148.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 122.103 0.954 . . . . 0.0 111.412 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 53.5 t -82.58 99.08 9.32 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.63 -20.47 66.3 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.687 -0.633 . . . . 0.0 111.566 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -64.25 -35.0 79.4 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.248 1.019 . . . . 0.0 111.79 -175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 26.4 p -131.8 -7.05 3.58 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.023 2.129 . . . . 0.0 115.464 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 69.34 59.62 0.32 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.89 2.876 . . . . 0.0 115.614 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.4 38.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 113.416 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.13 141.67 58.02 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 110.291 166.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.1 mt -108.48 -32.91 7.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.46 -169.62 35.59 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 127.487 2.47 . . . . 0.0 114.043 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -153.67 -179.48 7.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -152.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.22 145.92 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.805 1.642 . . . . 0.0 112.012 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -147.27 153.69 44.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.524 1.53 . . . . 0.0 111.965 171.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.81 137.0 15.57 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.524 2.816 . . . . 0.0 111.035 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -81.88 -0.07 41.97 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 165.52 -55.28 0.26 Allowed Glycine 0 CA--C 1.54 1.607 0 C-N-CA 126.05 1.786 . . . . 0.0 114.998 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -93.74 -153.72 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.279 3.319 . . . . 0.0 112.433 -169.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.45 171.22 0.29 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 127.327 2.251 . . . . 0.0 113.196 172.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -58.84 -5.98 3.08 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.954 2.436 . . . . 0.0 115.074 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.6 p -61.32 -26.42 67.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.71 1.204 . . . . 0.0 113.271 163.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.67 12.69 62.83 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.819 2.152 . . . . 0.0 115.765 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.92 132.61 49.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.335 1.067 . . . . 0.0 112.398 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -126.24 134.95 51.06 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.364 1.466 . . . . 0.0 108.711 174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -105.89 138.58 41.83 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.052 0.941 . . . . 0.0 110.982 -171.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 57.9 m -122.57 136.99 55.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.926 2.09 . . . . 0.0 109.466 -175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.0 tt -137.55 169.05 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.592 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.01 166.31 24.85 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 -170.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.6 m -133.87 36.5 3.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.944 1.297 . . . . 0.0 113.356 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.06 -47.63 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.586 -1.321 . . . . 0.0 112.6 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 23.62 4.03 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.84 1.656 . . . . 0.0 112.781 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.9 mt -133.88 155.21 50.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.577 1.951 . . . . 0.0 110.13 -165.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.7 mmpt? -104.55 156.38 18.01 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.967 0.889 . . . . 0.0 113.359 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -152.11 153.31 33.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.629 1.172 . . . . 0.0 111.426 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -139.0 150.87 66.72 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.544 1.538 . . . . 0.0 111.456 171.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.71 171.51 18.07 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.602 2.201 . . . . 0.0 112.559 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.33 -46.27 5.07 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.533 1.133 . . . . 0.0 112.011 -175.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.76 160.03 1.57 Allowed Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 127.631 2.372 . . . . 0.0 115.629 175.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.25 -165.51 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.926 3.084 . . . . 0.0 112.709 164.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.89 42.57 7.59 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.94 1.696 . . . . 0.0 113.869 -175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.11 -16.48 61.02 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.784 1.234 . . . . 0.0 112.912 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.53 129.92 42.79 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.415 1.086 . . . . 0.0 111.151 170.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.41 29.27 1.05 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -168.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -52.65 -31.37 36.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.655 1.982 . . . . 0.0 114.473 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -130.08 133.93 47.02 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.155 1.382 . . . . 0.0 110.212 174.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -155.06 120.31 4.95 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.168 0.987 . . . . 0.0 110.648 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -154.61 163.74 39.76 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.642 0.777 . . . . 0.0 112.412 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -86.47 141.11 29.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -143.83 168.4 20.03 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.203 2.201 . . . . 0.0 109.675 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 126.79 2.036 . . . . 0.0 114.833 -176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.42 -84.51 0.63 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.19 0.996 . . . . 0.0 109.822 171.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -103.9 -177.27 3.32 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.787 2.035 . . . . 0.0 112.886 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -99.43 -30.86 11.95 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.134 0.974 . . . . 0.0 113.191 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -58.04 -48.23 80.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.172 1.789 . . . . 0.0 111.079 -173.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -62.98 -24.9 68.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.885 1.274 . . . . 0.0 112.971 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -85.79 -45.38 11.66 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.327 1.851 . . . . 0.0 113.308 175.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.76 -32.21 31.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.337 1.055 . . . . 0.0 113.753 -173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 t -131.08 64.78 74.92 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 125.565 1.546 . . . . 0.0 109.938 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -64.57 159.6 43.94 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.118 2.545 . . . . 0.0 113.616 -172.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -111.26 -69.19 0.88 Allowed 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 123.954 0.901 . . . . 0.0 109.258 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -59.55 -34.54 72.79 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.229 0.538 . . . . 0.0 112.215 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.16 -24.07 43.52 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 176.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -81.09 -47.42 13.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.539 1.063 . . . . 0.0 111.805 172.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 t -53.29 -40.09 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.45 1.5 . . . . 0.0 111.998 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.26 -18.95 60.93 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 174.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.57 -27.01 27.58 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.18 0.992 . . . . 0.0 111.77 171.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -100.39 -7.27 24.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -68.1 51.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.072 1.349 . . . . 0.0 113.732 172.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.99 19.04 0.02 OUTLIER Glycine 0 CA--C 1.544 1.847 0 C-N-CA 127.641 2.543 . . . . 0.0 115.966 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 t -89.17 77.97 7.43 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.986 1.374 . . . . 0.0 114.706 -158.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -78.46 177.68 8.33 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.042 -1.662 . . . . 0.0 113.951 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.81 155.61 0.16 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 128.695 2.798 . . . . 0.0 117.43 171.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.28 93.26 0.75 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.205 2.603 . . . . 0.0 112.294 176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.42 ' H ' HG21 ' A' ' 58' ' ' THR . 27.3 p90 -108.79 -17.51 13.92 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -171.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.0 m -48.62 -22.74 0.82 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.435 1.894 . . . . 0.0 114.368 170.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.02 -107.46 0.56 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.984 1.278 . . . . 0.0 113.557 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.0 mtt -62.07 -12.85 21.3 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.87 7.52 41.55 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.12 1.768 . . . . 0.0 114.088 171.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.76 47.39 0.33 Allowed 'General case' 0 CA--C 1.552 1.048 0 O-C-N 119.645 -1.909 . . . . 0.0 112.861 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -141.63 18.31 2.18 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -168.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -148.52 151.19 34.71 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.729 -1.232 . . . . 0.0 112.143 165.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -149.79 113.94 5.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.68 1.992 . . . . 0.0 110.54 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.86 176.89 7.68 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.511 1.524 . . . . 0.0 113.668 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 m -128.36 155.48 44.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.773 1.629 . . . . 0.0 109.792 -162.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.69 -153.7 19.33 Favored Glycine 0 N--CA 1.471 0.972 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.432 ' HA ' ' H ' ' A' ' 50' ' ' SER . 1.8 pmm? -151.52 165.68 33.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.958 1.303 . . . . 0.0 113.965 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.31 153.23 37.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 127.66 2.384 . . . . 0.0 111.342 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 161.57 37.9 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.906 1.682 . . . . 0.0 109.979 173.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.7 m -56.87 154.21 9.74 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 122.737 1.256 . . . . 0.0 110.16 164.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.51 -10.75 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.656 157.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 89.9 m -92.49 -46.71 7.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -167.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.4 p -95.23 -101.45 0.16 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.051 1.34 . . . . 0.0 110.248 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -159.47 -47.26 0.05 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.609 1.964 . . . . 0.0 112.98 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.04 153.62 38.45 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 125.923 1.689 . . . . 0.0 115.258 -157.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 135.97 15.6 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.342 2.028 . . . . 0.0 113.594 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.4 tp -99.06 -30.44 12.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.432 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -157.09 157.95 35.49 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 112.162 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -101.65 147.22 26.7 Favored 'General case' 0 C--O 1.226 -0.156 0 O-C-N 121.274 -0.891 . . . . 0.0 111.412 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 37' ' ' MET . 0.4 OUTLIER -64.67 -17.27 63.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.482 1.113 . . . . 0.0 112.232 172.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -35.84 69.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.476 1.91 . . . . 0.0 113.747 168.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -77.56 -1.35 30.21 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.812 2.045 . . . . 0.0 112.53 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.58 116.96 8.89 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.784 0.802 . . . . 0.0 111.344 -171.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -81.37 136.32 35.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.956 1.302 . . . . 0.0 110.461 172.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 24.6 t 63.06 106.59 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.4 1.88 . . . . 0.0 112.999 -167.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.3 p -77.22 30.09 0.14 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.756 1.622 . . . . 0.0 113.833 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.12 -114.94 0.23 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.318 1.913 . . . . 0.0 115.018 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.42 HG21 ' H ' ' A' ' 25' ' ' PHE . 16.2 p -121.79 -116.04 0.31 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.198 1.799 . . . . 0.0 112.283 -165.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.74 22.63 2.74 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.841 1.2 . . . . 0.0 115.031 -171.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.93 104.06 47.38 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.712 1.205 . . . . 0.0 112.11 -159.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -93.89 117.16 0.28 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.771 2.314 . . . . 0.0 112.274 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.7 p -141.16 169.33 17.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 126.13 1.772 . . . . 0.0 111.256 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -149.41 141.32 23.76 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.85 1.26 . . . . 0.0 108.778 161.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.3 p -85.7 -16.83 37.78 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 0.0 113.799 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -158.38 159.8 36.2 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.068 1.747 . . . . 0.0 111.014 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.72 86.9 2.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.297 1.439 . . . . 0.0 109.408 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -105.9 119.52 39.39 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.96 0.904 . . . . 0.0 110.981 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.94 -33.21 0.48 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.45 1.5 . . . . 0.0 113.024 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.51 116.25 16.03 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.277 1.031 . . . . 0.0 112.194 -177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.9 mmpt? -139.25 137.88 36.3 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 126.408 1.883 . . . . 0.0 110.902 -173.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.88 -80.52 0.24 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 125.32 1.438 . . . . 0.0 115.007 162.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.9 m -52.32 -33.03 40.69 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.486 1.114 . . . . 0.0 111.317 162.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -124.77 18.94 8.63 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.594 1.187 . . . . 0.0 113.928 -166.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -127.18 -5.18 6.11 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.861 1.664 . . . . 0.0 110.721 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.77 -40.15 63.66 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.255 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -126.82 -56.92 1.36 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 164.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 p -162.72 -47.79 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -167.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.44 -7.71 3.49 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 124.501 1.048 . . . . 0.0 114.784 -160.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.68 177.24 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 127.411 2.284 . . . . 0.0 111.12 -172.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.91 170.35 16.78 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.588 1.555 . . . . 0.0 110.141 170.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.46 158.44 34.11 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -148.87 108.52 4.0 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 128.097 2.559 . . . . 0.0 108.699 -166.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.5 144.82 51.24 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.101 -0.999 . . . . 0.0 111.02 175.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -117.26 19.52 14.09 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.764 1.225 . . . . 0.0 112.486 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.4 t -70.3 35.18 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.453 2.301 . . . . 0.0 114.211 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 t -110.74 -23.64 10.93 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.324 2.25 . . . . 0.0 113.562 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -97.28 14.95 24.31 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.45 1.9 . . . . 0.0 113.164 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.82 -7.66 48.68 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.516 1.532 . . . . 0.0 114.836 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 37.7 t -111.06 103.53 54.99 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.341 1.857 . . . . 0.0 109.648 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.47 125.76 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.759 1.639 . . . . 0.0 111.613 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mmt-85 -151.26 156.96 41.92 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.807 2.443 . . . . 0.0 111.609 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.4 mtm -115.95 98.96 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 128.024 2.53 . . . . 0.0 107.407 167.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -83.06 148.6 27.43 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.118 -1.614 . . . . 0.0 108.974 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.0 m -138.22 145.47 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 122.343 1.068 . . . . 0.0 112.879 -167.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.656 HG12 ' H ' ' A' ' 103' ' ' LEU . 6.1 m -139.86 156.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.067 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.579 ' H ' ' HB2' ' A' ' 102' ' ' HIS . 48.9 t -80.11 155.37 27.53 Favored 'General case' 0 N--CA 1.413 -2.304 0 CA-C-O 124.079 1.895 . . . . 0.0 108.517 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -114.67 -18.22 11.45 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 110.906 -2.861 . . . . 0.0 113.497 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.63 -41.79 95.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.77 0.828 . . . . 0.0 112.185 168.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -110.85 -20.66 12.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.859 2.464 . . . . 0.0 113.369 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 64.8 122.51 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.06 1.744 . . . . 0.0 112.27 -162.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 75.47 77.88 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.694 1.998 . . . . 0.0 115.765 164.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.579 ' HB2' ' H ' ' A' ' 96' ' ' CYS 0.332 2.9 t60 -85.57 -21.44 28.52 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 176.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.656 ' H ' HG12 ' A' ' 95' ' ' VAL . 3.2 tp 53.16 27.84 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.308 2.643 . . . . 0.0 116.023 163.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.8 -179.55 52.96 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 123.103 1.391 . . . . 0.0 109.817 159.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.06 162.87 40.23 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 123.44 1.59 . . . . 0.0 113.393 -174.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.05 139.59 42.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 112.86 -1.973 . . . . 0.0 108.488 -169.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -131.41 144.25 52.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.49 142.72 49.91 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.204 2.603 . . . . 0.0 110.12 162.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -107.98 -3.13 19.08 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.57 -64.28 0.61 Allowed Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.897 1.713 . . . . 0.0 114.215 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.01 -170.96 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 124.584 3.523 . . . . 0.0 114.438 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -50.02 159.82 0.74 Allowed Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.761 1.624 . . . . 0.0 111.985 169.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.62 -5.42 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.861 2.374 . . . . 0.0 114.758 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.5 p -65.41 -10.88 37.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.753 1.621 . . . . 0.0 114.519 164.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.43 -9.17 48.06 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.831 1.682 . . . . 0.0 116.359 172.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -56.51 143.14 36.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.973 1.309 . . . . 0.0 113.061 -171.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -129.67 133.94 47.38 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 110.283 -166.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -104.8 129.02 53.15 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.634 1.174 . . . . 0.0 110.047 -174.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.7 p -131.17 129.27 41.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.391 1.077 . . . . 0.0 111.969 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 122' ' ' SER . 7.0 tp -109.34 161.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.31 1.044 . . . . 0.0 110.631 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -93.06 -21.51 19.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.83 1.252 . . . . 0.0 113.292 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.464 ' H ' HG13 ' A' ' 120' ' ' ILE . 50.6 m 58.25 19.67 6.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.3 p -71.85 -17.69 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.77 43.66 1.26 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.436 1.495 . . . . 0.0 113.167 -163.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.5 mt -117.55 156.01 28.82 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.759 1.266 . . . . 0.0 114.181 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -102.1 152.33 21.11 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.396 2.278 . . . . 0.0 109.76 157.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -146.32 145.59 30.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.81 0.844 . . . . 0.0 111.715 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -140.75 153.54 67.92 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.82 1.648 . . . . 0.0 110.553 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.38 171.9 14.28 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.373 2.049 . . . . 0.0 112.765 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.47 -37.89 22.55 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -71.39 160.05 83.72 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 128.932 2.893 . . . . 0.0 113.663 -174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.05 -179.16 0.5 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.102 2.535 . . . . 0.0 112.948 161.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 60.87 28.64 18.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.817 1.647 . . . . 0.0 113.296 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.35 -13.58 60.13 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.362 1.465 . . . . 0.0 112.669 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 52.01 57.41 6.52 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.045 1.738 . . . . 0.0 114.962 169.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 87.0 mt -139.66 40.88 2.02 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.508 1.923 . . . . 0.0 111.535 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.62 -31.24 32.52 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.389 1.476 . . . . 0.0 113.326 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -144.89 162.73 36.11 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.183 -0.948 . . . . 0.0 110.15 149.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -72.54 -52.97 13.34 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.797 -0.565 . . . . 0.0 111.756 174.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.62 161.54 40.8 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.448 1.499 . . . . 0.0 111.696 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -88.75 -23.73 22.84 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 62.04 -40.15 0.14 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 129.303 3.041 . . . . 0.0 119.149 172.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.037 1.335 . . . . 0.0 112.097 -157.461 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.91 17.37 0.77 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.937 1.295 . . . . 0.0 113.492 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.38 151.36 39.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 123.818 1.771 . . . . 0.0 114.506 -174.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -85.0 -29.47 24.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.253 -1.794 . . . . 0.0 111.297 -172.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -60.74 -42.6 97.67 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.964 0.906 . . . . 0.0 110.717 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -66.81 -27.5 67.62 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 176.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -75.76 -40.11 55.9 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.857 1.663 . . . . 0.0 112.875 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.46 -44.28 78.99 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.79 -0.569 . . . . 0.0 111.431 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 t -133.46 78.24 63.33 Favored Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 125.087 1.355 . . . . 0.0 112.448 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.02 174.91 5.21 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.106 2.537 . . . . 0.0 113.627 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -53.01 -44.8 67.57 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.196 -1.565 . . . . 0.0 113.739 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -61.08 -29.67 69.89 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -77.34 -39.03 49.04 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.298 1.039 . . . . 0.0 112.216 169.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -59.74 -44.34 93.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.932 1.293 . . . . 0.0 110.828 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.8 -30.96 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 174.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -89.35 -17.65 28.46 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 120.371 1.441 . . . . 0.0 113.435 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -61.62 -27.78 68.9 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.39 1.876 . . . . 0.0 111.782 177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -127.72 -32.88 2.33 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 167.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HZ2' ' CE1' ' A' ' 102' ' ' HIS . 0.0 OUTLIER 48.23 21.28 0.33 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 118.61 2.819 . . . . 0.0 118.61 -176.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.6 3.25 0.08 OUTLIER Glycine 0 CA--C 1.53 1.021 0 N-CA-C 117.011 1.564 . . . . 0.0 117.011 -172.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -132.34 149.64 52.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 118.444 1.122 . . . . 0.0 112.642 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -139.44 159.09 42.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 128.491 2.716 . . . . 0.0 108.304 163.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.69 65.4 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.153 0.981 . . . . 0.0 112.571 -171.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.56 118.83 5.64 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.679 2.253 . . . . 0.0 111.582 -175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -142.18 -17.07 0.74 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -26.06 43.4 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.484 -1.385 . . . . 0.0 112.81 171.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.9 -107.3 0.9 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 125.467 1.508 . . . . 0.0 113.614 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.2 ttm -54.68 -29.36 52.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.416 0.687 . . . . 0.0 112.45 170.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -90.61 8.56 33.6 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.965 1.306 . . . . 0.0 113.941 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.1 mt -72.7 73.05 1.07 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.119 -1.613 . . . . 0.0 110.802 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -76.63 -23.88 53.35 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.188 1.795 . . . . 0.0 113.659 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 56.49 -1.06 0.05 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.905 2.482 . . . . 0.0 117.256 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -155.45 114.62 3.59 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.294 2.238 . . . . 0.0 109.077 -168.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -129.3 -176.66 3.95 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.918 2.087 . . . . 0.0 110.925 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t -132.2 155.69 47.78 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 127.655 2.382 . . . . 0.0 111.862 169.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.21 -145.66 14.18 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.734 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.5 ptp -149.88 159.33 44.46 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 153.41 19.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.497 152.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -147.52 155.74 42.16 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.89 1.276 . . . . 0.0 109.785 158.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.45 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 71.5 m -61.57 165.86 4.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 124.134 1.921 . . . . 0.0 112.435 168.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.19 29.3 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 112.561 -2.109 . . . . 0.0 110.263 167.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 35.0 t -135.23 -47.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.107 1.363 . . . . 0.0 113.312 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.45 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 5.2 p -84.48 -84.57 0.14 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.854 1.262 . . . . 0.0 112.065 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -153.5 -48.94 0.09 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.5 p -145.02 165.07 23.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -139.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.1 144.4 46.87 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.409 2.74 . . . . 0.0 113.44 172.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -144.35 -4.63 0.79 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.38 129.05 21.53 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.525 -1.359 . . . . 0.0 110.299 169.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 p -94.48 142.45 27.42 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.164 -0.96 . . . . 0.0 111.488 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.17 -11.22 28.59 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.084 0.945 . . . . 0.0 113.336 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -38.92 72.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 120.43 -1.419 . . . . 0.0 114.054 163.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -73.32 -3.56 27.86 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.513 1.525 . . . . 0.0 112.619 176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -65.56 130.72 44.3 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.275 1.03 . . . . 0.0 110.26 -173.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 61.6 t80 -128.45 170.42 13.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.961 2.104 . . . . 0.0 112.163 -170.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.8 t 66.2 155.95 0.09 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.352 1.861 . . . . 0.0 113.729 -165.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.2 p -153.83 -168.56 3.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.812 1.645 . . . . 0.0 111.492 -167.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.68 -69.97 1.17 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.535 1.54 . . . . 0.0 114.142 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.3 m -83.82 -14.1 52.14 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.059 1.743 . . . . 0.0 113.71 -170.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.07 0.04 87.33 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.736 1.16 . . . . 0.0 113.472 -165.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.0 t90 -69.99 142.45 90.54 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 124.934 1.294 . . . . 0.0 114.151 -170.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -91.78 143.01 2.8 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.468 2.779 . . . . 0.0 115.486 -166.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.1 m -159.68 172.29 18.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.72 2.008 . . . . 0.0 110.271 169.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -140.19 121.76 15.21 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.393 1.877 . . . . 0.0 107.16 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -84.97 -10.8 56.67 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -160.93 164.1 31.38 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.106 0.962 . . . . 0.0 112.926 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.5 87.42 2.66 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.682 1.593 . . . . 0.0 109.331 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -70.72 161.38 30.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.511 1.124 . . . . 0.0 112.029 174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.34 1.28 75.37 Favored Glycine 0 CA--C 1.541 1.679 0 O-C-N 121.153 -0.967 . . . . 0.0 115.345 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.8 t -133.35 147.25 51.82 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.243 1.817 . . . . 0.0 110.493 166.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 1.3 tptt -144.3 73.14 1.37 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -159.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.99 -67.53 0.47 Allowed Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.017 1.77 . . . . 0.0 114.082 171.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.46 -31.88 71.85 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.751 0.82 . . . . 0.0 111.123 167.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 70' ' ' LYS . 11.6 m-20 -89.28 8.75 28.81 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -170.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.82 -33.89 76.16 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.078 -1.014 . . . . 0.0 111.851 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 t -89.57 -19.3 25.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.717 1.207 . . . . 0.0 112.154 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -72.19 -19.4 61.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.681 1.592 . . . . 0.0 112.904 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -55.1 -48.25 73.83 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.165 1.386 . . . . 0.0 112.932 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.11 17.67 79.57 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.3 -160.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -108.02 149.44 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 119.502 1.651 . . . . 0.0 110.253 170.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 mp -125.56 167.56 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.668 1.587 . . . . 0.0 111.499 -169.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.93 150.42 36.05 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.366 1.466 . . . . 0.0 111.391 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.98 117.79 4.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.918 1.687 . . . . 0.0 108.351 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.29 144.66 35.92 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.599 1.16 . . . . 0.0 111.416 174.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -124.8 34.45 4.99 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 123.009 1.385 . . . . 0.0 111.083 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.0 t -70.2 42.92 0.06 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 129.612 3.165 . . . . 0.0 112.48 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 t -126.08 -12.77 6.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.977 2.111 . . . . 0.0 113.277 -170.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -98.14 16.89 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.953 2.101 . . . . 0.0 113.598 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.14 5.52 89.61 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 124.054 0.835 . . . . 0.0 115.019 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 31.9 t -141.74 135.62 14.76 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 127.742 2.417 . . . . 0.0 110.284 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.5 125.77 11.54 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.336 2.691 . . . . 0.0 112.569 173.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -136.17 156.37 48.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.637 2.375 . . . . 0.0 109.89 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.2 mtt -133.77 131.19 39.06 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.386 2.274 . . . . 0.0 108.527 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -132.43 148.66 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 121.163 -0.961 . . . . 0.0 111.898 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.73 147.93 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.077 1.351 . . . . 0.0 112.513 -175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.54 152.11 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.198 1.399 . . . . 0.0 111.495 -174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 98' ' ' GLN . 43.6 t -90.07 117.55 28.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 164.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -97.55 -0.87 45.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.043 1.737 . . . . 0.0 113.188 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HB2' ' SG ' ' A' ' 96' ' ' CYS . 30.8 mt-30 -63.21 -45.25 92.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.194 1.398 . . . . 0.0 110.404 162.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 p -125.4 -14.09 6.48 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.329 2.252 . . . . 0.0 115.197 -169.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.275 75.5 mt-10 74.61 60.11 0.07 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.887 2.475 . . . . 0.0 115.656 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.44 141.11 28.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.526 ' CE1' ' HZ2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -68.8 115.2 7.86 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.147 -0.97 . . . . 0.0 111.672 172.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 tp -97.68 -36.1 10.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.455 1.121 . . . . 0.0 113.774 -159.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.34 155.85 26.46 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 127.399 2.428 . . . . 0.0 112.876 -169.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.44 146.16 29.46 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.745 0.818 . . . . 0.0 111.595 -176.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -138.22 135.22 44.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 110.453 -155.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.49 152.07 41.17 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.21 156.48 25.98 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.502 3.468 . . . . 0.0 112.182 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -123.81 5.17 8.77 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -164.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.75 -59.82 0.68 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 117.839 -1.534 . . . . 0.0 115.682 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -62.59 -166.55 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.83 3.02 . . . . 0.0 112.58 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -55.52 159.33 4.87 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 110.602 169.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -57.9 -8.19 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.224 2.616 . . . . 0.0 114.283 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -24.63 15.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.019 1.328 . . . . 0.0 113.487 163.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.85 2.4 76.26 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.655 1.598 . . . . 0.0 116.275 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -51.0 139.56 17.27 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.59 1.195 . . . . 0.0 112.964 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -109.81 126.94 54.32 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.768 1.227 . . . . 0.0 108.534 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.83 98.04 8.34 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.886 0.875 . . . . 0.0 109.267 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.6 t -77.18 148.29 35.99 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.09 0.956 . . . . 0.0 110.626 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.4 tp -126.98 157.17 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.467 1.107 . . . . 0.0 110.062 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.04 159.28 35.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.334 1.054 . . . . 0.0 112.879 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -123.04 19.41 10.01 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.1 p -44.29 -39.72 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 126.243 1.817 . . . . 0.0 115.868 -165.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.29 30.27 0.62 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.475 1.51 . . . . 0.0 112.804 -174.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.43 173.24 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.591 1.556 . . . . 0.0 109.946 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HE3' ' HA ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -115.29 149.61 37.55 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 122.429 1.109 . . . . 0.0 113.257 173.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -159.21 133.11 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.591 1.156 . . . . 0.0 110.001 -168.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -145.06 152.13 50.46 Favored Pre-proline 0 N--CA 1.472 0.669 0 C-N-CA 124.796 1.238 . . . . 0.0 112.1 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.67 168.97 23.61 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.135 1.89 . . . . 0.0 112.402 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -41.11 12.83 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.339 1.056 . . . . 0.0 111.776 177.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -66.57 147.6 98.93 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.192 0.997 . . . . 0.0 111.652 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.33 178.57 4.78 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.517 2.811 . . . . 0.0 113.798 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 66.32 36.85 5.11 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.212 2.205 . . . . 0.0 112.959 -164.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.83 -20.23 60.51 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.807 1.243 . . . . 0.0 112.642 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.9 143.36 50.09 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.535 1.534 . . . . 0.0 111.311 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.0 tp -159.19 37.01 0.21 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.863 1.265 . . . . 0.0 112.043 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . 0.262 10.8 tt0 45.43 44.72 9.8 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.8 2.84 . . . . 0.0 113.776 176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.95 161.25 30.36 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.679 -1.6 . . . . 0.0 112.913 170.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 9.6 m170 56.79 96.52 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.101 1.76 . . . . 0.0 115.547 171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -55.23 120.9 7.73 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.531 -1.356 . . . . 0.0 109.974 164.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -71.16 -17.38 62.55 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -162.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -152.3 -50.19 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.076 1.75 . . . . 0.0 110.641 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 . . . . . 0 C--O 1.245 0.858 0 C-N-CA 128.845 2.858 . . . . 0.0 108.39 170.583 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 ttp . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 117.431 -1.271 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.15 -85.52 0.12 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.176 1.353 . . . . 0.0 111.856 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -120.29 -178.67 3.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.104 1.362 . . . . 0.0 111.756 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -103.37 -26.44 12.91 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.069 0.948 . . . . 0.0 112.994 171.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -53.48 -52.67 58.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.387 1.875 . . . . 0.0 111.651 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.4 -28.04 67.59 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 176.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -70.39 -37.2 74.48 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.168 0.987 . . . . 0.0 112.408 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 pp -91.95 -19.84 22.02 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -137.31 58.19 16.74 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 171.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.08 140.13 27.81 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.212 3.275 . . . . 0.0 116.018 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -88.66 -52.26 5.24 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.297 1.839 . . . . 0.0 111.554 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -54.99 -21.01 10.43 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.796 2.038 . . . . 0.0 113.728 169.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -95.32 -20.74 18.9 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.359 1.863 . . . . 0.0 114.212 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -89.92 -53.99 4.25 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.445 1.498 . . . . 0.0 112.321 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.3 t -65.44 -24.59 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 120.885 -1.135 . . . . 0.0 112.34 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -68.47 -25.17 64.85 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.456 1.902 . . . . 0.0 113.079 171.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -67.21 -40.3 86.43 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.033 0.833 . . . . 0.0 111.501 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -79.22 -24.16 43.29 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.489 0.493 . . . . 0.0 110.669 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -66.86 63.58 0.05 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.29 2.236 . . . . 0.0 114.76 172.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.05 -21.29 0.13 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.928 1.728 . . . . 0.0 114.761 169.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 t -91.57 73.92 5.93 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 117.819 0.81 . . . . 0.0 111.779 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -68.78 142.15 55.0 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 123.232 1.491 . . . . 0.0 111.801 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.18 143.61 33.08 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 113.489 -1.687 . . . . 0.0 113.365 -158.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.35 168.96 23.57 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.368 2.712 . . . . 0.0 111.597 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -61.26 -29.94 70.16 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 t 69.67 -37.63 0.38 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.549 2.74 . . . . 0.0 113.509 176.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 51.29 -101.0 0.05 OUTLIER Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.797 2.141 . . . . 0.0 114.824 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.6 mtp -59.11 -22.4 60.8 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -99.65 10.53 41.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.577 1.951 . . . . 0.0 113.091 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.5 mt -68.97 65.72 0.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.034 -1.041 . . . . 0.0 111.282 161.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -65.59 154.17 39.5 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.485 1.914 . . . . 0.0 113.684 -171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.87 122.32 17.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.403 0.681 . . . . 0.0 110.674 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -143.84 -2.31 0.94 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -163.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 51.41 -160.93 0.09 Allowed 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 127.896 2.478 . . . . 0.0 114.648 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.618 HG23 ' HB2' ' A' ' 130' ' ' SER . 1.3 t -136.66 175.25 9.78 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -166.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.48 -140.51 6.37 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 124.56 1.076 . . . . 0.0 114.638 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -155.33 161.8 40.99 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.473 1.13 . . . . 0.0 112.564 173.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -133.52 145.7 50.38 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.999 1.32 . . . . 0.0 111.336 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.63 164.04 38.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.583 1.153 . . . . 0.0 111.648 -161.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 69.7 m -59.07 157.58 9.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 123.451 1.596 . . . . 0.0 113.874 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.259 8.7 p -125.73 41.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.557 158.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.3 t -135.64 -48.01 0.69 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.706 1.202 . . . . 0.0 112.945 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 9.4 p -96.42 -89.96 0.25 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.522 1.529 . . . . 0.0 113.844 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.32 -30.75 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.043 2.137 . . . . 0.0 113.114 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.3 p -85.37 125.69 69.06 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -161.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.16 138.8 28.48 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.046 1.831 . . . . 0.0 111.403 160.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.17 -27.9 4.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 113.372 -163.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.68 137.99 18.46 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.9 m -84.07 136.46 34.01 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.299 -0.875 . . . . 0.0 109.693 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.8 m -62.38 -12.42 21.27 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.964 1.706 . . . . 0.0 114.387 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -29.54 69.03 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.611 0.764 . . . . 0.0 111.322 172.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -74.68 -2.99 28.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.186 0.994 . . . . 0.0 113.497 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 16.2 ttpp -53.45 128.25 28.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.774 0.716 . . . . 0.0 109.84 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -67.12 164.99 16.81 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 18.1 t -52.6 137.9 29.48 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.071 0.949 . . . . 0.0 111.461 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.28 36.3 p 49.29 -74.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.493 2.317 . . . . 0.0 114.099 -162.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.9 55.01 19.98 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.503 1.525 . . . . 0.0 113.117 168.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.1 p -79.48 -82.48 0.1 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.389 1.476 . . . . 0.0 112.763 -161.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -86.09 -11.95 71.92 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.003 0.811 . . . . 0.0 112.949 163.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.404 ' CZ3' ' HB2' ' A' ' 62' ' ' SER . 37.9 t90 -97.03 105.71 26.01 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.432 1.493 . . . . 0.0 111.056 -175.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -84.96 123.36 2.74 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.393 2.062 . . . . 0.0 111.879 -170.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 60' ' ' TRP . 28.6 t -149.58 155.61 40.58 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.832 1.253 . . . . 0.0 111.547 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.66 115.25 4.85 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.559 1.544 . . . . 0.0 109.253 -159.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.6 p -72.26 -16.76 61.93 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -146.94 155.54 42.36 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.929 0.892 . . . . 0.0 112.399 166.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.04 108.02 3.38 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 142.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -112.98 152.7 29.1 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.86 1.664 . . . . 0.0 111.871 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.48 -30.4 4.9 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.611 1.101 . . . . 0.0 111.526 -156.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 p -107.62 133.28 52.3 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.345 1.858 . . . . 0.0 112.868 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -148.85 132.21 16.57 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.349 2.259 . . . . 0.0 110.613 174.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.76 -81.46 0.01 OUTLIER Glycine 0 N--CA 1.47 0.944 0 C-N-CA 127.257 2.361 . . . . 0.0 114.761 157.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -28.1 40.14 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.429 1.492 . . . . 0.0 112.278 168.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.84 4.67 53.54 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -171.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.02 -12.61 60.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.186 1.395 . . . . 0.0 113.255 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -103.0 -30.62 10.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.451 0.569 . . . . 0.0 112.053 163.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -73.75 -25.59 60.25 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.74 -30.64 56.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.427 1.491 . . . . 0.0 112.362 167.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.18 73.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.662 1.125 . . . . 0.0 112.73 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -80.16 166.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 123.176 1.465 . . . . 0.0 111.995 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -133.87 176.36 8.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.88 2.072 . . . . 0.0 108.792 166.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.568 ' H ' HD23 ' A' ' 80' ' ' LEU . 7.0 ptt180 -147.3 146.7 29.82 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.9 0.88 . . . . 0.0 112.967 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.86 108.63 7.05 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.191 1.796 . . . . 0.0 109.205 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -89.69 149.22 22.87 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.393 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.52 120.01 6.92 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.659 1.184 . . . . 0.0 109.205 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -130.08 35.27 4.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.218 1.007 . . . . 0.0 110.605 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 t -130.92 -6.47 3.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.736 2.015 . . . . 0.0 114.606 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.3 mt -88.21 24.39 1.88 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.702 2.001 . . . . 0.0 111.806 170.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.66 -10.27 46.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.636 2.065 . . . . 0.0 114.155 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.8 t -145.83 130.9 9.09 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.788 1.235 . . . . 0.0 109.807 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.25 133.01 23.7 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.094 2.53 . . . . 0.0 112.88 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.9 mmt-85 -138.6 157.87 45.32 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.829 2.852 . . . . 0.0 111.741 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.3 mtt -138.76 128.03 24.24 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.392 2.277 . . . . 0.0 107.915 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.89 153.29 47.63 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.205 1.002 . . . . 0.0 111.325 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.2 m -123.76 141.32 44.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.206 1.402 . . . . 0.0 111.827 169.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -117.52 152.03 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.186 1.394 . . . . 0.0 109.591 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 40.4 t -93.02 120.91 33.81 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 165.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -86.56 -14.96 41.4 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.073 1.349 . . . . 0.0 114.411 169.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -65.42 -38.36 89.7 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.691 0.796 . . . . 0.0 112.447 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.55 -12.22 10.38 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 127.604 2.361 . . . . 0.0 114.888 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.362 56.5 mt-10 62.19 64.1 1.0 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.912 2.485 . . . . 0.0 115.213 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -141.28 136.82 32.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -78.45 109.16 12.37 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.988 165.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.297 2.7 pp -141.27 -1.41 1.35 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 118.751 2.871 . . . . 0.0 118.751 -172.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.0 142.04 13.5 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 125.746 1.641 . . . . 0.0 111.515 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.17 160.18 43.45 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.753 -0.851 . . . . 0.0 111.308 -176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.0 p -148.35 139.11 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 125.138 1.375 . . . . 0.0 111.125 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -145.87 154.11 50.89 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.869 1.268 . . . . 0.0 114.007 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -84.38 141.01 8.79 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.574 2.849 . . . . 0.0 111.27 171.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.36 28.86 4.7 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.352 1.461 . . . . 0.0 113.158 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.42 -50.96 0.82 Allowed Glycine 0 CA--C 1.542 1.748 0 C-N-CA 126.542 2.02 . . . . 0.0 115.241 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -87.72 -165.38 0.23 Allowed 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.175 3.25 . . . . 0.0 112.295 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -56.28 149.13 38.91 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.819 1.648 . . . . 0.0 113.064 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -66.68 9.74 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 124.791 3.661 . . . . 0.0 115.261 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -31.51 62.09 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.85 -1.156 . . . . 0.0 112.373 162.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.0 14.12 65.17 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 -169.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.88 150.57 28.2 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -165.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -105.42 137.73 42.77 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.902 1.681 . . . . 0.0 108.652 170.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -90.48 160.82 15.81 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 123.824 0.85 . . . . 0.0 109.721 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.9 p -150.3 155.76 40.27 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.057 1.343 . . . . 0.0 110.834 166.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 mm -118.85 165.81 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 126.36 1.864 . . . . 0.0 109.368 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -132.85 103.84 6.28 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.305 -1.497 . . . . 0.0 113.622 150.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -74.73 21.23 0.11 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.31 -19.71 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.067 1.747 . . . . 0.0 114.895 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.11 17.53 10.8 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.304 1.842 . . . . 0.0 114.923 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 61.5 mt -120.69 157.52 29.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.324 1.059 . . . . 0.0 113.174 -168.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -104.57 161.9 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.267 2.227 . . . . 0.0 111.288 163.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -142.46 145.5 33.81 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 111.003 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -148.99 151.67 35.04 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.019 1.328 . . . . 0.0 112.144 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.91 170.31 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.801 2.334 . . . . 0.0 113.288 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.618 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.8 OUTLIER -86.18 -44.25 12.35 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 122.836 1.303 . . . . 0.0 112.532 -178.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -64.26 148.18 96.12 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 126.252 1.821 . . . . 0.0 112.016 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.18 -179.97 2.08 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.7 2.267 . . . . 0.0 112.566 168.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 62.96 32.16 15.74 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.183 1.393 . . . . 0.0 113.756 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.24 -19.85 57.97 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.55 1.14 . . . . 0.0 112.897 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.15 145.38 25.95 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.361 1.064 . . . . 0.0 110.881 167.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.86 35.34 2.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.461 1.505 . . . . 0.0 111.904 -166.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -58.76 -9.47 1.79 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.546 1.538 . . . . 0.0 114.901 -174.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -63.32 -21.85 66.51 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 171.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.94 172.17 9.47 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.267 1.427 . . . . 0.0 112.96 -178.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -148.57 131.48 16.16 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.422 -0.799 . . . . 0.0 111.049 171.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 49.49 -179.36 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 128.964 2.906 . . . . 0.0 117.953 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -125.76 166.97 15.82 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.364 1.866 . . . . 0.0 108.953 165.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 . . . . . 0 C--O 1.251 1.161 0 C-N-CA 124.897 1.279 . . . . 0.0 112.235 178.821 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 ttm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 118.119 -0.944 . . . . 0.0 108.907 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.63 29.97 10.16 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -135.63 168.34 19.45 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.889 2.076 . . . . 0.0 110.207 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -118.28 -40.14 2.97 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 169.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -57.7 8.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.051 1.34 . . . . 0.0 110.919 -172.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -64.24 -25.87 68.25 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.262 1.025 . . . . 0.0 112.956 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 43.8 tttt -74.19 -39.91 62.85 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 170.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.84 -21.75 54.57 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.121 1.368 . . . . 0.0 114.478 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.6 t -126.81 64.4 58.71 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.092 1.357 . . . . 0.0 111.551 171.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -84.12 131.84 5.17 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.666 2.244 . . . . 0.0 114.452 -168.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -82.13 -60.23 2.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.812 -1.54 . . . . 0.0 111.777 -158.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -27.39 50.57 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.198 1.399 . . . . 0.0 113.353 170.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.4 -12.12 35.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.382 1.873 . . . . 0.0 113.3 -176.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -106.21 -41.92 5.21 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.387 1.075 . . . . 0.0 113.602 175.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -50.87 -33.66 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.796 0.838 . . . . 0.0 111.532 173.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 p -79.01 -19.55 51.28 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 128.83 2.852 . . . . 0.0 114.738 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -82.68 -43.22 17.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.618 1.567 . . . . 0.0 110.241 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -92.41 -46.13 7.82 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.482 -174.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . 0.44 12.3 ptpt 42.54 24.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 1 N-CA-C 122.18 4.141 . . . . 0.0 122.18 171.782 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.7 46.87 0.14 Allowed Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.276 0.941 . . . . 0.0 111.921 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 t -122.51 101.38 7.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.114 1.366 . . . . 0.0 113.982 -161.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.06 144.77 30.22 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.902 0.881 . . . . 0.0 111.008 161.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.77 155.3 19.95 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.555 1.542 . . . . 0.0 110.833 -176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.76 94.85 1.05 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.225 1.95 . . . . 0.0 112.479 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -143.05 -87.09 0.14 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.84 2.056 . . . . 0.0 110.644 174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.4 t 69.0 -42.53 0.49 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 127.0 2.12 . . . . 0.0 111.543 -163.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 52.93 -107.95 0.64 Allowed Glycine 0 C--O 1.224 -0.483 0 C-N-CA 126.619 2.057 . . . . 0.0 114.281 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.1 ttm -57.43 -21.04 34.18 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.159 0.984 . . . . 0.0 113.311 173.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.92 9.05 40.76 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 175.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.29 38.46 0.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.072 1.349 . . . . 0.0 114.473 169.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -115.61 174.7 5.88 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.007 2.523 . . . . 0.0 111.648 -177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -74.67 43.12 0.18 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 122.591 1.186 . . . . 0.0 112.863 165.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.273 40.3 mmtm 55.3 86.29 0.06 Allowed 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 130.963 3.705 . . . . 0.0 115.059 168.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -81.88 168.48 17.89 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 112.109 -2.314 . . . . 0.0 112.762 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m -120.65 163.18 18.45 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 125.79 1.636 . . . . 0.0 110.082 -160.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.68 -160.2 23.89 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 114.125 0.41 . . . . 0.0 114.125 174.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.9 ptp -151.29 156.2 40.32 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.139 0.976 . . . . 0.0 113.052 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -104.4 140.72 37.52 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.464 2.706 . . . . 0.0 110.974 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -144.12 158.75 43.53 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.718 2.007 . . . . 0.0 110.861 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 1.3 t -72.86 168.39 19.0 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 123.833 1.778 . . . . 0.0 115.144 -172.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.72 3.97 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 112.877 -1.965 . . . . 0.0 111.774 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.9 t -117.57 -44.82 2.73 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.183 1.393 . . . . 0.0 111.156 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 4.3 p -90.21 -104.46 0.09 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.963 1.705 . . . . 0.0 108.239 162.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -156.8 -50.07 0.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.799 1.64 . . . . 0.0 114.147 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.56 154.96 53.9 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 -149.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.49 135.51 36.57 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.613 2.209 . . . . 0.0 111.037 162.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -22.89 0.85 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -168.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.42 120.41 10.03 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.997 -0.439 . . . . 0.0 110.8 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -86.04 135.08 33.77 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 123.565 1.65 . . . . 0.0 112.421 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -5.72 6.64 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.047 2.139 . . . . 0.0 112.885 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -23.69 57.86 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.705 1.202 . . . . 0.0 112.948 170.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -84.23 -1.13 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.652 1.181 . . . . 0.0 114.002 172.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -79.66 123.04 27.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.089 0.956 . . . . 0.0 111.143 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -77.61 70.14 3.95 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 122.426 1.108 . . . . 0.0 111.285 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.9 t -84.92 -6.03 59.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 p -71.6 45.73 0.11 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 128.855 2.862 . . . . 0.0 114.329 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.38 -63.86 0.19 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.287 0.946 . . . . 0.0 113.248 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -101.74 -9.81 20.51 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.542 0.671 . . . . 0.0 112.456 -161.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.43 11.12 46.31 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.102 0.858 . . . . 0.0 114.011 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -79.84 147.46 66.5 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -157.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -77.53 89.49 1.32 Allowed 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 123.062 2.508 . . . . 0.0 114.888 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -149.78 163.58 37.62 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 127.984 2.514 . . . . 0.0 111.443 -176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -154.98 145.39 22.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.924 2.09 . . . . 0.0 108.838 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 t -73.62 -34.04 64.84 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.112 167.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -153.94 165.21 36.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.289 1.435 . . . . 0.0 110.973 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.58 92.22 6.5 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 148.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.37 130.18 45.33 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 165.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.44 -28.9 1.63 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.093 1.33 . . . . 0.0 111.723 -166.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.7 p -134.25 147.27 50.65 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.986 1.315 . . . . 0.0 114.506 175.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -148.81 110.58 4.53 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 126.63 1.972 . . . . 0.0 110.055 175.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.17 -81.37 0.01 OUTLIER Glycine 0 N--CA 1.479 1.56 0 C-N-CA 126.747 2.118 . . . . 0.0 114.799 167.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.0 m -45.25 -34.68 2.96 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.109 1.763 . . . . 0.0 113.037 164.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 70' ' ' LYS . 35.9 m-20 -107.71 9.88 29.04 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -54.03 -39.76 66.46 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.43 1.092 . . . . 0.0 112.245 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.99 -11.43 24.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.173 1.389 . . . . 0.0 112.388 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -66.87 -25.44 66.41 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.388 -0.82 . . . . 0.0 112.0 171.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.7 p -49.97 -45.56 51.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.75 2.02 . . . . 0.0 114.049 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.23 24.94 76.46 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 119.384 -0.676 . . . . 0.0 112.296 -160.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.46 157.73 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.781 1.277 . . . . 0.0 112.417 174.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp -129.12 177.73 6.93 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 128.576 2.751 . . . . 0.0 109.134 -173.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.24 154.9 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.014 -1.054 . . . . 0.0 112.549 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.74 105.93 6.35 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 126.488 1.915 . . . . 0.0 109.222 175.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.78 154.42 19.53 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.933 0.893 . . . . 0.0 111.064 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -143.06 113.89 7.6 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.713 1.205 . . . . 0.0 108.444 166.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -129.33 37.57 4.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.889 1.328 . . . . 0.0 110.269 170.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.8 t -113.79 -17.93 11.95 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.798 1.639 . . . . 0.0 113.973 -168.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.44 22.14 5.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.355 2.262 . . . . 0.0 111.847 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.68 -12.01 54.08 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 126.634 2.064 . . . . 0.0 114.761 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.09 130.23 23.4 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.219 1.408 . . . . 0.0 110.025 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.29 128.36 11.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.402 2.068 . . . . 0.0 112.12 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -133.18 155.95 48.38 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 128.08 2.552 . . . . 0.0 109.904 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.3 mtt -141.27 130.81 23.92 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.06 1.744 . . . . 0.0 109.423 -172.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -133.42 153.67 51.41 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.29 1.436 . . . . 0.0 110.735 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.6 m -120.94 145.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.239 1.016 . . . . 0.0 111.217 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.38 138.7 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.593 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.7 t -79.02 108.76 12.74 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -79.89 -7.71 58.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.285 1.034 . . . . 0.0 113.272 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -63.89 -39.5 94.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.323 1.049 . . . . 0.0 112.073 170.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 25.5 p -134.77 -5.83 2.47 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.361 43.3 mt-10 71.33 53.25 0.24 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.613 2.365 . . . . 0.0 114.051 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -125.74 134.04 51.89 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.833 1.653 . . . . 0.0 113.207 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -78.88 76.59 5.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.355 1.462 . . . . 0.0 112.307 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 3.24 6.41 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 -171.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.9 172.41 19.31 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-O 122.825 1.236 . . . . 0.0 116.128 160.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -137.48 160.36 39.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.8 p -125.68 123.68 65.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.651 1.98 . . . . 0.0 110.506 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -124.58 149.15 61.06 Favored Pre-proline 0 C--O 1.241 0.654 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.192 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.69 152.32 53.09 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.288 2.658 . . . . 0.0 112.347 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -100.63 -0.46 37.5 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.51 1.924 . . . . 0.0 115.129 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 131.94 -61.48 0.66 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.437 1.494 . . . . 0.0 115.098 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.47 -157.94 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 124.795 3.663 . . . . 0.0 112.902 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.2 150.53 31.1 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 124.758 1.223 . . . . 0.0 112.304 169.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.21 2.17 2.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.138 3.226 . . . . 0.0 114.464 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.9 p -59.48 -24.01 63.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.312 -0.868 . . . . 0.0 113.141 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.59 0.66 85.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.579 1.392 . . . . 0.0 116.579 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -60.39 146.11 45.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.669 1.235 . . . . 0.0 113.422 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.0 149.59 28.33 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.258 1.823 . . . . 0.0 110.887 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -82.45 144.74 30.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.672 0.748 . . . . 0.0 111.834 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.3 p -129.49 134.63 47.89 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.57 2.748 . . . . 0.0 108.478 168.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.3 tp -127.85 126.47 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.358 -0.839 . . . . 0.0 112.265 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -119.68 3.05 11.17 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.3 m -134.17 39.44 3.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.132 1.773 . . . . 0.0 111.766 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.0 p -50.24 -39.73 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -163.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 69.95 -11.76 0.53 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.588 2.755 . . . . 0.0 117.516 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.4 pp -126.24 176.47 7.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.547 1.939 . . . . 0.0 114.094 -166.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.07 178.97 4.1 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 114.589 -165.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -156.59 160.92 39.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.766 1.226 . . . . 0.0 113.821 -169.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.7 152.74 79.22 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.914 1.686 . . . . 0.0 110.663 160.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.56 167.88 26.09 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.595 1.53 . . . . 0.0 111.284 160.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.35 -45.18 9.19 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.969 1.308 . . . . 0.0 112.507 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.65 160.26 62.1 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 127.149 2.18 . . . . 0.0 113.469 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.87 -177.33 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.92 3.08 . . . . 0.0 113.44 167.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 58.4 37.94 25.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.36 1.464 . . . . 0.0 113.131 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.47 -14.63 56.79 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.657 1.983 . . . . 0.0 113.447 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.31 -177.77 6.85 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.99 1.316 . . . . 0.0 111.262 168.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.0 tp 68.33 47.76 0.94 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.866 1.266 . . . . 0.0 111.406 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.66 -27.27 66.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.589 1.156 . . . . 0.0 113.03 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -89.64 173.3 8.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.271 1.029 . . . . 0.0 110.908 165.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -63.97 161.57 15.54 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -75.66 -147.22 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.04 2.136 . . . . 0.0 109.846 165.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 59.3 t60 56.72 30.62 17.91 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 172.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -78.54 54.57 1.48 Allowed 'General case' 0 CA--C 1.55 0.979 0 O-C-N 120.013 -1.68 . . . . 0.0 113.102 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 . . . . . 0 C--O 1.252 1.189 0 C-N-CA 127.934 2.493 . . . . 0.0 110.942 -177.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 118.558 -0.734 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.31 -79.78 0.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.238 1.015 . . . . 0.0 110.155 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.47 154.46 40.19 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -115.11 -31.05 6.16 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.432 1.493 . . . . 0.0 111.773 167.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -58.23 -65.26 0.68 Allowed 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 127.712 2.405 . . . . 0.0 111.655 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -67.99 -25.09 65.24 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 125.616 1.567 . . . . 0.0 112.995 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -66.47 -39.63 88.9 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.697 1.599 . . . . 0.0 112.715 172.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.27 -24.53 17.41 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -139.66 85.46 14.75 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.718 1.207 . . . . 0.0 111.187 170.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.16 161.42 32.39 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.167 2.578 . . . . 0.0 113.243 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -107.64 -71.29 0.76 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.073 0.549 . . . . 0.0 110.837 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -62.86 -30.55 71.6 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.729 -0.607 . . . . 0.0 111.685 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -19.45 45.5 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -77.73 -54.22 6.62 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.535 1.061 . . . . 0.0 110.433 165.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.3 t -50.17 -50.92 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.764 1.226 . . . . 0.0 112.108 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.7 p -63.44 -25.79 68.43 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.33 1.052 . . . . 0.0 112.897 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -67.68 -17.19 64.5 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.179 1.792 . . . . 0.0 112.801 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -122.95 -8.12 8.36 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.249 1.019 . . . . 0.0 112.822 171.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -70.28 71.8 0.44 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.532 2.333 . . . . 0.0 113.474 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.16 12.05 71.51 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 113.772 -1.558 . . . . 0.0 114.496 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 t -123.68 162.68 22.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.373 2.269 . . . . 0.0 106.647 160.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -109.31 149.53 29.33 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.059 0.943 . . . . 0.0 110.092 170.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.63 156.78 48.61 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.184 0.993 . . . . 0.0 112.968 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.37 83.4 2.23 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.538 2.159 . . . . 0.0 112.95 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -117.58 -23.09 7.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.03 -2.35 . . . . 0.0 113.372 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 54.14 19.64 2.21 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 162.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.64 -46.35 38.32 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 120.728 -1.232 . . . . 0.0 115.412 -168.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.7 mtp -66.69 -10.49 47.12 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -104.61 -5.85 21.06 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 128.494 2.718 . . . . 0.0 112.879 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.1 mt -112.86 -15.29 12.94 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.746 1.618 . . . . 0.0 112.729 -177.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.87 18.95 13.44 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -173.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . 0.25 50.3 m-20 51.04 -149.51 0.31 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.707 -151.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -115.5 10.6 15.72 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.917 1.69 . . . . 0.0 115.504 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -177.4 0.1 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.179 2.592 . . . . 0.0 115.112 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -126.26 153.63 44.51 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.298 1.439 . . . . 0.0 109.987 -164.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.31 -165.71 31.25 Favored Glycine 0 N--CA 1.474 1.22 0 O-C-N 119.914 -1.741 . . . . 0.0 116.013 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -155.57 161.25 40.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.502 1.121 . . . . 0.0 113.78 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.06 143.8 39.57 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 129.278 3.031 . . . . 0.0 111.018 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -136.76 165.19 26.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.968 2.107 . . . . 0.0 109.771 171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.72 158.57 10.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.76 1.267 . . . . 0.0 111.311 170.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 p -92.09 12.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 114.715 -1.129 . . . . 0.0 112.653 156.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.0 m -121.18 -43.61 2.42 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -162.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.6 p -103.78 -92.89 0.34 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.283 1.401 . . . . 0.0 113.679 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -160.73 -49.13 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.055 2.142 . . . . 0.0 113.7 -172.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p -113.02 156.71 42.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -158.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.82 152.49 16.99 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.73 2.953 . . . . 0.0 113.333 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.5 -26.39 1.84 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.262 1.025 . . . . 0.0 113.601 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -131.09 122.01 25.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.629 0.65 . . . . 0.0 112.041 -174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 p -85.3 130.92 34.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.947 -1.096 . . . . 0.0 109.55 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.99 -9.75 24.08 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 123.135 1.445 . . . . 0.0 112.331 174.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.8 tt0 -58.18 -33.1 68.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.807 1.243 . . . . 0.0 114.144 166.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 8.1 mmpt? -83.28 0.65 44.74 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.961 1.704 . . . . 0.0 113.092 171.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.1 117.44 7.71 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 120.097 1.317 . . . . 0.0 110.154 -169.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.8 135.19 54.54 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -164.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 72.4 m -58.51 163.34 3.2 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.656 1.583 . . . . 0.0 113.753 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.279 97.6 p 57.07 -6.63 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 128.706 2.802 . . . . 0.0 117.941 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.78 111.75 3.69 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 119.939 1.245 . . . . 0.0 110.857 164.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.5 p -71.9 -63.42 1.14 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.606 1.162 . . . . 0.0 113.645 -162.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -84.75 -22.51 53.08 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.858 0.742 . . . . 0.0 112.375 153.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.78 111.01 3.07 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -155.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.18 114.84 3.4 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.874 2.383 . . . . 0.0 111.661 -168.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 p -158.38 153.2 24.97 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.403 1.481 . . . . 0.0 111.089 -164.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.84 148.65 45.63 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.769 2.028 . . . . 0.0 109.379 -175.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.6 p -84.1 -25.9 29.38 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 126.053 1.741 . . . . 0.0 113.516 169.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -153.95 162.74 40.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.165 1.386 . . . . 0.0 112.146 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.54 52.5 2.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.752 1.221 . . . . 0.0 110.377 163.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -74.98 112.46 11.24 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.664 0.745 . . . . 0.0 111.302 -169.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.14 -41.26 1.07 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 127.273 2.368 . . . . 0.0 108.205 -153.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.2 p -91.16 161.29 15.14 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.182 1.793 . . . . 0.0 112.369 155.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -157.76 106.19 2.05 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.936 2.494 . . . . 0.0 112.636 169.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.58 -73.76 0.01 OUTLIER Glycine 0 N--CA 1.474 1.181 0 C-N-CA 128.503 2.954 . . . . 0.0 115.735 160.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.9 -24.9 66.15 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.715 1.606 . . . . 0.0 111.59 170.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.35 3.0 4.07 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 116.242 1.942 . . . . 0.0 116.242 -165.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -80.72 3.25 22.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.289 1.836 . . . . 0.0 114.06 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t -105.22 -15.15 15.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.332 1.053 . . . . 0.0 111.813 160.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -99.3 -34.22 10.41 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -168.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -18.39 65.26 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -168.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.74 16.16 71.89 Favored Glycine 0 CA--C 1.532 1.125 0 O-C-N 121.584 -0.697 . . . . 0.0 112.912 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.84 167.49 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.248 1.419 . . . . 0.0 112.204 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.69 173.62 11.92 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.14 1.776 . . . . 0.0 110.575 169.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 163.53 36.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.58 1.152 . . . . 0.0 113.157 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -149.73 118.23 6.51 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 127.147 2.179 . . . . 0.0 108.995 177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -74.85 147.41 41.12 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.615 0.766 . . . . 0.0 110.579 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -129.4 51.86 2.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 123.961 1.839 . . . . 0.0 111.215 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.3 p -79.51 47.97 0.87 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.765 2.026 . . . . 0.0 110.72 -177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.93 -1.22 2.22 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -174.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.6 mt -90.07 10.84 22.69 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.675 1.19 . . . . 0.0 113.043 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.67 -9.31 6.31 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.209 1.385 . . . . 0.0 113.967 -166.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.73 109.75 20.55 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 126.578 1.951 . . . . 0.0 108.129 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.62 126.44 12.1 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.374 2.049 . . . . 0.0 112.849 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -122.95 151.7 41.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.209 1.803 . . . . 0.0 109.183 174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 35.3 mtp -112.72 128.23 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.023 2.129 . . . . 0.0 105.77 164.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -124.9 144.94 50.07 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.804 -1.185 . . . . 0.0 111.943 172.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -145.48 138.71 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.31 1.053 . . . . 0.0 112.304 -156.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 103' ' ' LEU . 2.8 m -149.43 173.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 120.83 -1.169 . . . . 0.0 111.022 -166.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 34.6 t -94.14 150.32 20.43 Favored 'General case' 0 N--CA 1.404 -2.773 0 C-N-CA 127.398 2.279 . . . . 0.0 106.575 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -110.27 -18.09 13.36 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 127.762 2.425 . . . . 0.0 112.795 168.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -61.56 -44.94 96.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.569 1.148 . . . . 0.0 112.209 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -96.71 -29.57 13.72 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.411 2.284 . . . . 0.0 111.462 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 67.37 124.44 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.61 1.195 . . . . 0.0 111.041 -154.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 71.96 85.26 0.12 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.956 2.102 . . . . 0.0 114.515 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.308 2.7 t60 -74.85 -14.6 60.69 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 168.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.514 ' H ' HG12 ' A' ' 95' ' ' VAL . 0.5 OUTLIER 38.89 52.21 1.91 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.515 2.326 . . . . 0.0 113.591 -172.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.97 156.45 22.38 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 111.527 -2.579 . . . . 0.0 109.383 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.53 156.37 42.35 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.098 0.959 . . . . 0.0 109.373 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.2 t -139.82 126.13 22.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 123.799 0.84 . . . . 0.0 109.487 -174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -133.59 152.26 78.71 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.015 0.926 . . . . 0.0 111.496 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.46 140.38 15.12 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.77 2.313 . . . . 0.0 110.33 160.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.57 -5.61 59.26 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 157.12 -46.35 0.48 Allowed Glycine 0 CA--C 1.542 1.758 0 C-N-CA 126.891 2.186 . . . . 0.0 113.991 -162.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.93 179.04 6.88 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 CA-C-N 120.981 2.391 . . . . 0.0 113.768 -177.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.67 162.69 4.61 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.707 1.603 . . . . 0.0 111.819 170.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.25 -3.23 0.73 Allowed 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.168 3.245 . . . . 0.0 116.088 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 1.5 t -81.09 -21.54 39.88 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.982 1.713 . . . . 0.0 114.319 170.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.66 16.29 59.88 Favored Glycine 0 N--CA 1.471 1.032 0 C-N-CA 127.346 2.403 . . . . 0.0 115.443 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -70.9 159.52 34.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -167.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -118.75 129.27 55.16 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.473 1.909 . . . . 0.0 107.322 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -84.68 130.36 34.72 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.8 m -115.27 129.27 56.58 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.644 1.978 . . . . 0.0 108.784 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.8 tt -123.32 175.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 120.434 1.47 . . . . 0.0 110.054 175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.51 139.97 35.18 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.893 -1.129 . . . . 0.0 111.874 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.1 m -76.0 28.89 0.11 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -165.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -79.94 -30.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -167.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.83 41.56 0.77 Allowed 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 68.8 mt -132.06 153.64 50.22 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.056 -1.028 . . . . 0.0 112.947 -170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.58 153.72 35.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.316 1.846 . . . . 0.0 111.328 164.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -151.02 130.65 13.07 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.472 -0.767 . . . . 0.0 112.577 -174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -142.25 159.17 59.39 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 126.156 1.783 . . . . 0.0 111.702 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.46 164.63 33.53 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.613 2.209 . . . . 0.0 114.22 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.3 t -102.6 -66.79 0.91 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 128.257 2.623 . . . . 0.0 109.383 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.48 179.25 1.35 Allowed Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 129.492 3.117 . . . . 0.0 112.127 171.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -106.87 -178.96 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 124.383 3.389 . . . . 0.0 113.594 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 76.97 21.61 1.12 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.383 2.273 . . . . 0.0 116.323 169.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.19 -31.75 73.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.553 0.741 . . . . 0.0 111.813 167.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.54 179.47 0.07 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.547 2.339 . . . . 0.0 115.685 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.17 31.79 0.39 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -171.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.43 -53.78 42.92 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -149.88 158.0 43.73 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -170.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -68.1 160.38 29.05 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.312 1.445 . . . . 0.0 112.789 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -46.7 137.93 6.54 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.314 1.446 . . . . 0.0 112.653 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -83.1 172.88 12.23 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -59.5 134.12 56.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.18 0.592 . . . . 0.0 110.458 164.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 124.056 0.942 . . . . 0.0 112.474 -178.768 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.061 -0.019 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.65 26.14 0.33 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.977 1.311 . . . . 0.0 112.425 175.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -161.02 175.41 12.48 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.544 1.538 . . . . 0.0 111.367 -153.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.3 m95 -98.99 -34.02 10.59 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.194 0.997 . . . . 0.0 111.855 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -62.29 -51.21 68.59 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.003 0.921 . . . . 0.0 111.309 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -67.34 -25.13 65.84 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -78.08 -32.91 50.97 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.875 2.07 . . . . 0.0 112.983 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.273 3.6 pp -87.24 -24.04 24.52 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 174.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -120.57 60.91 8.33 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 119.596 1.089 . . . . 0.0 113.489 166.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.45 130.05 9.73 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.845 1.697 . . . . 0.0 113.411 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -78.51 -57.96 3.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.271 -1.786 . . . . 0.0 111.953 -153.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -64.41 -10.83 27.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.89 1.676 . . . . 0.0 114.129 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -99.27 -12.66 20.17 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.614 2.365 . . . . 0.0 115.352 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -110.44 -48.8 3.12 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.419 1.488 . . . . 0.0 113.233 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -63.12 -28.05 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 121.284 -0.885 . . . . 0.0 110.869 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -5.04 1.0 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 130.816 3.646 . . . . 0.0 114.716 170.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -71.74 -17.53 62.19 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 117.453 -1.26 . . . . 0.0 111.961 164.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.84 -7.85 0.1 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 171.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm 11.64 86.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 128.731 2.812 . . . . 0.0 114.885 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.83 42.02 0.72 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 128.11 2.767 . . . . 0.0 116.433 -169.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -80.38 105.84 11.94 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.299 1.44 . . . . 0.0 112.083 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -55.92 154.41 7.37 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.675 1.99 . . . . 0.0 113.173 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -132.42 155.79 80.85 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 127.197 2.199 . . . . 0.0 112.707 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -66.31 177.94 2.87 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.488 3.459 . . . . 0.0 112.956 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 64.81 -7.89 0.25 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.4 m -51.9 26.15 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.81 1 C-N-CA 132.211 4.204 . . . . 0.0 114.472 149.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.07 -28.97 19.68 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -166.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 74.5 mtp -75.83 -23.42 55.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.755 1.264 . . . . 0.0 114.279 171.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.32 -10.8 40.0 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 128.621 2.768 . . . . 0.0 112.05 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -98.41 66.09 1.7 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.268 1.827 . . . . 0.0 107.823 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -134.21 -151.95 0.46 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.628 1.571 . . . . 0.0 112.86 -152.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 34' ' ' GLU . 6.5 m-20 -67.7 76.34 0.19 Allowed 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.015 -1.053 . . . . 0.0 110.852 164.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -67.29 12.45 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 126.74 2.016 . . . . 0.0 115.323 176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 32' ' ' ASN . 2.6 tt0 46.51 -169.52 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 131.08 3.752 . . . . 0.0 115.176 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 m -142.44 157.69 44.49 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.118 1.367 . . . . 0.0 110.172 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.58 -141.8 8.23 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.469 1.509 . . . . 0.0 111.584 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.6 ptp -144.54 162.46 36.53 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.402 1.081 . . . . 0.0 112.198 173.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -109.88 134.18 52.35 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.02 2.128 . . . . 0.0 109.921 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -135.9 163.21 30.78 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 0.0 110.441 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.0 t -69.59 172.71 6.96 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 124.213 1.959 . . . . 0.0 114.802 -169.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.8 p -135.9 1.52 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 112.715 -2.038 . . . . 0.0 112.512 165.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.7 m -115.04 -26.89 7.54 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.177 1.391 . . . . 0.0 112.364 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.9 p -115.83 -98.11 0.45 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.608 1.963 . . . . 0.0 111.337 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.25 -50.18 0.07 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 p -95.62 160.01 31.31 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 116.563 2.061 . . . . 0.0 116.563 -150.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.35 132.83 40.24 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.841 2.361 . . . . 0.0 112.276 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -33.65 5.74 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.902 1.281 . . . . 0.0 111.66 -166.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.34 158.64 30.06 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.373 -0.83 . . . . 0.0 112.712 168.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 p -94.96 132.87 39.33 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 122.677 1.227 . . . . 0.0 110.953 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -4.83 24.12 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.11 0.964 . . . . 0.0 113.405 172.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.91 -29.36 64.24 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.578 1.951 . . . . 0.0 113.576 170.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.01 1.74 26.45 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.952 1.301 . . . . 0.0 113.621 172.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -69.89 121.43 17.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.315 1.846 . . . . 0.0 114.304 -167.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -83.74 79.5 9.44 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.9 t 68.96 135.12 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 128.708 2.803 . . . . 0.0 117.107 170.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.4 p -85.22 -6.66 59.26 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.7 -25.26 68.81 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 119.425 1.011 . . . . 0.0 114.541 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 m -109.89 -5.53 15.48 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.376 1.47 . . . . 0.0 111.14 166.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.07 -7.61 15.44 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 126.879 2.18 . . . . 0.0 114.672 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -90.22 133.97 32.31 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -138.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.9 103.75 1.23 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.766 2.311 . . . . 0.0 113.979 -168.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.7 p -158.55 142.29 15.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 127.798 2.439 . . . . 0.0 109.533 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -155.3 132.32 10.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.794 2.038 . . . . 0.0 107.733 -170.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 p -68.96 -24.32 64.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -139.82 142.55 36.64 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.479 0.657 . . . . 0.0 112.13 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.64 39.35 0.61 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.186 1.395 . . . . 0.0 111.555 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -78.18 119.37 21.47 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 120.421 -1.424 . . . . 0.0 110.742 -173.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.71 -34.09 0.17 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.215 1.388 . . . . 0.0 111.921 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.55 125.19 28.8 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.029 1.332 . . . . 0.0 109.766 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -135.77 119.03 16.65 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.266 1.426 . . . . 0.0 113.46 -162.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.34 -78.63 1.27 Allowed Glycine 0 N--CA 1.464 0.5 0 C-N-CA 124.722 1.154 . . . . 0.0 111.815 172.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -29.28 55.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.289 1.036 . . . . 0.0 113.311 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -105.64 -9.05 17.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.792 1.282 . . . . 0.0 113.526 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.51 4.55 38.71 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 127.098 2.159 . . . . 0.0 110.862 -171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.0 t -70.14 -32.43 70.42 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 165.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -129.98 -73.6 0.56 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.686 1.194 . . . . 0.0 113.303 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.2 p -167.04 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.019 1.728 . . . . 0.0 113.592 -165.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.2 -10.67 7.51 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.968 1.27 . . . . 0.0 113.784 -162.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.87 178.0 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.712 2.005 . . . . 0.0 111.874 -172.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.42 -177.59 4.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.186 2.194 . . . . 0.0 108.915 166.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -139.39 155.0 47.93 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.273 1.829 . . . . 0.0 110.742 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 118.57 10.88 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 126.85 2.06 . . . . 0.0 107.149 168.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.97 138.53 33.76 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.269 -0.895 . . . . 0.0 111.338 172.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -112.3 23.01 14.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.739 1.216 . . . . 0.0 112.294 -173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.2 t -71.1 38.65 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.81 2.444 . . . . 0.0 113.362 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.27 10.89 6.35 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.475 2.71 . . . . 0.0 112.387 -174.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -117.96 14.42 14.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.238 1.815 . . . . 0.0 112.462 172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.28 -12.22 7.55 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 126.019 1.771 . . . . 0.0 113.561 -171.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 48.9 t -102.22 107.05 51.56 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 108.616 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.19 126.96 12.22 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.554 1.503 . . . . 0.0 110.623 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.4 mmt-85 -147.89 156.03 42.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.478 2.711 . . . . 0.0 109.629 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.2 mtt -125.99 125.93 43.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.63 2.372 . . . . 0.0 106.994 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -116.39 154.46 30.23 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.522 1.129 . . . . 0.0 110.926 173.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.16 137.24 55.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 C-N-CA 125.408 1.483 . . . . 0.0 110.514 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.73 143.4 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.436 0.636 . . . . 0.0 111.516 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 39.7 t -70.05 108.02 3.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 160.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -63.72 -22.12 66.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.055 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -83.01 -39.5 21.2 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.412 1.485 . . . . 0.0 112.574 -167.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 18.3 p -115.36 6.04 14.76 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.963 1.705 . . . . 0.0 114.249 172.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.36 60.34 3.44 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.944 2.497 . . . . 0.0 114.616 174.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -150.01 148.77 29.45 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 172.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -69.6 136.35 51.14 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.871 0.868 . . . . 0.0 111.263 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.31 -20.99 1.39 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -172.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.0 151.56 23.77 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 127.078 2.275 . . . . 0.0 112.52 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.66 166.71 22.91 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 126.141 1.776 . . . . 0.0 111.557 172.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 55.9 t -143.54 136.17 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 126.396 1.879 . . . . 0.0 108.212 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -148.57 153.97 40.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.42 1.088 . . . . 0.0 113.069 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.91 135.43 7.63 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.996 2.464 . . . . 0.0 109.91 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.37 -1.5 45.72 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 173.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.22 -40.8 0.51 Allowed Glycine 0 CA--C 1.542 1.749 0 CA-C-O 117.376 -1.791 . . . . 0.0 116.559 -173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.68 -167.59 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.451 2.767 . . . . 0.0 113.446 -172.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -55.45 160.71 3.48 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.752 1.621 . . . . 0.0 112.345 171.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -59.93 -9.43 9.83 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.659 2.906 . . . . 0.0 114.136 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -22.64 62.03 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.507 1.523 . . . . 0.0 113.087 170.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.65 19.05 54.06 Favored Glycine 0 N--CA 1.469 0.894 0 C-N-CA 126.405 1.955 . . . . 0.0 115.893 -174.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -73.34 146.72 45.02 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -171.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -110.13 144.53 38.62 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.197 1.399 . . . . 0.0 109.308 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -91.39 137.66 32.19 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.009 1.724 . . . . 0.0 110.068 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 4.7 p -132.01 132.28 43.29 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.04 1.736 . . . . 0.0 112.769 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 122' ' ' SER . 10.2 mm -80.92 154.99 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.115 1.366 . . . . 0.0 110.611 174.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -91.22 -13.12 33.39 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 120' ' ' ILE . 68.7 m 57.14 82.68 0.11 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.067 2.147 . . . . 0.0 114.417 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 124' ' ' ALA 0.299 3.4 p -93.57 -96.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.619 1.168 . . . . 0.0 111.529 167.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.43 ' H ' HG13 ' A' ' 123' ' ' VAL . . . -157.07 20.92 0.31 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 -166.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.99 173.98 6.79 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.687 1.585 . . . . 0.0 113.166 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.26 163.17 12.83 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.202 1.801 . . . . 0.0 112.735 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -150.79 148.16 28.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.169 1.387 . . . . 0.0 111.861 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -140.4 149.87 59.04 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.069 1.348 . . . . 0.0 111.525 170.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.83 171.32 10.73 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.081 2.521 . . . . 0.0 114.533 -165.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.02 -40.5 11.62 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.065 1.346 . . . . 0.0 113.903 -173.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -95.64 157.41 36.12 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 127.598 2.359 . . . . 0.0 113.76 -169.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.05 173.92 3.56 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.007 2.472 . . . . 0.0 113.669 164.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 64.78 0.66 1.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.52 2.728 . . . . 0.0 114.558 -170.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -115.38 7.14 15.0 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.749 2.02 . . . . 0.0 113.702 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -140.99 163.32 33.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.249 1.819 . . . . 0.0 110.917 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -148.79 30.53 0.81 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -170.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -55.72 -27.95 53.17 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.931 1.692 . . . . 0.0 114.525 -173.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -65.73 -20.74 66.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.193 1.797 . . . . 0.0 115.239 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 12.3 m170 57.24 170.38 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.611 2.364 . . . . 0.0 114.932 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -56.56 117.15 3.59 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.688 1.595 . . . . 0.0 111.903 -175.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -125.17 174.24 8.21 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.336 1.454 . . . . 0.0 113.02 -173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -61.44 153.89 25.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.992 0.901 . . . . 0.0 112.414 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.376 1.87 . . . . 0.0 108.259 171.745 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 119.304 -0.379 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.05 8.49 1.48 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.163 1.785 . . . . 0.0 115.589 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -94.14 167.0 11.85 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.618 1.967 . . . . 0.0 112.77 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -91.15 -26.49 19.06 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.537 1.135 . . . . 0.0 111.452 178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -58.4 -46.65 86.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 124.674 1.19 . . . . 0.0 110.336 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.63 -36.18 82.96 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -67.42 -36.54 81.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.879 0.872 . . . . 0.0 113.118 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -83.36 -11.41 57.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.717 2.407 . . . . 0.0 114.49 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.4 p -115.58 57.04 1.2 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.193 1.397 . . . . 0.0 114.36 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.0 -177.85 3.18 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.596 2.197 . . . . 0.0 113.434 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -49.24 -49.07 44.91 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 120.321 -1.487 . . . . 0.0 113.596 -173.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.07 -34.1 67.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.595 1.158 . . . . 0.0 112.923 176.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -84.47 -35.24 23.11 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.46 1.504 . . . . 0.0 111.11 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -41.37 85.67 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.798 -1.189 . . . . 0.0 110.986 173.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.97 -35.13 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.157 1.383 . . . . 0.0 112.513 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 p -89.41 -22.86 22.34 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.851 1.26 . . . . 0.0 113.303 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -63.22 -44.06 96.37 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.838 1.655 . . . . 0.0 110.944 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -111.26 -21.89 11.65 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 tptm 15.21 72.49 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.016 2.527 . . . . 0.0 116.475 165.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.33 47.76 0.63 Allowed Glycine 0 N--CA 1.47 0.942 0 CA-C-N 113.352 -1.749 . . . . 0.0 113.291 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 t -117.98 174.31 6.27 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.78 1.632 . . . . 0.0 112.259 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -121.63 149.52 43.07 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 128.298 2.639 . . . . 0.0 111.963 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.73 144.67 12.33 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.756 0.822 . . . . 0.0 112.241 173.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.75 129.84 7.38 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.241 2.627 . . . . 0.0 111.573 175.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -136.6 -22.69 1.26 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 117.535 2.42 . . . . 0.0 117.535 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.21 -17.43 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 119.984 1.266 . . . . 0.0 114.404 -167.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.42 -108.69 2.52 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 119.896 1.226 . . . . 0.0 112.946 172.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.0 mtp -57.58 -31.1 65.83 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 167.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -3.61 49.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.38 -0.825 . . . . 0.0 112.607 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.2 mt -89.36 -24.5 21.95 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.415 1.086 . . . . 0.0 112.468 170.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.24 -30.39 19.72 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.724 1.147 . . . . 0.0 112.47 166.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 57.53 -68.11 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.094 2.958 . . . . 0.0 118.545 164.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -160.44 117.91 2.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.255 2.622 . . . . 0.0 108.766 -170.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.38 1.1 mp0 51.13 -147.46 0.41 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 149.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.401 HG23 ' HB2' ' A' ' 130' ' ' SER . 1.2 t -100.15 178.41 4.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.455 1.102 . . . . 0.0 111.545 170.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.71 -153.12 14.22 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.124 0.868 . . . . 0.0 114.47 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.7 ptp -154.12 161.05 42.15 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.329 1.061 . . . . 0.0 112.895 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -120.0 148.37 43.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.787 2.435 . . . . 0.0 110.553 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.35 159.87 42.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.812 2.045 . . . . 0.0 109.503 -167.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.7 m -74.11 165.7 24.7 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.158 1.456 . . . . 0.0 111.802 158.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.62 -9.98 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 113.853 -1.522 . . . . 0.0 113.948 154.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 t -83.24 -46.34 12.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 112.441 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 p -85.15 -87.93 0.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.895 1.278 . . . . 0.0 111.337 170.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -148.9 -57.02 0.21 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.0 p -130.14 156.0 79.93 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 117.172 2.286 . . . . 0.0 117.172 -135.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.69 139.45 40.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.502 2.801 . . . . 0.0 112.732 164.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 mt -143.94 -18.78 0.58 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -135.2 134.71 40.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.317 1.417 . . . . 0.0 111.313 -167.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -101.51 122.06 43.11 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.959 1.303 . . . . 0.0 111.007 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -60.15 -15.45 24.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.475 1.51 . . . . 0.0 113.578 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.415 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.51 -31.27 67.73 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 130.252 3.421 . . . . 0.0 113.269 178.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -74.25 4.09 6.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.828 1.251 . . . . 0.0 111.793 177.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -62.61 134.72 56.75 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 120.661 -1.275 . . . . 0.0 114.018 177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -129.88 132.12 46.31 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.179 2.192 . . . . 0.0 111.519 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.8 t 37.68 37.82 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 129.45 3.1 . . . . 0.0 117.489 170.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.2 p -121.48 -67.0 1.0 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.672 1.189 . . . . 0.0 113.102 -166.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.07 -74.94 0.08 OUTLIER Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.044 1.307 . . . . 0.0 112.674 -174.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.7 m -139.17 -36.06 0.54 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.332 2.253 . . . . 0.0 111.656 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.93 -31.61 61.47 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.039 0.828 . . . . 0.0 114.752 -167.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.29 134.21 5.61 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.655 0.782 . . . . 0.0 111.315 164.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.61 121.17 4.58 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.606 2.204 . . . . 0.0 115.206 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.3 p -129.91 178.51 6.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -156.78 142.35 17.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 130.821 3.649 . . . . 0.0 106.801 159.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 p -73.75 -35.1 64.98 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 111.402 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -146.33 157.32 43.78 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 122.718 1.247 . . . . 0.0 114.195 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.15 69.4 10.11 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.939 1.696 . . . . 0.0 110.113 166.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' HB3' ' HE3' ' A' ' 52' ' ' LYS . 23.1 t80 -79.47 130.27 35.25 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.343 -0.848 . . . . 0.0 112.094 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.71 -37.04 0.07 OUTLIER Glycine 0 CA--C 1.536 1.388 0 C-N-CA 127.27 2.367 . . . . 0.0 111.292 167.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.2 p -125.05 140.85 52.54 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.19 1.396 . . . . 0.0 114.608 -173.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -137.51 135.94 37.22 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.914 2.486 . . . . 0.0 111.007 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.44 -80.69 0.11 Allowed Glycine 0 N--CA 1.468 0.822 0 C-N-CA 127.103 2.287 . . . . 0.0 113.249 157.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.2 m -45.69 -38.49 6.89 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 127.094 2.158 . . . . 0.0 112.774 167.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -119.04 19.08 13.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -164.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -65.74 -34.68 78.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.789 0.836 . . . . 0.0 112.794 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.1 t -92.51 -23.08 19.22 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.426 1.091 . . . . 0.0 111.803 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -71.45 -13.13 61.73 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.162 1.385 . . . . 0.0 113.682 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.7 p -48.63 -39.54 24.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.853 1.661 . . . . 0.0 112.605 171.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.24 17.69 76.11 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 117.69 -1.617 . . . . 0.0 113.011 -167.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 pt -117.54 155.98 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.868 1.834 . . . . 0.0 114.564 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -136.08 176.62 8.52 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.595 2.758 . . . . 0.0 110.733 177.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.629 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -138.43 141.91 39.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.036 1.334 . . . . 0.0 113.375 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.42 112.7 10.53 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.882 1.673 . . . . 0.0 108.314 173.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.6 mp -80.6 157.28 26.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 125.886 1.674 . . . . 0.0 111.076 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -131.18 108.89 10.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 t -118.44 24.5 10.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 123.032 1.396 . . . . 0.0 109.836 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.62 -6.71 9.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 126.393 1.877 . . . . 0.0 113.682 -154.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.5 mt -105.26 18.66 21.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.071 2.148 . . . . 0.0 112.689 170.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.01 -7.01 64.45 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.061 1.315 . . . . 0.0 115.392 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 52.4 t -127.79 112.99 20.59 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.892 1.677 . . . . 0.0 109.648 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.68 125.88 7.05 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.778 2.319 . . . . 0.0 114.039 -170.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -129.42 154.2 47.18 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.129 2.572 . . . . 0.0 110.222 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 9.0 mtm -127.49 127.13 43.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.364 1.866 . . . . 0.0 108.224 167.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -123.25 144.59 49.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.813 0.816 . . . . 0.0 109.776 167.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.55 144.5 21.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 124.471 1.108 . . . . 0.0 109.608 -176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.4 m -128.28 151.82 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 0.0 111.301 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 43.2 t -93.02 119.04 31.86 Favored 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 126.71 2.004 . . . . 0.0 105.886 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -69.5 -16.77 63.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.606 1.962 . . . . 0.0 111.974 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -83.95 -45.84 12.72 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 2.2 p -106.78 -7.59 17.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.601 1.961 . . . . 0.0 113.835 179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 63.15 40.76 8.64 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.24 1.816 . . . . 0.0 113.066 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.92 154.46 51.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.451 1.5 . . . . 0.0 111.907 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -80.98 90.06 5.94 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.145 0.978 . . . . 0.0 113.149 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -74.3 8.59 2.1 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -175.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.68 179.63 30.06 Favored Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.002 -1.061 . . . . 0.0 114.065 165.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 156.49 44.88 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 111.684 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.03 137.47 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.316 1.055 . . . . 0.0 111.751 -173.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.83 151.2 45.21 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 113.063 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.53 133.44 10.55 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.043 2.495 . . . . 0.0 109.305 162.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -93.87 1.57 56.35 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.43 -62.19 0.28 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.387 -1.229 . . . . 0.0 114.396 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.37 -177.12 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.549 2.832 . . . . 0.0 112.967 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.77 149.83 4.23 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.254 1.022 . . . . 0.0 111.506 170.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.51 -3.77 9.64 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.975 2.45 . . . . 0.0 114.149 -171.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.9 p -54.92 -30.94 59.62 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.639 -0.663 . . . . 0.0 111.943 162.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.9 10.13 74.91 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.882 2.182 . . . . 0.0 117.091 173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -50.96 148.81 3.93 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.209 1.504 . . . . 0.0 113.957 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.7 132.02 43.57 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.695 1.198 . . . . 0.0 110.828 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.7 125.35 45.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.105 1.362 . . . . 0.0 110.275 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.5 p -108.13 126.06 52.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.897 2.079 . . . . 0.0 109.618 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.1 tp -92.41 156.8 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.844 0.831 . . . . 0.0 109.845 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -126.92 163.0 24.62 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.461 1.905 . . . . 0.0 109.957 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 m -96.42 18.43 13.97 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 p -47.39 -48.93 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -159.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.61 24.07 0.34 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 25.2 mt -125.07 154.92 40.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.426 1.09 . . . . 0.0 112.16 -161.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -128.01 157.14 41.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.779 2.032 . . . . 0.0 113.917 -171.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.4 143.16 33.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -167.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -137.94 152.98 73.23 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 125.597 1.559 . . . . 0.0 110.875 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.02 179.59 5.59 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.538 2.159 . . . . 0.0 112.022 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.497 ' HB3' ' HE3' ' A' ' 131' ' ' LYS . 5.8 t -102.59 -57.7 2.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.967 1.707 . . . . 0.0 111.469 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.497 ' HE3' ' HB3' ' A' ' 130' ' ' SER . 9.3 mmpt? -70.0 157.77 88.96 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 126.419 1.888 . . . . 0.0 112.976 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.4 -173.23 0.42 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.97 3.114 . . . . 0.0 113.639 167.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 59.74 29.48 19.04 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.988 1.715 . . . . 0.0 113.903 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -155.29 44.35 0.47 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.493 2.317 . . . . 0.0 110.906 -171.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.12 36.4 25.88 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.724 2.01 . . . . 0.0 114.174 -174.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.7 tp -148.15 37.74 0.87 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.269 1.828 . . . . 0.0 111.552 -171.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -73.11 0.34 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.743 1.217 . . . . 0.0 111.832 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -169.98 -172.11 1.29 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.737 2.015 . . . . 0.0 110.813 172.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 59.05 86.3 0.09 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.185 1.794 . . . . 0.0 114.685 163.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -122.84 25.61 8.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.811 1.244 . . . . 0.0 112.742 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -155.78 126.71 6.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.314 1.046 . . . . 0.0 111.384 -165.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.402 ' CG ' ' H ' ' A' ' 143' ' ' HIS . 2.5 t-80 53.52 -162.05 0.11 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.881 1.672 . . . . 0.0 113.994 177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.402 ' H ' ' CG ' ' A' ' 142' ' ' HIS . 11.9 t-160 . . . . . 0 C--O 1.251 1.145 0 C-N-CA 126.62 1.968 . . . . 0.0 113.178 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.08 19.87 7.76 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -171.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -139.0 176.33 8.78 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.07 1.748 . . . . 0.0 112.673 -168.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -115.82 -32.35 5.49 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 164.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -63.51 -59.99 3.93 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -173.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -63.34 -29.17 70.53 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.659 1.584 . . . . 0.0 112.244 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -71.76 -42.6 66.99 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.754 2.022 . . . . 0.0 112.058 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.1 mt -77.97 -33.42 51.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.841 1.256 . . . . 0.0 112.796 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.275 12.2 t -128.73 76.77 78.48 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.33 160.58 46.64 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.023 3.149 . . . . 0.0 113.299 170.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.48 -66.47 1.04 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.569 1.148 . . . . 0.0 110.706 174.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -53.2 -26.06 16.09 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.164 1.785 . . . . 0.0 113.722 175.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.58 -16.98 21.75 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.229 1.412 . . . . 0.0 113.829 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.48 -54.47 3.78 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 111.506 175.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.49 -23.29 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 O-C-N 120.314 -1.491 . . . . 0.0 111.964 -172.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -68.25 -23.73 64.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.087 2.155 . . . . 0.0 112.649 172.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -67.4 -48.31 67.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.145 1.378 . . . . 0.0 110.369 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -73.13 -25.9 61.02 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.837 0.855 . . . . 0.0 111.095 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -71.56 61.28 0.35 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.388 1.875 . . . . 0.0 112.935 172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.06 -6.98 0.12 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.509 1.528 . . . . 0.0 116.637 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.3 t -139.89 178.82 6.98 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.421 1.488 . . . . 0.0 110.987 -174.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -105.21 149.95 25.51 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.98 1.712 . . . . 0.0 111.811 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.61 154.32 44.1 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.792 1.237 . . . . 0.0 112.379 -173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.48 142.35 48.91 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.331 2.687 . . . . 0.0 111.527 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -80.75 45.14 0.78 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 -163.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.1 m -67.69 24.96 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 128.712 2.805 . . . . 0.0 114.559 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.23 -56.17 5.49 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 126.599 2.047 . . . . 0.0 117.254 -165.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.2 ttm -64.2 -16.06 61.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.486 1.143 . . . . 0.0 114.077 175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.9 -2.66 34.2 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 128.601 2.76 . . . . 0.0 112.159 176.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.7 mt -103.7 -9.46 19.11 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.18 1.792 . . . . 0.0 112.801 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -154.43 -32.89 0.1 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.742 1.617 . . . . 0.0 113.694 164.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.3 t30 55.04 -81.6 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.16 1.784 . . . . 0.0 112.718 -166.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -151.01 4.35 0.47 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -69.31 175.22 4.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 123.439 1.59 . . . . 0.0 113.104 173.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 m -146.63 154.46 41.5 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.496 1.518 . . . . 0.0 109.788 -166.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.62 -158.52 20.82 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 172.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ptp -155.2 167.55 29.99 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.436 1.494 . . . . 0.0 112.647 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.98 151.17 40.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 112.253 157.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -138.16 164.59 28.79 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.039 2.136 . . . . 0.0 109.834 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.445 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 59.4 m -62.16 169.72 2.61 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 124.085 1.898 . . . . 0.0 114.712 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.2 p -115.6 -2.37 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.952 -2.385 . . . . 0.0 112.301 169.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.2 m -124.57 -18.35 5.71 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -169.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.445 ' SG ' ' CB ' ' A' ' 40' ' ' CYS . 12.7 p -125.9 -101.29 0.37 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.137 1.375 . . . . 0.0 112.008 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -159.71 -35.77 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.404 2.282 . . . . 0.0 113.538 -170.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.44 124.32 87.96 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -157.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.43 127.02 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.066 1.844 . . . . 0.0 110.363 156.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.72 -45.07 1.63 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.931 -158.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -126.31 121.12 31.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.825 -171.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 p -82.28 131.13 35.23 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.185 0.993 . . . . 0.0 108.903 166.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -58.45 -13.95 6.66 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.236 1.815 . . . . 0.0 112.321 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 1.6 tt0 -58.11 -43.6 87.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 127.098 2.159 . . . . 0.0 114.548 168.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 51' ' ' GLU . 9.8 mmpt? -72.83 -2.09 19.27 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.215 1.406 . . . . 0.0 113.222 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -78.36 137.5 38.06 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.628 1.971 . . . . 0.0 110.522 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -84.29 61.85 6.81 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 123.0 1.381 . . . . 0.0 111.571 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.8 t -101.35 109.5 21.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.181 0.992 . . . . 0.0 110.471 174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.7 p -157.78 -40.47 0.07 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.557 1.143 . . . . 0.0 112.416 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.39 -49.67 0.39 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.305 1.431 . . . . 0.0 113.503 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.7 m -112.06 -20.56 11.91 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.302 1.041 . . . . 0.0 111.078 -169.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.15 6.15 6.92 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.543 1.068 . . . . 0.0 114.483 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -65.58 142.61 98.35 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.663 1.185 . . . . 0.0 111.043 -170.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.04 96.84 0.63 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 CA-C-O 124.618 1.841 . . . . 0.0 113.887 -164.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.1 p -152.0 161.82 42.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 128.599 2.76 . . . . 0.0 110.427 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -157.15 168.29 27.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.365 2.266 . . . . 0.0 106.559 -169.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 82.8 p -127.55 -7.07 5.73 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 164.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -135.12 147.9 49.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 122.139 0.971 . . . . 0.0 111.858 160.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.57 108.97 4.65 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.689 1.995 . . . . 0.0 105.811 165.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -30.08 95.92 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 129.803 3.241 . . . . 0.0 112.408 172.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.1 19.06 35.58 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.181 1.372 . . . . 0.0 114.109 -162.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -55.95 143.69 31.13 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.071 2.548 . . . . 0.0 115.125 -171.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.4 mmpt? -139.23 142.43 37.84 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 128.456 2.702 . . . . 0.0 111.342 172.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.88 -57.37 3.09 Favored Glycine 0 N--CA 1.478 1.476 0 C-N-CA 126.516 2.008 . . . . 0.0 114.82 163.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -25.92 64.91 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.0 1.32 . . . . 0.0 112.72 160.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -146.17 136.29 23.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.342 2.257 . . . . 0.0 109.811 167.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -139.74 7.02 2.28 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.497 1.519 . . . . 0.0 114.702 152.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.6 t -96.32 -41.32 8.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.719 1.208 . . . . 0.0 113.148 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -77.38 -32.98 55.27 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.906 1.682 . . . . 0.0 113.442 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.7 p -116.16 -54.57 2.47 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.037 1.735 . . . . 0.0 108.823 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.96 18.17 32.29 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.198 1.38 . . . . 0.0 113.914 -173.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -74.12 178.25 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 122.766 1.27 . . . . 0.0 113.091 -171.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.629 HD23 ' H ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -144.55 171.87 13.76 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.707 1.603 . . . . 0.0 110.152 174.136 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.629 ' H ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -160.79 157.78 27.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.766 1.627 . . . . 0.0 111.512 177.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -149.94 123.7 9.24 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 127.005 2.122 . . . . 0.0 107.916 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.03 147.35 42.97 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.745 161.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.04 23.27 11.47 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.201 1.001 . . . . 0.0 113.311 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.4 m -71.25 41.77 0.07 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 129.281 3.032 . . . . 0.0 112.876 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.88 -1.25 2.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 127.091 2.156 . . . . 0.0 113.438 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.9 mt -102.46 20.29 17.3 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.713 2.005 . . . . 0.0 112.224 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.73 -9.11 60.34 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.049 1.309 . . . . 0.0 114.75 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.2 t -136.37 134.41 19.88 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 110.608 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 140.89 37.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.149 2.566 . . . . 0.0 113.366 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 81.2 mmt-85 -146.34 156.04 43.06 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.631 1.972 . . . . 0.0 111.308 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -133.25 119.81 20.3 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.608 1.563 . . . . 0.0 108.928 171.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -137.71 148.34 45.58 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.631 -0.668 . . . . 0.0 112.207 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.18 142.8 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.316 1.446 . . . . 0.0 112.296 -167.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.91 157.43 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.807 1.243 . . . . 0.0 110.353 -172.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 49.1 t -92.98 128.43 38.85 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 123.008 1.385 . . . . 0.0 107.517 163.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -20.09 21.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.575 1.95 . . . . 0.0 112.166 170.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.82 -39.31 93.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.152 0.887 . . . . 0.0 112.616 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.05 -2.59 10.75 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.702 2.001 . . . . 0.0 114.856 -175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 52.43 63.67 2.15 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.461 1.505 . . . . 0.0 112.141 -175.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -129.91 131.49 46.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.337 1.055 . . . . 0.0 112.04 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -90.87 103.29 16.02 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.194 -0.941 . . . . 0.0 109.578 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.0 mt -103.36 -40.49 6.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -160.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.51 148.63 20.02 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.873 1.702 . . . . 0.0 113.763 -161.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.94 159.35 42.95 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.468 1.107 . . . . 0.0 111.831 -175.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.04 139.82 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 122.634 1.207 . . . . 0.0 111.37 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -147.95 154.98 44.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.572 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.39 135.79 13.61 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.681 2.921 . . . . 0.0 111.361 171.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -74.7 -4.61 38.44 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.95 -62.65 0.24 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.985 1.755 . . . . 0.0 114.213 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.12 -156.27 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.007 3.138 . . . . 0.0 112.707 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.96 160.51 0.81 Allowed Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 125.085 1.354 . . . . 0.0 112.217 170.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -58.34 -6.08 2.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.651 2.901 . . . . 0.0 114.949 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.92 -30.17 67.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.011 0.924 . . . . 0.0 112.446 164.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.3 30.85 6.42 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 126.664 2.078 . . . . 0.0 114.995 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -72.37 143.23 48.66 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.313 1.045 . . . . 0.0 112.923 174.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -131.06 127.0 37.31 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.366 1.066 . . . . 0.0 109.629 169.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.25 127.77 38.97 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.035 0.534 . . . . 0.0 109.978 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 m -126.06 134.22 51.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.953 1.701 . . . . 0.0 110.081 -171.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.9 tt -131.61 164.2 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.556 1.142 . . . . 0.0 110.624 -171.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.02 -55.41 1.28 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 m 45.85 34.66 1.97 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 -176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.77 -24.67 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -157.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -139.63 17.17 2.53 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.773 1.629 . . . . 0.0 114.415 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.7 mt -79.93 179.55 7.52 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.918 -1.114 . . . . 0.0 111.192 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -101.67 134.39 44.88 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.244 -0.91 . . . . 0.0 111.405 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -139.27 137.72 36.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.703 0.801 . . . . 0.0 111.454 -171.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -144.26 143.49 22.43 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.718 1.207 . . . . 0.0 110.831 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.12 168.53 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.472 1.448 . . . . 0.0 110.955 164.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.28 -44.68 5.34 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.666 1.186 . . . . 0.0 112.705 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.43 148.06 1.78 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.524 1.13 . . . . 0.0 112.488 167.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.38 -175.41 1.3 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.011 2.474 . . . . 0.0 113.243 173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . 0.258 . . 69.2 32.2 3.72 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.987 2.115 . . . . 0.0 114.532 -166.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.65 -20.24 29.74 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.032 1.333 . . . . 0.0 114.067 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 52.99 44.04 30.96 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.836 1.654 . . . . 0.0 114.916 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.4 tp -139.95 40.08 1.97 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.885 1.326 . . . . 0.0 111.716 -164.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.39 -42.83 70.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.285 1.434 . . . . 0.0 114.099 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -139.06 170.61 15.66 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.061 1.345 . . . . 0.0 111.86 -176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -132.28 -153.19 0.54 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.926 1.29 . . . . 0.0 110.298 -170.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -110.78 -41.73 4.2 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.184 -0.947 . . . . 0.0 113.225 166.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 55.73 174.25 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.447 1.099 . . . . 0.0 113.021 -164.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -127.92 158.08 38.8 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.414 1.486 . . . . 0.0 109.174 167.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 . . . . . 0 C--O 1.25 1.128 0 C-N-CA 124.801 1.24 . . . . 0.0 112.005 172.613 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_